Citrus Sinensis ID: 008052
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 579 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C821 | 509 | Proline-rich receptor-lik | yes | no | 0.649 | 0.738 | 0.730 | 1e-164 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.659 | 0.585 | 0.717 | 1e-162 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.816 | 0.659 | 0.591 | 1e-152 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.910 | 0.786 | 0.544 | 1e-148 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.782 | 0.715 | 0.573 | 1e-148 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.575 | 0.649 | 0.669 | 1e-137 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.618 | 0.511 | 0.680 | 1e-132 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.706 | 0.585 | 0.626 | 1e-132 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.858 | 0.7 | 0.481 | 1e-127 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.765 | 0.615 | 0.491 | 1e-123 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 580 bits (1495), Expect = e-164, Method: Compositional matrix adjust.
Identities = 279/382 (73%), Positives = 320/382 (83%), Gaps = 6/382 (1%)
Query: 189 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAE 248
++ FTYE+L AT NFS NLLGQGGFGYVH+GVL +G +VAIKQLK+GSGQGEREFQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
I+ IS+VHHRHLVSL+GYC G+QRLLVYEFVPNKTLEFHLH K+RPVM W RMKIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+A+GLAYLHEDC PK IHRD+K+ANIL+DDS+EAK+ADFGLA+ SLDTDTHVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA-DDSMVDWAKPFLAQGL 427
GYLAPEYASSGKLTEKSDVFS GV+LLELITG RP DK+ FA DDS+VDWAKP + Q L
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 428 ADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLN 486
DGNFD LVD +LE ++D EMTRM ACAAA +RHSA+RRP+MSQIVRA EGN+ +DDL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 487 EGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSS 546
EG PG STIY G SDY+S QY+ED+KKF+K+A ES GSS+ SGLTSD GQNP S
Sbjct: 428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESKTFGSSECSGLTSDNGQNPSGS 487
Query: 547 S--TEDRQATQETEP--NEKDT 564
S TE ++ TQE EP N KDT
Sbjct: 488 SSITEGQRTTQEIEPEKNTKDT 509
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 572 bits (1473), Expect = e-162, Method: Compositional matrix adjust.
Identities = 277/386 (71%), Positives = 319/386 (82%), Gaps = 4/386 (1%)
Query: 176 FPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLK 235
P SPG+ +G KSTFTYEEL AT+ FSEANLLGQGGFGYVHKG+L +GK VA+KQLK
Sbjct: 252 LPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK 311
Query: 236 AGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP 295
AGSGQGEREFQAE+EIIS+VHHRHLVSL+GYC G QRLLVYEFVPN LEFHLHGK RP
Sbjct: 312 AGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRP 371
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
M W TR+KIALGSA+GL+YLHEDC PKIIHRDIK++NIL+D FEAKVADFGLAK + D
Sbjct: 372 TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASD 431
Query: 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 415
T+THVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITG RP D + + DDS+
Sbjct: 432 TNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSL 491
Query: 416 VDWAKPFLAQGLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
VDWA+P L + +G+F+ L D K+ EYD EM RM ACAAAC+RHSARRRPRMSQIVR
Sbjct: 492 VDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVR 551
Query: 475 ALEGNMPLDDLNEGITPGHSTIYGSYGGS-DYNSMQYREDMKKFRKIALESVELGSS-DY 532
ALEGN+ L DLNEG+ PGHS +Y SYGGS DY++ QY +DM KFRK+AL + E G++ +Y
Sbjct: 552 ALEGNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEY 611
Query: 533 SGLTSDYGQNPPSSSTEDRQATQETE 558
S TSDYG P SS+E QAT+E E
Sbjct: 612 SNPTSDYGLYPSGSSSEG-QATREME 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 539 bits (1388), Expect = e-152, Method: Compositional matrix adjust.
Identities = 287/485 (59%), Positives = 342/485 (70%), Gaps = 12/485 (2%)
Query: 75 GMVVGVVIGAGIVL--AAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHHWQQNVSAPS 132
G +VG+ IG G VL A IF + K+R+R A P+ P+ G+ QQN S S
Sbjct: 226 GAMVGIAIGGGFVLLVALALIFFLCKKKRRRDNEAPPAPIDGVPYGGQQ---QQNASRRS 282
Query: 133 DYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTF 192
D+ + P + P S + ++ S S P P + +G ++ TF
Sbjct: 283 DHVVMSVPPPKSPSSAPPRPPHFMSSGSSGDYDSNYSDQSVLPPPSPGLALGLGIYQGTF 342
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEII 252
YEEL AT+ FSEANLLGQGGFGYV KG+L NGK VA+KQLK GS QGEREFQAE+ II
Sbjct: 343 NYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGII 402
Query: 253 SQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 312
S+VHHRHLV+LVGYC +QRLLVYEFVPN TLEFHLHGK RP M W +R+KIA+GSA+G
Sbjct: 403 SRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAKG 462
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
L+YLHE+C PKIIHRDIK++NIL+D FEAKVADFGLAK + DT+THVSTRVMGTFGYLA
Sbjct: 463 LSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLA 522
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432
PEYASSGKLTEKSDVFSFGV+LLELITG RP D + AD+S+VDWA+P L Q GNF
Sbjct: 523 PEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSELGNF 582
Query: 433 DALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITP 491
+ +VD+KL EYD EM RM ACAAAC+R +A RRPRM Q+ R LEGN+ DLN+GITP
Sbjct: 583 EVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSDLNQGITP 642
Query: 492 GHSTIYGSYGGS-DYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTED 550
GHS +YGS GGS DY+S Q E M KFRK+ LE+ +L YS S+Y P SST D
Sbjct: 643 GHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGLETQDL----YSNPISEYDLYPSWSST-D 697
Query: 551 RQATQ 555
Q TQ
Sbjct: 698 GQTTQ 702
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1355), Expect = e-148, Method: Compositional matrix adjust.
Identities = 309/568 (54%), Positives = 379/568 (66%), Gaps = 41/568 (7%)
Query: 11 PAPPETNSTFSPPAP-PPSVSA---------VSAPAPGNLTSPPSSGTPTSG-------- 52
PAPP+T S SP P PPS A + G+ SPPSSG TSG
Sbjct: 104 PAPPQTPSNQSPERPTPPSPGANDDRNRTNGGNNNRDGSTPSPPSSGNRTSGDGGSPSPP 163
Query: 53 --STVGTRRPSPTRNGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNL 110
+ + P A G+++GV++GAG++L I R+K+K + Q
Sbjct: 164 RSISPPQNSGDSDSSSGNHPQANIGLIIGVLVGAGLLLLLAVCICICCNRKKKKKSPQVN 223
Query: 111 PL---KNDPFAGKPHHWQQNVSAPSDYQELPKPSLP--PSNGPTAPLPTVPVSAFNEPLS 165
+ N+P+ G P Y+ P+ + G P PVS P S
Sbjct: 224 HMHYYNNNPYGGAPS------GNGGYYKGTPQDHVVNMAGQGGGNWGPQQPVSG---PHS 274
Query: 166 TSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN 225
+ +L P +G+ +STFTY+EL IAT+ F+++NLLGQGGFGYVHKGVL +
Sbjct: 275 DASNLTGRTAIPSPQAAT-LGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPS 333
Query: 226 GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285
GK VA+K LK GSGQGEREFQAE++IIS+VHHRHLVSLVGYC G QRLLVYEF+PN TL
Sbjct: 334 GKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTL 393
Query: 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345
EFHLHGK RPV++WPTR+KIALGSARGLAYLHEDC P+IIHRDIK+ANILLD SFE KVA
Sbjct: 394 EFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVA 453
Query: 346 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
DFGLAK S D THVSTRVMGTFGYLAPEYASSGKL++KSDVFSFGV+LLELITG P D
Sbjct: 454 DFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLD 513
Query: 406 KADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSAR 464
+DS+VDWA+P + DG+++ L D +LE Y EM +MA+CAAA IRHSAR
Sbjct: 514 LTGEM-EDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSAR 572
Query: 465 RRPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYG--GSDYNSMQYREDMKKFRKIAL 522
RRP+MSQIVRALEG+M +DDL+EG PG ST Y S G S+Y++ Y DMKKF+K+AL
Sbjct: 573 RRPKMSQIVRALEGDMSMDDLSEGTRPGQST-YLSPGSVSSEYDASSYTADMKKFKKLAL 631
Query: 523 ESVELGSSDYSGLTSDYGQNPPSSSTED 550
E+ E SS+Y G TS+YG NP +SS+E+
Sbjct: 632 ENKEYQSSEYGG-TSEYGLNPSASSSEE 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1352), Expect = e-148, Method: Compositional matrix adjust.
Identities = 274/478 (57%), Positives = 340/478 (71%), Gaps = 25/478 (5%)
Query: 76 MVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPH-----------HW 124
++VGV++GAG+++ + I + +++KRK + P+K + + + +W
Sbjct: 152 IIVGVLVGAGLLMIVL-IIVCLRRKKKRKDSFYPEPMKGNQYQYYGNNNNNNASQNYPNW 210
Query: 125 QQNVSAPSDYQELPKPSLPPSNGPTAPLPTV--PVSAFNEPLSTSGSLDSDKPFPRQSPG 182
N + PS P +PT S ++ P S P SP
Sbjct: 211 HLNSQGQNQQSTGGWGGGGPSPPPPPRMPTSGEDSSMYSGP--------SRPVLPPPSPA 262
Query: 183 MPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGE 242
+ +G KSTFTY+EL AT F++ANLLGQGGFGYVHKGVL +GK VA+K LKAGSGQGE
Sbjct: 263 LALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGE 322
Query: 243 REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
REFQAE++IIS+VHHR+LVSLVGYC QR+LVYEFVPNKTLE+HLHGK+ PVM + TR
Sbjct: 323 REFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTR 382
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
++IALG+A+GLAYLHEDC P+IIHRDIKSANILLD +F+A VADFGLAK + D +THVST
Sbjct: 383 LRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVST 442
Query: 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 422
RVMGTFGYLAPEYASSGKLTEKSDVFS+GV+LLELITG RP D + T DD++VDWA+P
Sbjct: 443 RVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITM-DDTLVDWARPL 501
Query: 423 LAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481
+A+ L DGNF+ L D +LE Y+ EM RM CAAA IRHS R+RP+MSQIVRALEG +
Sbjct: 502 MARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVS 561
Query: 482 LDDLNEGITPGHSTIYGSYGG-SDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSD 538
LD LNEG+ PGHS +YGS G SDY+ Y DMKKFR+IAL S E SD G +S+
Sbjct: 562 LDALNEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEFPVSDCEGTSSN 619
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 489 bits (1258), Expect = e-137, Method: Compositional matrix adjust.
Identities = 233/348 (66%), Positives = 276/348 (79%), Gaps = 15/348 (4%)
Query: 173 DKPFPRQSP-GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAI 231
DK P +P G+ +G +STFTY EL AT+ FSEANLLG+GGFG+V+KG+L NG VA+
Sbjct: 153 DKALP--APIGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAV 210
Query: 232 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291
KQLK GS QGE+EFQAE+ IISQ+HHR+LVSLVGYC G+QRLLVYEFVPN TLEFHLHG
Sbjct: 211 KQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHG 270
Query: 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
K RP M W R+KIA+ S++GL+YLHE+C PKIIHRDIK+ANIL+D FEAKVADFGLAK
Sbjct: 271 KGRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAK 330
Query: 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411
+LDT+THVSTRVMGTFGYLAPEYA+SGKLTEKSDV+SFGV+LLELITG RP D + +A
Sbjct: 331 IALDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYA 390
Query: 412 DDSMVDWAKPFLAQGLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMS 470
DDS+VDWA+P L Q L + NF+ L D KL EYD EM RM ACAAAC+R++ARRRPRM
Sbjct: 391 DDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMD 450
Query: 471 QIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFR 518
Q+VR LEGN+ DLN+GITPGHS N++ R D + R
Sbjct: 451 QVVRVLEGNISPSDLNQGITPGHS-----------NTVSVRLDARAVR 487
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 472 bits (1214), Expect = e-132, Method: Compositional matrix adjust.
Identities = 245/360 (68%), Positives = 290/360 (80%), Gaps = 2/360 (0%)
Query: 185 VGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE 244
+G KSTFTY+EL AT FS++ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQGERE
Sbjct: 318 LGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGERE 377
Query: 245 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
FQAE++IIS+VHHR LVSLVGYC G QR+LVYEF+PN TLEFHLHGK V++WPTR+K
Sbjct: 378 FQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLK 437
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
IALGSA+GLAYLHEDC P+IIHRDIK++NILLD+SFEAKVADFGLAK S D THVSTR+
Sbjct: 438 IALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRI 497
Query: 365 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424
MGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+TG RP D +DS+VDWA+P
Sbjct: 498 MGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICL 556
Query: 425 QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLD 483
DG++ LVD +LE +Y+ EM +M ACAAA +RHSARRRP+MSQIVRALEG+ LD
Sbjct: 557 NAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLD 616
Query: 484 DLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNP 543
DL+EG G S+ G SDY+S Y DMKKFRK+AL+S E G+S G TS+YG +P
Sbjct: 617 DLSEGGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGNTSEYGLDP 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1213), Expect = e-132, Method: Compositional matrix adjust.
Identities = 263/420 (62%), Positives = 309/420 (73%), Gaps = 11/420 (2%)
Query: 133 DYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTF 192
++Q +P P P S G S F +SG P P P + +G STF
Sbjct: 272 NWQPMPSPPAPVSGGANVIQSGEMSSNF-----SSGPYAPSLPPPH--PSVALGFNNSTF 324
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEII 252
TYEEL AT FS+ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQGEREFQAE+EII
Sbjct: 325 TYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVEII 384
Query: 253 SQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
S+VHHRHLVSLVGYC+ G QRLLVYEF+PN TLEFHLHGK VM+WPTR+KIALGSA+
Sbjct: 385 SRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIALGSAK 444
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
GLAYLHEDC PKIIHRDIK++NILLD +FEAKVADFGLAK S D +THVSTRVMGTFGYL
Sbjct: 445 GLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVSTRVMGTFGYL 504
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431
APEYASSGKLTEKSDVFSFGV+LLELITG P D + +DS+VDWA+P + DG
Sbjct: 505 APEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDWARPLCMRVAQDGE 563
Query: 432 FDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGIT 490
+ LVD LE +Y+ EM RM ACAAA +RHS RRRP+MSQIVR LEG+ LDDL++G+
Sbjct: 564 YGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGDASLDDLDDGVK 623
Query: 491 PGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTED 550
P S+ G SDY Y +M+KFRK+ LES + G+S G TS+YG +P SSS+E+
Sbjct: 624 PKQSSSG-GEGSSDYEMGTYGAEMRKFRKVTLESRDYGASSEYGATSEYGLDPSSSSSEE 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-127, Method: Compositional matrix adjust.
Identities = 263/546 (48%), Positives = 341/546 (62%), Gaps = 49/546 (8%)
Query: 21 SPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRNGYLPPGALAGMVVGV 80
S A PP +A P LTSP S G P+SG++V P P +G G + G
Sbjct: 192 SSHALPPKSTAAGGP----LTSP-SRGVPSSGNSV----PPPANSG---GGYQGKTMAGF 239
Query: 81 VIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHHWQQNVSAPSD---YQEL 137
I V+A + + + +++KR + D ++ + N S SD Y +
Sbjct: 240 AIAGFAVIALMAVVFLVRRKKKRNI---------DAYSDSQYLPPSNFSIKSDGFLYGQN 290
Query: 138 PKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPV-GNFKSTFTYEE 196
P G + + ++F G S +P V G+ ++ FTYEE
Sbjct: 291 PTKGYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSG-----SAPDSAVMGSGQTHFTYEE 345
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH 256
L T+ FS+ N+LG+GGFG V+KG L +GK+VA+KQLK GSGQG+REF+AE+EIIS+VH
Sbjct: 346 LTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVH 405
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
HRHLVSLVGYC S+RLL+YE+VPN+TLE HLHGK RPV+ W R++IA+GSA+GLAYL
Sbjct: 406 HRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYL 465
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 376
HEDC PKIIHRDIKSANILLDD FEA+VADFGLAK + T THVSTRVMGTFGYLAPEYA
Sbjct: 466 HEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYA 525
Query: 377 SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436
SGKLT++SDVFSFGV+LLELITG +P D+ ++S+V+WA+P L + + G+F LV
Sbjct: 526 QSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELV 585
Query: 437 DQKLEE-YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITPGHST 495
D++LE+ Y E+ RM AAAC+RHS +RPRM Q+VRAL+ + D++ G G S
Sbjct: 586 DRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQS- 644
Query: 496 IYGSYGGSDYNSMQYREDMKKFRKIAL---ESVELG--SSDYSGLTSDYGQNPPSS---- 546
S Y+S QY D KFRK+A +S + G S DYS S G N SS
Sbjct: 645 -------SAYDSGQYNNDTMKFRKMAFGFDDSSDSGMYSGDYSVQDSRKGSNGASSEFTR 697
Query: 547 -STEDR 551
TE+R
Sbjct: 698 NETENR 703
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 443 bits (1140), Expect = e-123, Method: Compositional matrix adjust.
Identities = 238/484 (49%), Positives = 318/484 (65%), Gaps = 41/484 (8%)
Query: 77 VVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHHWQQNVSAPSD--- 133
+VG+ + ++A +G+ + +++KR + + N + + P N S SD
Sbjct: 247 MVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYN----HSQYLPHP-----NFSVKSDGFL 297
Query: 134 YQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPR-QSPGMP----VGNF 188
Y + P S+GP + + ++ G+ P + QS G P +G+
Sbjct: 298 YGQDPGKGY--SSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSG 355
Query: 189 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAE 248
++ F+YEEL T F+ N+LG+GGFG V+KG L +GKVVA+KQLKAGSGQG+REF+AE
Sbjct: 356 QTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAE 415
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
+EIIS+VHHRHLVSLVGYC RLL+YE+V N+TLE HLHGK PV+ W R++IA+G
Sbjct: 416 VEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIG 475
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
SA+GLAYLHEDC PKIIHRDIKSANILLDD +EA+VADFGLA+ + T THVSTRVMGTF
Sbjct: 476 SAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTF 535
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428
GYLAPEYASSGKLT++SDVFSFGV+LLEL+TG +P D+ ++S+V+WA+P L + +
Sbjct: 536 GYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIE 595
Query: 429 DGNFDALVDQKLEE-YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNE 487
G+ L+D +LE+ Y E+ RM AAAC+RHS +RPRM Q+VRAL+ + D++
Sbjct: 596 TGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISN 655
Query: 488 GITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIAL---ESVELG----------SSDYSG 534
GI G ST Y+S QY ED+ KFRK+A SVE G SSD+SG
Sbjct: 656 GIKIGQSTT--------YDSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSDFSG 707
Query: 535 LTSD 538
S+
Sbjct: 708 NESE 711
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 579 | ||||||
| 255549982 | 374 | ATP binding protein, putative [Ricinus c | 0.633 | 0.981 | 0.774 | 1e-173 | |
| 356521887 | 570 | PREDICTED: proline-rich receptor-like pr | 0.948 | 0.963 | 0.566 | 1e-172 | |
| 121308607 | 665 | PERK1-like protein kinase [Nicotiana tab | 0.841 | 0.732 | 0.618 | 1e-172 | |
| 359484580 | 650 | PREDICTED: proline-rich receptor-like pr | 0.835 | 0.744 | 0.628 | 1e-169 | |
| 147828268 | 603 | hypothetical protein VITISV_010509 [Viti | 0.861 | 0.827 | 0.596 | 1e-166 | |
| 225442587 | 551 | PREDICTED: proline-rich receptor-like pr | 0.861 | 0.905 | 0.596 | 1e-166 | |
| 356520519 | 671 | PREDICTED: proline-rich receptor-like pr | 0.813 | 0.701 | 0.638 | 1e-165 | |
| 297852980 | 524 | kinase family protein [Arabidopsis lyrat | 0.873 | 0.965 | 0.579 | 1e-165 | |
| 351725713 | 443 | putative receptor protein kinase PERK1 [ | 0.666 | 0.871 | 0.720 | 1e-165 | |
| 224059084 | 410 | predicted protein [Populus trichocarpa] | 0.683 | 0.965 | 0.698 | 1e-164 |
| >gi|255549982|ref|XP_002516042.1| ATP binding protein, putative [Ricinus communis] gi|223544947|gb|EEF46462.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 616 bits (1588), Expect = e-173, Method: Compositional matrix adjust.
Identities = 285/368 (77%), Positives = 328/368 (89%), Gaps = 1/368 (0%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR 258
+AT+ FS+ANL+GQGGFGYVHKG+L +GKV+AIKQLKAGSGQGEREFQAEIEIIS+VHHR
Sbjct: 1 MATNGFSDANLIGQGGFGYVHKGILNDGKVIAIKQLKAGSGQGEREFQAEIEIISRVHHR 60
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
HLVSL+GYC G+QR+LVYEFVPN TLEFHLHGK RP MNW TRMKIA+GSA+GLAYLHE
Sbjct: 61 HLVSLLGYCITGAQRMLVYEFVPNDTLEFHLHGKGRPTMNWSTRMKIAVGSAKGLAYLHE 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+CQPKIIHRDIK+ANIL+DDSFEAKVADFGLAK+SLDTDTHVSTRVMGTFGY+APEYASS
Sbjct: 121 ECQPKIIHRDIKAANILIDDSFEAKVADFGLAKYSLDTDTHVSTRVMGTFGYMAPEYASS 180
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438
GKLTEKSDVFSFGV+LLELITG RP D+ TF DDS+VDWA+P L Q L G +DAL D
Sbjct: 181 GKLTEKSDVFSFGVVLLELITGRRPVDRTQTF-DDSIVDWARPLLNQALESGIYDALADP 239
Query: 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITPGHSTIYG 498
KL++YDS EMTRM ACAAAC+RHSAR RPRMSQI+RALEGNM LD+L++GITPGHST+YG
Sbjct: 240 KLQDYDSTEMTRMIACAAACVRHSARLRPRMSQIIRALEGNMSLDELSDGITPGHSTVYG 299
Query: 499 SYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTEDRQATQETE 558
SYG DY+S QY+ED+K+FRK+ALES E SS+YSG+TS++G P SSSTE +Q TQE E
Sbjct: 300 SYGSIDYSSSQYKEDLKRFRKMALESQEHVSSEYSGVTSEFGLQPSSSSTEGQQTTQEME 359
Query: 559 PNEKDTNV 566
+K+T V
Sbjct: 360 AQKKETAV 367
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521887|ref|XP_003529582.1| PREDICTED: proline-rich receptor-like protein kinase PERK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1575), Expect = e-172, Method: Compositional matrix adjust.
Identities = 322/568 (56%), Positives = 407/568 (71%), Gaps = 19/568 (3%)
Query: 10 LPAPPETNS-TFSPPA---PPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRN 65
+ AP E S T SPP+ P P+ +A+S P P + + T + P+ T N
Sbjct: 1 MSAPAEAPSFTASPPSETTPSPNSTALSPPPPSTINA-----TVSPPPPEAASPPTSTVN 55
Query: 66 GYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPL-KNDPFAGKPHHW 124
L G ++G+V+G V+G+ +L GIF FY+ KRK P K D G +W
Sbjct: 56 SGLSTGTVSGIVIGAVLGSVGMLIIGGIFFCFYRNWKRKKNHSQPPQPKADIAGGTLQNW 115
Query: 125 QQNVSAPSDYQELPKPSLPP-----SNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQ 179
Q +V +D + P PP +A L T+ V++ N S+S + K +
Sbjct: 116 QDSVPPTTDGKVGFSPKPPPGGLVNQQQSSAALLTLVVNSSNT--SSSLGSEKAKSYISP 173
Query: 180 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG 239
SPG + +STFTY+EL +ATD FS +NLLGQGGFGYVHKGVL NGK+VA+KQLK+ S
Sbjct: 174 SPGTSLALSQSTFTYDELSMATDGFSRSNLLGQGGFGYVHKGVLPNGKIVAVKQLKSESR 233
Query: 240 QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 299
QGEREF AE+++IS+VHHRHLVSLVGYC SQ++LVYE+V N TLEFHLHGKDR M+W
Sbjct: 234 QGEREFHAEVDVISRVHHRHLVSLVGYCVSDSQKMLVYEYVENDTLEFHLHGKDRLPMDW 293
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
TRMKIA+GSA+GLAYLHEDC PKIIHRDIK++NILLD+SFEAKVADFGLAK S DTDTH
Sbjct: 294 STRMKIAIGSAKGLAYLHEDCNPKIIHRDIKASNILLDESFEAKVADFGLAKFSSDTDTH 353
Query: 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 419
VSTRVMGTFGY+APEYA+SGKLTEKSDVFSFGV+LLELITG +P DK TF DDSMV+WA
Sbjct: 354 VSTRVMGTFGYMAPEYAASGKLTEKSDVFSFGVVLLELITGRKPVDKTQTFIDDSMVEWA 413
Query: 420 KPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478
+P L+Q L +GN + LVD +L+ Y+ EM RM CAA C+R+SAR RPRMSQ+VRALEG
Sbjct: 414 RPLLSQALENGNLNGLVDPRLQTNYNLDEMIRMTTCAATCVRYSARLRPRMSQVVRALEG 473
Query: 479 NMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSD 538
N+ L+DLN+GI PGHS ++GS+ S Y+S+QYRED+K F+K+ALES E G S+YSG +S+
Sbjct: 474 NISLEDLNDGIAPGHSRVFGSFESSSYDSVQYREDLKNFKKLALESQEQGISEYSGPSSE 533
Query: 539 YGQNPPSSSTEDRQATQETE-PNEKDTN 565
YG++P S++ D+Q TQE E N+K +N
Sbjct: 534 YGRHPSVSTSSDQQNTQEMEMGNKKGSN 561
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121308607|dbj|BAF43699.1| PERK1-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-172, Method: Compositional matrix adjust.
Identities = 316/511 (61%), Positives = 374/511 (73%), Gaps = 24/511 (4%)
Query: 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLA---------AQNLPL--KNDPFAG 119
G G+VVG+ IG ++LA + + I RRK++ AQ P+ K DP+
Sbjct: 135 GVSTGLVVGIAIGGVLILAVLSLLFICCSRRKKRRNHGPVEYYPPAQPPPMGYKADPYGD 194
Query: 120 KPHHWQQNVSAPSDY---------QELPKPSLPPSNGPTAP-LPTVPVSAFNEPLSTSGS 169
HHWQ N +P+D+ S PP + TA L P + S +
Sbjct: 195 PVHHWQHNAPSPADHVVSIPPKPSPPPAGASRPPHSPVTASSLQPPPPPPYMSSSGASSN 254
Query: 170 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 229
P P SPGM +G KSTFTYEEL ATD FS ANLLGQGGFGYVH+GVL NGK V
Sbjct: 255 YSGFDPLPPPSPGMVLGFSKSTFTYEELVRATDGFSNANLLGQGGFGYVHRGVLPNGKEV 314
Query: 230 AIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL 289
A+KQLKAGSGQGEREFQAE+EIIS+VHH+HLVSLVGYC GSQRLLVYEFVPN TLEFHL
Sbjct: 315 AVKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHL 374
Query: 290 HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
HGK RP ++WP R+KIALGSA+GLAYLHEDCQPKIIHRDIK+ANIL+D +FEAKVADFGL
Sbjct: 375 HGKGRPPLDWPIRLKIALGSAKGLAYLHEDCQPKIIHRDIKAANILVDFNFEAKVADFGL 434
Query: 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
AK + D +THVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+G++LLELITG RP D + T
Sbjct: 435 AKLTSDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGIMLLELITGRRPVDSSQT 494
Query: 410 FADDSMVDWAKPFLAQGLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPR 468
+ DDS+VDWA+P L + L D FD+L+D +L +Y+ E+ RM ACAAAC+RHSARRRPR
Sbjct: 495 YMDDSLVDWARPQLTRALEDEKFDSLIDPRLGNDYNHNEVARMVACAAACVRHSARRRPR 554
Query: 469 MSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELG 528
MSQ+VRALEG++ L DLNEGI PGHST+Y S+G SDY++ QY EDMKKFRK+AL S E G
Sbjct: 555 MSQVVRALEGDVSLSDLNEGIRPGHSTVYSSHGSSDYDASQYNEDMKKFRKMALGSQEYG 614
Query: 529 SS-DYSGLTSDYGQNPPSSSTEDRQATQETE 558
S+ YS TS+YG P SS+E Q T+E E
Sbjct: 615 STGQYSNPTSEYGLYPSGSSSEG-QPTREME 644
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484580|ref|XP_002284430.2| PREDICTED: proline-rich receptor-like protein kinase PERK1-like isoform 2 [Vitis vinifera] gi|297738823|emb|CBI28068.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1550), Expect = e-169, Method: Compositional matrix adjust.
Identities = 316/503 (62%), Positives = 373/503 (74%), Gaps = 19/503 (3%)
Query: 75 GMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPL------KNDPFAGKPHHWQQNV 128
G+VVG+ IG ++L + + I K++KR+ Q+ + KNDP+ G P WQ NV
Sbjct: 131 GLVVGIAIGGVVILVVLSLLFICCKKKKRRDHRQDYYVPPPPGPKNDPYGGPPQQWQHNV 190
Query: 129 SAPSDY--QELPKPSLPPSNGPTAPLPTVPVS----------AFNEPLSTSGSLDSDKPF 176
P+D+ PKPS PP P V V + S S SD P
Sbjct: 191 PPPADHAVTVFPKPSPPPGTASRPPHSPVQVPTPPPPPQPPFVSSSGGSGSNYSGSDNPL 250
Query: 177 PRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKA 236
P SP + +G KSTFTYEEL +ATD FS ANLLGQGGFGYVH+GVL NGK VA+KQLKA
Sbjct: 251 PPPSPSIALGFSKSTFTYEELVMATDGFSNANLLGQGGFGYVHRGVLPNGKEVAVKQLKA 310
Query: 237 GSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPV 296
GSGQGEREFQAE+EIIS+VHH+HLV+L GYC GS RLLVYEFVPN TLEFHLHGK RP
Sbjct: 311 GSGQGEREFQAEVEIISRVHHKHLVTLAGYCITGSHRLLVYEFVPNNTLEFHLHGKGRPT 370
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
M+W TR+KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD FEAKVADFGLAK S D
Sbjct: 371 MDWSTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSDA 430
Query: 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 416
+THVSTRVMGTFGYLAPEYA+SGKL++KSDVFSFGV+LLEL+TG RP D TF +DS+V
Sbjct: 431 NTHVSTRVMGTFGYLAPEYAASGKLSDKSDVFSFGVMLLELLTGRRPVDANQTFMEDSLV 490
Query: 417 DWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475
DWA+P L + L DGNFD LVD +L+ +Y+ EM RM ACAAAC+RHSARRRPRMSQIVRA
Sbjct: 491 DWARPLLTRALEDGNFDTLVDPRLQKDYNHHEMARMVACAAACVRHSARRRPRMSQIVRA 550
Query: 476 LEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGL 535
LEG+ L DLNEG+ PG S+IY S+G SDY++ QY EDM KFRK+AL S + GSS+YSG
Sbjct: 551 LEGDASLSDLNEGMRPGQSSIYSSHGSSDYDTNQYNEDMIKFRKMALASRDYGSSEYSGP 610
Query: 536 TSDYGQNPPSSSTEDRQATQETE 558
TS+YG P SS+E ++ T+E E
Sbjct: 611 TSEYGLYPSGSSSEGQRTTREME 633
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147828268|emb|CAN75405.1| hypothetical protein VITISV_010509 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 304/510 (59%), Positives = 368/510 (72%), Gaps = 11/510 (2%)
Query: 68 LPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK--LAAQNLPLKNDPFAGKPHHWQ 125
L L ++VG+VIG VL VG+ +IF +++KR+ N+ D + HWQ
Sbjct: 99 LTTATLITLIVGIVIGGLFVLIGVGVLVIFCRQKKRREQYGLTNVSGSKDDPSAPLQHWQ 158
Query: 126 QNVSAPSDYQE--LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGM 183
QN P++ + LPK + S G L V + A P+ G L ++KP SPG+
Sbjct: 159 QNAHQPTNNTDPMLPKHAPLLSIGSKPQLSPVHIPASPPPM---GILGTEKPLAPPSPGI 215
Query: 184 PVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGER 243
+G KS FTYEEL IATD FS NLLGQGGFGYVHKGVL NG+ VAIK LKAGSGQGER
Sbjct: 216 SLGFSKSAFTYEELAIATDGFSNINLLGQGGFGYVHKGVLPNGREVAIKHLKAGSGQGER 275
Query: 244 EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM 303
EFQAE+EIIS+VHH+HLVSLVGYCT G+QR+LVYEFVPN TL+ HLHG RP MNW TR+
Sbjct: 276 EFQAEVEIISRVHHKHLVSLVGYCTTGAQRMLVYEFVPNGTLQHHLHGTGRPTMNWATRI 335
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD +FEAKVADFGLAK + DTDTHVSTR
Sbjct: 336 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDHNFEAKVADFGLAKFASDTDTHVSTR 395
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423
VMGTFGYLAPEYASSGKLT+KSDVFSFGV+LLELITG RP DK + ++S+VDWA+P L
Sbjct: 396 VMGTFGYLAPEYASSGKLTDKSDVFSFGVVLLELITGRRPIDKTE---NESIVDWARPLL 452
Query: 424 AQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 482
Q L + +DALVD L+ +Y+ EM RM ACAA C+R+ AR RPRMSQ+VRALEGN+PL
Sbjct: 453 TQALEESKYDALVDPNLQKDYNYNEMARMVACAAVCVRYLARLRPRMSQVVRALEGNLPL 512
Query: 483 DDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQN 542
DDLNEGI PGHS+ + YG SD +++ ED+KKFRK+ALES E G + + S +
Sbjct: 513 DDLNEGIIPGHSSFHCRYGSSDDDTIHGSEDLKKFRKMALESHEQGRIECTVPISASDPH 572
Query: 543 PPSSSTEDRQATQETEPNEKDTNVINQSSS 572
+SS E +Q +E E + N+ N S
Sbjct: 573 TSNSSFEGQQTCKEVEMEKHKENIQNSGES 602
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225442587|ref|XP_002279197.1| PREDICTED: proline-rich receptor-like protein kinase PERK1 [Vitis vinifera] gi|297743250|emb|CBI36117.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 592 bits (1525), Expect = e-166, Method: Compositional matrix adjust.
Identities = 304/510 (59%), Positives = 368/510 (72%), Gaps = 11/510 (2%)
Query: 68 LPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK--LAAQNLPLKNDPFAGKPHHWQ 125
L L ++VG+VIG VL VG+ +IF +++KR+ N+ D + HWQ
Sbjct: 47 LTTATLITLIVGIVIGGLFVLIGVGVLVIFCRQKKRREQYGLTNVSGSKDDPSAPLQHWQ 106
Query: 126 QNVSAPSDYQE--LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGM 183
QN P++ + LPK + S G L V + A P+ G L ++KP SPG+
Sbjct: 107 QNAHQPTNNTDPMLPKHAPLLSIGSKPQLSPVHIPASPPPM---GILGTEKPLAPPSPGI 163
Query: 184 PVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGER 243
+G KS FTYEEL IATD FS NLLGQGGFGYVHKGVL NG+ VAIK LKAGSGQGER
Sbjct: 164 SLGFSKSAFTYEELAIATDGFSNINLLGQGGFGYVHKGVLPNGREVAIKHLKAGSGQGER 223
Query: 244 EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM 303
EFQAE+EIIS+VHH+HLVSLVGYCT G+QR+LVYEFVPN TL+ HLHG RP MNW TR+
Sbjct: 224 EFQAEVEIISRVHHKHLVSLVGYCTTGAQRMLVYEFVPNGTLQHHLHGTGRPTMNWATRI 283
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
KIALGSA+GLAYLHEDC PKIIHRDIK+ANILLD +FEAKVADFGLAK + DTDTHVSTR
Sbjct: 284 KIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDHNFEAKVADFGLAKFASDTDTHVSTR 343
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423
VMGTFGYLAPEYASSGKLT+KSDVFSFGV+LLELITG RP DK + ++S+VDWA+P L
Sbjct: 344 VMGTFGYLAPEYASSGKLTDKSDVFSFGVVLLELITGRRPIDKTE---NESIVDWARPLL 400
Query: 424 AQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 482
Q L + + ALVD L+ +Y+ EM RM ACAA C+R+ AR RPRMSQ+VRALEGN+PL
Sbjct: 401 TQALEESKYGALVDPNLQKDYNYNEMARMVACAAVCVRYLARLRPRMSQVVRALEGNLPL 460
Query: 483 DDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQN 542
DDLNEGI PGHS+ + YG SD +++ ED+KKFRK+ALES E GS + + S +
Sbjct: 461 DDLNEGIIPGHSSFHCRYGSSDDDTIHGSEDLKKFRKMALESHEQGSIECTVPISASDPH 520
Query: 543 PPSSSTEDRQATQETEPNEKDTNVINQSSS 572
+SS E +Q +E E + N+ N S
Sbjct: 521 TSNSSFEGQQTCKEVEMEKHKENIQNSGES 550
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520519|ref|XP_003528909.1| PREDICTED: proline-rich receptor-like protein kinase PERK15-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 311/487 (63%), Positives = 367/487 (75%), Gaps = 16/487 (3%)
Query: 88 LAAVGIFLIFYKRRKRKLAAQNLPL--------KNDPFAGKPHHWQQNVSAPSDY---QE 136
L + I I +++KR+ + K+D + G P WQ NV P D+
Sbjct: 171 LLVLSILCICCRKKKRRRDEEYYAPPPQPPRGPKDDAYGGPPRQWQHNVPPPQDHVVSMM 230
Query: 137 LPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPF-PRQSPGMPVGNFKSTFTYE 195
PKPS PP+ A P P F SGS S F P SPG+ +G KSTFTYE
Sbjct: 231 PPKPSPPPAPPAYAAQPPPPPPPFIISSGGSGSNYSGGEFLPPPSPGIALGFSKSTFTYE 290
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV 255
EL ATD FS+ANLLGQGGFGYVH+G+L NGK VA+KQLKAGSGQGEREFQAE+EIIS+V
Sbjct: 291 ELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLKAGSGQGEREFQAEVEIISRV 350
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
HH+HLVSLVGYC GSQRLLVYEFVPN TLEFHLHG+ RP M+WPTR++IALGSA+GLAY
Sbjct: 351 HHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGRGRPTMDWPTRLRIALGSAKGLAY 410
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LHEDC PKIIHRDIK+ANILLD FEAKVADFGLAK S D +THVSTRVMGTFGYLAPEY
Sbjct: 411 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSDVNTHVSTRVMGTFGYLAPEY 470
Query: 376 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435
ASSGKLT+KSDVFS+GV+LLELITG RP DK TF +DS+VDWA+P L + L + +FD++
Sbjct: 471 ASSGKLTDKSDVFSYGVMLLELITGRRPVDKNQTFMEDSLVDWARPLLTRALEEDDFDSI 530
Query: 436 VDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITPGHS 494
+D +L+ +YD EM RM A AAACIRHSA+RRPRMSQ+VRALEG++ L DLNEGI PGHS
Sbjct: 531 IDPRLQNDYDPNEMARMVASAAACIRHSAKRRPRMSQVVRALEGDVSLADLNEGIRPGHS 590
Query: 495 TIYGSYGGSDYNSMQYREDMKKFRKIALESVELG-SSDYSGLTSDYGQNPPSSSTE--DR 551
T+Y S+ SDY++ QY+EDMKKFRK+AL + E G SS+YS TS+YG NP SS+E R
Sbjct: 591 TMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYSAATSEYGLNPSGSSSEAQSR 650
Query: 552 QATQETE 558
Q T+E E
Sbjct: 651 QTTREME 657
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852980|ref|XP_002894371.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297340213|gb|EFH70630.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 324/559 (57%), Positives = 385/559 (68%), Gaps = 53/559 (9%)
Query: 14 PETNSTFSPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRNGYLPPGAL 73
PE ST A P+ S S P L+ P + T G G+R AL
Sbjct: 15 PEFLSTTQNTATSPAPSQPSINGPSWLSPFPETTTNIDG---GSRNV-----------AL 60
Query: 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHHWQQNVSAPSD 133
G++ GVV+GA VL V IF+ FYKR++RKL + + + AP D
Sbjct: 61 TGLITGVVLGATFVLIGVCIFVCFYKRKQRKLKMKKKKD------------LEAILAPKD 108
Query: 134 YQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFT 193
K S+P F + +S +L +Q +G+ + FT
Sbjct: 109 SIFFMKLSIPL--------------FFFFFIESSNNL-------QQWGSSEIGH--NLFT 145
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIIS 253
YE+L AT NFS NL+GQGGFGYVH+GVL +G +VAIKQLKAGSGQGEREFQAEI+ IS
Sbjct: 146 YEDLSKATSNFSNTNLIGQGGFGYVHRGVLVDGTLVAIKQLKAGSGQGEREFQAEIQTIS 205
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
+VHHRHLVSL+GYC G+QRLLVYEFVPNKTLEFHLH K RPVM W RMKIALG+A+GL
Sbjct: 206 RVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKGRPVMEWSKRMKIALGAAKGL 265
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
AYLHEDC PK IHRD+K+ANIL+DDS+EAK+ADFGLA+ SLDTDTHVSTR+MGTFGYLAP
Sbjct: 266 AYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTFGYLAP 325
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA-DDSMVDWAKPFLAQGLADGNF 432
EYASSGKLT+KSDVFSFGV+LLELITG RP DK+ FA DDS+VDWAKP + Q L GNF
Sbjct: 326 EYASSGKLTDKSDVFSFGVVLLELITGRRPVDKSQPFADDDSLVDWAKPLMIQVLNGGNF 385
Query: 433 DALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITP 491
D LVD +LE ++D EMTRM ACAAA +RHSA+RRP+MSQIVRA EGN+ +DDL EG P
Sbjct: 386 DGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLTEGAAP 445
Query: 492 GHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSS--TE 549
GHSTIY G SDY+S QY+ED+KKF+K+ALES GSS+ SGLTSD GQNP SS TE
Sbjct: 446 GHSTIYSLDGSSDYSSTQYKEDLKKFKKMALESQTFGSSECSGLTSDNGQNPSVSSSITE 505
Query: 550 DRQATQETEPNEKDTNVIN 568
++ TQE EP K I+
Sbjct: 506 GQRTTQEIEPEMKTNETIS 524
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725713|ref|NP_001237102.1| putative receptor protein kinase PERK1 [Glycine max] gi|77403742|dbj|BAE46451.1| putative receptor protein kinase PERK1 [Glycine max] gi|223452349|gb|ACM89502.1| PERK1-like protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1512), Expect = e-165, Method: Compositional matrix adjust.
Identities = 281/390 (72%), Positives = 328/390 (84%), Gaps = 4/390 (1%)
Query: 180 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG 239
SPG+ +G KSTFTYEEL ATD FS+ANLLGQGGFGYVH+G+L NGK VA+KQLKAGSG
Sbjct: 47 SPGISLGFSKSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLKAGSG 106
Query: 240 QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 299
QGEREFQAE+EIIS+VHH+HLVSLVGYC GSQRLLVYEFVPN TLEFHLHGK RP M+W
Sbjct: 107 QGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGKGRPTMDW 166
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
PTR++IALGSA+GLAYLHEDC PKIIHRDIKSANILLD FEAKVADFGLAK S D +TH
Sbjct: 167 PTRLRIALGSAKGLAYLHEDCHPKIIHRDIKSANILLDFKFEAKVADFGLAKFSSDVNTH 226
Query: 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 419
VSTRVMGTFGYLAPEYASSGKLT+KSDVFS+G++LLELITG RP DK T+ +DS+VDWA
Sbjct: 227 VSTRVMGTFGYLAPEYASSGKLTDKSDVFSYGIMLLELITGRRPVDKNQTYMEDSLVDWA 286
Query: 420 KPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478
+P L + L + +FD+++D +L+ +YD EM RM A AAACIRHSA+RRPRMSQ+VRALEG
Sbjct: 287 RPLLTRALEEDDFDSIIDPRLQNDYDPHEMARMVASAAACIRHSAKRRPRMSQVVRALEG 346
Query: 479 NMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELG-SSDYSGLTS 537
++ L DLNEGI PGHST+Y S+ SDY++ QY+EDMKKFRK+AL + E G SS+YS TS
Sbjct: 347 DVSLADLNEGIRPGHSTMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYSAATS 406
Query: 538 DYGQNPPSSSTE--DRQATQETEPNEKDTN 565
+YG NP SS+E RQ T+E E + N
Sbjct: 407 EYGLNPSGSSSEAQSRQTTREMEMRKMKNN 436
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059084|ref|XP_002299708.1| predicted protein [Populus trichocarpa] gi|222846966|gb|EEE84513.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 586 bits (1510), Expect = e-164, Method: Compositional matrix adjust.
Identities = 285/408 (69%), Positives = 329/408 (80%), Gaps = 12/408 (2%)
Query: 170 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 229
+ SDK FP +PG+ +G +STFTYEEL +ATDNFSEANLLGQGGFGYVHKG+L NG VV
Sbjct: 1 MGSDKQFPPPTPGIALGYSQSTFTYEELAMATDNFSEANLLGQGGFGYVHKGILANGTVV 60
Query: 230 AIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL 289
AIKQLK+GSGQGEREF+AEIEIIS+VHHRHLVSL GYC G+QR+LVYEFVPN TLEFHL
Sbjct: 61 AIKQLKSGSGQGEREFRAEIEIISRVHHRHLVSLFGYCIAGAQRMLVYEFVPNYTLEFHL 120
Query: 290 HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
H RP MNW T MKIA+G+A+GLAYLHEDCQPKIIHRDIK++NIL+D SFEAKVADFGL
Sbjct: 121 HENGRPTMNWSTTMKIAVGAAKGLAYLHEDCQPKIIHRDIKASNILIDHSFEAKVADFGL 180
Query: 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
AKHSLDT+THVSTRVMGTFGY+APEYASSGKLT KSDV+SFGV+LLELI+G RP D+ +
Sbjct: 181 AKHSLDTETHVSTRVMGTFGYMAPEYASSGKLTAKSDVYSFGVVLLELISGRRPVDRTQS 240
Query: 410 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 469
F DDS+VDWA+P L Q L DGNFDA+VD KL++YDS EM RM CAAAC+RH R RPRM
Sbjct: 241 FIDDSIVDWARPLLKQALEDGNFDAVVDPKLQDYDSNEMIRMICCAAACVRHLGRFRPRM 300
Query: 470 S-QIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVE-- 526
S QIVRALEGNMPL +LNEGITPG S +Y S SDY + QY ED+KKFRK+ALES E
Sbjct: 301 SQQIVRALEGNMPLGELNEGITPGPSMVYSS-ASSDYTNRQYEEDLKKFRKLALESPEHD 359
Query: 527 --------LGSSDYSGLTSDYGQNPPSSSTEDRQATQETEPNEKDTNV 566
S + + TS+ G+NP SSTE +Q E + K+ N+
Sbjct: 360 SRVNPLASTSSQECTEPTSESGRNPFRSSTEGQQTKPEMDSQRKEENI 407
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 579 | ||||||
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.763 | 0.677 | 0.634 | 2e-147 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.763 | 0.683 | 0.622 | 3.4e-143 | |
| TAIR|locus:2018209 | 509 | PERK15 "proline-rich extensin- | 0.649 | 0.738 | 0.688 | 1.2e-140 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.721 | 0.597 | 0.587 | 3.3e-130 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.680 | 0.622 | 0.611 | 7e-128 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.742 | 0.641 | 0.58 | 1.5e-127 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.721 | 0.597 | 0.587 | 1.2e-125 | |
| TAIR|locus:2125692 | 731 | PERK14 "proline-rich extensin- | 0.656 | 0.519 | 0.533 | 1.9e-108 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.740 | 0.604 | 0.512 | 9.2e-107 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.685 | 0.582 | 0.490 | 1e-105 |
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1417 (503.9 bits), Expect = 2.0e-147, Sum P(2) = 2.0e-147
Identities = 290/457 (63%), Positives = 336/457 (73%)
Query: 111 PLKNDPFAGKPHHWQQ-NVSAPSDYQ---ELPKPSLPPSNGPTAPLPTVPVSAFNEPLST 166
P P+ G+ +WQQ N S PSD LP P PPS P P P P AF +S+
Sbjct: 186 PKAGGPYGGQQQYWQQQNASRPSDNHVVTSLPPPK-PPSP-PRKPPPPPPPPAF---MSS 240
Query: 167 SGSLD-SDKP-FPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT 224
SG D SD P P SPG+ +G KSTFTYEEL AT+ FSEANLLGQGGFGYVHKG+L
Sbjct: 241 SGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILP 300
Query: 225 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284
+GK VA+KQLKAGSGQGEREFQAE+EIIS+VHHRHLVSL+GYC G QRLLVYEFVPN
Sbjct: 301 SGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNN 360
Query: 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
LEFHLHGK RP M W TR+KIALGSA+GL+YLHEDC PKIIHRDIK++NIL+D FEAKV
Sbjct: 361 LEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKV 420
Query: 345 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
ADFGLAK + DT+THVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITG RP
Sbjct: 421 ADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPV 480
Query: 405 DKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL-EEYDXXXXXXXXXXXXXXXXXXX 463
D + + DDS+VDWA+P L + +G+F+ L D K+ EYD
Sbjct: 481 DANNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSA 540
Query: 464 XXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGS-DYNSMQYREDMKKFRKIAL 522
PRMSQIVRALEGN+ L DLNEG+ PGHS +Y SYGGS DY++ QY +DM KFRK+AL
Sbjct: 541 RRRPRMSQIVRALEGNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMAL 600
Query: 523 ESVELGSS-DYSGLTSDYGQNPPSSSTEDRQATQETE 558
+ E G++ +YS TSDYG P SS+E QAT+E E
Sbjct: 601 GTQEYGTTGEYSNPTSDYGLYPSGSSSEG-QATREME 636
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 1382 (491.5 bits), Expect = 3.4e-143, Sum P(2) = 3.4e-143
Identities = 284/456 (62%), Positives = 330/456 (72%)
Query: 111 PLKNDPFAGKPHHW-QQNVSAPSDY--QELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTS 167
P P+ G+ W QQN + PSD+ LP P PS P P P P F +S+S
Sbjct: 182 PKAGGPYGGQQQQWRQQNATPPSDHVVTSLPPPPKAPSP-PRQP-PPPPPPPF---MSSS 236
Query: 168 GSLD-SDKP-FPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN 225
G D SD+P P SPG+ +G KSTFTYEEL AT+ FSEANLLGQGGFGYVHKGVL +
Sbjct: 237 GGSDYSDRPVLPPPSPGLVLGFSKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPS 296
Query: 226 GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285
GK VA+KQLK GSGQGEREFQAE+EIIS+VHHRHLVSLVGYC G++RLLVYEFVPN L
Sbjct: 297 GKEVAVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNL 356
Query: 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345
E HLHG+ RP M W TR+KIALGSA+GL+YLHEDC PKIIHRDIK++NIL+D FEAKVA
Sbjct: 357 ELHLHGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVA 416
Query: 346 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
DFGLAK + DT+THVSTRVMGTFGYLAPEYA+SGKLTEKSDVFSFGV+LLELITG RP D
Sbjct: 417 DFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVD 476
Query: 406 KADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE-YDXXXXXXXXXXXXXXXXXXXX 464
+ + DDS+VDWA+P L + G+F+ L D K+ YD
Sbjct: 477 ANNVYVDDSLVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSAR 536
Query: 465 XXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGS-DYNSMQYREDMKKFRKIALE 523
PRMSQIVRALEGN+ L DLNEG+ PG S +Y SYGGS DY+S QY EDMKKFRK+AL
Sbjct: 537 RRPRMSQIVRALEGNVSLSDLNEGMRPGQSNVYSSYGGSTDYDSSQYNEDMKKFRKMALG 596
Query: 524 SVELGSS-DYSGLTSDYGQNPPSSSTEDRQATQETE 558
+ E ++ +YS TSDYG P SS+E Q T+E E
Sbjct: 597 TQEYNATGEYSNPTSDYGLYPSGSSSEG-QTTREME 631
|
|
| TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 1.2e-140, Sum P(2) = 1.2e-140
Identities = 263/382 (68%), Positives = 302/382 (79%)
Query: 189 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAE 248
++ FTYE+L AT NFS NLLGQGGFGYVH+GVL +G +VAIKQLK+GSGQGEREFQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
I+ IS+VHHRHLVSL+GYC G+QRLLVYEFVPNKTLEFHLH K+RPVM W RMKIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+A+GLAYLHEDC PK IHRD+K+ANIL+DDS+EAK+ADFGLA+ SLDTDTHVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQGL 427
GYLAPEYASSGKLTEKSDVFS GV+LLELITG RP DK+ FADD S+VDWAKP + Q L
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 428 ADGNFDALVDQKLE-EYDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLN 486
DGNFD LVD +LE ++D P+MSQIVRA EGN+ +DDL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 487 EGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSS 546
EG PG STIY G SDY+S QY+ED+KKF+K+A ES GSS+ SGLTSD GQNP S
Sbjct: 428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESKTFGSSECSGLTSDNGQNPSGS 487
Query: 547 S--TEDRQATQETEP--NEKDT 564
S TE ++ TQE EP N KDT
Sbjct: 488 SSITEGQRTTQEIEPEKNTKDT 509
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1237 (440.5 bits), Expect = 3.3e-130, Sum P(2) = 3.3e-130
Identities = 249/424 (58%), Positives = 301/424 (70%)
Query: 132 SDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPF----PRQSPGMPVGN 187
+++ P P P S P+ P P PVS S+ S + P P P + +G
Sbjct: 261 NNWMNSPPPPPPGSWQPSPPPPPPPVSGGMNGNSSDFSSNYSGPHGPSVPPPHPSVALGF 320
Query: 188 FKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQA 247
KSTFTY+EL AT FS++ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQGEREFQA
Sbjct: 321 NKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQA 380
Query: 248 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
E++IIS+VHHR LVSLVGYC G QR+LVYEF+PN TLEFHLHGK V++WPTR+KIAL
Sbjct: 381 EVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIAL 440
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
GSA+GLAYLHEDC P+IIHRDIK++NILLD+SFEAKVADFGLAK S D THVSTR+MGT
Sbjct: 441 GSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGT 500
Query: 368 FGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427
FGYLAPEYASSGKLT++SDVFSFGV+LLEL+TG RP D +DS+VDWA+P
Sbjct: 501 FGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEM-EDSLVDWARPICLNAA 559
Query: 428 ADGNFDALVDQKLE-EYDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLN 486
DG++ LVD +LE +Y+ P+MSQIVRALEG+ LDDL+
Sbjct: 560 QDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLDDLS 619
Query: 487 EGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSS 546
EG G S+ G SDY+S Y DMKKFRK+AL+S E G+S G TS+YG +P SS
Sbjct: 620 EGGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGNTSEYGLDPSSS 679
Query: 547 STED 550
S+E+
Sbjct: 680 SSEE 683
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1224 (435.9 bits), Expect = 7.0e-128, Sum P(2) = 7.0e-128
Identities = 249/407 (61%), Positives = 298/407 (73%)
Query: 147 GPTAPLPT-VPVSAFNEPLSTSGSLDSDKP-FPRQSPGMPVGNFKSTFTYEELKIATDNF 204
GP+ P P +P S + + + S +P P SP + +G KSTFTY+EL AT F
Sbjct: 229 GPSPPPPPRMPTSGEDSSMYSGPS----RPVLPPPSPALALGFNKSTFTYQELAAATGGF 284
Query: 205 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
++ANLLGQGGFGYVHKGVL +GK VA+K LKAGSGQGEREFQAE++IIS+VHHR+LVSLV
Sbjct: 285 TDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLV 344
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
GYC QR+LVYEFVPNKTLE+HLHGK+ PVM + TR++IALG+A+GLAYLHEDC P+I
Sbjct: 345 GYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALGAAKGLAYLHEDCHPRI 404
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
IHRDIKSANILLD +F+A VADFGLAK + D +THVSTRVMGTFGYLAPEYASSGKLTEK
Sbjct: 405 IHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMGTFGYLAPEYASSGKLTEK 464
Query: 385 SDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EY 443
SDVFS+GV+LLELITG RP D + T DD++VDWA+P +A+ L DGNF+ L D +LE Y
Sbjct: 465 SDVFSYGVMLLELITGKRPVDNSITM-DDTLVDWARPLMARALEDGNFNELADARLEGNY 523
Query: 444 DXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGS 503
+ P+MSQIVRALEG + LD LNEG+ PGHS +YGS G S
Sbjct: 524 NPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSLDALNEGVKPGHSNVYGSLGAS 583
Query: 504 -DYNSMQYREDMKKFRKIALESVELGSSDYSGLTS----DYGQNPPS 545
DY+ Y DMKKFR+IAL S E SD G +S D G P+
Sbjct: 584 SDYSQTSYNADMKKFRQIALSSQEFPVSDCEGTSSNDSRDMGTKSPT 630
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1233 (439.1 bits), Expect = 1.5e-127, Sum P(2) = 1.5e-127
Identities = 261/450 (58%), Positives = 313/450 (69%)
Query: 113 KNDPFAGKPHHWQQNV--SAPSD----YQELPKPSLPPSNGPTAPL--PTVPVSAFNEPL 164
K P H++ N APS Y+ P+ + G P PVS P
Sbjct: 217 KKSPQVNHMHYYNNNPYGGAPSGNGGYYKGTPQDHVVNMAGQGGGNWGPQQPVSG---PH 273
Query: 165 STSGSLDSDKPFPRQSP-GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVL 223
S + +L P SP +G+ +STFTY+EL IAT+ F+++NLLGQGGFGYVHKGVL
Sbjct: 274 SDASNLTGRTAIP--SPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVL 331
Query: 224 TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283
+GK VA+K LK GSGQGEREFQAE++IIS+VHHRHLVSLVGYC G QRLLVYEF+PN
Sbjct: 332 PSGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNN 391
Query: 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343
TLEFHLHGK RPV++WPTR+KIALGSARGLAYLHEDC P+IIHRDIK+ANILLD SFE K
Sbjct: 392 TLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETK 451
Query: 344 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
VADFGLAK S D THVSTRVMGTFGYLAPEYASSGKL++KSDVFSFGV+LLELITG P
Sbjct: 452 VADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPP 511
Query: 404 FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDXXXXXXXXXXXXXXXXXX 462
D +DS+VDWA+P + DG+++ L D +LE Y
Sbjct: 512 LDLTGEM-EDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHS 570
Query: 463 XXXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGG--SDYNSMQYREDMKKFRKI 520
P+MSQIVRALEG+M +DDL+EG PG ST Y S G S+Y++ Y DMKKF+K+
Sbjct: 571 ARRRPKMSQIVRALEGDMSMDDLSEGTRPGQST-YLSPGSVSSEYDASSYTADMKKFKKL 629
Query: 521 ALESVELGSSDYSGLTSDYGQNPPSSSTED 550
ALE+ E SS+Y G TS+YG NP +SS+E+
Sbjct: 630 ALENKEYQSSEYGG-TSEYGLNPSASSSEE 658
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 1.2e-125, Sum P(2) = 1.2e-125
Identities = 253/431 (58%), Positives = 301/431 (69%)
Query: 129 SAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSD---KPF----PRQSP 181
S +++ P P PP N P P PVS + SG + S+ P+ P P
Sbjct: 256 SMGTNWVSSPPPP-PPGNWQPMPSPPAPVSGGANVIQ-SGEMSSNFSSGPYAPSLPPPHP 313
Query: 182 GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG 241
+ +G STFTYEEL AT FS+ LLGQGGFGYVHKG+L NGK +A+K LKAGSGQG
Sbjct: 314 SVALGFNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQG 373
Query: 242 EREFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWP 300
EREFQAE+EIIS+VHHRHLVSLVGYC+ G QRLLVYEF+PN TLEFHLHGK VM+WP
Sbjct: 374 EREFQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWP 433
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
TR+KIALGSA+GLAYLHEDC PKIIHRDIK++NILLD +FEAKVADFGLAK S D +THV
Sbjct: 434 TRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHV 493
Query: 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 420
STRVMGTFGYLAPEYASSGKLTEKSDVFSFGV+LLELITG P D + +DS+VDWA+
Sbjct: 494 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDWAR 552
Query: 421 PFLAQGLADGNFDALVDQKLE-EYDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGN 479
P + DG + LVD LE +Y+ P+MSQIVR LEG+
Sbjct: 553 PLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGD 612
Query: 480 MPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDY 539
LDDL++G+ P S+ G G SDY Y +M+KFRK+ LES + G+S G TS+Y
Sbjct: 613 ASLDDLDDGVKPKQSSS-GGEGSSDYEMGTYGAEMRKFRKVTLESRDYGASSEYGATSEY 671
Query: 540 GQNPPSSSTED 550
G +P SSS+E+
Sbjct: 672 GLDPSSSSSEE 682
|
|
| TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 998 (356.4 bits), Expect = 1.9e-108, Sum P(3) = 1.9e-108
Identities = 216/405 (53%), Positives = 271/405 (66%)
Query: 154 TVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQG 213
T+P + +S+ G + ++ MP G F+YEEL AT FSE NLLG+G
Sbjct: 343 TMPPPIHAKYISSGGCDTKENNSVAKNISMPSG----MFSYEELSKATGGFSEENLLGEG 398
Query: 214 GFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273
GFGYVHKGVL NG VA+KQLK GS QGEREFQAE++ IS+VHH+HLVSLVGYC G +R
Sbjct: 399 GFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVDTISRVHHKHLVSLVGYCVNGDKR 458
Query: 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333
LLVYEFVP TLEFHLH V+ W R++IA+G+A+GLAYLHEDC P IIHRDIK+AN
Sbjct: 459 LLVYEFVPKDTLEFHLHENRGSVLEWEMRLRIAVGAAKGLAYLHEDCSPTIIHRDIKAAN 518
Query: 334 ILLDDSFEAKVADFGLAKHSLDTD---THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF 390
ILLD FEAKV+DFGLAK DT+ TH+STRV+GTFGY+APEYASSGK+T+KSDV+SF
Sbjct: 519 ILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVVGTFGYMAPEYASSGKVTDKSDVYSF 578
Query: 391 GVLLLELITGFRP--FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE-YDXXX 447
GV+LLELITG RP F K D+ + S+VDWA+P L + ++ +FD LVD +LE+ YD
Sbjct: 579 GVVLLELITG-RPSIFAK-DSSTNQSLVDWARPLLTKAISGESFDFLVDSRLEKNYDTTQ 636
Query: 448 XXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNS 507
PRMSQ+VRALEG + L + E G+S Y S + +
Sbjct: 637 MANMAACAAACIRQSAWLRPRMSQVVRALEGEVALRKVEE---TGNSVTYSSSENPNDIT 693
Query: 508 MQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTEDRQ 552
+Y + ++F + GSSD G TS+YG NP SS+E +Q
Sbjct: 694 PRYGTNKRRF--------DTGSSD--GYTSEYGVNPSQSSSEHQQ 728
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1034 (369.0 bits), Expect = 9.2e-107, Sum P(2) = 9.2e-107
Identities = 234/457 (51%), Positives = 297/457 (64%)
Query: 125 QQNVSAPSDYQELPKPSLP-PSNGPT-APLPTVPVSA---FN-EPLSTSG-SLDSDKP-- 175
++N+ A SD Q LP + S+G PT S +N + S SG S S +
Sbjct: 261 KRNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGG 320
Query: 176 -FPRQ--SPGMPV-GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAI 231
+ R +P V G+ ++ FTYEEL T+ FS+ N+LG+GGFG V+KG L +GK+VA+
Sbjct: 321 GYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAV 380
Query: 232 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291
KQLK GSGQG+REF+AE+EIIS+VHHRHLVSLVGYC S+RLL+YE+VPN+TLE HLHG
Sbjct: 381 KQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG 440
Query: 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
K RPV+ W R++IA+GSA+GLAYLHEDC PKIIHRDIKSANILLDD FEA+VADFGLAK
Sbjct: 441 KGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK 500
Query: 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411
+ T THVSTRVMGTFGYLAPEYA SGKLT++SDVFSFGV+LLELITG +P D+
Sbjct: 501 LNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLG 560
Query: 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEE-YDXXXXXXXXXXXXXXXXXXXXXXPRMS 470
++S+V+WA+P L + + G+F LVD++LE+ Y PRM
Sbjct: 561 EESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMV 620
Query: 471 QIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQYREDMKKFRKIAL---ESVEL 527
Q+VRAL+ + D++ G G S S Y+S QY D KFRK+A +S +
Sbjct: 621 QVVRALDSEGDMGDISNGNKVGQS--------SAYDSGQYNNDTMKFRKMAFGFDDSSDS 672
Query: 528 G--SSDYSGLTSDYGQNPPSSSTEDRQATQETEPNEK 562
G S DYS S G N SS R T+ N +
Sbjct: 673 GMYSGDYSVQDSRKGSNGASSEFT-RNETENRNFNNR 708
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.0e-105, Sum P(3) = 1.0e-105
Identities = 204/416 (49%), Positives = 269/416 (64%)
Query: 141 SLPPS--NGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELK 198
++PPS + P + S + P SD + GM V N +S F+Y+EL
Sbjct: 275 TMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGM-VSNQRSWFSYDELS 333
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR 258
T FSE NLLG+GGFG V+KGVL++G+ VA+KQLK G QGEREF+AE+EIIS+VHHR
Sbjct: 334 QVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHR 393
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
HLV+LVGYC RLLVY++VPN TL +HLH RPVM W TR+++A G+ARG+AYLHE
Sbjct: 394 HLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARGIAYLHE 453
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGTFGYLAPEYA 376
DC P+IIHRDIKS+NILLD+SFEA VADFGLAK LD +THVSTRVMGTFGY+APEYA
Sbjct: 454 DCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYA 513
Query: 377 SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436
+SGKL+EK+DV+S+GV+LLELITG +P D + D+S+V+WA+P L Q + + FD LV
Sbjct: 514 TSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELV 573
Query: 437 DQKL-EEYDXXXXXXXXXXXXXXXXXXXXXXPRMSQIVRALEGNMPLDDLNEGITPGHST 495
D +L + + P+MSQ+VRAL+ D+ G+ PG S
Sbjct: 574 DPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITNGMRPGQSQ 633
Query: 496 IYGSYGGSDYNSMQYREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPSSSTEDR 551
++ +S Q ++ F+++A GS DYS D Q+ S + D+
Sbjct: 634 VF--------DSRQQSAQIRMFQRMAF-----GSQDYSSDFFDRSQSHSSWGSRDQ 676
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9C821 | PEK15_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7303 | 0.6493 | 0.7387 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 579 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 5e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 9e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.001 | |
| pfam03600 | 377 | pfam03600, CitMHS, Citrate transporter | 0.001 | |
| pfam08693 | 40 | pfam08693, SKG6, Transmembrane alpha-helix domain | 0.002 | |
| cd12087 | 38 | cd12087, TM_EGFR-like, Transmembrane domain of the | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 8e-54
Identities = 80/274 (29%), Positives = 124/274 (45%), Gaps = 30/274 (10%)
Query: 210 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG+G FG V+KG L VA+K LK + + + EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G CT +V E++ L +L K+RP ++ + AL ARG+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 383
IHRD+ + N L+ ++ K++DFGL++ D D + ++APE GK T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 384 KSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442
KSDV+SFGVLL E+ T G +P+ + + L +G
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----------VLEYLKNGYR-----LPQPP 226
Query: 443 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476
E+ + C RP S++V L
Sbjct: 227 NCPPELYDLMLQ---CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 1e-53
Identities = 73/192 (38%), Positives = 106/192 (55%), Gaps = 9/192 (4%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYC 267
LG+GGFG V+ GK VAIK +K E EIEI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
+ LV E+ +L+ L + ++ ++I L GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 328 DIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTEKS 385
D+K NILLD D+ + K+ADFGL+K L +D + ++GT Y+APE G +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 386 DVFSFGVLLLEL 397
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 80/274 (29%), Positives = 120/274 (43%), Gaps = 29/274 (10%)
Query: 210 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V+KG L VA+K LK S Q EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G CT ++V E++P L +L ++ + AL ARG+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 383
IHRD+ + N L+ ++ K++DFGL++ D D + ++APE GK T
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 384 KSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442
KSDV+SFGVLL E+ T G P+ + + L G
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMSNAE-----------VLEYLKKGYR-----LPKPP 227
Query: 443 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476
E+ ++ C RP S++V L
Sbjct: 228 NCPPELYKLMLQ---CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 5e-51
Identities = 71/204 (34%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVG 265
LG+G FG V+ GK+VAIK +K + +RE EI+I+ ++ H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ LV E+ L L K R ++ L YLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSK---GIV 119
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKS 385
HRD+K NILLD+ K+ADFGLA+ LD ++T V GT Y+APE +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGYGKAV 177
Query: 386 DVFSFGVLLLELITGFRPFDKADT 409
D++S GV+L EL+TG PF D
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQ 201
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 6e-51
Identities = 84/283 (29%), Positives = 131/283 (46%), Gaps = 47/283 (16%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG+G FG V+KG L VA+K LK G+ + ER EF E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G CT G +V E++P L L + +++AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL-TLKDLLQMALQIAKGMEYLESK---N 122
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG---YLAPEYASSGK 380
+HRD+ + N L+ ++ K++DFGL++ + D + G ++APE GK
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLKDGK 180
Query: 381 LTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439
T KSDV+SFGVLL E+ T G +P+ + + + + L DG +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPY---------PGMSNEE--VLELLEDGY-------R 222
Query: 440 LE--EYDSAE----MTRMAACAAACIRHSARRRPRMSQIVRAL 476
L E E M + C + RP S++V L
Sbjct: 223 LPRPENCPDELYELMLQ-------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 8e-51
Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 52/292 (17%)
Query: 208 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG+G FG V+KG L VA+K LK + + ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAY 315
L+G CT LV E++ L +L ++ ++ + A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST-------RVMGTF 368
L K +HRD+ + N L+ + K++DFGL++ D D + R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGL 427
++APE G T KSDV+SFGVLL E+ T G P+ +++ ++++ L
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY---PGLSNEEVLEY--------L 220
Query: 428 ADGNFDALVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
G +L EY E+ + C + RP S++V LE
Sbjct: 221 RKGY-------RLPKPEYCPDELYELMLS---CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 78/201 (38%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
LG G FG V+K GK+VA+K LK S + ++ + EI I+ ++ H ++V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRLID 65
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
LV E+ L F + P ++ KIAL RGL YLH + II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDL-FDYLSRGGP-LSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTEK 384
HRD+K NILLD++ K+ADFGLAK L + + ++T V GT Y+APE K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 385 SDVFSFGVLLLELITGFRPFD 405
DV+S GV+L EL+TG PF
Sbjct: 180 VDVWSLGVILYELLTGKPPFS 200
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-42
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLV 264
LLG+G FG V+ + G+++A+K ++ E + EI I+S + H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 265 GYCT--FGSQRLLVYEFVPNKTLEFHLHGKDR---PVMNWPTRMKIALGSARGLAYLHED 319
G + + E+V +L L + PV+ TR + GLAYLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----EGLAYLHSN 120
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-GTFGYLAPEYASS 378
I+HRDIK ANIL+D K+ADFG AK D +T T + GT ++APE
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPF 404
+ +D++S G ++E+ TG P+
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 7/202 (3%)
Query: 204 FSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS 262
F +G+GGFG V+K GK VAIK +K S + + + EI+I+ + H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
G + +V EF +L+ L ++ + + +GL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN--- 117
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT 382
IIHRDIK+ANILL E K+ DFGL+ +DT ++GT ++APE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 383 EKSDVFSFGVLLLELITGFRPF 404
K+D++S G+ +EL G P+
Sbjct: 176 YKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 70/196 (35%), Positives = 110/196 (56%), Gaps = 4/196 (2%)
Query: 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
F+ LG G FG V +G+ N VAIK LK+ +++FQ E++ + ++ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
C+ G ++ E + +L L + V+ + + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 383
IHRD+ + NIL+ + KVADFGLA+ + D ++S+ + + APE AS G +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAASHGTFST 183
Query: 384 KSDVFSFGVLLLELIT 399
KSDV+SFG+LL E+ T
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGEREF-QAEIEIISQVHHRHLVSLV 264
+G+G FG V+ ++GK+ +K++ + + ERE E++I+ +++H +++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 265 GYCTFGSQRLL-VYEFVPNKTLEFHLH---GKDRP-----VMNWPTRMKIALGSARGLAY 315
+L V E+ L + + +P +++W ++ L L Y
Sbjct: 66 E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKY 118
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LH KI+HRDIK NI L + K+ DFG++K L + ++ V+GT YL+PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYYLSPEL 174
Query: 376 ASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
+ KSD++S G +L EL T PF+
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 68/192 (35%), Positives = 99/192 (51%), Gaps = 8/192 (4%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VA+K LK G+ E F E +I+ ++ H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V E++ +L L + + P + +A A G+AYL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 387
+ NIL+ ++ K+ADFGLA+ L D + R F + APE A+ G+ T KSDV
Sbjct: 130 AARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 388 FSFGVLLLELIT 399
+SFG+LL E++T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 64/190 (33%), Positives = 98/190 (51%), Gaps = 4/190 (2%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V +G+ N VA+K LK G+ + +F AE +I+ ++ H L+ L CT
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V E + +L +L G + P + +A A G+AYL IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDL 129
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 389
+ N+L+ ++ KVADFGLA+ + + APE A + + KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189
Query: 390 FGVLLLELIT 399
FG+LL E++T
Sbjct: 190 FGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 63/189 (33%), Positives = 100/189 (52%), Gaps = 9/189 (4%)
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+G+G FG V G KV A+K LK S + F AE +++ + H +LV L+G
Sbjct: 13 TIGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
G+ +V E++ +L +L + R V+ ++ AL G+ YL E +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 388
+ + N+L+ + AKV+DFGLAK + + S ++ + APE K + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEA--SQGQDSGKL--PVKWTAPEALREKKFSTKSDVW 183
Query: 389 SFGVLLLEL 397
SFG+LL E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGE-REFQAEIEIISQVHHRH 259
N+ +L+G+G FG V+KG+ L G VAIKQ+ + + EI+++ + H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGK--DRPVMNWPTRMKIALGSARGLAY 315
+V +G ++ E+ N +L G + V + ++ +GLAY
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAY 114
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LHE +IHRDIK+ANIL K+ADFG+A L+ + V+GT ++APE
Sbjct: 115 LHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATK-LNDVSKDDASVVGTPYWMAPEV 170
Query: 376 ASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ SD++S G ++EL+TG P+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-30
Identities = 71/212 (33%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQV-HHRHLVSLV 264
LG+G FG V+ K+VA+K L + F EI+I++ + H ++V L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHL-HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+ LV E+V +LE L + ++ + I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 324 IIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTR-----VMGTFGYLAPEYAS 377
IIHRDIK NILLD D K+ DFGLAK D + S +GT GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 378 SGKL---TEKSDVFSFGVLLLELITGFRPFDK 406
L + SD++S G+ L EL+TG PF+
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 208 NLLGQGGFGYVHKGVLTN-----GKVVAIKQLKA-GSGQGEREFQAEIEIISQVHHRHLV 261
LG+G FG V G+ VA+K L G Q +F+ EIEI+ + H ++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 262 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
G C R L+ E++P+ +L +L + R +N + + +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVST--RVMGTFGYLAPEYA 376
+ IHRD+ + NIL++ K++DFGLAK D D + F Y APE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 377 SSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ K + SDV+SFGV L EL T P
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 72/214 (33%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVS 262
LG+G FG V K GK+ A+K LK +E + E I+S+++H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 263 LVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-----IALGSARGLAY 315
L + F ++ LV E+ P L HL + R + I L L Y
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFS-EERARFYAAEIVLA----LEY 108
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LH II+RD+K NILLD K+ DFGLAK + +T GT YLAPE
Sbjct: 109 LHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEV 164
Query: 376 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
+ D +S GVLL E++TG PF D
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 13/239 (5%)
Query: 210 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVG-Y 266
LGQG G V+K GK+ A+K++ + ++ E++ + ++V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
G + V E++ +L L K + P IA +GL YLH IIH
Sbjct: 69 YKEGEISI-VLEYMDGGSLA-DLLKKVGKI-PEPVLAYIARQILKGLDYLHTK--RHIIH 123
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 386
RDIK +N+L++ E K+ADFG++K +T +T V GT Y++PE + +D
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAAD 182
Query: 387 VFSFGVLLLELITGFRPFDKAD--TFAD--DSMVDWAKPFLAQGLADGNFDALVDQKLE 441
++S G+ LLE G PF +F + ++ D P L F + L+
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQ 241
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 210 LGQGGFGYVHKGV--LTNGKV--VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLV 264
LG G FG V KGV + +GK VA+K LK G++EF E +++Q+ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G C G +LV E P L +L K R + ++A A G+AYL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESK---HF 116
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLT 382
+HRD+ + N+LL + +AK++DFG+++ + G + + APE + GK +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 383 EKSDVFSFGVLLLELIT-GFRPF 404
KSDV+S+GV L E + G +P+
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 66/197 (33%), Positives = 104/197 (52%), Gaps = 6/197 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
+G G FG V G + VAIK ++ G+ E +F E +++ ++ H LV L G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
S LV+EF+ + L +L + R + T + + L G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 389
+ N L+ ++ KV+DFG+ + LD ST + +PE S K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 390 FGVLLLELIT-GFRPFD 405
FGVL+ E+ + G P++
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 23/213 (10%)
Query: 210 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSL 263
LG G FG V+KGV K+ VAIK L+ + + +E E +++ V H H+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHG-KDR----PVMNWPTRMKIALGSARGLAYLHE 318
+G C SQ L+ + +P L ++ KD ++NW ++ A+G++YL E
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFGYLAPEYAS 377
+++HRD+ + N+L+ K+ DFGLAK +D + + ++A E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 378 SGKLTEKSDVFSFGVLLLELIT-GFRPFDKADT 409
T KSDV+S+GV + EL+T G +P++
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 68/208 (32%), Positives = 110/208 (52%), Gaps = 19/208 (9%)
Query: 208 NLLGQGGFGYVHKGVLT-NGK---VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
++G G FG V +G L GK VAIK LKAGS +R +F E I+ Q H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
L G T +++ E++ N +L+ L D + + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF-TVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR-----VMGTFGYLAPEYAS 377
+HRD+ + NIL++ + KV+DFGL++ D++ +T+ + T APE +
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIA 181
Query: 378 SGKLTEKSDVFSFGVLLLELIT-GFRPF 404
K T SDV+SFG+++ E+++ G RP+
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
LG+G FG V G + + +VA+K LK + R+ F+ E E+++ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWP-------TR---MKIALGSA 310
G CT G ++V+E++ + L L HG D + P T ++IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFG 369
G+ YL +HRD+ + N L+ K+ DFG+++ TD + V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++ PE K T +SDV+SFGV+L E+ T G +P+
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 72/212 (33%), Positives = 109/212 (51%), Gaps = 19/212 (8%)
Query: 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRH 259
+F N +G+G FG V K V + +V A+KQ L + + E E +++++ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 260 LVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHG-KDRPVMN---WPTRMKIALGSARGL 313
++ Y +F + L V E+ N L L + RP+ W ++I LG L
Sbjct: 61 IIRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
A+LH KI+HRDIKS N+ LD K+ D G+AK L +T+ + ++GT YL+P
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSP 170
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
E EKSDV++ GV+L E TG PFD
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 8e-27
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 6/197 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG VH G VAIK ++ G+ E +F E +++ ++ H +LV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V E++ N L +L + + + + + + YL + IHRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 389
+ N L+ + KV+DFGLA++ LD S + PE + + KSDV+S
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 390 FGVLLLELIT-GFRPFD 405
FGVL+ E+ + G P++
Sbjct: 187 FGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLV 264
N +G G FG V+ V L G+++A+K+++ + +E E++++ + H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G + + E+ TLE L + + L GLAYLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH---GI 120
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV---MGTFGYLAPEYASSGKL 381
+HRDIK ANI LD + K+ DFG A + T + V GT Y+APE + GK
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 382 TEK---SDVFSFGVLLLELITGFRPFDKADT 409
+D++S G ++LE+ TG RP+ + D
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 72/244 (29%), Positives = 115/244 (47%), Gaps = 36/244 (14%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQVHHRHLVS 262
LLG G FG V++G+ L +G A+K++ ++ + EI ++S++ H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHE 318
+G + E VP +L L K PV+ TR + GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILL-----GLEYLHD 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY-AS 377
+HRDIK ANIL+D + K+ADFG+AK ++ S G+ ++APE A
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQ 175
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA--------------DDSMVDWAKPFL 423
G +D++S G +LE+ TG P+ + + A D + D AK F+
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235
Query: 424 AQGL 427
+ L
Sbjct: 236 LKCL 239
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 40/213 (18%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVG-- 265
LG+G +G V+K + G+VVAIK + +E EI I+ Q ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSY 67
Query: 266 -----------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSAR 311
YC GS ++ + NKTL T +IA + +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMK--ITNKTL---------------TEEEIAAILYQTLK 110
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
GL YLH K IHRDIK+ NILL++ +AK+ADFG++ DT +T V+GT ++
Sbjct: 111 GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWM 166
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
APE K+D++S G+ +E+ G P+
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 68/192 (35%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VAIK LK GS E F AE ++ Q+ H LV L T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT- 71
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
++ E++ N +L L + + + +A A G+A++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 387
++ANIL+ ++ K+ADFGLA+ L D + R F + APE + G T KSDV
Sbjct: 129 RAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 388 FSFGVLLLELIT 399
+SFG+LL E++T
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 39/285 (13%)
Query: 210 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LGQG FG V++G+ VAIK + + ER EF E ++ + + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-----DRPVMNWPTRMKI---ALGSARGLA 314
L+G + G L+V E + L+ +L + + P + PT K A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAP 373
YL K +HRD+ + N ++ + K+ DFG+ + +TD + + + ++AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA-DGNF 432
E G T KSDV+SFGV+L E+ T A +P+ QGL+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA----------TLA-------EQPY--QGLSNEEVL 231
Query: 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
++D + ++ C +++ + RP +IV +L+
Sbjct: 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 73/208 (35%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH 257
+I ++ LG G FG V G VA+K LK G+ E F E +I+ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRH 60
Query: 258 RHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
LV L Y + + +V E++ +L L + + P + +A A G+AY+
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPE 374
+ IHRD++SANIL+ D K+ADFGLA+ L D + R F + APE
Sbjct: 119 E---RMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPE 173
Query: 375 YASSGKLTEKSDVFSFGVLLLELITGFR 402
A G+ T KSDV+SFG+LL EL+T R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 72/196 (36%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 270 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ + +V E++ +L L G+ + P + +A A G+AY+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 386
+++ANIL+ ++ KVADFGLA+ L D + R F + APE A G+ T KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 387 VFSFGVLLLELITGFR 402
V+SFG+LL EL T R
Sbjct: 186 VWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 63/302 (20%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQ---AE 248
YE L+ +G+G FG V K V ++GK++ K++ G+ E+E Q +E
Sbjct: 2 YEVLET----------IGKGSFGTVRK-VRRKSDGKILVWKEIDYGN-MTEKEKQQLVSE 49
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL----EFHLHG----------KDR 294
+ I+ ++ H ++V Y R++ N+TL E+ G K+R
Sbjct: 50 VNILRELKHPNIV---RYY----DRIIDRS---NQTLYIVMEYCEGGDLAQLIQKCKKER 99
Query: 295 PVMNWPTRMKIALGSARGLAYLH--EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+ +I L H D ++HRD+K ANI LD + K+ DFGLAK
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK- 158
Query: 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
L D+ + +GT Y++PE + EKSD++S G L+ EL PF A
Sbjct: 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQ 217
Query: 413 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQI 472
LA + +G F + + E + + + +RP ++
Sbjct: 218 ----------LASKIKEGKFRRIPYRYSSELNEV--------IKSMLNVDPDKRPSTEEL 259
Query: 473 VR 474
++
Sbjct: 260 LQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
+ LG G +G V++GV VA+K LK + + E EF E ++ ++ H +LV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
CT ++ EF+ L +L +R +N + +A + + YL + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEK 384
RD+ + N L+ ++ KVADFGL++ L T + F + APE + K + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 385 SDVFSFGVLLLELIT-GFRPFDKAD 408
SDV++FGVLL E+ T G P+ D
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGID 210
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 68/213 (31%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF-QAEIEIISQVHHRHLV 261
F+ +G+G FG V+K + +VVAIK + + E E Q EI+ +SQ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 262 SLVG-------------YCTFGSQR-LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
G YC GS LL + + F L R V+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL----REVL---------- 108
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
GL YLHE+ IHRDIK+ANILL + + K+ADFG++ T + +T V GT
Sbjct: 109 ---LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GT 161
Query: 368 FGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400
++APE EK+D++S G+ +EL G
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 209 LLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 264 VGYCTFGSQRL---LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G C + + R LV E++P +L +L K R ++ + A +G+ YL
Sbjct: 71 KGVC-YSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK- 127
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMG---TFGYLAPEYA 376
+ +HRD+ + NIL++ K+ DFGL K D + + R G F Y APE
Sbjct: 128 --RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK-VREPGESPIFWY-APESL 183
Query: 377 SSGKLTEKSDVFSFGVLLLELIT 399
+ K + SDV+SFGV+L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 68/201 (33%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 210 LGQGGFGYV--HKGVLTN---GKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSL 263
LG+G FG V + N G++VA+K LK GQ ++ EI I+ ++H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 264 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G C+ + L+ E+VP +L +L + +N + A G+AYLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ-- 126
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG---TFGYLAPEYASS 378
IHRD+ + N+LLD+ K+ DFGLAK + + R G F Y A E
Sbjct: 127 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKE 184
Query: 379 GKLTEKSDVFSFGVLLLELIT 399
K + SDV+SFGV L EL+T
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 39/218 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA----EIEIISQVHHRHLVSLV 264
LG+G +G V+K G++VA+K+++ E + EI ++ ++ H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHG---KDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
+ LV+E+ + L K ++ I RGLAY H
Sbjct: 65 DVIHTERKLYLVFEY-----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAPE---- 374
+I+HRD+K NIL++ K+ADFGLA+ L T TH V+ T Y APE
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRAPEILLG 172
Query: 375 ---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
Y+++ D++S G + E+ITG +P D+
Sbjct: 173 SKHYSTA------VDIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYC 267
+G+G FG V+KGVL VA+K ++ + F E EI+ Q H ++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+V E VP +L L K V ++++L +A G+ YL I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK---LLQMSLDAAAGMEYLESKN---CI 115
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT-FGYLAPEYASSGKLTEK 384
HRD+ + N L+ ++ K++DFG+++ VS + + APE + G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 385 SDVFSFGVLLLELITG 400
SDV+S+G+LL E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 75/196 (38%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LGQG FG V G VAIK LK G+ E F E +I+ ++ H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 270 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ + +V EF+ +L L D + P + +A A G+AY+ + IHRD
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 386
+++ANIL+ D+ K+ADFGLA+ L D + R F + APE A G+ T KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 387 VFSFGVLLLELITGFR 402
V+SFG+LL EL+T R
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 210 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V N +VA+K LK S ++FQ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMN-----------WPTRMKIALGSA 310
G CT G L+V+E++ + L L HG D ++ + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFG 369
G+ YL +HRD+ + N L+ K+ DFG+++ TD + V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++ PE K T +SD++SFGV+L E+ T G +P+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 75/219 (34%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 208 NLLGQGGFGYVHKGVL--TNGKVV--AIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
++G+G FG V+ G L ++G+ + A+K L + E E F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-------MKIALGSARGLAY 315
L+G C L E P L + HG R + T + L A+G+ Y
Sbjct: 61 LLGIC-------LPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD---THVSTRVMGTFGYLA 372
L K +HRD+ + N +LD+SF KVADFGLA+ D + H T ++A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTF 410
E + K T KSDV+SFGVLL EL+T G P+ D+F
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF 209
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 14/204 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VAIK +K GS E EF E +++ ++ H LV L G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 270 GSQRLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+V E++ N L +L R + +++ G+AYL + IHRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS--QLLEMCKDVCEGMAYLESK---QFIHRD 125
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT---FGYLAPEYASSGKLTEKS 385
+ + N L+DD KV+DFGL+++ LD D + S+ +G+ + PE K + KS
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSS--VGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 386 DVFSFGVLLLELIT-GFRPFDKAD 408
DV++FGVL+ E+ + G P+++ +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 48/219 (21%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSL 263
+G+G +G V+K G++VA+K+++ + E+E A EI+++ ++ H ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 264 VGYCT--FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GL 313
T +V+E++ + + +K + GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE----------VKFTESQIKCYMKQLLEGL 113
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFGYLA 372
YLH I+HRDIK +NIL+++ K+ADFGLA+ + + RV+ T Y
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 373 PE-------YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
PE Y + D++S G +L EL G +P
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 70/241 (29%), Positives = 115/241 (47%), Gaps = 46/241 (19%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLK-AGSGQGEREFQAE 248
E+ ++ F E LG+G FG V+KG LT + VAIK LK + ++EF+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------ 302
E++S + H ++V L+G CT +++E++ + L L V N P
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL------VRNSPHSDVGAES 112
Query: 303 --------------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
+ IA+ A G+ YL +HRD+ + N L+ + K++DFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFG 169
Query: 349 LAKHSLDTDTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRP 403
L++ D + RV ++ PE GK T +SD++SFGV+L E+ + G +P
Sbjct: 170 LSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
Query: 404 F 404
+
Sbjct: 227 Y 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 66/220 (30%), Positives = 118/220 (53%), Gaps = 30/220 (13%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGERE-------FQAEIEIISQVHHR 258
L+G G FG V+ G+ ++G+++A+KQ L + S + EI ++ ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 259 HLVSLVGYCTFGSQRLLVY-EFVPNKTLEFHLHG----KDRPVMNWPTRMKIALGSARGL 313
++V +G + + L ++ E+VP ++ L+ ++ V N+ ++ +GL
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGL 119
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK----HSLDTDTHVS-TRVMGTF 368
YLH IIHRDIK ANIL+D+ K++DFG++K +SL T T+ + + G+
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
++APE T K+D++S G L++E++TG PF
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-22
Identities = 65/200 (32%), Positives = 110/200 (55%), Gaps = 16/200 (8%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+G+G FG V +G T G+ VA+K +K + Q F E +++++HH++LV L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-VI 68
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ +V E + L L + R +++ ++ +L A G+ YL K++HRD
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 329 IKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 387
+ + NIL+ + AKV+DFGLA+ S+ D +++ + APE K + KSDV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDN---SKL--PVKWTAPEALKHKKFSSKSDV 180
Query: 388 FSFGVLLLELIT-GFRPFDK 406
+S+GVLL E+ + G P+ K
Sbjct: 181 WSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH 257
+I ++ LG G FG V G N VA+K LK G+ + F E ++ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 60
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
LV L T ++ E++ +L L + + P + + A G+AY+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEY 375
+ IHRD+++AN+L+ +S K+ADFGLA+ + D + R F + APE
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEA 175
Query: 376 ASSGKLTEKSDVFSFGVLLLELIT 399
+ G T KSDV+SFG+LL E++T
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 12/215 (5%)
Query: 203 NFSEANLLGQGGFGYVHK-GVLTNGKVVAIKQLKAGS-GQGEREFQA-EIEIISQVHHRH 259
+F LG+G +G V+K L++ + A+K++ GS Q ERE EI I++ V+H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLH 317
++S G++ +V E+ P L + + + P + +I + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 377
E KI+HRD+KSANILL + K+ D G++K + T +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKT-QIGTPHYMAPEVWK 174
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
+ KSD++S G LL E+ T PF+ A + D
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQD 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 210 LGQGGFGYVHK-GVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 266
+G+G G V K G+ VA+K++ +G QA EI+ + H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--MKIALGSARGLAYLHEDCQPKI 324
GS +LV E++P+ L L ++RP+ + M++ L +G+AY+H + I
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN---GI 120
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE--YASSGKL 381
+HRD+K AN+L+ K+ADFGLA+ S + S +V T Y APE Y + K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR-KY 178
Query: 382 TEKSDVFSFGVLLLELITGFRPF 404
D+++ G + EL+ G P
Sbjct: 179 DPGVDLWAVGCIFAELLNG-SPL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 64/240 (26%), Positives = 98/240 (40%), Gaps = 53/240 (22%)
Query: 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQL---------KAGSGQGEREFQAEIEI 251
D+F ++G+G F V K AIK L K + E+E +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE------V 54
Query: 252 ISQV-HHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLH---GKDRPVMNWPTRMKI 305
++++ H ++ L Y TF + L V E+ PN L ++ D TR
Sbjct: 55 LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYA 108
Query: 306 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
A + A L YLH IIHRD+K NILLD K+ DFG AK + S +
Sbjct: 109 AEILLA--LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 365 M-------------------GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
GT Y++PE + + SD+++ G ++ +++TG PF
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 36/227 (15%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVS 262
LG+G FG V K K VA+K LK + E R+ +E ++ QV+H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----------------------HGKDRPVMNW 299
L G C+ LL+ E+ +L L + +R +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL-TM 126
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
+ A +RG+ YL E K++HRD+ + N+L+ + + K++DFGL++ + D++
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 360 VS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
V ++ ++A E T +SDV+SFGVLL E++T G P+
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-22
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 210 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V N +VA+K LK S ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVM---NWPTRMK------IALGSARG 312
G C G ++V+E++ + L L HG D +M N P + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYL 371
+ YL +HRD+ + N L+ ++ K+ DFG+++ TD + V M ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
PE K T +SDV+S GV+L E+ T G +P+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 37/226 (16%)
Query: 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLV 261
LG+G + V+K G++VAIK++K G + ++ F A EI+++ ++ H +++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 262 SLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-IALGSARGLAYLHE 318
L+ FG + LV+EF+ LE + KD+ ++ P +K L + RGL YLH
Sbjct: 66 GLLD--VFGHKSNINLVFEFMETD-LEKVI--KDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE---- 374
+ I+HRD+K N+L+ K+ADFGLA+ + ++ +V+ T Y APE
Sbjct: 121 N---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFG 176
Query: 375 ---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
Y D++S G + EL+ PF DS +D
Sbjct: 177 ARHYGVG------VDMWSVGCIFAELLLR-VPF-----LPGDSDID 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 66/216 (30%), Positives = 117/216 (54%), Gaps = 14/216 (6%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVL-TNGK---VVAIKQLKAGSGQGER-EFQAEIEII 252
+I + ++ ++G G FG V +G+L G+ VAIK LK G + +R +F +E I+
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 253 SQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 312
Q H +++ L G T +++ E++ N L+ +L D ++ + + G A G
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAG 119
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG---TFG 369
+ YL + +HRD+ + NIL++ + E KV+DFGL++ L+ D + G
Sbjct: 120 MKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIR 175
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
+ APE + K T SDV+SFG+++ E+++ G RP+
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-22
Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 6/198 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG VH G VAIK + G+ E +F E +++ ++ H LV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V EF+ N L +L + + ++ + + G+ YL + IHRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 389
+ N L+ + KV+DFG+ ++ LD + S+ + PE + K + KSDV+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 390 FGVLLLELIT-GFRPFDK 406
FGVL+ E+ T G PF+K
Sbjct: 187 FGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 71/224 (31%), Positives = 109/224 (48%), Gaps = 20/224 (8%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV---LTNGKV---VAIKQL-KAGSGQGEREFQAEIE 250
++ D+ + LG G FG V++G+ V VA+K L ++ S Q E +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMK----I 305
I+S+ +H+++V L+G R ++ E + L+ F + RP MK
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSLDTDTH-VS 361
A A+G YL E+ IHRDI + N LL AK+ADFG+A+ +
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
R M ++ PE G T K+DV+SFGVLL E+ + G+ P+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 8/199 (4%)
Query: 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYC 267
LLG+G FG V KG L + VA+K K Q + +F +E I+ Q H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKIIH 326
T +V E VP L K + + +K AL +A G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 386
RD+ + N L+ ++ K++DFG+++ D S + APE + G+ + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 387 VFSFGVLLLELIT-GFRPF 404
V+S+G+LL E + G P+
Sbjct: 177 VWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 210 LGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
LG+GGFG V V GK+ A K+L + +GE+ E +I+ +V R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 266 YCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
Y L LV + L++H++ P + A GL +LH Q +I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
++RD+K N+LLDD +++D GLA GT GY+APE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 385 SDVFSFGVLLLELITGFRPF 404
D F+ G L E+I G PF
Sbjct: 175 VDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 209 LLGQGGFGYVHKGVLTN--GKV--VAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSL 263
LG G FG V +G + GKV VA+K LK+ +F E I+ + H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
G ++V E P +L L T A+ A G+ YL +
Sbjct: 62 YG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST----RVMGTFGYLAPEYASSG 379
IHRD+ + NILL + K+ DFGL + + H +V F + APE +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTR 175
Query: 380 KLTEKSDVFSFGVLLLELIT-GFRPF 404
+ SDV+ FGV L E+ T G P+
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 60/220 (27%), Positives = 112/220 (50%), Gaps = 25/220 (11%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ----------AEIEIISQVHH 257
L+G+G +G V+ + +T G+++A+KQ++ + R +EIE + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGK-DRPVMNWPTRMKIALGSARGLA 314
++V +G+ T + E+VP ++ +G+ + ++ + T + GLA
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-GTFGYLAP 373
YLH I+HRD+K+ N+L+D K++DFG++K S D + M G+ ++AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 374 EYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFA 411
E S + K D++S G ++LE+ G RP+ + A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 210 LGQGGFG--YVHKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLV 264
+ +G +G ++ K T G + AIK +K + + E +I+SQ ++V L
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL- 58
Query: 265 GYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM------KIALGSARGLAYL 316
Y +F G + L LV E++P L L V + + +I L L YL
Sbjct: 59 -YYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLA----LEYL 109
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL-------DTDTHVSTRVMGTFG 369
H IIHRD+K NIL+D + K+ DFGL+K L + D R++GT
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
Y+APE ++ D +S G +L E + G PF
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 203 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQV 255
+F ++G+G FG V + K+ A+K + K R E I+ ++
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57
Query: 256 HHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARG 312
+H LV+L + +F LV + + L +HL + + I + A
Sbjct: 58 NHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLA-- 112
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
L YLH IIHRDIK NILLD+ + DF +A + DT ++ GT GY+A
Sbjct: 113 LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTS-GTPGYMA 167
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDK 406
PE + D +S GV E + G RP+
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 24/244 (9%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 264
LG G G V H+ GK++A+K ++ + + + E++I+ + + ++V
Sbjct: 9 LGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G + E++ +L+ + + + + KIA+ +GL YLHE + KI
Sbjct: 66 GAFYNNGDISICMEYMDGGSLD-KILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVSTRVMGTFGYLAPEYASSGKLT 382
IHRD+K +NIL++ + K+ DFG++ +++ T V GT Y+APE +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYS 177
Query: 383 EKSDVFSFGVLLLELITGFRPFDKADTFAD------DSMVDWAKPFLAQGLADGNFDALV 436
KSD++S G+ L+EL TG P+ + D +V+ P L G +F V
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237
Query: 437 DQKL 440
+ L
Sbjct: 238 NLCL 241
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 208 NLLGQGGFGYVHKGVLTN------GKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRH 259
N LG G FG V++G T+ G + VA+K L+ G+ E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLA 314
+V L+G C + ++ E + L +L P++ + I L A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 315 YLHEDCQPKIIHRDIKSANILL-----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGT-- 367
YL Q IHRD+ + N L+ D K+ DFGLA+ +D + R G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 368 --FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++APE GK T +SDV+SFGVL+ E++T G +P+
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-21
Identities = 62/222 (27%), Positives = 111/222 (50%), Gaps = 22/222 (9%)
Query: 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---GEREF---QAEIEIISQVHH 257
+++ +LG+G +G V+ G+ G+++A+KQ++ + E+E+ Q E++++ + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRPVMNWPTRMKIALGSARGLA 314
++V +G C + + EFVP ++ L+ PV T+ + G+A
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVA 116
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-----GTFG 369
YLH +C ++HRDIK N++L + K+ DFG A+ H + M GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411
++APE + KSD++S G + E+ TG P D A
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVSLVGYC 267
+G G V+ + L N + VAIK++ Q E + E++ +SQ +H ++V Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YT 66
Query: 268 TF--GSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+F G + LV ++ +L + R ++ + +GL YLH + Q
Sbjct: 67 SFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV----MGTFGYLAPEYASSG 379
IHRDIK+ NILL + K+ADFG++ SL + +V +GT ++APE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSA-SLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 380 K-LTEKSDVFSFGVLLLELITGFRPFDK 406
K+D++SFG+ +EL TG P+ K
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 29/210 (13%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
+++ +G G +G V+K + G++VAIK +K G Q EI ++ + H ++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 261 VSLVG-YCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGLAY 315
V+ G Y +L +V E+ +L+ P+ + ++IA + +GLAY
Sbjct: 63 VAYFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETLKGLAY 116
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA---KHSLDTDTHVSTR--VMGTFGY 370
LHE IHRDIK ANILL + + K+ADFG++ ++ + R +GT +
Sbjct: 117 LHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI------AKRKSFIGTPYW 167
Query: 371 LAPEYA---SSGKLTEKSDVFSFGVLLLEL 397
+APE A G K D+++ G+ +EL
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 40/221 (18%)
Query: 209 LLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHL 260
LG+G FG V K VA+K LK + + + + +E+E++ + H+++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVM-------NWPTRMKI-------- 305
++L+G CT +V E+ + L L + RP P +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLD-----TDT 358
A ARG+ +L K IHRD+ + N+L+ + K+ADFGLA+ H +D T+
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT 399
+ + M APE T +SDV+SFGVLL E+ T
Sbjct: 195 RLPVKWM------APEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 204 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 259
F + +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+VSL LV + L+FH++ + A GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
Q +I++RD+K NILLDD +++D GLA H + T + RV GT GY+APE +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDK 406
+ T D ++ G LL E+I G PF +
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 20/203 (9%)
Query: 210 LGQGGFGYVH------KGVLTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVS 262
LG+G FG V +G T G+ VA+K LK SG + + EIEI+ ++H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 263 LVGYCT--FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G CT G+ L+ EF+P+ +L+ +L +++ +N ++K A+ +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR- 128
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST----RVMGTFGYLAPEYA 376
+ +HRD+ + N+L++ + K+ DFGL K +++TD T F Y APE
Sbjct: 129 --QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 377 SSGKLTEKSDVFSFGVLLLELIT 399
K SDV+SFGV L EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 210 LGQGGFGYV-----HKGVLTNGK-VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V + T K +VA+K LK + ++FQ E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVM--NWPTRMKIALG----------S 309
G C G ++V+E++ + L L HG D ++ P + K LG
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTF 368
A G+ YL +HRD+ + N L+ + K+ DFG+++ TD + V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++ PE K T +SDV+SFGV+L E+ T G +P+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 7/205 (3%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ + +G+G G V+K GK VAIK+++ E EI I+ H +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPN 76
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V G + +V E++ +L + MN P + +GL YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEYLH-- 133
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
+IHRDIKS NILL K+ADFG A L + V+GT ++APE
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ-LTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 380 KLTEKSDVFSFGVLLLELITGFRPF 404
K D++S G++ +E+ G P+
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
LG G FG V KGV K VAIK LK + + R E E EI+ Q+ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPK 323
C +LV E L L GK V N M + G+ YL
Sbjct: 63 VCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQV---SMGMKYLEGK---N 115
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKL 381
+HRD+ + N+LL + AK++DFGL+K D++ R G + + APE + K
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 382 TEKSDVFSFGVLLLELIT-GFRPFDK 406
+ +SDV+S+G+ + E + G +P+ K
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKK 201
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 70/215 (32%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG----SGQGEREFQAEIEIIS 253
D+F LG G FG V HKG +GK A+K L Q E E I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVL-NEKRILQ 56
Query: 254 QVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGS 309
+ H LV+L G L LV E+VP L F K R ++ L
Sbjct: 57 SIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLA- 113
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
L YLH I++RD+K N+LLD K+ DFG AK + T+ + GT
Sbjct: 114 ---LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYT---LCGTPE 163
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
YLAPE S + D ++ G+L+ E++ G+ PF
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 67/216 (31%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 202 DNFSEANLLGQGGFGYVHK----GVLTNGKV--VAIKQLKAGSGQGERE-FQAEIEIISQ 254
+N S LG G FG V + G+ + V VA+K LK + ERE +E++I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 255 V-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
+ +H ++V+L+G CT G L++ E+ L L K + + + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 314 AYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV---STRVMGTFG 369
A+L ++C IHRD+ + N+LL K+ DFGLA+ ++ +V + R+
Sbjct: 155 AFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVK 208
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++APE + T +SDV+S+G+LL E+ + G P+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 11/212 (5%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGERE-FQAEIEIIS 253
I ++ + +G+G FG V++GV + + VA+K K + RE F E I+
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
Q H H+V L+G T + +V E P L +L ++ ++ + + + + L
Sbjct: 63 QFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTAL 120
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
AYL + +HRDI + N+L+ K+ DFGL+++ D + +++ ++AP
Sbjct: 121 AYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
Query: 374 EYASSGKLTEKSDVFSFGVLLLE-LITGFRPF 404
E + + T SDV+ FGV + E L+ G +PF
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 68/282 (24%), Positives = 130/282 (46%), Gaps = 42/282 (14%)
Query: 203 NFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVH 256
++ +LG+G FG + L + +V K+ L S + R+ EI I+S +
Sbjct: 1 HYIPIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGK----DRPVMNWPTRMKIALGSAR 311
H ++++ + + L+ E+ TL + + K + ++ W + SA
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW---YLFQIVSA- 113
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
++Y+H+ I+HRDIK+ NI L + K+ DFG++K L ++ ++ V+GT Y+
Sbjct: 114 -VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTPYYM 168
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431
+PE K KSD+++ G +L EL+T R FD + L + GN
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----------LVVKIVQGN 217
Query: 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 473
+ +V Y S+E+ + + ++ +RP +++
Sbjct: 218 YTPVVSV----Y-SSELISL---VHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 65/219 (29%), Positives = 113/219 (51%), Gaps = 21/219 (9%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKV-------VAIKQLKAGSGQGER-EFQAEI 249
++A + + + LGQG FG V++G+ G V VAIK + + ER EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG-----KDRPVMNWPTRMK 304
++ + + H+V L+G + G L++ E + L+ +L ++ PV P+ K
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 305 I---ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-V 360
+ A A G+AYL+ + K +HRD+ + N ++ + F K+ DFG+ + +TD +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT 399
+ + +++PE G T SDV+SFGV+L E+ T
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-20
Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 206 EANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
E N++ +G G +KG + NG +K++ + +EI + ++ H ++V L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLI 749
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G C L++E++ K L L ++W R KIA+G A+ L +LH C P +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
+ ++ I++D E + + SL T+ + Y+APE + +TEK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEK 858
Query: 385 SDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYD 444
SD++ FG++L+EL+TG P D A+ S+V+WA+ +D + D +D +
Sbjct: 859 SDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWAR----YCYSDCHLDMWIDPSIRGDV 913
Query: 445 SA---EMTRMAACAAACIRHSARRRPRMSQIVRALE 477
S E+ + A C RP + +++ LE
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 32/224 (14%)
Query: 210 LGQGGFGYVHK----GVLTNGK--VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVS 262
+GQG FG V + G+L +VA+K LK S + +FQ E ++++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 263 LVGYCTFGSQRLLVYEFV--------------------PNKTLEFHLHGKDRPVMNWPTR 302
L+G C G L++E++ + T G + ++ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VS 361
+ IA A G+AYL E K +HRD+ + N L+ ++ K+ADFGL+++ D + S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++ PE + T +SDV+++GV+L E+ + G +P+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 69/209 (33%), Positives = 111/209 (53%), Gaps = 20/209 (9%)
Query: 209 LLGQGGFGYVHKGVLTN-GK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 263
++G G FG V +G L GK VAIK LK+G + + R+F +E I+ Q H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQ 321
G T +++ EF+ N L+ L D V+ ++ G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE--- 124
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG-----YLAPEYA 376
+HRD+ + NIL++ + KV+DFGL++ L+ DT T G + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 377 SSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
+ K T SDV+S+G+++ E+++ G RP+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 9/202 (4%)
Query: 204 FSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 261
F++ +G+G FG V KG+ + VVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G G++ ++ E++ + L T +K L +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 120
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
K IHRDIK+AN+LL + + K+ADFG+A DT +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178
Query: 382 TEKSDVFSFGVLLLELITGFRP 403
K+D++S G+ +EL G P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRH 259
+ E + LG+G G V K L G + A+K + +++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 260 LVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRM------KIALGSAR 311
+V G S + E+ +L+ ++ K + R+ KIA +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGG---RIGEKVLGKIAESVLK 116
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
GL+YLH KIIHRDIK +NILL + K+ DFG+ S + ++ GT Y+
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV---SGELVNSLAGTFTGTSFYM 170
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
APE + SDV+S G+ LLE+ PF
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 209 LLGQGGFGYVHKGV-LTNGKV----VAIKQLKAGSGQGEREFQA---EIEIISQVHHRHL 260
LLG G FG VHKG+ + G VAIK ++ SG+ + FQ + + + H ++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYI 71
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRP--VMNWPTRMKIALGSARGLAY 315
V L+G C G+ LV + P +L H+ P ++NW ++ A+G+ Y
Sbjct: 72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL-DTDTHVSTRVMGTFGYLAPE 374
L E ++HR++ + NILL ++ADFG+A D + + ++A E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 375 YASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
G+ T +SDV+S+GV + E+++ G P+
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 38/291 (13%)
Query: 203 NFSEANLLGQGGFGYVHKGVLTNG------KVVAIKQLKAGSGQG-EREFQAEIEIISQV 255
N E LG+G FG V +V +K L+ + + EF+ E+++ ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HGKDRPVMNWPT----RMKIALG 308
H+++V L+G C ++ E+ L+ L KD + P ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
A G+ +L + +HRD+ + N L+ E KV+ L+K +++ + +
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP-FLAQG 426
+LAPE + KSDV+SFGVL+ E+ T G PF +D+ +++ + L
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG---LSDEEVLNRLQAGKLELP 239
Query: 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ +G L KL M C A + + RP S++V AL
Sbjct: 240 VPEGCPSRL--YKL----------MTRCWAV----NPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 204 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 259
F +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+VSL LV + L+FH++ P + + A GL LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
+I++RD+K NILLDD +++D GLA + +T + RV GT GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNE 176
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDK 406
+ T D + G L+ E+I G PF +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 73/221 (33%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQAE------IEIISQVHHRH 259
LG+G FG V +K G++ AIK LK G E ++ E + H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 260 LVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
LV+L C + V E+ L H+H V + P + A GL YLHE
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+ KI++RD+K N+LLD K+ADFGL K + ST GT +LAPE +
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTE 175
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPF---DKADTFADDSMV 416
T D + GVL+ E++ G PF D+ + F DS+V
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF--DSIV 214
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
+G+G FG V G G VA+K +K + + F AE +++Q+ H +LV L+G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 270 GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
L +V E++ +L +L + R V+ +K +L + YL + +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 388
+ + N+L+ + AKV+DFGL K + T V T APE K + KSDV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 389 SFGVLLLEL 397
SFG+LL E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 71/208 (34%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 204 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 259
F +LG+GGFG V V GK+ A K+L + +GE E I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 260 LVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
+VSL Y L LV + L+FH++ P + + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+ +I++RD+K NILLDD +++D GLA + +T V RV GT GY+APE ++
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDK 406
K T D + G L+ E+I G PF K
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 70/240 (29%), Positives = 104/240 (43%), Gaps = 54/240 (22%)
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV 255
L T F ++G+G +G V+K G++VAIK + E E + E I+ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKY 59
Query: 256 -HHRHLVSLVG-------------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRP 295
+H ++ + G C GS V + V L K +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKG------LRKKGK- 108
Query: 296 VMNWPTRMK------IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
R+K I + RGLAYLHE+ K+IHRDIK NILL + E K+ DFG+
Sbjct: 109 ------RLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159
Query: 350 AKHSLDTDTHVSTRVMGTFGYLAPEY-ASSGKLTE----KSDVFSFGVLLLELITGFRPF 404
+ LD+ +GT ++APE A + +SDV+S G+ +EL G P
Sbjct: 160 SAQ-LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 62/219 (28%), Positives = 113/219 (51%), Gaps = 29/219 (13%)
Query: 208 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLVS 262
+++G+G FG V K + + AIK++K + + + R+F E+E++ ++ HH ++++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL--------------EFHLHGKDRPVMNWPTRMKIALG 308
L+G C L E+ P+ L F + ++ + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
ARG+ YL Q + IHRD+ + NIL+ +++ AK+ADFGL++ + +V + MG
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK-KTMGRL 185
Query: 369 G--YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++A E + T SDV+S+GVLL E+++ G P+
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 209 LLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHLVSLVG 265
++G+G +G V K G++VAIK+ K + + E++++ Q+ H ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ LV+E+V LE L + R + +AY H II
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVR-SYIWQLLQAIAYCH---SHNII 122
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKH-----SLDTDTHVSTRVMGTFGYLAPE----YA 376
HRDIK NIL+ +S K+ DFG A+ + +V+TR Y APE
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPELLVGDT 177
Query: 377 SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
+ GK DV++ G ++ EL+ G P F DS +D
Sbjct: 178 NYGK---PVDVWAIGCIMAELLDG-EPL-----FPGDSDID 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQA---EIEIISQVH 256
N+ LLGQG FG V+ + G+ +A+KQ+ S + ++E A EI+++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 257 HRHLVSLVGYCTFGSQRLLVY-EFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGL 313
H +V G C + L ++ E++P +++ L +G + TR K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTR-KYTRQILEGV 117
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGTFGYL 371
YLH + I+HRDIK ANIL D + K+ DFG +K ++ + V GT ++
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELIT 399
+PE S K+DV+S G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 203 NFSEANLLGQGGFGYVH--KGVLTNGKVVAIKQLKA-GSGQGERE-FQAEIEIISQVHHR 258
+ + ++G+G FG VH + + K+V IKQ+ + ER Q E +++ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
+++ ++V E+ P TL ++ + +++ T + + L ++H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH- 118
Query: 319 DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 377
I+HRD+K+ NILLD K+ DFG++K L + + T V+GT Y++PE
Sbjct: 119 --TKLILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYISPELCE 174
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
+KSD+++ G +L EL + R F+ A+
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
LG G FG V+K G A K ++ S + +F EI+I+S+ H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ ++ ++ EF L+ + +R + P + L +LH K+IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA-----SSGKLTE 383
+K+ NILL + K+ADFG++ + T T + GT ++APE
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDY 187
Query: 384 KSDVFSFGVLLLEL 397
K+D++S G+ L+EL
Sbjct: 188 KADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 254
E + D E +LG+G +G V+ L+ +AIK++ + + EI + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK------DRPVMNWPTRMKIALG 308
+ HR++V +G + + E VP +L L K + + + T+ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
GL YLH++ +I+HRDIK N+L++ S K++DFG +K + T GT
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGT 172
Query: 368 FGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPF 404
Y+APE G +D++S G ++E+ TG PF
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 71/215 (33%), Positives = 115/215 (53%), Gaps = 25/215 (11%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVV----AIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVS 262
+LG G FG V+KG+ + G+ V AIK L +G + EF E I++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLH-GKD----RPVMNWPTRMKIALGSARGLAYLH 317
L+G C + +L V + +P+ L ++H KD + ++NW ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEY 375
E +++HRD+ + N+L+ K+ DFGLA+ L+ D G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEKEYNADGGKMPIKWMALEC 182
Query: 376 ASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADT 409
K T +SDV+S+GV + EL+T G +P+D T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 64/232 (27%), Positives = 116/232 (50%), Gaps = 28/232 (12%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLK-AGSGQGEREFQAEI 249
EL ++ F E LG+ FG ++KG L + ++VAIK LK + Q EFQ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHL--------------HGKDR 294
+++++HH ++V L+G T +++E++ L EF + G +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 295 PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
++ + IA+ A G+ YL +H+D+ + NIL+ + K++D GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 355 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
D + V + + ++ PE GK + SD++SFGV+L E+ + G +P+
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLV 261
+ L+G+G +G V++G + G+VVA+K + + + + Q E+ ++SQ+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 262 SLVGY--CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN-WPTRMKIALGSAR----GLA 314
++ Y RL + +E+ G R +M P K R L
Sbjct: 63 NITKYYGSYLKGPRLWI-------IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK 115
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 374
Y+H+ +IHRDIK+ANIL+ ++ K+ DFG+A L+ ++ + +GT ++APE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAA-LLNQNSSKRSTFVGTPYWMAPE 171
Query: 375 YASSGKLTE-KSDVFSFGVLLLELITGFRPFDKADTF 410
+ GK + K+D++S G+ + E+ TG P+ D F
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 204 FSEANLLGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRH 259
F + +LG+GGFG V V GK+ A K+L + +GE E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V+L LV + L+FH++ P + A GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
+ ++RD+K NILLDD +++D GLA + ++ + RV GT GY+APE ++
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQ 176
Query: 380 KLTEKSDVFSFGVLLLELITGFRPF 404
+ T D + G L+ E+I G PF
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 204 FSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 261
F++ +G+G FG V+KG+ K VVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 262 SLVGYCTFGSQRLLVYEFV----------PNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
G G++ ++ E++ P E ++ R ++ +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-------------K 112
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
GL YLH + + IHRDIK+AN+LL + + K+ADFG+A DT +T V GT ++
Sbjct: 113 GLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 168
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
APE K+D++S G+ +EL G P
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 67/206 (32%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 209 LLGQGGFGYVHKGVL-TNGK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 263
++G G FG V G L GK VAIK LKAG + + R+F +E I+ Q H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQ 321
G T ++V E++ N +L+ L D V+ ++ G A G+ YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSD--- 124
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG--YLAPEYASSG 379
+HRD+ + NIL++ + KV+DFGL++ D T G + APE +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 380 KLTEKSDVFSFGVLLLELIT-GFRPF 404
K T SDV+S+G+++ E+++ G RP+
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 266
+G+G +G V+K G++VAIK++K A EI+++ +++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
LV+EF+ + L + + R + +GLA+ H I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPE-SLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTD----TH-VSTRVMGTFGYLAPE--YASSG 379
RD+K N+L++ K+ADFGLA+ S + TH V TR Y APE G
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVVTR-----WYRAPELLLGDKG 175
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
+ D++S G + EL++ RP F S +D
Sbjct: 176 -YSTPVDIWSVGCIFAELLSR-RPL-----FPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 63/190 (33%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V VA+K +K GS E F AE ++ + H LV L T
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT- 71
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
++ EF+ +L L + P + + A G+A++ Q IHRD+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 128
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 389
++ANIL+ S K+ADFGLA+ D + + APE + G T KSDV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 390 FGVLLLELIT 399
FG+LL+E++T
Sbjct: 189 FGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 210 LGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLV 264
LG G FG V KG+ + K VA+K LK + + E E ++ Q+ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 265 GYCTFGSQRLLVYEFVP----NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G C +LV E NK L+ + H ++ + ++ + G+ YL E
Sbjct: 63 GICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET- 114
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASS 378
+HRD+ + N+LL AK++DFGL+K + + + G + + APE +
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 379 GKLTEKSDVFSFGVLLLELIT-GFRPF 404
K + KSDV+SFGVL+ E + G +P+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 210 LGQGGFGYVH----KGVLT-----------NGKVVAIKQLKAGSGQGER-EFQAEIEIIS 253
LG+G FG VH +G+ +VA+K L+A + R +F EI+I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL----------HGKDRPVMNWPTRM 303
++ + +++ L+G C ++ E++ N L L H + P ++ +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VST 362
+A+ A G+ YL +HRD+ + N L+ + + K+ADFG++++ D + +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT 399
R + ++A E GK T SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 31/220 (14%)
Query: 208 NLLGQGGFGYVHKGVLT---NGKVVAIKQLKA-GSGQGEREFQAEIEIISQV-HHRHLVS 262
+++G+G FG V + ++ AIK LK S R+F E+E++ ++ HH ++++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPT---------------RMKIAL 307
L+G C + E+ P L L K R + P ++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
A G+ YL E + IHRD+ + N+L+ ++ +K+ADFGL++ + +V + MG
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK-KTMGR 179
Query: 368 FG--YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++A E + T KSDV+SFGVLL E+++ G P+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 210 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLVG 265
LG+GGFG V + GK+ A K+L + + ++ E I+++VH R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA- 59
Query: 266 YCTFGSQR--LLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
F ++ LV + L +H++ ++ P P GL +LH Q
Sbjct: 60 -YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---Q 115
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
+II+RD+K N+LLD+ +++D GLA D + + GT G++APE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174
Query: 382 TEKSDVFSFGVLLLELITGFRPF 404
D F+ GV L E+I PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 23/215 (10%)
Query: 204 FSEANLLGQGGFGYVHKGVLT----NGKV-VAIKQLK-AGSGQGEREFQAEIEIISQVHH 257
F + +LG G FG V+KG+ K+ VAIK+L+ A S + +E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVP-NKTLEFHLHGKDR----PVMNWPTRMKIALGSARG 312
H+ L+G C S L+ + +P L++ KD ++NW ++ A+G
Sbjct: 69 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYL 371
+ YL E +++HRD+ + N+L+ K+ DFGLAK D + + ++
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFD 405
A E T +SDV+S+GV + EL+T G +P+D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 209 LLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSL 263
+LG+G FG V L ++ A+K LK + + E +++ H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 264 VGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
+ F ++ RL V E+V L FH+ R + P A GL +LHE
Sbjct: 62 --HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER-- 115
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
II+RD+K N+LLD K+ADFG+ K + ST GT Y+APE S
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPEILSYQPY 173
Query: 382 TEKSDVFSFGVLLLELITGFRPFDKAD 408
D ++ GVLL E++ G PF+ D
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 46/221 (20%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQ 254
F + N +G+G +G V++ T+G++VA+K+++ + E EI ++
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-----DNERDGIPISSLREITLLLN 62
Query: 255 VHHRHLVSL----VGYCTFGSQRL----LVYEFVPNKTLEFHLHGKDRPVMNWPT----- 301
+ H ++V L VG + L LV E+ + N PT
Sbjct: 63 LRHPNIVELKEVVVG------KHLDSIFLVMEYCE--------QDLASLLDNMPTPFSES 108
Query: 302 RMK-IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
++K + L RGL YLHE+ IIHRD+K +N+LL D K+ADFGLA+ +
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 361 STRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITG 400
+ +V+ T Y APE T D+++ G +L EL+
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 69/219 (31%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 209 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVS 262
L+G+G +G V HK G++VAIK+ + A EI ++ Q+ H +LV+
Sbjct: 8 LVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL---EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
L+ + LV+EFV + L E + +G D + K RG+ + H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-----KYLFQILRGIEFCHSH 119
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY-ASS 378
IIHRDIK NIL+ S K+ DFG A+ +L V T + T Y APE
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
K D+++ G L+ E++TG P F DS +D
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG-EPL-----FPGDSDID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-17
Identities = 62/219 (28%), Positives = 115/219 (52%), Gaps = 29/219 (13%)
Query: 208 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLVS 262
+++G+G FG V K + + AIK++K + + + R+F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 263 LVGYCTFGSQRLLVYEFVP----------NKTLE----FHLHGKDRPVMNWPTRMKIALG 308
L+G C L E+ P ++ LE F + ++ + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
ARG+ YL + + IHRD+ + NIL+ +++ AK+ADFGL++ + +V + MG
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK-KTMGRL 173
Query: 369 G--YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++A E + T SDV+S+GVLL E+++ G P+
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 45/242 (18%)
Query: 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGE-REFQAEI 249
FT E+LK + +G+G FG V+K + G ++A+K++++ + E + ++
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 250 EIISQVHHRHLVSLVGY--CTFGSQRLLV------------YEFVPNKTLEFHLHGKDRP 295
+++ + +V + F + Y++V + K
Sbjct: 54 DVV--MRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYV-------YEVLKSV- 103
Query: 296 VMNWPTRM--KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
P + KIA+ + + L YL E+ KIIHRD+K +NILLD + K+ DFG++
Sbjct: 104 ---IPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158
Query: 354 LDTDTHVSTRVMGTFGYLAPE-YASSG--KLTEKSDVFSFGVLLLELITGFRPFDKADTF 410
+ D+ TR G Y+APE S +SDV+S G+ L E+ TG P+ K ++
Sbjct: 159 V--DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216
Query: 411 AD 412
D
Sbjct: 217 FD 218
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 78/238 (32%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIEIISQVHH 257
+G G +G V V G+ VAIK++ F EI+++ + H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH------------LHGKDRPVMNWPTRMKI 305
+++ L L + P +F+ LH V+ +
Sbjct: 59 ENIIGL----------LDI--LRPPSPEDFNDVYIVTELMETDLH----KVI----KSPQ 98
Query: 306 ALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
L RGL YLH +IHRD+K +NIL++ + + K+ DFGLA+ +D
Sbjct: 99 PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVD 154
Query: 356 TDT--------HVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
D +V TR Y APE SS + T+ D++S G + EL+T +P
Sbjct: 155 PDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGEREFQAE 248
E+L+ +D LG G G V K G + KVV I + Q RE Q
Sbjct: 5 EDLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ-- 55
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIA 306
I+ + ++VS G + + EF+ +L+ ++ K P+ P + KIA
Sbjct: 56 --IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD-RIYKKGGPI---PVEILGKIA 109
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHVSTRV 364
+ GL YL+ +I+HRDIK +NIL++ + K+ DFG++ +++ DT V
Sbjct: 110 VAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---- 163
Query: 365 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 414
GT Y++PE GK T KSDV+S G+ ++EL G PF ++ D
Sbjct: 164 -GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 210 LGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG G FG V+K G L KV+ K S + ++ EIEI++ +H ++V L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G + + ++ EF P ++ + DR + P I L YLH K
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVICRQMLEALQYLH---SMK 130
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 383
IIHRD+K+ N+LL + K+ADFG++ ++ T +GT ++APE + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 384 -----KSDVFSFGVLLLEL 397
K+D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 204 FSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKA-GSGQGE-REFQAEIEIISQVH 256
+LG+G FG V +G L + KV A+K +K E EF +E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 257 HRHLVSLVGYCTFGSQR------LLVYEFVPNKTLE---FHLHGKDRPVMNWPTRM--KI 305
H +++ L+G C S +++ F+ + L + P P + K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE-KLPLQTLLKF 118
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+ A G+ YL IHRD+ + N +L + VADFGL+K D + R+
Sbjct: 119 MVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 366 GT-FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++A E + T KSDV++FGV + E+ T G P+
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 69/207 (33%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQ---AEIEIISQV-HHRHLVSL 263
+LG+G FG V L + AIK LK + + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 264 VGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
YCTF ++ L V E++ L FH+ + + P A GL +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK-- 115
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
I++RD+K NILLD K+ADFG+ K ++ D T GT Y+APE K
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKY 173
Query: 382 TEKSDVFSFGVLLLELITGFRPFDKAD 408
D +SFGVLL E++ G PF D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 49/301 (16%)
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGERE-FQAEIE 250
+ I+ D + ++LL +G FG + G+L + K V +K +K + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK-TLEFHLH-GKDRPVMNW---PTRMKI 305
++ + H++++ ++ C + V N L+ L + N T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 306 ALGS--ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
+ A G++YLH + +IH+DI + N ++D+ + K+ D L++ D H
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC--- 174
Query: 364 VMGT-----FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVD 417
+G ++A E + + + SDV+SFGVLL EL+T G P+ + D F
Sbjct: 175 -LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------ 227
Query: 418 WAKPFLAQGLADGNFDALVDQKLEEYDSA--EMTRMAACAAACIRHSARRRPRMSQIVRA 475
+A L DG +L + + E+ + AC C RP SQ+V+
Sbjct: 228 -----MAAYLKDG-------YRLAQPINCPDELFAVMAC---CWALDPEERPSFSQLVQC 272
Query: 476 L 476
L
Sbjct: 273 L 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 210 LGQGGFGYVHKGV---LTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LGQG FG V++G + G+ VA+K + + ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--------MKIALGSARGLA 314
L+G + G L+V E + + L+ +L N P R +++A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAP 373
YL+ K +HRD+ + N ++ F K+ DFG+ + +TD + + + ++AP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 374 EYASSGKLTEKSDVFSFGVLLLELIT 399
E G T SD++SFGV+L E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 203 NFSEANLLGQGGFG--YVHKGVLTNGKVVAIKQLK---AGSGQGEREFQA---EIEIISQ 254
+ + LG G F Y + V T G ++A+KQ+ S + E +A EI ++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMAR 59
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
++H H++ ++G S L E++ ++ L K + RGL+
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVI-INYTEQLLRGLS 117
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLAKHSLDTDT---HVSTRVMGTFGY 370
YLHE+ +IIHRD+K AN+L+D + + ++ADFG A T +++GT +
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 371 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
+APE + DV+S G +++E+ T P++
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLV 261
F++ +G+G FG V KG+ KVVAIK + + E E Q EI ++SQ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G ++ ++ E++ + L T ++ L +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 120
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
K IHRDIK+AN+LL + E K+ADFG+A DT +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 382 TEKSDVFSFGVLLLELITGFRP 403
K+D++S G+ +EL G P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 42/217 (19%)
Query: 211 GQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLV 264
G+G +G V+K N GK AIK+ K Q Q+ EI ++ ++ H ++VSLV
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 265 GYC-TFGSQRL-LVYEFVPNKTLE---FHLHGKDRPVMNWPTRMKIALGSA-----RGLA 314
+ + L++++ + + FH K + P M + S G+
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI---PPSM---VKSLLWQILNGVH 122
Query: 315 YLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLA-------KHSLDTDTHVSTR 363
YLH + ++HRD+K ANIL+ + K+ D GLA K D D
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-----P 174
Query: 364 VMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELIT 399
V+ T Y APE + T+ D+++ G + EL+T
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 38/245 (15%)
Query: 203 NFSEANLLGQGGFGYVH------------KGVLTNGKV-----VAIKQLKAGSGQGER-E 244
NF E LG+G FG VH K N VA+K L+ + R +
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 245 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP----NKTLEFHLHGKDRPVMNWP 300
F E++I+S++ ++ L+G CT ++ E++ N+ L+ H+ N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 301 -----TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
T + +A A G+ YL +HRD+ + N L+ ++ K+ADFG++++
Sbjct: 126 SLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 356 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR--PFDKADTFAD 412
+D + V R ++A E GK T KSDV++FGV L E++T R P++ D
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---D 239
Query: 413 DSMVD 417
+++
Sbjct: 240 QQVIE 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 69/262 (26%), Positives = 101/262 (38%), Gaps = 64/262 (24%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG----SGQGEREFQAEIEIIS 253
D+F ++G+G FG V K G+V A+K L+ Q +AE +I++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILA 56
Query: 254 QVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTR-----MKIA 306
+V L Y +F + L V E++P L L KD R + +A
Sbjct: 57 DADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA 113
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--------------- 351
L S L + IHRDIK NIL+D K+ADFGL K
Sbjct: 114 LDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 352 -------------HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 398
+ +GT Y+APE + D +S GV+L E++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 399 TGFRPFDKADTFADDSMVDWAK 420
GF PF ++D + K
Sbjct: 225 YGFPPF-----YSDTLQETYNK 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 73/220 (33%), Positives = 112/220 (50%), Gaps = 31/220 (14%)
Query: 209 LLGQGGFG---YVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIE--IISQVHHRHLVS 262
+LGQG FG V K + G++ A+K LK + + + ++E I+++V+H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 263 L-VGYCTFGSQRLLVYEFVPNKTLEFHLHGKD------RPVMNWPTRMKIALGS-ARGLA 314
L + T G L+ L+F L G D + VM +K L A L
Sbjct: 63 LHYAFQTEGKLYLI---------LDF-LRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 112
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 374
+LH II+RD+K NILLD+ K+ DFGL+K S+D + + GT Y+APE
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 168
Query: 375 YASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
+ T+ +D +SFGVL+ E++TG PF D+ +T
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 209 LLGQGGFGYVHKG-VLTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQVHH-RHLVSLVG 265
+G G G V+K G V+A+KQ+ + G+ + + +++++ + H ++V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 266 YCTFGS-------------QRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
Y S +LL + +P L GK M +A+ A
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDIL-----GK----------MTVAIVKA 126
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
L YL E +IHRD+K +NILLD S K+ DFG++ +D+ TR G Y
Sbjct: 127 --LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAY 180
Query: 371 LAPEYASSGKLTEK----SDVFSFGVLLLELITGFRPFDKADT 409
+APE K +DV+S G+ L+EL TG P+ T
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 24/153 (15%)
Query: 266 YCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLAY 315
+CTF ++ L V E++ L FH+ R AR GL +
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----------FDEARARFYAAEIICGLQF 111
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LH+ II+RD+K N+LLD K+ADFG+ K +++ + ST GT Y+APE
Sbjct: 112 LHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEI 167
Query: 376 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
K E D +SFGVLL E++ G PF D
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 204 FSEANLLGQGGFGYVH--KGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHR 258
F++ +G G FG V+ + V TN +VVAIK++ Q ++Q E+ + Q+ H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 259 HLVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+ + G LV E+ + LE H + + I G+ +GLAY
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVH-----KKPLQEVEIAAICHGALQGLAY 130
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LH + IHRDIK+ NILL + K+ADFG A ++ V GT ++APE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182
Query: 376 ---ASSGKLTEKSDVFSFGVLLLEL 397
G+ K DV+S G+ +EL
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 25/211 (11%)
Query: 209 LLGQGGFGYVHKGVLT----NGKV-VAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVS 262
+LG G FG V+KG+ N K+ VAIK L+ S + +E E +++ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-HGKDR----PVMNWPTRMKIALGSARGLAYLH 317
L+G C S LV + +P L ++ KDR ++NW ++ A+G++YL
Sbjct: 74 LLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT--FGYLAPEY 375
E +++HRD+ + N+L+ K+ DFGLA+ LD D G ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLDIDETEYHADGGKVPIKWMALES 182
Query: 376 ASSGKLTEKSDVFSFGVLLLELIT-GFRPFD 405
+ T +SDV+S+GV + EL+T G +P+D
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 210 LGQGGFGYVHK-GVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVG 265
LG GGFG V V + + A+K +K + +E EI+ + +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 266 YCTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMN-WPTRMKIALGSARGLAYLHEDCQ 321
Y TF ++ +Y E+ L L DR + + + R IA YLH
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILR--DRGLFDEYTARFYIA-CVVLAFEYLHNR-- 112
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
II+RD+K N+LLD + K+ DFG AK L + T GT Y+APE +
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFC-GTPEYVAPEIILNKGY 169
Query: 382 TEKSDVFSFGVLLLELITGFRPF 404
D +S G+LL EL+TG PF
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 4e-16
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 49/217 (22%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--------EIEIISQV-HHRH 259
LG G FG V+ G++VAIK++K ++F + E++ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 260 LVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
+V L F + L V+E++ + K +P + I +GLA++H
Sbjct: 60 IVKL--KEVFRENDELYFVFEYMEGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIH 116
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD----TDTHVSTRVMGTFGYLAP 373
+ HRD+K N+L+ K+ADFGLA+ TD +VSTR Y AP
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD-YVSTR-----WYRAP 167
Query: 374 E-------YASSGKLTEKSDVFSFGVLLLELITGFRP 403
E Y+S D+++ G ++ EL T RP
Sbjct: 168 EILLRSTSYSS------PVDIWALGCIMAELYT-LRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 74/312 (23%), Positives = 133/312 (42%), Gaps = 67/312 (21%)
Query: 210 LGQGGFGYVHKGVLTNGK-----------------VVAIKQLKAGSGQGER-EFQAEIEI 251
LG+G FG VH + N + +VA+K L+ + + R +F E++I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HGKDR-------------- 294
+S++ +++ L+G C ++ E++ N L L H D+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 295 PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
P +++ + + +AL A G+ YL +HRD+ + N L+ ++ K+ADFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 355 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR--PFDKADTFA 411
D + + R + ++A E GK T SDV++FGV L E++ + P+ +
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE---LT 246
Query: 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAA-------CIRHSAR 464
D+ +++ A F DQ + Y + R C C R
Sbjct: 247 DEQVIENAGEFFR------------DQGRQVY----LFRPPPCPQGLYELMLQCWSRDCR 290
Query: 465 RRPRMSQIVRAL 476
RP S I L
Sbjct: 291 ERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 60/174 (34%), Positives = 80/174 (45%), Gaps = 31/174 (17%)
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG--- 369
L +H +IHRDIKSANILL + K+ DFG +K T VS V TF
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTP 209
Query: 370 -YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428
Y+APE ++K+D+FS GVLL EL+T RPFD + M + LA
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLA---- 259
Query: 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 482
G +D L E M A + +RRP S+++ NMP+
Sbjct: 260 -GRYDPLPPSISPE--------MQEIVTALLSSDPKRRPSSSKLL-----NMPI 299
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLV 264
+LG+G FG V L G+ A+K LK + + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 265 GYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
YCTF ++ L V EF+ L FH+ K R + T + GL +LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQFLHSK--- 115
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT 382
II+RD+K N++LD K+ADFG+ K ++ D ST GT Y+APE K T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 383 EKSDVFSFGVLLLELITGFRPFDKAD 408
D +SFGVLL E++ G PF D
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 53/200 (26%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 210 LGQGGFGYVHKG-VLTNGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
LG G G V+K L +++A+K + + + +++ +E+EI+ + +++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG-A 67
Query: 268 TFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
F R+ + EF+ +L+ ++ K + +IA+ +GL YL KI+H
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYL---WSLKILH 118
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 386
RD+K +N+L++ + K+ DFG++ +++ ++ +GT Y+APE S + SD
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 387 VFSFGVLLLELITGFRPFDK 406
V+S G+ +EL G P+ +
Sbjct: 176 VWSLGISFMELALGRFPYPQ 195
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 38/218 (17%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQA----EIEIISQV 255
D + + N + +G +G V++ G++VA+K+LK E+E F EI I+ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKL 61
Query: 256 HHRHLVSLVGYCTFGS---QRLLVYEFVPN--KTLEFHLHG-------KDRPVMNWPTRM 303
H ++V+ V GS + +V E+V + K+L + K M
Sbjct: 62 QHPNIVT-VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK--------CLM 112
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
L G+A+LH++ I+HRD+K++N+LL++ K+ DFGLA+ T+
Sbjct: 113 LQLL---SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQ 165
Query: 364 VMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITG 400
++ T Y APE + + + D++S G + EL+T
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 210 LGQGGFGYVHKGVLTNGKVVA---IKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
+G G FG V G G A +K+L+A + E+ F E++ +++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGSARGLAYLHEDCQP 322
C LLV EF P L+ +L V + ++A A GL +LH Q
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT-FGYLAPEYASS--- 378
IH D+ N L K+ D+GLA D +++ +LAPE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 379 ----GKLTEKSDVFSFGVLLLELIT-GFRPF 404
T+KS+++S GV + EL T +P+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 18/188 (9%)
Query: 226 GKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL-VYEFVP 281
G VAIK L+ + + E + F+ E + ++++H ++V+L+ L V+E+VP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DD 338
+TL L + ++ L LA H I+HRD+K NI++
Sbjct: 63 GRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 339 SFEAKVADFGL------AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 392
AKV DFG+ + + +T V+GT Y APE +T SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 393 LLLELITG 400
+ LE +TG
Sbjct: 178 IFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLK-AGSGQGERE-FQAEIEIISQVHHRHLVSLV 264
LG+G FG V +G L VA+K +K A + E E F +E + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 265 GYCTFGSQR------LLVYEFVPNKTLE-FHLHGK--DRPVMNWPTRM--KIALGSARGL 313
G C + +++ F+ + L F L+ + D P PT+M K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY-LPTQMLVKFMTDIASGM 125
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT-FGYLA 372
YL IHRD+ + N +L+++ VADFGL+K + D + R+ ++A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
E + T KSDV+SFGV + E+ T G P+
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLV 261
F L+G G +G V+KG + G++ AIK + +G E E + EI ++ + HHR++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 262 SLVGYCT------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+ G Q LV EF ++ + + I RGL++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LH Q K+IHRDIK N+LL ++ E K+ DFG++ LD +GT ++APE
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPEV 182
Query: 376 ASSGKLTE-----KSDVFSFGVLLLELITGFRPF 404
+ + + KSD++S G+ +E+ G P
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
G+ LH+ IIHRDIK N+L+D + K+ DFGL+++ L + + +GT YL
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYL 160
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
APE + SD +S G ++ E + G+ PF A+T
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH-AET 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHH 257
D+ +G G FG VH + A+K + + E+ E ++ +V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 258 RHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
++ L + T QR L + E+VP L +L R + T + A L Y
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEY 116
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD-TDTHVSTRVMGTFGYLAPE 374
LH +I++RD+K NILLD K+ DFG AK D T T + GT YLAPE
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPE 168
Query: 375 YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 410
S + D ++ G+L+ E++ G+ PF + F
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK--AGSGQGEREFQA---EIEIISQVH 256
N+ LLGQG FG V+ + G+ +A KQ++ S + +E A EI+++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 257 HRHLVSLVGYCTFGSQRLLV--YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +V G +++ L E++P +++ L K + K G++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMS 120
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST---RVMGTFGYL 371
YLH + I+HRDIK ANIL D + K+ DFG +K L T T V GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR-LQTICMSGTGIRSVTGTPYWM 176
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411
+PE S K+DV+S G ++E++T P+ + + A
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 71/234 (30%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGEREFQA---------EIEI 251
D + + +G G +G V T VAIK+L R FQ+ E+ +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRL 67
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-F-------HLHGKDRPVMNWPTRM 303
+ + H +++ L L V F P +LE F HL G D +N +
Sbjct: 68 LKHMDHENVIGL----------LDV--FTPASSLEDFQDVYLVTHLMGAD---LNNIVKC 112
Query: 304 K---------IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+ + RGL Y+H IIHRD+K +NI +++ E K+ DFGLA+H+
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
Query: 355 DTDT-HVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITG 400
D T +V+TR Y APE Y + D++S G ++ EL+TG
Sbjct: 170 DEMTGYVATR-----WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 31/234 (13%)
Query: 198 KIATDNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAE 248
++ D LG+G FG V K VA+K LK+ + + + + +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 249 IEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW---PTRMK 304
+E++ + H+++++L+G CT ++ E+ L +L + P M + PT++
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 305 IALGS-----------ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-- 351
S ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
H +D + + ++APE T +SDV+SFGVLL E+ T G P+
Sbjct: 191 HHIDYYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 209 LLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLV 264
+LG+G FG V L +G++ A+K LK + + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 265 GYCTFGSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
C RL V EFV L FH+ R + A L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---G 116
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 383
II+RD+K N+LLD K+ADFG+ K + ST GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYGP 175
Query: 384 KSDVFSFGVLLLELITGFRPFD 405
D ++ GVLL E++ G PF+
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 202 DNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAEIEII 252
D + LG+G FG V K VA+K LK + + + + +E+E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 253 SQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW----------PT 301
+ H+++++L+G CT ++ E+ L +L + P M +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 302 RMKIALGS----ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
K + ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+ + D
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 358 THVSTRVMGTFG-----YLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
+ T T G ++APE T +SDV+SFGVL+ E+ T G P+
Sbjct: 192 YYKKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVH 256
NF +G+G F V+K + L +G+VVA+K+++ + Q EI+++ Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
H +++ + ++ +V E + H + R + T K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTIWKYFVQLCSAL 119
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
++H +I+HRDIK AN+ + + K+ D GL + + T + ++GT Y++P
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSP 175
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITGFRPF--DKADTFA 411
E KSD++S G LL E+ PF DK + ++
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 23/198 (11%)
Query: 210 LGQGGFGYVHKGVL-TNGKVVAIK--------QLKAGSGQGEREFQAEIEIISQVHHRHL 260
+G+G FG V G L + VA+K LKA +F E I+ Q H ++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-------KFLQEARILKQYSHPNI 55
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
V L+G CT +V E V L + P + +++ +A G+ YL
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASS 378
IHRD+ + N L+ + K++DFG+++ D + ST M + APE +
Sbjct: 115 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEED-GVYASTGGMKQIPVKWTAPEALNY 170
Query: 379 GKLTEKSDVFSFGVLLLE 396
G+ + +SDV+SFG+LL E
Sbjct: 171 GRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 210 LGQGGFGYV--------HKGVLTNGKVVAIKQLKA-GSGQGEREFQAEIEIISQV-HHRH 259
LG+G FG V K VA+K LK + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW-------PTR-------MKI 305
+++L+G CT ++ E+ L +L + P M++ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTR 363
A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+ H++D +
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
+ ++APE T +SDV+SFGVLL E+ T G P+
Sbjct: 197 RL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 73/214 (34%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 203 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQV 255
+F LG G FG V HKG G+ AIK LK ++ Q E I+ ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 256 HHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
H +V++ C+F + + + EFV L HL R +P + + L
Sbjct: 76 SHPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHL----RKAGRFPNDVAKFYHAELVL 129
Query: 314 A--YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD-TDTHVSTRVMGTFGY 370
A YLH II+RD+K N+LLD+ KV DFG AK D T T + GT Y
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEY 181
Query: 371 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
LAPE S + D ++ GVLL E I G+ PF
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQA--------------EIEII 252
LG+G +G V K T GK+VAIK++K + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 253 SQVHHRHLVSLVG-YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK------I 305
+++ H +++ LV Y +F+ N ++ + + V++ R+ I
Sbjct: 75 NEIKHENIMGLVDVYVE--------GDFI-NLVMDI-MASDLKKVVDRKIRLTESQVKCI 124
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK---------HSLDT 356
L GL LH + +HRD+ ANI ++ K+ADFGLA+
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 357 DTHVSTRVMG----TFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITG 400
+T M T Y APE + K D++S G + EL+TG
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 9/199 (4%)
Query: 210 LGQGGFGYVHK-GVLTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
LG+GGFG V V GK+ A K+L + GE+ E EI+ +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ LV + L++H++ + + + G+ +LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKS 385
+RD+K N+LLDD +++D GLA D T T+ GT GY+APE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 386 DVFSFGVLLLELITGFRPF 404
D F+ G + E++ G PF
Sbjct: 176 DWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 18/216 (8%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-EIEIISQVHHRHL 260
NF + LG+G + V+KG T G++VA+K++ + +G EI ++ ++ H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 261 VSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
V L ++ +LV+E++ K ++ H + L +G+A+ H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCH 117
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPEYA 376
E+ +++HRD+K N+L++ E K+ADFGLA+ + +T + V T Y AP+
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVL 172
Query: 377 SSGKLTEKS-DVFSFGVLLLELITG---FRPFDKAD 408
+ S D++S G ++ E+ITG F + D
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 209 LLGQGGFGYVHKGVLT----NGKVVAIKQLKAG----SGQGEREFQAEIEIISQVHHRHL 260
+LG+GG+G V + GK+ A+K LK + + +AE I+ V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHED 319
V L+ G + L+ E++ L HL +R + L + L +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLH-- 117
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
Q II+RD+K NILLD K+ DFGL K S+ T V+ GT Y+APE
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRS 175
Query: 380 KLTEKSDVFSFGVLLLELITGFRPF 404
+ D +S G L+ +++TG PF
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 62/243 (25%)
Query: 200 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-F----QAEIEIIS 253
++ LG+G FG V+K + G+VVA+K++ + E++ F EI+I+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILK 62
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPV--MNWP----------- 300
++ H ++V L+ + E + R M P
Sbjct: 63 KLKHPNVVPLID---------MAVERPDK-------SKRKRGSVYMVTPYMDHDLSGLLE 106
Query: 301 -TRMKIALGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA- 350
+K+ + G+ YLHE+ I+HRDIK+ANIL+D+ K+ADFGLA
Sbjct: 107 NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
Query: 351 ---------KHSLDTDTHVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLELITG 400
K T T ++ T Y PE + T D++ G + E+ T
Sbjct: 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 401 FRP 403
RP
Sbjct: 224 -RP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYCT 268
LG G FG V+K V+A ++ + E E + EI+I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ + ++ EF ++ + +RP+ P + + L YLHE+ KIIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTE-PQIRVVCKQTLEALNYLHEN---KIIHRD 128
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE----- 383
+K+ NIL + K+ADFG++ + T +GT ++APE +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 384 KSDVFSFGVLLLEL 397
K+DV+S G+ L+E+
Sbjct: 188 KADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 203 NFSEANLLGQGGFG--YVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHR 258
+ +G+G FG Y+ K + V IK+ L + + + E+ +++++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---HG---KDRPVMNWPTRMKIALGSARG 312
++V+ + +V E+ L + G + +++W ++I+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG---- 113
Query: 313 LAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
L ++H+ KI+HRDIKS NI L + AK+ DFG+A+ L+ ++ +GT YL
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYL 169
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
+PE + K+D++S G +L EL T PF+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 209 LLGQGGFGYVHKGVLT-NGK---VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSL 263
+LG G FG + +G L K VAI L+AG S + R F AE + Q H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
G T G+ ++V E++ N L+ L K + M + G A G+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSE---MG 127
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 383
+H+ + + +L++ K++ F + + + + APE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187
Query: 384 KSDVFSFGVLLLELIT-GFRPF 404
SDV+SFG+++ E+++ G RP+
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVG 265
+G G FG V+ +VVA+K++ Q ++Q E++ + Q+ H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 266 YCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
LV E+ + LE H +P+ I G+ +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEI-AAITHGALQGLAYLHSHN-- 141
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY---ASSG 379
+IHRDIK+ NILL + + K+ADFG A S ++ V GT ++APE G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 380 KLTEKSDVFSFGVLLLEL 397
+ K DV+S G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 39/209 (18%)
Query: 210 LGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQG-ER-EFQAEIEIISQVHHRHLVS- 262
+G+G FG K +L +GK IK++ ER E + E+ ++S + H ++V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 263 ------------LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++ YC G L + + + F + +++W ++ +AL
Sbjct: 65 QESFEENGNLYIVMDYCEGGD---LYKKINAQRGVLF----PEDQILDWFVQICLAL--- 114
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
++H+ KI+HRDIKS NI L K+ DFG+A+ L++ ++ +GT Y
Sbjct: 115 ---KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYY 167
Query: 371 LAPEYASSGKLTEKSDVFSFGVLLLELIT 399
L+PE + KSD+++ G +L E+ T
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 202 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHR 258
D++ + LG+G + V+KG NGK+VA+K ++ +G F A E ++ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHA 63
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLH 317
++V L LV+E+V ++ P P +K+ L RGL+Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-YA 376
Q I+HRD+K N+L+ D+ E K+ADFGLA+ + +H + + T Y P+
Sbjct: 121 ---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 377 SSGKLTEKSDVFSFGVLLLELITGFRPF 404
S + + D++ G + +E+I G F
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 61/230 (26%), Positives = 112/230 (48%), Gaps = 25/230 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG-SGQGEREFQAEIEI-ISQVHHR 258
D+ LG+G +G V K + G ++A+K+++A + Q ++ +++I + V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPV-MNWPTRMKIALGSARGLAYL 316
+ V+ G F + + V + +L+ F+ D+ + + KIA+ + L YL
Sbjct: 61 YTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY- 375
H + +IHRD+K +N+L++ + + K+ DFG++ + D+ T G Y+APE
Sbjct: 120 HS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERI 175
Query: 376 ---ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 422
+ KSDV+S G+ ++EL TG P+D W PF
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPF 214
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 71/253 (28%), Positives = 117/253 (46%), Gaps = 19/253 (7%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQA---EIEIISQVH 256
N+ LLG+G FG V+ G+ +A+KQ+ S + +E A EI+++ +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 257 HRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +V G ++ L E++P +++ L N R + +G++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVS 120
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST---RVMGTFGYL 371
YLH + I+HRDIK ANIL D + K+ DFG +K + T T V GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR-IQTICMSGTGIKSVTGTPYWM 176
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD--DSMVDWAKPFLAQGLAD 429
+PE S K+DV+S ++E++T P+ + + A KP L G++D
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236
Query: 430 GNFDALVDQKLEE 442
D L +EE
Sbjct: 237 ACRDFLKQIFVEE 249
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 37/100 (37%), Positives = 61/100 (61%), Gaps = 5/100 (5%)
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
KI++ RGL YL E + KI+HRD+K +NIL++ E K+ DFG++ +D+ ++
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
+GT Y++PE T +SD++S G+ L+E+ G P
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 202 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
DNF + +G+G G V + G+ VA+K++ Q E+ I+ H ++
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
V + G + +V EF+ L + H + MN + L + L++LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ 134
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGL-AKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+IHRDIKS +ILL K++DFG A+ S + S ++GT ++APE S
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISR 189
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPF 404
+ D++S G++++E++ G P+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 40/219 (18%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQL--KAGSGQGEREFQAEIEIISQVHHRHLVS- 262
+G+G +G V H+ T+GK IK+L + S + + + E +++SQ+ H ++V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 263 -------------LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
++G+C G +Y + + + + V+ W ++ +AL
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP---ENQVVEWFVQIAMAL-- 115
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
YLHE I+HRD+K+ N+ L + KV D G+A+ L+ +++ ++GT
Sbjct: 116 ----QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPY 167
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
Y++PE S+ KSDV++ G + E+ T F+ D
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 202 DNFSEANLLGQGGFGYVH-KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
DNF + +G+G G V V ++GK+VA+K++ Q E+ I+ H ++
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
V + G + +V EF+ L + H + MN + L + L+ LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQ 135
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
+IHRDIKS +ILL K++DFG + + ++GT ++APE S
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ-VSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 380 KLTEKSDVFSFGVLLLELITGFRPF 404
+ D++S G++++E++ G P+
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 209 LLGQGGFGYVHKGVLTNG--KVVAIKQLKA-----GSGQGERE-----FQAEIEII-SQV 255
LG G FG V+K N ++A+K++ G + ER+ +E+ II Q+
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 256 HHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSAR 311
H ++V Y TF + +V + + L H + + I +
Sbjct: 67 RHPNIVRY--YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
L YLH+ + +I+HRD+ NI+L + + + DFGLAK T V+GT Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK--QPESKLTSVVGTILYS 180
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
PE + EK+DV++FG +L ++ T PF
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 17/220 (7%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK--AGSGQGEREFQA---EIEIISQVH 256
N+ LLGQG FG V+ G+ +A+KQ++ S + +E A EI+++ +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 257 HRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +V G +R L E +P +++ L K + K G++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST---RVMGTFGYL 371
YLH + I+HRDIK ANIL D K+ DFG +K L T T V GT ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR-LQTICLSGTGMKSVTGTPYWM 176
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411
+PE S K+D++S G ++E++T P+ + + A
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 204 FSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHH 257
F+ +LG+G FG V + L + + VA+K LKA S EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 258 RHLVSLVGYC--TFGSQRLLVYEFVPNKTLEFHLHGK-----------DRPVMNWP--TR 302
+++ L+G + RL + P L F HG + P P T
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPI----PMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTL 115
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
++ + A G+ YL IHRD+ + N +L+++ VADFGL+K D +
Sbjct: 116 VRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 363 RVMG-TFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
+LA E + T SDV++FGV + E++T G P+
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 9/181 (4%)
Query: 225 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284
GK VA+K++ Q E+ I+ HH ++V + G + +V EF+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 285 L-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343
L + H + MN + L R L+YLH +IHRDIKS +ILL K
Sbjct: 106 LTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158
Query: 344 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
++DFG + + ++GT ++APE S + D++S G++++E+I G P
Sbjct: 159 LSDFGFCAQ-VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
Query: 404 F 404
+
Sbjct: 218 Y 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 204 FSEANLLGQGGFG--YVHKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHR 258
F++ +G G FG Y + V TN +VVAIK++ Q ++Q E++ + ++ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 259 HLVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+ + G LV E+ + LE H +P+ I G+ +GLAY
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEI-AAITHGALQGLAY 140
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LH +IHRDIK+ NILL + + K+ADFG A + ++ V GT ++APE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192
Query: 376 ---ASSGKLTEKSDVFSFGVLLLEL 397
G+ K DV+S G+ +EL
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 71/233 (30%), Positives = 114/233 (48%), Gaps = 36/233 (15%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGERE-FQA----EIE 250
K D F +G+G +G V+K T G++VA+K+++ E+E F EI+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRL---DNEKEGFPITAIREIK 58
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL----------LVYEFVPNK---TLEFHL-HGKDRPV 296
I+ Q++HR++V+L T L LV+E++ + LE L H + +
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
++ MK L GL Y H+ +HRDIK +NILL++ + K+ADFGLA+
Sbjct: 119 KSF---MKQLL---EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 357 DTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
++ T + T Y PE + DV+S G +L EL T +P +A+
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK-KPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 31/230 (13%)
Query: 202 DNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLK-AGSGQGEREFQAEIEII 252
D LG+G FG V K VA+K LK + + + +E+E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 253 SQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN------------- 298
+ H+++++L+G CT ++ E+ L L + P +
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 299 -WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLD 355
+ + A ARG+ YL + IHRD+ + N+L+ + K+ADFGLA+ H +D
Sbjct: 132 SFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
S + ++APE T +SDV+SFG+L+ E+ T G P+
Sbjct: 189 YYKKTSNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 70/211 (33%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 210 LGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEI-ISQVHHRHLV 261
+G+G FG V HK +GK A+K L+ + ++E AE + + V H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 262 SLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHE 318
L + +F + L V ++V L FHL ++R R A + SA L YLH
Sbjct: 60 GL--HYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFYAAEIASA--LGYLHS 114
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
II+RD+K NILLD + DFGL K ++ ST GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRK 170
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
D + G +L E++ G PF DT
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 71/304 (23%), Positives = 134/304 (44%), Gaps = 59/304 (19%)
Query: 210 LGQGGFGYVH----KGVLTNGK-------------VVAIKQLKAGSGQGER-EFQAEIEI 251
LG+G FG VH +G+ +VA+K L+ + + R +F EI+I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---------HGKDRPVMNWPTR 302
+S++ +++ L+ C ++ E++ N L L D +++ T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VS 361
+ +A A G+ YL +HRD+ + N L+ ++ K+ADFG++++ D + +
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR--PFDKADTFADDSMVDWA 419
R + +++ E GK T SDV++FGV L E++T + P+ + +D+ +++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ---LSDEQVIENT 246
Query: 420 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAA-------CIRHSARRRPRMSQI 472
F DQ + Y + + A C + C R +A+ RP +I
Sbjct: 247 GEFFR------------DQGRQVY----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
Query: 473 VRAL 476
L
Sbjct: 291 HATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 20/197 (10%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+G G +G V+K L G++ A+K +K G Q EI ++ + H ++V+ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 269 FGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIAL---GSARGLAYLHEDCQPK 323
+ + E+ +L+ +H+ G P+ + ++IA + +GLAYLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG---PL----SELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS---SGK 380
+HRDIK ANILL D+ + K+ADFG+A T + +GT ++APE A+ +G
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEKNGG 185
Query: 381 LTEKSDVFSFGVLLLEL 397
+ D+++ G+ +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 59/193 (30%), Positives = 92/193 (47%), Gaps = 47/193 (24%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQVHHRHLV 261
+GQG FG V K ++VA+K++ E E + EI+I+ + H ++V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPITALREIKILQLLKHENVV 74
Query: 262 SLVGYCT--------FGSQRLLVYEF--------VPNKTLEFHLHGKDRPVMNWPTRMKI 305
+L+ C + LV+EF + NK ++F L + MK+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL-----SEIK--KVMKM 127
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTH---VS 361
L GL Y+H + KI+HRD+K+ANIL+ K+ADFGLA+ SL ++ +
Sbjct: 128 LLN---GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 362 TRVMGTFGYLAPE 374
RV+ T Y PE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLK-AGSGQGEREFQAE 248
E+ ++T F E LG+ FG V+KG L + VAIK LK G EF+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK------DRPV- 296
+ S++ H ++V L+G T +++ + + L L H D+ V
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 297 --MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+ + I A G+ +L ++H+D+ + N+L+ D K++D GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 355 DTDTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
D + ++MG +++PE GK + SD++S+GV+L E+ + G +P+
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLV 261
F ++G G +G V+KG + G++ AIK + + E E + EI ++ + HHR++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 262 SLVGYCTFGS------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
+ G S Q LV EF ++ + + I RGLA+
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LH K+IHRDIK N+LL ++ E K+ DFG++ LD +GT ++APE
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPEV 192
Query: 376 ASSGKLTE-----KSDVFSFGVLLLELITGFRPF 404
+ + + +SD++S G+ +E+ G P
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 23/242 (9%)
Query: 198 KIATDNFSEANLLGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 251
++ D+F + LG G G V K G++ K++ ++ A Q RE Q +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----V 56
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGS 309
+ + + ++V G + + E + +L+ L R P + K+++
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAV 112
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
RGLAYL E Q I+HRD+K +NIL++ E K+ DFG++ +D+ ++ +GT
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 167
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429
Y++PE + +SD++S G+ L+EL G P D A + + +P + +
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEAIFGRPVVDGEEGE 225
Query: 430 GN 431
+
Sbjct: 226 PH 227
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 70/224 (31%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 203 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR 258
+F+ +LG+G FG V KG ++ AIK LK + Q + + V R
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKK-----DVIIQDDDVECTMVEKR 52
Query: 259 ---------HLVSLVGYCTFGS-QRL-LVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKI 305
L L + F + RL V E+V L +H+ GK + P +
Sbjct: 53 VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE----PHAVFY 106
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
A A GL +LH II+RD+K N++LD K+ADFG+ K ++ +TR
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTF 161
Query: 366 -GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
GT Y+APE + + D ++FGVLL E++ G PFD D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 59/220 (26%), Positives = 110/220 (50%), Gaps = 16/220 (7%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRH 259
++++ +G+G +G V+KG G++VA+K+++ S + A EI ++ ++ H +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHE 318
+V L S+ L++EF+ + L+ +L + +K L +G+ + H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-YAS 377
+++HRD+K N+L+D+ K+ADFGLA+ + V T + T Y APE
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
S + + D++S G + E+ T K F DS +D
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT------KKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 210 LGQGGFGYVHKGVL-------TNGKVVAIKQLKAGSGQGER---EFQAEIEIISQVHHRH 259
LGQG F ++KGVL G + + G R F ++SQ+ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSARGLAYLHE 318
LV L G C + ++V E+V L+ LH + V ++W ++ +A A L YL +
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 319 DCQPKIIHRDIKSANILL---DDSFE----AKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
K++H ++ NIL+ + K++D G+ L + V ++
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171
Query: 372 APEYASSG--KLTEKSDVFSFGVLLLEL 397
APE +G LT +D +SFG LLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 209 LLGQGGFGYVHKGVLTN-GKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
++G+GGFG V+ + GK+ A+K L + QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 265 --GYCTFGSQRLLVYEF-VPNKTL---------EFHLHGKDRPVMNWPTRMKIALGSARG 312
G C F + Y F P+K + H H V + A G
Sbjct: 52 STGDCPF--IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG 109
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
L ++H +++RD+K ANILLD+ +++D GLA H S +GT GY+A
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163
Query: 373 PEYASSGKLTEKS-DVFSFGVLLLELITGFRPFDKADT 409
PE G + S D FS G +L +L+ G PF + T
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-------EIEIISQVHHRHLV 261
+G+G +G V+K G++VA+K+++ E E + EI ++ +++H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHEDC 320
L+ ++ LV+EF+ + L+ ++ ++ P +K L +G+AY H
Sbjct: 62 RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAYCH--- 116
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTHVSTRVMGTFGYLAPEYAS 377
+++HRD+K N+L+D K+ADFGLA+ + T TH V+ T Y APE
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILL 172
Query: 378 SGKLTEKS-DVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
+ D++S G + E++ RP F DS +D
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNR-RPL-----FPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGE-----REFQAEIEIISQVH 256
+ E +G+G +G V+K L G+ VA+K+++ S +G RE A ++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59
Query: 257 HRHLVSLVGYCTFGSQR------LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
H ++V L+ C G + LV+E V ++ L +L +P + T +
Sbjct: 60 HPNIVRLLDVCH-GPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
RG+ +LH I+HRD+K NIL+ + K+ADFGLA+ + + T V+ T Y
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR--IYSFEMALTSVVVTLWY 172
Query: 371 LAPE------YASSGKLTEKSDVFSFGVLLLEL 397
APE YA+ D++S G + EL
Sbjct: 173 RAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 65/209 (31%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G FG V +L GK A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 319
+L Y RL V E+ L FHL ++R R A + SA L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSA--LGYLHSC 114
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
+++RD+K N++LD K+ DFGL K + +D GT YLAPE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDN 170
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKAD 408
D + GV++ E++ G PF D
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 54/285 (18%), Positives = 114/285 (40%), Gaps = 66/285 (23%)
Query: 217 YVHKGVLTNGKVVAIKQLKA---GSGQGEREFQAEIEIISQVHHRHLVSLVG-------- 265
++KG+ N K V I+ K G + EI+ + ++ +++ + G
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 266 ---------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
YCT G R ++ + K L F T++ +A+ +GL L
Sbjct: 94 LPRLSLILEYCTRGYLREVLDK---EKDLSFK------------TKLDMAIDCCKGLYNL 138
Query: 317 HE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
++ +P ++++ S + L+ ++++ K+ GL K + + + Y + +
Sbjct: 139 YKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEK----ILSSPPFKNVNFMVYFSYKM 191
Query: 376 ASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433
+ + T K D++S GV+L E+ TG PF+ T + + +D
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---------------KEI----YD 232
Query: 434 ALVDQKLEEYDSAEMTRMAACAA-ACIRHSARRRPRMSQIVRALE 477
++++ + C AC H + +RP + +I+ L
Sbjct: 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRH 259
FS+ +G G FG V+ + N +VVAIK++ Q ++Q E+ + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 260 LVSLVGYCTFGSQRLLVYEFV---PNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGL 313
+ G LV E+ + LE H +P+ ++IA G+ +GL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQ----EVEIAAVTHGALQGL 128
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
AYLH +IHRD+K+ NILL + K+ DFG A + V GT ++AP
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAP 180
Query: 374 EY---ASSGKLTEKSDVFSFGVLLLEL 397
E G+ K DV+S G+ +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 39/94 (41%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
L +LH Q II+RDIK NILLD + DFGL+K L + + GT Y+A
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 373 PEYASSGKLTEKS--DVFSFGVLLLELITGFRPF 404
PE G D +S GVL EL+TG PF
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 19/216 (8%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVH 256
NF +LG+G FG V ++ AIK LK + + + E +++
Sbjct: 1 DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 257 HRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGL 313
++ + C RL V E+V L +H+ GK + P + A + GL
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE----PQAVFYAAEISVGL 114
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-GTFGYLA 372
+LH II+RD+K N++LD K+ADFG+ K + V+TR GT Y+A
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIA 169
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
PE + + D +++GVLL E++ G PFD D
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 58/250 (23%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE----FQAEIEIIS 253
D+F ++G+G FG V K G + A+K+L+ S E+E +AE +I++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKK---DTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILA 56
Query: 254 QVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ + +V L Y +F + L+ E++P + L KD TR IA +
Sbjct: 57 EADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIA-ETIL 112
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK---------------HSLDT 356
+ +H + IHRDIK N+LLD K++DFGL H+L +
Sbjct: 113 AIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 357 DTHVSTR----------------------VMGTFGYLAPEYASSGKLTEKSDVFSFGVLL 394
+ +GT Y+APE ++ D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 395 LELITGFRPF 404
E++ G+ PF
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 203 NFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGS----GQGEREFQAEIE 250
NF +LG G +G V H +GK+ A+K LK + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD----SGKLYAMKVLKKATIVQKAKTTEHTRTERQ 56
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
++ + + + Y +L L+ +++ L HL ++R ++I G
Sbjct: 57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ---EVQIYSGE 113
Query: 310 -ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
L +LH + II+RDIK NILLD + + DFGL+K + + + GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 369 GYLAPEYASSGKLTEKS--DVFSFGVLLLELITGFRPF 404
Y+AP+ G D +S GVL+ EL+TG PF
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 69/208 (33%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G FG V +L +GK A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
SL Y RL V E+V L FHL ++R TR A L YLH
Sbjct: 59 SL-KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGA-EIVSALDYLHSG- 114
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 380
KI++RD+K N++LD K+ DFGL K + TD GT YLAPE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI-TDAATMKTFCGTPEYLAPEVLEDND 171
Query: 381 LTEKSDVFSFGVLLLELITGFRPFDKAD 408
D + GV++ E++ G PF D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE---FQAEIEII-SQVHHRHLVSL 263
++G+G FG V +GK A+K L+ +E AE ++ V H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 264 VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
Y +++L V +FV L FHL ++R R A A L YLH
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLH---SI 115
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT 382
I++RD+K NILLD + DFGL K + + +T GT YLAPE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 383 EKSDVFSFGVLLLELITGFRPFDKADT 409
D + G +L E++ G PF D
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDV 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
++F +G G +G V+K + G++ AIK +K G+ Q EI ++ H ++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIALGSA---RGLAY 315
V+ G + + EF +L+ +H+ G P+ + +IA S +GL Y
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PL----SESQIAYVSRETLQGLYY 121
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEY 375
LH + +HRDIK ANILL D+ K+ADFG++ T + +GT ++APE
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEV 177
Query: 376 AS---SGKLTEKSDVFSFGVLLLEL 397
A+ G + D+++ G+ +EL
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 210 LGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVG 265
+GQGG+G V + G++VA+K++K E + E +I++ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 266 YCTFGSQRL-LVYEFVPNKTLEFHLHG----KDRPVMNWPTRMKIALGSARGLAYLHEDC 320
Y + L L E+VP L+ + + M A+ + L Y
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----- 122
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 380
IHRD+K N L+D S K+ DFGL+K + + V+G+ Y+APE
Sbjct: 123 ----IHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKG 174
Query: 381 LTEKSDVFSFGVLLLELITGFRPFD 405
D +S G +L E + GF PF
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 209 LLGQGGFGYVHKGVLTN-GKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
++G+GGFG V+ + GK+ A+K L + QGE ++ R ++SLV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLV 51
Query: 265 --GYCTFGSQRLLVYEFVPNKTLEF----------HLHGKDRPVMNWPTRMKIALGSARG 312
G C F + Y F L F H H V + A G
Sbjct: 52 STGDCPF--IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
L ++H +++RD+K ANILLD+ +++D GLA H S +GT GY+A
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 163
Query: 373 PEYASSGKLTEKS-DVFSFGVLLLELITGFRPFDKADT 409
PE G + S D FS G +L +L+ G PF + T
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 24/281 (8%)
Query: 138 PKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDK----PFPRQSPGMPVGNFKSTFT 193
P P P+ T P T D P P P + S+
Sbjct: 3 PIQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSA 62
Query: 194 YEELKIATDNFSE---ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAE 248
A + SE N +G G G V+K + G++ A+K + R+ E
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
IEI+ V+H ++V + ++ EF+ +LE ++ + + +A
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD------VARQ 176
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
G+AYLH + I+HRDIK +N+L++ + K+ADFG+++ T ++ V GT
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTI 232
Query: 369 GYLAPEYASS----GKLTEKS-DVFSFGVLLLELITGFRPF 404
Y++PE ++ G + D++S GV +LE G PF
Sbjct: 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 210 LGQGGFGYVHKGVL--TNGKVVAIKQLKAGSGQGE-REFQAEIEIISQVHHRHLVSLVGY 266
LG+G +G V+K VL G +A+K+++ + + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 267 CTFGSQRLLVYEFVPNKTLE------FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
+ E++ +L+ G V+ +I +GL +L E+
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFLKEEH 122
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 380
IIHRD+K N+L++ + + K+ DFG+ S + ++ +G Y+APE SG
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGV---SGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 381 LTE------KSDVFSFGVLLLELITGFRPF 404
+ +SDV+S G+ +LE+ G P+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 210 LGQGGFGYVHKGVLTNG---KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVG 265
+G G FG V G + +G V +K+L+ + Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWP---TRMKIALGSARGLAYLHEDCQP 322
CT + LLV EF P L+ +L + + P T ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASS--G 379
IH D+ N LL K+ D+GL+ + D +V ++ ++APE G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 380 KL-----TEKSDVFSFGVLLLELIT-GFRPF 404
L T++S+V+S GV + EL G +P+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA-EIEIISQVHHRHLVSLVGYC 267
+GQG G V+ + + G+ VAIKQ+ Q ++E EI ++ + H ++V+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
G + +V E++ +L + M+ + + L +LH + ++IHR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 139
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 387
DIKS NILL K+ DFG + ST V GT ++APE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 388 FSFGVLLLELITGFRPF 404
+S G++ +E++ G P+
Sbjct: 199 WSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+GQG G V+ + + G+ VAIKQ+ + EI ++ + + ++V+ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 388
IKS NILL K+ DFG + ST V GT ++APE + K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 389 SFGVLLLELITGFRPF 404
S G++ +E++ G P+
Sbjct: 200 SLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHR 258
NF +G+G F V++ L + K VA+K+++ + ++ EI+++ Q++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
+++ + ++ +V E L K + ++ T K + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 376
H +++HRDIK AN+ + + K+ D GL + + T + ++GT Y++PE
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSPERI 178
Query: 377 SSGKLTEKSDVFSFGVLLLELITGFRPF--DKADTFA 411
KSD++S G LL E+ PF DK + F+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 36/83 (43%), Positives = 53/83 (63%), Gaps = 1/83 (1%)
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT-DTHVSTRVMGTFGYLAPEYASSGKL 381
K++HRD+KSANI L + K+ DFG +K D+ V++ GT YLAPE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 382 TEKSDVFSFGVLLLELITGFRPF 404
++K+D++S GV+L EL+T RPF
Sbjct: 249 SKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+GQG G V + + G+ VAIKQ+ + EI ++ ++ + ++V+ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 388
IKS N+LL K+ DFG + ST V GT ++APE + K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 389 SFGVLLLELITGFRPF 404
S G++ +E++ G P+
Sbjct: 200 SLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 21/222 (9%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRH 259
NF + +G+G +G V+K G+VVA+K+++ + A EI ++ +++H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V L+ ++ LV+EF+ ++ L+ + + P +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTHVSTRVMGTFGYLAPEYA 376
+++HRD+K N+L++ K+ADFGLA+ + T TH V+ T Y APE
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEIL 172
Query: 377 SSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
K + D++S G + E++T + F DS +D
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT------RRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 40/98 (40%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
L +LH+ I++RD+K NILLD + + DFGL+K +L TD + GT YLA
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANL-TDNKTTNTFCGTTEYLA 164
Query: 373 PEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADT 409
PE K T+ D +S GVL+ E+ G+ PF DT
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 71/271 (26%), Positives = 106/271 (39%), Gaps = 79/271 (29%)
Query: 210 LGQGGFGYVHK----GV--LTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLV 261
LG+G FG V + G+ + VA+K LK G+ E R +E++I+ + HH ++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 262 SLVGYCTFGSQRLLVY------------------EFVPNKTLEFHLHGKDRPVMNWPTRM 303
+L+G CT L+V EFVP KT + + +
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 304 KIALGS------------------------------------------------ARGLAY 315
K L S A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL-DTDTHVSTRVMGTFGYLAPE 374
L K IHRD+ + NILL ++ K+ DFGLA+ D D ++APE
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 375 YASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
T +SDV+SFGVLL E+ + G P+
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 60/210 (28%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 210 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 266
LG+G + V KG LT +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPKII 325
LV+E++ + ++ + + M+ +KI + RGL+Y H+ KI+
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCHKR---KIL 125
Query: 326 HRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTE 383
HRD+K N+L+++ E K+ADFGLA+ S+ T T+ + V T Y P+ S + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYST 183
Query: 384 KSDVFSFGVLLLELITGFRPFDKADTFADD 413
D++ G +L E+ TG RP T ++
Sbjct: 184 PIDMWGVGCILYEMATG-RPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 201 TDNFSEANLLGQGGFGYV--HKGVLTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQV 255
T+ + + +G G FG V + LT G+ VAIK++ + +R ++ E++++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHL 66
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
H +++SL F S +Y + H RP+ + RGL Y
Sbjct: 67 RHENIISLSD--IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-FLYQILRGLKY 123
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPE 374
+H ++HRD+K +NIL++++ + K+ DFGLA+ T +VSTR Y APE
Sbjct: 124 VH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPE 175
Query: 375 YASS-GKLTEKSDVFSFGVLLLELITG 400
+ K + D++S G + E++ G
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 6/134 (4%)
Query: 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334
V E+V L + + R P + A A GL +LH II+RD+K N+
Sbjct: 78 FVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV 132
Query: 335 LLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLL 394
+LD K+ADFG+ K ++ D + GT Y+APE + + D ++FGVLL
Sbjct: 133 MLDSEGHIKIADFGMCKENM-WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 395 LELITGFRPFDKAD 408
E++ G PF+ D
Sbjct: 192 YEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 34/227 (14%)
Query: 196 ELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAE 248
+L++ ++F ++G+G FG V HK ++ +V A+K L + F E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWP----TR 302
+I++ + +V L + F + L V E++P L + D P W
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIP-EKWARFYTAE 150
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA-KHSLDTDTHVS 361
+ +AL + + + IHRD+K N+LLD S K+ADFG K +
Sbjct: 151 VVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 362 TRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVLLLELITGFRPF 404
T V GT Y++PE S G + D +S GV L E++ G PF
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 48/214 (22%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA------EIEIISQVHHRHLVS 262
+G+G +G V K G++VAIK+ + E + EI ++ Q+ H +LV+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 263 LVGYCTFGSQRL--LVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
L+ F +R LV+E+ + LE + G ++ KI + + + + H
Sbjct: 65 LIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQAVNFCH 117
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK----HSLDTDTHVSTRVMGTFGYLAP 373
+ IHRD+K NIL+ + K+ DFG A+ D +V+TR Y AP
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 374 E-------YASSGKLTEKSDVFSFGVLLLELITG 400
E Y DV++ G + EL+TG
Sbjct: 170 ELLVGDTQYGPP------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 4e-11
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 8/196 (4%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+GQG G V+ + + G+ VAI+Q+ + EI ++ + + ++V+ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
G + +V E++ +L + M+ + + L +LH + ++IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 388
IKS NILL K+ DFG + + + ++GT ++APE + K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 389 SFGVLLLELITGFRPF 404
S G++ +E+I G P+
Sbjct: 201 SLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 209 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEII-SQVHHRHL 260
++G+G FG V K ++G A+K L+ + ++E AE ++ + H L
Sbjct: 2 VIGKGSFGKVLLAKRK---SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL 58
Query: 261 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
V L Y +++L V ++V L FHL ++R + P A A + YLH
Sbjct: 59 VGL-HYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLE-PRARFYAAEVASAIGYLH-- 113
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
II+RD+K NILLD + DFGL K ++ + ST GT YLAPE
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKE 171
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKAD 408
D + G +L E++ G PF D
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 35/105 (33%), Positives = 62/105 (59%), Gaps = 5/105 (4%)
Query: 304 KIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
K+++ +GL YL E + KI+HRD+K +NIL++ E K+ DFG++ +D+ ++
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
+GT Y++PE + +SD++S G+ L+E+ G P D
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 33/206 (16%)
Query: 210 LGQGGFGYVHKGVLTNGKVVA------IKQLKAGSGQGEREFQAEIE--IISQVHHRHLV 261
LG+G FG V+ ++ + K VA +K++ G QA E ++S++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 262 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLH-----GKDRP---VMNWPTRMKIALGSAR 311
+ +F + ++ E+ + L+ L GK V W ++ +
Sbjct: 66 KF--HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
G+ Y+H Q +I+HRD+K+ NI L ++ K+ DFG+++ L ++T GT Y+
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYM 172
Query: 372 APEYASSGKLTEKSDVFSFGVLLLEL 397
+PE KSD++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 209 LLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSL 263
++G+G + V L ++ A+K +K + + Q E + +H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM---KIALGSARGLAYLHEDC 320
S+ V EFV L FH+ + R + R +I+L L +LHE
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARFYSAEISLA----LNFLHER- 115
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 380
II+RD+K N+LLD K+ D+G+ K + ST GT Y+APE
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPEILRGED 172
Query: 381 LTEKSDVFSFGVLLLELITGFRPFD 405
D ++ GVL+ E++ G PFD
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 11/98 (11%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM----G 366
RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + H T +
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR--IADPEHDHTGFLTEYVA 171
Query: 367 TFGYLAPEYASSGKLTEKS-DVFSFGVLLLELITGFRP 403
T Y APE + K K+ D++S G +L E+++ RP
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 54/162 (33%), Positives = 75/162 (46%), Gaps = 9/162 (5%)
Query: 246 QAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
Q E + Q +H LV L S+ V E+V L FH+ + R + R
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY 101
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT-DTHVSTR 363
A S L YLHE II+RD+K N+LLD K+ D+G+ K L DT ++
Sbjct: 102 SAEISL-ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TST 155
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
GT Y+APE D ++ GVL+ E++ G PFD
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 69/267 (25%), Positives = 107/267 (40%), Gaps = 77/267 (28%)
Query: 210 LGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGE-REFQAEIEIISQV-HHRHLV 261
LG+G FG V + + + VA+K LK G+ E + E++I+ + HH ++V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 262 SLVG--------------YCTFGSQ----RLLVYEFVP--NKTLEFHLH----GKDRPVM 297
+L+G YC FG+ R F P NK+ GK + +
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 298 NWPTRMKIALGS------------------------------------ARGLAYLHEDCQ 321
+ + A ARG+ +L
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV---STRVMGTFGYLAPEYASS 378
K IHRD+ + NILL ++ K+ DFGLA+ +V R+ ++APE
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFD 249
Query: 379 GKLTEKSDVFSFGVLLLELIT-GFRPF 404
T +SDV+SFGVLL E+ + G P+
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 10/204 (4%)
Query: 210 LGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVG 265
+G+G FG V + + ++ A+K ++ E AE +++QV+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ LV F+ L HL + R + +R + +A L L + +I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARFY--TAELLCALENLHKFNVI 115
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKS 385
+RD+K NILLD + DFGL K ++ D +T GT YLAPE T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKAV 174
Query: 386 DVFSFGVLLLELITGFRPFDKADT 409
D ++ GVLL E++TG PF +
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENV 198
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 38/232 (16%)
Query: 202 DNFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQA-------EIEII 252
D + + +G+G +G V+K +TN + +A+K+++ E+E + EI ++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRL-----EQEDEGVPSTAIREISLL 55
Query: 253 SQVHHRHLVSL--VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRM-KIALG 308
++ H ++V L V + +RL LV+E++ L+ H P R+ K L
Sbjct: 56 KEMQHGNIVRLQDVVHS---EKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 309 SA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-KVADFGLAKHSLDTDTHVSTRVMG 366
RG+AY H +++HRD+K N+L+D A K+ADFGLA+ + T +
Sbjct: 110 QILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV 165
Query: 367 TFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
T Y APE S + D++S G + E++ +P F DS +D
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ-KPL-----FPGDSEID 211
|
Length = 294 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 9/167 (5%)
Query: 234 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
+KAG G E I+ ++H ++ L G T+ L+ +P + + +
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA 175
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
+ + + I R + YLHE+ +IIHRDIK+ NI ++ + + DFG A
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232
Query: 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400
+D + + GT APE + D++S G++L E+ T
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 209 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIIS-QVHHRHL 260
+LG+G FG V KG +V AIK LK + + E I++ H L
Sbjct: 2 VLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 261 VSLVGYCTF-GSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
+L +C F RL V E+V L F + + R +R A L +LH
Sbjct: 59 TAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRF-YAAEVTLALMFLH- 113
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+ +I+RD+K NILLD K+ADFG+ K + +T GT Y+APE
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-FCGTPDYIAPEILQE 170
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFD 405
+ D ++ GVL+ E++ G PF+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 210 LGQGGFGYVHKGVLTN-GKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
+G+G +G V K ++VA+K+++ G + EI ++ ++ H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 266 YCTFGSQRLLVYEFVPNKTLEF--HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+ LV+E+ ++ +G ++ +GLA+ H
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE 383
++HRD+K N+L++ + E K+ADFGLA+ S V+ T Y P+ KL
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 384 KS-DVFSFGVLLLELITGFRP 403
S D++S G + EL RP
Sbjct: 179 TSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 209 LLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS---GQGEREFQAEIEII-SQVHHRHL 260
++G+G FG V HK K A+K L+ + + E+ +E ++ V H L
Sbjct: 2 VIGKGSFGKVLLARHK---AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
V L + V +++ L +HL ++R + P A A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLE-PRARFYAAEIASALGYLH--- 113
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 380
I++RD+K NILLD + DFGL K +++ + ST GT YLAPE
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQP 172
Query: 381 LTEKSDVFSFGVLLLELITGFRPFDKADT 409
D + G +L E++ G PF +T
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 38/211 (18%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 266
LG+G + V+KG G++VA+K+++ +G F A E ++ + H ++V+L +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTL--H 69
Query: 267 CTFGSQRLL--VYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLAYLHEDC 320
+++ L V+E++ + ++ G +++ L RGLAY H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLS------MHNVRLFLFQLLRGLAYCH--- 120
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAP------ 373
Q +++HRD+K N+L+ + E K+ADFGLA+ S+ + T+ + V T Y P
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGS 178
Query: 374 -EYASSGKLTEKSDVFSFGVLLLELITGFRP 403
EY++S D++ G + E+ TG RP
Sbjct: 179 TEYSTS------LDMWGVGCIFYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGEREFQAEIEI 251
E L TD + +G+G +G V+K +TN G + A+K L S E E +AE I
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDE-EIEAEYNI 71
Query: 252 ISQV-HHRHLVSLVG------YCTFGSQRLLVYEFVPNKTLEFHLHGK-------DRPVM 297
+ + +H ++V G G Q LV E ++ + G D ++
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLV-GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 298 NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
++ I G+ GL +LH + +IIHRD+K NILL K+ DFG++ T
Sbjct: 131 SY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 358 THVSTRVMGTFGYLAPEYASSGKLTEKS-----DVFSFGVLLLELITGFRPF 404
+T V GT ++APE + + + S DV+S G+ +EL G P
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 210 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 266
LG+G + V+KG LT+ +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
LV+E++ +K L+ +L +N RGL Y H + K++H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCH---RRKVLH 127
Query: 327 RDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTEK 384
RD+K N+L+++ E K+ADFGLA+ S+ T T+ + V T Y P+ S + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQ 185
Query: 385 SDVFSFGVLLLELITGFRPF 404
D++ G + E+ TG RP
Sbjct: 186 IDMWGVGCIFYEMSTG-RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 66/289 (22%), Positives = 118/289 (40%), Gaps = 56/289 (19%)
Query: 210 LGQGGFGYVHKG----VLTNGKV----VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
LGQG F + KG V G++ V +K L F ++SQ+ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G C G + ++V E+V +L+ +L K++ ++N ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDK-- 119
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT------FGYLAPEY 375
+ H ++ + N+LL + K + K S D +S V+ ++ PE
Sbjct: 120 -GLTHGNVCAKNVLLIREEDRKTGNPPFIKLS---DPGISITVLPKEILLERIPWVPPEC 175
Query: 376 ASSGK-LTEKSDVFSFGVLLLELITGF-RPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433
+ + L+ +D +SFG L E+ +G +P D+
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------------------------ 211
Query: 434 ALVDQKLEEYDSAEM------TRMAACAAACIRHSARRRPRMSQIVRAL 476
+KL+ Y+ T +A C+ + RP I+R L
Sbjct: 212 ---QKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 81/358 (22%), Positives = 138/358 (38%), Gaps = 101/358 (28%)
Query: 198 KIATDNFSEANLLGQGGFGYV--------HKGVLTNGKVVAIKQLKAGSGQGE-REFQAE 248
+ D +LG G FG V K ++ VA+K LK G+ E + +E
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKK--SSCNTVAVKMLKEGATASEHKALMSE 60
Query: 249 IEIISQV-HHRHLVSLVG--------------YCTFGS---------------------Q 272
++I+ + +H ++V+L+G +C +G+ Q
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120
Query: 273 RLLVYEFVPNKTLEFHLH-GKDRPVMN-------------------WPTRMKI------A 306
R V ++ + G+ + + W + + + +
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV---STR 363
ARG+ +L K IHRD+ + NILL ++ K+ DFGLA+ +V S R
Sbjct: 181 FQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 422
+ ++APE T +SDV+SFGVLL E+ + G P+ +
Sbjct: 238 L--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---------- 285
Query: 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480
Q L DG + E + E+ R+ AC + + RP S +V L G++
Sbjct: 286 FCQRLKDGT-----RMRAPENATPEIYRI---MLACWQGDPKERPTFSALVEIL-GDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 20/212 (9%)
Query: 210 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGY 266
LG+G + V KG LT +VA+K+++ +G E+ ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPK 323
LV+E++ +K L+ ++ G + N +KI L RGLAY H + K
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN----VKIFLYQILRGLAYCH---RRK 124
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE-YASSGKL 381
++HRD+K N+L+++ E K+ADFGLA+ S+ T T+ + V T Y P+ S +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEY 182
Query: 382 TEKSDVFSFGVLLLELITGFRPFDKADTFADD 413
+ + D++ G + E+ +G RP T D+
Sbjct: 183 STQIDMWGVGCIFFEMASG-RPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEI-----ISQVHHRHLVSL 263
+G G +G V+K +G VA+K ++ + + E+ + H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 264 VGYC-TFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
+ C T + R LV+E V ++ L +L P + T + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+C I+HRD+K NIL+ + K+ADFGLA+ + + T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLAR--IYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
D++S G + E+ F + F +S D
Sbjct: 182 STYATPVDMWSVGCIFAEM------FRRKPLFCGNSEAD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 210 LGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVH---HRHLVS 262
+G+G +G V K + G+ VA+K+++ +G+ E+ ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 263 LVGYCTFG-----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
L CT ++ LV+E V ++ L +L P + T + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 377
+++HRD+K NIL+ S + K+ADFGLA+ + + T V+ T Y APE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLWYRAPEVLL 182
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
D++S G + E+ F + F S VD
Sbjct: 183 QSSYATPVDLWSVGCIFAEM------FRRKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKA---GSGQGEREFQAEIEIISQVHHR 258
NF +G+G F V++ L +G VA+K+++ + + EI+++ Q++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGLAYL 316
+++ ++ +V E L + K + ++ T K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 376
H +++HRDIK AN+ + + K+ D GL + + T + ++GT Y++PE
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSPERI 178
Query: 377 SSGKLTEKSDVFSFGVLLLELITGFRPF--DKADTFA 411
KSD++S G LL E+ PF DK + ++
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 52/239 (21%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIEI 251
D + + +G G +G V + G VAIK+L R FQ+ E+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRL 67
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVM--NWPTRMKIA-L 307
+ + H +++ L+ F P+ +L+ FH P M + MK L
Sbjct: 68 LKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115
Query: 308 GSAR----------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
R GL Y+H IIHRD+K N+ +++ E K+ DFGLA+ TD
Sbjct: 116 SEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TD 169
Query: 358 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 415
+ ++ V+ T Y APE + T+ D++S G ++ E++TG +P K D M
Sbjct: 170 SEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLM 226
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM----G 366
RGL Y+H +IHRD+K +N+L+++ E ++ DFG+A+ L + M
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPTEHKYFMTEYVA 173
Query: 367 TFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELI 398
T Y APE S + T D++S G + E++
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 21/104 (20%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT----------HV 360
+ L Y+H +IHRD+K +NILL+ K+ADFGLA+ SL +V
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR-SLSELEENPENPVLTDYV 173
Query: 361 STRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRP 403
+TR Y APE S + T+ D++S G +L E++ G +P
Sbjct: 174 ATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 46/135 (34%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 330
S+ LV E+V L FH+ + R + R A L +LHE II+RD+K
Sbjct: 69 SRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YAAEICIALNFLHER---GIIYRDLK 123
Query: 331 SANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF 390
N+LLD K+ D+G+ K L ST GT Y+APE + D ++
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDWWAL 182
Query: 391 GVLLLELITGFRPFD 405
GVL+ E++ G PFD
Sbjct: 183 GVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 16/218 (7%)
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKV--VAIKQLKAGSGQGEREFQ---A 247
+ K+ ++F+ LG G FG V N VAIK+ + +++ +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 248 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
E +I++ ++H V+L G S LV EFV L R +P +
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR----FPN--DVGC 134
Query: 308 GSARGLAYLHEDCQP-KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
A + + E Q I++RD+K N+LLD K+ DFG AK +DT T+ + G
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-VVDTRTYT---LCG 190
Query: 367 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
T Y+APE + + +D ++ G+ + E++ G PF
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 7/180 (3%)
Query: 225 NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284
+G+ VA+K + Q E+ I+ H+++V + G + ++ EF+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
L + + R +N + + L YLH +IHRDIKS +ILL K+
Sbjct: 105 LT-DIVSQTR--LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKL 158
Query: 345 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+DFG + D ++GT ++APE S + D++S G++++E++ G P+
Sbjct: 159 SDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 10/109 (9%)
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
++ W +M + G+ ++HE +++HRDIKS NI L + + K+ DFG A+
Sbjct: 102 ILQWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152
Query: 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ T V GT Y+ PE + KSD++S G +L EL T PF
Sbjct: 153 PGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 67/257 (26%), Positives = 110/257 (42%), Gaps = 35/257 (13%)
Query: 169 SLDSDKPFPRQSPGMPVGNFKSTF-----TYEELKIATDNFSEANLLGQGGFGYV----H 219
SL D FP + NF + + +L++ +++ ++G+G FG V H
Sbjct: 5 SLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRH 64
Query: 220 KGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL- 275
K ++ KV A+K L + F E +I++ + +V L +C F + L
Sbjct: 65 K---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLY 119
Query: 276 -VYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 331
V E++P L + D P + + +AL + + +IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---------LIHRDVKP 170
Query: 332 ANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS----GKLTEKSDV 387
N+LLD K+ADFG +T +GT Y++PE S G + D
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 388 FSFGVLLLELITGFRPF 404
+S GV L E++ G PF
Sbjct: 231 WSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 28/220 (12%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHH 257
+F +L+G+G FG V G + A+K +K + F+ E +I+S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 258 RHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRP-----VMNWPTRMKIALGSAR 311
+ L Y L LV E+ P L L+ + + + +A+ S
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGY 370
+ Y +HRDIK N+L+D + K+ADFG A L + V S +GT Y
Sbjct: 120 QMGY---------VHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDY 169
Query: 371 LAPEYASSGKLTEKS------DVFSFGVLLLELITGFRPF 404
+APE ++ K D +S GV+ E+I G PF
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA-KHSLDTDTHVSTRVMGTFG 369
RGL YLH I+HRDIK N+L++ + K+ DFGLA D H++ V+ +
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 370 YLAPE-YASSGKLTEKSDVFSFGVLLLELITG 400
Y APE S T D++S G + EL+
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + + ++ V+ T Y
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 371 LAPE-YASSGKLTEKSDVFSFGVLLLELIT 399
APE + + T DV+S G + EL+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 5/88 (5%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
GL YLH +IIHRD+K+ NI ++D + + D G A+ + + + GT
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 371 LAPEYASSGKLTEKSDVFSFGVLLLELI 398
APE + K K+D++S G++L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 38/100 (38%), Positives = 57/100 (57%), Gaps = 10/100 (10%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFG 369
RGL Y+H IIHRD+K +N+ +++ E K+ DFGLA+H+ D T +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 370 YLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKAD 408
Y APE + + D++S G ++ EL+TG F D
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G FG V +L G+ A+K L+ + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 319
+L Y RL V E+ L FHL ++R R A + SA L YLH
Sbjct: 59 AL-KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA--LEYLHSR 114
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
+++RDIK N++LD K+ DFGL K + +D GT YLAPE
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDN 170
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKAD 408
D + GV++ E++ G PF D
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 210 LGQGGFGYVH----KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
L G G V G KV+ +KA +G EI+I+ + HR +++L+
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVI----VKAVTGGKTPG--REIDILKTISHRAIINLIH 153
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
+ S +V +P + + + + I LAYLH II
Sbjct: 154 AYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GII 207
Query: 326 HRDIKSANILLDDSFEAKVADFGLA-KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
HRD+K+ NI LD+ A + DFG A K DT GT +PE + K
Sbjct: 208 HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK 267
Query: 385 SDVFSFGVLLLELITGFRPF 404
+D++S G++L E+
Sbjct: 268 TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 203 NFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS----GQGEREFQAEIEIISQ 254
NF +LG G +G V GK+ A+K L+ + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 255 VHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RG 312
V + + Y +L L+ ++V + HL+ +D + ++ G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILA 117
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
L +LH + I++RDIK NILLD + DFGL+K L + + GT Y+A
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 373 PEYA-SSGKLTEKSDVFSFGVLLLELITGFRPF 404
PE G + D +S G+L+ EL+TG PF
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 37/258 (14%)
Query: 169 SLDSDKPFPRQSPGMPVGNFKSTFT-----YEELKIATDNFSEANLLGQGGFGYV----H 219
+L D FP + NF + + +L++ +++ ++G+G FG V H
Sbjct: 5 ALVYDLDFPALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 64
Query: 220 KGVLTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHHRHLVSLVGYCTFGSQRLL- 275
K + KV A+K L + F E +I++ + +V L + F R L
Sbjct: 65 K---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLY 119
Query: 276 -VYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 331
V E++P L + D P + + +AL + + + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKP 170
Query: 332 ANILLDDSFEAKVADFGLA-KHSLDTDTHVSTRVMGTFGYLAPEYASS----GKLTEKSD 386
N+LLD S K+ADFG K + + T V GT Y++PE S G + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 387 VFSFGVLLLELITGFRPF 404
+S GV L E++ G PF
Sbjct: 230 WWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 62/208 (29%), Positives = 88/208 (42%), Gaps = 17/208 (8%)
Query: 209 LLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G FG V +L G+ A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
+L Y RL V E+ L FHL ++R R A L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDYLHS-- 113
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 380
+ +++RD+K N++LD K+ DFGL K + + T GT YLAPE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 381 LTEKSDVFSFGVLLLELITGFRPFDKAD 408
D + GV++ E++ G PF D
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVS-TRVMGTF 368
R L Y+H + HRD+K NIL + + K+ DFGLA+ DT T + T + T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 369 GYLAPEYASS--GKLTEKSDVFSFGVLLLELITG 400
Y APE S K T D++S G + E++TG
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 64/251 (25%)
Query: 209 LLGQGGFGYVH----KGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLV 261
LLG+G G V KG GK+ A+K L + + E EI++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 262 SLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR-------- 311
+L Y +F ++ LV ++ P E + +P ++ AR
Sbjct: 65 TL--YASFQTETYLCLVMDYCPGG--ELFRLLQRQP------GKCLSEEVARFYAAEVLL 114
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV------- 364
L YLH I++RD+K NILL +S ++DF L+K S VS +
Sbjct: 115 ALEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 365 ---------------------MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
+GT Y+APE S D ++ G+LL E++ G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 404 F---DKADTFA 411
F ++ +TF+
Sbjct: 232 FKGSNRDETFS 242
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 66/229 (28%), Positives = 97/229 (42%), Gaps = 21/229 (9%)
Query: 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSGQGEREFQAE 248
T ++ +D + +G+G +G V K VL NG A+K L E E +AE
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EIEAE 64
Query: 249 IEIISQVH-HRHLVSLVGY-----CTFGSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWP 300
I+ + H ++V G G Q LV E ++ + G K M P
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
I + GL +LH + K IHRD+K NILL K+ DFG++ T
Sbjct: 125 IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 361 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPF 404
+T V GT ++APE + + DV+S G+ +EL G P
Sbjct: 182 NTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
N++G G FG V++ + + + VAIK++ RE I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127
Query: 267 CTFGSQRL--------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS---ARGLAY 315
+ +V EF+P +T+ ++ R P + + L S R LAY
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAY 185
Query: 316 LHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 374
+H I HRD+K N+L+D ++ K+ DFG AK+ L VS + F Y APE
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPE 240
Query: 375 YA-SSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ T D++S G ++ E+I G+ F
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 38/116 (32%), Positives = 63/116 (54%), Gaps = 17/116 (14%)
Query: 299 WPTRM----KIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
WP + + + A+G+ +L ++C IHRD+ + N+LL D AK+ DFGLA+
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI 262
Query: 354 LDTDTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++ +V V G ++APE T +SDV+S+G+LL E+ + G P+
Sbjct: 263 MNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 54/231 (23%)
Query: 204 FSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI---------EIIS 253
++ +G G +G V + G+ VAIK+L R FQ+EI ++
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRELTLLK 69
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
+ H +++ L+ F S ++ +F+L VM + M+ L G
Sbjct: 70 HMQHENVIGLLD--VFTSAVSG------DEFQDFYL------VMPY---MQTDLQKIMGH 112
Query: 314 AYLHEDCQ---------------PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
+ Q IIHRD+K N+ +++ E K+ DFGLA+H+ D
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DA 169
Query: 359 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKAD 408
++ V+ T Y APE + + D++S G ++ E++TG F D
Sbjct: 170 EMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 210 LGQGGFGYVHKGVLTNGKVVA---IKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
+G G FG V + VA +K+LKA + E+ EF + + + H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLHEDCQPK 323
C LLV+E+ L+ +L + N + ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST--RVMGTFGYLAPEYASS--G 379
+H D+ N L KV D+G+ D ++ T +LAPE G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELVGEFHG 178
Query: 380 KL-----TEKSDVFSFGVLLLEL 397
L T+ S+V++ GV L EL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHRHLVSLVGY 266
LG+G + V+KG+ NG++VA+K + + +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA-RGLAYLHEDCQPKII 325
V+E++ ++ + P P +++ + RGLAY+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125
Query: 326 HRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTE 383
HRD+K N+L+ E K+ADFGLA+ S+ + T+ S V T Y P+ + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSS 183
Query: 384 KSDVFSFGVLLLELITG 400
D++ G + +E++ G
Sbjct: 184 ALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 46/172 (26%), Positives = 73/172 (42%), Gaps = 32/172 (18%)
Query: 248 EIEIISQVH-----HRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWP 300
IE + VH + + + L Y + + + +L+ +++ + L F L K+ +
Sbjct: 56 AIEPM--VHQLMKDNPNFIKL--YYSVTTLKGHVLIMDYIKDGDL-FDLLKKEGKLSEAE 110
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHSLDTDTH 359
+ KI L LH+ IIH DIK N+L D + + D+GL K
Sbjct: 111 VK-KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IG 161
Query: 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSF-----GVLLLELITGFRPFDK 406
+ GT Y +PE K+ + SF GVL EL+TG PF +
Sbjct: 162 TPSCYDGTLDYFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 45/228 (19%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGERE---FQAEIEI------ 251
++F ++G+G FG V L N KV A+K L E F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 252 --ISQVHH-----RHLVSLVGYCTFGSQRLLVYEF---VPNKTLEFHLHGKDRPVMNWPT 301
I+ +H+ +L ++ Y G L+ +F +P F+L
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-----------A 109
Query: 302 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
M IA+ S L Y +HRDIK NIL+D + ++ADFG ++ T S
Sbjct: 110 EMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160
Query: 362 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPF 404
+ +GT Y++PE + GK + D +S GV + E++ G PF
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 50/236 (21%), Positives = 97/236 (41%), Gaps = 45/236 (19%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLV 264
L+G+GG G V+ + VA+K+++ + + ++ F E +I + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 265 GYCTFGSQRLLVY---EFVPNKTLEFHL------------HGKDRPVMNWPTRMKIALGS 309
C S VY ++ TL+ L + V + I
Sbjct: 69 SIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV---GAFLSIFHKI 122
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-----------------H 352
+ Y+H ++HRD+K NILL E + D+G A +
Sbjct: 123 CATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
+ + +++GT Y+APE +E +D+++ GV+L +++T P+ +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
|
Length = 932 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQVHHR 258
D + + +G+G +G V+K GK+VA+K+ + + A EI ++ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 259 -HLVSL-----VGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGS 309
++V L V LV+E++ + K ++ + G RP + T
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQL 119
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-KVADFGLAKHSLDTDTHVSTRVMGTF 368
+G+A+ H+ ++HRD+K N+L+D K+AD GL + + T + T
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIVTL 175
Query: 369 GYLAPE-YASSGKLTEKSDVFSFGVLLLELITG 400
Y APE S + D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNG-KVVAIK------QLKAGSGQGERE-----FQAEI 249
D+F ++G+G FG V + + ++ A+K LK RE +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 250 EIISQVHH-----RHLVSLVGYCTFGSQRLLVYEF---VPNKTLEFHLHGKDRPVMNWPT 301
+ I+ +H+ +L ++ Y G L+ +F +P F++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI-----------A 109
Query: 302 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
M +A+ S L Y +HRDIK N+LLD + ++ADFG T S
Sbjct: 110 EMVLAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160
Query: 362 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPF 404
+ +GT Y++PE + GK + D +S GV + E++ G PF
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 63/241 (26%), Positives = 101/241 (41%), Gaps = 43/241 (17%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQL-KAGSGQGER--EFQAEIEIISQVHH 257
++F ++G+G FG V + G V A+K L KA + E+ +AE +I+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
+V + L+ EF+P + L KD + T+ IA + + +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIA-ETVLAIDSIH 118
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLA---------------KHSLDTD----- 357
Q IHRDIK N+LLD K++DFGL HSL +D
Sbjct: 119 ---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 358 --------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
++ +GT Y+APE + D +S GV++ E++ G+ P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 404 F 404
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAI-KQLKAGSGQGEREFQAEIEIISQVH 256
++F L+ G +G V HK + I KQ Q ++ F E +I++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 257 HRHLVSLVGYCTFGSQRLL--VYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ +VS+ +C+F ++R L V E+V TL ++ + RM A +
Sbjct: 60 NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFA-ETVL 112
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK------------HSLDTDTH 359
L YLH I+HRD+K N+L+ K+ DFGL+K ++ DT
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 360 --VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ +V GT Y+APE + D ++ G++L E + G PF
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 38/221 (17%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
++ K +VA+K+ L + S + + Q EI Q+ H +++ V
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVM--NWPTRMK---IAL---GSARGLAYLHED 319
S+ +V + +G ++ ++P + IA L Y+H
Sbjct: 69 IVDSELYVVSPLMA--------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH-- 118
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADF---------GLAKHSLDTDTHVSTRVMGTFGY 370
IHR +K+++ILL + ++ G + + S + + +
Sbjct: 119 -SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---W 174
Query: 371 LAPE--YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
L+PE + EKSD++S G+ EL G PF D
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF--KDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 202 DNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQA--EIEIISQV 255
+ F ++G+G +G V HK ++VAIK+ K E + E++++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHK---ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL 57
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-ARGLA 314
++V L + LV+E+V LE ++ P P +++ + + +
Sbjct: 58 KQENIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIH 114
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 374
+ H++ I+HRDIK N+L+ + K+ DFG A++ + T + T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 375 YASSGKLTEKSDVFSFGVLLLELITG 400
+ D++S G +L EL G
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIK------QLKAGSGQGERE-----FQAEI 249
D+F ++G+G FG V + N G+V A+K LK RE +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 250 EIISQVHH-----RHLVSLVGYCTFGSQRLLVYEF---VPNKTLEFHLHGKDRPVMNWPT 301
I+ +H+ +L ++ Y G L+ +F +P F+L
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-----------A 109
Query: 302 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
M +A+ S L Y +HRDIK N+LLD + ++ADFG L T S
Sbjct: 110 EMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160
Query: 362 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPF 404
+GT Y++PE + G+ + D +S GV + E++ G PF
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 52/215 (24%)
Query: 210 LGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQVHHRHLVSL 263
+G+G F V K GK AIK +K E RE QA + H +++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA---LRRLSPHPNILRL 63
Query: 264 VGYCTFGSQRLLVYEFVPNK-TLEFHL---------HGKDRP-----VMNWPTRMKIALG 308
+ ++++ + L F L G+ RP V ++ ++
Sbjct: 64 IE---------VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL----- 109
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDT-HVSTRVM 365
+ L ++H + I HRDIK NIL+ D K+ADFG + +S T ++STR
Sbjct: 110 -LKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-- 162
Query: 366 GTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELIT 399
Y APE + G K D+++ G + E+++
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFG 369
RGL Y+H IIHRD+K +N+ +++ E ++ DFGLA+ + D T +V+TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 370 YLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKAD 408
Y APE + + D++S G ++ EL+ G F D
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGS 309
++SQV H HL + G C GS+ ++V EFV + L+ L K R + W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILL-------DDSFEAKVADFGLAKHSLDTDTHVST 362
A L+YL ED ++H ++ + NILL S K++D G++ +L + V
Sbjct: 127 ASALSYL-ED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE- 182
Query: 363 RVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLEL 397
++APE G L+ +D +SFG LLE+
Sbjct: 183 ----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 49/244 (20%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGERE----FQAEIEIISQVH 256
D+F ++G+G FG V + G + A+K L+ + E+E +AE +I+ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRK-ADMLEKEQVAHIRAERDILVEAD 59
Query: 257 HRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+V + + +F +R L+ EF+P + L KD + T+ IA + +
Sbjct: 60 GAWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIA-ETVLAID 115
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA---------------KHSLDTD-- 357
+H Q IHRDIK N+LLD K++DFGL H+ +D
Sbjct: 116 AIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 358 -----------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400
++ +GT Y+APE + D +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 401 FRPF 404
+ PF
Sbjct: 233 YPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++ QV H+H+V L G C + ++V EFV L+ +H K + P + K+A A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT-PWKFKVAKQLA 115
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILL-DDSFEA------KVADFGLAKHSLDTDTHVSTR 363
L+YL ED ++H ++ + NILL + + K++D G+ L V R
Sbjct: 116 SALSYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-R 171
Query: 364 VMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLEL 397
+ ++APE K L+ +D +SFG L E+
Sbjct: 172 I----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK----HSLDTDTHVSTRVMG 366
GL Y+H ++HRD+K N+L++ E K+ DFGLA+ + + + T +
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVA 171
Query: 367 TFGYLAPEYASSGKLTEKS-DVFSFGVLLLELITGFRPFDKADTFAD 412
T Y APE S + K+ DV+S G +L EL+ G +P K + D
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVD 217
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 33/213 (15%)
Query: 210 LGQGGFGYVHKGVLTNGK---VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
+G+G +G+V+K +GK A+KQ++ G+G + EI ++ ++ H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 267 CTFGSQR--LLVYEFVPNK---TLEFHLHGK-DRPVMNWPTRMKIAL--GSARGLAYLHE 318
S R L++++ + ++FH K ++ M P M +L G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 319 DCQPKIIHRDIKSANILL----DDSFEAKVADFGLA-------KHSLDTDTHVSTRVMGT 367
+ ++HRD+K ANIL+ + K+AD G A K D D V+ T
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP-----VVVT 178
Query: 368 FGYLAPEYASSGK-LTEKSDVFSFGVLLLELIT 399
F Y APE + T+ D+++ G + EL+T
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 41/147 (27%), Positives = 59/147 (40%), Gaps = 19/147 (12%)
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFH----LHGKDRPVMNWPTRMKIALGSARGLA 314
++V L Y LV + L H L+ + V W M +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT-DTHVSTRVMGTFGYLAP 373
LH + I+ RD+ NILLDD ++ F D+ D + Y AP
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITG 400
E + TE D +S G +L EL+TG
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 13/101 (12%)
Query: 310 ARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT- 367
A+G+++L ++C IHRD+ + NILL K+ DFGLA+ D + V G
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR---DIRNDSNYVVKGNA 276
Query: 368 ---FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
++APE + T +SDV+S+G+LL E+ + G P+
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 293 DRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
+ P +++ + + A G+ +L ++C +HRD+ + N+L+ + K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 352 HSLDTDTHVSTRVMGTF---GYLAPEYASSGKLTEKSDVFSFGVLLLELIT 399
+ ++S TF ++APE + T SDV+SFG+LL E+ T
Sbjct: 288 DIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 49/240 (20%)
Query: 190 STFT----YEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLK---AGSGQG 241
STFT Y++LK +G G G V T G VA+K+L
Sbjct: 15 STFTVLKRYQQLKP----------IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 64
Query: 242 EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVM--N 298
+R ++ E+ ++ V+H++++SL+ F P K+LE F +M N
Sbjct: 65 KRAYR-ELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDAN 111
Query: 299 WPTRMKIALGSAR----------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
+ + L R G+ +LH IIHRD+K +NI++ K+ DFG
Sbjct: 112 LCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 168
Query: 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
LA+ + T+ ++ V+ + Y APE E D++S G ++ EL+ G F D
Sbjct: 169 LAR-TACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTF 368
G+ +LH IIHRD+K +NI++ K+ DFGLA+ S +V TR
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400
Y APE E D++S G ++ E+I G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 310 ARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
ARG+ +L ++C +HRD+ + N+LL K+ DFGLA+ + +VS TF
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STF 300
Query: 369 ---GYLAPEYASSGKLTEKSDVFSFGVLLLELIT 399
++APE T SDV+S+G+LL E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 33/213 (15%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
+G+G +G+V+K +GK A+KQ++ G+G + EI ++ ++ H +++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 267 CTFGSQR--LLVYEFVPNK---TLEFHLHGK-DRPVMNWPTRMKIAL--GSARGLAYLHE 318
+ R L++++ + ++FH K ++ + P M +L G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 319 DCQPKIIHRDIKSANILL----DDSFEAKVADFGLA-------KHSLDTDTHVSTRVMGT 367
+ ++HRD+K ANIL+ + K+AD G A K D D V+ T
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP-----VVVT 178
Query: 368 FGYLAPEYASSGK-LTEKSDVFSFGVLLLELIT 399
F Y APE + T+ D+++ G + EL+T
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS-----TRV 364
RGL Y+H ++HRD+K AN+ ++ + K+ DFGLA+ D H S +
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYLSEG 178
Query: 365 MGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITG 400
+ T Y +P S T+ D+++ G + E++TG
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 8/86 (9%)
Query: 202 DNFSEANLLGQGGFGYVHK------GVLTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQ 254
DN LG G FG V + G N VA+K LKA + ERE +E++I+S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 255 V-HHRHLVSLVGYCTFGSQRLLVYEF 279
+ H+++V+L+G CT G L++ E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 75/263 (28%)
Query: 202 DNFSEANLLGQGGFG---YVHKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV 255
++F ++G+G FG V K GK+ A+K L + + +AE +++++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 256 HHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWP------TRMKIAL 307
+VSL Y +F +Q L L+ EF+P L L + + TR +A
Sbjct: 59 DSPWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA- 108
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL------------------ 349
+ +H + IHRDIK NIL+D K++DFGL
Sbjct: 109 ECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 350 ---AKHSLDTDTHV--------------------STRVM-----GTFGYLAPEYASSGKL 381
K+ +D V + R+M GT Y+APE
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 382 TEKSDVFSFGVLLLELITGFRPF 404
++ D +S G ++ E + G+ PF
Sbjct: 226 GQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 11/92 (11%)
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTF 368
G+ +LH IIHRD+K +NI++ K+ DFGLA+ S +V TR
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 190
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400
Y APE E D++S G ++ E+I G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 23/109 (21%)
Query: 323 KIIHRDIKSANILLDDSFE-----------------AKVADFGLAKH-SLDTDTHVSTRV 364
+++HRD+K NI L AK+ DFGL+K+ +++ H
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SC 201
Query: 365 MGTFGYLAPEYA--SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411
+GT Y +PE + +KSD+++ G ++ EL +G PF KA+ F+
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 37/183 (20%), Positives = 48/183 (26%), Gaps = 9/183 (4%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPG-NLTSPPSSGTPTSGSTVGTRRPSPT 63
S SP P +AV APA + P+ P S T P P
Sbjct: 2784 TRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTA-PPPP 2842
Query: 64 RNGYLPPGALAGMVV--GVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKP 121
P L G V G V + + R+LA + + FA P
Sbjct: 2843 PGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPP 2902
Query: 122 HHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSP 181
+ + P P P P P P P P S
Sbjct: 2903 -----DQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSG 2957
Query: 182 GMP 184
+P
Sbjct: 2958 AVP 2960
|
Length = 3151 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 13/126 (10%)
Query: 276 VYEFVPNKTLEFHLHGKDRPVMNWPTR--MKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333
+Y F+ ++ ++ KDRP++ TR MK L + + Y+H+ K+IHRDIK N
Sbjct: 249 LYSFMYDEAFDW----KDRPLL-KQTRAIMKQLLCA---VEYIHDK---KLIHRDIKLEN 297
Query: 334 ILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVL 393
I L+ + + DFG A +GT +PE + E +D++S G++
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357
Query: 394 LLELIT 399
LL++++
Sbjct: 358 LLDMLS 363
|
Length = 501 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 34/186 (18%)
Query: 229 VAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285
VAIK+L +R ++ E+ ++ V+H++++SL+ F P K+L
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV------------FTPQKSL 91
Query: 286 E-FHLHGKDRPVM--NWPTRMKIALGSAR----------GLAYLHEDCQPKIIHRDIKSA 332
E F +M N +++ L R G+ +LH IIHRD+K +
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPS 148
Query: 333 NILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 392
NI++ K+ DFGLA+ + + + T + T Y APE E D++S G
Sbjct: 149 NIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 393 LLLELI 398
++ E++
Sbjct: 207 IMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 36/180 (20%), Positives = 44/180 (24%), Gaps = 13/180 (7%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTR 64
PP T PAP S P P + S P P P + PT
Sbjct: 2704 PPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTT 2763
Query: 65 NGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHHW 124
G P A G A + ++LP DP
Sbjct: 2764 AGPPAPAPPAAPAAGPPRRLTRPAVA-----------SLSESRESLPSPWDPADPPAAVL 2812
Query: 125 QQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMP 184
+ P P LPP P P L GS+ R+ P
Sbjct: 2813 APAAALPP--AASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRS 2870
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 37/161 (22%), Positives = 51/161 (31%), Gaps = 7/161 (4%)
Query: 2 TSQPPLTSLPAPPETNSTFSPPAPP---PSVSAVSAPAPG-NLTSPPSSGTPTSGSTVGT 57
LT + S S P+P +AV APA + P+ P S T
Sbjct: 2778 GPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPT 2837
Query: 58 RRPSPTRNGYLPPGALAGMVV--GVVIGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKND 115
P P P L G V G V + + R+LA + +
Sbjct: 2838 -APPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTE 2896
Query: 116 PFAGKPHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVP 156
FA P ++ + P+P PP P P P P
Sbjct: 2897 SFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPP 2937
|
Length = 3151 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 39/140 (27%), Positives = 55/140 (39%), Gaps = 45/140 (32%)
Query: 325 IHRDIKSANILLDDSFEAKVADFGLA-------------------KHSLDTDTHVS---- 361
IHRDIK NIL+D K+ DFGL + S++ S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 362 --------------TRVM-----GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 402
R + GT Y+APE T+ D +S GV+L E++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 403 PFDKADTFADDSM--VDWAK 420
PF ADT A+ + ++W
Sbjct: 243 PF-LADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 20/52 (38%), Positives = 32/52 (61%), Gaps = 3/52 (5%)
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
A L YLH + IIHRD+K N+L+ + K+ DFGL+K +L+ + ++
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 21/104 (20%), Positives = 29/104 (27%), Gaps = 20/104 (19%)
Query: 5 PPLTSLPAPPETNSTFSPPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTR 64
P T+ PAP S S S PA P P + RR
Sbjct: 271 QPATAAPAPS------RMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGR--- 321
Query: 65 NGYLPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRKLAAQ 108
+ V+ AAVG + R+ +L +
Sbjct: 322 ---------GSAALWFVVVVLACAAAVGGY--ALNRKVDRLDQE 354
|
Length = 656 |
| >gnl|CDD|217633 pfam03600, CitMHS, Citrate transporter | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 22/102 (21%), Positives = 37/102 (36%), Gaps = 13/102 (12%)
Query: 22 PPAPPPSVSAVSAPAPGNLTSPPSSGTPTSGSTVGTRRPSPTRNGYLPPGALAGMVVGVV 81
PP A+ A G + +P G P R + + P A M+ GV+
Sbjct: 131 PPRLLLGAIALGANI-GGMLTPW--GGPQ------NRAAAGL--NFFPTDFFAPMIPGVI 179
Query: 82 IGAGIVLAAVGIFLIFYKRRKRKLAAQNLPLKNDPFAGKPHH 123
G IV+ G + + K RKR + ++ + +
Sbjct: 180 AGLLIVIL--GAYYLGKKERKRLGEGELELERDTLEELEAEY 219
|
Length = 377 |
| >gnl|CDD|149674 pfam08693, SKG6, Transmembrane alpha-helix domain | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.002
Identities = 12/30 (40%), Positives = 18/30 (60%)
Query: 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103
+ VGVVI G++ A + FL + RRK+
Sbjct: 11 VAIAVGVVIPVGVIAAVLLAFLFLWYRRKK 40
|
SKG6/Axl2 are membrane proteins that show polarised intracellular localisation. SKG6_Tmem is the highly conserved transmembrane alpha-helical domain of SKG6 and Axl2 proteins. The full-length fungal protein has a negative regulatory function in cytokinesis. Length = 40 |
| >gnl|CDD|213052 cd12087, TM_EGFR-like, Transmembrane domain of the Epidermal Growth Factor Receptor family of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.002
Identities = 7/35 (20%), Positives = 17/35 (48%)
Query: 70 PGALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104
+ + V+G +VL +G+ + ++RR+
Sbjct: 1 RTSKTTSIAAGVVGGLLVLVILGLIVFLFRRRRHI 35
|
PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. They are receptor PTKs (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane (TM) helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. They are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. The TM domain not only serves as a membrane anchor, but also plays an important role in receptor dimerization and optimal activation. Mutations in the TM domain of EGFR family RTKs have been associated with increased breast cancer risk. Length = 38 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 9/90 (10%)
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV------MG 366
L Y+HE I H DIK NI++D + + D+G+A H + H+ G
Sbjct: 139 LEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195
Query: 367 TFGYLAPEYASSGKLTEKSDVFSFGVLLLE 396
T Y + + +T + D+ S G +L+
Sbjct: 196 TLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 33/126 (26%), Positives = 47/126 (37%), Gaps = 46/126 (36%)
Query: 325 IHRDIKSANILLDDSFEAKVADFGLA-------------------KHSLDTDTH------ 359
IHRDIK NIL+D K+ DFGL + S+D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 360 ---------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 398
++ ++GT Y+APE T+ D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 399 TGFRPF 404
G PF
Sbjct: 243 VGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 579 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.35 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.3 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.22 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.12 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.01 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.95 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.74 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.74 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.7 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.67 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.52 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.5 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 97.39 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.37 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.2 | |
| PLN02236 | 344 | choline kinase | 97.05 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 97.03 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.96 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.92 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.88 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 96.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.81 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 96.71 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.69 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.65 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 96.64 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.59 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.53 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 96.49 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.43 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.39 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.39 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.31 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.2 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-61 Score=502.35 Aligned_cols=288 Identities=59% Similarity=1.012 Sum_probs=256.3
Q ss_pred CcCcCHHHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 008052 189 KSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (579)
Q Consensus 189 ~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 268 (579)
...|+|.||+.+|++|+..+.||+|+||.||+|.+.+|+.||||++.....+..++|.+|+++|.+++|||||+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34799999999999999999999999999999999999999999987765542456999999999999999999999999
Q ss_pred eCC-eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 269 FGS-QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 269 ~~~-~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
+.+ +++||||||+||+|.++|+......++|.+|++||.++|+||+|||+.|.+.|||||||++|||||+++++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 988 5999999999999999999865537899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
|||+.......+..+...||++|+||||+..+.+++|+|||||||+|+||+||+.+.+.........+++|+.+.+.
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~--- 298 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE--- 298 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH---
Confidence 99976543122222222799999999999999999999999999999999999999987765566679999977765
Q ss_pred cCCCchhhhchhhh--cCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 428 ADGNFDALVDQKLE--EYDS-AEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 428 ~~~~~~~l~d~~l~--~~~~-~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
++.+.+++|+.+. .+.. .++.++..++.+|++.++.+||+|.||++.|+...
T Consensus 299 -~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 -EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred -CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 4488999999985 5554 68899999999999999999999999999997654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=411.97 Aligned_cols=256 Identities=34% Similarity=0.548 Sum_probs=212.1
Q ss_pred ccccceecccCceEEEEEEEeCCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEEEEEEec
Q 008052 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLVYEFV 280 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~--~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~lV~E~~ 280 (579)
+...+.||.|+||+||+|.+.+...||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..+||||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33446699999999999999755559999997654332 458999999999999999999999999887 789999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc-eEeCCCCCCceEeCCCC-CeEEeecccccccCCCCc
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK-IIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-ivHrDikp~NILl~~~~-~~kL~DFGla~~~~~~~~ 358 (579)
++|+|..+|+......+++..+++||.|||+||.|||++ + |||||||++||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999875556799999999999999999999998 6 99999999999999997 99999999998754332
Q ss_pred ceeecccccccccChhhhc--cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 359 HVSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~--~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....... . +.... .
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~---~~~v~------------~ 260 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---V---ASAVV------------V 260 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---H---HHHHH------------h
Confidence 2223367999999999999 6699999999999999999999999998765311 0 00000 0
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
.......+..+...+..++..||+.||..||++.+|+..|+..+.
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 111113344477889999999999999999999999999996643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=388.50 Aligned_cols=251 Identities=28% Similarity=0.440 Sum_probs=212.5
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~lV~E~ 279 (579)
+++..+.||+|..|+|||+.++ +++.+|+|.+..+.. ...+++.+|++++.+.+||+||.++|.|.... ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455689999999999999986 689999999955433 34578999999999999999999999999988 59999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
|++|+|+..+... ..+++....+|+.++++||.|||+. .+||||||||+||||+..|++||||||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 9999999999654 4589999999999999999999963 29999999999999999999999999999987554
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....+||..|||||.+.+..|+.++||||||++|+|+.+|+.||.... .....|+. .+..+++..
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~----~~~~~~~~----------Ll~~Iv~~p 298 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN----PPYLDIFE----------LLCAIVDEP 298 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC----CCCCCHHH----------HHHHHhcCC
Confidence 5567889999999999999999999999999999999999999997652 11223332 123444433
Q ss_pred hhcCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 440 LEEYDSA-EMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 440 l~~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+.. ...++..++..||++||.+||++.|+++
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3344443 6788999999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=402.59 Aligned_cols=254 Identities=31% Similarity=0.482 Sum_probs=218.8
Q ss_pred CccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
.+...+.||+|.||.||.|.++....||||.++... ...++|.+|+++|.+|+|+|||+|+|+|..++.++||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 344468899999999999999877799999998864 4467899999999999999999999999998899999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|.++|....+..+...+.+.++.|||+|++||+++ ++|||||.++||||++++.+||+||||++...+.......
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 9999999886777899999999999999999999999 9999999999999999999999999999966665555555
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
...-...|.|||.+..++++.|||||||||+||||+| |+.||......+ ++ +.++.|- ++
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~--------~~le~Gy-------Rl- 423 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VL--------ELLERGY-------RL- 423 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HH--------HHHhccC-------cC-
Confidence 5556779999999999999999999999999999999 999987654311 11 1111111 01
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+..++..+.+++..||+.+|++|||+..+...|+..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 45667888999999999999999999999999998864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=413.19 Aligned_cols=260 Identities=26% Similarity=0.478 Sum_probs=223.2
Q ss_pred HhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 271 (579)
+...+....+.||+|.||+||+|... +.+.||||.||..... ...+|++|+++|..++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34456666789999999999999953 3468999999987665 6789999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~ 339 (579)
..+||+|||..|+|.++|.... ...|+..+.+.||.|||.|++||-++ .+|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 9999999999999999986321 22388899999999999999999998 89999999999999999
Q ss_pred CCeEEeecccccccCCCCcceee-cccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhh
Q 008052 340 FEAKVADFGLAKHSLDTDTHVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVD 417 (579)
Q Consensus 340 ~~~kL~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~ 417 (579)
..|||+||||++.....+..... ..+-...||+||.+..++|+.+||||||||+|||+++ |+.||.+... +..
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EV-- 714 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEV-- 714 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHH--
Confidence 99999999999998877766544 5566789999999999999999999999999999999 9999976543 111
Q ss_pred hhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 418 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
+..+-+..+-..+.+++.++.+|+..||+.+|++||+++||-..|+...
T Consensus 715 --------------Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 715 --------------IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred --------------HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 1222233334677889999999999999999999999999999998643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=386.29 Aligned_cols=267 Identities=27% Similarity=0.437 Sum_probs=223.2
Q ss_pred HHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+...+...+.+.||+|-||+|+++...++..||||+++.+.... ..+|.+||++|.+|+|||||+|+|+|..++.++||
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 34556677789999999999999999888999999999876544 47999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
+|||++|+|.++|..+..+.+.-...++|+.||+.|++||.+. ++|||||.++|||+|.++++||+|||+++.+...
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999999877666667777889999999999999987 9999999999999999999999999999977666
Q ss_pred Ccce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh--CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 357 DTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 357 ~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
+.+. ..+.+-...|||+|.+.-++++.++|||+|||+|||+++ ...||.... ++..++-+..++. .+...
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~----~~~~~ 763 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFR----DQGRQ 763 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcC----CCCcc
Confidence 6543 445667889999999999999999999999999999865 778987543 2333333322221 11110
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. ....+..++..+.+++..||+.|-++||++++|...|+..
T Consensus 764 ~-----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 V-----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred e-----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 0 0134556778899999999999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=380.22 Aligned_cols=200 Identities=30% Similarity=0.440 Sum_probs=180.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|...+.||.|.|++||+|+++ ++..||||.+... .....+.+..|+.+|+.++|+|||+|+++++.++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56888888999999999999976 5889999999665 34445668899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC------CCeEEeecccccc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS------FEAKVADFGLAKH 352 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~------~~~kL~DFGla~~ 352 (579)
||+||+|.++|+..+ .+++.+...++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+|+.
T Consensus 90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999997664 589999999999999999999999 99999999999999764 4589999999998
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
... .....+.+|++-|||||+++..+|+.|+|+||+|++|||+++|+.||+...
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 753 334567899999999999999999999999999999999999999998544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=391.55 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=211.2
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
..|...++||+|||..||+++. ..|+.||+|++.+. .....+.+.+||+|.+.|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999997 78999999999652 2233567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|+|.+++|..+++ .++.+.+.+...++.||+.||.|||++ +|||||||-.|+||+++.+|||+|||||......
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 9999999999885 556799999999999999999999999 9999999999999999999999999999886543
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....+.|||+.|+|||++.....+..+||||+|||||-||+|++||+...... .+..+..
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------------------ty~~Ik~ 232 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------------------TYNKIKL 232 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------------------HHHHHHh
Confidence 234456899999999999999999999999999999999999999998654211 0111110
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. ..++........+|+.++|+.+|.+||++++|++
T Consensus 233 ~~-Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 233 NE-YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cC-cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0234455677889999999999999999999995
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=374.40 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=204.9
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 271 (579)
..+.|...+.||+|+||.|-+|..+ +|+.||||+++.... ......++|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456788899999999999999954 799999999965321 12334679999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC---CCeEEeecc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFG 348 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kL~DFG 348 (579)
..|||||||.||.|.+.+-.+. .+.+.....++.|++.||.|||++ ||+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999986554 467777788999999999999999 99999999999999766 789999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCC---CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhh
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 425 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 425 (579)
||+... ......+.|||+.|.|||++.++. +..++|+|||||+||-+|+|.+||.+.... .++.+
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~e-------- 392 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKE-------- 392 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHH--------
Confidence 999865 334456789999999999997654 345889999999999999999999765431 11111
Q ss_pred cccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 426 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+..|.+... ........++..+++.+||..||++||++.|+++.
T Consensus 393 QI~~G~y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 393 QILKGRYAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHhcCccccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1112222110 02234556788999999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=370.78 Aligned_cols=243 Identities=28% Similarity=0.394 Sum_probs=203.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|+..++||+|+||+||.++.. .++.+|+|++++..- ...+..++|..||.+++||+||+|+..|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999965 589999999976432 2345678999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
+||+.||.|..||+.+. .+.+.....++.+|+.||.|||++ +||||||||+|||||.+|+++|+|||||+.....
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999997554 488888888899999999999999 9999999999999999999999999999975443
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.. ...+++||+.|||||++.+..|+..+|+|||||++|||++|.+||...+. ..+.+..+
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~------------- 238 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKIL------------- 238 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHh-------------
Confidence 32 33458999999999999999999999999999999999999999976553 22222221
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPR 468 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 468 (579)
..++...+.-......+++...+..||++|-.
T Consensus 239 ~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 239 KGKLPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred cCcCCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 11111222224467889999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=363.73 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=212.0
Q ss_pred cCccccceecccCceEEEEEE-EeCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEE-EEEeCCe-EEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVG-YCTFGSQ-RLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g-~~~~~~~-~~lV 276 (579)
.+|.+.++||+|.||+|||++ +.+|+.||.|.++-+ +....++...|+.+|++|+|||||++++ -+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 346667899999999999999 568999999998754 3344567899999999999999999998 4455555 7899
Q ss_pred EEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 277 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
||||..|+|...++. +....+++...+++..|++.||.++|... ++ |+||||||.||+|+.+|.|||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999988853 34567999999999999999999999943 24 99999999999999999999999999998
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
+... .......+|||.||+||.+.+..|+.|+||||+||+||||+.-+.||.+.+- .. +.+.++++++
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~-----L~~KI~qgd~ 245 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LS-----LCKKIEQGDY 245 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HH-----HHHHHHcCCC
Confidence 6443 2334567899999999999999999999999999999999999999987632 11 3344455544
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+.+ ......+.+++..|+..|++.||+...+|..+...
T Consensus 246 ~~~p~-------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 246 PPLPD-------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCCcH-------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 32221 44567899999999999999999977777666653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=365.46 Aligned_cols=265 Identities=27% Similarity=0.494 Sum_probs=214.1
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
+++.+..+.+.+...||+|.||+||+|.|.+ .||||+|+... ....+.|++||..|++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4556666777788999999999999999864 48999997653 3346789999999999999999999999998777
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.||.-+|+|.+|..|||... ..++..+.+.||.||++|+.|||.+ +|||||||..||||.+++.|||+||||+..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence 89999999999999999765 4589999999999999999999999 999999999999999999999999999863
Q ss_pred cCC-CCcceeecccccccccChhhhcc---CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhccc
Q 008052 353 SLD-TDTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 353 ~~~-~~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 428 (579)
-.. ........-.|...|||||+++. .+|+..+||||||+|+|||+||..||..... + .+ -|. +-
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--d-qI-ifm-------VG 606 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--D-QI-IFM-------VG 606 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--h-he-EEE-------ec
Confidence 211 11112233458889999999964 5799999999999999999999999983321 1 11 111 01
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
.| ..-+++.....++.+.|.+|+..||..++++||.+.+|+..|+....
T Consensus 607 rG----~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 RG----YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cc----ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 11122223445677889999999999999999999999999987765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=368.36 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=205.5
Q ss_pred HhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 270 (579)
+..++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....+.+|+.+|.++ +|||||+++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34578999999999999999999742 356899999975433 2345788999999999 899999999998764
Q ss_pred C-eEEEEEEecCCCchhhhhcCCC--------------------------------------------------------
Q 008052 271 S-QRLLVYEFVPNKTLEFHLHGKD-------------------------------------------------------- 293 (579)
Q Consensus 271 ~-~~~lV~E~~~~g~L~~~l~~~~-------------------------------------------------------- 293 (579)
+ ..++||||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 5789999999999998886431
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc-eeecccccc
Q 008052 294 ----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTF 368 (579)
Q Consensus 294 ----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~ 368 (579)
...+.+.+++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 12478889999999999999999998 9999999999999999999999999999865332221 122334678
Q ss_pred cccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHH
Q 008052 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAE 447 (579)
Q Consensus 369 ~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~ 447 (579)
.|+|||++.+..++.++|||||||+||||++ |..||...... ..+. +.+..+.. ...+...
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~--------~~~~~~~~--------~~~~~~~ 302 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFC--------QRLKDGTR--------MRAPENA 302 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHH--------HHHhcCCC--------CCCCCCC
Confidence 8999999999999999999999999999997 99999764321 1110 00111110 0112233
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 448 MTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 448 ~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
...+.+++.+||+.||.+||++.||++.|+...
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=380.71 Aligned_cols=256 Identities=28% Similarity=0.433 Sum_probs=214.7
Q ss_pred cCccccceecccCceEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
....+.++||.|.||+||+|.++- ...||||.||..-. ..+++|+.|+.||.++.||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345677999999999999999762 35799999998743 3467999999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
.|||+||+|+.+|..++++ +.+.+..-++.+||.|+.||-+. ++|||||.++||||+.+..+||+||||++...+.
T Consensus 709 TEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999999987765 99999999999999999999998 9999999999999999999999999999976554
Q ss_pred Ccceeecc--cccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 357 DTHVSTRV--MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 357 ~~~~~~~~--~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.....+.. .-...|.|||.+...+++.++|||||||||||.++ |.+||-+....+ . +.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---V----------------Ik 845 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---V----------------IK 845 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---H----------------HH
Confidence 32222222 23468999999999999999999999999999998 999986543211 1 11
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.+-+.-.-.-+.+++..|.+|++.||++|-.+||++.|||..|...+
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 11111111345678899999999999999999999999999998765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=368.49 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=215.4
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
..|.....||+|..|.||.+.. .+++.||||++.......++-+.+|+.+|+..+|+|||+++.-|..++++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577788999999999999984 468899999998877676778899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++|+|.+.+.. ..|++.++..|+.++++||+|||.+ +|||||||.+||||+.+|.+||+|||+|..+..... .
T Consensus 353 ~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999998854 3499999999999999999999999 999999999999999999999999999988655443 4
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....+||+.|||||+.....|+.|.||||||+|++||+-|.+||-..++.....++ . ....+
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-----------a-------~ng~P 487 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----------A-------TNGTP 487 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-----------h-------hcCCC
Confidence 55678999999999999999999999999999999999999999765542211100 0 01111
Q ss_pred h-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcC
Q 008052 441 E-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEGN 479 (579)
Q Consensus 441 ~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~~ 479 (579)
. .........+.+++.+||+.|+.+|+++.|+|+ +|+-+
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 1 344556788999999999999999999999997 45433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=364.20 Aligned_cols=269 Identities=23% Similarity=0.310 Sum_probs=214.7
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHH-HHHHHHHHHHhcC-CCCcceEEEEEEeCC-eEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGER-EFQAEIEIISQVH-HRHLVSLVGYCTFGS-QRLL 275 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~-~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~-~~~l 275 (579)
..++|...+.||.|.||.||+|+- ..|..||||++|..-...++ .=++|+..|++|+ |||||+|.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346788899999999999999994 46899999999876544333 3368999999999 999999999998887 9999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|||||+ .+|.+++... +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+||||||....
T Consensus 88 VfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 999995 5898888776 66799999999999999999999999 999999999999999888999999999998654
Q ss_pred CCcceeecccccccccChhhh-ccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc----------hhhhhhhhHhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD----------SMVDWAKPFLA 424 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~-~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~----------~~~~~~~~~~~ 424 (579)
.. -.+.++.|.+|+|||++ +.+.|+.+.|||++|||++||.+-++-|-+.++.+.. ...+|...+-.
T Consensus 163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 33 34778899999999987 5688999999999999999999999989877654321 12233332111
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.....-.+.......+...-.....+.++++.+|+.+||.+|||+.|.++.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111122222222333334467789999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.67 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=205.8
Q ss_pred cCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~lV~E 278 (579)
.++...+.||+|.||.||++...+ |..+|||.+........+.+.+|+.+|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356677999999999999999764 8999999987764444667899999999999999999999855444 6889999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecccccccCC--
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLD-- 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~~~~~-- 355 (579)
|+++|+|.+++...+. .+++....++..||++||+|||++ +|||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999987766 699999999999999999999998 9999999999999999 79999999999987653
Q ss_pred CCcceeecccccccccChhhhccCC-CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
..........||+.|||||++..+. ...++|||||||+++||+||+.||.... ....+.-...
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig----------- 236 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIG----------- 236 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHh-----------
Confidence 1112233467999999999999643 3459999999999999999999997631 0111111111
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.......++........+++..|+..+|+.||++.++++..-
T Consensus 237 -~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 237 -REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111111344446677899999999999999999999998653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=360.28 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=206.6
Q ss_pred cCccccceecccCceEEEEEE-EeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV 276 (579)
+.|+.+++||+|.||.||||+ ..+|+.||+|++..+.. ....-..+||.||++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 567788999999999999999 45799999999976542 2234567899999999999999999998876 689999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||+. +|.-++... .-.|+..++.-++.|++.||+|||.+ +|+|||||.+|||||++|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999976 666665543 33589999999999999999999999 9999999999999999999999999999987666
Q ss_pred CcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccch----------hhhhhhhHhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS----------MVDWAKPFLAQ 425 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~----------~~~~~~~~~~~ 425 (579)
.....+..+-|.+|.|||++.+ ..|+.+.|+||.||||.||++|++.|.+..+..... ...|....+..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 6555677889999999999876 479999999999999999999999998766432111 11233111110
Q ss_pred c--c-cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 G--L-ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 ~--~-~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. + ....+...+... -.......++|+..+|..||.+|.|+.++|+
T Consensus 352 ~~~~kp~~~y~r~l~E~----~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRET----FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHH----hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 0 001111111111 1223456788999999999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.46 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=211.7
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.+.|++.++||.|..+.||+|+. ..+..||||++.....+. ...+++|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 46788999999999999999995 467999999997654433 4789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
||.+|++.+.+...-...|++..+..|..++++||.|||.+ |.||||||+.||||+.+|.|||+|||..-.+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999876666799999999999999999999999 999999999999999999999999998776555432
Q ss_pred cee---ecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 359 HVS---TRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 359 ~~~---~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
... ...+||++|||||+++. ..|+.|+||||||++.+||.+|..||....+.. .+...+... ..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk----------vLl~tLqn~-pp 250 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK----------VLLLTLQND-PP 250 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH----------HHHHHhcCC-CC
Confidence 221 45689999999999653 469999999999999999999999998766422 111111111 11
Q ss_pred hhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 434 ALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 434 ~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.-..+. +........+.+++..||+.||.+||+++++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11101111 222333458899999999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=341.02 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=206.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+.|+....+|+|+||.|||++.+ +|+.||||++..... .-.+-.++||.+|++|+|+|+|.|+.+|......+||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46778889999999999999976 599999999965433 223456799999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
||+..-|.++-+. ...++.....+++.|+++|+.|+|++ +||||||||+||||+.++.+||||||+|+.... ..
T Consensus 82 ~~dhTvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9988777654432 23488888999999999999999999 999999999999999999999999999998764 34
Q ss_pred ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhh-h---hhHhhhccc-CCCc
Q 008052 359 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW-A---KPFLAQGLA-DGNF 432 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~-~---~~~~~~~~~-~~~~ 432 (579)
...+.++.|.+|.|||.+.+ .+|+..+|||++||++.||++|.+-|-+....+...++.- . .+...+.+. ...|
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 45677889999999999986 7899999999999999999999998876553222111110 0 011111111 1112
Q ss_pred hhhhchh------hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 433 DALVDQK------LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 433 ~~l~d~~------l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.-+.-|. ++.-......-++++++.|++.||.+|++-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2111111 12112233457899999999999999999999973
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=361.04 Aligned_cols=268 Identities=25% Similarity=0.352 Sum_probs=217.6
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 272 (579)
+....+|...+.||+|.|++|++|+.. .++.+|||++.+. .......+..|-++|.+| .||.||+|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344578999999999999999999954 6899999998653 222234567889999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+|+|+||++||+|.++|+..+ .+++.....++.+|+.||+|||++ |||||||||+|||||+|+++||+|||-|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999997654 488888899999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcc----------ee--ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhh
Q 008052 353 SLDTDTH----------VS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 420 (579)
Q Consensus 353 ~~~~~~~----------~~--~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~ 420 (579)
+...... .. ..++||..|.+||+|..+..+..+|+|+||||||+|+.|++||...++..
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--------- 294 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL--------- 294 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---------
Confidence 6542211 11 44789999999999999999999999999999999999999998776421
Q ss_pred hHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCCCCCCCCCCCCC
Q 008052 421 PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGNMPLDDLNEGITP 491 (579)
Q Consensus 421 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~--Le~~~~~~~~~~~~~~ 491 (579)
.+..+++-.. .++...+..+.+|+++.|..||.+|++..||-+. +++ +..+++|+...|
T Consensus 295 ----------iFqkI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~-Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 295 ----------IFQKIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG-VDWENLWQQTPP 355 (604)
T ss_pred ----------HHHHHHHhcc-cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc-CChhhhhhcCCC
Confidence 1222222111 4555666788999999999999999999888763 232 233445544443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=363.30 Aligned_cols=247 Identities=30% Similarity=0.480 Sum_probs=208.2
Q ss_pred HHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++..+....++.||.|..|-||+|++. ++.||||+++.- -..+|+.|++|+|+||+.+.|+|...-.+||||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 444455666789999999999999996 477999987532 235789999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|||..|-|...|+. +..+.-.....|..+||.|+.|||.+ +|||||||.-||||+.+..|||+|||-++...+..
T Consensus 192 EfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred eccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 99999999999964 34578888899999999999999999 99999999999999999999999999998765543
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
+ ...++||..|||||++...+.++|+|||||||||||||||..||.+.+... +-|- +-.
T Consensus 267 T--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG-------VGs-------- 325 (904)
T KOG4721|consen 267 T--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG-------VGS-------- 325 (904)
T ss_pred h--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe-------ccC--------
Confidence 2 345789999999999999999999999999999999999999998765421 1121 111
Q ss_pred hhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 438 QKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 438 ~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
..|. ..+..++..+.-|++.||+..|.+||+++||+..|+=
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 1122 3566778889999999999999999999999999873
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=400.97 Aligned_cols=260 Identities=27% Similarity=0.508 Sum_probs=214.7
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
..|...+.||+|+||.||+|+. .+++.||||+++..... ..+|++++++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577889999999999999997 47899999998654322 234688999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++|+|.++++. ++|..+.+|+.|+++||+|||..+.++|+||||||+|||++.++.+++. ||+......
T Consensus 766 ~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 766 EGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 99999999952 8999999999999999999998777799999999999999999888875 666543221
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....|+..|||||++.+..++.++|||||||++|||+||+.||+.... ....+++|++.... ......++|+.+
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~ 909 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS----DCHLDMWIDPSI 909 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC----ccchhheeCccc
Confidence 1223688999999999999999999999999999999999999964332 34567778765432 233445556555
Q ss_pred h---cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 441 E---EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 441 ~---~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
. ....++..++.+++.+|++.||++||+|.||++.|+....
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3 3456677889999999999999999999999999997643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=392.50 Aligned_cols=258 Identities=31% Similarity=0.500 Sum_probs=217.1
Q ss_pred hcCccccceecccCceEEEEEEEeC--Ce----EEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN--GK----VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~--g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++....+.||+|.||.||+|+..+ |. .||||.++.. +.+...+|.+|..+|++++|||||+|+|+|......
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556677899999999999999753 33 4999999776 445567999999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 274 LLVYEFVPNKTLEFHLHGKD-----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
+|++|||.+|+|..+|+... ...+.....+.|+.|||+|+.||+++ ++|||||.++|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997641 34588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceeec-ccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 349 LAKHSLDTDTHVSTR-VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 349 la~~~~~~~~~~~~~-~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
||+...+.+...... .+-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+ .+..|.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v~~~~~------- 918 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--VLLDVL------- 918 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--HHHHHH-------
Confidence 999766655443332 355679999999999999999999999999999999 999998766422 111121
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..+ +| ..+..++..+.+++..||+.+|++||++..|++.++...
T Consensus 919 -~gg--------RL-~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 -EGG--------RL-DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred -hCC--------cc-CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 122 12 345667888999999999999999999999999877654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=349.64 Aligned_cols=246 Identities=20% Similarity=0.317 Sum_probs=199.6
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEEEEEe
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLVYEF 279 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~---~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~lV~E~ 279 (579)
...||+|++|.||+|.+ +|+.||||.++...... .+.|.+|+.+|.+++|||||+++|+|.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 68899999997643322 3577899999999999999999999977 3467899999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++|+|.+++... ..++|...++++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999999754 35899999999999999999999742 78899999999999999999999999998643321
Q ss_pred eeecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 360 VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+.. .... +...
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~---~i~~-----~~~~---- 240 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYD---LIIN-----KNNS---- 240 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHh-----cCCC----
Confidence 23468899999999976 68999999999999999999999999765321 1111 1110 0000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. ..+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 241 --~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 --L-KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred --C-CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 12223456789999999999999999999999999854
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=348.74 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=203.0
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.|...+.||+|+||.||+|... +|+.||||.+.... ......+.+|+.++.+++|+||++++++|.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999964 78999999986532 2223467899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++|+|..++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888654445689999999999999999999998 99999999999999999999999999998653322
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......||..|+|||++.+..++.++|||||||+||||++|+.||.......... ... ..+..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~--------------~~~~~ 219 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVD--------------RRVKE 219 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHH--------------HHhhc
Confidence 2234579999999999999999999999999999999999999998654311100 000 00000
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
....+.......+.+++..||+.||.+||+ +.++++
T Consensus 220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 011233334567889999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.91 Aligned_cols=236 Identities=28% Similarity=0.403 Sum_probs=202.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~---~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||.|+||.|.+++.+ +|..+|+|+|+...-.. .+...+|..+|+.+.||++++|++.|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888899999999999999965 68899999997654332 334668999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||++||.|..+|+..+ .++.+....+|.+|+.||+|||+. .|++|||||+|||||.+|.+||+|||+|+...+.
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999997654 489999999999999999999998 9999999999999999999999999999986543
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.-+.|||+.|+|||.+....+..++|+|+|||++|||+.|.+||...+... .++.++.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------------------iY~KI~~ 255 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------------------IYEKILE 255 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------------------HHHHHHh
Confidence 345799999999999999999999999999999999999999998766411 1222222
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCC
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRR 466 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~R 466 (579)
..+ .++.-....+.+|+...++.|-.+|
T Consensus 256 ~~v-~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV-KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc-cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 222 3555566778899999999998888
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.68 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=205.9
Q ss_pred hcCccccceecccCceEEEEEEEeC-----------------CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcce
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN-----------------GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVS 262 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~ 262 (579)
.++|.+.+.||+|+||.||++.+.+ +..||||.++... .....+|.+|+.+|.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999998642 3479999987653 333567999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhhhhcCCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 008052 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD-----------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325 (579)
Q Consensus 263 l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iv 325 (579)
++++|.+.+..+|||||+++|+|.+++.... ...++|..+++|+.|++.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999998885421 13478899999999999999999998 999
Q ss_pred eCCCCCCceEeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh--CCC
Q 008052 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFR 402 (579)
Q Consensus 326 HrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt--G~~ 402 (579)
||||||+||||+.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 2233456789999999998999999999999999999987 566
Q ss_pred CCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 403 PFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 403 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
||..... .....+....+.... .... ...+..++..+.+++.+||+.+|.+||+|.||++.|++
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~-----~~~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQG-----RQVY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhcc-----cccc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7765432 222222222211100 0000 01122344678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=344.24 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=206.3
Q ss_pred hcCccccceecccCceEEEEEEEe----CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|++.+.||+|+||.||+|++. .+..||+|.++.... .....|.+|+.++.+++||||++++|++..++..+|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999864 356899999976533 334578999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++|+|.+++.... ..++|..++.++.|++.||+|||+. +++||||||+||||+.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999986543 3589999999999999999999998 999999999999999999999999998765322
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
..........++..|+|||++.++.++.++|||||||++|||++ |..||...... .+... +..+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~--------~~~~~--- 225 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA--------VEDGF--- 225 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH--------HHCCC---
Confidence 22111122345678999999999999999999999999999875 99999755421 11111 01110
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+...+..+.+++..||+.+|.+||++.||++.|+..
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0012233456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=362.67 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=205.1
Q ss_pred hhcCccccceecccCceEEEEEEE------eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 271 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 271 (579)
..++|...+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+.+|..+ +|||||+++++|...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788889999999999999974 235689999997543 23345788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCC----------------------------------------------------------
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKD---------------------------------------------------------- 293 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~---------------------------------------------------------- 293 (579)
..++||||+++|+|.++++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999998885421
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 294 ---------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 294 ---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
...++|..+++|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 12478899999999999999999998 999999999999999999999999999986543322
Q ss_pred c-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 359 H-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 359 ~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
. ......++..|+|||++.+..++.++|||||||+||||++ |..||...... ..+..+.. .+. ..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~--------~~~-~~-- 336 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIK--------EGY-RM-- 336 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHH--------hCc-cC--
Confidence 1 1122345678999999999999999999999999999998 88898654321 11111111 110 00
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+......+.+++..||+.||++||+|.||++.|+..
T Consensus 337 -----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 -----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01112245788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.82 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=210.2
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.++|+..+.||+|+||.||+|...+++.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 467889999999999999999988888999999875432 3568899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.++++......+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999766556689999999999999999999998 99999999999999999999999999998754433222
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....++..|+|||++..+.++.++|||||||++|||++ |..||...... ....+. .. + .. .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~----~-~~---~-- 223 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----QR----G-YR---M-- 223 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----Hc----C-CC---C--
Confidence 233446778999999998999999999999999999998 99999654321 111111 00 0 00 0
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
.........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 --PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.51 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=206.1
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC----Cc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG----SG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~----~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~ 272 (579)
..++|...+.||+|.||+|++|... ++..||||+++.. .. .....+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3468999999999999999999854 6899999977553 11 23456678999999999 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeeccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAK 351 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFGla~ 351 (579)
.++||||+.+|+|.+++.. ...+.+....+++.|++.|++|||++ +|+|||||++|||||.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999976 34588889999999999999999998 99999999999999999 999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCC-CC-cccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGK-LT-EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||++.+.. .+.. .+..
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~--------ki~~ 237 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYR--------KIRK 237 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHH--------HHhc
Confidence 764 2233456689999999999999876 75 8999999999999999999999874321 1111 1111
Q ss_pred CCchhhhchhhhcCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAE-MTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~-~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
+.+ .++... ...+..++.+|+..+|.+|+++.+|+
T Consensus 238 ~~~---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 238 GEF---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCc---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111 222223 67789999999999999999999999
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=362.79 Aligned_cols=242 Identities=30% Similarity=0.435 Sum_probs=208.2
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~ 272 (579)
....++|...++||+|.||+|+++.++ +++.+|||.++++.. ...+..+.|..|+.... ||.|++|+..|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999976 578999999988643 33456778888888876 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++||||+.||++..+.+ ...+++.....+|..|+.||.|||++ +|||||||-+|||||.+|.+||+|||||+.
T Consensus 444 l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 999999999999554443 34589999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
...... ...+++||+.|||||++.+..|+..+|+|+|||+|||||.|+.||.++++.
T Consensus 518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------------- 574 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------------- 574 (694)
T ss_pred cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------------------
Confidence 654333 456799999999999999999999999999999999999999999876641
Q ss_pred hhhhchhhh---cCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 433 DALVDQKLE---EYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 433 ~~l~d~~l~---~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
++.|..+. .|+.....+.+.++.++++.+|++|..+
T Consensus 575 -e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12222222 4677778889999999999999999987
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.61 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=204.8
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
++|...+.||+|+||.||++.+.++..+|+|.++... ....+|.+|+.+|++++|+||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577889999999999999999888889999986543 335678999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+|+|.++++... ..++|..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999987543 2589999999999999999999998 999999999999999999999999999986543322222
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....++..|+|||++....++.++||||||+++|||++ |+.||...+. ...+.+.. .+. ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~--------~~~--~~----- 220 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMIS--------RGF--RL----- 220 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--------CCC--CC-----
Confidence 22345668999999998899999999999999999999 8999975542 11111111 110 00
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
..+......+.+++.+||+.+|.+||+|.++++.|
T Consensus 221 -~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 -YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01111235689999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=339.58 Aligned_cols=256 Identities=28% Similarity=0.449 Sum_probs=209.7
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
..++|+..+.||+|+||.||+|...+++.||||.++... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456788999999999999999998888899999987644 3356799999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999765555689999999999999999999998 9999999999999999999999999999876432221
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
.......+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+... +. . ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~----~-~~~----- 222 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQ----VD----Q-GYR----- 222 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HH----c-CCC-----
Confidence 1122223458999999998999999999999999999999 99999754321 11110 00 0 000
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
+ .........+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 223 -~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 -M-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -C-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 1122344678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=341.91 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=213.8
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
...+|...+.||.|+||.||+|...+++.+|+|.++........++..|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678889999999999999999888999999999876655567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.......+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999876666789999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......++..|++||++..+.++.++||||||+++|+|++ |+.||..... .....+.. ..
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~----------------~~ 220 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT----------------AG 220 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH----------------hC
Confidence 1223346778999999998899999999999999999998 8999965442 11111111 00
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
.....+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0001122344678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=362.84 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=211.1
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC--C--eE-EEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTN--G--KV-VAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~--g--~~-vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 269 (579)
+...++....+.||+|.||.||+|.+.. + .. ||||..+.. ......+|.+|+++|++++|+|||+|+|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3444566667999999999999999753 2 23 899999852 34556789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccc
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGl 349 (579)
...++||||+|+||+|.++|..... .++..++++++.+.|.||+|||++ ++|||||.++|+|++.++.+||+||||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999999986544 699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhccc
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 428 (579)
++....... ......-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.... .+..|+ .
T Consensus 309 s~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI--------~ 376 (474)
T KOG0194|consen 309 SRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI--------V 376 (474)
T ss_pred ccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH--------H
Confidence 886431111 1111235679999999999999999999999999999999 88899776532 111111 0
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
...+.. ..+...+..+..++..|+..+|++||+|.+|.+.|+....
T Consensus 377 ~~~~r~-------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 377 KNGYRM-------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred hcCccC-------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 111111 2333556778888999999999999999999999987643
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=344.62 Aligned_cols=249 Identities=32% Similarity=0.556 Sum_probs=197.2
Q ss_pred ccceecccCceEEEEEEEe-----CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 206 EANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
..+.||.|.||.||+|.+. .+..|+||.++.... ...++|.+|++++.+++|+||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 257899999976433 3467899999999999999999999999988889999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc-
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT- 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~- 358 (579)
+++|+|.++|+......+++..++.|+.|+++||.|||++ +|+|+||+++||||++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999887556799999999999999999999998 899999999999999999999999999987632222
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.......+...|+|||.+....++.++||||||+++|||++ |+.||...+. ..+.... ..+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~--------~~~------- 221 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKL--------KQG------- 221 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHH--------HTT-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc--------ccc-------
Confidence 22233457789999999999999999999999999999999 7889865532 1111111 011
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
.....+......+.+++..||+.+|.+||+|.+|++.|
T Consensus 222 -~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 -QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11112223456788999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.42 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=204.1
Q ss_pred hhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 271 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 271 (579)
..++|+..+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.+++.+ +|+|||+++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457888999999999999999842 245799999976433 2345688999999999 8999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCC----------------------------------------------------------
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKD---------------------------------------------------------- 293 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~---------------------------------------------------------- 293 (579)
..+|||||+++|+|.++++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999998875321
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc-eee
Q 008052 294 ----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VST 362 (579)
Q Consensus 294 ----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~ 362 (579)
...+++...++|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 12478889999999999999999998 9999999999999999999999999999865332211 112
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
...++..|||||++....++.++|||||||+||||++ |+.||....... .... ... .+ . ..
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~----~~-~----~~--- 334 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVK----RG-Y----QM--- 334 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHH----cc-c----Cc---
Confidence 2335678999999998999999999999999999997 999997543211 0000 000 00 0 00
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111246789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=341.78 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=207.6
Q ss_pred cCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
++|+..+.||+|+||.||+|.... .+.||+|.++.... .....|.+|+.++.+++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998643 25799999875432 33457899999999999999999999999989999
Q ss_pred EEEEecCCCchhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC
Q 008052 275 LVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 340 (579)
++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999998864321 4588899999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhh
Q 008052 341 EAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 418 (579)
Q Consensus 341 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~ 418 (579)
.+||+|||+++....... .......+++.|+|||++..+.++.++|||||||+||||++ |..||...... .+..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986543322 12233457889999999998999999999999999999998 99999764421 11111
Q ss_pred hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 419 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
. ..+ .....+...+..+.+++.+||+.+|.+||++.||++.|+.
T Consensus 239 i--------~~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 I--------RSR--------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H--------HcC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 011 1112233456789999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=337.92 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=208.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.+|...+.||+|+||.||+|... .++.||+|.++... ....++.+|++++.+++|+||++++++|......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999975 58899999987543 33567899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.......+++..++.++.|+++||+|||++ +++||||||+|||+++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999766556689999999999999999999998 99999999999999999999999999998754332222
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....++..|+|||++.+..++.++|||||||++|||++ |..||...+.. ++... +... +.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~-~~~~-----~~------ 223 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYEL-LEKG-----YR------ 223 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-HHCC-----CC------
Confidence 222334668999999999999999999999999999998 99998654321 11111 1000 00
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 224 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 -MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 012223346789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=349.95 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=197.0
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
+.||+|+||.||+++.. +|+.||||+++... ......+.+|+.+|.+++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68899999987532 223356788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeec
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 363 (579)
+|..++... ..+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 999888643 3589999999999999999999998 99999999999999999999999999997532222 12234
Q ss_pred ccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcC
Q 008052 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 443 (579)
Q Consensus 364 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 443 (579)
.+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+... . ..+.. .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~---~-----~~~~~---------~~ 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---I-----LMEEI---------RF 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHH---H-----HcCCC---------CC
Confidence 57999999999999999999999999999999999999999754321 11110 0 00100 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 444 DSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 444 ~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
+......+.+++..||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 233456788999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=353.16 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=210.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|-..+.||+|.||.||||+.+ +.+.||+|.+.+... ...+.+++|++|+++++|||||.+++.|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56777889999999999999965 689999999965433 234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+.| +|..+|.. ...|+++....|+.+++.||.|||++ +|+|||+||.||||+.++.+|++|||+|+... ..+
T Consensus 82 ~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~-~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS-TNT 154 (808)
T ss_pred hhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc-cCc
Confidence 9977 99999954 34599999999999999999999999 99999999999999999999999999999754 356
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
.+.+.+.||+.|||||++.++.|+..+|+|||||+||||++|++||.... +...++.++ .|+
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~------------~d~ 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSIL------------KDP 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHh------------cCC
Confidence 77788999999999999999999999999999999999999999996432 122221111 111
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. .++......+..++...+.+||..|.+-.+++.
T Consensus 217 v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 V--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C--CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 345567788999999999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=350.17 Aligned_cols=244 Identities=27% Similarity=0.370 Sum_probs=200.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 58899999986532 123456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+.+.....++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999998654 3478888999999999999999998 99999999999999999999999999998653322
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
....||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..... +..+.+
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~-----i~~~~~----- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEK-----ILAGRL----- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHH-----HhcCCc-----
Confidence 2357999999999999999999999999999999999999999754321 00011 111111
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
.++......+.+++..||+.||.+|++ +.+++.
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112223356789999999999999997 566553
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.39 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=204.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++.+++|+||+++++++...+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 58899999987532 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+.+.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999643 3588999999999999999999998 999999999999999999999999999986533
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcccc-chhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ..+..|... + .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~---~ 218 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------L---Q 218 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------c---c
Confidence 22445799999999999999999999999999999999999999976543110 011111100 0 0
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+............+.+++.+|++.+|.+||++.|+++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000012334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=335.67 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=205.1
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
++|...+.||+|+||.||+|.+.++..+|||.++... ....+|.+|+.++.+++||||++++++|.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998777789999987543 235679999999999999999999999998888999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.+++..... .+.+..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999865433 589999999999999999999998 999999999999999999999999999886544332222
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....++..|++||++.+..++.++|||||||++|||++ |..||...... ...... ..+..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~--------~~~~~-------- 219 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV--------SQGLR-------- 219 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH--------hcCCC--------
Confidence 22345678999999998899999999999999999999 99998654321 111111 01100
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
..........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011123467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=348.35 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=208.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
..|...++||+|.||.||||... .++.||+|++..... ...+++++|+.+|+.++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34667789999999999999964 689999999976543 3457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
|.||++.+.|... ..+++....-|+.+++.||.|||.+ +.+|||||+.||||..+|.+||+|||++.........
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999543 3457778888999999999999999 9999999999999999999999999999876544433
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
. .+++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.....+ +.+-.-|.
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------------Ipk~~PP~ 230 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------------IPKSAPPR 230 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------------ccCCCCCc
Confidence 3 678899999999999988999999999999999999999999987665221111 11111222
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
|+ ......+.+++..||+.+|+.||++.++++
T Consensus 231 L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LD---GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cc---cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22 245567899999999999999999999984
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.23 Aligned_cols=268 Identities=20% Similarity=0.266 Sum_probs=203.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|...+.||+|+||.||+++.. +++.||||+++... ....+.+.+|++++.+++|+||++++++|...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999976 57899999987542 2234567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|++++.|..+... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999887765432 23588999999999999999999998 999999999999999999999999999987543332
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhhhhhh----HhhhcccCCCch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWAKP----FLAQGLADGNFD 433 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~ 433 (579)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... +.....+ .+........+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 23334578999999999998899999999999999999999999997654321100 0000000 000000000010
Q ss_pred hhhchhh------h-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 434 ALVDQKL------E-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 434 ~l~d~~l------~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+..+.. . .+.......+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0 111223457999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=346.20 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=194.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556789999999999999965 689999999865432 3346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.... .+.+..+..|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 9999986532 356677889999999999999998 999999999999999999999999999986533211
Q ss_pred eeecccccccccChhhhcc-----CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 360 VSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
......||..|+|||++.. ...+.++|||||||+||||++|+.||..... .+|....... ...
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~------~~~~~~~~~~--~~~---- 291 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ------GDWASLMCAI--CMS---- 291 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------ccHHHHHHHH--hcc----
Confidence 1234579999999998743 2345689999999999999999999974322 1222111000 000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
............+.+++..||+.||++||++.||++.
T Consensus 292 ----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001222345678999999999999999999999974
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=321.89 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=213.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+..+++.+|++|-+.|+||||+++++||.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 67889999999999999999965 6778999998543 2334678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||..+|.|...|.......+++.....++.|+|.||.|+|.. +||||||||+|+|++.++..||+|||-+....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 999999999999877777799999999999999999999998 99999999999999999999999999987643
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....+.|||..|++||...+...+.++|+|++||+.||++.|.+||...... ..+.++..
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------------------etYkrI~k 236 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------------------ETYKRIRK 236 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-------------------HHHHHHHH
Confidence 33456689999999999999999999999999999999999999999865421 11112111
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
-++ .++........+++..|+.++|.+|....||+..
T Consensus 237 ~~~-~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VDL-KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccc-cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 3445566788999999999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=338.76 Aligned_cols=255 Identities=26% Similarity=0.489 Sum_probs=207.9
Q ss_pred hcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++|...+.||+|+||.||+|.+.+ ++.||||.++..... ....|.+|+++|.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567888999999999999998643 478999999765444 457899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC
Q 008052 274 LLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 341 (579)
++||||+++++|.+++.... ...+.+.....++.|++.||.|||++ +++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999986532 24578999999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhh
Q 008052 342 AKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWA 419 (579)
Q Consensus 342 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~ 419 (579)
+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||..... ...+++.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH
Confidence 99999999976433221 11233446788999999999999999999999999999998 9999865442 1112111
Q ss_pred hhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 420 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
. .+. ....+......+.+++.+||+.+|.+||++.||++.|+
T Consensus 238 ~--------~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T--------QGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H--------cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 111 11122234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=343.86 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=205.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|+..+.||+|+||.||+++.. ++..||+|.+..... .....+.+|+++|.+++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999976 588899999876432 334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999998653 34889999999999999999999852 6999999999999999999999999999765332
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc-----------
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL----------- 427 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------- 427 (579)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...+... +............
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccc
Confidence 2234569999999999999999999999999999999999999997543211 1100000000000
Q ss_pred ------------c---CCCchhhhchhh----hc-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 428 ------------A---DGNFDALVDQKL----EE-YDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 428 ------------~---~~~~~~l~d~~l----~~-~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
. ......+.+... .. ........+.+++.+||+.||++||++.||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000001111100 00 011234678999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.33 Aligned_cols=254 Identities=29% Similarity=0.456 Sum_probs=206.8
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.++|+..+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|+|++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357888899999999999999988888899999876443 3467999999999999999999999885 45678999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.++++......+++.+++.++.+++.||+|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999765555689999999999999999999998 99999999999999999999999999998654332222
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....++..|+|||++....++.++||||||+++|||++ |..||...+. ....++.. .+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~--------~~~-------- 220 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVE--------RGY-------- 220 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH--------cCC--------
Confidence 223345678999999998899999999999999999999 8999965432 11111110 000
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
....+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001222344679999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=354.00 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=211.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~---~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
+-|.+.+.||.|+.|.|-+|++. +|+.+|||++....... ...+.+||-||+.+.|||+++|++++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 44777899999999999999964 79999999997653222 345788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|-|.++|-.++ .+.+.+..+++.||+.|+.|||.. +|+||||||+|+|||..+++||+|||+|.... .
T Consensus 92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--P 164 (786)
T ss_pred EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--C
Confidence 9999999999997654 488899999999999999999998 99999999999999999999999999998643 3
Q ss_pred cceeecccccccccChhhhccCCCC-cccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.....+.||++.|.|||++++.+|+ .++||||+|||||.||||+.||++++. +. +...+..|.|
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----------r~-LLlKV~~G~f---- 229 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----------RV-LLLKVQRGVF---- 229 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----------HH-HHHHHHcCcc----
Confidence 3455678999999999999998884 799999999999999999999985442 11 1112223333
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEGN 479 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~~ 479 (579)
+.+.+...+..+|+.+|+..||++|-|+.||++ .|.+-
T Consensus 230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 345666778899999999999999999999997 34443
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=333.64 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=206.7
Q ss_pred cCccccceecccCceEEEEEEEeC----CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|...+.||+|+||.||+|.+.. ...||||.++... .....+|.+|+.++.+++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999753 3579999987543 33346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999875433 589999999999999999999998 9999999999999999999999999999876422
Q ss_pred Ccc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 357 DTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 357 ~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.++. ..+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~--------~~~~--- 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV--------EDGY--- 225 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH--------HcCC---
Confidence 221 1222345678999999998999999999999999999998 9999864331 1111111 0000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
........+..+.+++.+|++.+|.+||++.||++.|+..
T Consensus 226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=343.74 Aligned_cols=244 Identities=26% Similarity=0.357 Sum_probs=200.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999975 68899999986432 123456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999998654 3588999999999999999999998 9999999999999999999999999999865332
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....|++.|+|||++.+..++.++|||||||+||||++|+.||...... ....... .+
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~-----~~------- 213 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKIL-----AG------- 213 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-----hC-------
Confidence 12356999999999999889999999999999999999999999764321 1111110 11
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
.+ .++......+.+++.+||+.||.+||+ +.++++
T Consensus 214 -~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 214 -KL-EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -Cc-CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 00 122223456889999999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=355.38 Aligned_cols=266 Identities=26% Similarity=0.403 Sum_probs=224.5
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
++++....+....++||.|.||.||.|+|+. .-.||||.|+.+. ...++|++|+.+|+.++|||+|+|+|+|..+-.+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4556666778888999999999999999874 4579999998765 4478999999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
|||.|||.+|+|.++|...++..+.--..+++|.||+.|++||..+ ++|||||.++|+|+.++..|||+||||++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999988888888888999999999999999998 8999999999999999999999999999986
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
............-...|.|||-+..+.++.|+|||+|||+|||+.| |..||-+.+... +-.++.. .+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEk-----gy 483 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEK-----GY 483 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhc-----cc
Confidence 5543322222334678999999999999999999999999999999 999997665311 1111111 11
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLD 483 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~~~ 483 (579)
+. +.+..++..+.+|+.+||+++|.+||++.|+-+.||....-.
T Consensus 484 RM-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 484 RM-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred cc-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 10 446678889999999999999999999999999999765443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=342.06 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=204.5
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--------------hhHHHHHHHHHHHHhcCCCCcceE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--------------QGEREFQAEIEIISQVHHRHLVSL 263 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------------~~~~~~~~Ei~~l~~l~Hpniv~l 263 (579)
...+.|.+.+.||+|.||+|-+|+.. +++.||||++.+... ...+..++||.||++++|+|||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999954 789999999854211 112467899999999999999999
Q ss_pred EEEEEe--CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC
Q 008052 264 VGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (579)
Q Consensus 264 ~g~~~~--~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 341 (579)
+.+..+ .+.+|||+|||..|.+...- .+...+...+..+++.+++.||+|||.+ +||||||||+|+||+++|.
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 999876 56889999999998875432 1222389999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccCCCC----cceeecccccccccChhhhccCC----CCcccceechHHHHHHHHhCCCCCCCCCccccc
Q 008052 342 AKVADFGLAKHSLDTD----THVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVLLLELITGFRPFDKADTFADD 413 (579)
Q Consensus 342 ~kL~DFGla~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~ 413 (579)
|||+|||.+....... ........||+.|||||.+.++. .+.+.||||+||+||.|+.|+.||-+....
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--- 325 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--- 325 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence 9999999988652221 11223467999999999987643 467899999999999999999999754421
Q ss_pred hhhhhhhhHhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 414 SMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
..++.++...|. ....++...+.+|++++|++||..|-+..+|....
T Consensus 326 ----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 ----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 124455555555 33345678899999999999999999999997654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.62 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=203.6
Q ss_pred CccccceecccCceEEEEEEEe-C-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-N-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.|...+.||+|+||.||+|... + ++.||+|.+..........+++|+.+|++++|||||+++++|...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999854 3 5788888876655555567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 281 PNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 281 ~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
++|+|.++|+.. ....+++.....++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 234588889999999999999999998 999999999999999999999999999987543322
Q ss_pred -ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 -HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 -~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.....+ .+..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-----~~~~----- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-----YGKY----- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-----hCCC-----
Confidence 223456799999999999999999999999999999999999999965432 11111111 1111
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..++......+.+++..||+.+|.+||++.+++.
T Consensus 289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122233457899999999999999999999874
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.78 Aligned_cols=255 Identities=30% Similarity=0.440 Sum_probs=206.6
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.++|.+.+.||+|+||.||+|++.+...||+|+++.... ....|.+|++++++++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 456889999999999999999987777899999975332 3467899999999999999999999875 45678999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++|+|.+++.......+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999765445689999999999999999999998 99999999999999999999999999997654333222
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....++..|++||++.++.++.++|||||||++|||++ |..||...... .+.. . +..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~---~-----~~~~~-------- 220 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---Q-----VERGY-------- 220 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH---H-----HhcCC--------
Confidence 223446778999999998999999999999999999999 88898654321 1000 0 00000
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
........+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0012234456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=347.74 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=201.6
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
+...++|+.+..||+|+||.||+++.+ +|..+|+|+|++..-. ....++.|-.+|....+++||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345688999999999999999999965 6999999999875332 345678899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
||||||++||++..+|...+ .|.+.....++.+++.||+-||+. |+|||||||+|+|||..|++||+|||||.-+
T Consensus 217 YLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999996554 588888888999999999999999 9999999999999999999999999998522
Q ss_pred CC----------------------CCcc-----eee-------------------cccccccccChhhhccCCCCcccce
Q 008052 354 LD----------------------TDTH-----VST-------------------RVMGTFGYLAPEYASSGKLTEKSDV 387 (579)
Q Consensus 354 ~~----------------------~~~~-----~~~-------------------~~~gt~~y~APE~~~~~~~~~ksDV 387 (579)
.. .+.. ..+ ..+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0000 000 1469999999999999999999999
Q ss_pred echHHHHHHHHhCCCCCCCCCcccc-chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCC
Q 008052 388 FSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR 466 (579)
Q Consensus 388 wSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~R 466 (579)
||||||+||||.|.+||....+... ..++.|...+-. ........+..++|.+|+. ||.+|
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-----------------P~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-----------------PEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-----------------CCcCcccHHHHHHHHHHhc-CHHHh
Confidence 9999999999999999987765321 234445322110 0111223678899999999 99999
Q ss_pred CC
Q 008052 467 PR 468 (579)
Q Consensus 467 Pt 468 (579)
-.
T Consensus 434 LG 435 (550)
T KOG0605|consen 434 LG 435 (550)
T ss_pred cC
Confidence 87
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.67 Aligned_cols=242 Identities=26% Similarity=0.350 Sum_probs=197.1
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
+.||+|+||.||++... +++.||||+++... ......+.+|+.+|++++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 68999999997542 223456788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeec
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 363 (579)
+|..++... ..+++.+...++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 999888643 3589999999999999999999998 99999999999999999999999999987533221 12234
Q ss_pred ccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcC
Q 008052 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 443 (579)
Q Consensus 364 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 443 (579)
.+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ....... .... .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~-----~~~~---------~~ 214 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL-----MEDI---------KF 214 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc-----cCCc---------cC
Confidence 57999999999999999999999999999999999999999754321 1111000 0000 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008052 444 DSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 475 (579)
Q Consensus 444 ~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 475 (579)
+......+.+++.+||+.||.+|+ ++.|+++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223345688999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.03 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=209.5
Q ss_pred cCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++|...+.||+|+||.||+|... ++..+++|.++.........+.+|++++++++|+||++++++|...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999853 356799999887666666789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC
Q 008052 276 VYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 341 (579)
||||+++++|.+++.... ...++|..++.++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986432 23489999999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhh
Q 008052 342 AKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWA 419 (579)
Q Consensus 342 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~ 419 (579)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-
Confidence 99999999976543322 12233456789999999999999999999999999999999 99998654421 11111
Q ss_pred hhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 420 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+..+... ......+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 238 -------~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 238 -------ITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -------HhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111 11122346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.70 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=209.1
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+..++|+..+.||+|+||.||+|...+++.||+|.+..... ...+|.+|+.++++++|+||+++++++. .+..++|||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34567889999999999999999988899999999876543 3467899999999999999999999874 456899999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+.+++|.+++.......+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999998766666789999999999999999999988 999999999999999999999999999976543322
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.......++..|+|||++....++.++|||||||++|||++ |+.||..... ..+.... ..+ ..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~--------~~~-~~---- 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL--------ERG-YR---- 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH--------HcC-CC----
Confidence 22233446778999999998999999999999999999999 9999975432 1111110 000 00
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
. .........+.+++.+|++.+|++||++++++..|+.
T Consensus 222 --~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 --M-PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 1112234579999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.04 Aligned_cols=267 Identities=24% Similarity=0.346 Sum_probs=198.1
Q ss_pred cCccccceecccCceEEEEEEEe--CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEEe-----
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSG--QGEREFQAEIEIISQV---HHRHLVSLVGYCTF----- 269 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~----- 269 (579)
++|...+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 468899999865432 2234566788777766 69999999999863
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccc
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGl 349 (579)
....++||||++ ++|.+++.......+++..+..|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346789999996 5888888765555689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcccc-chhhhhhhhHhhhc--
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQG-- 426 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~-- 426 (579)
++..... .......|++.|+|||.+....++.++|||||||+||||++|+.||........ ..+.+.........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9765332 223345689999999999988999999999999999999999999986543211 01111100000000
Q ss_pred ----ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 ----LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ----~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+....+.......++.........+.+++.+|++.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000001111111223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.53 Aligned_cols=257 Identities=25% Similarity=0.449 Sum_probs=204.9
Q ss_pred hhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
..++|+..+.||+|+||.||+|.+. .+..||||+++.... ....+|.+|+.++++++|+||++++++|..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999853 246799999865432 334578899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEE
Q 008052 273 RLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL 344 (579)
.++||||+++++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999886422 12467889999999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhH
Q 008052 345 ADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 422 (579)
Q Consensus 345 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 422 (579)
+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||...... ....+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~--- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFV--- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 999998765433221 1122346788999999998999999999999999999999 78898654321 111110
Q ss_pred hhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 423 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
..+.. ...+......+.+++.+|++.+|++||++.|+++.|+.
T Consensus 235 -----~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -----MEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -----HcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 01111 01122334578999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=344.20 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=198.6
Q ss_pred CccccceecccCceEEEEEEEe----CCeEEEEEEeccCC----chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS----GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 273 (579)
+|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999853 57899999986432 12234678899999999 499999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++|+|..++... ..+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999988643 3588999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
............||+.|||||++.+. .++.++|||||||+||||++|+.||.......... ....... .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~-----~--- 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRIL-----K--- 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHh-----c---
Confidence 44333333456799999999999865 47899999999999999999999997543211111 1111000 0
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
.++ .++......+.+++.+||+.||++|| ++.++++
T Consensus 226 ---~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 001 12223345678999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.40 Aligned_cols=241 Identities=25% Similarity=0.325 Sum_probs=194.6
Q ss_pred ecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
||+|+||.||++... +++.||+|+++.. .......+.+|+.+|.+++||||++++++|...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 5789999998643 223345678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeeccc
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 365 (579)
.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 9998654 3489999999999999999999998 99999999999999999999999999998643222 2234467
Q ss_pred ccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCH
Q 008052 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 445 (579)
Q Consensus 366 gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 445 (579)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+. +. + .++.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-----~~--------~-~~~~ 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-----EP--------L-RFPD 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-----CC--------C-CCCC
Confidence 99999999999999999999999999999999999999975432 111111110 00 0 1223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 446 AEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 446 ~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
.....+.+++.+||+.||.+||++..+.+.|
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 3446688999999999999998654433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.56 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=195.9
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
+.||+|+||.||++... +|+.||+|+++... ......+.+|+.++.+++||||++++++|...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 68999999997532 223456778999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeec
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 363 (579)
+|..++... ..+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 999888643 3589999999999999999999998 99999999999999999999999999987532222 12234
Q ss_pred ccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcC
Q 008052 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 443 (579)
Q Consensus 364 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 443 (579)
..||+.|+|||++.++.++.++|||||||+||||++|+.||...+.. .+.. ... .... .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~---~~~-----~~~~---------~~ 214 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LIL-----MEEI---------RF 214 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHh-----cCCC---------CC
Confidence 57999999999999999999999999999999999999999754321 0000 000 0000 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 444 DSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 444 ~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
+......+.+++..||+.||.+|+ ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 223345688999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.86 Aligned_cols=260 Identities=23% Similarity=0.377 Sum_probs=206.5
Q ss_pred hhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS 271 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~ 271 (579)
..++|.+.+.||+|+||.||+|+.. .+..||||+++.... ...+.|.+|+++|.++. |||||+++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568888999999999999999853 134799999975433 33457899999999996 999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCC----------------------------------------------------------
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKD---------------------------------------------------------- 293 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~---------------------------------------------------------- 293 (579)
..+||||||++|+|.++|+...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998875421
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC
Q 008052 294 ------------------------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 337 (579)
Q Consensus 294 ------------------------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~ 337 (579)
...+++..+++++.|+++||+|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 12478888999999999999999998 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchh
Q 008052 338 DSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSM 415 (579)
Q Consensus 338 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~ 415 (579)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||+||||++ |..||...... ..+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH
Confidence 9999999999999865432221 1223457788999999999999999999999999999997 99998654221 111
Q ss_pred hhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 416 VDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
... + ..+. ....+......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 350 ~~~----~----~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 YNK----I----KSGY--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHH----H----hcCC--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 100 0 0100 00112234567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=318.34 Aligned_cols=266 Identities=24% Similarity=0.371 Sum_probs=206.5
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~--~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|...+.||+|.||.||+|+. .+|+.||||+++.....+ .....+||..|+.++|+||+.|+++|-+.+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999995 479999999998753321 3467899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
||+ .+|+..++.+. ..+.-.....++.++++||+|||.+ .|+||||||.|+||+.+|.+||+||||++.+...+.
T Consensus 82 fm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 995 48988887654 3578888999999999999999999 899999999999999999999999999998765543
Q ss_pred ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhh-------cccCC
Q 008052 359 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ-------GLADG 430 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 430 (579)
. .+..+-|.+|.|||.+.+ ..|+...||||.|||+.||+-|.+-|.+....+ .+....+.+... .....
T Consensus 157 ~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 I-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred c-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCccccccc
Confidence 3 333478999999998875 579999999999999999999877666554322 222111111100 00011
Q ss_pred Cc---hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 431 NF---DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 431 ~~---~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
++ .....+.+...-..+.....+++..++..||.+|.+++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1112222223344555667999999999999999999999864
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=337.66 Aligned_cols=258 Identities=25% Similarity=0.450 Sum_probs=208.7
Q ss_pred hcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++.+++|+||++++++|...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467889999999999999999852 34578999987766555678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeE
Q 008052 275 LVYEFVPNKTLEFHLHGKD-----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~k 343 (579)
+||||+++++|.+++.... ...+++.+++.++.|++.+|+|||++ +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999886432 23489999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhh
Q 008052 344 VADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 344 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~--- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIEC--- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---
Confidence 9999999865432221 1223346778999999998899999999999999999999 99998654421 11111
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
+..+... .........+.+++.+|++.+|.+||++.+|++.|+...
T Consensus 235 -----i~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 -----ITQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred -----HHcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 011123356899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=331.44 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=203.3
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
.+|.+.+.||+|+||.||+|.+.++..+|+|.+..... ....|.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35777899999999999999987777899999865432 34578899999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.+++..... .++|..++.|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...+......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999999875433 589999999999999999999998 999999999999999999999999999986543222211
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..... .. .+ + . .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~----~~-~----~--~ 220 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES----VS----AG-Y----R--L 220 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH----HH----cC-C----c--C
Confidence 22234457999999999999999999999999999999 89999754321 11110 00 00 0 0 0
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
..+...+..+.+++.+|+..+|++||+|.||++.|
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 -YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11122456799999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.01 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=203.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||+|... +++.||||+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999975 68999999986532 233457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999998755 4589999999999999999999998 99999999999999999999999999998654332
Q ss_pred ----------------------------cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCc
Q 008052 358 ----------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409 (579)
Q Consensus 358 ----------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~ 409 (579)
........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345699999999999999999999999999999999999999976542
Q ss_pred ccc-chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 008052 410 FAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVRA 475 (579)
Q Consensus 410 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-m~evl~~ 475 (579)
... ..+..|.. .+ . +. ........+.+++..|++ +|.+||+ +.|+++.
T Consensus 236 ~~~~~~i~~~~~----------~~---~---~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKE----------SL---R---FP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCC----------cc---c---CC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 110 00111100 00 0 00 001135668889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=335.25 Aligned_cols=255 Identities=26% Similarity=0.481 Sum_probs=204.2
Q ss_pred cCccccceecccCceEEEEEEE-----eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++|+..+.||+|+||.||+|++ .+++.||+|.++... ......|.+|++++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999985 246789999997543 3334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC
Q 008052 276 VYEFVPNKTLEFHLHGKD---------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~---------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 340 (579)
||||+++++|.+++.... ...+++.+.+.++.|++.||+|||++ +|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999885321 23478899999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhh
Q 008052 341 EAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 418 (579)
Q Consensus 341 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~ 418 (579)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |..||..... ..+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986533221 12233446778999999998899999999999999999998 9999865432 111111
Q ss_pred hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 419 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
.. .... ...+......+.+++.+|++.+|.+||++.+|++.|..
T Consensus 239 ~~--------~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR--------KRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH--------cCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 10 0000 01222334678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.76 Aligned_cols=256 Identities=23% Similarity=0.273 Sum_probs=202.3
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
....++|...+.||+|+||.||+++.. +++.||||+++.. .......+.+|+.+++.++|+||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 344578999999999999999999975 5889999998642 122334578899999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+|||||+++|+|..++... .++......++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999988643 377888889999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccChhhhccC----CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
............||+.|+|||++... .++.++|||||||+||||++|+.||...... ....... .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~-----~ 261 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM-----D 261 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHH-----c
Confidence 43322223346799999999998653 4789999999999999999999999765421 0000000 0
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRA 475 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 475 (579)
... .+. . .........+.+++..||+.+|.+ |+++.|+++.
T Consensus 262 ~~~-~~~---~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKN-SLT---F-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-cCC---C-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 000 0 011123467889999999999988 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=336.63 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=208.8
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~ 268 (579)
+....++|+..+.||+|+||.||++...+ ...+|+|.++... ......+.+|++++.++ +|+||++++++|.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34455678889999999999999998642 3689999987543 23345688999999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCce
Q 008052 269 FGSQRLLVYEFVPNKTLEFHLHGK--------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (579)
Q Consensus 269 ~~~~~~lV~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NI 334 (579)
..+..++||||+++|+|..+++.. ....+++..+++++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999998642 234689999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCcccc
Q 008052 335 LLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 412 (579)
Q Consensus 335 Ll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~ 412 (579)
|+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 99999999999999998754432211 122335678999999998999999999999999999998 999986543211
Q ss_pred chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 413 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
+... +. .+ .....+......+.+++.+|++.+|.+||++.||++.|+..+
T Consensus 243 --~~~~----~~----~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 --LFKL----LK----EG--------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHH----HH----cC--------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1100 00 00 000122234567889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=348.25 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=214.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-EEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ-RLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~lV~ 277 (579)
++|...++||+|+||.++..+++ +++.+++|++.... ...++...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999999865 57889999986543 2334567899999999999999999999999888 89999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
+||+||+|.+.+....+..+++.++.+++.|++.||.|||++ +|+|||||+.|||++.+..+||+|||+++......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999887777899999999999999999999988 99999999999999999999999999999876544
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
. ....+.||+.||+||.+.+.+|..|+|||||||++|||++-+++|...+.. .++. .++.
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~----------------ki~~ 220 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL----------------KINR 220 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH----------------HHhh
Confidence 2 345678999999999999999999999999999999999999999876531 1111 1111
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
......+......+..++..|++.+|..||++.++|..
T Consensus 221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11223455566789999999999999999999999865
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=330.40 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=210.4
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+..++|.+.+.||+|+||.||+|...+++.||||.+..... ...++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34578999999999999999999988888999999875432 35679999999999999999999999998889999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++.......+++..+..++.+++.||.|||++ +|+|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999999776556799999999999999999999998 999999999999999999999999999886543222
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ........ .+ +.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~--------~~-~~---- 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVE--------RG-YR---- 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--------cC-CC----
Confidence 11222335678999999998899999999999999999999 9999965432 11111110 00 00
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
...+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ---MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01112224578999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.88 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=204.1
Q ss_pred cCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.+|...+.||+|+||.||+|...+ ++.||||+++..... ..+.|.+|+.++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346677899999999999998642 478999999765433 2456889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC
Q 008052 275 LVYEFVPNKTLEFHLHGK--------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 340 (579)
+++||+.+++|.+++... ....+++..+++++.|++.||+|||++ +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999887421 123488889999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhh
Q 008052 341 EAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 418 (579)
Q Consensus 341 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~ 418 (579)
.+||+|||+++........ ......+++.|+|||++..+.++.++|||||||++|||++ |..||..... . ++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~---~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q---DV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H---HH
Confidence 9999999998865433221 1223446789999999998899999999999999999998 8888865432 1 11
Q ss_pred hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 419 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
... +.+.....++......+.+++..|++.+|.+||++.+|++.|+.
T Consensus 236 ~~~-------------i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEM-------------IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH-------------HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 11111112233445668999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=329.73 Aligned_cols=253 Identities=31% Similarity=0.453 Sum_probs=205.7
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
++|...+.||+|+||.||+|.+.++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 56888899999999999999987777899998865432 3467889999999999999999999875 456789999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.++++......++|..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999765555689999999999999999999998 999999999999999999999999999976543322222
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....++..|+|||++.++.++.++|||||||++|||++ |+.||..... .....+.. .+ ..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~--------~~-~~------- 221 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVE--------RG-YR------- 221 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--------cC-CC-------
Confidence 23346778999999998999999999999999999999 8999975432 11111110 00 00
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
...+...+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01122345678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=326.88 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=206.6
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|...+.||+|+||.||+|+.. +++.|++|.+... .......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999975 6889999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.++++......+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999865556789999999999999999999998 999999999999999999999999999886543322
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......|+..|+|||++.++.++.++|||||||++|||++|+.||..... .....+. ..+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~--------~~~~~------- 218 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKI--------IRGVF------- 218 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH--------HcCCC-------
Confidence 22335688999999999999999999999999999999999999975542 1111110 01111
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..........+.+++.+|++.+|++||+|.++++.
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 -PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11222345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.28 Aligned_cols=245 Identities=24% Similarity=0.295 Sum_probs=199.9
Q ss_pred cCccccceecccCceEEEEEEEeC--CeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|...+.||+|+||.||+|.+.+ +..||||++.... ......+.+|+.++..++|||||++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578889999999999999998653 3689999986432 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 9999999999998654 3588999999999999999999998 9999999999999999999999999999865321
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||...+... .+ +.+..+..
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~------~~i~~~~~---- 245 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-----IY------QKILEGII---- 245 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-----HH------HHHhcCCC----
Confidence 234579999999999998889999999999999999999999997644210 00 00111110
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 475 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 475 (579)
.++......+.+++..|++.||.+|+ ++.++++.
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222334578999999999999995 78887753
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.38 Aligned_cols=254 Identities=24% Similarity=0.296 Sum_probs=200.5
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
+....++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999975 5789999998642 22234567899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++||||+++|+|.+++... .+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999998543 378888999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccChhhhccC----CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhccc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 428 (579)
.............||+.|+|||++.+. .++.++|||||||+||||++|+.||...... ....
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~-------- 257 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYS-------- 257 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHH--------
Confidence 543333233456799999999998753 3789999999999999999999999754321 0001
Q ss_pred CCCchhhhchh--hh-cCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008052 429 DGNFDALVDQK--LE-EYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRA 475 (579)
Q Consensus 429 ~~~~~~l~d~~--l~-~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 475 (579)
.+++.. +. .........+.+++..|++.++.+ |+++.|+++.
T Consensus 258 -----~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 -----KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111110 00 011123456778888899755544 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=340.43 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=202.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCe----EEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.+|+..+.||+|+||.||+|++. +++ .||||.++... ....+++.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999864 333 48999987543 33456789999999999999999999999864 5679
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|+||+++|+|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999987543 3488999999999999999999998 999999999999999999999999999987543
Q ss_pred CCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
..... .....++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+..+ +. .+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~~----~~----~~~~- 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LE----KGER- 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----Hh----CCCC-
Confidence 32221 122335678999999999999999999999999999998 99999754321 11111 10 1100
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
+ ..+..+...+.+++..||+.+|.+||++.+|+..|....
T Consensus 230 ------~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 ------L-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ------C-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 111123356889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.69 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=195.9
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
+.||+|+||.||++... +++.||+|+++... ......+..|++++.+++|+||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68899999997532 223456778999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
+|..++... ..+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 999888643 358999999999999999999997 5 899999999999999999999999999875432221 223
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...||+.|+|||++.+..++.++|||||||+||||++|+.||...+... ...... .... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~i~-----~~~~---------~ 214 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELIL-----MEEI---------R 214 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHHHh-----cCCC---------C
Confidence 4569999999999999999999999999999999999999997543211 110000 0000 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 475 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 475 (579)
++......+.+++.+||+.||++|+ ++.++++.
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2222345688999999999999996 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.66 Aligned_cols=241 Identities=27% Similarity=0.410 Sum_probs=194.7
Q ss_pred ceecccCceEEEEEEEe----CCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 208 NLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+.||+|+||.||+++.. +++.||||+++... ......+.+|+.+|.+++||||++++++|..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999853 57899999987532 12234678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|..++... ..+.+.....++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 9999999988643 3478888889999999999999998 999999999999999999999999999875433222
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ....... .+.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-----~~~-------- 216 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-----KGK-------- 216 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-----cCC--------
Confidence 223457999999999999888999999999999999999999999764421 1111110 111
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
. ..+......+.+++.+||+.+|++|| ++.++++
T Consensus 217 ~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 L-NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C-CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 12222345688999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=341.72 Aligned_cols=201 Identities=26% Similarity=0.422 Sum_probs=175.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|+..+.||+|+||.||++... ++..+|+|.++.... .....+.+|++++.+++|+||++++++|...+..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999976 578899998876432 334578999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++... ..+++.....++.+++.||.|||+.+ +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999998653 34888999999999999999999742 6999999999999999999999999998764322
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1234568999999999998899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=334.59 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=203.0
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+|+..+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 688999999865322 223457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++|+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888655445689999999999999999999998 999999999999999999999999999986532221
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ..+.... .+..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~-------------~~~~ 219 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVER-------------RVKE 219 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHH-------------Hhhh
Confidence 233468999999999998899999999999999999999999997643211 0000000 0011
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 475 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 475 (579)
....++......+.+++..|++.||.+|| ++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11123334556789999999999999999 77777643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=335.83 Aligned_cols=267 Identities=20% Similarity=0.299 Sum_probs=199.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|...+.||.|+||.||+|... +++.||+|.++.... .....+.+|+.++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999965 688999999865432 2345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++ +|.+++.... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 975 8888875432 3478899999999999999999998 999999999999999999999999999976432221
Q ss_pred eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchh-hhhh----hhHhhhcccCCCch
Q 008052 360 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM-VDWA----KPFLAQGLADGNFD 433 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~ 433 (579)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||........... .... ...+........+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1233468999999999865 5689999999999999999999999976543111000 0000 00000000001111
Q ss_pred hhhchhhh-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 434 ALVDQKLE-----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 434 ~l~d~~l~-----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+... .........+.+++..|++.||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111100 001112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=333.89 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=205.6
Q ss_pred cCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.+|...+.||+|+||.||++... ++..+|+|.++.........|.+|++++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999999742 356899999887666666789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 276 VYEFVPNKTLEFHLHGKDR-------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~-------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999998865321 3589999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhh
Q 008052 343 KVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAK 420 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 420 (579)
||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~-- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIEC-- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHHH--
Confidence 99999999765332211 1222345788999999999999999999999999999998 999986543211 1100
Q ss_pred hHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 421 PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 421 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
+........+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 237 --------------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 --------------ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --------------HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000000111233456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=347.72 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=198.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||+|+||.||+|+.. +++.||||+++... ......+.+|+++|..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 68899999996532 223456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+++.....|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999998654 3489999999999999999999998 99999999999999999999999999987542211
Q ss_pred cc-------------------------------------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhC
Q 008052 358 TH-------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400 (579)
Q Consensus 358 ~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG 400 (579)
.. .....+||+.|+|||++....++.++|||||||+||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCCcccc-chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 008052 401 FRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR---MSQIVR 474 (579)
Q Consensus 401 ~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt---m~evl~ 474 (579)
+.||........ ..+..|... + ..+ ........+.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~~----------~---~~~----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKET----------L---QFP----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCCc----------c---CCC----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999976543110 011111100 0 000 001123457788888986 8999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.54 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=202.0
Q ss_pred ccccceecccCceEEEEEEEeC----CeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 008052 204 FSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ----- 272 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~----- 272 (579)
|.+.+.||+|+||.||+|.+.. +..||||+++... ......+.+|++++++++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999999753 3679999987543 2334678999999999999999999999876554
Q ss_pred -EEEEEEecCCCchhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 273 -RLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 273 -~~lV~E~~~~g~L~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
.++|+||+++|+|..++... ....+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999999887532 224689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhh
Q 008052 348 GLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQ 425 (579)
Q Consensus 348 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 425 (579)
|+++......... .....++..|+|||++....++.++|||||||++|||++ |..||..... ..+.++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~------ 228 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL------ 228 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH------
Confidence 9998754433221 122335678999999998899999999999999999999 8899865432 1111111
Q ss_pred cccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 426 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+. ....+......+.+++.+|++.||.+||++.||++.|+..
T Consensus 229 --~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 --RHGN--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HcCC--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0110 0112233456789999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.33 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=199.0
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
..++|+..+.||+|+||.||++... +++.||+|... ...+.+|+++|++++|||||++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999964 68899999753 2356789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
++. ++|..++... ..+++..++.|+.|++.||+|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 164 ~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 995 6787777543 3488999999999999999999998 999999999999999999999999999975433322
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch----hhhhhhhHhh---hcc---c
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS----MVDWAKPFLA---QGL---A 428 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~----~~~~~~~~~~---~~~---~ 428 (579)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||...+...... ........+. ..+ .
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 23344679999999999999999999999999999999999998875433211110 0000000000 000 0
Q ss_pred CCCchhhhch-------hhh-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 429 DGNFDALVDQ-------KLE-----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 429 ~~~~~~l~d~-------~l~-----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+..+... ... .........+.+++.+||+.||.+||++.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000100000 000 001123457889999999999999999999985
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.11 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=203.8
Q ss_pred hhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEEEEeC-
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG- 270 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~- 270 (579)
..++|++.+.||+|+||.||+|... .++.||+|+++..... ....+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457888999999999999999742 2478999998754332 345678899999999 799999999988654
Q ss_pred CeEEEEEEecCCCchhhhhcCCC---------------------------------------------------------
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------------------------- 293 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~--------------------------------------------------------- 293 (579)
...+++|||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56789999999999998875321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce-eecccccccc
Q 008052 294 --RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGY 370 (579)
Q Consensus 294 --~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y 370 (579)
...++|..+.+++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 12589999999999999999999998 99999999999999999999999999998754332221 2234467789
Q ss_pred cChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHH
Q 008052 371 LAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMT 449 (579)
Q Consensus 371 ~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~ 449 (579)
+|||++.+..++.++|||||||+||||++ |..||...... +.+.. .+ ..+... ..+.....
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~----~~----~~~~~~--------~~~~~~~~ 303 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCR----RL----KEGTRM--------RAPEYATP 303 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHH----HH----hccCCC--------CCCccCCH
Confidence 99999999999999999999999999998 99999753321 11111 00 011000 11122345
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 450 RMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 450 ~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.+.+++.+||+.+|++||++.||++.|+..+
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.70 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=195.4
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.|...+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++|.+++|+|||++++++.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 67899999996532 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC-
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD- 357 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~- 357 (579)
|+++|+|.+++... ..+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999998654 3488888889999999999999998 99999999999999999999999999976321000
Q ss_pred ---------------------------------------------cceeecccccccccChhhhccCCCCcccceechHH
Q 008052 358 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 392 (579)
Q Consensus 358 ---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGv 392 (579)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00112357999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCcccc-chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHH--hhccCCCCCCCH
Q 008052 393 LLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAA--CIRHSARRRPRM 469 (579)
Q Consensus 393 vl~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~--cl~~dp~~RPtm 469 (579)
+||||++|+.||........ ..+..|... + . . .........+.+++.+ |+..++..|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------~---~---~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENT----------L---H---I-PPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccc----------c---C---C-CCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 99999999999976543110 011111100 0 0 0 0001123456667766 556667779999
Q ss_pred HHHHHH
Q 008052 470 SQIVRA 475 (579)
Q Consensus 470 ~evl~~ 475 (579)
.||++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=333.09 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=211.1
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhH---HHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~---~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
..+|++.+.||+|.||+|-++.. ..|+.||||.++++....+ -.+++||+||+.|+||||+.++.+|++.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788889999999999999995 6899999999977654444 4567999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||..+|.|.+++... ..|++.+..+++.||..++.|||.+ +++|||||.+|||||+|+++||+||||+..+.+.
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999654 4599999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
...+++||++-|.+||.+.+.+| ...+|-|||||+||-|+.|..||++.+. ..++ +.+..|.+.+
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lv--------rQIs~GaYrE- 272 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLV--------RQISRGAYRE- 272 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHH--------HHhhcccccC-
Confidence 34577899999999999999887 4789999999999999999999987663 1122 2233343332
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
...+....-|+.+||..+|++|.|+.+|....
T Consensus 273 ---------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ---------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 22334567789999999999999999998654
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.54 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=207.1
Q ss_pred hcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 272 (579)
.++|...+.||+|+||.||++... .+..||||+++.... ...+.+.+|+.+++++ +|+||++++++|...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888999999999999999742 345799999875432 3345789999999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++||||+++|+|.++++......+++.+++.++.|++.||+|||++ +|+|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999999765545589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 353 SLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 353 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
....... ......++..|+|||++.++.++.++|||||||++|||++ |..||...... .....+. . .+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~----~----~~ 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLI----K----EG 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHH----H----cC
Confidence 5433221 1222346778999999999999999999999999999998 99998754321 1111110 0 00
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.. ..........+.+++.+|++.+|++||++.||++.|+..
T Consensus 261 -~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -YR-------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -Cc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 011112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.50 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=195.7
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
++||+|+||.||++... +++.||||+++... ......+..|+.++.++ +||||++++++|...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999975 68899999997532 22234678899999998 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 9999888543 3589999999999999999999998 99999999999999999999999999987532221 1223
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccc--cchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA--DDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
...||..|+|||++.+..++.++|||||||++|||++|+.||+...... .....+|....+. ... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~--------~ 222 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL----EKQ--------I 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH----cCC--------C
Confidence 4679999999999999999999999999999999999999997433211 1112222211111 110 0
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCC------HHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPR------MSQIV 473 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt------m~evl 473 (579)
..+......+.+++..||+.||.+|++ +.+++
T Consensus 223 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 223 -RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 122233456889999999999999997 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.01 Aligned_cols=247 Identities=29% Similarity=0.464 Sum_probs=200.2
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchh
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~ 286 (579)
++||+|+||.||+|...+++.+|+|.++..... ....+.+|++++.+++|+||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888899999998765433 3446889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccc
Q 008052 287 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366 (579)
Q Consensus 287 ~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 366 (579)
+++.... ..+++..++.++.|++.+|.|||+. +++||||||+||++++++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9886543 3589999999999999999999998 99999999999999999999999999987543322212222345
Q ss_pred cccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCH
Q 008052 367 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 445 (579)
Q Consensus 367 t~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 445 (579)
+..|+|||++..+.++.++|||||||++|||++ |..||...... .... .... + . .. ....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~----~~~~----~-~------~~-~~~~ 217 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE----QVEK----G-Y------RM-SCPQ 217 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHc----C-C------CC-CCCC
Confidence 678999999999999999999999999999998 99999654321 1110 0100 0 0 00 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 446 AEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 446 ~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
..+..+.+++.+|++.+|.+||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 34567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=331.39 Aligned_cols=256 Identities=28% Similarity=0.442 Sum_probs=204.0
Q ss_pred hhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ...+..|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999999753 5678999886543 3335678999999999999999999999999889
Q ss_pred EEEEEEecCCCchhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC---CeEE
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKV 344 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~kL 344 (579)
.++||||+++++|.++++.... ..++|..+++++.||+.||+|||+. +++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999998865431 2589999999999999999999998 899999999999998754 5999
Q ss_pred eecccccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhH
Q 008052 345 ADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 422 (579)
Q Consensus 345 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 422 (579)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~---~- 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME---F- 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---H-
Confidence 9999998753322111 112234568999999999999999999999999999997 99999754421 1111 0
Q ss_pred hhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 423 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
+. ... ....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ~~----~~~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VT----GGG--------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HH----cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 000 00122233567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.46 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=208.1
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
..++|...+.||+|+||.||++.+.++..+|+|.++... ...+.|.+|+.++++++|+||+++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 457889999999999999999998777889999887543 335678999999999999999999999887 778999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999765556689999999999999999999998 9999999999999999999999999999765433222
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......++..|+|||++..+.++.++|||||||++|+|++ |+.||..... ..+..+.. .+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~--------~~~~------ 221 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALE--------RGYR------ 221 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHh--------CCCC------
Confidence 2223346678999999998899999999999999999999 9999975432 11111110 1100
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
+ .........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 222 -~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -M-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -C-CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 1112234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.53 Aligned_cols=252 Identities=23% Similarity=0.277 Sum_probs=201.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||++... +++.||||+++... ......+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999965 68899999997542 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999986542 3589999999999999999999998 99999999999999999999999999998754433
Q ss_pred cceeecccccccccChhhhc------cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 358 THVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~------~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
........||+.|+|||++. ...++.++|||||||+||||++|+.||...... ......+. ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~----~~~ 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMN----FQR 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHc----CCC
Confidence 33334457999999999986 456789999999999999999999999754321 11111110 000
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.... .........+.+++..|++ +|.+||++.+++.
T Consensus 227 ~~~~------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKF------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCC------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0000 0111234567889999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=338.30 Aligned_cols=239 Identities=26% Similarity=0.399 Sum_probs=190.5
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|... +++.||||.++... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57889999987532 12234456677777654 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 9999988654 3488999999999999999999998 99999999999999999999999999998643322 2234
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+. ... ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~---~~i-----~~~---------~~~ 214 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELF---DSI-----LND---------RPH 214 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHH---HHH-----HcC---------CCC
Confidence 467999999999999999999999999999999999999999764421 110 000 000 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMSQI 472 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~ev 472 (579)
++......+.+++..||+.+|.+||++.+.
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 222334567899999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=331.43 Aligned_cols=256 Identities=26% Similarity=0.467 Sum_probs=207.1
Q ss_pred hhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
..++|...+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+|.+++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34678889999999999999998653 36899999875532 334578899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEE
Q 008052 273 RLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL 344 (579)
.++||||+++++|.+++.... ...+.|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 999999999999999986432 23478999999999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhH
Q 008052 345 ADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 422 (579)
Q Consensus 345 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 422 (579)
+|||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ |..||..... .....+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~-- 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI-- 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh--
Confidence 99999986543322 12233456789999999998899999999999999999998 9999965432 11111110
Q ss_pred hhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 423 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.+.. ...+......+.+++..||+.+|++||++.+++..|+
T Consensus 236 ------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ------DGGH--------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------cCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1110 0122223567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=344.59 Aligned_cols=202 Identities=25% Similarity=0.393 Sum_probs=175.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||+|+||+||++... +++.||||+++... ......+++|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 58899999996532 222356788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999998654 3589999999999999999999998 99999999999999999999999999987542211
Q ss_pred c----------------------------------ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCC
Q 008052 358 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403 (579)
Q Consensus 358 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~P 403 (579)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 008052 404 FDKAD 408 (579)
Q Consensus 404 f~~~~ 408 (579)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=359.94 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=213.0
Q ss_pred HHhhcCccccceecccCceEEEEEEEeCC-eEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEE-EEe---C-
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGY-CTF---G- 270 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~-~~~---~- 270 (579)
.+...++++.+.|.+|||+.||+++...+ ..||+|++-..+....+.+++||++|++|. |+|||.+++. ... .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34566788899999999999999998766 999999998888888889999999999998 9999999993 221 1
Q ss_pred --CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 271 --SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 271 --~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
-+.+|+||||.||.|-++|.......|.+.++++|+.|+++|+++||. +.|+|||||||.+||||+.++..||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 257899999999999999976555569999999999999999999998 57889999999999999999999999999
Q ss_pred cccccCCCCccee--------ecccccccccChhhh---ccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhh
Q 008052 349 LAKHSLDTDTHVS--------TRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417 (579)
Q Consensus 349 la~~~~~~~~~~~--------~~~~gt~~y~APE~~---~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~ 417 (579)
-+........... -...-|+.|+|||.+ .+..+++|+|||+|||+||-||....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 8865322221100 012468999999977 4678999999999999999999999999865321
Q ss_pred hhhhHhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 418 WAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.+++.... ........+|.+||..||+.+|.+||++.||+..+..++
T Consensus 265 ----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 ----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 12222222 122467889999999999999999999999998887654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=333.63 Aligned_cols=260 Identities=26% Similarity=0.444 Sum_probs=206.4
Q ss_pred HhhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 271 (579)
+..++|++.+.||+|+||.||+|...+ +..||||.++.... .....+.+|+.++++++|+||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345789999999999999999997542 45799998865432 23456889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeE
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~k 343 (579)
..++||||+++|+|.+++.... ...+.+..+.+++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999986422 23457778899999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhh
Q 008052 344 VADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 344 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... ++...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 9999999865432221 1222345778999999999999999999999999999999 78898654321 11111
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
. ++......+......+.+++.+|++.+|++||++.++++.|+..+
T Consensus 234 ~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 V-------------MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H-------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 111011112233467999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.68 Aligned_cols=239 Identities=29% Similarity=0.430 Sum_probs=191.3
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHH---HhcCCCCcceEEEEEEeCCeEEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEII---SQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l---~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
|.+.+.||+|+||.||+|... +++.||||+++... ....+.+..|+.++ .+++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 68999999997532 12234566666655 566799999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|..+++. ..+++.....++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988754 3589999999999999999999998 9999999999999999999999999998753322
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
. ......+|++.|||||++.+..++.++|||||||+||||++|+.||...+.. +...... .+..
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~-----~~~~---- 218 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIV-----NDEV---- 218 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-----hCCC----
Confidence 2 2223467999999999999999999999999999999999999999754421 1111110 0000
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
.++......+.+++.+||+.||.+||++
T Consensus 219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 -----RYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 1222334667899999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.93 Aligned_cols=268 Identities=22% Similarity=0.344 Sum_probs=197.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++|+||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999976 688999999875432 223467789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+. ++|.+++.... ..+.+..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 56766665432 3488889999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccc-----------hhhhhhhhHhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-----------SMVDWAKPFLAQG 426 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-----------~~~~~~~~~~~~~ 426 (579)
.......|++.|+|||++.+ ..++.++|||||||+||||++|+.||......... ....|........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12234568999999999865 45889999999999999999999999764321100 0000100000000
Q ss_pred ccCCCchhhhchhhhc-C-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDALVDQKLEE-Y-DSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~-~-~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.....+.......+.. + .......+.+++..|++.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000000 0 0011245789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.35 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=195.2
Q ss_pred ecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
||+|+||+||++... +++.||||++..... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999965 688999999865322 2234677899999999999999999999999999999999999999
Q ss_pred hhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeec
Q 008052 286 EFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363 (579)
Q Consensus 286 ~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 363 (579)
..++... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 8877532 234689999999999999999999998 999999999999999999999999999976543222 2234
Q ss_pred ccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcC
Q 008052 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 443 (579)
Q Consensus 364 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 443 (579)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...... .+..... .+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~-------------~~~~~~~-~~ 220 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQ-------------RILNDSV-TY 220 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHH-------------hhcccCC-CC
Confidence 5689999999999999999999999999999999999999975432110 000000 0000000 22
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 444 DSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 444 ~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
+......+.+++.+||+.||.+|| ++.++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 334456788999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=346.37 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=196.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||++... +++.||||++.... ......+++|++++.+++|||||++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999864 68899999986432 223456888999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+.+.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998643 3588888899999999999999998 99999999999999999999999999986322110
Q ss_pred c------------c----------------------------------eeecccccccccChhhhccCCCCcccceechH
Q 008052 358 T------------H----------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFG 391 (579)
Q Consensus 358 ~------------~----------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlG 391 (579)
. . .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 0 00124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcccc-chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCC---CC
Q 008052 392 VLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR---RP 467 (579)
Q Consensus 392 vvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~---RP 467 (579)
|+||||++|+.||........ ..+..|... +.-+ ........+.+++..|++ +|.+ |+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------~~~p----~~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRET-------------LYFP----DDIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCc-------------cCCC----CCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999976543110 011111100 0000 001123567889999997 6665 46
Q ss_pred CHHHHHHH
Q 008052 468 RMSQIVRA 475 (579)
Q Consensus 468 tm~evl~~ 475 (579)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 88888864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.58 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=205.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CC---eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NG---KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|+..+.||+|+||.||+|.+. ++ ..+|||.++... ......+..|++++.+++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999975 23 379999987653 3335678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999986543 3589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcceee--cccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 356 TDTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 356 ~~~~~~~--~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
....... ....+..|+|||++....++.++|||||||++|||++ |+.||...... ++.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i-----~~~~- 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAI-----NDGF- 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHH-----hcCC-
Confidence 3222111 1223457999999998899999999999999999998 99999654321 111111 0100
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...........+.+++.+|++.+|.+||+|.+|++.|++.
T Consensus 228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123346789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.28 Aligned_cols=266 Identities=20% Similarity=0.314 Sum_probs=196.1
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQRL 274 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~~ 274 (579)
+|+..+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999965 6899999998643 222345688999999999999999999988643 2479
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+||||+. ++|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6888887543 3489999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCc--ceeecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCCCCCccccchh-hhhhh---hHhhhc
Q 008052 355 DTDT--HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM-VDWAK---PFLAQG 426 (579)
Q Consensus 355 ~~~~--~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~-~~~~~---~~~~~~ 426 (579)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||...+....... .+... ......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 11234579999999999875 6789999999999999999999999976542110000 00000 000000
Q ss_pred ccCCCchhhhch-------hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+........+.. .+..........+.+++.+||+.||.+||++.|+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000000 000000112356789999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.68 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=192.4
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||++... +++.||+|+++... ......+..|+.++.++ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999975 57899999997532 22345677899988877 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 9999888543 3589999999999999999999998 99999999999999999999999999997532222 1223
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccc--cchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA--DDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
...||..|+|||++.+..++.++|||||||++|||++|+.||....... ......|...... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~----~~~~-------- 222 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EKQI-------- 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh----cCCC--------
Confidence 4679999999999999999999999999999999999999996432211 1111122111110 1100
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
.++......+.+++.+||+.||.+||+.
T Consensus 223 -~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 -RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1233345668899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.55 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=197.6
Q ss_pred ecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
||+|+||.||++... +|+.||+|.+.... ......+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999965 58999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeeccc
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 365 (579)
.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9888766555689999999999999999999998 99999999999999999999999999987654322 223456
Q ss_pred ccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCH
Q 008052 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 445 (579)
Q Consensus 366 gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 445 (579)
|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+....+ ...+ .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~-----~~~~--------~~~~~ 220 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTL-----EDEV--------KFEHQ 220 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhh-----cccc--------ccccc
Confidence 8999999999998899999999999999999999999997543211 1111111111 0000 00011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 446 AEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 446 ~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.....+.+++..||+.||.+||++.|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 23456899999999999999999988775443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.90 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=204.4
Q ss_pred CccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
+|+..+.||+|+||.||+|+.. ....+++|.+..... .....+.+|+.++++++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4777899999999999999863 235789998875543 334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCC----------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCc
Q 008052 276 VYEFVPNKTLEFHLHGK----------------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~----------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~N 333 (579)
|+||+.+++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999887532 123478999999999999999999998 99999999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccc
Q 008052 334 ILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 411 (579)
Q Consensus 334 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~ 411 (579)
|||++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999865433221 1223346778999999998899999999999999999999 9999965432
Q ss_pred cchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..+..+.. .. +. . ..+......+.+++..|++.+|.+||++.||++.|+..+
T Consensus 236 -~~~~~~~~----~~-----~~----~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 -ERLFNLLK----TG-----YR----M---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHHHHHHh----CC-----CC----C---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111111 00 00 0 112223457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=359.00 Aligned_cols=258 Identities=25% Similarity=0.325 Sum_probs=206.1
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-
Q 008052 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS- 271 (579)
Q Consensus 196 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~- 271 (579)
+.+...++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++..++|+||++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445578999999999999999999854 68999999986542 333457889999999999999999988775432
Q ss_pred -------eEEEEEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 272 -------QRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 272 -------~~~lV~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
..++||||+++|+|.++++.. ....+.+.....|+.|++.||.|||+. +|+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 367999999999999988643 234588899999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCC-cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh
Q 008052 343 KVADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 343 kL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||+||||++|+.||...+. .++...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH
Confidence 999999998654322 1223446799999999999999999999999999999999999999975432 111111
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+ .+.+ ...+......+.+++..||+.||.+||++.++++.
T Consensus 257 ~~-----~~~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TL-----AGRY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hh-----cCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 1111 11223345678999999999999999999999864
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=349.10 Aligned_cols=262 Identities=25% Similarity=0.426 Sum_probs=206.8
Q ss_pred HHhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCchh-HHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQG-EREFQAEIEIISQVH-HRHLVSLVGYCTF 269 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~ 269 (579)
.+..++|.+.+.||+|+||.||+|++. .++.||||+++...... .+.+.+|+.+|.++. |+|||+++|+|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344566778899999999999999864 24689999997653332 346889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCC--------------------------------------------------------
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKD-------------------------------------------------------- 293 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~-------------------------------------------------------- 293 (579)
.+..++||||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCc
Q 008052 294 ----------------------------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (579)
Q Consensus 294 ----------------------------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~N 333 (579)
...++|...++|+.|++.||+|||+. +|+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 12477888899999999999999988 99999999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccc
Q 008052 334 ILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 411 (579)
Q Consensus 334 ILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~ 411 (579)
||+++++.+||+|||+++....... .......++..|+|||++....++.++|||||||+||||++ |..||.......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986433221 11223457789999999998899999999999999999998 899986543211
Q ss_pred cchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
. ....+. .+ . ++ ..+......+.+++..||+.+|.+||++++|++.|+..+
T Consensus 350 --~----~~~~~~----~~-~------~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --Q----FYNAIK----RG-Y------RM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --H----HHHHHH----cC-C------CC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 000010 00 0 00 112223467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.80 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=208.5
Q ss_pred hhcCccccceecccCceEEEEEEEeC-----CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~ 272 (579)
..++|...+.||+|+||.||+|.+.+ ++.|++|+++... ......+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45788999999999999999999865 7889999987543 3335678899999999999999999999876 467
Q ss_pred EEEEEEecCCCchhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEee
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDR------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~D 346 (579)
.++++||+++++|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 8899999999999999865322 4589999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhh
Q 008052 347 FGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 347 FGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
||+++.......+. .....++..|+|||++....++.++|||||||++|||++ |+.||...+.. .+..+..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK---- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH----
Confidence 99998654433322 122346778999999998889999999999999999999 99999765431 1222111
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.+. .+ ......+..+.+++.+|++.+|++||++.+|++.|+..
T Consensus 234 ----~~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 ----DGY-------RL-AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ----cCC-------CC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 00 01122345689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.49 Aligned_cols=241 Identities=26% Similarity=0.377 Sum_probs=193.7
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57899999987542 22334577889999876 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++..+..++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 9999888643 3488999999999999999999998 999999999999999999999999999875432222 223
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.. ... .+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~---~i~-----~~~~---------~ 214 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE---SIL-----HDDV---------L 214 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH---HHH-----cCCC---------C
Confidence 457999999999999999999999999999999999999999765421 1111 111 1100 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRP-------RMSQIVR 474 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RP-------tm~evl~ 474 (579)
++......+.+++..||+.||.+|+ ++.++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1122345688999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=323.85 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=197.6
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
+.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++|+||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999975 68899999876433 33456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce-eecc
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-STRV 364 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~ 364 (579)
.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986432 3589999999999999999999998 99999999999999999999999999987543221110 0111
Q ss_pred cccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcC
Q 008052 365 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 443 (579)
Q Consensus 365 ~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 443 (579)
.++..|+|||.+.++.++.++|||||||++|||++ |..||....... . ...+.. . . ....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~----~~~~~~----~-~-------~~~~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---T----REAIEQ----G-V-------RLPC 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---H----HHHHHc----C-C-------CCCC
Confidence 23467999999999999999999999999999998 888986543210 0 000000 0 0 0012
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 444 DSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 444 ~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
+......+.+++.+|++.+|.+||++.+|+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2233567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=324.22 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=196.9
Q ss_pred eecccCceEEEEEEEe---CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 209 LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
.||+|+||.||+|++. +++.+|+|+++.... ...+++.+|+.++++++|+||++++++|. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578999999865432 33567899999999999999999999986 45678999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce--e
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV--S 361 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~ 361 (579)
+|.+++... ..+++..+++++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998643 3589999999999999999999998 99999999999999999999999999998754433221 1
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.... ..+...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i--------~~~~~~------- 217 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMI--------ESGERM------- 217 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH--------HCCCCC-------
Confidence 22234678999999988889999999999999999998 99999754321 111111 111100
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
..+......+.+++..|++.||++||++.+|++.|++
T Consensus 218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1222344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.07 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=194.7
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
+|...+.||+|+||.||+|+.. +++.||||+++... ......+..|..++..+ +|++|+++++++...+..+|||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999976 57899999987542 12234566788888877 5899999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|..++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999888644 3488999999999999999999998 99999999999999999999999999997533221
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+... .. ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~---i~-----~~~------ 217 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS---IM-----EHN------ 217 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHH---HH-----hCC------
Confidence 1233467999999999999999999999999999999999999999764421 11111 00 110
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
. .++......+.+++.+|++.+|.+|++.
T Consensus 218 --~-~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --V-AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --C-CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 1223345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.11 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=197.8
Q ss_pred ccccceecccCceEEEEEEEeC-Ce--EEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 008052 204 FSEANLLGQGGFGYVHKGVLTN-GK--VVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQ 272 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~-g~--~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~~ 272 (579)
|.+.+.||+|+||.||+|++.+ +. .||||.++.. .......+..|++++.+++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456889999999999999764 32 6899988654 233456788999999999999999999988542 24
Q ss_pred EEEEEEecCCCchhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 273 RLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
.++||||+++|+|..++... ....+++...+.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998876321 224589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 349 LAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 349 la~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
+++......... .....+++.|++||++....++.++|||||||++|||++ |+.||..... ..+.+ .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~--- 227 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YL--- 227 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HH---
Confidence 998754332211 122346778999999999999999999999999999999 8899865332 11111 01
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+.. ..........+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 228 -~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 -RQGNR--------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11110 011122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.40 Aligned_cols=241 Identities=26% Similarity=0.369 Sum_probs=194.0
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~ 277 (579)
+|...+.||+|+||.||+|+.. +++.||||+++... ....+.+..|+.++..+.| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999975 57889999987532 2334567889999999976 46888999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|..++... ..+.+..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999888644 3488999999999999999999998 99999999999999999999999999987532222
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+... +....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~--------i~~~~------ 217 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQS--------IMEHN------ 217 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH--------HHcCC------
Confidence 1 223457999999999999999999999999999999999999999754421 11110 00000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
. .++......+.+++.+||+.||.+|++.
T Consensus 218 --~-~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --V-SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --C-CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 1222334568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.49 Aligned_cols=237 Identities=27% Similarity=0.383 Sum_probs=191.5
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|+.++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 58899999986532 22345677888888876 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 9999888644 3488999999999999999999998 99999999999999999999999999987543222 2233
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+. .... .+.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~---~~i~-----~~~~---------~ 214 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLF---EAIL-----NDEV---------V 214 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH---HHHh-----cCCC---------C
Confidence 457999999999999999999999999999999999999999765421 111 1110 1100 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMS 470 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 470 (579)
++......+.+++.+||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 1222345688999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=327.27 Aligned_cols=265 Identities=27% Similarity=0.388 Sum_probs=203.3
Q ss_pred ccccceecccCceEEEEEEE-----eCCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLL 275 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~l 275 (579)
|...+.||+|+||.||++.. .+++.||+|.++.... .....|.+|+++|++++|+||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47789999999999988753 3577899999876532 3456788999999999999999999998763 35789
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++++|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998643 489999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... ......++..|+|||.+....++.++|||||||++|||++|..||....... ..+..+... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~----~~~~~~~~ 234 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQG----QMTVVRLI 234 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccc----ccchhhhh
Confidence 2211 1122345667999999998899999999999999999999999986543211 111111100 00000111
Q ss_pred hhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 434 ALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 434 ~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.+++.... ..+...+..+.+++..|++.+|++||++++|++.|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111 12233456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.51 Aligned_cols=261 Identities=23% Similarity=0.272 Sum_probs=203.6
Q ss_pred HHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 008052 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (579)
Q Consensus 194 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 269 (579)
+.++....++|...+.||+|+||.||++... +++.||+|++... .......+.+|+.++..++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455666789999999999999999999976 5789999998542 12223457889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccc
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGl 349 (579)
+...++||||+++|+|..++... .++...+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999988543 378888889999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccC----CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhh
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 425 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 425 (579)
++..............||+.|+|||++... .++.++|||||||+||||++|+.||...+.. ......+.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~- 261 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMN- 261 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHc-
Confidence 987544333333456799999999998753 3789999999999999999999999764421 11111110
Q ss_pred cccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 008052 426 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRAL 476 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~L 476 (579)
......+ .........+.+++..|++.++.+ |+++.||++..
T Consensus 262 ---~~~~~~~------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 ---HKNSLTF------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---CCCcccC------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000000 011223456788899999844443 78999888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=325.47 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=205.1
Q ss_pred cCccccceecccCceEEEEEEEe----CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|.+.+.||+|+||.||+|.+. .+..+|+|.++... ......|.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888899999999999999864 23479999987543 23346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++.... ..+++.+++.|+.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997543 3589999999999999999999998 9999999999999999999999999999876443
Q ss_pred Ccceee--cccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 357 DTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 357 ~~~~~~--~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.....+ ...++..|++||++.++.++.++|||||||++|||++ |..||...... ....+.. .+ ..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~--------~~-~~ 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE--------EG-YR 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh--------CC-Cc
Confidence 322221 1223568999999998899999999999999999887 99999754321 1111110 10 00
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. ......+..+.+++.+|++.+|.+||+|.+|++.|+..
T Consensus 228 ------~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ------L-PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------C-CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 11122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=323.42 Aligned_cols=250 Identities=29% Similarity=0.480 Sum_probs=207.4
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.++|...+.||.|+||.||+|... |+.||||.++.... ....+.+|+.++.+++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999875 78899999976654 4567899999999999999999999999889999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.......+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 999999999766555799999999999999999999998 99999999999999999999999999998753221
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
....++..|+|||++..+.++.++||||||+++|||++ |+.||...... .+... + ..+ . .
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~----~~~-~------~ 217 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPH----V----EKG-Y------R 217 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----H----hcC-C------C
Confidence 12345678999999998899999999999999999998 99998654321 11111 0 000 0 0
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
...+...+..+.+++.+|++.+|.+||++.+|+++|+.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 -MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01122335678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.17 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=201.3
Q ss_pred cCccccceecccCceEEEEEEEeC-C--eEEEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN-G--KVVAIKQLKAG-SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~-g--~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|++.+.||+|+||.||+|+..+ + ..+++|.++.. .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999999753 3 34788888753 333456789999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 277 YEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
+||+++++|.++++... ...+.+..++.|+.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986432 13488999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhh
Q 008052 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||...... .+ ...
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~---~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---EL---YEK 230 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHH
Confidence 999999986422111 1111223557999999998899999999999999999998 99999754321 11 111
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.. .+ + ....+......+.+++.+|++.+|.+||++.+|++.|+...
T Consensus 231 ~~-----~~-~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 LP-----QG-Y-------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred Hh-----cC-C-------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 00 0 00112223456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.67 Aligned_cols=261 Identities=20% Similarity=0.235 Sum_probs=196.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
..+|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|+++|++|+|+|||++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999976 478899996432 3467899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc-
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT- 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~- 358 (579)
+. ++|..++.... ..++|.+++.|+.|++.||.|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 YR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred cC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 95 67877775432 3589999999999999999999998 999999999999999999999999999986533221
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccc-----cchhhhhhhhHhhhcccCCCch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA-----DDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.......||..|+|||++.+..++.++|||||||+||||++|..++....... ...+....... .+....+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~---~~~~~~~~ 393 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA---QVHVDEFP 393 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh---ccccccCC
Confidence 12234579999999999999999999999999999999999887654322110 01111111100 00000000
Q ss_pred -----hhhchh--------hhcCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 434 -----ALVDQK--------LEEYD-------SAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 434 -----~l~d~~--------l~~~~-------~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+.... ...+. ......+.+|+.+||+.||.+||++.|||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 00000 0122367889999999999999999999974
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=327.54 Aligned_cols=267 Identities=25% Similarity=0.361 Sum_probs=203.4
Q ss_pred cCccccceecccCceEEEEEEEe-----CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~ 274 (579)
.+|...+.||+|+||.||++... +++.||||+++.......+.|.+|++++++++|+||++++++|... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999853 5789999999876666667899999999999999999999987543 4678
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+||||+++++|.+++.... ..++|..++.++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999986542 3589999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcce--eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 355 DTDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 355 ~~~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
...... .....++..|+|||++.+..++.++|||||||++|||++|..++...... |..............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 232 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMIV 232 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccch
Confidence 332211 11223445699999999889999999999999999999988765432210 000000000000000
Q ss_pred h---hhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 D---ALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~---~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. +++..... .........+.+++.+||+.+|++||+|.||++.|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 00100000 11223446799999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.86 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=208.1
Q ss_pred HhhcCccccceecccCceEEEEEEEe--------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~ 268 (579)
...++|.+.+.||+|+||.||+|+.. ++..||+|.++... ....+.+.+|+.++..+ +|+||++++++|.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567888999999999999999742 24579999987543 33456789999999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCce
Q 008052 269 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (579)
Q Consensus 269 ~~~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NI 334 (579)
.....++||||+++|+|.+++.... ...++|.+++.++.|++.||.|||++ +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999986532 23578899999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCcccc
Q 008052 335 LLDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 412 (579)
Q Consensus 335 Ll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~ 412 (579)
|++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 99999999999999998654332221 222346678999999998899999999999999999998 7888864321
Q ss_pred chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCC
Q 008052 413 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 482 (579)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~~ 482 (579)
.++..... .+. ...........+.+++.+||+.+|.+||+|.||++.|+....+
T Consensus 246 ---~~~~~~~~-----~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 ---EELFKLLK-----EGH--------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHHHHHHH-----cCC--------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111110 000 0011223456788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=324.63 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=203.2
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
++|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788899999999999999996 468899999997655455567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.++++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999999988643 3588999999999999999999998 999999999999999999999999999986532211 1
Q ss_pred eecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 361 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ...+. ...+ ..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~~---------~~~~---~~ 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMS---------KSNF---QP 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heeee---------cCCC---CC
Confidence 23346889999999884 45578899999999999999999999865432110 00000 0000 00
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
+.. .........+.+++.+||+.+|++||++.+|++.|
T Consensus 229 ~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111 01112346788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.28 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=204.9
Q ss_pred hhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
..++|+..+.||+|+||.||++... ++..||+|++.... .....+|.+|+.++++++|+||++++++|..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467899999999999999999864 46789999987543 3345679999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCC
Q 008052 273 RLLVYEFVPNKTLEFHLHGKD--------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSA 332 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~ 332 (579)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999986321 13478889999999999999999998 9999999999
Q ss_pred ceEeCCCCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCcc
Q 008052 333 NILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTF 410 (579)
Q Consensus 333 NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~ 410 (579)
|||++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875433221 11222335678999999998999999999999999999998 88888654321
Q ss_pred ccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 411 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
++... +..+.. ...+......+.+++.+|++.+|.+||++.||++.|+
T Consensus 240 ------~~~~~-----~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 ------EVIYY-----VRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ------HHHHH-----HhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11111 111111 1112234567899999999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=328.00 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=201.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCe----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++|...+.||+|+||.||+|.+. +++ .|++|.+..... ....++..|+.++.++.|+||++++++|. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46777899999999999999964 343 478888765432 23457888999999999999999999986 455789
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
++||+++|+|.+++.... ..++|..++.|+.|++.||+|||+. +++||||||+|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 3589999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... ......++..|++||++.++.++.++|||||||++|||++ |+.||...... .+.++. ..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~--------~~~~~- 229 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDLL--------EKGER- 229 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH--------HCCCc-
Confidence 3221 2233457789999999998999999999999999999998 99999765421 111111 01110
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.. .+......+..++.+|+..+|.+||++.|+++.|+...
T Consensus 230 -~~------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 -LA------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -CC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00 01112345788899999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=339.01 Aligned_cols=238 Identities=28% Similarity=0.365 Sum_probs=193.3
Q ss_pred ceecccCceEEEEEEE----eCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 208 NLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
+.||+|+||.||++.. .+|+.||||+++.... .....+..|+++|.+++|+||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 3578999999975322 123456789999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 99999988543 3589999999999999999999998 999999999999999999999999999986543322 22
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
....|++.|+|||.+.+..++.++|||||||+||||++|+.||...+.. .... ... ...+
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~---~i~-----~~~~--------- 215 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT---MIL-----KAKL--------- 215 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH---HHH-----cCCC---------
Confidence 3467999999999999888999999999999999999999999754321 1110 000 0000
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQ 471 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~e 471 (579)
..+......+.+++.+||+.||.+||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 122223456789999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.65 Aligned_cols=201 Identities=25% Similarity=0.325 Sum_probs=172.5
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|+|||+++++|.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 68899999986532 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC-
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD- 357 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~- 357 (579)
||++|+|.+++... ..+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998654 3478888889999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------cceeecccccccccChhhhccCCCCcccceechHH
Q 008052 358 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 392 (579)
Q Consensus 358 ---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGv 392 (579)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 008052 393 LLLELITGFRPFDKAD 408 (579)
Q Consensus 393 vl~eLltG~~Pf~~~~ 408 (579)
+||||++|+.||...+
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=328.46 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=200.9
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
|+..+.||+|+||.||++... +++.||||.+..... .....+.+|+.++.+++|+||+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999965 688999999865322 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999988655555689999999999999999999998 999999999999999999999999999876432221
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..+ . .+.+..
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~-~-------------~~~~~~ 220 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEV-E-------------RLVKEV 220 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHH-H-------------hhhhhh
Confidence 12346899999999999999999999999999999999999999754321100 000 0 000000
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
...+.......+.+++..||+.||++||+ +.|+++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01122233456889999999999999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=322.60 Aligned_cols=258 Identities=20% Similarity=0.323 Sum_probs=206.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|++++++++|+||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999965 6889999987542 2233457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 278 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 278 E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||+++++|.+++... ....+++...+.++.|+++||+|||++ +|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999998887532 234578889999999999999999998 999999999999999999999999999886543
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.... .......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-----~~~~~~~- 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-----EQCDYPP- 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-----hcCCCCC-
Confidence 221 11234688899999999988899999999999999999999999865332 111111110 0111100
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.........+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 228 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 ------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11123446789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=321.68 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=202.2
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE-eCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~-~~~~~~lV~E~~ 280 (579)
++|...+.||+|+||.||++... |..||+|.++... ....|.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57888899999999999999875 6789999987543 2457899999999999999999999865 456789999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.......+++..+++++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999998766556689999999999999999999998 99999999999999999999999999987643221
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+..+. .. +..
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~----~~----~~~------- 217 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EK----GYK------- 217 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hc----CCC-------
Confidence 22345678999999998899999999999999999998 9999864331 1111111 00 000
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
.......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 -MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 01122335678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.31 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=194.7
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||++... +++.||||+++... ......+..|++++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57899999997532 22345677899999888 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 9999888654 3589999999999999999999998 999999999999999999999999999875322221 223
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
..+|+..|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.. .. ..... .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~---~i-----~~~~~---------~ 214 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQ---SI-----LEDEV---------R 214 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHH---HH-----HcCCC---------C
Confidence 456999999999999999999999999999999999999999754321 1111 00 01100 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRM-----SQIVR 474 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm-----~evl~ 474 (579)
++......+.+++.+||+.||.+||++ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 222334578899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.56 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=195.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.+|...+.||+|+||.||+++.. +++.||||++.... ......+.+|+++|.+++|+||+++++.+.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999965 58899999986432 122456789999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999998654 3478888889999999999999998 99999999999999999999999999975321000
Q ss_pred ------------------------------------------cceeecccccccccChhhhccCCCCcccceechHHHHH
Q 008052 358 ------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLL 395 (579)
Q Consensus 358 ------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ 395 (579)
.......+||+.|||||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00012347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcccc-chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC---CHHH
Q 008052 396 ELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP---RMSQ 471 (579)
Q Consensus 396 eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP---tm~e 471 (579)
||++|+.||........ ..+..|... +..+ ........+.+++.+|+ .+|.+|+ ++.|
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------~~~~----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETT-------------LHIP----SQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCcc-------------ccCC----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999976543211 011111100 0000 01112345666777766 4999999 7888
Q ss_pred HHHH
Q 008052 472 IVRA 475 (579)
Q Consensus 472 vl~~ 475 (579)
+++.
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=331.44 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=200.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCe--EEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGK--VVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|++.+.||+|+||.||+|.+. ++. .+|+|.++... ......+.+|++++.++ +|+||++++++|..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999965 443 46788776533 33456788999999999 899999999999999999999
Q ss_pred EEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 277 YEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
|||+++++|.++++... ...+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999986432 23588999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhh
Q 008052 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
||+|||+++...... ......++..|+|||++....++.++|||||||+||||+| |..||...+.. .....
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~--- 235 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK--- 235 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHH---
Confidence 999999986421111 1111234668999999988889999999999999999998 99999654321 11110
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. ..+. .. ..+......+.+++.+|++.+|.+||++.++++.|+..
T Consensus 236 ~-----~~~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 L-----PQGY-------RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred H-----hcCC-------cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0000 00 11112345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.24 Aligned_cols=240 Identities=27% Similarity=0.397 Sum_probs=190.4
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||+||+|+.. +|+.||||++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999986432 122234445544 56789999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+.+.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 9999888643 3588999999999999999999998 99999999999999999999999999987543222 1233
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+ ...+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~-------------~~~~-~ 214 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNIL-------------NKPL-R 214 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHH-------------cCCC-C
Confidence 457999999999999999999999999999999999999999754321 1111111 1111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
........+.+++.+|++.||.+||++.+.+
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 1122356688999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=334.56 Aligned_cols=240 Identities=28% Similarity=0.389 Sum_probs=191.8
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|+.. +|+.||||+++... ......+..|..++..+ +|+||+++++++.+.+..+|||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 58899999997532 12334567788888765 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++.....++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 9999888653 3488999999999999999999998 99999999999999999999999999987532221 2234
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.+. +... .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~--------~~~~------~~---~ 214 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFES--------IRVD------TP---H 214 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH--------HHhC------CC---C
Confidence 46799999999999999999999999999999999999999975432 111110 0000 00 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMS-QIV 473 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~-evl 473 (579)
++......+.+++.+||+.||.+||++. +++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1222345678999999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=322.29 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=203.8
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
.+|+..+.||+|+||.||++.+.+++.+|+|.++.... ...+|.+|++++++++|+|++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999987788999999875433 34678999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.+++.... ..+.+..+..++.+++.+|+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999987543 3478999999999999999999998 899999999999999999999999999876543322212
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....++..|+|||++.++.++.++|||||||++|||++ |+.||..... ..+... +..+ . ....+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~--------~~~~-~-~~~~~-- 223 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVET--------INAG-F-RLYKP-- 223 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH--------HhCC-C-CCCCC--
Confidence 22335678999999998999999999999999999998 9999965432 111111 0010 0 00011
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
......+.+++.+||+.+|.+||++.+|++.|.
T Consensus 224 ----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ----RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=319.61 Aligned_cols=248 Identities=29% Similarity=0.497 Sum_probs=204.4
Q ss_pred ceecccCceEEEEEEEeC----CeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|.... +..|+||.++...... .+.+.+|++++.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 7889999997654433 57889999999999999999999999999999999999999
Q ss_pred CchhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 283 KTLEFHLHGKD-------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 283 g~L~~~l~~~~-------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
++|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 35689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
... .......++..|+|||.+....++.++|||||||++|||++ |..||..... ..+.... ..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~--------~~~--- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYL--------RKG--- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH--------HcC---
Confidence 321 12234557889999999998899999999999999999999 6999976532 1111110 010
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.....+......+.+++.+|++.+|.+||++.|+++.|+
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001222334567899999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.08 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=208.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||+|... +|+.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 7899999988642 2223567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 278 EFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 278 E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||+++++|..++.. .....+++.+++.++.++++||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999988853 2234589999999999999999999998 999999999999999999999999999876433
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
... ......++..|+|||++.+..++.++|||||||++|+|++|+.||..... .+.++... +..+.+
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-----~~~~~~--- 225 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK-----IEKCDY--- 225 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh-----hhcCCC---
Confidence 221 12234688999999999988899999999999999999999999965431 11111111 011111
Q ss_pred hchhhhcCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 436 VDQKLEEYD-SAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 436 ~d~~l~~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+ ......+.+++.+|+..+|.+||++.+|++.|+..
T Consensus 226 -----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 -----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1111 13456788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.32 Aligned_cols=240 Identities=28% Similarity=0.386 Sum_probs=191.7
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|+.. +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57899999987542 12234566778888764 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++.+...++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 9999998643 3588999999999999999999998 999999999999999999999999999875322221 223
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...||..|+|||++.+..++.++|||||||++|||++|+.||...+.. .+..... .. .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~--------~~------~~---~ 214 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR--------MD------NP---C 214 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH--------hC------CC---C
Confidence 457999999999999999999999999999999999999999764321 1111100 00 00 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMS-QIV 473 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~-evl 473 (579)
++......+.+++.+||+.||.+||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1222345678999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=328.40 Aligned_cols=262 Identities=24% Similarity=0.429 Sum_probs=203.1
Q ss_pred hcCccccceecccCceEEEEEEEeC---------------CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN---------------GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLV 264 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~---------------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~ 264 (579)
.++|++.+.||+|+||.||+++... ...||||.++... ......|.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578889999999999999988642 2358999987653 33345789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCce
Q 008052 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKD----------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (579)
Q Consensus 265 g~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NI 334 (579)
++|...+..++||||+++++|.+++.... ...+.|..+++++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999885432 12478999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh--CCCCCCCCCccc
Q 008052 335 LLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFRPFDKADTFA 411 (579)
Q Consensus 335 Ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt--G~~Pf~~~~~~~ 411 (579)
|+++++.+||+|||++......... ......++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 9999999999999999765433221 1223345778999999998999999999999999999998 6677765432
Q ss_pred cchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
...+.......... +. ... ...+...+..+.+++.+|++.+|.+||+|.+|++.|+
T Consensus 239 -~~~~~~~~~~~~~~---~~--~~~----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 -EQVIENTGEFFRNQ---GR--QIY----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHHhhhhc---cc--ccc----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111000 00 000 0111123467999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=327.66 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=200.0
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
|+..+.||+|+||+||+|... +++.||+|.+..... .....+.+|+++|++++|+||+.+.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999965 688999999865432 2234578899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999888765555699999999999999999999998 99999999999999999999999999987643221
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......|+..|+|||++.+..++.++|+|||||++|||++|..||........ ...+... + ...
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~-~----~~~--------- 220 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRR-V----LET--------- 220 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh-h----hcc---------
Confidence 12345689999999999989999999999999999999999999975432110 1111100 0 000
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
...+.......+.+++..|++.||++||+ +.+++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00122233456789999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=320.04 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=204.1
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+|+..+.||+|+||.||++... +++.+|+|.++... ....+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 68899999986432 333567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.......+++...+.++.|++.||.|||++ +|+|+||||+|||+++++.++|+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999888655555688999999999999999999998 999999999999999999999999999876543221 2
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...+.. ..... +..+.+.
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~-----~~~~~~~------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK-----VCQGSYK------- 218 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH-----HhcCCCC-------
Confidence 23456899999999999889999999999999999999999999754321 01000 0111111
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+......+.+++.+||+.||.+||++.+|+..
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=340.44 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=198.8
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRL 274 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~~ 274 (579)
+|+..+.||+|+||.||++... +++.||||++... .....+.+.+|+++|..++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999964 6899999998643 2233457889999999999999999999998766 789
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+|+||+. ++|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 5677766433 3589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhh-h---------h-----
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-D---------W----- 418 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~-~---------~----- 418 (579)
...........++..|+|||++.+. .++.++|||||||++|||++|+.||...+.......+ + +
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 3333333445689999999998764 5799999999999999999999999865532111000 0 0
Q ss_pred -hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 419 -AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 419 -~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
....+...... ... . ..+..........+.+++.+||+.||.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~--~~~-~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHK--PPS-L-PVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCC--CCc-h-HHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 000 0 00001112234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.76 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=205.6
Q ss_pred hcCccccceecccCceEEEEEEEe--------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 270 (579)
.++|.+.+.||+|+||.||++... .+..+|+|.++... .....++..|+.++.++ +|+||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367889999999999999999853 23579999997643 23345788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl 336 (579)
+..++||||+++|+|.+++.... ...++|.++++++.|++.||+|||++ +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999986532 13589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccch
Q 008052 337 DDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDS 414 (579)
Q Consensus 337 ~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 414 (579)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 999999999999987654322111 112234568999999998899999999999999999998 8888864332
Q ss_pred hhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 415 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
.+.... +. .+. ....+......+.+++..|++.+|.+||+|.+|++.|+....
T Consensus 249 -~~~~~~-~~----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 -EELFKL-LK----EGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred -HHHHHH-HH----cCC--------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 111111 00 000 001222345678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=325.37 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=200.6
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC------C
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG------S 271 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~------~ 271 (579)
+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+||++++++|... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999965 57889999986543 3356788999999998 699999999998753 4
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+++++|.+++.......+.|..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 678999999999999998765555689999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
....... ......|+..|+|||++. ...++.++|||||||++|||++|..||....... .+.. ..
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~--~~-- 229 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL--IP-- 229 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH--Hh--
Confidence 6433221 223456899999999986 3468889999999999999999999996543211 1100 00
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
......+ ........+.+++.+||..+|.+||++.||++
T Consensus 230 --~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 --RNPAPRL-------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --cCCCCCC-------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000000 11123456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.12 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=193.5
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||++... +++.||||+++.... .....+..|+.++.++ +|+||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 578999999975422 2234678899999888 599999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 9999888543 3589999999999999999999998 99999999999999999999999999997532222 1223
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||............++...... .... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~~~-~ 221 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------------EKPI-R 221 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH------------hCCC-C
Confidence 46799999999999999999999999999999999999999975432111111122111110 0000 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMS 470 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 470 (579)
++......+.+++.+||+.||.+|+++.
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 2223345678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=322.34 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=205.9
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 196 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
|++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||++++++|..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34566778888889999999999999965 57789999987766666778999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeeccccc
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVM--NWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAK 351 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~ 351 (579)
+|+||+++++|.+++..... .+ ++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999875422 24 7888899999999999999998 9999999999999976 6799999999987
Q ss_pred ccCCCCcceeecccccccccChhhhccCC--CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
....... ......|+..|+|||++.... ++.++|||||||++|+|++|+.||...... ....|.....
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~------ 227 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMF------ 227 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhh------
Confidence 6533221 122345889999999987644 789999999999999999999999654321 1111111000
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.....++......+.+++.+|++.+|.+||++.||++.
T Consensus 228 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 --------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00112233345678899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=321.34 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=202.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-----~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++|...+.||+|+||.||++... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999964 688999999864321 123468889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|+||+++++|.+++... ..+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999988643 3488899999999999999999998 999999999999999999999999999976533
Q ss_pred CCccee--ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~~~~--~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
...... ....|+..|+|||++.+..++.++||||||+++|||++|+.||...+... ...+. . ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~---~-----~~~-- 223 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFKI---A-----TQP-- 223 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHHH---h-----ccC--
Confidence 221111 23468889999999999889999999999999999999999997543211 00000 0 000
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.....+......+.+++..|++.+|.+||++.|+++.
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0012223344568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.50 Aligned_cols=262 Identities=26% Similarity=0.435 Sum_probs=206.0
Q ss_pred hcCccccceecccCceEEEEEEEeC-----------------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcce
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN-----------------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVS 262 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~ 262 (579)
.++|.+.+.||+|+||.||+++..+ +..||+|.+..... .....+.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999998642 24689999876533 34567899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhhhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCc
Q 008052 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD---------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (579)
Q Consensus 263 l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~N 333 (579)
++++|..++..++||||+++++|..++.... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999986543 12589999999999999999999998 99999999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh--CCCCCCCCCcc
Q 008052 334 ILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFRPFDKADTF 410 (579)
Q Consensus 334 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt--G~~Pf~~~~~~ 410 (579)
||++.++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 99999999999999999865433221 2234456789999999998899999999999999999998 6778865432
Q ss_pred ccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 411 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.....+....+ ......... ..+...+..+.+++.+|++.||.+||++.||++.|+
T Consensus 240 --~~~~~~~~~~~----~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFF----RDDGRQIYL-----PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhcc----ccccccccC-----CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222211110 000000000 112223467999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=331.83 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=204.7
Q ss_pred hhcCccccceecccCceEEEEEEEe--------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 269 (579)
..++|.+.+.||+|+||.||+++.. ....+|+|+++... ......+.+|+.++.++ +|+||++++++|..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467888999999999999999742 24579999987543 23356788999999999 59999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceE
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANIL 335 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NIL 335 (579)
.+..++||||+++|+|.+++.... ...++|.++++++.|++.||.|||++ +|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 899999999999999999986432 24589999999999999999999998 9999999999999
Q ss_pred eCCCCCeEEeecccccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccc
Q 008052 336 LDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADD 413 (579)
Q Consensus 336 l~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~ 413 (579)
+++++.+||+|||+++......... .....++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999999998654322211 112234567999999998899999999999999999999 88998654321
Q ss_pred hhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 414 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.+... +. .+.. ...+......+.+++.+|++.+|.+||++.||++.|+...
T Consensus 244 ~~~~~----~~----~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 ELFKL----LR----EGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHH----HH----cCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111 00 1100 0112233457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=320.52 Aligned_cols=247 Identities=27% Similarity=0.434 Sum_probs=196.3
Q ss_pred eecccCceEEEEEEEe---CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCc
Q 008052 209 LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~ 284 (579)
.||+|+||.||+|++. .+..||||+++.... ...+.|.+|+.++++++|+||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 356799999876543 23457899999999999999999999986 457789999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee--e
Q 008052 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS--T 362 (579)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~--~ 362 (579)
|.+++.... ..+++..+++++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999986432 3589999999999999999999998 999999999999999999999999999986543322111 1
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
...++..|+|||.+....++.++|||||||++|||++ |..||...... ..... +. .+. ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~----~~~--------~~ 217 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSF----IE----QGK--------RL 217 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HH----CCC--------CC
Confidence 1234578999999998889999999999999999996 99999754321 11111 10 110 00
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+......+.+++..||..+|++||++.+|.+.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 12233456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=333.20 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=196.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||+++.. +++.||||++... .......|.+|+.++..++|+||++++++|.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47888999999999999999965 5889999998642 1223456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ...+.+..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999998643 23588899999999999999999998 99999999999999999999999999987654433
Q ss_pred cceeecccccccccChhhhcc-----CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 358 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
........||+.|||||++.. +.++.++|||||||+||||++|+.||..... .+.....+.. ...+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~---~~~~ 227 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNH---KEHF 227 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcC---CCcc
Confidence 333334569999999999863 4678899999999999999999999975432 1111111100 0000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSA--RRRPRMSQIVRA 475 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp--~~RPtm~evl~~ 475 (579)
. +..........+.+++.+|+..++ ..|+++.++++.
T Consensus 228 -~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 -Q-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -c-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 001111134556777777665433 448899888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=321.50 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=206.8
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||+|+||.||++.. .+++.+|||.+.... .....++.+|+.++++++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999996 478999999876432 223457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 278 EFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 278 E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||+++++|.+++.. .....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999988863 2234589999999999999999999998 999999999999999999999999999876533
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||..... ....+..... . .
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-----~-----~ 223 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE-----Q-----C 223 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhh-----c-----C
Confidence 221 12234688999999999988899999999999999999999999964332 1111111100 0 0
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+.+ ........+.+++.+|++.+|.+||+|.+|++.|+..
T Consensus 224 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 DYPPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00100 1123456789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=322.67 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=203.4
Q ss_pred cCccccceecccCceEEEEEEEeC-C---eEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN-G---KVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.+|...+.||+|+||.||+|.+.. + ..||||.++.. ......+|..|+.++.+++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999753 3 36999998764 233456899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999987543 3589999999999999999999998 9999999999999999999999999998765332
Q ss_pred Ccce-eec-c--cccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 357 DTHV-STR-V--MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 357 ~~~~-~~~-~--~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
.... ... . ..+..|+|||++....++.++|||||||++|||++ |..||...+. .....+... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~--------~- 227 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ--------D- 227 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc--------C-
Confidence 2111 111 1 12457999999999999999999999999999887 9999975442 112222110 0
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. .+ ..+.+.+..+.+++..|++.+|.+||+|.+|+..|+..
T Consensus 228 ~------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 Y------RL-PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C------cC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 11123345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=319.92 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=201.4
Q ss_pred ceecccCceEEEEEEEeC--C--eEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~--g--~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|.+.+ + ..||||.+..... ...+.|.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999753 3 3699999987665 556789999999999999999999999988 888999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc--e
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH--V 360 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~--~ 360 (579)
++|.+++.......++|...+.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999998765434689999999999999999999998 9999999999999999999999999999876443222 1
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....++..|+|||++.+..++.++|||||||++|||++ |..||...... .+.... .. .. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~---~~----~~-------~~ 219 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKI---DK----EG-------ER 219 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hh----cC-------Cc
Confidence 123457889999999999999999999999999999999 99999654321 111110 00 00 00
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
...+...+..+.+++.+|++.+|.+||++.+|++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0112233567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=333.60 Aligned_cols=255 Identities=20% Similarity=0.263 Sum_probs=197.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||+++.. +++.||+|.++... ......+.+|+.++..++|+||+++++++...+..+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999975 57889999986421 222345788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|..++.... ..+++.....++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997532 3588899999999999999999998 99999999999999999999999999998654433
Q ss_pred cceeecccccccccChhhhcc-----CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 358 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
........||+.|+|||++.+ +.++.++|||||||+||||++|+.||...+.. +........ ...+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~---~~~~ 227 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNH---EERF 227 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcC---CCcc
Confidence 333334579999999999875 56889999999999999999999999754321 111110000 0000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRA 475 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 475 (579)
.+..........+.+++.+|+..++.+ |+++.++++.
T Consensus 228 ------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000111123456788888888765544 4577777643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=323.18 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=204.6
Q ss_pred hcCccccceecccCceEEEEEEEeCC----eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g----~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|...+.||+|+||.||+|.+.+. ..||||...... ....+.+.+|+.++++++|+||++++++|.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688889999999999999996532 468999887654 3445689999999999999999999999875 55789
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++++|.+++.... ..+++..++.++.+++.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999996543 3589999999999999999999998 999999999999999999999999999986544
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
..........++..|+|||.+....++.++|||||||++|||++ |..||...... ....+.. .+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~--------~~~~-- 226 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIE--------NGER-- 226 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH--------cCCc--
Confidence 33222233345568999999988889999999999999999996 99999755421 1111110 0000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+ ......+..+.+++.+|+..+|.+||++.++++.|+..
T Consensus 227 -----~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 -----L-PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -----C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 11223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=334.61 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=192.2
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|... +|+.||||++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 68999999986532 122334555554 56779999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++.....++.||+.||+|||+. +|+||||||+||||++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 9999888543 3589999999999999999999998 99999999999999999999999999987532221 1234
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...||..|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+ .. .+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~-----~~--------~~-~ 214 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNIL-----HK--------PL-V 214 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHH-----cC--------Cc-c
Confidence 467999999999999999999999999999999999999999754321 1111111 00 00 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
........+.+++..|++.+|.+||++++.++.+.
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 11123456788999999999999999875554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=333.52 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=193.0
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHH-HHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEI-EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei-~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 57889999986532 12223444444 456788999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|.+++... ..+.+.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 9999988653 3477888888999999999999998 999999999999999999999999999975432221 234
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.. ... ...+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~-------------~~~~-~ 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NIL-------------NKPL-Q 214 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHH---HHH-------------hCCc-C
Confidence 467999999999999999999999999999999999999999754421 1111 110 0001 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+.......+.+++..|++.+|.+|+++.+.+..+...
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~ 251 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH 251 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence 1223345688999999999999999988666555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=332.88 Aligned_cols=237 Identities=26% Similarity=0.397 Sum_probs=188.4
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
++||+|+||.||+|+.. +++.||+|++..... .....+..|+. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 688999999864321 22334555554 67889999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
++|..++... ..+.+.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 9998888543 3578888889999999999999998 99999999999999999999999999987532222 1234
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ...... ....+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i-------------~~~~~-~ 214 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNI-------------LHKPL-Q 214 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHH-------------hcCCC-C
Confidence 457999999999999889999999999999999999999999764321 111111 10001 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMS 470 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 470 (579)
++......+.+++.+||+.||.+||+..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2223345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=322.44 Aligned_cols=248 Identities=28% Similarity=0.467 Sum_probs=195.3
Q ss_pred ceecccCceEEEEEEEeC-Ce--EEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLTN-GK--VVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~-g~--~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|++.+ +. .+++|.++... ......+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999753 43 57888887533 33456788999999999 799999999999999999999999999
Q ss_pred CchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 283 KTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 283 g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
|+|.++++... ...+.+.+++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 13478999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||...+.. ..... .
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~---~----- 224 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK---L----- 224 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHH---H-----
Confidence 986322111 1111224567999999998899999999999999999997 99999654321 11110 0
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+. .+ .........+.+++.+|++.+|.+||++.++++.|+..
T Consensus 225 ~~~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 PQGY-------RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred hCCC-------CC-CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0000 00 11122345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=330.10 Aligned_cols=267 Identities=19% Similarity=0.301 Sum_probs=198.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|...+.||+|+||.||+|+.. +++.||||.++.... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 578899999875432 2234678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++ +|..++.... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 975 7777765432 3478899999999999999999998 999999999999999999999999999976432221
Q ss_pred eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhh-h----hHhhhcccCCCch
Q 008052 360 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA-K----PFLAQGLADGNFD 433 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~ 433 (579)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+........ . ..+........+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2233467899999999864 56899999999999999999999999765432111110000 0 0000000000000
Q ss_pred hhhchh-----hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 434 ALVDQK-----LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 434 ~l~d~~-----l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+. +..........+.+++.+|++.||.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 00011123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=332.74 Aligned_cols=253 Identities=28% Similarity=0.389 Sum_probs=214.2
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
.....+.|..-++||+||||.||-++.. +|+.+|.|++.+.. .+.+...++|-.||.+++.+.||.|-..|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 3344567999999999999999999965 69999999985542 3345567889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+|||+..|+||+|..||...+.+.+++...+.++.+|+.||++||+. +||+|||||+|||||+.|+++|+|+|||..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999999988888899999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
+.+...+ ...+||.+|||||+++.+.|+...|+|+|||+||||+.|+.||..... .+.| ..+
T Consensus 337 i~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-----Kvk~-----------eEv 398 (591)
T KOG0986|consen 337 IPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-----KVKR-----------EEV 398 (591)
T ss_pred cCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----hhhH-----------HHH
Confidence 7665543 334899999999999999999999999999999999999999975432 1111 112
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 470 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 470 (579)
+..+-..-.+|+....++...+....|+.||.+|..-+
T Consensus 399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 22222222356777778889999999999999997644
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=323.70 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=203.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCe----EEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.++|...+.||+|+||.||+|.+. +++ .||||.++... .....++.+|+.++.+++|+||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888999999999999999854 444 48999987543 3345678899999999999999999999975 4567
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+++||+++|+|.++++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999986543 3589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 355 DTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 355 ~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
...... .....++..|++||.+.+..++.++|||||||++|||++ |..||..... ..+..+.. .+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~--------~~~~ 229 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE--------KGER 229 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--------CCCc
Confidence 322211 112235678999999998899999999999999999998 9999865432 11222111 1100
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
. .........+.+++..||+.||++||++.++++.|+...
T Consensus 230 ~--------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 L--------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred C--------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0 111223456889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.66 Aligned_cols=255 Identities=21% Similarity=0.269 Sum_probs=196.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999976 47789999985421 122345788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999996532 3588999999999999999999998 99999999999999999999999999997654333
Q ss_pred cceeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 358 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.......+||+.|+|||++. .+.++.++|||||||+||||++|+.||...+.. +........ ...+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~---~~~~ 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNH---KERF 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCC---Cccc
Confidence 33334467999999999986 356889999999999999999999999754321 111111100 0000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARR--RPRMSQIVRA 475 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 475 (579)
............+.+++.+|+..++.+ |+++.|+++.
T Consensus 228 ------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000111223456777888877554444 6888888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.44 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=200.1
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchh
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~ 286 (579)
++||+|+||.||++...+++.||+|+++..... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765433 4568999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee-eccc
Q 008052 287 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS-TRVM 365 (579)
Q Consensus 287 ~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~~~ 365 (579)
+++.... ..+++..++.++.+++.+|+|||++ +++||||||+|||++.++.+||+|||+++.......... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9986543 3578999999999999999999998 999999999999999999999999999986432211111 1223
Q ss_pred ccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCC
Q 008052 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYD 444 (579)
Q Consensus 366 gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 444 (579)
++..|+|||++.++.++.++|||||||++|||++ |..||....... ..... ... . . + ..+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~--------~~~-~-~-----~-~~~ 217 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERI--------ESG-Y-R-----M-PAP 217 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHH--------hcC-C-C-----C-CCC
Confidence 4667999999998999999999999999999999 888886543211 11110 000 0 0 0 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 445 SAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 445 ~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
...+..+.+++.+|++.+|.+||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 233467999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.65 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=205.7
Q ss_pred cCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
++|+....||+|+||.||+|+.. +.+.|++|.+...... ....+.+|+.++++++|+||++++++|.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67888999999999999999964 2467999988665433 3467999999999999999999999999989999
Q ss_pred EEEEecCCCchhhhhcCCCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 275 LVYEFVPNKTLEFHLHGKDR-------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~-------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999875441 2589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
|+++..............++..|++||.+.+..++.++|||||||++|+|++ |..||..... ..++.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~------ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQ------ 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHH------
Confidence 9987543332222233456788999999988889999999999999999999 8889864332 11111110
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.+.... ......+..+.+++.+|++.+|.+||++.|+++.|.
T Consensus 233 --~~~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 --AGKLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --cCCcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111100 111223457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.11 Aligned_cols=264 Identities=23% Similarity=0.367 Sum_probs=203.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||+|+||.||++... +++.+|+|.++.... ....++.+|++++.+++|+||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999965 578899999875432 2345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.++++.. ..+++..+..++.|+++||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999999654 45889999999999999999999742 89999999999999999999999999987643321
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC----------
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD---------- 429 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------- 429 (579)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...+... ...+...........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCC
Confidence 234568999999999988889999999999999999999999996543211 111110000000000
Q ss_pred ------CCchhhhchhhh----cCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 430 ------GNFDALVDQKLE----EYD-SAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 430 ------~~~~~l~d~~l~----~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
....++.+.... ..+ ......+.+++.+|++.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011111000 000 1134568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.50 Aligned_cols=262 Identities=24% Similarity=0.418 Sum_probs=203.4
Q ss_pred hcCccccceecccCceEEEEEEEe-----------------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcce
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-----------------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVS 262 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~ 262 (579)
.++|+..+.||+|+||.||++... +...||+|.++... .....+|.+|+.+|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 24479999997643 334568999999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhhhhcCCCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCc
Q 008052 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR---------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (579)
Q Consensus 263 l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~---------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~N 333 (579)
+++++...+..++||||+++++|.+++..... ..+++.+.+.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999998865321 2477889999999999999999998 99999999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh--CCCCCCCCCcc
Q 008052 334 ILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT--GFRPFDKADTF 410 (579)
Q Consensus 334 ILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt--G~~Pf~~~~~~ 410 (579)
||++.++.+||+|||+++........ ......++..|++||....+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865333221 1222345678999999988899999999999999999998 77888654321
Q ss_pred ccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 411 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
............. . ..... ..+..++..+.+++.+||+.||.+||+|.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~~---~--~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 ---QVIENTGEFFRDQ---G--RQVYL----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHHhhc---c--ccccC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111000 0 00000 111223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.26 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=198.1
Q ss_pred ceecccCceEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
++||+|+||.||+|.+.. +..+|+|.+..... ....++.+|+.+++++.|+|||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 26899999876544 24567899999999999999999999876 4568999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee-
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS- 361 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~- 361 (579)
++|.+++.... .+++..++.++.|++.+|+|||.. +++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999996543 589999999999999999999998 999999999999999999999999999986543332211
Q ss_pred -ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 362 -TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 362 -~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...+. ..+..+... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~--------~~~------- 216 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES--------GER------- 216 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc--------CCc-------
Confidence 11224568999999998999999999999999999998 9999975432 122222110 000
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+...+..+.+++.+|+..+|.+||++.+|++.|++.
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 011222345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.46 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=202.7
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~E 278 (579)
+|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 57889999986532 2334578899999999999999999998764 446789999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++.......+++.++..++.+++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998765455689999999999999999999998 999999999999999999999999999986533222
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......+++.|+|||++.+..++.++|||||||++|||++|+.||...+. ..+..... .+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~-----~~-------- 217 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII-----EG-------- 217 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-----hc--------
Confidence 22345689999999999999999999999999999999999999975432 11111111 11
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+..........+.+++.+|++.+|.+||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111223345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.19 Aligned_cols=251 Identities=30% Similarity=0.487 Sum_probs=204.3
Q ss_pred ccccceecccCceEEEEEEEeC-----CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
|++.+.||.|+||.||+++..+ +..||+|.++..... ....+..|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999764 378999999766543 4678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765443489999999999999999999998 99999999999999999999999999998765443
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
........++..|+|||.+....++.++||||||++++||++ |+.||..... ..+..... .+..
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~--------~~~~---- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLK--------KGYR---- 222 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh--------cCCC----
Confidence 322222337789999999988899999999999999999999 8888865332 11111110 1100
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
..........+.+++.+|++.+|++||++.|+++.|
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011222456789999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=335.39 Aligned_cols=259 Identities=28% Similarity=0.446 Sum_probs=201.2
Q ss_pred hcCccccceecccCceEEEEEEE------eCCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC-C
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFG-S 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~-~ 271 (579)
.++|.+.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.+|.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36788999999999999999973 3478999999976433 2345688999999999 689999999988654 4
Q ss_pred eEEEEEEecCCCchhhhhcCCC----------------------------------------------------------
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKD---------------------------------------------------------- 293 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~---------------------------------------------------------- 293 (579)
..++||||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999998886421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc-eeeccc
Q 008052 294 -------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVM 365 (579)
Q Consensus 294 -------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~ 365 (579)
...++|..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12368888999999999999999998 9999999999999999999999999999865332211 112234
Q ss_pred ccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCC
Q 008052 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYD 444 (579)
Q Consensus 366 gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~ 444 (579)
++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+. ..+..+... ..+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~--------~~~~~~~~~--------~~~ 304 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC--------RRLKEGTRM--------RAP 304 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHH--------HHHhccCCC--------CCC
Confidence 5678999999998899999999999999999997 99998654321 0000 000011000 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 445 SAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 445 ~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
......+.+++..|++.+|.+||++.||++.|+..+
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112346889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.89 Aligned_cols=266 Identities=26% Similarity=0.381 Sum_probs=203.1
Q ss_pred cCccccceecccCceEEEEEEE-----eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~ 273 (579)
..|...+.||+|+||.||++.+ .+++.||+|.++... ......+.+|+.++++++|+||++++++|... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999984 247889999987553 33346789999999999999999999999875 567
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++.... ..++|..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 89999999999999986442 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc----hhhhhhhhHhhhcc
Q 008052 354 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD----SMVDWAKPFLAQGL 427 (579)
Q Consensus 354 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 427 (579)
...... ......++..|+|||++.+..++.++|||||||++|||++++.|+......... ....+........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433221 112345677899999999889999999999999999999987765322110000 00000000000000
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+ .........+..+.+++.+|++.+|.+||++.+|++.|+..
T Consensus 240 ~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEG--------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcC--------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 00011223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=315.83 Aligned_cols=267 Identities=21% Similarity=0.262 Sum_probs=202.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~--~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV 276 (579)
+.|+..+.|++|.||.||+|+.. ++..||+|+++...... --.-++||.+|.+++|||||.+-.+... -+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777899999999999999965 68999999998754211 1245789999999999999999888754 3578999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||+. +|...++... +.+...+..-++.|+++||+|||.+ .|+|||||++|+|+.+.|.+||+|||||+.+...
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999965 8888887654 4578888888999999999999999 8999999999999999999999999999987655
Q ss_pred CcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccch----------hhhhhhhHhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS----------MVDWAKPFLAQ 425 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~----------~~~~~~~~~~~ 425 (579)
. ...+..+-|.+|.|||.+.+ ..|+...|+||+|||+.||+++++-|.+....+... -..|..-....
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 34466788999999999875 569999999999999999999999998765433211 11222111111
Q ss_pred cccCCCchhhhchhhh-cCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 GLADGNFDALVDQKLE-EYDSA-EMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~-~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+..-.+....-..+. .|... ....-.+++..++..||.+|-|+.|.|+
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1111111111111121 22222 3356678899999999999999999875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=316.88 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=205.6
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|+..+.||.|+||.||.+... +++.+++|.+.... .....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999854 58889999876432 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.......+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765455689999999999999999999998 999999999999999999999999999986543332
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......++..|+|||++.+..++.++||||||+++|||++|..||...... +...... .+.+.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-----~~~~~------ 219 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-----QGNYT------ 219 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-----cCCCC------
Confidence 223456899999999998888999999999999999999999999754321 1111111 11111
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
.........+.+++..|++.+|.+||++.++++.+
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 --PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123345688999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.17 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=196.2
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCcceEEEEEEe-----CC
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQV---HHRHLVSLVGYCTF-----GS 271 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~-----~~ 271 (579)
+|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|+.++.++ +|+||++++++|.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999975 6889999998653221 233566777777665 69999999999864 24
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+++ +|..++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 788888665555689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhhhhhHhhhcc---
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQGL--- 427 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~--- 427 (579)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .+..+........+
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 653221 123356899999999999889999999999999999999999999754321100 01110000000000
Q ss_pred ---cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 428 ---ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 428 ---~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+.......+..........+.+++.+|++.||++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000111122234456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=335.09 Aligned_cols=284 Identities=26% Similarity=0.403 Sum_probs=231.1
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeC---C--eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTN---G--KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~---g--~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~ 270 (579)
+++..+.....++||.|-||.||+|+..+ | -.||||..|.+. ....+.|++|..+|++++|||||+|+|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 34445566677899999999999999643 2 358999988753 4456789999999999999999999999986
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
...|||||.++-|.|..+|+.+. ..|+......++.||..+|+|||+. ++|||||..+|||+...--|||+||||+
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 56789999999999999997653 4588889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
+...+......++..-...|||||.+.-.+++.++|||.|||.+||++. |..||......+.. ..++.
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------~~iEn 607 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------GHIEN 607 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------EEecC
Confidence 9988877766666667789999999999999999999999999999998 99999765432210 01112
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCCCCCcccCCCCCCCCCchh
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITPGHSTIYGSYGGSDYNSMQ 509 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (579)
|. ....+.+++..|..++.+||..+|.+||++.|+...|......+ ..+
T Consensus 608 Ge--------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee-----------------------k~~ 656 (974)
T KOG4257|consen 608 GE--------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE-----------------------KIN 656 (974)
T ss_pred CC--------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh-----------------------hhh
Confidence 21 11456778899999999999999999999999999998654322 122
Q ss_pred hHHHHHHHHHhhhccccC
Q 008052 510 YREDMKKFRKIALESVEL 527 (579)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~ 527 (579)
-.|.+++-|+.+..+.+-
T Consensus 657 ~~Eq~r~~R~~a~~~~~~ 674 (974)
T KOG4257|consen 657 SSEQLRRQRKVASMIWQN 674 (974)
T ss_pred hHHHHHhhhcccceeecc
Confidence 245567777777666553
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.62 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=204.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.+|+..+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.+.|+||++++++|..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999964 68899999997665555677889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.. ..+.+.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 99999999854 2478999999999999999999998 999999999999999999999999999876433221 1
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .+..+. ..+ . +.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~--------~~~-~-----~~~ 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIA--------TNG-T-----PEL 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHh--------cCC-C-----CCC
Confidence 233468899999999998889999999999999999999999997544211 111110 000 0 000
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+......+.+++.+|+..+|++||++.+|++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112234466889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.73 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=206.1
Q ss_pred hhcCccccceecccCceEEEEEEEeC--------CeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 269 (579)
...+|.+.+.||+|+||.||++.... +..||+|.++... ....+++.+|+.++.++ +|+||++++++|..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34568889999999999999998531 2368999887543 23356789999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceE
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANIL 335 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NIL 335 (579)
.+..+++|||+++|+|.+++.... ...+.|.+++.++.|++.||+|||++ +|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 999999999999999999986421 23588999999999999999999998 9999999999999
Q ss_pred eCCCCCeEEeecccccccCCCCcce-eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccc
Q 008052 336 LDDSFEAKVADFGLAKHSLDTDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADD 413 (579)
Q Consensus 336 l~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~ 413 (579)
++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 9999999999999998654322211 122234568999999999999999999999999999998 8889865432
Q ss_pred hhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 414 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
.++..... .+. ...........+.+++.+|++.+|.+||+|.||++.|+....
T Consensus 243 --~~~~~~~~-----~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 --EELFKLLK-----EGH--------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred --HHHHHHHH-----cCC--------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11111111 000 001122334578899999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.64 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=194.3
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ 277 (579)
+|+..+.||+|+||.||+|... +|+.||||+++... ....+.+..|+.++..+. |++|+++++++...+..+|||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999965 68899999987532 223356778899998886 577888999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+++.+++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999988644 3489999999999999999999998 99999999999999999999999999987543221
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..+... .. ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~---i~-----~~~------ 217 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQS---IM-----EHN------ 217 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHH---HH-----hCC------
Confidence 122345699999999999999999999999999999999999999976542 111111 00 000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 470 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 470 (579)
. .++......+.+++.+|++.+|.+|++..
T Consensus 218 --~-~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 --V-SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --C-CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0 12223345678999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.05 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=204.8
Q ss_pred cCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
++|+..+.||+|+||.||+|...+ ++.+++|.++.... ..++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999864 78999999875433 578999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.... ..+++.....++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999986433 4589999999999999999999998 999999999999999999999999999987543321 2
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||........ .... .... ...+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~---------~~~~-----~~~~ 219 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMI---------PNKP-----PPTL 219 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhh---------ccCC-----CCCC
Confidence 2334588999999999988999999999999999999999999975443110 0000 0000 0000
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+......+.+++.+|++.+|.+||++.||++
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 -SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112233457899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=337.89 Aligned_cols=202 Identities=25% Similarity=0.401 Sum_probs=174.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++|+||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 58899999986432 223456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999998654 3488999999999999999999998 99999999999999999999999999987542210
Q ss_pred c----------------------------------ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCC
Q 008052 358 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403 (579)
Q Consensus 358 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~P 403 (579)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 008052 404 FDKAD 408 (579)
Q Consensus 404 f~~~~ 408 (579)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.24 Aligned_cols=239 Identities=26% Similarity=0.391 Sum_probs=189.2
Q ss_pred eecccCceEEEEEEEeC-------------------------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceE
Q 008052 209 LLGQGGFGYVHKGVLTN-------------------------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l 263 (579)
+||+|+||.||+|.+.. ...|++|.+..........|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998531 13589999876544445678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC---
Q 008052 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF--- 340 (579)
Q Consensus 264 ~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~--- 340 (579)
+++|......+|||||+++|+|..++... ...+++..+++|+.|+++||+|||+. +|+||||||+||||+.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999888643 34588999999999999999999998 999999999999997643
Q ss_pred ----CeEEeecccccccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHH-hCCCCCCCCCccccch
Q 008052 341 ----EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELI-TGFRPFDKADTFADDS 414 (579)
Q Consensus 341 ----~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLl-tG~~Pf~~~~~~~~~~ 414 (579)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 3799999998653221 22357888999998865 56899999999999999995 6999987543211
Q ss_pred hhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 415 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
...+ ... .. ..+......+.+++.+||+.+|.+||+|.+|++.|.
T Consensus 230 ~~~~----~~~-------------~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERF----YEK-------------KH-RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH----HHh-------------cc-CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 000 00 011112246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=319.29 Aligned_cols=250 Identities=22% Similarity=0.378 Sum_probs=198.8
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.++.+++|+||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3677889999999999999986 468899999986542 33346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|..+. .+++.....++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999996542 367888999999999999999998 9999999999999999999999999999765332
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhhhhhhHhhhcccCCCchhhhch
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... ...+.... .... .+
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~-----~~ 218 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-----VDED-----PP 218 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-----hccC-----CC
Confidence 1233578999999999998899999999999999999999999997543211100 00111000 0000 00
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+. .......+.+++.+|++.+|.+||++.|+++.
T Consensus 219 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 110 11233568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=321.29 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=209.5
Q ss_pred cCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
+.|+..+.||+|.-|+||++.+.+ +..+|+|++.+.... .....+.|-+||+.++||.|+.|++.++.++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778999999999999999874 589999999765433 3345677999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC--
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD-- 355 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~-- 355 (579)
|||+||+|..+++.+....++......++.+++-||+|||.. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999999999999999999999999999999998 999999999999999999999999998743210
Q ss_pred -------------------------------CCc----------------------ceeecccccccccChhhhccCCCC
Q 008052 356 -------------------------------TDT----------------------HVSTRVMGTFGYLAPEYASSGKLT 382 (579)
Q Consensus 356 -------------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~~~~ 382 (579)
... ..+..++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 111235799999999999999999
Q ss_pred cccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhcc
Q 008052 383 EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRH 461 (579)
Q Consensus 383 ~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~ 461 (579)
.++|+|.|||+|||||.|..||.+.+.. ..+..++-..+. ......+..+.+||+..|.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~-------------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK-------------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch-------------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 9999999999999999999999887641 123333433333 22235667899999999999
Q ss_pred CCCCCCC----HHHHHH
Q 008052 462 SARRRPR----MSQIVR 474 (579)
Q Consensus 462 dp~~RPt----m~evl~ 474 (579)
||.+|-. +.||-+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999998 666654
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=318.19 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=193.5
Q ss_pred ceecccCceEEEEEEEeC----CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEEEEecC
Q 008052 208 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYEFVP 281 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~E~~~ 281 (579)
+.||+|+||.||+|.+.+ ...||+|.+.... ......+.+|+.+++.++|+||++++++|.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 4579999985432 3345678899999999999999999998864 556789999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc--
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-- 359 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~-- 359 (579)
+++|.+++.... ..+.+..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999987543 3467888899999999999999998 9999999999999999999999999999765332211
Q ss_pred -eeecccccccccChhhhccCCCCcccceechHHHHHHHHhC-CCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 360 -VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG-FRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 360 -~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......++..|+|||++....++.++|||||||++|||++| ..||...+. ..+..+. . .+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~---~-----~~~~----- 220 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYL---L-----QGRR----- 220 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---h-----cCCC-----
Confidence 11233467789999999988999999999999999999995 556654322 1111110 0 0000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+...+..+.+++..||+.+|++||++.||++.|+..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=343.80 Aligned_cols=270 Identities=21% Similarity=0.310 Sum_probs=196.2
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC------CCcceEEEEE
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH------RHLVSLVGYC 267 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H------pniv~l~g~~ 267 (579)
+++....++|.+.+.||+|+||+||+|+.. .++.||||+++.... ..+++..|+.++.+++| .++++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 455566789999999999999999999965 578999999965322 23456677777777754 4588999988
Q ss_pred EeC-CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC------
Q 008052 268 TFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF------ 340 (579)
Q Consensus 268 ~~~-~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~------ 340 (579)
... ...+||||++ +++|.+++... ..+.+..+..|+.||+.||+|||+++ +||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 764 4778999988 77888877543 35899999999999999999999732 899999999999998765
Q ss_pred ----------CeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcc
Q 008052 341 ----------EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 410 (579)
Q Consensus 341 ----------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~ 410 (579)
.+||+|||++.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||+..+..
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999886432 2234567999999999999999999999999999999999999999865532
Q ss_pred ccchhh---------hhhhhHhh----hcc-cCCCchhhhchh-h----h-c--CCHHHHHHHHHHHHHhhccCCCCCCC
Q 008052 411 ADDSMV---------DWAKPFLA----QGL-ADGNFDALVDQK-L----E-E--YDSAEMTRMAACAAACIRHSARRRPR 468 (579)
Q Consensus 411 ~~~~~~---------~~~~~~~~----~~~-~~~~~~~l~d~~-l----~-~--~~~~~~~~l~~l~~~cl~~dp~~RPt 468 (579)
....++ .|...... ..+ ..+.+....++. + . . ........+++|+..||+.||.+||+
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111111 11110000 000 000000000000 0 0 0 00112356789999999999999999
Q ss_pred HHHHHH
Q 008052 469 MSQIVR 474 (579)
Q Consensus 469 m~evl~ 474 (579)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999996
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.12 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=200.1
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
|+..+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||++++++|...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999976 4788999998766555567789999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
++|..++.... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 99988876433 3589999999999999999999998 99999999999999999999999999987643322 1223
Q ss_pred cccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 363 RVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 363 ~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
...++..|+|||++. ...++.++|||||||++|||++|+.||...... ....... ......+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~---------~~~~~~~-- 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIA---------KSEPPTL-- 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHh---------hcCCCCC--
Confidence 356899999999984 345788999999999999999999999754321 1111110 0000000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+......+.+++.+||+.+|.+||++.++++.
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112234578899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=319.21 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=192.7
Q ss_pred ceecccCceEEEEEEEeC---CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 208 NLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++|+||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998653 45799999876543 33457889999999999999999999999988999999999999
Q ss_pred chhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 284 TLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 284 ~L~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
+|.++++... ....++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 23467788889999999999999998 99999999999999999999999999997543332211
Q ss_pred -eecccccccccChhhhccC-------CCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 361 -STRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 361 -~~~~~gt~~y~APE~~~~~-------~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
.....++..|+|||++... .++.++|||||||++|||++ |+.||....... ...+. + .+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~-------~-~~~ 226 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT-------V-REQ 226 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH-------h-hcc
Confidence 2234578899999998642 35789999999999999996 999996543211 11110 0 001
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
...+.++.+. ......+.+++..|+ .+|.+||++.||++.|+
T Consensus 227 ~~~~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111122211 112345777889998 68999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=319.09 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=203.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999965 68899999986543 33446788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++... .+++.....++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999998654 589999999999999999999998 99999999999999999999999999998764432 2
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......++..|+|||++.+..++.++|||||||++|||++|+.||...+... ... .+..... +.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~--------~~~~~~~-----~~ 217 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLF--------LIPKNNP-----PS 217 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHH--------HhhhcCC-----CC
Confidence 2234568889999999998889999999999999999999999997544210 000 0000000 01
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.. ......+.+++.+||..+|++||+++++++
T Consensus 218 ~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Ccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 110 013456889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=317.42 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=199.9
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch---------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
+|.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 5789999988653221 12467889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++||||+++++|..++... ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999654 3488899999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcc-----eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 353 SLDTDTH-----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 353 ~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
....... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----------- 222 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIF----------- 222 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHH-----------
Confidence 5422111 1122458889999999998899999999999999999999999997543210 000
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+........+......+.+++.+||+.||.+||++.||++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ------KIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------HHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000111222334567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=315.93 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=204.2
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|+..+.||+|+||.||++... +|+.||+|.+... ......++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999964 6889999998643 223345789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.......+++.++++++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999988765444688999999999999999999998 999999999999999999999999999976533221
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......|+..|+|||++.+..++.++|||||||++++|++|+.||...+.. +.....+ .+..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-----~~~~------- 218 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKII-----RGSY------- 218 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHh-----cCCC-------
Confidence 122345888999999999899999999999999999999999999754321 1111111 1111
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...+......+.+++.+|++.+|.+||+|.+|++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 -PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11222345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.77 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=196.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 271 (579)
.++|...+.||+|+||.||++... +|+.||||+++.. .......+.+|+.++..++|+||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999964 5889999998643 2233457789999999999999999999986543
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+++ +|...++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999976 45555532 378888999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc------------hhhhh-
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD------------SMVDW- 418 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~------------~~~~~- 418 (579)
..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...+..... .+...
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 64322 1223457899999999999999999999999999999999999999865431100 00000
Q ss_pred ---hhhHhhhc--ccCCCchhhhc----hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 419 ---AKPFLAQG--LADGNFDALVD----QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 419 ---~~~~~~~~--~~~~~~~~l~d----~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...+.... .....+.++.. +............+.+++.+||+.||++||++.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00000000000 00001111224568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=317.74 Aligned_cols=240 Identities=26% Similarity=0.436 Sum_probs=190.2
Q ss_pred ceecccCceEEEEEEEeC-------------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 208 NLLGQGGFGYVHKGVLTN-------------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
+.||+|+||.||+|++.. ...|++|.+..........|.+|+.++..++||||++++++|......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899887655444567889999999999999999999999998999
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC-------eEEeec
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-------AKVADF 347 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~-------~kL~DF 347 (579)
+||||+++++|..+++... ..+++..+++|+.||++||+|||+. +|+||||||+||||+.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999998886543 3489999999999999999999998 9999999999999987654 899999
Q ss_pred ccccccCCCCcceeecccccccccChhhhc-cCCCCcccceechHHHHHHHH-hCCCCCCCCCccccchhhhhhhhHhhh
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELI-TGFRPFDKADTFADDSMVDWAKPFLAQ 425 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~eLl-tG~~Pf~~~~~~~~~~~~~~~~~~~~~ 425 (579)
|++...... ....++..|+|||++. +..++.++|||||||+||||+ .|..||........ . .+.
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~---~~~-- 222 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----E---RFY-- 222 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----H---HHH--
Confidence 998754321 2345788999999987 567899999999999999998 58888865432110 0 000
Q ss_pred cccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 426 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.+.+ .+ .......+.+++..||+.||.+||++.+|++.|.
T Consensus 223 ---~~~~-~~--------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 ---EGQC-ML--------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---hcCc-cC--------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 00 0112346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.80 Aligned_cols=238 Identities=28% Similarity=0.443 Sum_probs=191.4
Q ss_pred ceecccCceEEEEEEEeCCe-----------EEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 208 NLLGQGGFGYVHKGVLTNGK-----------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+.||+|+||.||+|.+.+.. .|++|.++..... ...|.+|+.+|++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986432 5788887655433 6788999999999999999999999988 778999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-------CeEEeeccc
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-------EAKVADFGL 349 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-------~~kL~DFGl 349 (579)
|||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999875432 589999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccC--CCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
+..... .....++..|+|||++... .++.++|||||||++|||++ |..||....... +...+.
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~--- 220 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQ--- 220 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHh---
Confidence 986533 1223467789999999876 78999999999999999999 577776543211 111100
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.... + .......+.+++.+|+..+|.+||++.+|++.|+
T Consensus 221 --~~~~-------~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHR-------L---PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCC-------C---CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0 0001167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=321.57 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=201.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.|++.+.||.|+||.||+|+.. +++.|++|.+........+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999975 48899999998766666678899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|..++.... ..+++..+..++.|++.+|+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 9999988775433 3589999999999999999999998 99999999999999999999999999987543221 11
Q ss_pred eecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 361 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.....++..|+|||++. ...++.++|||||||++|||++|..||....... ....+. ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~---------~~~~--- 232 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA---------KSEP--- 232 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHh---------cCCC---
Confidence 23345888999999984 3457889999999999999999999996543210 000100 0000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.. ..+......+.+++.+||+.+|++||++.+|++
T Consensus 233 --~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 --PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 112233456889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=314.21 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=203.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.+.|++.++||+|.|+.||++... .|+.+|+|++... +....+++.+|+.|.+.|+|||||+|...+.+...++||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 356777899999999999999854 6899999987533 3345678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC---CCCCeEEeecccccccC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSL 354 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~---~~~~~kL~DFGla~~~~ 354 (579)
|+|.|++|..-+-.. ...++...-..+.||+.+|.|+|.+ +|||||+||.|+||. ...-+||+|||++..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997655322 3466777788999999999999999 999999999999994 34569999999999876
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
.........||++|||||++...+|+..+|||+.||+||-|+.|++||.+.+.. .+.+.+..+.++.
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----------rlye~I~~g~yd~ 231 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----------RLYEQIKAGAYDY 231 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----------HHHHHHhccccCC
Confidence 333445578999999999999999999999999999999999999999764421 1222222333221
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
++ .+.....+...+++.+||..||.+|-|+.|.|+
T Consensus 232 --~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 --PS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11 123344567889999999999999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.97 Aligned_cols=248 Identities=29% Similarity=0.521 Sum_probs=198.2
Q ss_pred ceecccCceEEEEEEEeC-------CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 208 NLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+.||+|+||.||+|+..+ ++.+|||.+.... ......+.+|+.++++++|+||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2579999886543 23356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-----CeEEeeccc
Q 008052 280 VPNKTLEFHLHGK-----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-----EAKVADFGL 349 (579)
Q Consensus 280 ~~~g~L~~~l~~~-----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-----~~kL~DFGl 349 (579)
+++++|.+++... ....++|.+++.++.|++.||+|||+. +++|+||||+|||++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998643 224488999999999999999999988 899999999999999877 899999999
Q ss_pred ccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 350 AKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 350 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||...+.. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~-------- 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV-------- 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH--------
Confidence 9765433221 1122346788999999999999999999999999999998 99999654321 111110
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
..+. .. ......+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 227 ~~~~-------~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 TAGG-------RL-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hcCC-------cc-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000 00 122234567889999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=305.11 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=211.4
Q ss_pred HHHhhcCccccceecccCceEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS---- 271 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~---- 271 (579)
+.+..++|.+.+.||+|||..||+++ +.+++.+|+|++.-...+..+..++|++..++++|||++++++++..+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 44566789999999999999999999 6678999999998887777888999999999999999999998875543
Q ss_pred -eEEEEEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 272 -QRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 272 -~~~lV~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
..||++.|...|+|.+++... .+..+++.+.++|+.++.+||++||+. .+.+.||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 489999999999999988643 234699999999999999999999997 3469999999999999999999999999
Q ss_pred cccccCCCCccee--------ecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhh
Q 008052 349 LAKHSLDTDTHVS--------TRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417 (579)
Q Consensus 349 la~~~~~~~~~~~--------~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~ 417 (579)
.+....-...... .....|..|.|||.+. +..+++++|||||||+||+|+.|.-||+..-. ..+++.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla- 252 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA- 252 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE-
Confidence 9875422111000 1134788999999986 34578999999999999999999999976433 111111
Q ss_pred hhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 418 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. ++..+.+. - .......+.+.+++++|++.||.+||++.+++..++..
T Consensus 253 L-------Av~n~q~s---~----P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 L-------AVQNAQIS---I----PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred E-------eeeccccc---c----CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0 00111111 0 11122567899999999999999999999999998754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.02 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=210.2
Q ss_pred hcCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCch---hHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ---GEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~l 275 (579)
.+.|.+.+.||+|.||.||+++... |+.+|+|.++..... ....+.+|+.+|+++. |||||.++++++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3568888999999999999999775 999999999664332 3468899999999999 9999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC----CCeEEeeccccc
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS----FEAKVADFGLAK 351 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~----~~~kL~DFGla~ 351 (579)
|||++.||.|.+.+... .+++.....++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998765 389999999999999999999998 99999999999999543 579999999999
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+..+.
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----------~i~~~~ 254 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----------AILRGD 254 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----------HHHcCC
Confidence 8655 445567899999999999999999999999999999999999999998765322111 111122
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
++ ............+.+++..|+..||.+|+++.++++
T Consensus 255 ~~-----f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 FD-----FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CC-----CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 20 001333445678899999999999999999999998
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.28 Aligned_cols=264 Identities=16% Similarity=0.261 Sum_probs=195.7
Q ss_pred ccceeccc--CceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 206 EANLLGQG--GFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 206 ~~~~LG~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.++||+| +|++||++... +|+.||||+++... ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999864 68999999997542 233456788999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc-
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH- 359 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~- 359 (579)
++|+|.+++.......+++..+++++.|++.||+|||+. +|+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998655445689999999999999999999998 9999999999999999999999999865433211110
Q ss_pred -----eeecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh--------
Q 008052 360 -----VSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA-------- 424 (579)
Q Consensus 360 -----~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-------- 424 (579)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccccccch
Confidence 0112346778999999976 458999999999999999999999997533210 00000000000
Q ss_pred --hcc--------cCCCchhhh---------c-hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 --QGL--------ADGNFDALV---------D-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 --~~~--------~~~~~~~l~---------d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+ ....+.... . .....+.......+.+++.+||+.||++||++.||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000000000 0 0000122234467899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.54 Aligned_cols=269 Identities=22% Similarity=0.288 Sum_probs=203.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCC-cceEEEEEEeCC-----
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRH-LVSLVGYCTFGS----- 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpn-iv~l~g~~~~~~----- 271 (579)
...|...+.||+|.||+||+|+.. +|+.||+|++...... ......+|+.+|.+|+|+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666788999999999999954 7899999999765442 2345678999999999999 999999998877
Q ss_pred -eEEEEEEecCCCchhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 272 -QRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 272 -~~~lV~E~~~~g~L~~~l~~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
..+|||||+ .-+|..++..... ..++...+..++.||++||+|||++ +|+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 788999999 4588888875543 3577788999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccc----------cchhhh
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFA----------DDSMVD 417 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~----------~~~~~~ 417 (579)
+|+...-.. ...+..++|.+|.|||++.+. .|+...||||+|||+.||++++.-|.+....+ ..+...
T Consensus 166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 999654222 234566799999999999876 79999999999999999999998887765421 112223
Q ss_pred hhhhHhhhcccCCCchhhhchh-hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 418 WAKPFLAQGLADGNFDALVDQK-LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~-l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
|..-.....+.. .+...-.+. +............+++..|++.+|.+|.++..++..
T Consensus 245 Wp~v~~~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 322111100000 011111000 001111111468899999999999999999999875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=356.05 Aligned_cols=258 Identities=20% Similarity=0.307 Sum_probs=203.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||+|+||.||+|+.. +++.||||+++.... ...+.|.+|++++++++||||++++++|.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999975 588999999975422 22457899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 278 EFVPNKTLEFHLHGK---------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 278 E~~~~g~L~~~l~~~---------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
||++|++|.+++... ....+++..+++++.||++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988531 113466788899999999999999998 99999999999999999999999999
Q ss_pred cccccCCCC-----------------cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccc
Q 008052 349 LAKHSLDTD-----------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411 (579)
Q Consensus 349 la~~~~~~~-----------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~ 411 (579)
+++...... .......+||+.|||||++.+..++.++|||||||++|||+||+.||...+...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652110 011123569999999999999999999999999999999999999997643210
Q ss_pred cchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhcC
Q 008052 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-RMSQIVRALEGN 479 (579)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-tm~evl~~Le~~ 479 (579)
+. +. ..+.++.........+..+.+++.+|++.||++|+ ++.++++.|+..
T Consensus 239 ---i~-~~-------------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ---IS-YR-------------DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ---hh-hh-------------hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 00000000000123345688999999999999996 567777777654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.20 Aligned_cols=247 Identities=28% Similarity=0.481 Sum_probs=200.9
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
++|...+.||+|+||.||+|.. +++.||+|.++... ....+.+|+.++.+++|+||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688889999999999999986 57789999986543 245788999999999999999999998764 4789999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.+++.......+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999766555689999999999999999999998 99999999999999999999999999987543211
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....+..|+|||++.++.++.++|||||||++|||++ |+.||...... ++... .. .+ .. .
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~----~~-~~--~---- 216 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VE----KG-YR--M---- 216 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-Hh----CC-CC--C----
Confidence 12234568999999998999999999999999999998 99999754421 11111 10 11 00 0
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
......+..+.+++.+|++.+|.+||++.+|+..|+.
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 -EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=319.66 Aligned_cols=269 Identities=25% Similarity=0.362 Sum_probs=206.0
Q ss_pred cCccccceecccCceEEEEEEEe-----CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~ 273 (579)
+.|...+.||+|+||.||++++. +++.||||.++..... ...+|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777799999999999999864 3688999999765543 46789999999999999999999999987 5578
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997543 2589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 354 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 354 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
...... ......++..|++||.+....++.++||||||+++|||++|+.||....... ..++.....+ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~-~~~~~ 234 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF----LRMIGIAQGQ-MIVTR 234 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh----cccccccccc-ccHHH
Confidence 432211 1112345667999999998899999999999999999999999986532211 0000000000 00000
Q ss_pred chhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 432 FDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 432 ~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+...+..... ..+......+.+++.+|++.+|.+||+|.||+++|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0001111000 11223346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.06 Aligned_cols=240 Identities=24% Similarity=0.432 Sum_probs=191.3
Q ss_pred ceecccCceEEEEEEEeC--------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 208 NLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.++.+++|+||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998642 234888888665545556788999999999999999999999998999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC--------eEEeeccccc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AKVADFGLAK 351 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~--------~kL~DFGla~ 351 (579)
+++|+|..+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999975433 589999999999999999999998 9999999999999987765 5999999987
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCC-CCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGF-RPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||...+... .... .
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~----~------ 218 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQF----Y------ 218 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHH----H------
Confidence 54322 23457889999999986 45899999999999999999985 5654433211 0000 0
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
... ..++......+.+++..||+.+|++||++++|++.|+
T Consensus 219 -------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 -------EDR-HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------Hcc-ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0112223356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=321.97 Aligned_cols=249 Identities=22% Similarity=0.363 Sum_probs=204.6
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.+|...+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||++++++|..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999996 478999999997665555667889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.. ..+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 99999998853 3478999999999999999999998 999999999999999999999999999876433221 2
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+...... ..+ ..+ . +.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~---------~~~-~-----~~~ 235 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIA---------TNG-T-----PEL 235 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eec---------cCC-C-----CCC
Confidence 233568899999999998899999999999999999999999997644311000 000 000 0 000
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+++.+||+.+|.+||++.+|++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112233456788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=316.22 Aligned_cols=250 Identities=25% Similarity=0.438 Sum_probs=200.7
Q ss_pred CccccceecccCceEEEEEEEeCCeEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+|...+.||+|+||.||+|...+++.+|||.++.... .....+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677899999999999999988899999999865321 1224688999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++... ..+.+..+..++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999998654 3478999999999999999999998 8999999999999999999999999998754221
Q ss_pred C-----cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 357 D-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 357 ~-----~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
. ........|+..|+|||++.+..++.++|||||||++|||++|+.||...+.... ..... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~-------~~~~~ 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFYIG-------AHRGL 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHHhh-------hccCC
Confidence 1 1112234689999999999988899999999999999999999999975432110 00000 00000
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. ...+......+.+++.+||+.+|.+||++.|+++
T Consensus 227 ~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 M--------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C--------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 1112234466889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=340.23 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=208.5
Q ss_pred ccccceecccCceEEEEEEEe--CCe--EEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLT--NGK--VVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~--~g~--~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
....++||+|.||.|++|.|. +|+ .||||.++.+... ...+|++|+.+|.+|+|+|+++|||+..+ ...+||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344588999999999999986 344 6899999887655 56799999999999999999999999886 67789999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
.++.|+|.+.|+......|-......++.|||.|+.||..+ ++|||||.++||||-..-.|||+||||.+.+...+.
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999999885666788889999999999999999998 999999999999998888999999999998766554
Q ss_pred ce--eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 359 HV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 359 ~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
+. .....-.+.|.|||.+...+++.++|||+|||+||||+| |..||.+..... +.+ .
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------IL~---------~ 327 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------ILK---------N 327 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------HHH---------h
Confidence 32 223345678999999999999999999999999999999 888987765421 111 1
Q ss_pred hc-hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VD-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+| ..+-..+..+.+.+.++++.||.++|.+||++..|.+
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 22 1111456778899999999999999999999999973
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.29 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=201.0
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.|+..+.||+|+||.||+|.+. +++.||+|.++... ......+.+|++++++++|+||++++++|......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566788999999999999865 57899999987543 333457889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.. ..+.+..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 99999998854 3488999999999999999999998 999999999999999999999999999976543221 1
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...+ +..+ ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~--------~~~~--------~~ 218 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL--------IPKN--------SP 218 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh--------hhcC--------CC
Confidence 223468889999999998899999999999999999999999986543211 0000 0000 00
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..........+.+++.+|++.+|.+||+|.+|++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11222345678899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=324.44 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=203.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++.+++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999976 4899999998754322 3457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+.+++|.+++.......+++..+..++.|+++||+|||+. +++||||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998765556789999999999999999999998 99999999999999999999999999987543211
Q ss_pred cc----------------------------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCc
Q 008052 358 TH----------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409 (579)
Q Consensus 358 ~~----------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~ 409 (579)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11134688999999999988999999999999999999999999975542
Q ss_pred cccchhhhhhhhHhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 008052 410 FADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPR----MSQIVR 474 (579)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPt----m~evl~ 474 (579)
.. .+ ..+.+.... .........+.+++.+|++.+|++||+ +.|+++
T Consensus 238 ~~--~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DE--TF-----------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH--HH-----------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 00 001111111 011114577999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.72 Aligned_cols=263 Identities=23% Similarity=0.351 Sum_probs=192.7
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--------
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-------- 270 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-------- 270 (579)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+|+.+|++++|+|||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999975 68899999886432 2345799999999999999999886432
Q ss_pred CeEEEEEEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeec
Q 008052 271 SQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADF 347 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DF 347 (579)
...++||||+++ +|.+++.. .....+++.....++.||+.||+|||+. +|+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 235689999986 56555432 2334689999999999999999999998 999999999999998664 7999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH----
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---- 422 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---- 422 (579)
|+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|.+||....... .+.......
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCC
Confidence 9998654322 2234568999999999865 468999999999999999999999997654311 111111000
Q ss_pred ---hh---hcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 423 ---LA---QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 423 ---~~---~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+. ..+..-.+..+....+. .++......+.+++..||+.||.+||++.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 00000000011111111 122234467899999999999999999999984
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=320.94 Aligned_cols=264 Identities=28% Similarity=0.460 Sum_probs=197.6
Q ss_pred ccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeCC----eEEEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFGS----QRLLVY 277 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~~~~----~~~lV~ 277 (579)
..+.++||+|+||.||||++. ++.||||++.. +..+.|++|-+|.+. |+|+||++++++-..+. +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 344578999999999999996 48999999965 345678888888765 57999999999876655 889999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC------QPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
||.++|+|.++|..+ .++|....+|+..+++||+|||+.. +|.|+|||||++||||..|+.+.|+|||||.
T Consensus 288 ~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999654 5899999999999999999999863 5789999999999999999999999999998
Q ss_pred ccCCCCcc-eeecccccccccChhhhccCC-CC-----cccceechHHHHHHHHhCCCCCCC--CCccc--------cch
Q 008052 352 HSLDTDTH-VSTRVMGTFGYLAPEYASSGK-LT-----EKSDVFSFGVLLLELITGFRPFDK--ADTFA--------DDS 414 (579)
Q Consensus 352 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~-~~-----~ksDVwSlGvvl~eLltG~~Pf~~--~~~~~--------~~~ 414 (579)
.+...... ..-..+||..|||||++.+.. +. .+.||||+|.|||||++...-++. ..++. ...
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 76533221 122367999999999997532 22 368999999999999996654431 11110 000
Q ss_pred hhhhhhhHhhhcccCCCchhhhchhhhc--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCC
Q 008052 415 MVDWAKPFLAQGLADGNFDALVDQKLEE--YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 482 (579)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~--~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~~ 482 (579)
-++-.+.++.+ +-..|.+.+ .....+..+.+.+..||++|++-|.|+.-|-+.+....-+
T Consensus 445 t~e~mq~~VV~--------kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 445 TLEEMQELVVR--------KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CHHHHHHHHHh--------hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 01111111110 001111110 1124567899999999999999999999999888876544
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=319.65 Aligned_cols=265 Identities=20% Similarity=0.280 Sum_probs=198.4
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|+..+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++.+++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 68899999986532 22245788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 280 VPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
++ ++|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 57877775433 25689999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh---hhcc----cCC
Q 008052 359 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL---AQGL----ADG 430 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~----~~~ 430 (579)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.||....... .+........ ...+ ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 122334578999999988654 57899999999999999999999997654211 1110000000 0000 000
Q ss_pred Cchh----hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 431 NFDA----LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 431 ~~~~----l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.. .....+.........++.+++.+||+.||.+||++.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0001111111123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=331.12 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=197.6
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 270 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------ 270 (579)
..++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3478999999999999999999864 58899999986532 22345678899999999999999999988643
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
...++||||+++ +|...+.. .+++..+..++.|+++||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 356899999976 55555532 378899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hh-------------
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MV------------- 416 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~------------- 416 (579)
+..... .......||..|+|||++.+..++.++|||||||+||||++|+.||...+...... ..
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 864332 12234578999999999998899999999999999999999999997654211100 00
Q ss_pred --hhhhhHhhhcc--cCCCchhhh-chhh---hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 417 --DWAKPFLAQGL--ADGNFDALV-DQKL---EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 417 --~~~~~~~~~~~--~~~~~~~l~-d~~l---~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.....++.... ..-.+.... +... ..........+.+++.+|++.||++||++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 000000000 0000 01112234578899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=314.28 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=200.9
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHH--HHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGER--EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~--~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
|+..+.||+|+||+||++... +++.||+|++......... ....|+.++.+++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567799999999999999976 4678999999876544332 3456999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++. ....+++..++.++.|+++||+|||+. +|+|+||||+|||++.++.++|+|||++.... .....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999997 234589999999999999999999998 99999999999999999999999999997541 22223
Q ss_pred eecccccccccChhhhc-cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....++..|+|||++. +..++.++||||||+++|+|++|..||............ .. .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~-------------~~~~~ 218 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EK-------------ILKRP 218 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HH-------------HHHTH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hh-------------ccccc
Confidence 44567899999999998 889999999999999999999999999865211111111 00 00000
Q ss_pred hh-cCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 440 LE-EYD--SAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 440 l~-~~~--~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+. ... ......+.+++..||+.||.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 000 011278999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=316.91 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=200.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.++..++|+||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999964 68899999987665555567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.... .+++.+.+.++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999886443 589999999999999999999998 99999999999999999999999999987653221 12
Q ss_pred eecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 361 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||........ +... ....+. .
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~---------~~~~~~---~ 228 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM---------TKSNFQ---P 228 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhh---------hccCCC---C
Confidence 23456899999999984 45688999999999999999999999865432110 0000 000000 0
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+... ........+.+++.+|++.+|++||++.+|++
T Consensus 229 ~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Cccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 00112345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=321.77 Aligned_cols=264 Identities=21% Similarity=0.323 Sum_probs=198.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999975 57899999986543 22234677899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
++ ++|..++.... ..+++.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 58887776432 3588999999999999999999998 999999999999999999999999999976432221
Q ss_pred eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh--------hhcccCC
Q 008052 360 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL--------AQGLADG 430 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 430 (579)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+... ........+ .......
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccc
Confidence 1223457889999999865 457889999999999999999999997654311 110000000 0000000
Q ss_pred C-----chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 431 N-----FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 431 ~-----~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. +.......+..........+.+++.+|++.||.+||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0001111111111223456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=317.53 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=203.2
Q ss_pred cCccccceecccCceEEEEEEEeC-Ce----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN-GK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~----~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++|...+.||+|+||.||+|.+.+ |. .+|+|.++.... ....++.+|+.++.+++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999999653 32 689998876543 345678899999999999999999999987 78899
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++|+|.++++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999976433 489999999999999999999997 999999999999999999999999999987543
Q ss_pred CCccee-ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~~~~-~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
...... ....++..|+|||.+....++.++|||||||++|||++ |+.||...... ++.... ..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~-----~~~~-- 228 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLL-----EKGE-- 228 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHH-----hCCC--
Confidence 322211 11224568999999988899999999999999999999 99999764321 111111 0110
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++.+||..+|..||++.++++.|+..
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011112335688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=319.67 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=201.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||+|+||.||++... +++.||+|.++... ......+.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999976 68999999887542 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 280 VPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
+++++|..+++... ...+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999998886532 235899999999999999999999642 8999999999999999999999999998764322
Q ss_pred ceeecccccccccChhhhccCC------CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~------~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||...... ....- +
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~-------------~ 219 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQ-------------L 219 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHH-------------H
Confidence 123345888999999986543 588999999999999999999999653321 11000 0
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.+......+......+.+++.+|++.+|.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 220 SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111111112233445677899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=318.56 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=205.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||+|+||.||++... +++.||+|++.... ......+.+|++++..++|+||+++++++.....++|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56777899999999999999965 68899999886543 23356889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|..++... ..+.+.....++.+++.+|.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 9999999888653 35899999999999999999999742 79999999999999999999999999987542221
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcccc-----chhhhhhhhHhhhcccCCCchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-----DSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
.....|+..|+|||++.++.++.++|||||||++|+|++|+.||.......+ ..+.++.....
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 226 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV----------- 226 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-----------
Confidence 2345689999999999888999999999999999999999999986543211 11112211111
Q ss_pred hhchhhhcCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 435 LVDQKLEEYD-SAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 435 l~d~~l~~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
........ ......+.+++.+|++.||.+||++.||++.+
T Consensus 227 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 --QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111 12446788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=331.79 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=197.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~ 271 (579)
.++|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++|+||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999964 57899999986532 23345678899999999999999999987543 3
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+++ +|...+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 57899999976 56665532 378889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchh-h--------hh---h
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM-V--------DW---A 419 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~-~--------~~---~ 419 (579)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||...+....... . ++ .
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 643321 22345689999999999999999999999999999999999999976543211000 0 00 0
Q ss_pred hhHhhhcc------cCCCchhhhchhhh----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 420 KPFLAQGL------ADGNFDALVDQKLE----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 420 ~~~~~~~~------~~~~~~~l~d~~l~----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...+.... ..-.+..+....+. .........+.+++.+|++.||.+||++.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 00000011000000 1111223568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=315.78 Aligned_cols=253 Identities=24% Similarity=0.421 Sum_probs=200.8
Q ss_pred CccccceecccCceEEEEEEEeC--CeEEEEEEeccC----------CchhHHHHHHHHHHHHh-cCCCCcceEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAG----------SGQGEREFQAEIEIISQ-VHHRHLVSLVGYCTF 269 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~l~~~----------~~~~~~~~~~Ei~~l~~-l~Hpniv~l~g~~~~ 269 (579)
+|+..+.||+|+||.||+|.+.. ++.+|||.+... ......++.+|+.++.+ ++|+||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999999765 688999987532 12223457788888875 789999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
++..++||||+++++|.+++.. .....+++..+++++.|++.||.|||+.. +|+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999887743 22345889999999999999999999632 7999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
|++....... ......|+..|++||.+.++.++.++||||||+++|||++|+.||...+.. .......
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~---- 226 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKIV---- 226 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHHh----
Confidence 9998654432 233456899999999999888999999999999999999999999654321 1111100
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
.+..... . .......+.+++.+|++.||.+||++.||..+|+
T Consensus 227 -~~~~~~~----~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 -EAVYEPL----P---EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -hccCCcC----C---cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111100 0 1123456889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.02 Aligned_cols=249 Identities=20% Similarity=0.372 Sum_probs=204.3
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.+|+..+.||.|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 468999999987655555677899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|..++.. ..+++.+++.++.+++.||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 99999998853 2489999999999999999999998 999999999999999999999999999876433221 2
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... +..+ . ..... .+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~----~-----~~~~~-----~~ 235 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI----A-----TNGTP-----EL 235 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH----H-----hcCCc-----cc
Confidence 2334688999999999988899999999999999999999999976543211 0000 0 00000 00
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+......+.+++.+||..||.+||++.+|+.
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112233456888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.74 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=203.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
..|+..+.||.|+||.||+|... +++.||||.++... ......+.+|+.+++++.|+||++++++|..+...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667789999999999999975 58899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999998864 2478889999999999999999998 999999999999999999999999999976543221
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......++..|+|||++.+..++.++|||||||++|||++|..||........ .. ..... .
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~--------~~~~~--------~ 217 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---LF--------LIPKN--------N 217 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---hh--------hhhcC--------C
Confidence 22334688899999999988999999999999999999999999975432110 00 00000 0
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...........+.+++..||+.+|.+||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 112334566778999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=311.71 Aligned_cols=247 Identities=25% Similarity=0.431 Sum_probs=201.1
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+|...+.||+|+||.||+|+.. +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 78999999986533 22346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
+||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999998654 3488999999999999999999998 9999999999999999999999999998765332
Q ss_pred CcceeecccccccccChhhhccCC-CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||...... .....+.. ...
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~--------~~~---- 219 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIGR--------SKE---- 219 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHHHh--------ccc----
Confidence 2 223456899999999998766 899999999999999999999999754321 11111100 000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+...+......+.+++.+|++.+|.+||++.++++
T Consensus 220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01122233466788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=311.62 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=202.6
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|+..+.||+|+||.||++... +++.+|||.+.... ......+.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 67899999986532 23356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeecccccccCCCCc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFGla~~~~~~~~ 358 (579)
+++++|.+++.......+++..+++++.+++++|+|||++ +|+|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999765555689999999999999999999998 99999999999999865 468999999998654322
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ....+. . .+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~-----~~~~------ 218 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---M-----SGTF------ 218 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---H-----hcCC------
Confidence 122356889999999999888999999999999999999999999754421 111111 0 0001
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..........+.+++..||+.+|.+||++.|+++.
T Consensus 219 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 --APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01122234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.11 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=205.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
++|...+.||.|+||.||+|... +++.+++|.+..........+.+|++++++++|+||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67888999999999999999975 57889999998765556678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++....... ..
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999999886542 3588999999999999999999998 99999999999999999999999999987643321 12
Q ss_pred eecccccccccChhhhccC---CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 361 STRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~---~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....++..|+|||.+... .++.++|||||||++|||++|+.||....... ...... ...+ ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~~---------~~~~---~~ 223 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLIS---------KSNF---PP 223 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---------hccC---CC
Confidence 2335688899999999776 88999999999999999999999997644211 110000 0000 00
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+ .........+.+++.+|+..+|.+||++.+|+.
T Consensus 224 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKL-KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc-cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 122334567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=311.37 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=205.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||.|+||.||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 67899999986543 23456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 280 VPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
+++++|.+++..... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999875432 4689999999999999999999998 999999999999999999999999999876554332
Q ss_pred c---eeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 359 H---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 359 ~---~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
. ......|+..|++||++... .++.++|||||||++|||++|+.||....... ....+.. .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~---------~---- 222 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ---------N---- 222 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc---------C----
Confidence 2 22334689999999999877 78999999999999999999999997554311 1111100 0
Q ss_pred hhchhhhc--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEE--YDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~--~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.+.. ........+.+++..|++.||.+||++.+|++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 -DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011110 01234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=318.23 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=204.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|.+.+.||.|+||.||+|... +++.||+|.++.........|.+|++++++++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999975 6889999999876655667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|..++.... ..+++.....++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999999886533 3589999999999999999999998 999999999999999999999999999876433221
Q ss_pred eeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 360 VSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
......++..|++||++. ...++.++|||||||++|||++|+.||...+... .+..+. .+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~~---------~~~~-- 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKIL---------KSEP-- 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHHh---------cCCC--
Confidence 223356899999999985 3457789999999999999999999997543211 111110 0000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+.+ ..+......+.+++..||+.+|.+||++.+|++.
T Consensus 226 ---~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ---PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 1112234568899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.10 Aligned_cols=236 Identities=25% Similarity=0.328 Sum_probs=183.7
Q ss_pred ecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV---HHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
||+|+||.||+|+.. +++.||||++..... .....+..|..++.++ +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 588999999864321 1223445677777665 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|..++... ..+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 9999888643 3589999999999999999999998 999999999999999999999999999875432221 233
Q ss_pred cccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 363 RVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
..+||..|+|||++.+. .++.++|||||||+||||++|+.||...+.. ..... +..+.. .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~-----i~~~~~------~~~ 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRN-----IAFGKV------RFP 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHH-----HHcCCC------CCC
Confidence 46799999999998754 4899999999999999999999999754321 00000 001110 000
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMS 470 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 470 (579)
.......+.+++.+||+.||.+||++.
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 011235678899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=318.93 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=203.4
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEE--
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCT-- 268 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~-- 268 (579)
.++.+..+.++|+..+.||+|+||.||++... +++.+|+|+++.... ...++.+|+.++.++ +|+||++++++|.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556667889999999999999999999965 578999998865332 245788999999999 6999999999984
Q ss_pred ---eCCeEEEEEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeE
Q 008052 269 ---FGSQRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (579)
Q Consensus 269 ---~~~~~~lV~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~k 343 (579)
.++..++||||+++++|.++++.. ....+++..+..++.|+++||.|||+. +|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 345689999999999999877532 234588999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCcceeecccccccccChhhhcc-----CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhh
Q 008052 344 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 418 (579)
Q Consensus 344 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~ 418 (579)
|+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+..+
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~~ 241 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFKI 241 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhhc
Confidence 999999876533221 2233468999999999853 457889999999999999999999997543211 00000
Q ss_pred hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 419 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
.......+. .+......+.+++.+|++.+|.+||++.||++.+
T Consensus 242 ---------~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 ---------PRNPPPTLH------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---------cccCCCccc------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000000000 1111234688999999999999999999999753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=313.33 Aligned_cols=264 Identities=24% Similarity=0.330 Sum_probs=219.8
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEE
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVG 265 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g 265 (579)
...||.+..++++...++-+|.||.||+|.|.+ .+.|-||.++....+ ....|+.|..++..+.|||+..+.|
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 456788888899999999999999999997643 456778888776443 3457889999999999999999999
Q ss_pred EEEeC-CeEEEEEEecCCCchhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC
Q 008052 266 YCTFG-SQRLLVYEFVPNKTLEFHLHG------KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (579)
Q Consensus 266 ~~~~~-~~~~lV~E~~~~g~L~~~l~~------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~ 338 (579)
+|.++ +..+.+|.++.-|+|..+|.. +....+...+...++.|++.|++|||.+ +|||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 99774 466889999999999999862 2234577788899999999999999999 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCcceeec-ccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhh
Q 008052 339 SFEAKVADFGLAKHSLDTDTHVSTR-VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMV 416 (579)
Q Consensus 339 ~~~~kL~DFGla~~~~~~~~~~~~~-~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~ 416 (579)
..++||+|-.|++.....+.+.... ......||++|.+....|+..+|||||||+||||+| |+.||...++++..
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--- 508 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--- 508 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH---
Confidence 9999999999999888777765443 345679999999999999999999999999999999 99999888764311
Q ss_pred hhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 417 DWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
.+ +.|...-..+.+++.+|..++..||+..|++||+++|++.-|.+
T Consensus 509 ----~y------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 ----HY------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----HH------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11 12221113455788899999999999999999999999998864
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=319.04 Aligned_cols=196 Identities=23% Similarity=0.328 Sum_probs=160.0
Q ss_pred cceecccCceEEEEEEEe---CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEEEecC
Q 008052 207 ANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVYEFVP 281 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV~E~~~ 281 (579)
.+.||+|+||.||+|+.. +++.||+|.++.... ...+.+|+.+|++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999964 467899999865432 3457889999999999999999998854 456789999986
Q ss_pred CCchhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe----CCCCCeEEeecccc
Q 008052 282 NKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLA 350 (579)
Q Consensus 282 ~g~L~~~l~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl----~~~~~~kL~DFGla 350 (579)
+ +|.+++... ....+++.....|+.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 676665321 123488889999999999999999998 99999999999999 45678999999999
Q ss_pred cccCCCCc--ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 351 KHSLDTDT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 351 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 86543221 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.38 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=189.4
Q ss_pred eecccCceEEEEEEEeC---CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCc
Q 008052 209 LLGQGGFGYVHKGVLTN---GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~ 284 (579)
.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999998643 3568888876543 2334578899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc-e
Q 008052 285 LEFHLHGKDR---PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-V 360 (579)
Q Consensus 285 L~~~l~~~~~---~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 360 (579)
|.+++..... ....+...+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 2356788899999999999999998 9999999999999999999999999998754332211 1
Q ss_pred eecccccccccChhhhcc-------CCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 361 STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~-------~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....... .. ...+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~-------~~~~~~~~- 227 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VL-------KQVVREQD- 227 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH-------HHHhhccC-
Confidence 123346778999998743 356889999999999999999 788886543211 00 00001111
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
..+.++. ........+.+++..|+ .||++||++.+|++.|.
T Consensus 228 ~~~~~~~---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCc---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111111 12233455667778888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=333.67 Aligned_cols=264 Identities=20% Similarity=0.233 Sum_probs=198.4
Q ss_pred hcCccccceecccCceEEEEEEEe---CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
..+|.+.+.||+|+||.||++... .++.||||.+... ..+.+|+++|++++|+|||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999853 3578999988643 24568999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|++. ++|..++.. ...+++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 577777733 34589999999999999999999998 99999999999999999999999999997654332
Q ss_pred cc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhhhhhHhhhc--ccCCC--
Q 008052 358 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQG--LADGN-- 431 (579)
Q Consensus 358 ~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~--~~~~~-- 431 (579)
.. ......||..|+|||++....++.++|||||||+||||++|+.||......... .+....+..-... +....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 223457999999999999999999999999999999999999999765432111 1111000000000 00000
Q ss_pred -c----hhhhchhhhcC-------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 432 -F----DALVDQKLEEY-------DSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 432 -~----~~l~d~~l~~~-------~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+ ..........+ .......+.+++..||+.||.+||++.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000000 01123467889999999999999999999864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.78 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=202.4
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|...+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999965 68899999987543 23346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+ +++|.+++.... ..+++.+++.++.|++++|+|||+. +|+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999886543 4589999999999999999999998 9999999999999999999999999999875443322
Q ss_pred eeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh--------hcccCC
Q 008052 360 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA--------QGLADG 430 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 430 (579)
......|+..|+|||.+.+. .++.++|||||||++|||++|.++|...... ....+....+. ......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 23345689999999998654 4689999999999999999998888654321 11111100000 000000
Q ss_pred Cchhhhc-----hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 431 NFDALVD-----QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 431 ~~~~l~d-----~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+..+.. ..+.....+....+.+++.+|++.+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 00111112234788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.87 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=194.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-----GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~ 273 (579)
.+|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999964 58899999886432 1223468889999999999999999998875 3567
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999986533 488999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCc--ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 354 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 354 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...+... .. .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~-~~~~----~~~- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AI-FKIA----TQP- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HH-HHHh----cCC-
Confidence 32111 11123458899999999998889999999999999999999999997543210 00 0000 000
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. ..++......+..++ .|+..+|++||+|+||++
T Consensus 226 ----~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ----TN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00 122223334556666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.81 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=205.4
Q ss_pred cCHHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 008052 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (579)
Q Consensus 192 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 269 (579)
+...++..+.++|...+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++ +|+|+++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455667777899999999999999999999974 688999999865432 245678899999999 79999999999875
Q ss_pred C-----CeEEEEEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 270 G-----SQRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 270 ~-----~~~~lV~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
. +..++||||+++++|.++++.. ....+.+..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 3579999999999999887532 234589999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCC-----CCcccceechHHHHHHHHhCCCCCCCCCccccchhhh
Q 008052 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK-----LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~ 417 (579)
||+|||++........ ......|+..|+|||++..+. ++.++|||||||++|||++|+.||...... ..+..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK 244 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH
Confidence 9999999886533221 122346889999999986443 689999999999999999999999754321 11111
Q ss_pred hhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 418 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+.+ +....+ .........+.+++.+|++.+|++||++.|+++.
T Consensus 245 ~~~---------~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPR---------NPPPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Hhc---------CCCCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 110 000000 0112233568999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.37 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=198.4
Q ss_pred ccccceecccCceEEEEEEEe----CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 008052 204 FSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 271 (579)
|.+.+.||+|+||.||+|.+. .++.||||+++... ....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999864 36889999987542 233567889999999999999999999986542
Q ss_pred eEEEEEEecCCCchhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 272 QRLLVYEFVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
..++++||+.+|+|..++... ....+++...++++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 237899999999998876422 122478899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhh
Q 008052 348 GLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQ 425 (579)
Q Consensus 348 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 425 (579)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||...+. ..+..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHc----
Confidence 999865332211 1122345678999999998899999999999999999999 8899865432 111111100
Q ss_pred cccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 426 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.... .........+.+++.+|++.+|.+||++.||++.|++.
T Consensus 231 ---~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 ---GNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 11122346799999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=321.55 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=200.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCe----EEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.++|...+.||+|+||.||+|++. ++. .||+|.+..... ....++.+|+.++.+++|+||++++|+|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356778899999999999999864 343 578898875433 2234788999999999999999999999754 467
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+++||+++|+|.+++.... ..+.+..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999986543 3488999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 355 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 355 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.++.. .+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~~--------~~~~ 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLLE--------KGER 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--------CCCC
Confidence 32221 1122345778999999998899999999999999999997 9999965432 11112111 0000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+ .........+.+++..|+..+|++||+|.+|++.|+..
T Consensus 230 -------~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 -------L-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -------C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01112335688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.40 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=203.9
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe-
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF- 269 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~- 269 (579)
++.++..+.+.|+..+.||.|+||.||+|... +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44566667788999999999999999999974 68899999986543 2345788899999998 69999999999853
Q ss_pred -----CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEE
Q 008052 270 -----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (579)
Q Consensus 270 -----~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL 344 (579)
....+++|||+++|+|.+++.......+.+..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999988765555688888999999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCcceeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhh
Q 008052 345 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 419 (579)
Q Consensus 345 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~ 419 (579)
+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|..||.............
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-- 239 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-- 239 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh--
Confidence 99999876432221 123356899999999986 3568889999999999999999999996543211100000
Q ss_pred hhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 420 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...... .........+.+++.+||+.||.+||++.||++
T Consensus 240 --------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 --------------RNPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --------------hCCCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 011123457899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.73 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=201.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 58999999986432 2234567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|..++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99999998876543 3489999999999999999999998 999999999999999999999999999987543321
Q ss_pred ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH---hh---hcccCCC
Q 008052 359 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---LA---QGLADGN 431 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~---~~~~~~~ 431 (579)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+..+.... .. ..+....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhccccc
Confidence 1223457889999999875 568899999999999999999999997654321 111111000 00 0000000
Q ss_pred -chhhhchhhh------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 -FDALVDQKLE------EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 -~~~l~d~~l~------~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+..+..+... .........+.+++.+|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000011110 011123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.06 Aligned_cols=251 Identities=27% Similarity=0.465 Sum_probs=202.4
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|...+.||+|+||.||+|... +++.|++|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999965 6889999998765443 567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++... ..+++..+..|+.++++||.|||+. +|+|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998654 3478999999999999999999998 9999999999999999999999999999876443332
Q ss_pred eee---cccccccccChhhhccCC---CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 360 VST---RVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 360 ~~~---~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
... ...++..|++||++.... ++.++||||||+++|||++|+.||...+. .|...+... .+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~~~~~~---~~~-- 223 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQIMFHVG---AGH-- 223 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHHHHHHh---cCC--
Confidence 211 346788999999998766 89999999999999999999999975431 111111000 000
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.+. ........+.+++.+|++.+|.+||++.+++.
T Consensus 224 ---~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00011 11122556789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.88 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=189.3
Q ss_pred ceecccCceEEEEEEEeCC---eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 208 NLLGQGGFGYVHKGVLTNG---KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
+.||+|+||.||+|...++ ..+++|.++... ....+.|.+|+.++++++||||++++++|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986543 346677766543 234568999999999999999999999999999999999999999
Q ss_pred chhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC-cce
Q 008052 284 TLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-THV 360 (579)
Q Consensus 284 ~L~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~-~~~ 360 (579)
+|.++++... ...+.+.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999987532 23466777889999999999999998 99999999999999999999999999986432211 112
Q ss_pred eecccccccccChhhhcc-------CCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 361 STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~-------~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... ++....+. +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~-----~~~ 226 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK-----DQQ 226 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh-----hcc
Confidence 234568899999999853 245789999999999999997 56788643321 11111111 111
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
..+.++.+. ......+.+++..|+ .+|.+||++.||++.|.
T Consensus 227 ~~~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 VKLFKPQLE---LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccCCCccC---CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 112222222 112346777888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=311.67 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=202.7
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++|+||++++++|......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999975 57889999986532 22345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeecccccccCCCCc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGla~~~~~~~~ 358 (579)
+++++|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||++++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999998765555689999999999999999999998 999999999999999885 469999999876543221
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+. .++..... .+..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-----~~~~------ 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-----QGYF------ 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-----cccC------
Confidence 22334589999999999988899999999999999999999999965432 11111111 1111
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..........+.+++.+|++.+|++||++.||++.
T Consensus 220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 --APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11112234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.18 Aligned_cols=193 Identities=23% Similarity=0.330 Sum_probs=164.7
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
....+|...+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||++++++|......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34467999999999999999999976 4678999975432 2356899999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+. ++|..++... ...++|..++.|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9995 5777777543 34589999999999999999999998 99999999999999999999999999997532221
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCC
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf 404 (579)
......||..|+|||++.+..++.++|||||||+||||+++..++
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456999999999999999999999999999999999965554
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.24 Aligned_cols=267 Identities=20% Similarity=0.325 Sum_probs=197.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888999999999999999975 6889999998654322 234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+.+ +|.+++..... .+.+.....++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 985 89888865433 588999999999999999999998 99999999999999999999999999987542211 1
Q ss_pred eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhh-----------hhhhhHhhhcc
Q 008052 360 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-----------DWAKPFLAQGL 427 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~-----------~~~~~~~~~~~ 427 (579)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......+.... .|.........
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1222346889999999875 45889999999999999999999999654421110000 00000000000
Q ss_pred cCCCchhhhchhhhcC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 428 ADGNFDALVDQKLEEY--DSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~--~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
............+... .......+.+++..|++.+|.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000111100 0111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=355.41 Aligned_cols=260 Identities=22% Similarity=0.339 Sum_probs=200.0
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQR 273 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~ 273 (579)
...++|.+.+.||+|+||.||++... .++.||+|.+.... ......|..|+.+|.+|+|||||+++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34478999999999999999999975 57789999986532 2334678899999999999999999998865 3568
Q ss_pred EEEEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CceEeCCCCCCceEeCCC--------
Q 008052 274 LLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQ----PKIIHRDIKSANILLDDS-------- 339 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~----~~ivHrDikp~NILl~~~-------- 339 (579)
+|||||+++|+|..+|... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999988642 12458999999999999999999998521 259999999999999642
Q ss_pred ---------CCeEEeecccccccCCCCcceeecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 340 ---------FEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 340 ---------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
+.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998653221 2234579999999999854 458899999999999999999999997543
Q ss_pred ccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH--HHHhcC
Q 008052 409 TFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV--RALEGN 479 (579)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl--~~Le~~ 479 (579)
.. ..+... + ... +.+. .......+.+|+..||+.+|.+||++.|++ ..|...
T Consensus 248 ~~-----~qli~~-l----k~~-------p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 NF-----SQLISE-L----KRG-------PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cH-----HHHHHH-H----hcC-------CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 21 111110 0 000 0000 011245688999999999999999999998 345433
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.41 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=200.8
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC------
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS------ 271 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~------ 271 (579)
.+++|+..+.||+|+||.||+|... +++.+++|.+..... ....+.+|+.+++++ +|+||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4578999999999999999999975 578899999876543 346789999999999 6999999999997644
Q ss_pred eEEEEEEecCCCchhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGl 349 (579)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998886533 35689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhcc-----CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
+........ ......|+..|+|||++.. ..++.++|||||||+||+|++|+.||...... ..+...
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~------ 230 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKI------ 230 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHh------
Confidence 876433221 2233568999999998853 34678999999999999999999999643321 011100
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.... + .........+.+++.+||..||.+||++.||++
T Consensus 231 ---~~~~~~~-----~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 ---PRNPPPT-----L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---hccCCCC-----C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000000 0 112234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=317.58 Aligned_cols=196 Identities=23% Similarity=0.329 Sum_probs=159.5
Q ss_pred cceecccCceEEEEEEEe---CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEEEecC
Q 008052 207 ANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVYEFVP 281 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV~E~~~ 281 (579)
...||+|+||.||+|+.. +++.||+|.++.... ...+.+|+.+|++++|+||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999965 357899999865432 3467889999999999999999999854 457789999997
Q ss_pred CCchhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe----CCCCCeEEeecccc
Q 008052 282 NKTLEFHLHGK-------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLA 350 (579)
Q Consensus 282 ~g~L~~~l~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl----~~~~~~kL~DFGla 350 (579)
+ +|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 665555321 123478889999999999999999998 99999999999999 56678999999999
Q ss_pred cccCCCCcc--eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 351 KHSLDTDTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 351 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 865433221 1234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.45 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=202.2
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVY 277 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV~ 277 (579)
+|+..+.||.|+||.||++... +++.||+|.++... ....+.+..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999864 67899999986532 3334578899999999999999999998764 45678999
Q ss_pred EecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 278 EFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDC--QPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 278 E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
||+++++|.+++... ....+++..++.++.|+++||+|||..+ ..+|+|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999888642 2346899999999999999999999322 239999999999999999999999999999875
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
..... ......++..|++||++....++.++||||||+++|+|++|+.||...+. ..+... +..+.
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~--------~~~~~-- 226 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASK--------IKEGK-- 226 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHH--------HhcCC--
Confidence 44332 12335689999999999988899999999999999999999999976542 111111 11111
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
....+......+.+++.+|++.+|.+||++.+|++.
T Consensus 227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112333455778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.50 Aligned_cols=265 Identities=24% Similarity=0.359 Sum_probs=204.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|+..+.||+|+||.||+|... +++.||||.++... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 57899999986532 2234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|++++.|..++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99998887665432 3489999999999999999999998 999999999999999999999999999987654433
Q ss_pred ceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh-------hhcc-cC
Q 008052 359 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL-------AQGL-AD 429 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~-~~ 429 (579)
.......++..|+|||++.+. .++.++||||||++||+|++|+.||......+ ........+ ...+ ..
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcccC
Confidence 233446688999999999888 88999999999999999999999997543211 000000000 0000 00
Q ss_pred CCc-----hhhhchh-hh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 430 GNF-----DALVDQK-LE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 430 ~~~-----~~l~d~~-l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+ ....+.. .. .++......+.+++.+||..+|++||++++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000000 01 223334678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=307.31 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=207.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||+|+||.||+++.. +++.|+||++..... .....+.+|+.++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 489999999876544 3457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
+++++|.+++... ..+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999654 458999999999999999999999 8 999999999999999999999999999986543322
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
. .....++..|+|||.+....++.++||||||+++|||++|+.||..........+..+. ...
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----------------~~~ 218 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----------------CDG 218 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----------------hcC
Confidence 2 22456889999999999999999999999999999999999999765421111111111 111
Q ss_pred hhhcCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 439 KLEEYDSA-EMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 439 ~l~~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
........ ....+.+++.+|++.+|.+||++.|+++
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11112222 4568999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.81 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=201.0
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch-----hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-----GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+|...+.||+|+||.||+|... +++.||||.++..... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999965 6889999999765322 234577899999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+ +++|..++.... ..+++..++.++.|+++||.|||++ +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997544 3589999999999999999999998 9999999999999999999999999999865433
Q ss_pred CcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH---hhhcc-----
Q 008052 357 DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---LAQGL----- 427 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~----- 427 (579)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|....... .+....... ....+
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhccc
Confidence 22 1223456888999999864 467899999999999999999988876543211 010000000 00000
Q ss_pred --cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 428 --ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 428 --~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
............+..........+.+++.+|++.+|.+||++.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000011111222345678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=318.57 Aligned_cols=267 Identities=25% Similarity=0.375 Sum_probs=200.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++|+||++++++|...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999976 588999999864322 234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|..+.... ..++|..++.++.|+++||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999998876543 2489999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCcccc-chhhhhhhhHhhh---cccCCC-c
Q 008052 359 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQ---GLADGN-F 432 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~---~~~~~~-~ 432 (579)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+..+...+... .+.... +
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22234568899999999875 4578899999999999999999999965432110 0001100000000 000000 0
Q ss_pred hhhhchhh------hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 433 DALVDQKL------EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 433 ~~l~d~~l------~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.....+.. ..........+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 0011233567899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=309.14 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~ 273 (579)
++|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999975 58899999885322 12235788899999999999999999988763 467
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++... ..+++...++++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999988643 3478888999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc--ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 354 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 354 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~-~~~-------- 222 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AIF-KIA-------- 222 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HHH-HHh--------
Confidence 32111 11223468899999999988889999999999999999999999996542210 000 000
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+.....+......+.+++.+|+. +|++||+++||++.
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 ----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000112233445667888899985 89999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.35 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=199.0
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch----------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ----------GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~----------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 271 (579)
+|...+.||.|+||.||+|... +++.||||.++..... ..+.+.+|+.++.+++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999864 6889999988542111 1235788999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999998654 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcc-eeecccccccccChhhhccCC--CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhccc
Q 008052 352 HSLDTDTH-VSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 352 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 428 (579)
........ ......|+..|+|||++.... ++.++||||||+++|||++|..||...+.. ..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~--------- 225 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMFKLG--------- 225 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHHHhh---------
Confidence 64332211 123346889999999987654 889999999999999999999999643321 0000000
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.......+. ..........+.+++..|++.+|.+||++.+|++.
T Consensus 226 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 NKRSAPPIP---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccCCcCC---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000000 01112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=311.57 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=204.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|+..+.||.|+||.||++... +++.||+|.+..... ....++.+|++++++++|+||++++++|...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999976 588999999876533 3456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
+++++|.+++.... ..+++....+++.|++.+|+|||+ . +++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999986543 458889999999999999999999 6 999999999999999999999999999876532221
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
....++..|+|||++.+..++.++||||||+++|+|++|+.||...+.. .....+...... ..
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-------------~~ 219 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIV-------------NE 219 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHh-------------cC
Confidence 1266889999999999999999999999999999999999999755321 111222221111 10
Q ss_pred hhhcCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 439 KLEEYDSA-EMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 439 ~l~~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
........ ....+.+++..|+..+|.+||++.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00111111 4566899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=319.75 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=209.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+-|.+.+.||+|.|..|-++++- .|..||||++.+..-. ....+.+|+..|+.++|||||+||.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34677789999999999999853 7999999999664332 34568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe-CCCCCeEEeecccccccCCCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-DDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl-~~~~~~kL~DFGla~~~~~~~ 357 (579)
.-++|+|.+++.... ..+.+....+++.||..++.|+|+. .+|||||||+||.+ .+-|-|||+|||++..+...
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG- 172 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence 999999999997554 3488888899999999999999998 89999999999987 55689999999999876443
Q ss_pred cceeecccccccccChhhhccCCCC-cccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
...++.||+..|-|||.+.+..|+ +++||||||||||.|+||+.||...+... .+..++
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------------TLTmIm 232 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------------TLTMIM 232 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------------hhhhhh
Confidence 345678999999999999998887 57899999999999999999998766422 233444
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
|-.. ..+.....+..+||..||..||.+|.+.+||+.
T Consensus 233 DCKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4333 345667788999999999999999999999985
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.02 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=199.7
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|+..+.||.|+||.||+|+.. +++.||||+++.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999975 688999999865432 2235788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+. ++|..++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 6888888765556789999999999999999999998 999999999999999999999999999876433221
Q ss_pred eeecccccccccChhhhccCC-CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhh------c---c--
Q 008052 360 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ------G---L-- 427 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~------~---~-- 427 (579)
......++..|+|||++.+.. ++.++|||||||++|||+||+.||....... .+.......... . +
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 123345788999999887644 6889999999999999999999997544211 111111000000 0 0
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+.......+..........+.+++.+|++.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000011111111122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.21 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=199.3
Q ss_pred cccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
.....||+|+||.||++... +++.||+|.+..........+.+|+.++..++||||++++++|..++..++||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999965 68899999987655455567889999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeec
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 363 (579)
+|..++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 104 ~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 104 ALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred CHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 99987743 3489999999999999999999998 99999999999999999999999999987543322 12233
Q ss_pred ccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcC
Q 008052 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 443 (579)
Q Consensus 364 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 443 (579)
..|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...... ... .... ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~--------~~~-----~~~~-~~ 239 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLR--------DSP-----PPKL-KN 239 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh--------ccC-----CCCc-cc
Confidence 568999999999998899999999999999999999999997543211 111100 000 0000 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 444 DSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 444 ~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.......+.+++..|++.+|.+||++.+|++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11223567899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.83 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=198.0
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRLLV 276 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~~lV 276 (579)
.|...+++|.|.||.||+|++. +++.||||+.-.+.. .-.+|+++|+++.|||||+|+-+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4667799999999999999975 578999999865543 2246899999999999999998886532 23489
Q ss_pred EEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeeccccccc
Q 008052 277 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHS 353 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFGla~~~ 353 (579)
||||+. +|...++. ..+..++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999977 77776652 1234577777777899999999999997 99999999999999976 89999999999987
Q ss_pred CCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhc---c--
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQG---L-- 427 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~-- 427 (579)
...... .....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+... .+.++..++-+.... +
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhh
Confidence 655433 44568899999999875 5799999999999999999999999987553 344444433222110 0
Q ss_pred -----cCCCchhhhchhhhc-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 428 -----ADGNFDALVDQKLEE-YDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 428 -----~~~~~~~l~d~~l~~-~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+..+..+....... +........++++.++++.+|.+|-++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011112222222222 34455678999999999999999999999874
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.01 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=199.2
Q ss_pred cccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
.....||+|+||.||++... +++.||||.+........+.+.+|+.++.+++|+||+++++.+..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33467999999999999864 58899999987655555667889999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeec
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 363 (579)
+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++........ ....
T Consensus 105 ~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 105 ALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 99998853 2488999999999999999999998 999999999999999999999999999875433221 2233
Q ss_pred ccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcC
Q 008052 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEY 443 (579)
Q Consensus 364 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~ 443 (579)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...+... .+.. +. ..+...+. .
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~-----~~---------~~~~~~~~-~ 240 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRR-----IR---------DNLPPRVK-D 240 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HH---------hcCCCccc-c
Confidence 568999999999998899999999999999999999999997543211 0000 00 00111111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 444 DSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 444 ~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.......+.+++..|++.||.+||++.|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234467889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.39 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=202.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||++... .++.||+|.++.... .....+.+|++++.+++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999975 578999999876532 22456789999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++... ..+++.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999654 3589999999999999999999998 99999999999999999999999999987421110
Q ss_pred --------------cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 358 --------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 358 --------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
........++..|+|||++....++.++|+|||||++|||++|..||...... ++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 00112245788999999999889999999999999999999999999754321 1111100
Q ss_pred hhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 424 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
.+.. ..+. ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 -----~~~~---~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 -----SDDI---EWPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -----hccc---CCCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 0000 011234568999999999999999998777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.54 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=196.3
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 270 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------ 270 (579)
..++|...+.||+|+||.||+|... +++.||||+++.... .....+.+|+.+|++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999964 678999999865322 2335677899999999999999999987543
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
...++++|++ +++|..++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 3568999988 7888877743 3489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh------Hh
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP------FL 423 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~------~~ 423 (579)
+..... .....||..|+|||++.+ ..++.++|||||||+||||++|+.||...+... .+..+... ..
T Consensus 166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSPEV 239 (343)
T ss_pred eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence 865332 234568999999999876 578999999999999999999999997644211 11111000 00
Q ss_pred hhcccCCCchhhhc-------hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 424 AQGLADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 424 ~~~~~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...+........+. ..+..........+.+++.+|++.||.+||++.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 00000001122357899999999999999999999953
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=302.95 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=204.9
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
+|...+.||+|+||.||++... +++.+++|++..........+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999976 688999999977655556789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.+++.... ..+++..+..++.+++.+|.|||+. +++||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999886543 4589999999999999999999997 999999999999999999999999999987544322 2
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
....++..|++||++....++.++||||||+++|+|++|+.||....... .+ .... ......+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~-~~~~--------~~~~~~~------ 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--AL-FKIA--------TNGPPGL------ 217 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HH-HHHH--------hcCCCCc------
Confidence 34568899999999998889999999999999999999999997543211 00 0000 0000000
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+++.+|++.||.+||++.|+++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011112467899999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.67 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=198.9
Q ss_pred CccccceecccCceEEEEEEE-eCCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
-|..++.||.|+||-||.++. .+.++||||++....++ .+.++..||..|.+|+|||+|.+.|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 377788999999999999995 47889999999765433 45688999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
||- |+-.++|.-. .+.|...++..|+.+.+.||+|||++ +.||||||+.||||++.|.|||+|||.+.....
T Consensus 107 YCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 994 4556666433 24588889999999999999999999 999999999999999999999999999876543
Q ss_pred ceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 359 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
...++||+.|||||++. .|.|+-|+||||||++..||.-.++|+-..+... .+...+ ..
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYHIA---------QN----- 240 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA---------QN----- 240 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHHHH---------hc-----
Confidence 34578999999999874 6899999999999999999999999986554311 111111 10
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
-.|.|. ..+....++.++..||++-|.+||+..++++
T Consensus 241 esPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 112222 2344567899999999999999999998864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=310.63 Aligned_cols=247 Identities=24% Similarity=0.432 Sum_probs=199.3
Q ss_pred CccccceecccCceEEEEEEE-eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.|+..+.||+|+||.||+|.. .+++.||||.++... .....++.+|+.++++++ |+|+++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 468899999986542 334567889999999997 999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++... .+++...+.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988543 589999999999999999999998 99999999999999999999999999998764433
Q ss_pred cceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
. ......|+..|+|||++..+ .++.++|||||||++|+|++|+.||....... ...+. ... .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~--------~~~-----~ 218 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMMLI--------PKS-----K 218 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhcc--------ccC-----C
Confidence 2 22334689999999998754 46899999999999999999999997543211 00000 000 0
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.+.. ......+.+++.+|++.||.+||++.++++
T Consensus 219 ~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLED--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 011110 013457889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=310.15 Aligned_cols=246 Identities=27% Similarity=0.404 Sum_probs=200.5
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
|...+.||.|+||.||+|... +++.||||.+.... ......+.+|+.++.+++|+||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667789999999999999864 68899999986443 2334578899999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|..++.. ..+++.....++.+++.+|.|||+. +++|+||||+||+++.++.++|+|||++....... ...
T Consensus 86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 86 GGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 9999998854 2489999999999999999999998 99999999999999999999999999987653322 122
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
....++..|++||++....++.++|||||||++|+|++|..||...... .+... +.... ..
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~-----~~~~~--------~~ 219 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFL-----IPKNN--------PP 219 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHH-----HhcCC--------CC
Confidence 3346888999999999888999999999999999999999999653321 01000 00000 01
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.........+.+++.+|++.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1222345668899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=300.30 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=204.3
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-----h---hHHHHHHHHHHHHhcC-CCCcceEEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-----Q---GEREFQAEIEIISQVH-HRHLVSLVGYCT 268 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-----~---~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~ 268 (579)
...++|...+.||+|..+.|-++.++ +|+.+|+|++..... + -.+.-.+|++||+++. ||||+.|.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 33467888899999999999998865 688999999854321 1 1234567999999986 999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 269 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
.....++|+|.|+.|.|.++|... -.+++....+|+.|+..|++|||.+ +||||||||+|||+|++.++||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999999654 3589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhcc------CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 422 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 422 (579)
+++.+... ......|||++|+|||.+.. ..|+...|+|++||+||.|+.|.+||-..... .
T Consensus 169 Fa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----------l 235 (411)
T KOG0599|consen 169 FACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----------L 235 (411)
T ss_pred eeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----------H
Confidence 99987544 34567899999999998864 34788999999999999999999999543211 1
Q ss_pred hhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 423 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.+.+.+|.+.- - .....+......+++.+||+.||.+|-|.+|+|+
T Consensus 236 MLR~ImeGkyqF-~----speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 MLRMIMEGKYQF-R----SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHhccccc-C----CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 122222333211 0 0223445567899999999999999999999985
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=313.40 Aligned_cols=244 Identities=28% Similarity=0.394 Sum_probs=200.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||++... +++.||+|.++... ......+.+|++++++++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999975 58999999986532 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||+|+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998654 4589999999999999999999998 9999999999999999999999999999875443
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...+.. .. + +.+..+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~--~------~~~~~~~~----- 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QI--Y------EKILEGKV----- 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH--H------HHHhcCCc-----
Confidence 23346899999999998888999999999999999999999999754410 00 0 00001100
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
.++......+.+++.+||+.+|.+|+ ++.|+++
T Consensus 216 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 12222356788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.27 Aligned_cols=258 Identities=26% Similarity=0.333 Sum_probs=202.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV~ 277 (579)
++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++|+||++++++|... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999975 588999999875433 3456789999999999999999999998653 4689999
Q ss_pred EecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 278 EFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 278 E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||+++++|.+++.. .....+++.....|+.|++.||+|||+. +++|+||+++||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887653 2234578889999999999999999998 999999999999999999999999999876433
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcc--ccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF--ADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+..|... ....
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--------MPNP 226 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc--------CCch
Confidence 22 12345788999999999999999999999999999999999999865321 11112222111 0000
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+.+.. .........+.+++.+|++.+|.+||++.||++.
T Consensus 227 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 227 ELKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hhccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 010000 0011234678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=311.07 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=205.6
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
..+.|+..+.||+|+||.||+|.+. +++.|++|.++.... ....+.+|++++.+++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4467888899999999999999986 688999999976554 45678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++.... ..+++..+..++.+++.||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999997643 3689999999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......++..|++||++.+..++.++|||||||++|+|++|+.||...+... ....+. ......+
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~~~---------~~~~~~~--- 236 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFLIT---------TKGIPPL--- 236 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---------hcCCCCC---
Confidence 2233457889999999998889999999999999999999999997544311 000000 0000000
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+++.+|++.+|.+||++.+|++
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 ---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011123467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=311.39 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=201.0
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
|...+.||+|+||.||++... +++.+++|+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 445679999999999999964 6889999998765555556788999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~ 173 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK 173 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence 999999865 3489999999999999999999998 99999999999999999999999999987543322 1223
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.. .+..... ... .+.+ .
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~-----~~~-----~~~~-~ 236 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR-----DNL-----PPKL-K 236 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-----hcC-----CCCC-c
Confidence 356899999999999888999999999999999999999999754321 1111110 000 0000 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
........+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11123457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=306.59 Aligned_cols=252 Identities=22% Similarity=0.384 Sum_probs=201.0
Q ss_pred CccccceecccCceEEEEEEE-eCCeEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
+|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 4688999999864321 124578899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeecccccccC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSL 354 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGla~~~~ 354 (579)
||||+++++|.+++... ..+++.....++.|++.||.|||++ +++|+||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999998643 3588999999999999999999998 999999999999998775 59999999987654
Q ss_pred CCCcc---eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 355 DTDTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 355 ~~~~~---~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... ......|+..|+|||++.+..++.++||||||+++|+|++|..||.......... ...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~-----~~- 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIA-----SA- 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHh-----cc-
Confidence 32211 1223468899999999988889999999999999999999999996543211111 000000 00
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
......+......+.+++.+|++.+|.+||++.++++
T Consensus 227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0001233445577889999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=306.82 Aligned_cols=243 Identities=26% Similarity=0.364 Sum_probs=201.9
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHH---HHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGER---EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~---~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
..++|..+++||+|.||+|.+++.+ .++.+|+|++++...-... .-+.|-.+|+..+||.+..|...|...+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3478999999999999999999955 6999999999876433333 34578899999999999999988999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+.||.|..||... ..+++.....+-..|+.||.|||++ +||.||||.+|.|||.||++||+|||||+....
T Consensus 246 VMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999999654 4578877778889999999999998 999999999999999999999999999997433
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
. .....++|||+.|+|||++....|+..+|+|.+||++|||+||+.||...+... +.+. .+. +
T Consensus 321 ~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeL---Il~-----e----- 383 (516)
T KOG0690|consen 321 Y-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFEL---ILM-----E----- 383 (516)
T ss_pred c-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHH---HHh-----h-----
Confidence 2 234466899999999999999999999999999999999999999998766421 1110 010 0
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPR 468 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 468 (579)
.+ .++.....+...++...|.+||.+|..
T Consensus 384 ---d~-kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 384 ---DL-KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred ---hc-cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 01 355555667788899999999999974
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=309.69 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=192.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEI-ISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|+..+.||+|+||.||+++.. +|+.||+|+++... ......+..|+.+ ++.++|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 68999999987643 2234456666665 556789999999999999999999999
Q ss_pred ecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 279 FVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 279 ~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|++ |+|..++... ....+++..++.++.|++.||+|||+++ +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6776666432 2346899999999999999999999854 7999999999999999999999999999865332
Q ss_pred CcceeecccccccccChhhhcc----CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 357 DTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
. ..+...++..|+|||.+.+ ..++.++|+|||||++|||++|+.||....... ..+.
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~---------------- 218 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK---------------- 218 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH----------------
Confidence 1 1233468899999998864 456889999999999999999999996432100 0000
Q ss_pred hhhhchhhhcCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 433 DALVDQKLEEYD-SAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 433 ~~l~d~~l~~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.......+ ......+.+++.+||..+|.+||++.+|++
T Consensus 219 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 -QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000111 123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.94 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=206.6
Q ss_pred cccceecccCceEEEEEEE-eCC----eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 205 SEANLLGQGGFGYVHKGVL-TNG----KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~-~~g----~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
...++||.|.||+||||.+ ..| -+||+|++.... .+...+|++|+-+|.+|.||||++|+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3458899999999999996 333 368999986654 344678999999999999999999999998765 789999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
||+.|+|.++++.+. ..+.-...+.|..|||+||.|||++ ++|||||.++||||..-..+||.|||+++.......
T Consensus 778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998643 4578889999999999999999998 999999999999999999999999999998765443
Q ss_pred ceee-cccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 359 HVST-RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 359 ~~~~-~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.... ...-.+.|||-|.+....|+.++|||||||++|||+| |..||+.....+..++ + +.+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------l----e~g------ 916 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------L----EKG------ 916 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------H----hcc------
Confidence 3322 2334668999999999999999999999999999999 9999987653221111 1 111
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.+| ..++.+...+..++.+||..|+..||+++++...+....
T Consensus 917 -eRL-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 917 -ERL-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -ccC-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 011 345667778999999999999999999999998876543
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=312.50 Aligned_cols=257 Identities=23% Similarity=0.384 Sum_probs=206.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999854 67889999987554444567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999988543 478999999999999999999998 999999999999999999999999999876543322 2
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....|++.|++||.+..+.++.++|||||||++|+|++|+.||...+.... +..+. ..+. +..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~~--------~~~~------~~~ 235 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIA--------TNGT------PEL 235 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeehh--------cCCC------CCC
Confidence 2334688999999999988899999999999999999999999976543111 00000 0000 000
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcCCCC
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGNMPL 482 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~--Le~~~~~ 482 (579)
.........+.+++..||+.+|.+||++.+++.. ++...++
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 1122234568899999999999999999999964 4444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=307.57 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=202.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEecc--CCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-----CCe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKA--GSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-----GSQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~--~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-----~~~ 272 (579)
...|...+.||+|.||.|+.+... +|+.||||++.. ......+...+|+.+|++++|+||+.+++++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 455666789999999999999965 689999999863 333344567789999999999999999998865 457
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.|+|+|+| ..+|...++.+ +.|.......++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||||+.
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceee
Confidence 89999999 77898888654 3488888899999999999999998 999999999999999999999999999997
Q ss_pred cCCC-CcceeecccccccccChhhhc-cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhh----hhHhhhc
Q 008052 353 SLDT-DTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA----KPFLAQG 426 (579)
Q Consensus 353 ~~~~-~~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~----~~~~~~~ 426 (579)
.... .....+..+-|.+|.|||++. ...|+...||||.||||.||++|+.-|.+.+......++-.. .......
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 6432 112235678899999999875 568999999999999999999999999877653322211100 0000001
Q ss_pred ccCCCchhhhc-------hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+........+. ......-.......++++.+||..||.+|+|++|.++
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111111111 0011111234466889999999999999999999886
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=311.99 Aligned_cols=267 Identities=21% Similarity=0.290 Sum_probs=200.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV 276 (579)
++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+.++.+++|+||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999976 5889999999754322 233567899999999999999999999877 889999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++ +|.+++.... ..+++...+.++.|+++||+|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999974 8888876543 3589999999999999999999998 9999999999999999999999999999865443
Q ss_pred CcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccch-h---------hhhhhhHhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-M---------VDWAKPFLAQ 425 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~---------~~~~~~~~~~ 425 (579)
.. ......++..|+|||.+.+. .++.++|+||||+++|||++|..||.......... + ..|.......
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 21 12334578899999998754 46899999999999999999999997654321100 0 0111000000
Q ss_pred cccCCCchhhhchhhh-cCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 GLADGNFDALVDQKLE-EYDSA-EMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~-~~~~~-~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..............+. .+... ....+.+++..|++.+|++||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000111111111111 12222 3566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.03 Aligned_cols=199 Identities=31% Similarity=0.413 Sum_probs=174.8
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-C-----CCcceEEEEEEeCCeEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-H-----RHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----pniv~l~g~~~~~~~~~l 275 (579)
+|.+.+.||+|.||.|.||+.. +++.||||+++.... -.++-..|+.+|.+|+ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6888999999999999999954 699999999987543 2456678999999997 4 489999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC--CCeEEeeccccccc
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS--FEAKVADFGLAKHS 353 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~--~~~kL~DFGla~~~ 353 (579)
|+|.+ .-+|.++|+.+....++......|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.+...
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99998 66999999988878899999999999999999999998 99999999999999653 47999999999874
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcc
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 410 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~ 410 (579)
...- ....-+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+.++.
T Consensus 342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 3321 2566788999999999999999999999999999999998888776653
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.26 Aligned_cols=261 Identities=22% Similarity=0.275 Sum_probs=195.1
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC--CeEEEEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFG--SQRLLVYE 278 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~--~~~~lV~E 278 (579)
|...+.||+|+||.||+|... +++.||+|+++.... .......+|+.++.++. |+||++++++|.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556789999999999999965 688999999875422 22234557899999986 99999999999987 88999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++ +|.+++.... ..++|.+++.++.|++.||+|||+. +|+||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9974 7766665432 3589999999999999999999998 9999999999999999 9999999999986543222
Q ss_pred ceeecccccccccChhhhc-cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh-------hhcccCC
Q 008052 359 HVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL-------AQGLADG 430 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 430 (579)
.....++..|+|||++. ++.++.++|||||||++|||++|..||...+.. ..+.+....+ .+.....
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhccc
Confidence 12345789999999765 456789999999999999999999999765431 1112111110 0000000
Q ss_pred -----CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 431 -----NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 431 -----~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+.......+..........+.+++.+||+.+|++||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000111111111122446789999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=328.83 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=203.6
Q ss_pred ceecccCceEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchh
Q 008052 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~ 286 (579)
-+||+|.||+||-|+..+ ...+|||.+........+-+.+||.+.++|+|.|||+++|.|.+++.+.+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 469999999999999654 5679999997766666677899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-CCCCeEEeecccccccCCCCcceeecc
Q 008052 287 FHLHGKDRPV-MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRV 364 (579)
Q Consensus 287 ~~l~~~~~~~-l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~ 364 (579)
.+|..+=++. =.+.+.-.+-.||++||.|||++ .|||||||-.||||+ -.|.+||+|||-++++..-+ ....++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccccc
Confidence 9998654432 25667778899999999999999 999999999999995 57899999999999865433 345567
Q ss_pred cccccccChhhhccCC--CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 365 MGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 365 ~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
.||..|||||++..|. |+..+|||||||++.||.||++||....... +. .+.-|-+ ..-..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-------AA-----MFkVGmy-----KvHP~ 799 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-------AA-----MFKVGMY-----KVHPP 799 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-------Hh-----hhhhcce-----ecCCC
Confidence 8999999999998764 8899999999999999999999997543210 00 0111211 11125
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.+...+..+++.+|+..||.+||++.++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 67788889999999999999999999999875
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.51 Aligned_cols=264 Identities=19% Similarity=0.272 Sum_probs=195.4
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|+..+.||+|+||.||+|... +|+.||+|.++.... .....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999975 688999999865322 2235678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++ +|..++.... ..+++...+.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 975 6766665432 3489999999999999999999998 999999999999999999999999999986433221
Q ss_pred eeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccc-----------hhhhhhhhHhhhcc
Q 008052 360 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-----------SMVDWAKPFLAQGL 427 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-----------~~~~~~~~~~~~~~ 427 (579)
......++..|+|||++.+. .++.++|||||||++|||++|..||......... ....|.. +.+..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG--VSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH--hhhcc
Confidence 12334578999999998764 4789999999999999999999986543321100 0000100 00000
Q ss_pred cCCCchhhhch-hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 428 ADGNFDALVDQ-KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 428 ~~~~~~~l~d~-~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+...... ............+.+++.+||+.||.+||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000 000111223467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=324.34 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=205.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEecc--CCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeE
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKA--GSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~ 273 (579)
+.+....|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+.+|.+|+ |.+||+|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3445567889999999999999999988888999988754 34455678999999999997 99999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
||||||- .-+|..+|..+......| .+..+..|++.++.++|++ ||||.||||.|+|+-+ |.+||+|||+|...
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9999975 668999998776655667 6678899999999999999 9999999999999975 48999999999977
Q ss_pred CCCCcc-eeecccccccccChhhhccC-----------CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh
Q 008052 354 LDTDTH-VSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 354 ~~~~~~-~~~~~~gt~~y~APE~~~~~-----------~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
....+. .....+||+.||+||.+... ++++++||||||||||+|+.|+.||..... .|++
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aK- 581 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAK- 581 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHH-
Confidence 654443 34557899999999988543 256899999999999999999999975431 2222
Q ss_pred HhhhcccCCCchhhhchhhh-cCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 422 FLAQGLADGNFDALVDQKLE-EYDSAE-MTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~-~~~~~~-~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+..+.|+.-+ +|+.-- ...++++++.||..||.+||+..++|+
T Consensus 582 ----------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 ----------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 3345555443 222111 122999999999999999999999996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=311.60 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=203.0
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeC----CeE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFG----SQR 273 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~~~----~~~ 273 (579)
......+.+.||+|.||+||+|.++ |..||||++... .++.+.+|.+|.+. |+|+||+.+++.-..+ .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3457788899999999999999996 678999999653 35678888888886 4899999999876443 378
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-----CQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-----~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
|||.+|-++|+|.++|.. ..++-...++++..+|.||+|||.. ..|.|.|||||+.|||+.+++.+.|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999965 4588999999999999999999964 57889999999999999999999999999
Q ss_pred cccccCCCCc---ceeecccccccccChhhhccCC----C--CcccceechHHHHHHHHhC----------CCCCCCCCc
Q 008052 349 LAKHSLDTDT---HVSTRVMGTFGYLAPEYASSGK----L--TEKSDVFSFGVLLLELITG----------FRPFDKADT 409 (579)
Q Consensus 349 la~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~----~--~~ksDVwSlGvvl~eLltG----------~~Pf~~~~~ 409 (579)
||........ ...+..+||-.|||||++...- + -..+||||||+||||+... +.||.+.-+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9976543321 1234568999999999997532 1 1369999999999999642 356654433
Q ss_pred cccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 410 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
. +.+..+-. ..+-...++..++.+. .....+..|.++++.||..+|.-|-++=-|-+.|....
T Consensus 442 ~-DPs~eeMr-----kVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 S-DPSFEEMR-----KVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred C-CCCHHHHh-----cceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1 12221111 1111122222222221 23567889999999999999999999998888887654
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.80 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=204.0
Q ss_pred cCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.|.++..||.|.||+|||++.++ +-..|.|.+...+....++|.-||+||..+.||+||+|++.|...+.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346667889999999999999765 4455678888777777889999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
.||..+..+-.-+ ..|...++..++.+++.+|.|||++ +|||||||+.|||++.+|.++|+|||++..... ....
T Consensus 112 ~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred CCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 9999988775443 4589999999999999999999999 999999999999999999999999999754211 1223
Q ss_pred eecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 361 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
...+.||++|||||+++ ..+|+.++||||||++|.||..+.+|-...++.. .++..+ ...
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKia---------KSe---- 251 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA---------KSE---- 251 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHh---------hcC----
Confidence 34578999999999875 4579999999999999999999999987655421 111111 000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.|.| -.+......+.+++..||..+|..||++.|+++
T Consensus 252 -PPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 252 -PPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -CCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 0111 123444567899999999999999999999974
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=309.91 Aligned_cols=264 Identities=20% Similarity=0.296 Sum_probs=199.1
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
|+..+.||.|++|.||+|... +|+.||||++..... .....+.+|++++++++|+|++++++++..++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999965 789999999865432 22356889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
+ ++|.+++.......+++..++.++.|+++||+|||++ +++||||+|+|||++.++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 6898888765545689999999999999999999998 999999999999999999999999999976432221 1
Q ss_pred eecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH---hhhc---c-cCCC-
Q 008052 361 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---LAQG---L-ADGN- 431 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~---~-~~~~- 431 (579)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... .+....+.. .... + ....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223568899999988654 57899999999999999999999997654211 111111000 0000 0 0000
Q ss_pred ---chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 ---FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ---~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.......+..........+.+++.+|++.+|.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000001111112223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.05 Aligned_cols=268 Identities=20% Similarity=0.276 Sum_probs=195.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+++|...+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999864 6889999998654322 23467889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+. ++|..++.... ..+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 996 56655554332 3478888899999999999999998 999999999999999999999999999876432221
Q ss_pred ceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH---------hhh--c
Q 008052 359 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---------LAQ--G 426 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---------~~~--~ 426 (579)
......++..|+|||++.+. .++.++|||||||+||||++|+.||.......+.....|.... +.. .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 12334578999999998753 5788999999999999999999999765431111111110000 000 0
Q ss_pred ccCCCchhhhchhhhcC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDALVDQKLEEY--DSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~--~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.....+.......+... .......+.+++.+|++.||.+||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 0012456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.89 Aligned_cols=266 Identities=22% Similarity=0.332 Sum_probs=200.5
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+|+..+.||.|++|.||+|+.. +|+.||||+++..... ....+.+|++++++++|+||++++++|...+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999975 6889999998765332 2456778999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 281 PNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 281 ~~g~L~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
++ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 7777775433 34589999999999999999999998 999999999999999999999999999975433211
Q ss_pred eeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhh---------hhhhHhhhccc
Q 008052 360 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVD---------WAKPFLAQGLA 428 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~---------~~~~~~~~~~~ 428 (579)
......++..|++||++.+. .++.++|||+|||++|||++|+.||...+..... .+.+ |..-.....+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY- 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh-
Confidence 12334578899999998654 5788999999999999999999999765431100 0000 0000000000
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+....+.............+.+++..|++.||.+||++.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001111111111122234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=301.45 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=205.5
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|...+.||.|+||.||++... +++.|++|++..... .....+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999975 588999999876533 4456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 280 VPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 280 ~~~g~L~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
+++++|.+++.... ...+++..+..++.++++||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987543 35689999999999999999999998 99999999999999999999999999998654432
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.......|++.|+|||.+....++.++||||||+++|+|++|+.||...+.. ..... +..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-------------~~~ 217 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALK-------------ILK 217 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHH-------------Hhc
Confidence 2233456899999999999889999999999999999999999999654421 11111 011
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+...+......+.+++.+|+..+|.+||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 218 GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111122234467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.93 Aligned_cols=247 Identities=25% Similarity=0.314 Sum_probs=202.4
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+|+..+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 58899999986532 2335678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+.+++|..++... ..+.+.....|+.|+++||.|||+. +++|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998654 4589999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......|+..|+|||++....++.++|+||||+++|+|++|+.||...+... .++..... ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~-------------~~ 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQ-------------ET 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHh-------------cc
Confidence 2233568889999999998889999999999999999999999998655311 11111100 00
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRM--SQIV 473 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm--~evl 473 (579)
.....+......+.+++.+|++.||.+||++ +|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0012233345788999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.78 Aligned_cols=241 Identities=27% Similarity=0.363 Sum_probs=192.5
Q ss_pred ecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
||+|+||+||++... +|+.||+|.+.... ......+..|+++|++++|+||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68899999986432 22244667899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeeccc
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 365 (579)
.+++.......+++..++.++.|++.||.|||+. +++||||||+|||+++++.+||+|||++...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 9998765555689999999999999999999998 9999999999999999999999999998765331 1122345
Q ss_pred ccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCH
Q 008052 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 445 (579)
Q Consensus 366 gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 445 (579)
++..|++||++.++.++.++|||||||++|+|++|+.||........... +.+.. ......++.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~---------~~~~~~~~~ 219 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------LKRRT---------LEMAVEYPD 219 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------HHhcc---------ccccccCCc
Confidence 78899999999988899999999999999999999999976543111000 00000 000012223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHH
Q 008052 446 AEMTRMAACAAACIRHSARRRPRMSQ 471 (579)
Q Consensus 446 ~~~~~l~~l~~~cl~~dp~~RPtm~e 471 (579)
.....+.+++.+||+.+|.+||+..+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCc
Confidence 34567899999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.85 Aligned_cols=246 Identities=25% Similarity=0.365 Sum_probs=195.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
+.|...+.||+|+||.||+|... +++.||+|.+..... ....++.+|++++++++|+||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999975 688999999864322 23357889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++ +|.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~g-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCLG-SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhCC-CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99974 5655554322 3589999999999999999999998 9999999999999999999999999998764322
Q ss_pred cceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 358 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
....++..|+|||++. .+.++.++||||||+++|||++|+.||...+... .... +.....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~~~~--------~~~~~~-- 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH--------IAQNDS-- 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---HHHH--------HhcCCC--
Confidence 2345888999999874 4668899999999999999999999996543211 0000 000000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+. .........+.+++.+||+.+|.+||+|.+|+..
T Consensus 232 ---~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ---PT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0112244578999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.80 Aligned_cols=267 Identities=17% Similarity=0.236 Sum_probs=187.0
Q ss_pred hcCccccceecccCceEEEEEEEeC--CeEEEEE------------------EeccCCchhHHHHHHHHHHHHhcCCCCc
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN--GKVVAIK------------------QLKAGSGQGEREFQAEIEIISQVHHRHL 260 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK------------------~l~~~~~~~~~~~~~Ei~~l~~l~Hpni 260 (579)
.++|.+.+.||+|+||+||++.+.. +..+++| .++. .......+.+|+.+|.+++|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence 4789999999999999999987542 2222222 1111 11234568899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCchhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC
Q 008052 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 337 (579)
Q Consensus 261 v~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~ 337 (579)
|++++++...+..++|+|++.+ +|..++.... ...........|+.||+.||+|||++ +||||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999854 5555553321 11233456678999999999999998 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCC-CCCCCCccccchhh
Q 008052 338 DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR-PFDKADTFADDSMV 416 (579)
Q Consensus 338 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~-Pf~~~~~~~~~~~~ 416 (579)
.++.+||+|||+++..............||..|+|||++.+..++.++|||||||+||||++|.. ||..........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998765443333344679999999999999999999999999999999999875 44433221111111
Q ss_pred hhhhhHh--hhcc-----------cCCCch---hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 417 DWAKPFL--AQGL-----------ADGNFD---ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 417 ~~~~~~~--~~~~-----------~~~~~~---~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....... ...+ ....+. ..+...+.. ......+.+++.+||+.||.+||++.|++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN--LGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh--cCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111000 0000 000000 000000000 012235677899999999999999999986
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=307.84 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=208.2
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
-|.+.+.||+|.||.|||+.++ .|+++|||++.... ..+++..||.||+++..+++|+++|.+.....+|+|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4677889999999999999976 69999999986554 35789999999999999999999999988899999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
-|++.+.+... ++.|.+.++..|+...++||+|||.. +-||||||+.||||+-+|.+||+|||++..+.+... ..
T Consensus 112 AGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR 186 (502)
T KOG0574|consen 112 AGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR 186 (502)
T ss_pred CCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence 99999988754 45699999999999999999999998 889999999999999999999999999987654433 34
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
+++.||+.|||||++..-.|+.++||||||++..||..|++||.+..+... +..+......
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------------------IFMIPT~PPP 247 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------------------IFMIPTKPPP 247 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------------------eEeccCCCCC
Confidence 567899999999999988999999999999999999999999987654211 1111111111
Q ss_pred --cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 442 --EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 442 --~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.-++.....+-++++.||-+.|++|-++-++++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 234455678999999999999999999988864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.26 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=199.3
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVYE 278 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV~E 278 (579)
|...+.||.|+||.||+|... +++.+|+|++.... ......+.+|++++.+++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999976 58899999997653 22345788999999999999999999999988 78999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++ +|..++.... ..+++..++.++.|+++||+|||+. +++|+||||+|||+++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 7887775442 4589999999999999999999998 999999999999999999999999999987654432
Q ss_pred ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh----hcc---c--
Q 008052 359 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA----QGL---A-- 428 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~----~~~---~-- 428 (579)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+... .......... ..+ .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccc
Confidence 22233457889999998764 467899999999999999999999997655311 1110000000 000 0
Q ss_pred ----CCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 429 ----DGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 429 ----~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...........+. .+...+...+.+++..|++.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000011111 111113567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.35 Aligned_cols=269 Identities=25% Similarity=0.283 Sum_probs=198.9
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS---- 271 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~---- 271 (579)
...++|++.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999976 588999999975432 23356788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEe
Q 008052 272 ------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (579)
Q Consensus 272 ------~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~ 345 (579)
..++|+||+++ +|...+... ...+++..++.|+.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 565666543 33589999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH--
Q 008052 346 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF-- 422 (579)
Q Consensus 346 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~-- 422 (579)
|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+.......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRLCGS 236 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCC
Confidence 999998654433222233356788999998864 457899999999999999999999997544211 111100000
Q ss_pred ----hhhcccCCC-c-----hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 423 ----LAQGLADGN-F-----DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 423 ----~~~~~~~~~-~-----~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+.... + ...............+..+.+++..||+.+|.+||++.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 0 000000010011123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.35 Aligned_cols=268 Identities=19% Similarity=0.226 Sum_probs=195.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCe-----
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQ----- 272 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~----- 272 (579)
++|+..+.||+|+||.||+|... +++.||||.++.... .....+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 689999998865432 22356888999999995 6999999999987665
Q ss_pred EEEEEEecCCCchhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKD---RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFG 348 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~---~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFG 348 (579)
.++||||+++ +|..++.... ...+++..++.++.||++||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 7877775432 23589999999999999999999998 9999999999999998 8899999999
Q ss_pred cccccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhhhhhHhhhc
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQG 426 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~ 426 (579)
+++...... .......+++.|+|||++.+ ..++.++|||||||++|||++|..||......... .+.........+.
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 987643221 11223357889999998865 45799999999999999999999999754321100 0000000000000
Q ss_pred c----cCCC---chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 L----ADGN---FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~----~~~~---~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+ .... +.......+..........+.+++.+||+.+|.+||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000 0000000011111234567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.06 Aligned_cols=268 Identities=21% Similarity=0.254 Sum_probs=196.1
Q ss_pred CccccceecccCceEEEEEEEe---CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRL 274 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~ 274 (579)
.|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++.+++||||++++++|.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777899999999999999975 47899999997633 23345678899999999999999999999988 7899
Q ss_pred EEEEecCCCchhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC----CCCeEEeec
Q 008052 275 LVYEFVPNKTLEFHLHGK---DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADF 347 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~----~~~~kL~DF 347 (579)
|||||+++ +|..++... ....+++.....|+.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 555554321 123588899999999999999999998 9999999999999999 899999999
Q ss_pred ccccccCCCCc--ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCcccc-------chhhh
Q 008052 348 GLAKHSLDTDT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-------DSMVD 417 (579)
Q Consensus 348 Gla~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-------~~~~~ 417 (579)
|+++....... .......+++.|+|||++.+ ..++.++|||||||+||||++|+.||........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 12233568899999998875 4578999999999999999999999976543220 00111
Q ss_pred hhhhHh-------hhcccCCCchhhhc---------hhhh-cCCH--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 418 WAKPFL-------AQGLADGNFDALVD---------QKLE-EYDS--AEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 418 ~~~~~~-------~~~~~~~~~~~l~d---------~~l~-~~~~--~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+...+. ........+..+.+ ..+. .+.. .....+.+++.+|++.||++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00000000000000 0000 0001 23456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.32 Aligned_cols=268 Identities=19% Similarity=0.275 Sum_probs=197.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|+..+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999975 688999999865322 223568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecccccccCCCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~~~~~~~ 357 (579)
|++ ++|..++.......+++.....++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5777777554444467888889999999999999998 9999999999999985 5679999999997643221
Q ss_pred cceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhhhhhHhhhcccC----CC
Q 008052 358 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQGLAD----GN 431 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~----~~ 431 (579)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ....+......+.+.. ..
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 12233457889999999875 45789999999999999999999999765431110 0000000000000000 00
Q ss_pred ch----hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FD----ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~----~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+. ......+..........+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00001111112233456889999999999999999999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=298.87 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=205.6
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLVY 277 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV~ 277 (579)
+|...+.||+|+||.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 688999999876543 3456889999999999999999999999988 8899999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++.... .+++..++.++.+++.+|+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999986543 689999999999999999999998 99999999999999999999999999988765433
Q ss_pred cc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.. ......++..|++||.+.....+.++||||||+++|+|++|+.||...+. .....|. +..
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~-------~~~------- 218 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYK-------IGS------- 218 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHh-------ccc-------
Confidence 21 12345688999999999988899999999999999999999999976541 0000010 000
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.......+......+.+++.+|++.+|.+||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00001223334678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.37 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=196.6
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.|...+.||+|+||.||+++.. +++.||+|++..... .....+.+|++++++++|+|+++++++|..++..+||||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999964 688999999864322 233578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+.+ +|.+++... ...++|.++..++.+++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 9975 676666433 23489999999999999999999998 9999999999999999999999999998754322
Q ss_pred ceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 359 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||...+... .+..+.. +..
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~---------~~~--- 241 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ---------NES--- 241 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHh---------ccC---
Confidence 2346889999999973 4678999999999999999999999986543210 0111100 000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
...........+.+++.+|++.+|.+||++.+|++.+.-
T Consensus 242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 001112234568899999999999999999999986653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.57 Aligned_cols=254 Identities=25% Similarity=0.434 Sum_probs=195.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 34556688999999999999965 58899999986543 234567889999999996 9999999999999999999999
Q ss_pred ecCCCchh---hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 279 FVPNKTLE---FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 279 ~~~~g~L~---~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|+.. +|. ..+.......+++....+++.++++||+|||+.+ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 443 3333333356899999999999999999999743 899999999999999999999999999976543
Q ss_pred CCcceeecccccccccChhhhccC---CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~---~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
... .....|+..|+|||++... .++.++|||||||++|||++|+.||..... ...- +.+.. .+.
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~----~~~~~-~~~- 227 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ----LTQVV-KGD- 227 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHH----Hhhhc-CCC-
Confidence 221 1234588999999999866 689999999999999999999999965431 0000 00000 000
Q ss_pred hhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 433 DALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 433 ~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+.+. .........+.+++.+|++.+|.+||++.+|++.
T Consensus 228 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 1112345678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=290.29 Aligned_cols=250 Identities=25% Similarity=0.433 Sum_probs=195.5
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEec
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
...+..||.|..|.|+++++. .|..+|||.+.... ....+.++..++++.+-+ +|.||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 334567999999999999976 58999999996543 334456777888887776 899999999999999999999998
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
...++.+|..-.. .+++.-.-++...+++||.||.+++ +|||||+||+|||||+.|++||||||++-++.+...+
T Consensus 174 -s~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 174 -STCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred -HHHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 4456666654333 3777777789999999999999876 8999999999999999999999999999887665544
Q ss_pred eecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 361 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
++..|.+.|||||.+. ..+|+-++||||||+.|+||.||+.||...+..- +.+. ..+ + +. .
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~lt----kvl-----n----~e-P 312 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLT----KVL-----N----EE-P 312 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHH----HHH-----h----cC-C
Confidence 4557999999999986 3478999999999999999999999998755311 0000 000 0 00 1
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+.|. ........+++++..||++|+.+||...++++.
T Consensus 313 P~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2222 122245778999999999999999999998753
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=298.47 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=203.5
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|...+.||+|+||.||+++.. +++.|+||.+..... .....+.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 578999999976643 3456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++... ..+++..+..++.|++.+|.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998654 4589999999999999999999998 9999999999999999999999999999876443321
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....++..|+|||.+.+..++.++|||+||+++|+|++|+.||...... ...|... ....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~-------~~~~------- 216 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIV-------QDDH------- 216 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHh-------ccCC-------
Confidence 23356889999999998888999999999999999999999999754321 1111100 0000
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+......+.+++.+|+..+|++||++.+++.
T Consensus 217 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0122233567889999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.26 Aligned_cols=268 Identities=23% Similarity=0.362 Sum_probs=198.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC--CeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG--SQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~--~~~~ 274 (579)
.++|...+.||+|+||.||+|... +++.+|||++... .......+..|+.++.++ +|+||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999975 5889999988542 222335677899999999 999999999998653 3679
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+||||++ ++|..++... .++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 5888888543 588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCc----ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhhhhhh-------
Q 008052 355 DTDT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWAKP------- 421 (579)
Q Consensus 355 ~~~~----~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~~~~~------- 421 (579)
.... .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......... +..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3322 12234568999999998754 567899999999999999999999997543221100 0000000
Q ss_pred HhhhcccCCCchhhhc---hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 422 FLAQGLADGNFDALVD---QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d---~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+........+..+.. ..+..........+.+++.+|++.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000000 00011111245678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.07 Aligned_cols=243 Identities=25% Similarity=0.347 Sum_probs=197.8
Q ss_pred ecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
||.|+||.||+++.. +|+.+++|.+..... .....+.+|++++.+++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 489999999865433 3456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc-------
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT------- 358 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~------- 358 (579)
.+++.... .+++..++.++.|+++||+|||+. +++|+||+|+|||+++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99986543 589999999999999999999998 999999999999999999999999999876433211
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
.......++..|++||.+.....+.++||||||+++|||++|..||...... . +.... ..+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~---~~~~~-----~~~~~------ 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---E---IFQNI-----LNGKI------ 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---H---HHHHH-----hcCCc------
Confidence 1223356888999999999888999999999999999999999999754421 1 11100 01111
Q ss_pred hhhcCCHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 439 KLEEYDSA--EMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 439 ~l~~~~~~--~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
..... ....+.+++.+|++.+|.+||++.+|.+.|+
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11111 2567899999999999999999977777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.56 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=203.3
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|+..+.||+|+||.||++... +++.+|+|.++... ......+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 67899999986532 23345778899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 280 VPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 280 ~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
+++++|..++... ....+++..++.++.|++.||+|||+. +++|+||+|.||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999888542 234589999999999999999999998 9999999999999999999999999999876443
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......++..|++||++.+..++.++|+||||+++|||++|+.||...+.. .+.. .+..+.+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~--------~~~~~~~----- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY--------KVQRGKY----- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH--------HHhcCCC-----
Confidence 222345889999999999999999999999999999999999999755421 1100 0011111
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..........+.+++.+|++.+|.+||++.|+++.
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 ---PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12223455678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=313.64 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=198.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~ 271 (579)
.++|+..+.||+|+||.||+|... +++.||||.+... .......+.+|+.++.+++|+||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 478999999999999999999965 6889999998643 223345677899999999999999999988643 3
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+.+ +|.+.+... +++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 56899999964 777777432 78889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hh--------hhhhh--
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SM--------VDWAK-- 420 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~--------~~~~~-- 420 (579)
...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .+ .+|..
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 653322 123346889999999999999999999999999999999999999765421100 00 00000
Q ss_pred -hHhhhcc------cCCCchhhhchhhh-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 421 -PFLAQGL------ADGNFDALVDQKLE-----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 421 -~~~~~~~------~~~~~~~l~d~~l~-----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.... ....+..+....+. .........+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 00011111111110 112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=305.60 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=199.5
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEec
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
|.+.+.||+|+||.||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999976 478899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
+|+|.+++.......+++..++.++.|++.+|.|||++ +++|+||||+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 88998888765545689999999999999999999998 999999999999999999999999999986543222
Q ss_pred eecccccccccChhhhc-cCCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhh---------hhhhhHhhhcccC
Q 008052 361 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMV---------DWAKPFLAQGLAD 429 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~---------~~~~~~~~~~~~~ 429 (579)
.....++..|+|||++. ...++.++|+||||++++||++|+.||......+.. ... .|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23345888999999875 455789999999999999999999999655431110 000 1111110000000
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+.......+..........+.+++.+|++.+|++||++.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000001111111111224678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=300.94 Aligned_cols=241 Identities=25% Similarity=0.311 Sum_probs=195.7
Q ss_pred ecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
||.|+||.||+++.. +++.||+|.+..... .....+.+|+.++++++|+||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999975 488999999865332 2346789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeeccc
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 365 (579)
.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 9999654 3488999999999999999999998 99999999999999999999999999998764432 223346
Q ss_pred ccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc-hhhhcCC
Q 008052 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD-QKLEEYD 444 (579)
Q Consensus 366 gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d-~~l~~~~ 444 (579)
++..|++||.+....++.++|+||||+++|+|++|..||...... ..++... +.+ .....++
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-------------~~~~~~~~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYND-------------ILKGNGKLEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHH-------------HhccCCCCCCC
Confidence 889999999998888999999999999999999999999765420 0111111 110 0001223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 445 SAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 445 ~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
......+.+++.+||+.+|.+||+ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 333567999999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=304.89 Aligned_cols=242 Identities=24% Similarity=0.347 Sum_probs=187.3
Q ss_pred eecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHh---cCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQ---VHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~---l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
.||+|+||.||++... +++.+|||.+..... .....+.+|..++.. .+|+||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999998865321 222334455544443 479999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.+++... ..+.+.....|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 99999888644 3589999999999999999999998 99999999999999999999999999987543322 1
Q ss_pred ecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....|+..|+|||.+.. ..++.++|||||||++|||++|+.||..........+... .. . ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~-----~------~~~-- 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL-----T------VNV-- 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh-----c------CCc--
Confidence 23468999999999864 5689999999999999999999999975432111100000 00 0 000
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRA 475 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~ 475 (579)
..+......+.+++..|++.||.+|| ++.|+++.
T Consensus 217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12233456788999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=299.86 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=197.6
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhc---CCCCcceEEEEEEeCCe-----
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQV---HHRHLVSLVGYCTFGSQ----- 272 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~~~~----- 272 (579)
|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++.++ +|+||++++++|...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999986 489999999974322 2234566788887766 59999999999988776
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+++|||+.+ +|.+++.......+++..++.++.|+++||.|||+. +++|+||||+|||++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 788888655444689999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh---hccc-
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA---QGLA- 428 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~- 428 (579)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+...... ..+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhcCC
Confidence 533221 12335788999999999999999999999999999999999999754421 111111110000 0000
Q ss_pred -----CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 429 -----DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 429 -----~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+..................+.+++.+||+.||.+||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0001111111111122234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=304.62 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=192.9
Q ss_pred CccccceecccCceEEEEEEE----eCCeEEEEEEeccCCc----hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 008052 203 NFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGSG----QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~~----~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 273 (579)
+|+..+.||+|+||.||++.. .+|+.||+|+++.... ...+.+.+|+.++.++ +|+||+.+++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999986 3688999999875322 2235678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++... ..+.+.....++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998654 3478889999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccChhhhccC--CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
............|+..|+|||.+..+ .++.++||||||+++|+|++|..||...... ....++......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~------- 226 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILK------- 226 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhc-------
Confidence 43322222345689999999998753 4788999999999999999999999643221 111122111110
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP 467 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP 467 (579)
....++......+.+++.+|++.+|.+||
T Consensus 227 -------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 227 -------SEPPYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred -------cCCCCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 00012233456788999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.68 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=197.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~ 273 (579)
.+|...+.||+|+||.||+|... +++.||+|.+... .......+++|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999964 5889999987432 123345788999999999999999999998764 467
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++|+||+++++|.+++.... .+.+....+++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999886433 478899999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCc--ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 354 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 354 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~------------- 221 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI------------- 221 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH-------------
Confidence 32111 11223568999999999998889999999999999999999999997543211 00000
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..-+....++......+.+++..|++. +.+||+..+++.
T Consensus 222 ---~~~~~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~ 260 (264)
T cd06653 222 ---ATQPTKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLR 260 (264)
T ss_pred ---HcCCCCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhc
Confidence 000011123444556789999999994 699999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.78 Aligned_cols=264 Identities=19% Similarity=0.321 Sum_probs=196.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~ 273 (579)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 68899999986432 22345678899999999999999999987654 357
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++|+||+.+ +|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 899999975 77777643 3489999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCcc--eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 354 LDTDTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 354 ~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
...... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+... .+ .+....+... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~-~~~~~~~~~~-~~~ 232 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QL-NLILGVLGTP-SQE 232 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH-HHHHHHcCCC-CHH
Confidence 332221 1123568999999998754 568999999999999999999999997544211 00 0000000000 000
Q ss_pred Cchhhhchh---------------hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 431 NFDALVDQK---------------LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 431 ~~~~l~d~~---------------l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+..+.+.. +..........+.+++.+||+.+|.+||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001000 000111234668899999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=304.39 Aligned_cols=255 Identities=25% Similarity=0.314 Sum_probs=201.0
Q ss_pred CccccceecccCceEEEEEEEe----CCeEEEEEEeccCCc----hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSG----QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~----~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 273 (579)
+|...+.||+|+||.||+++.. +++.||||.++.... .....+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677899999999999999853 567899999864321 2234678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|..++... ..+.+.....++.|++++|.|||+. +++||||||+|||++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999988643 3588999999999999999999998 9999999999999999999999999998865
Q ss_pred CCCCcceeecccccccccChhhhccCC--CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
............|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ...++..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~-----~~- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRIL-----KS- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHH-----cc-
Confidence 443332233356899999999987665 7889999999999999999999996433211 1111111110 00
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
....+......+.+++.+||+.+|++||++.++.+.|+-
T Consensus 228 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 --------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 001222234567899999999999999999999888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=305.73 Aligned_cols=243 Identities=22% Similarity=0.360 Sum_probs=197.4
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchh
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~ 286 (579)
..||+|+||.||++... +++.||||++..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 68999999987655555667899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccc
Q 008052 287 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366 (579)
Q Consensus 287 ~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g 366 (579)
+++.. ..+++.....++.|++.+|+|||+. +++||||||+||+++.++.++|+|||++....... .......|
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 178 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 178 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence 88743 2478999999999999999999998 99999999999999999999999999987653322 12233568
Q ss_pred cccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHH
Q 008052 367 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSA 446 (579)
Q Consensus 367 t~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~ 446 (579)
+..|++||++.+..++.++|||||||++|||++|..||....... ...... .. ....+. ....
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~~~----~~---------~~~~~~-~~~~ 241 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIR----DN---------LPPKLK-NLHK 241 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hh---------CCcccC-Cccc
Confidence 899999999988889999999999999999999999997543211 111100 00 001110 1112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 447 EMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 447 ~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+.+++.+||+.+|.+||++.+|++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 3456788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.76 Aligned_cols=262 Identities=18% Similarity=0.240 Sum_probs=194.3
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCc
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~ 284 (579)
.+.+|.|+++.||++.. +++.||||+++.. .......+.+|++++++++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34456666666666655 6899999998754 33345678999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc------
Q 008052 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT------ 358 (579)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~------ 358 (579)
|.+++.......+++.....++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999765445688999999999999999999998 999999999999999999999999998875432211
Q ss_pred ceeecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhccc-------C
Q 008052 359 HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA-------D 429 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------~ 429 (579)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.+-........+. .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhc
Confidence 11123457788999999876 358899999999999999999999997644211 111100000000000 0
Q ss_pred CCchh----hhchhh-----hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 430 GNFDA----LVDQKL-----EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 430 ~~~~~----l~d~~l-----~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..... ..++.. ..........+.+++..||+.||.+||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 000000 1223344567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.29 Aligned_cols=268 Identities=19% Similarity=0.297 Sum_probs=199.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~ 274 (579)
++|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+|.+++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68899999999999999999965 68999999986542 2234567789999999999999999988753 34679
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+||||+. ++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 9999995 6888888654 3489999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCcc---eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhh----hhhHhhhc
Q 008052 355 DTDTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW----AKPFLAQG 426 (579)
Q Consensus 355 ~~~~~---~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~----~~~~~~~~ 426 (579)
..... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+.........- ....+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 1234578999999999865 5689999999999999999999999976543111000000 00000000
Q ss_pred ccCCCchhhhch-------hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 427 LADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 427 ~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.....+....+. ............+.+++..|++.+|.+||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000111111110 0011112345779999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.32 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=194.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-------
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------- 271 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------- 271 (579)
++|+..+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57899999999999999999975 689999999864322 22345678999999999999999999987643
Q ss_pred -eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 272 -QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 272 -~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
..++||||+.+ +|.+.+.... ..+++.+.+.++.|++.||+|||++ +++|+||||+|||++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 7777765432 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhh----hH
Q 008052 351 KHSLDTDTH---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK----PF 422 (579)
Q Consensus 351 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~----~~ 422 (579)
......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||...+............ +.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 865432211 12234578899999998764 47889999999999999999999997654321111111000 00
Q ss_pred hhhccc----------CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 423 LAQGLA----------DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 423 ~~~~~~----------~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+..... .......+...+. .......+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLK--PYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcc--cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 0000000001110 0011245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=301.74 Aligned_cols=265 Identities=21% Similarity=0.269 Sum_probs=200.4
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
|...+.||+|++|.||+|... +++.+++|.++..... ....+..|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999975 6889999998654322 3467888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++ +|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 7777776543 4589999999999999999999998 99999999999999999999999999987654433 12
Q ss_pred eecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchh-hhh-------hhhHhhhcccCC-
Q 008052 361 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM-VDW-------AKPFLAQGLADG- 430 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~-~~~-------~~~~~~~~~~~~- 430 (579)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+.... .+. ....+.+.....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234578899999998776 789999999999999999999999976543211000 000 000000000000
Q ss_pred -CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 431 -NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 431 -~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+....+.............+.+++..||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000111122345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=306.85 Aligned_cols=268 Identities=25% Similarity=0.311 Sum_probs=196.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~l 275 (579)
.++|+..+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367999999999999999999975 5899999998654321 123567899999999999999999998764 46799
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+.+ +|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999975 7777775432 4589999999999999999999998 999999999999999999999999999987543
Q ss_pred CCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhhhhh---HhhhcccC-
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKP---FLAQGLAD- 429 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~~~~---~~~~~~~~- 429 (579)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..... .+..+... .+...+..
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 321 1223346788999999865 56789999999999999999999999765432110 00110000 00000000
Q ss_pred ---CCchhhhchh---hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 430 ---GNFDALVDQK---LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 430 ---~~~~~l~d~~---l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+.+ .+.... +..........+.+++..|++.||++||++.|+++.
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000000 000001124567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.04 Aligned_cols=259 Identities=19% Similarity=0.238 Sum_probs=184.6
Q ss_pred hcCccccceecccCceEEEEEEEeC----CeEEEEEEeccCCchh--H---------HHHHHHHHHHHhcCCCCcceEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQG--E---------REFQAEIEIISQVHHRHLVSLVG 265 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~--~---------~~~~~Ei~~l~~l~Hpniv~l~g 265 (579)
.++|.+.+.||+|+||.||+|.+.+ +..+|+|+........ + .....++..+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999754 3456666543322111 1 11223334455678999999999
Q ss_pred EEEeCC----eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC
Q 008052 266 YCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (579)
Q Consensus 266 ~~~~~~----~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 341 (579)
++.... ..++++|++.. ++.+.+... ...++..+..|+.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 876543 34677777643 454444322 2357788899999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchh
Q 008052 342 AKVADFGLAKHSLDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 415 (579)
Q Consensus 342 ~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~ 415 (579)
+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .+
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~ 242 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NL 242 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HH
Confidence 999999999865432211 1122469999999999999999999999999999999999999997653211 11
Q ss_pred hhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 416 VDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
+.-...-+ +..+....+. .......+.+++..|++.+|++||++.++++.|+
T Consensus 243 ~~~~~~~~--------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDF--------IKRLHEGKIK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHH--------HHHhhhhhhc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11110000 0111111111 1123567899999999999999999999998773
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.49 Aligned_cols=262 Identities=19% Similarity=0.289 Sum_probs=193.3
Q ss_pred ceeccc--CceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQG--GFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
..||+| +||+||+++.. +|+.||||++.... ....+.+.+|+.+++.++|+||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999974 78999999986543 22345788999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce--
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-- 360 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-- 360 (579)
++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988765445689999999999999999999998 99999999999999999999999998654322111100
Q ss_pred ----eecccccccccChhhhccC--CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh---------Hh--
Q 008052 361 ----STRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP---------FL-- 423 (579)
Q Consensus 361 ----~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~---------~~-- 423 (579)
.....++..|+|||++.++ .++.++|||||||++|||++|+.||....... .+...... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccch
Confidence 0112356679999999764 47899999999999999999999997653211 11000000 00
Q ss_pred ------------hhcccCCCc-----hhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 424 ------------AQGLADGNF-----DALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 424 ------------~~~~~~~~~-----~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+....+ ..+.+..+. .........+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000000 001111111 122345678899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.64 Aligned_cols=254 Identities=25% Similarity=0.431 Sum_probs=194.8
Q ss_pred hhcCccccceecccCceEEEEEEEeC-CeEEEEEEeccCC-chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGS-GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV 276 (579)
..++|...+.||+|+||.||+|.+.+ ++.||||.++... ......+..|+.++.++. |+||++++++|......++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678888999999999999999864 8999999997543 233456677888777776 99999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+.+ +|..++.... ..+++..+..++.|+++||+|||+.+ +|+||||+|+|||+++++.+||+|||++......
T Consensus 93 ~e~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999854 6665554322 36899999999999999999999732 8999999999999999999999999998765432
Q ss_pred CcceeecccccccccChhhhccCC----CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.. .....++..|+|||++.... ++.++||||||+++|||++|+.||...... .+.+.. .+ .+..
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~----~~-----~~~~ 236 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTK----IL-----QEEP 236 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHH----Hh-----cCCC
Confidence 22 12335788999999987554 889999999999999999999999653211 001110 00 0000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.. . .........+.+++.+||+.||.+||++.++++.
T Consensus 237 ~~-----~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PS-----L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-----C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 0111234568999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.08 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=190.0
Q ss_pred ceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHH-HhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEII-SQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l-~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|... +++.||||.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999974 588999999865432 1223445555544 445899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
++|..++... ..+++..+..++.|++.||.|||+. +|+||||+|+|||+++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 9999998644 3488899999999999999999998 999999999999999999999999999876432 23
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
...++..|++||.+.+..++.++||||||+++|||++|..||...+.. .+ + .... .+... . ...
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~--~-~~~~-----~~~~~--~---~~~ 215 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AV--F-DNIL-----SRRIN--W---PEE 215 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HH--H-HHHH-----hcccC--C---CCc
Confidence 346889999999998888999999999999999999999999754321 10 1 0000 00000 0 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 443 YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 443 ~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
........+.+++.+|++.+|.+||++.++.+.|.
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11234567899999999999999998776655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.10 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=187.3
Q ss_pred eecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHH---HHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 209 LLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIE---IISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~---~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
.||+|+||.||++... +++.||+|.+..... .....+..|.. ++....|+||+.+++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999999865321 11223444444 3444579999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.+++... ..+++..+..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999888543 4599999999999999999999998 99999999999999999999999999987643322 1
Q ss_pred ecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....|+..|+|||++.++ .++.++|||||||++|||++|+.||.......... ..... . ....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~-------~------~~~~-- 216 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMT-------L------TMAV-- 216 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHh-------h------ccCC--
Confidence 234689999999999754 68999999999999999999999997653211100 00000 0 0000
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
..+......+.+++.+|+..+|.+|| ++.++++
T Consensus 217 -~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 12222356789999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=320.77 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=193.7
Q ss_pred cceecccCceEEEEEEEe-CCeEEEEEEecc----CCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe--EEEEEEe
Q 008052 207 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKA----GSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ--RLLVYEF 279 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~----~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~lV~E~ 279 (579)
..+||+|.|-+||||... +|..||--.++. .+....+.|..|+++|+.|+|+|||+++.++.+... ..+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 478999999999999964 577777332221 122334679999999999999999999999987655 6789999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecccccccCCCCc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~~~~~~~~ 358 (579)
|..|+|..++.... .++......|+.||++||.|||++ .|+|||||||..||||+. .|.|||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 99999999996554 478889999999999999999997 789999999999999975 489999999999875432
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
....+.|||.|||||... ..|++.+||||||++++||+|+..||..-.... .+.. .+..++.-..+..+
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYK----KV~SGiKP~sl~kV--- 268 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYK----KVTSGIKPAALSKV--- 268 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHH----HHHcCCCHHHhhcc---
Confidence 224478999999999988 889999999999999999999999997654311 1110 01111111112222
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 478 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~ 478 (579)
...++.++|..||.. ..+||++.|+|. +|..
T Consensus 269 --------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 269 --------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred --------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 235688999999999 999999999985 4443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=301.54 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=202.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV 276 (579)
++|...+.||+|+||.||+|+.. +++.||+|++... .......+..|++++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 6899999998653 2233467889999999999 99999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++... ..+++..++.|+.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999998654 3599999999999999999999998 9999999999999999999999999998865433
Q ss_pred Cc-------------------ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhh
Q 008052 357 DT-------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417 (579)
Q Consensus 357 ~~-------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~ 417 (579)
.. .......++..|++||.+....++.++||||||+++++|++|+.||....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQ 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH
Confidence 21 11223457899999999998889999999999999999999999997654210 000
Q ss_pred hhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 008052 418 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM----SQIVR 474 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm----~evl~ 474 (579)
.+.+ ....++......+.+++.+||+.+|.+||++ .++++
T Consensus 233 ----------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 ----------------KILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----------------HHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 0002233335678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.01 Aligned_cols=271 Identities=19% Similarity=0.286 Sum_probs=200.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~ 273 (579)
++|...+.||+|+||.||+|+.. +++.||||.++.. .......+.+|+.++++++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 57888999999999999999964 6889999998653 222345677899999999999999999988654 347
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+|||||+. ++|.+++... ..+.+.....++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 99999996 6788877543 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhhhhh---hHhhhccc
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWAK---PFLAQGLA 428 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~~~~---~~~~~~~~ 428 (579)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+...... +..... .-....+.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4332 12233467889999998864 568999999999999999999999997543211000 000000 00000000
Q ss_pred CCCchhhh-------chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcC
Q 008052 429 DGNFDALV-------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGN 479 (579)
Q Consensus 429 ~~~~~~l~-------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~--Le~~ 479 (579)
.......+ +.............+.+++.+||+.+|++||++.|+++. |+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000 111111112345678999999999999999999999976 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.81 Aligned_cols=269 Identities=20% Similarity=0.315 Sum_probs=197.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~ 271 (579)
.++|...+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++.+++|+||++++++|... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999964 68999999986532 22235678999999999999999999998654 3
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++|+||+.+ +|..++. ..+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 46899999964 6766542 2488999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhh----hhhHhhhc
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW----AKPFLAQG 426 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~----~~~~~~~~ 426 (579)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.........+ ..+.+.+.
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 64321 123467889999999876 4689999999999999999999999976542111000000 00000000
Q ss_pred ccCCCchhhhc-------hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcCCC
Q 008052 427 LADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEGNMP 481 (579)
Q Consensus 427 ~~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~~~~ 481 (579)
+........+. ..+..........+.+++.+||+.||.+||++.|++. .+++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 10000000000 0000001123456889999999999999999999995 3665433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.01 Aligned_cols=267 Identities=21% Similarity=0.304 Sum_probs=202.0
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRL 274 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~~ 274 (579)
+|...+.||.|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 48899999987643 334467889999999999999999999998765 789
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+||||+. ++|..++.... .+++..++.++.+++.||+|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 47888886543 689999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCc--ceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhhhhhHhhhc---c
Q 008052 355 DTDT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQG---L 427 (579)
Q Consensus 355 ~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~---~ 427 (579)
.... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .+..+......+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 112334688899999999877 8899999999999999999999999765531100 0000000000000 0
Q ss_pred cCCCchhhhc-------hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 428 ADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 428 ~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
........+. ..+..........+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 00011112245678999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.15 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=205.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
...|.+...||+|.|++|.+|++. .+..||||.+.+.... ..+.+.+|+++|..|+|||||+|+.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467889999999999999999965 5889999999765433 2345889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+.+|.++++|...++ +.......+..|+..+++|||.+ .|||||||++||||+.+.++||+|||++..+. .
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--c
Confidence 99999999999976654 56677788899999999999999 89999999999999999999999999998865 3
Q ss_pred cceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.......+|++.|.|||++.+..| ++++|+||+||+||-|++|.+||++.... .+-
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----------------------~Lr 264 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----------------------ELR 264 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----------------------ccc
Confidence 445677899999999999998766 58999999999999999999999865431 111
Q ss_pred chhhh---cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 437 DQKLE---EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 437 d~~l~---~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
++.+. ..+.-....+-++++.+|-.+|.+|+++.++.+.
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111 1222233556788999999999999999999753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.51 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=201.2
Q ss_pred hhcCcccc-ceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe----CCe
Q 008052 200 ATDNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF----GSQ 272 (579)
Q Consensus 200 ~~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~----~~~ 272 (579)
.+++|++. ++||-|-.|+|-.+..+ .++.+|+|+|... ...++|+++..+.. |+|||+++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34566553 67999999999999865 6889999998643 45678999888875 9999999999865 345
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeeccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGL 349 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFGl 349 (579)
+++|||+|+||.|...++.++...+.+.+...|+.||..|+.|||+. +|.||||||+|+|... |..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 67899999999999999988888899999999999999999999999 9999999999999954 56799999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
|+...... ...+-+.|+.|.|||++...+|+...|+||+||++|-|++|.+||....... + .+-+...+..
T Consensus 211 AK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---i----spgMk~rI~~ 281 (400)
T KOG0604|consen 211 AKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---I----SPGMKRRIRT 281 (400)
T ss_pred ccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---C----ChhHHhHhhc
Confidence 99754322 2345678999999999999999999999999999999999999998654311 0 0111111222
Q ss_pred CCchhhhchhhhcCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 430 GNFDALVDQKLEEYD----SAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~----~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.+ .|+ ....+...++++.+|+.+|.+|.|+.|++.
T Consensus 282 gqy---------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 GQY---------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCc---------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 222 233 234466788999999999999999999985
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.16 Aligned_cols=269 Identities=23% Similarity=0.265 Sum_probs=194.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 271 (579)
.++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++.+++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 5889999998543221 2346778999999999999999999875433
Q ss_pred --eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccc
Q 008052 272 --QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (579)
Q Consensus 272 --~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGl 349 (579)
..++|+||+.+ +|...+... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999975 566655443 33599999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCc----------ceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchh-hh
Q 008052 350 AKHSLDTDT----------HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM-VD 417 (579)
Q Consensus 350 a~~~~~~~~----------~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~-~~ 417 (579)
++....... ...+...++..|+|||++.+. .++.++|||||||++|||++|+.||........... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 976433211 111234678899999988654 588999999999999999999999976543211000 00
Q ss_pred hh-------hhHhh--hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 418 WA-------KPFLA--QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 418 ~~-------~~~~~--~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .+.+. .............+.+..........+.+++.+|++.+|.+||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00 00000 00000000000111111111122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=300.70 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=192.5
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
|...+.||+|+||.||+|+.. +++.|++|++..... .....+.+|++++++++|+|+++++++|.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566688999999999999964 688999999864322 2335688899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+. ++|.+.+.... ..+++.+++.++.|++.+|.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 46666664332 3589999999999999999999998 999999999999999999999999999865322
Q ss_pred eeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 360 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||...+... ...+. . ......
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~~~---~-----~~~~~~-- 239 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI---A-----QNDSPT-- 239 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH---H-----hcCCCC--
Confidence 12356889999999984 4678899999999999999999999987654211 11100 0 000000
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 240 -----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223458889999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=295.03 Aligned_cols=249 Identities=22% Similarity=0.262 Sum_probs=192.7
Q ss_pred HHHHHhhcCcccccee--cccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 008052 195 EELKIATDNFSEANLL--GQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (579)
Q Consensus 195 ~el~~~~~~f~~~~~L--G~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 270 (579)
.++....++|.+.+.+ |+|+||.||+++.. +++.+|+|.+...... .. |+.....+ +|+||++++++|...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444445677777776 99999999999964 6788999998653211 11 22222222 699999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeeccc
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGL 349 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGl 349 (579)
+..++||||+++++|.+++.... .++|.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999986543 689999999999999999999998 899999999999999988 999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||...... ......|...
T Consensus 157 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-------- 222 (267)
T PHA03390 157 CKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKR-------- 222 (267)
T ss_pred ceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHh--------
Confidence 8764322 2245889999999999889999999999999999999999999744321 1111122111
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVR 474 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-m~evl~ 474 (579)
..... .........+.+++.+||+.+|.+||+ +.|+++
T Consensus 223 ------~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 ------QQKKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------hcccC-CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00000 122234567899999999999999995 688874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.81 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=194.7
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.|...+.||+|+||.||+|+.. +++.||+|.+... ......++.+|++++++++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999965 5788999998642 22334568889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+. |+|.+++.... ..+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 57766664332 3488999999999999999999998 9999999999999999999999999998764322
Q ss_pred ceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 359 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...+.. ..+..+. .+..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~---------~~~~--- 231 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA---------QNES--- 231 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHh---------hcCC---
Confidence 2345889999999974 356889999999999999999999998654321 0111111 0000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
+. .........+.+++.+||+.+|.+||++.+|++...
T Consensus 232 --~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 --PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 011233456889999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.64 Aligned_cols=273 Identities=20% Similarity=0.286 Sum_probs=202.3
Q ss_pred cCHHHHHHhhcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 008052 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (579)
Q Consensus 192 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 268 (579)
....++....++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.+++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34456777889999999999999999999985 468999999987532 223456788999999999999999999886
Q ss_pred eC------CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 269 FG------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 269 ~~------~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 43 3467888876 78898877532 489999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhh--
Q 008052 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDW-- 418 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~-- 418 (579)
||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..... .+..+
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999998764321 233468899999999865 56889999999999999999999999654421100 00000
Q ss_pred -hhhHhhhcccCCCchhhh-------chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 419 -AKPFLAQGLADGNFDALV-------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 419 -~~~~~~~~~~~~~~~~l~-------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+.+...+........+ ..............+.+++.+|++.||.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000111111111000000 000001111234568899999999999999999998863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.68 Aligned_cols=248 Identities=20% Similarity=0.311 Sum_probs=195.0
Q ss_pred CccccceecccCceEEEEEEEeC-CeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+|.+.+.||+|+||.||++.... +..+++|.++.. .......+..|+.++.+++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778999999999999998653 444556655432 222344677899999999999999999999998999999
Q ss_pred EEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 277 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|||+++++|..++.. .....+++..++.++.|++.||.|||+. +++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988753 2334689999999999999999999998 9999999999999986 469999999987654
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
.... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... .......
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~------------ 217 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRI------------ 217 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH------------
Confidence 3322 22335588899999999888899999999999999999999999964321 1111110
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
........+......+.+++.+|++.+|++||++.|+++
T Consensus 218 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 -VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011111223345567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=331.97 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=191.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-------- 270 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-------- 270 (579)
..+|++.++||+||||.|||++.+ ||+.+|||++.... ...-..+.+|+.+|++|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 357888899999999999999976 89999999996653 23345688999999999999999986411000
Q ss_pred --------------------------------------------------------------------------------
Q 008052 271 -------------------------------------------------------------------------------- 270 (579)
Q Consensus 271 -------------------------------------------------------------------------------- 270 (579)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 008052 271 -------------------------------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319 (579)
Q Consensus 271 -------------------------------~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~ 319 (579)
..+||-||||+..+|.++++.+.... .-...++++.+|+.||+|+|+.
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC
Confidence 12478899999999988886543211 3556788999999999999999
Q ss_pred CCCceEeCCCCCCceEeCCCCCeEEeecccccccC------C-----------CCcceeecccccccccChhhhccC---
Q 008052 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL------D-----------TDTHVSTRVMGTFGYLAPEYASSG--- 379 (579)
Q Consensus 320 ~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~APE~~~~~--- 379 (579)
+||||||||.|||||.+..|||+|||+++... + ......+..+||.-|+|||++.+.
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998621 0 011123557899999999999754
Q ss_pred CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhh
Q 008052 380 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACI 459 (579)
Q Consensus 380 ~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl 459 (579)
+|+.|+|+|||||||+||+. ||...-+ +......+..+.+..- ..+.......-..++.+++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsME----------Ra~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSME----------RASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHH----------HHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHh
Confidence 59999999999999999986 5643211 1112222222322111 2345556666788999999
Q ss_pred ccCCCCCCCHHHHHH
Q 008052 460 RHSARRRPRMSQIVR 474 (579)
Q Consensus 460 ~~dp~~RPtm~evl~ 474 (579)
++||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999974
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.56 Aligned_cols=262 Identities=27% Similarity=0.460 Sum_probs=210.8
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeC--------CeEEEEEEeccCCch-hHHHHHHHHHHHHhcC-CCCcceEEEE
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVH-HRHLVSLVGY 266 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~-Hpniv~l~g~ 266 (579)
+++..+++.+.+.||+|.||.|++|.... ...||||.++..... ..+.+..|+++|..+- |+|||.|+|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 33444555566799999999999998531 357999999876443 4568999999999985 9999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhcCCC------C--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCC
Q 008052 267 CTFGSQRLLVYEFVPNKTLEFHLHGKD------R--------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSA 332 (579)
Q Consensus 267 ~~~~~~~~lV~E~~~~g~L~~~l~~~~------~--------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~ 332 (579)
|...+..++|+||+..|+|..+|..+. . ..+.....+.++.|||.|++||++. ++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999997654 0 2388899999999999999999999 8999999999
Q ss_pred ceEeCCCCCeEEeecccccccCCCCcceeecccc--cccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCc
Q 008052 333 NILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG--TFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADT 409 (579)
Q Consensus 333 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~ 409 (579)
||||.++..+||+||||++............-.| ...|||||.+....|+.|+|||||||+||||+| |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999765554433222222 456999999999999999999999999999999 9999965221
Q ss_pred cccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 410 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+.++. ..|. ....+..+..++.++++.||+.+|++||++.|+++.|+..
T Consensus 528 --~~~l~~~l--------~~G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 --TEELLEFL--------KEGN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --HHHHHHHH--------hcCC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11122221 1121 1133445577889999999999999999999999999974
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=295.65 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=199.2
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
|+..+.||+|+||.||+|+.. +++.||+|.++... ......+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999976 48999999987653 222456788999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
+ ++|.+++.... ..+++..+..++.++++||+|||+. +|+||||+|+||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 58999887543 3589999999999999999999998 999999999999999999999999999986543322 1
Q ss_pred eecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh-------hhcc-----
Q 008052 361 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL-------AQGL----- 427 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------~~~~----- 427 (579)
.....++..|+|||.+... .++.++|||||||++|||++|+.||....... ...+....+ ...+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccccc
Confidence 2234467889999998766 88999999999999999999999997654211 000000000 0000
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+..................+.+++.+|++.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00011111111111111122567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.02 Aligned_cols=266 Identities=21% Similarity=0.277 Sum_probs=194.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC----------
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG---------- 270 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~---------- 270 (579)
.+|...+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67889999999999999999975 5889999998766555567788999999999999999999776543
Q ss_pred ----CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-CCCCeEEe
Q 008052 271 ----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVA 345 (579)
Q Consensus 271 ----~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-~~~~~kL~ 345 (579)
...++||||++ ++|..++.. ..+.+.....++.|+++||.|||+. +|+||||||+|||++ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 588877743 2488999999999999999999998 999999999999997 45678999
Q ss_pred ecccccccCCCCcce--eecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH
Q 008052 346 DFGLAKHSLDTDTHV--STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 422 (579)
Q Consensus 346 DFGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 422 (579)
|||+++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||................+.
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999997643221111 122357889999998754 56888999999999999999999999765432111100000000
Q ss_pred h----hhcccCCCchhhh------chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 423 L----AQGLADGNFDALV------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 423 ~----~~~~~~~~~~~l~------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. ...........+. ...+..........+.+++..|++.||.+||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0000000000000 00000111123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=291.18 Aligned_cols=267 Identities=23% Similarity=0.401 Sum_probs=206.9
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFG 270 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~ 270 (579)
+++|+-..++ ++||+|.|+.|--++ +.+|+.+|||++.+.....+..+.+|++++.+.+ |+||+.|+.+|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3566666553 789999999999988 6789999999998888788888999999999997 99999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC---CeEEeec
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVADF 347 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~kL~DF 347 (579)
+.+|||||-|.||.|..|++. +..+++.+..++..+|+.||.|||.+ +|.||||||+|||..+-. -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999965 45699999999999999999999999 999999999999996654 4799999
Q ss_pred ccccccCCC------CcceeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhh
Q 008052 348 GLAKHSLDT------DTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 416 (579)
Q Consensus 348 Gla~~~~~~------~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~ 416 (579)
.|..-.-.. .+....+-+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.-..+ .
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----C 299 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----C 299 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----C
Confidence 886532111 111223467999999999763 3468999999999999999999999998765421 2
Q ss_pred hhhhhHhhhcccCCCchhhhchhhhcCCHHH----HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 417 DWAKPFLAQGLADGNFDALVDQKLEEYDSAE----MTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~----~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.|.+....+.-.+..+..+-+... +|+.++ ..+..+++...+-.|+.+|-++.+++.
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 343221111100111111111111 344443 345677888888899999999999987
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=303.50 Aligned_cols=267 Identities=23% Similarity=0.284 Sum_probs=195.3
Q ss_pred cCcc-ccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh--------------HHHHHHHHHHHHhcCCCCcceEEE
Q 008052 202 DNFS-EANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--------------EREFQAEIEIISQVHHRHLVSLVG 265 (579)
Q Consensus 202 ~~f~-~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~Ei~~l~~l~Hpniv~l~g 265 (579)
++|. ..+.||.|+||.||+|... +++.||||+++...... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 3577999999999999965 68999999986543221 124778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEe
Q 008052 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (579)
Q Consensus 266 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~ 345 (579)
++...+..++||||+. ++|.+++... ..+++.....++.|++.||.|||+. +|+|||||++|||++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999997 5888888543 3488999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCC-------------cceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccc
Q 008052 346 DFGLAKHSLDTD-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411 (579)
Q Consensus 346 DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~ 411 (579)
|||+++...... ........++..|+|||++.+. .++.++|||||||++|||++|..||...+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999987654111 0111223468899999998764 47899999999999999999999997655321
Q ss_pred cc-hhhhhhhhHhhhcccC----C---CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 412 DD-SMVDWAKPFLAQGLAD----G---NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 412 ~~-~~~~~~~~~~~~~~~~----~---~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .+..+........+.. . .+..................+.+++..|++.+|++||++.|++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 10 0001000000000000 0 00000111111111223466889999999999999999999996
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.47 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=204.0
Q ss_pred hcCccccceecccCceEEEEEE-EeCCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
+-++...+.||.|.||.||.|. ..+|...|||-++..... ....+.+|..+|..|+|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4567778999999999999999 457999999998654333 3456789999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|||.+|+|.+.+... ...++.....+-.|++.||+|||++ |||||||||.||||+.+|.+|++|||.|+......
T Consensus 1314 EyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 999999999998543 2355555566788999999999999 99999999999999999999999999998765442
Q ss_pred cc---eeecccccccccChhhhccCC---CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 358 TH---VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 358 ~~---~~~~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
.. .....+||+-|||||++.+.+ -..+.||||||||++||+||++||...+. +|+.-+- +..|.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~---V~~gh 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYH---VAAGH 1458 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhH---HhccC
Confidence 11 123568999999999997543 45689999999999999999999987654 4553322 22222
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
.. .++.....+=.+++..||+.||++|.++.|+++.-
T Consensus 1459 ~P--------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 KP--------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CC--------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 11 34455667788999999999999999988877643
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.85 Aligned_cols=272 Identities=26% Similarity=0.361 Sum_probs=204.4
Q ss_pred ccccceecccCceEEEEEEE-eCCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeC------CeEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQRLL 275 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~~~~l 275 (579)
+...+.||+|+||.||+|+. ..|+.||||.++..... ..+.+.+|+++|++|+|+|||+++++=+.. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 33457899999999999995 47999999999765432 345677999999999999999998875443 34579
Q ss_pred EEEecCCCchhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe--CCCC--CeEEeecccc
Q 008052 276 VYEFVPNKTLEFHLHGK-DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL--DDSF--EAKVADFGLA 350 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl--~~~~--~~kL~DFGla 350 (579)
|||||.+|+|...|..- +...|++.+.+.+..++..||.|||++ +||||||||.||++ ..+| -.||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999754 345799999999999999999999998 99999999999998 3334 4799999999
Q ss_pred cccCCCCcceeecccccccccChhhhc-cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh------
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL------ 423 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~------ 423 (579)
+...+.. ..+.++||..|++||... .+.|+..+|.|||||++||++||.+||...........+-|....-
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9876554 557789999999999998 5899999999999999999999999998655432222222221100
Q ss_pred --hhcccCCCchhh-hchhhhcCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHhcCC
Q 008052 424 --AQGLADGNFDAL-VDQKLEEYDSAEMTRMAACAAACIRHSARRRP--RMSQIVRALEGNM 480 (579)
Q Consensus 424 --~~~~~~~~~~~l-~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP--tm~evl~~Le~~~ 480 (579)
.+....|.++.- .-|...........++-.....++..++++|- ...+....+.+++
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 000011111100 00001133445567788888889999999998 6666666665554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=327.95 Aligned_cols=145 Identities=28% Similarity=0.370 Sum_probs=130.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+..|+.++..++|+||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67889999999999999999976 68899999986532 223467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
||+.+++|..++... ..+.+...+.|+.||+.||+|||.+ +||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998643 3478899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=304.44 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=196.9
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-----
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----- 271 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----- 271 (579)
..++|...+.||+|+||.||++... +++.||||+++... ......+.+|+.+|++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999854 68899999986432 223456889999999999999999999987543
Q ss_pred -eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 272 -QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 272 -~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
..++||||+ +++|..++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7788888753 3489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCcccc-chhhhhh---hhHhhh
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWA---KPFLAQ 425 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~---~~~~~~ 425 (579)
...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... ..+.... ...+..
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 864322 123457889999999875 4688999999999999999999999976542110 0000000 000000
Q ss_pred cccCCCchhhhc-------hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 GLADGNFDALVD-------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 ~~~~~~~~~l~d-------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.......... ..+..........+.+++.+|++.||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111111111000 0011111223456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.28 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=191.9
Q ss_pred CccccceecccCceEEEEEEEe-C--CeEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC----Ce
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-N--GKVVAIKQLKAG--SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG----SQ 272 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~--g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~----~~ 272 (579)
+|...+.||+|+||.||+++.. . ++.||||++... .......+.+|++++.++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999965 3 678999998643 222345678899999999 599999999976543 35
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++++||+. ++|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 678889885 6888887543 4589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcc---eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCcccc-------------chh
Q 008052 353 SLDTDTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-------------DSM 415 (579)
Q Consensus 353 ~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-------------~~~ 415 (579)
....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1233568999999998865 4689999999999999999999999976542110 000
Q ss_pred hhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 416 VDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.......... .........+..........+.+++.+|++.+|.+||++.|++.
T Consensus 235 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIR--SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHH--hccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 00000000011111112457889999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.71 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=210.9
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEE
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCT 268 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~ 268 (579)
...+++...++|.++++||+|+||.|+..+++ .+++||.|+++++. ......|.+|-++|..-+.+=||+|...|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34678888899999999999999999999976 58999999997742 223457899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 269 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
+..++|||||||+||+|-.+|...+ .++......++..|.-||.-||+. |+|||||||.|||||..|++||+|||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999997665 578887888899999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhc----c-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYAS----S-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
-|-.+.....-.+...+|||.|++||++. + +.|+..+|+||+||++||||.|..||.. +++++--.
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~--- 291 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYG--- 291 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHH---
Confidence 99877655555566778999999999995 3 6799999999999999999999999964 33443322
Q ss_pred hhcccCCCchhhhchhhh-cCC--HHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 008052 424 AQGLADGNFDALVDQKLE-EYD--SAEMTRMAACAAACIRHSARRRPR---MSQIVR 474 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~-~~~--~~~~~~l~~l~~~cl~~dp~~RPt---m~evl~ 474 (579)
.+++..-. .|+ .+......+||.+.+. +++.|.. +.++-.
T Consensus 292 ----------KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 292 ----------KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ----------HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 23332111 233 3355677888887776 4677776 777654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=302.39 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=198.4
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCe
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQ 272 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~ 272 (579)
+...+++|+..+.||.|+||.||++... +++.||||++... .....+.+..|++++.+++||||++++++|.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999865 7899999987542 22234678899999999999999999999876 567
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++|+||+ +++|..++... .+.+.....++.|+++||.|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 88999998 56888887532 478888889999999999999998 999999999999999999999999999875
Q ss_pred cCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCcccc-chhhhhhhh---Hhhhcc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKP---FLAQGL 427 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~---~~~~~~ 427 (579)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.++... .+.+.+
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4221 123457889999998865 5689999999999999999999999975542110 001111000 000000
Q ss_pred cCCCchhhh-chhhh-cCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 428 ADGNFDALV-DQKLE-EYD-----SAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 428 ~~~~~~~l~-d~~l~-~~~-----~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+....++ .-... ..+ ......+.+++.+|++.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00000 011 1234678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=294.32 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=194.6
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+.+.+..||.|.||+|+|-.++ .|+..|||++..... ....+|+.|.+...+- +.||||+++|.+..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444578999999999999975 699999999987655 3345788888877665 599999999999999999999999
Q ss_pred cCCCchhhh---hcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 280 VPNKTLEFH---LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 280 ~~~g~L~~~---l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|+- +|+.+ .+......+++.-.-+|......||.||.+.. +||||||||+|||||..|.+||||||++-.+.+.
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 954 44432 33333455888888899999999999998875 8999999999999999999999999999765443
Q ss_pred CcceeecccccccccChhhhc--cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 357 DTHVSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~--~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
- ..+.-.|...|||||.+. +..|+-++||||||++|||+.||..||...+. +.+..... ..+....
T Consensus 222 i--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~V-----v~gdpp~ 289 (361)
T KOG1006|consen 222 I--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQV-----VIGDPPI 289 (361)
T ss_pred H--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHH-----HcCCCCe
Confidence 2 234456999999999985 33489999999999999999999999976542 11111111 1121111
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+... ....+....|+.++..|+.+|-.+||+..++.+
T Consensus 290 l~~~---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 290 LLFD---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ecCc---ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1110 111235577999999999999999999998875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.07 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=213.0
Q ss_pred HHHHHHhhcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe--
Q 008052 194 YEELKIATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF-- 269 (579)
Q Consensus 194 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~-- 269 (579)
++.+...++-|.+.+.||.|.+|+||+++. ++++.+|||++..+... .+++..|.+||+.+ +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 334444567789999999999999999994 57899999998776543 46788899999888 49999999999864
Q ss_pred ---CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEee
Q 008052 270 ---GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (579)
Q Consensus 270 ---~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~D 346 (579)
++++|||||||.+|+..+++++..+..|.|..+..|+..++.||.+||.+ .+||||||-.||||+.++.|||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 67899999999999999999877777899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccChhhhccC-----CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh
Q 008052 347 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 347 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
||++..... ......+..||+.|||||++... .|+..+|+||||++..||--|.+|+.+.-+.. .
T Consensus 167 FGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------a 236 (953)
T KOG0587|consen 167 FGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------A 236 (953)
T ss_pred eeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------h
Confidence 999876432 23344567899999999999643 47889999999999999999999987654311 1
Q ss_pred HhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 422 FLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
++ .-.-.|... ..+..-.+++.+++..||.+|.++||++.++++
T Consensus 237 LF---------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LF---------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hc---------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00 001122222 345667789999999999999999999999885
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.04 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=198.0
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe----
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ---- 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~---- 272 (579)
..++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999975 57899999986532 2233567789999999999999999988766554
Q ss_pred --EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 273 --RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 273 --~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 6789888854 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhh---hhhHhhh
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDW---AKPFLAQ 425 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~---~~~~~~~ 425 (579)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+.+. ....+..
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 865332 233467889999999865 46789999999999999999999999755431100 00000 0000111
Q ss_pred cccCCCchhhhch-------hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 GLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 ~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+........+.. ............+.+++.+|++.+|.+||++.||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 1111111111110 001111123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=284.64 Aligned_cols=236 Identities=29% Similarity=0.350 Sum_probs=193.4
Q ss_pred ecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
||+|+||.||++... +++.+|+|.+..... .....+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 588999999865432 2345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeeccc
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 365 (579)
.+++.... .+++.....++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99986543 589999999999999999999997 99999999999999999999999999997654332 1223456
Q ss_pred ccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCH
Q 008052 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 445 (579)
Q Consensus 366 gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 445 (579)
++..|++||.+.+...+.++|+||||+++|||++|+.||...+. ..+.... ....+ .++.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~----------------~~~~~-~~~~ 214 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI----------------LKDPL-RFPE 214 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----------------hcCCC-CCCC
Confidence 88899999999988899999999999999999999999975542 1111110 00000 1222
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHH
Q 008052 446 AEMTRMAACAAACIRHSARRRPRMSQ 471 (579)
Q Consensus 446 ~~~~~l~~l~~~cl~~dp~~RPtm~e 471 (579)
.....+.+++..|+..||.+||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 33567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=295.26 Aligned_cols=242 Identities=27% Similarity=0.384 Sum_probs=199.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhH---HHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGE---REFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~---~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~l 275 (579)
..+|..+.+||+|+||+|.+|..+ ....+|||+|+++..-.. +--..|-.+|... +-|.+++|..++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888999999999999999866 467899999987643222 2233466666655 46889999999998999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+.||+|..+++.-+ .+.++....+|..||-||-+||++ +||+||||..|||||.+|++||+|||+++.-..
T Consensus 428 VMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999996544 378888999999999999999999 999999999999999999999999999997433
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.. ....+.+||+.|+|||.+...+|+..+|+|+|||+||||+.|+.||++.++.. .+..+
T Consensus 503 ~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------------------lF~aI 562 (683)
T KOG0696|consen 503 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------------------LFQAI 562 (683)
T ss_pred CC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HHHHH
Confidence 32 23456899999999999999999999999999999999999999999876421 12222
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPR 468 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 468 (579)
++... .|+.....+.+.+++..+.+.|.+|..
T Consensus 563 ~ehnv-syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEHNV-SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHccC-cCcccccHHHHHHHHHHhhcCCccccC
Confidence 32222 467777888899999999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=302.95 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=184.9
Q ss_pred hhcCccccceecccCceEEEEEEE-----------------eCCeEEEEEEeccCCchhHHHH--------------HHH
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVL-----------------TNGKVVAIKQLKAGSGQGEREF--------------QAE 248 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~~~--------------~~E 248 (579)
..++|++.++||+|+||.||+|.+ ..++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999974 2356799999876543323333 347
Q ss_pred HHHHHhcCCCCc-----ceEEEEEEe--------CCeEEEEEEecCCCchhhhhcCCCC---------------------
Q 008052 249 IEIISQVHHRHL-----VSLVGYCTF--------GSQRLLVYEFVPNKTLEFHLHGKDR--------------------- 294 (579)
Q Consensus 249 i~~l~~l~Hpni-----v~l~g~~~~--------~~~~~lV~E~~~~g~L~~~l~~~~~--------------------- 294 (579)
+.++.+++|.++ +++++||.. .+..+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 778888864 3567999999999999999875321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccccccccCh
Q 008052 295 -PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373 (579)
Q Consensus 295 -~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~AP 373 (579)
..++|..+..|+.|++.+|.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 2346788889999999999999998 899999999999999999999999999976433222112223458899999
Q ss_pred hhhccCCC----------------------CcccceechHHHHHHHHhCCC-CCCCCCccc------cchhhhhhhhHhh
Q 008052 374 EYASSGKL----------------------TEKSDVFSFGVLLLELITGFR-PFDKADTFA------DDSMVDWAKPFLA 424 (579)
Q Consensus 374 E~~~~~~~----------------------~~ksDVwSlGvvl~eLltG~~-Pf~~~~~~~------~~~~~~~~~~~~~ 424 (579)
|.+..... ..+.||||+||+||||++|.. ||.....+. ...+..|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~---- 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM---- 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh----
Confidence 98864321 235799999999999999875 775433221 111122211
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSA---RRRPRMSQIVRA 475 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp---~~RPtm~evl~~ 475 (579)
+....++ . ...........+++..||..++ .+|+++.|+++.
T Consensus 456 --~~~~~~~------~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 --YKGQKYD------F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --hcccCCC------c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0011110 0 1112234567888999998765 789999999863
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.72 Aligned_cols=315 Identities=24% Similarity=0.338 Sum_probs=225.9
Q ss_pred ccccceecccCceE-EEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecC
Q 008052 204 FSEANLLGQGGFGY-VHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 204 f~~~~~LG~G~fg~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
|...+++|.|.-|+ ||+|.. +|+.||||++-... ..-.++||..|+.-+ |||||++++.-.+...+||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 45567789998775 799998 57899999985432 335578999998875 999999977777778899999999
Q ss_pred CCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---C--CCeEEeecccccccC
Q 008052 282 NKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---S--FEAKVADFGLAKHSL 354 (579)
Q Consensus 282 ~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~--~~~kL~DFGla~~~~ 354 (579)
..+|.+++... +.....-...+.+..|+++||++||+. +||||||||.||||+. + .+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 66999998763 221122134567889999999999996 9999999999999975 2 579999999999876
Q ss_pred CCCcce--eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 355 DTDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 355 ~~~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
...... .....||-+|+|||.+....-+..+||||||||+|..++ |.+||.+.-.- +.++ ..++
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NI------------l~~~ 729 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANI------------LTGN 729 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhh------------hcCc
Confidence 544332 345679999999999998888889999999999999999 58999754321 1111 1111
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH------------HHHhcCCC------------------
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV------------RALEGNMP------------------ 481 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl------------~~Le~~~~------------------ 481 (579)
+.- + .++. ..++ ...+||.+|++.+|..||++.+|+ +.|++.-.
T Consensus 730 ~~L-~--~L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s~lL~~le 803 (903)
T KOG1027|consen 730 YTL-V--HLEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPSELLRALE 803 (903)
T ss_pred cce-e--eecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCchHHHHhhc
Confidence 110 0 0111 1111 678899999999999999999996 23322110
Q ss_pred -------CCCCCCCCCCCCCcccCCCCCCCCCchh-----hHHHHHHHHHhhhccccCCCCccCCCCCCCCCCCCC
Q 008052 482 -------LDDLNEGITPGHSTIYGSYGGSDYNSMQ-----YREDMKKFRKIALESVELGSSDYSGLTSDYGQNPPS 545 (579)
Q Consensus 482 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (579)
..+|.+.+..........+++..+++.. .++..+++|+++.+..+..+...+|+..+|--++|-
T Consensus 804 ~~~~~vv~~~W~~kl~~~~~~~l~kyR~Yk~~svrDLLR~iRNk~hHyrELp~~v~ellG~vPdgF~~YFt~RFP~ 879 (903)
T KOG1027|consen 804 AGARVVVSGDWTEKLDKTFMDNLRKYRSYKGSSVRDLLRAIRNKKHHYRELPPEVRELLGDVPDGFDLYFTKRFPN 879 (903)
T ss_pred cCCceEecCchhhhhCHHHHHHHHHhcCcccccHHHHHHHHHhhhhhhhhcCHHHHHhcCCCCcHHHHHHHHhhhH
Confidence 0122222222111223344555555544 677889999999999998888888888888777663
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=289.57 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=193.5
Q ss_pred cCccccceecccCceEEEEEE-EeCCeEEEEEEeccCC---chhHH----HHHHHHHHHHhcCCCCcceEEEEEEe-CCe
Q 008052 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGS---GQGER----EFQAEIEIISQVHHRHLVSLVGYCTF-GSQ 272 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~----~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~ 272 (579)
++|-.+++||+|||+.|||+. +...+.||||+-..+. ....+ ...+|..|...|.||.||++++|+.. .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 446778999999999999998 4567889999864332 22222 24479999999999999999999965 557
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeeccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGL 349 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFGl 349 (579)
+|-|+|||+|.+|+++|.. ...+++.+...|++||+.+|.||.+. .++|||-||||.||||-+ -|.+||+||||
T Consensus 543 FCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 7899999999999999954 45699999999999999999999986 679999999999999954 47899999999
Q ss_pred ccccCCCCcc------eeecccccccccChhhhccC----CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhh
Q 008052 350 AKHSLDTDTH------VSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 419 (579)
Q Consensus 350 a~~~~~~~~~------~~~~~~gt~~y~APE~~~~~----~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~ 419 (579)
++.+.+.... ......||.+|++||.+.-+ +++.|+||||.|||+|+.+.|+.||....... .++...
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILqeN 697 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQEN 697 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHhhh
Confidence 9987654322 23456799999999987533 68899999999999999999999998764311 111110
Q ss_pred hhHhhhcccCCCchhhhchhhhcCC--HHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 420 KPFLAQGLADGNFDALVDQKLEEYD--SAEMTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~~~~--~~~~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
. ++...--.|+ +....+..+++.+||+..-++|-...|+.
T Consensus 698 T--------------IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 T--------------ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred c--------------hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 0 0000000111 22345678899999999999998755543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=292.21 Aligned_cols=243 Identities=24% Similarity=0.364 Sum_probs=194.6
Q ss_pred cceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 207 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
.++||.|.||+||-|+++ +|+.||||++.+- ....+.++++|+.||++++||.||.|.-.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 488999999999999965 7999999999654 2344678999999999999999999999999999999999999555
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC---CCeEEeecccccccCCCCcce
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kL~DFGla~~~~~~~~~~ 360 (579)
-|+ ++-......|+...-..++.||+.||.|||.+ +|+|+||||+||||... -++||||||+|+...+.. .
T Consensus 649 MLE-MILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 649 MLE-MILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred HHH-HHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 454 44444455688877788899999999999998 99999999999999653 379999999999876543 3
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
...++||+.|+|||++..+.|...-|+||.|||+|--++|..||..+....+ .+. +..+ +-+.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-QIQ------------NAaF---MyPp- 785 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-QIQ------------NAAF---MYPP- 785 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-Hhh------------cccc---ccCC-
Confidence 3567899999999999999999999999999999999999999976543111 100 1111 1000
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
+-..+.....++++...|+..-++|-+..+-+
T Consensus 786 -~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 -NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 12234456678889999999888888877665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=273.00 Aligned_cols=238 Identities=28% Similarity=0.329 Sum_probs=194.1
Q ss_pred CceEEEEEEEe-CCeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchhhhhcC
Q 008052 214 GFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291 (579)
Q Consensus 214 ~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~ 291 (579)
+||.||+|+.. +++.+|+|++....... ...+.+|++.+++++|+||+++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999997665444 67899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeeccccccccc
Q 008052 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371 (579)
Q Consensus 292 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~ 371 (579)
... +++..++.++.+++++|.|||+. +|+|+||+|+||+++.++.++|+|||++....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 433 88999999999999999999998 99999999999999999999999999998754432 223456888999
Q ss_pred ChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHH
Q 008052 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRM 451 (579)
Q Consensus 372 APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l 451 (579)
+||.+....++.++|||+||+++++|++|..||..... ...+.++.. ...... ..........+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~--------~~~~~~------~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG--------KPKPPF------PPPEWKISPEA 217 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh--------ccCCCC------ccccccCCHHH
Confidence 99999988899999999999999999999999975321 111111111 000000 00000144678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 008052 452 AACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 452 ~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+++.+|+..+|.+||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.36 Aligned_cols=239 Identities=23% Similarity=0.284 Sum_probs=195.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++.|.....||.|.|+.|-++... .++..+||++... ..+-.+|+.++.+. +|+||+++.+.|.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 466777888999999999999864 6889999999765 23445678777776 59999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe-CCCCCeEEeecccccccCCCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-DDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl-~~~~~~kL~DFGla~~~~~~~ 357 (579)
.+.++-|.+.+..+.. +. ..+..|+.+|+.++.|||++ +||||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999888765433 23 67778999999999999998 99999999999999 58899999999999876443
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
...-+-|..|.|||++....|++++|+||||++||+||+|+.||...... .. +...+..+
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e--------i~~~i~~~------- 529 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE--------IHTRIQMP------- 529 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH--------HHHhhcCC-------
Confidence 22345788999999999999999999999999999999999999865431 00 11111111
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.........+|+..||+.||.+||+|.|+..
T Consensus 530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 233555677889999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=308.19 Aligned_cols=262 Identities=21% Similarity=0.214 Sum_probs=172.6
Q ss_pred hhcCccccceecccCceEEEEEEEe-C----CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEE------EE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-N----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGY------CT 268 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~------~~ 268 (579)
..++|...+.||+|+||.||+|++. + +..||||+++..... +.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999975 4 689999988643221 111111 1222223333322211 34
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCCC------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCC
Q 008052 269 FGSQRLLVYEFVPNKTLEFHLHGKDRP------------------VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 330 (579)
Q Consensus 269 ~~~~~~lV~E~~~~g~L~~~l~~~~~~------------------~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDik 330 (579)
.+...+|||||+.+++|.++++..... ...+..+..|+.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567889999999999999888654211 011233557899999999999998 99999999
Q ss_pred CCceEeCC-CCCeEEeecccccccCCCCcceeecccccccccChhhhccC----------------------CCCcccce
Q 008052 331 SANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG----------------------KLTEKSDV 387 (579)
Q Consensus 331 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~~~ksDV 387 (579)
|+||||+. ++.+||+|||+++..............+++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986544433444567899999999965322 24557799
Q ss_pred echHHHHHHHHhCCCCCCCCCcc-------ccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhc
Q 008052 388 FSFGVLLLELITGFRPFDKADTF-------ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIR 460 (579)
Q Consensus 388 wSlGvvl~eLltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~ 460 (579)
|||||+||||+++..+++..... .+..+..|..... .....++ .... +..........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~-~~~~-~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-----PRASPDL-RRGF-EVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-----cccchhh-hhhh-hhccccchHHHHHHHHHcc
Confidence 99999999999987765432100 0111222221110 0000000 0000 0000112245689999999
Q ss_pred cCCCCCCCHHHHHHH
Q 008052 461 HSARRRPRMSQIVRA 475 (579)
Q Consensus 461 ~dp~~RPtm~evl~~ 475 (579)
.||++||++.|+++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999973
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=276.30 Aligned_cols=220 Identities=21% Similarity=0.180 Sum_probs=176.8
Q ss_pred cCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchhhhhcC
Q 008052 213 GGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291 (579)
Q Consensus 213 G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~ 291 (579)
|.||.||+++.. +++.||+|+++... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 68899999987543 334455555666799999999999999999999999999999998864
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeeccccccccc
Q 008052 292 KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371 (579)
Q Consensus 292 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~ 371 (579)
. ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...... .....++..|+
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 3 3489999999999999999999998 9999999999999999999999999988654332 12234677899
Q ss_pred ChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHH
Q 008052 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRM 451 (579)
Q Consensus 372 APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l 451 (579)
|||.+..+.++.++|||||||++|||++|+.||....... .. ...+ ..+......+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~~----------~~~~---------~~~~~~~~~~ 205 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----NT----------HTTL---------NIPEWVSEEA 205 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----cc----------cccc---------CCcccCCHHH
Confidence 9999988889999999999999999999998875322100 00 0000 1122234568
Q ss_pred HHHHHHhhccCCCCCCCHH
Q 008052 452 AACAAACIRHSARRRPRMS 470 (579)
Q Consensus 452 ~~l~~~cl~~dp~~RPtm~ 470 (579)
.+++.+|++.||.+||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=275.25 Aligned_cols=203 Identities=26% Similarity=0.345 Sum_probs=167.3
Q ss_pred cCccccceecccCceEEEEEEEeC-----CeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTF-GSQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~--~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~ 273 (579)
..|+....||+|.||.||||+-.+ .+.+|+|+++...... ....-+|+.+++.++|+||+.|+.++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 568888999999999999997432 2479999997653321 2345689999999999999999999877 7788
Q ss_pred EEEEEecCCCchhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC----CCeEEee
Q 008052 274 LLVYEFVPNKTLEFHLHGK---DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS----FEAKVAD 346 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~----~~~kL~D 346 (579)
+|++||.+. +|...++.. ....++......|+.||+.|+.|||++ =|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 555555432 224678888899999999999999999 69999999999999877 8999999
Q ss_pred cccccccCCCCcc--eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 347 FGLAKHSLDTDTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 347 FGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
|||++.+.+.-.. ....++-|++|.|||++.+ ..|+.+.|||+.|||+.||+|-.+-|....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999987654332 2355788999999999876 469999999999999999999988886543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.04 Aligned_cols=212 Identities=24% Similarity=0.324 Sum_probs=175.3
Q ss_pred CccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchh---HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQG---EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~---~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
-|..++.||-|.||+|+++.. +....+|.|.|.+.+... ....++|-+||..-..+-||+|+.-|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 377889999999999999984 456789999997654332 3356789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC---
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD--- 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~--- 355 (579)
|++||++..+|-..+ .+.+.....++.++..++++.|.. |+|||||||.|||||.+|++||+|||||.-+..
T Consensus 710 YIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 999999999886543 477777777888999999999999 999999999999999999999999999863211
Q ss_pred -----CCccee---------------------------------ecccccccccChhhhccCCCCcccceechHHHHHHH
Q 008052 356 -----TDTHVS---------------------------------TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLEL 397 (579)
Q Consensus 356 -----~~~~~~---------------------------------~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eL 397 (579)
...|.. -..+||+.|+|||++....++..+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 000000 014699999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcccc-chhhhhh
Q 008052 398 ITGFRPFDKADTFAD-DSMVDWA 419 (579)
Q Consensus 398 ltG~~Pf~~~~~~~~-~~~~~~~ 419 (579)
+.|+.||....+... ..+..|.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehh
Confidence 999999987665443 2345553
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=289.10 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=200.1
Q ss_pred cCccccceecccCceEEEEEEEeCCe-EEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGK-VVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~-~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.++..+..||-||||.|=+....+.. .+|+|++++.. ....+.+..|-.||...+.+.||+||--|.+....||+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999876543 38899887642 222445678999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|-|-||.|...|... ..++..+...++..+.+|++|||.+ +||+|||||+|.|||.+|-+||.|||+|+......
T Consensus 500 EaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999644 4588888889999999999999999 99999999999999999999999999999875443
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
..-++|||+.|.|||.+.....+.++|.|+||+++|||++|.+||...++...-+++ ..+ ++.+
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-------LkG-----id~i-- 638 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-------LKG-----IDKI-- 638 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-------Hhh-----hhhh--
Confidence 345689999999999999999999999999999999999999999987764321111 111 1111
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPR 468 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 468 (579)
.++........++++..++.+|.+|..
T Consensus 639 ----~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 ----EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 355556677888999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=264.64 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=197.7
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 274 (579)
..++|.++++||+|.|.+|..+.+. ..+.+|+|++++.- .....-.+.|-.+..+. +||.+|-|..+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468999999999999999999965 67899999987642 22233455666666665 6999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+|.||++||+|..|++.+. .++++....+...|..+|.|||++ |||.||||..|||||..|++||+|+|+++...
T Consensus 328 fvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999999986553 488888888889999999999999 99999999999999999999999999999754
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcc-ccchhhhhhhhHhhhcccCCCch
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF-ADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
... ....+++||+.|+|||.+.+..|....|+|+|||+++||+.|+.||+-.... .+.+..++. .+.+.+..+
T Consensus 403 ~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl----fqvilekqi- 476 (593)
T KOG0695|consen 403 GPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL----FQVILEKQI- 476 (593)
T ss_pred CCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH----HHHHhhhcc-
Confidence 333 3445689999999999999999999999999999999999999999743211 122222222 111111111
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR 468 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt 468 (579)
..+.....+...+++.-|++||.+|..
T Consensus 477 --------riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 --------RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 233344556777889999999998864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=244.02 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=192.1
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|...++||+|.||+||||+.. .++.||+|+++.+... -.....+||-+|+.++|.|||+|+++...+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666788999999999999954 5889999998654322 235678999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
|+ .+|..+...-++ .++.+....++.|+++||.|+|++ ++.||||||.|.||+.+|++||+||||++.+.-.-..
T Consensus 83 cd-qdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hh-HHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 94 467666654433 488888999999999999999999 9999999999999999999999999999976543322
Q ss_pred eeecccccccccChhhhccC-CCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCC---chh
Q 008052 360 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN---FDA 434 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 434 (579)
....+-|.+|.+|.++-+. -|+...|+||-||++.||.. |++-|.+.+.. +.+-...+.+. ...++. +..
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg--~p~ed~wps~t~ 232 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLG--TPTEDQWPSMTK 232 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhC--CCccccCCcccc
Confidence 2334579999999998765 57899999999999999988 66666655532 22222211111 011111 112
Q ss_pred hhchhhh-cCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLE-EYD---------SAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~-~~~---------~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.|-..- .|+ +.....=.++....+.-+|..|-++++.++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222211 111 111123356667777778888888877664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=270.68 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=202.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-C-C----CcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-H-R----HLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H-p----niv~l~g~~~~~~~~ 273 (579)
+++|.+...||+|.||.|..+... .+..||||+++.-.+. .+..+-|+++|+++. + | -+|.+.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999999965 4689999999865433 345677999999994 2 2 367788889999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC----------------
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---------------- 337 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~---------------- 337 (579)
|||+|.+ |-++.++|..+.-..++...+..|+.|++++++|||+. +++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999988 66899999887777889999999999999999999999 999999999999983
Q ss_pred ----CCCCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc
Q 008052 338 ----DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 413 (579)
Q Consensus 338 ----~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~ 413 (579)
.+..+||+|||-|+..... + ..++.|..|.|||++.+-.++..+||||+||||+||++|..-|...+.....
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~--h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH--H--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccC--c--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 1346899999999864322 1 4567899999999999999999999999999999999999988765521100
Q ss_pred hh-hhh-------------hhhHhhhc-------ccCCCchhhhchh--hh---cCCHHHHHHHHHHHHHhhccCCCCCC
Q 008052 414 SM-VDW-------------AKPFLAQG-------LADGNFDALVDQK--LE---EYDSAEMTRMAACAAACIRHSARRRP 467 (579)
Q Consensus 414 ~~-~~~-------------~~~~~~~~-------~~~~~~~~l~d~~--l~---~~~~~~~~~l~~l~~~cl~~dp~~RP 467 (579)
.+ ... +..++..+ ...+......++. +. .....+...|.+|+..+|..||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 00 000 00000000 0001011111111 11 23345667899999999999999999
Q ss_pred CHHHHHH
Q 008052 468 RMSQIVR 474 (579)
Q Consensus 468 tm~evl~ 474 (579)
|++|++.
T Consensus 399 Tl~EAL~ 405 (415)
T KOG0671|consen 399 TLREALS 405 (415)
T ss_pred cHHHHhc
Confidence 9999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=249.47 Aligned_cols=206 Identities=25% Similarity=0.410 Sum_probs=167.4
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 274 (579)
++..++......||+|+||.|-+-++. +|+..|||.+...- .+..+.++.|+++..+. .+|.+|+++|........+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 344455666788999999999998864 79999999997643 33445778889888775 5999999999999999999
Q ss_pred EEEEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 275 LVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+.||.|+. +|+.+-.. +.+..+++...-+||..+.+||.|||++. .|||||+||+||||+.+|++|+||||++-.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999954 55433221 23456888889999999999999999985 899999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccChhhhcc----CCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
+.+.-. .+-..|.-.|||||.+.. ..|+-|+||||||+.+.||.+++.||+...
T Consensus 199 L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 199 LVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 654322 122458889999998853 368999999999999999999999997543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=258.79 Aligned_cols=266 Identities=24% Similarity=0.367 Sum_probs=191.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chh-HHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQG-EREFQAEIEIISQVHHRHLVSLVGYCTF--------G 270 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--------~ 270 (579)
..|....+||+|.||+||+|+.. .|+.||+|++-... +.. -....+|+.+|..|.|+|++.|+..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34556678999999999999965 57888988764321 111 2356789999999999999999998853 2
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
..++|||++|+. +|.-+|... ...++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 357999999965 565555332 24588899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhh----------
Q 008052 351 KHSLDTDTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV---------- 416 (579)
Q Consensus 351 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~---------- 416 (579)
+.+...... ..+..+-|.+|+.||.+.+ ..|+.+.|||.-|||+.||+||.+-+..........++
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 765433321 2344567999999998875 56999999999999999999999888765432211111
Q ss_pred hhhh---hHhhhcc-----cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 417 DWAK---PFLAQGL-----ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 417 ~~~~---~~~~~~~-----~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
-|.. -.+.+.+ ..+.++. +..++..|-. ....++++..++..||.+|+.+.+++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rk-v~n~~kp~~k--d~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRK-VKNRLKPYVK--DDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhh-hhhhcccccC--ChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1110 0000111 1111111 1111111100 1256788999999999999999999853
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=241.09 Aligned_cols=211 Identities=35% Similarity=0.523 Sum_probs=184.2
Q ss_pred ecccCceEEEEEEEeC-CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchhh
Q 008052 210 LGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 287 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~ 287 (579)
||+|.+|.||++...+ ++.++||++...... ....+.+|+..+.++.|++|+++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 889999999766443 34678999999999999999999999999899999999999999999
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecccccccCCCCcceeecccc
Q 008052 288 HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMG 366 (579)
Q Consensus 288 ~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~g 366 (579)
++.... ..+++..+..++.+++++|.|||+. +++|+||++.||+++. ++.++|+|||++........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 986542 3589999999999999999999998 9999999999999999 89999999999986543321 1233457
Q ss_pred cccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCH
Q 008052 367 TFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDS 445 (579)
Q Consensus 367 t~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~ 445 (579)
...|++||.+... ..+.+.|+|+||+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 446 AEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 446 ~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
..+.+++..|++.+|.+||++.++++.|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3578889999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=241.96 Aligned_cols=260 Identities=20% Similarity=0.320 Sum_probs=198.1
Q ss_pred hcCccccceecccCceEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC--eEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS--QRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~--~~~lV 276 (579)
.++|++.+.+|+|.|++||.|. ..+.+.++||+++.-. .+.+.+|+.||..|. |+||++|+++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3678999999999999999999 4567889999998743 467899999999998 999999999987644 55799
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeecccccccCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHSLD 355 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFGla~~~~~ 355 (579)
+||++|.+...+. +.+....+..++.++++||.|||+. ||+|||+||.||+||.. -.++|+|+|||.+.-.
T Consensus 114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9999998887654 3477778889999999999999999 99999999999999865 4699999999987643
Q ss_pred CCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc-------
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL------- 427 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------- 427 (579)
... ....+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-.... .-+.++..++-+....+
T Consensus 186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHHHH
Confidence 322 223356778899999864 5689999999999999999999999865432 33556655543332211
Q ss_pred ---cCCCchhhhchhh----hcCC----H-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 428 ---ADGNFDALVDQKL----EEYD----S-AEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 428 ---~~~~~~~l~d~~l----~~~~----~-~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+..+..++..-. ..|- . -...+.++++...|+.|-.+|+|++|.+.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111222221110 1110 0 11257889999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=243.26 Aligned_cols=199 Identities=33% Similarity=0.421 Sum_probs=173.5
Q ss_pred ccccceecccCceEEEEEEEeC-CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 204 FSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
|...+.||.|++|.||++...+ ++.+|+|.+...... ....+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 889999999766544 56788999999999999999999999999899999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+++|.+++...... +++.....++.+++.+|.|||+. +++|+||++.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999998654322 78999999999999999999998 999999999999999999999999999987644321122
Q ss_pred ecccccccccChhhh-ccCCCCcccceechHHHHHHHHhCCCCCCC
Q 008052 362 TRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPFDK 406 (579)
Q Consensus 362 ~~~~gt~~y~APE~~-~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~ 406 (579)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 335678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=253.39 Aligned_cols=131 Identities=27% Similarity=0.400 Sum_probs=113.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----C---CCcceEEEEEEe---
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----H---RHLVSLVGYCTF--- 269 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---pniv~l~g~~~~--- 269 (579)
.+|-..++||-|.|++||+++.. +.+.||+|+.+... .-.+....||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67888999999999999999965 56789999987543 33456778999999984 2 479999999975
Q ss_pred -CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe
Q 008052 270 -GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336 (579)
Q Consensus 270 -~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl 336 (579)
+.+.|||+|++ |.+|..++....-..++.....+|+.||+.||.|||.+| +|||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999998 777878887777778999999999999999999999999 99999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-29 Score=258.41 Aligned_cols=196 Identities=26% Similarity=0.385 Sum_probs=166.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhH--------HHHHHHHHHHHhcC---CCCcceEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGE--------REFQAEIEIISQVH---HRHLVSLVGYCTF 269 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~--------~~~~~Ei~~l~~l~---Hpniv~l~g~~~~ 269 (579)
.+|...+.||+|+||.|++|+++ +...|+||.+.+.+.... -.+-.||.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999976 567899999876432211 12336999999998 9999999999999
Q ss_pred CCeEEEEEEec-CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 270 GSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 270 ~~~~~lV~E~~-~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
++.+||++|-- ++-+|.+++..+ +.|++.+...|..|++.|+++||+. +|||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999999964 566788888655 4599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCC
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFD 405 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~ 405 (579)
.+...-... ...++||.+|.|||++.+.+| ...-|||+||++||.++...-||.
T Consensus 716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 987643322 234679999999999998876 567899999999999999888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=267.75 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=203.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|.....+|.|.||.|||++.. .++..|||+++........-+++|+.++...+|+|||.++|-+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468889999999999999999954 6899999999988887788889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
|.+|+|++.-|.. ..+++.++..++...++||+|||+. +=+|||||-.|||+++.|.+||+|||.+-.+...- .
T Consensus 94 cgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred cCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 9999999887654 3588889999999999999999999 88999999999999999999999999986543322 2
Q ss_pred eeecccccccccChhhh---ccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 360 VSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~---~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
+...+.||+.|||||+. ..+.|..++|||++|+...||---+.|..+.-+... -+++ .... .
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--------l~Lm---TkS~----~ 232 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--------LFLM---TKSG----F 232 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--------HHHh---hccC----C
Confidence 34557899999999987 457799999999999999999877777433322110 0000 0111 1
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
++.-.+....-...+.++++.|+.++|++||++..++
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1111122333456788999999999999999988765
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=242.83 Aligned_cols=267 Identities=21% Similarity=0.281 Sum_probs=190.1
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQRLL 275 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~~l 275 (579)
.+-.+.||-|.||.||..+.. +|+.||.|++..- +-...+.+.+|+.+|.-++|.|++.++++..-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344578999999999999864 7999999988542 222345678899999999999999998876433 24567
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|.|.| ..+|...+-. ...++-....-+..||++||.|||+. +|.||||||.|.|++.|..+|||||||++....
T Consensus 135 ~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 78877 4567666633 23466666667889999999999998 999999999999999999999999999997655
Q ss_pred CCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhh-hhhhHh---hhcccCC
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD-WAKPFL---AQGLADG 430 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~-~~~~~~---~~~~~~~ 430 (579)
.+....+..+-|-.|.|||.+++. .|+...||||.|||+.||+..+.-|....+.....++. ....-- ++...+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555555666789999999999864 69999999999999999999988887665533222211 100000 0000111
Q ss_pred Cchhhhc-----h---hhhcC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 008052 431 NFDALVD-----Q---KLEEY--DSAEMTRMAACAAACIRHSARRRPRMSQIVRAL 476 (579)
Q Consensus 431 ~~~~l~d-----~---~l~~~--~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~L 476 (579)
.-..++. + .|-.. ......+-..+...++..||++|-+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111 1 11111 112233456677889999999999988887655
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=251.92 Aligned_cols=265 Identities=23% Similarity=0.265 Sum_probs=200.1
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC------CCCcceEEEEEEeCC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH------HRHLVSLVGYCTFGS 271 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~------Hpniv~l~g~~~~~~ 271 (579)
..-..|......|+|-|++|.+|... -|+.||||++..+... ...=+.|++||.+|+ --|+++|+-.|.+.+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34467888888999999999999964 4789999999876433 334568999999996 358999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeeccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGL 349 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFGl 349 (579)
++|||||-+ ..+|.+.|...+. -.|.......++.|+.-||..|... +|+|.||||.|||+++. ..+||||||.
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcc
Confidence 999999987 5688888875443 3477788889999999999999875 99999999999999875 5689999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhh----hhhHhhh
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW----AKPFLAQ 425 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~----~~~~~~~ 425 (579)
|-...+... +.+.-+..|.|||++.+-.|+...|+||.||+||||.||+.-|.+... ..++.+ ..++...
T Consensus 584 A~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN---N~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 584 ASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN---NQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc---HHHHHHHHHhcCCCcHH
Confidence 987654432 334556679999999999999999999999999999999998876432 111111 1111111
Q ss_pred cccCCCc---------------------------hhhhc------------hhhhcCCHHHHHHHHHHHHHhhccCCCCC
Q 008052 426 GLADGNF---------------------------DALVD------------QKLEEYDSAEMTRMAACAAACIRHSARRR 466 (579)
Q Consensus 426 ~~~~~~~---------------------------~~l~d------------~~l~~~~~~~~~~l~~l~~~cl~~dp~~R 466 (579)
.+..+.| ...+. +++..........+.+|+..|+..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 1101100 00011 11223344556789999999999999999
Q ss_pred CCHHHHHH
Q 008052 467 PRMSQIVR 474 (579)
Q Consensus 467 Ptm~evl~ 474 (579)
-+..|.|+
T Consensus 738 it~nqAL~ 745 (752)
T KOG0670|consen 738 ITVNQALK 745 (752)
T ss_pred CCHHHHhc
Confidence 99998875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=278.93 Aligned_cols=195 Identities=15% Similarity=0.188 Sum_probs=139.1
Q ss_pred hcCC-CCcceEEEEE-------EeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 008052 254 QVHH-RHLVSLVGYC-------TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325 (579)
Q Consensus 254 ~l~H-pniv~l~g~~-------~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iv 325 (579)
.++| .||++++++| .+.+..++++||+ +++|.++|... ...+++.+++.|+.||++||+|||++ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4455 5888888887 2334567889987 66999999643 34589999999999999999999998 999
Q ss_pred eCCCCCCceEeCCC-------------------CCeEEeecccccccCCCCc---------------ceeeccccccccc
Q 008052 326 HRDIKSANILLDDS-------------------FEAKVADFGLAKHSLDTDT---------------HVSTRVMGTFGYL 371 (579)
Q Consensus 326 HrDikp~NILl~~~-------------------~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~ 371 (579)
||||||+||||+.. +.+||+|||+++....... ......+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 4456666666653211000 0011246889999
Q ss_pred ChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHH
Q 008052 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRM 451 (579)
Q Consensus 372 APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l 451 (579)
|||++.+..++.++|||||||+||||++|..|+..... .+..+.. ....+.. ......+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~-------------~~~~~~~----~~~~~~~ 241 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH-------------RVLPPQI----LLNWPKE 241 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH-------------hhcChhh----hhcCHHH
Confidence 99999999999999999999999999999888653211 0000000 0011100 1112345
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 008052 452 AACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 452 ~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..++..||+.+|.+||+|.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67888999999999999999975
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=233.43 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=192.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------Ce
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQ 272 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~~ 272 (579)
.+|.....+|.|.- .|..+... .++.||+|++... .....+...+|..++..++|+||++++.++.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 55555532 5788999987543 223345677899999999999999999998643 35
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.|+||||| ..+|...++- .++-.+..+|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+++.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 68999999 4577776652 266778889999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch----------------hh
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS----------------MV 416 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~----------------~~ 416 (579)
.... ...+.++.|..|.|||++.+..+.+.+||||+||++.||++|..-|.+.+..+.-. +.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 4322 35567789999999999998889999999999999999999999887654322110 11
Q ss_pred hhhhhHhhh--cccCCCchhhhchhh-h---cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 417 DWAKPFLAQ--GLADGNFDALVDQKL-E---EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 417 ~~~~~~~~~--~~~~~~~~~l~d~~l-~---~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.-++.++.. ....-.+.+++...+ . +.+.-......+++.+||-.+|++|-+..++|+.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111110 000011112111111 1 1222334567889999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=227.06 Aligned_cols=251 Identities=19% Similarity=0.330 Sum_probs=185.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEE-EEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGY-CTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~-~~~~~~~~lV~E 278 (579)
+.|.+.+.||+|.||.+-++.++ ..+.+++|.+... ....++|.+|...--.|. |.||+.-+++ |...+.+.+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 67888999999999999999987 4677888877542 334678999988766664 9999987764 455667779999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe-C-CCCCeEEeecccccccCCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-D-DSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl-~-~~~~~kL~DFGla~~~~~~ 356 (579)
|++.|+|...+.. ..+.+....+++.|++.||.|||++ ++||||||.+|||| + +..++||||||+.+....
T Consensus 103 ~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred cCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 9999999887754 3477778889999999999999999 99999999999999 3 345899999999875322
Q ss_pred CcceeecccccccccChhhhccC-----CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
......-+..|.+||..... .....+|||.||++++.++||.+||.. ...++....+|..-. .+.
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~------~rk 245 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWL------KRK 245 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHh------ccc
Confidence 11223456779999987532 346789999999999999999999984 344556666664321 111
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
. +++...-.....++..+.++-+.+++++|=...++-++
T Consensus 246 ~-----~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 246 N-----PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred C-----ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1 11111111123456777888899999999555555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=235.33 Aligned_cols=268 Identities=23% Similarity=0.333 Sum_probs=196.7
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe----CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS 271 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~ 271 (579)
+....+.|...++||+|.|+.||++++. ..+.||+|.+...+. -..+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3444567899999999999999999954 367899999876543 356889999999996 999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLA 350 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla 350 (579)
+.++|+||++.....+++.. ++...+..++..+.+||.++|.+ |||||||||+|+|.+. .+.-.|+||||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 99999999999998888743 66788889999999999999999 9999999999999975 467799999998
Q ss_pred cccCCC------------------C---------------c----------ceeecccccccccChhhhc-cCCCCcccc
Q 008052 351 KHSLDT------------------D---------------T----------HVSTRVMGTFGYLAPEYAS-SGKLTEKSD 386 (579)
Q Consensus 351 ~~~~~~------------------~---------------~----------~~~~~~~gt~~y~APE~~~-~~~~~~ksD 386 (579)
...... . . .......||+||.|||++. ....+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 621000 0 0 0001146999999999985 567889999
Q ss_pred eechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhh----------c--ccC-CC----------chhh-hchh---
Q 008052 387 VFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ----------G--LAD-GN----------FDAL-VDQK--- 439 (579)
Q Consensus 387 VwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------~--~~~-~~----------~~~l-~d~~--- 439 (579)
|||-|||++-+++++.||-.... +.+.+.+.+..+... . +.+ .+ ++.+ ....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999865432 112222211110000 0 000 11 1111 0000
Q ss_pred ----hh--cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 440 ----LE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 440 ----l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
++ ......+..+.+++.+|++.||.+|-++++.|+.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01 1112223478899999999999999999998753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=231.61 Aligned_cols=165 Identities=21% Similarity=0.211 Sum_probs=129.5
Q ss_pred hhcCccccceecccCceEEEEEEEe--CCeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
..++|...+.||+|+||+||+|++. +++.||||++... .....+.|.+|+++|.+++|+|++..+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3467999999999999999999865 5788899987533 12234568999999999999999954322 245
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCC-CCCceEeCCCCCeEEeeccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI-KSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi-kp~NILl~~~~~~kL~DFGla~ 351 (579)
.+|||||++|++|... ... . ...++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||+++
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 7999999999999632 110 1 146788999999999998 9999999 9999999999999999999998
Q ss_pred ccCCCCcce-------eecccccccccChhhhccC
Q 008052 352 HSLDTDTHV-------STRVMGTFGYLAPEYASSG 379 (579)
Q Consensus 352 ~~~~~~~~~-------~~~~~gt~~y~APE~~~~~ 379 (579)
......... .+..++++.|+|||++...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 764432111 1356789999999998643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=210.06 Aligned_cols=166 Identities=19% Similarity=0.181 Sum_probs=125.1
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
|+|.++++.. ...++|.+++.|+.|+++||.|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 6888888653 33599999999999999999999998 4 999999999999999 99998653321
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhc
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE 442 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~ 442 (579)
..||+.|||||++.+..++.++|||||||++|||++|+.||....... ..+..+... .. ... +....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~----~~-~~~------~~~~~ 130 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNG----MP-ADD------PRDRS 130 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHH----hc-cCC------ccccc
Confidence 258999999999999999999999999999999999999996543211 111111110 00 000 00000
Q ss_pred CCHHHH--HHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 443 YDSAEM--TRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 443 ~~~~~~--~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
...... ..+.+++.+|++.+|.+||++.|+++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 111222 268999999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=218.93 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=196.2
Q ss_pred CccccceecccCceEEEEEEEeCC--eEEEEEEeccCCchhHHHHHHHHHHHHhcCC----CCcceEEEEE-EeCCeEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTNG--KVVAIKQLKAGSGQGEREFQAEIEIISQVHH----RHLVSLVGYC-TFGSQRLL 275 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H----pniv~l~g~~-~~~~~~~l 275 (579)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.. .++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788888765433333368889999998873 6899999888 47778899
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-----CCeEEeecccc
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-----FEAKVADFGLA 350 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-----~~~kL~DFGla 350 (579)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+. |+|||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99987 88999887655556799999999999999999999998 99999999999999765 46999999999
Q ss_pred c--ccCCCCcc----e---eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh
Q 008052 351 K--HSLDTDTH----V---STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 351 ~--~~~~~~~~----~---~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
+ ........ . .....||..|.++..+.+...+.+.|+||++.++.||+.|..||........ .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~~ 252 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEKD 252 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHHH
Confidence 8 43222211 1 1234599999999999999999999999999999999999999965443211 0000000
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
........ +....+..+..+...+-..+...+|....+...|+...
T Consensus 253 ---------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 253 ---------PRKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred ---------hhhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 00000000 11223345666666677799999999999998887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-22 Score=205.91 Aligned_cols=259 Identities=28% Similarity=0.373 Sum_probs=197.2
Q ss_pred ccccceecccCceEEEEEEEeCCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCC-CcceEEEEEEeCCeEEEEEEe
Q 008052 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHR-HLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~Hp-niv~l~g~~~~~~~~~lV~E~ 279 (579)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 78899998665433 366899999999999988 799999999777778999999
Q ss_pred cCCCchhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeecccccccCCCC
Q 008052 280 VPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTD 357 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGla~~~~~~~ 357 (579)
+.+++|.+++..... ..+.......++.+++.++.|+|.. +++||||||+|||++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966654322 2588889999999999999999998 899999999999999988 79999999998554433
Q ss_pred cc-----eeecccccccccChhhhcc---CCCCcccceechHHHHHHHHhCCCCCCCCCcc-ccchhhhhhhhHhhhccc
Q 008052 358 TH-----VSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTF-ADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 358 ~~-----~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~ 428 (579)
.. ......|+..|++||.+.. ..+....|+|++|++++++++|..||...... ........ +.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI----ILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH----HHhcCC
Confidence 22 2356789999999999987 68899999999999999999999997655421 00011111 100000
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
. .+..... ..........+.+++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLS---PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccC---ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 0000000 00002223568889999999999999999987764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-25 Score=211.12 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=193.0
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
..-+|.+...|+.|+|++..+ .+++|+++.. .....++|.+|.-.|+.+.||||+.++|.|....+..++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345688899999999999644 4566777543 3333578999999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeec
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 363 (579)
+|...||+...-..+-.+..+++.++|+|++|||+. .|-|.---|.+..|+||++..++|. .+-.++.. ....
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf-----qe~g 345 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF-----QEVG 345 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee-----eccc
Confidence 999999998877788899999999999999999986 3334444689999999999988874 22222211 1122
Q ss_pred ccccccccChhhhccCCCC---cccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 364 VMGTFGYLAPEYASSGKLT---EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 364 ~~gt~~y~APE~~~~~~~~---~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....+.||+||.++..+-+ +.+|+|||.++||||.|...||.+..+..-.- +-.+....
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------------------kialeglr 407 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------------------KIALEGLR 407 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------------------hhhhcccc
Confidence 3467899999999876543 57999999999999999999998765422100 00011111
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
-..++.....+.+++.-|++.||.+||.+..|+-.||..
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 145666777899999999999999999999999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=195.08 Aligned_cols=173 Identities=12% Similarity=0.131 Sum_probs=135.1
Q ss_pred HHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHH---------HHHHHHHHHhcCCCCcceEEEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---------FQAEIEIISQVHHRHLVSLVGYCT 268 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~---------~~~Ei~~l~~l~Hpniv~l~g~~~ 268 (579)
....++|...++||.|+||.||+... +++.+|||.+.......+.. +.+|+..+.+++|++|..+..++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34568899999999999999999665 56789999997543332222 679999999999999999988865
Q ss_pred eC--------CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC
Q 008052 269 FG--------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (579)
Q Consensus 269 ~~--------~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 340 (579)
.. +..+|||||++|.+|.++.. ++. ....+++.+|..||+. +++||||||+||+++.++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 43 35789999999999977631 222 3456899999999998 999999999999999988
Q ss_pred CeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHH
Q 008052 341 EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 398 (579)
Q Consensus 341 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLl 398 (579)
++|+|||..+........ -.++....+..++|+|+|||++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754221110 11444556778999999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-22 Score=188.42 Aligned_cols=139 Identities=14% Similarity=0.132 Sum_probs=108.1
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCch--h------------------------HHHHHHHHHHHHhcCCCCc
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--G------------------------EREFQAEIEIISQVHHRHL 260 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--~------------------------~~~~~~Ei~~l~~l~Hpni 260 (579)
...||+|+||.||+|...+|+.||||+++..... . ......|+.+|.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999754211 0 0122359999999988776
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceEeCCCCCCceEeCCC
Q 008052 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDS 339 (579)
Q Consensus 261 v~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~ivHrDikp~NILl~~~ 339 (579)
.....+.. ...+|||||+++++|...+.. ...+++.....++.|++.+|.|| |+. +|+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 44332222 233899999999877644322 23588899999999999999999 677 999999999999998 4
Q ss_pred CCeEEeeccccccc
Q 008052 340 FEAKVADFGLAKHS 353 (579)
Q Consensus 340 ~~~kL~DFGla~~~ 353 (579)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-23 Score=227.33 Aligned_cols=252 Identities=22% Similarity=0.252 Sum_probs=183.4
Q ss_pred CccccceecccCceEEEEEEEeCCeEEEEEEecc-CCchhHHHHHHHHHH--HHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKA-GSGQGEREFQAEIEI--ISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~-~~~~~~~~~~~Ei~~--l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+|...+.||.+.|=+|.+|+.+.|. |+||++-. +..-..+.|.++++- ...++|||++.+.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 78888743 334445555544433 4456899999988776666666788888
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+. .+|.+.| ..++.+...++..|+.|+++||..+|.. +|+|+|||.+||||+.-+.+.|+||.-.+-..-....
T Consensus 103 vk-hnLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 84 4888888 4566788889999999999999999998 9999999999999999999999999876643211110
Q ss_pred ------eeecccccccccChhhhccC-----------CCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhh
Q 008052 360 ------VSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 360 ------~~~~~~gt~~y~APE~~~~~-----------~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
...+...-.+|+|||.+... .++++.||||+||++.||++ |+++|....- ..+.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~aYr-- 248 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LAYR-- 248 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------HhHh--
Confidence 01111233489999987541 26789999999999999999 8888864321 1111
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.+. +......|+.. +...+.+++..|++.||.+|-++.+.|+.-.|.+
T Consensus 249 -------~~~-~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 249 -------SGN-ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred -------ccC-ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 111 11111111111 1125788999999999999999999999877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.8e-22 Score=185.99 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=195.0
Q ss_pred hcCccccceecccCceEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~E 278 (579)
.++|..++.||.|+||.+|.|. ..+|..||||.-...... .++..|..+...|+| ..|..+..|..+.+.-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999999 568999999986554433 467889999999985 677788888888888899999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC---CCeEEeecccccccCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHSLD 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kL~DFGla~~~~~ 355 (579)
.+ |-+|+++..-..+ .++..+.+-++-|++.-|+|+|.+ ++|||||||+|+|..-+ ..+.|+||||++.+.+
T Consensus 92 LL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 88 8899888764433 488889999999999999999999 89999999999999644 4689999999998765
Q ss_pred CCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 356 TDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 356 ~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
..+. ......||..|.+=-.+.+...+.+.|+-|+|.+|..+.-|..||.+..........+- .. +
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk---I~-----E 238 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK---IS-----E 238 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH---HH-----H
Confidence 4332 12345799999998888888889999999999999999999999987654221111110 00 0
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHH---HHHHHHh
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS---QIVRALE 477 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~---evl~~Le 477 (579)
.-+...++......+.++...+.-|-..--++-|... ++.+.|-
T Consensus 239 ----kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 239 ----KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred ----hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 0011112222333455667777788888888888754 4444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-23 Score=226.53 Aligned_cols=253 Identities=21% Similarity=0.240 Sum_probs=186.6
Q ss_pred cccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHH----HHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGERE----FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~----~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
...+++|.|.+|.|+..... ..+.++.|..... ....++. +..|+.+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35688999999988877743 3343444433210 1112222 556777888899999988777776666555669
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|||++ +|..++... ..+...++.-++.|++.||.|||+. +|.|||||++|++++.+|.+||+|||.+..+.-..
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999888654 2477778888999999999999999 99999999999999999999999999987643322
Q ss_pred ---cceeecccccccccChhhhccCCCCc-ccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 358 ---THVSTRVMGTFGYLAPEYASSGKLTE-KSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 358 ---~~~~~~~~gt~~y~APE~~~~~~~~~-ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.+.....+|+..|+|||++....|+. ..||||.|+++..|++|+.||......+... .+. .....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------~~~--~~~~~ 543 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------KTN--NYSDQ 543 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---------hhh--ccccc
Confidence 25566788999999999999998875 5899999999999999999998765433211 000 00000
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.-+...........+.+...++.++|+.+|.+|-+|.+|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00111111233455677889999999999999999999985
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-21 Score=181.72 Aligned_cols=139 Identities=14% Similarity=0.096 Sum_probs=110.7
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCch---------------------h-----HHHHHHHHHHHHhcCCCCc
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ---------------------G-----EREFQAEIEIISQVHHRHL 260 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~---------------------~-----~~~~~~Ei~~l~~l~Hpni 260 (579)
...||+|+||.||+|...+|+.||||+++..... . ...+..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998764211 0 1123579999999999987
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCchhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeCCCCCCceEeCC
Q 008052 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFH-LHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDD 338 (579)
Q Consensus 261 v~l~g~~~~~~~~~lV~E~~~~g~L~~~-l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~ 338 (579)
.....+... ..+|||||++++++... +.. ..++......++.+++.+|.+||+ . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 554444332 24899999998865433 321 246778889999999999999999 7 999999999999999
Q ss_pred CCCeEEeecccccccC
Q 008052 339 SFEAKVADFGLAKHSL 354 (579)
Q Consensus 339 ~~~~kL~DFGla~~~~ 354 (579)
++.++|+|||+++...
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=181.09 Aligned_cols=186 Identities=17% Similarity=0.090 Sum_probs=141.4
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccCCchh----HHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEec
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG----EREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~----~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
....|++|+||+||.+.- .+..++.+.+....... ...|.+|+++|.+|+ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997666 56778877776554321 125789999999995 5889999886 3468999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCC-CCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI-KSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi-kp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
.|.+|...+.. ....++.+++.+|.+||++ ||+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998654321 1135778999999999999 9999999 799999999999999999999864433210
Q ss_pred ----e--------eecccccccccChhhhccC-CCC-cccceechHHHHHHHHhCCCCCCCCC
Q 008052 360 ----V--------STRVMGTFGYLAPEYASSG-KLT-EKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 360 ----~--------~~~~~gt~~y~APE~~~~~-~~~-~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
. ......++.|+.|+...-- ..+ ...+.++.|..+|.++|++.++-.+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 1123478889999865422 223 46788999999999999998875544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=187.08 Aligned_cols=201 Identities=23% Similarity=0.333 Sum_probs=169.9
Q ss_pred cCccccceecccCceEEEEEE-EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
-+|...++||+|.||.++.|+ +-+++.||||.-...+ ..-+++.|....+.|. .++|...+.|..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468889999999999999999 5578999999743322 2357888888888886 68999998888888888899998
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-----CCeEEeecccccccC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-----FEAKVADFGLAKHSL 354 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-----~~~kL~DFGla~~~~ 354 (579)
+ |-+|+++..-.++ .++..+.+.||.|++.-++|+|++ .+|.|||||+|+||..- ..+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8 8889887765544 489999999999999999999999 89999999999999643 358999999999987
Q ss_pred CCCccee------ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCc
Q 008052 355 DTDTHVS------TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409 (579)
Q Consensus 355 ~~~~~~~------~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~ 409 (579)
+..+... ....||..||+=-.+.+...+.+.|+-+||=|++..|-|..||.+...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 7665322 234699999999999999999999999999999999999999987653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.7e-20 Score=183.29 Aligned_cols=232 Identities=19% Similarity=0.283 Sum_probs=150.1
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCC----------CCcceEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHH----------RHLVSLVGYCT 268 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H----------pniv~l~g~~~ 268 (579)
.+...+.||.|+|+.||.+++. .|+.+|||++.... ....+++++|.-.+..+.+ -.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456789999999999999986 48999999974432 2234667777766655332 12222222211
Q ss_pred ---------eC--C------eEEEEEEecCCCchhhhhc---C--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 008052 269 ---------FG--S------QRLLVYEFVPNKTLEFHLH---G--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326 (579)
Q Consensus 269 ---------~~--~------~~~lV~E~~~~g~L~~~l~---~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH 326 (579)
.. . ..+++|+-+ -++|.+.+. . .....+....++.+..|+++.+++||.. ||||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 11 1 235677766 567776643 1 1112345566778889999999999999 9999
Q ss_pred CCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccccccccChhhhccC--------CCCcccceechHHHHHHHH
Q 008052 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG--------KLTEKSDVFSFGVLLLELI 398 (579)
Q Consensus 327 rDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~~~ksDVwSlGvvl~eLl 398 (579)
+|||++|+|++.+|.++|+||+........ ......+..|.+||..... .++.+.|.|+||++||.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999987653221 1113456789999977442 5788999999999999999
Q ss_pred hCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCC
Q 008052 399 TGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR 466 (579)
Q Consensus 399 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~R 466 (579)
||+.||+........ +| ....+. +.++.+..++..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~---~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP---EW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS---GG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc---cc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999865432111 11 222444 778889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-21 Score=204.39 Aligned_cols=233 Identities=27% Similarity=0.310 Sum_probs=181.5
Q ss_pred eecccCceEEEEEE----EeCCeEEEEEEeccCCchh-H-HHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecC
Q 008052 209 LLGQGGFGYVHKGV----LTNGKVVAIKQLKAGSGQG-E-REFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~----~~~g~~vAvK~l~~~~~~~-~-~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
.+|+|.||.|++.. .+.|+.+|.|.+++..... . .....|-.++..++ |+.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 3457788988886543211 1 13456778888887 9999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+|.|..++... ..+.......+...++-+++++|+. +|+|||+|++||+++.+|++|+.|||+.+...+...
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 99998887543 3466666667778899999999998 999999999999999999999999999987654332
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
.|||..|||||++. .....+|.||||++++||+||..||.. +-.+. ++...+
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~-------------Il~~~~- 204 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKR-------------ILKAEL- 204 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHH-------------Hhhhcc-
Confidence 28999999999998 457789999999999999999999975 11111 111111
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHH--HHHHHHh
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMS--QIVRALE 477 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~--evl~~Le 477 (579)
..+.+.......++..++..+|.+|-... -+.+.++
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 34566667778888889999999998763 4444444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=174.20 Aligned_cols=137 Identities=18% Similarity=0.200 Sum_probs=107.2
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-----CCCCcceEEEEEEeCC---e-E
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-----HHRHLVSLVGYCTFGS---Q-R 273 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-----~Hpniv~l~g~~~~~~---~-~ 273 (579)
+...+.||+|+||.||. +. ++.. +||++........+.+.+|+.++.++ .||||++++|++..+. . .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34467899999999996 43 3444 68988765444567899999999999 5799999999998863 3 3
Q ss_pred EEEEEe--cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCceEeCCCCCCceEeCC----CCCeEEee
Q 008052 274 LLVYEF--VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL-AYLHEDCQPKIIHRDIKSANILLDD----SFEAKVAD 346 (579)
Q Consensus 274 ~lV~E~--~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~~ivHrDikp~NILl~~----~~~~kL~D 346 (579)
.+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||++ +||||||||+|||++. ++.++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 378999 6679999999542 25544 35677888888 999999 9999999999999974 34799999
Q ss_pred ccccc
Q 008052 347 FGLAK 351 (579)
Q Consensus 347 FGla~ 351 (579)
|+.+.
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.5e-20 Score=193.59 Aligned_cols=216 Identities=24% Similarity=0.385 Sum_probs=164.0
Q ss_pred HHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCC
Q 008052 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 331 (579)
Q Consensus 252 l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp 331 (579)
|+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+... ...++|.-...++.+|++||+|||.- +...|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence 35678999999999999999999999999999999999763 34599999999999999999999976 2339999999
Q ss_pred CceEeCCCCCeEEeecccccccCCCC-cceeecccccccccChhhhccCC-------CCcccceechHHHHHHHHhCCCC
Q 008052 332 ANILLDDSFEAKVADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGK-------LTEKSDVFSFGVLLLELITGFRP 403 (579)
Q Consensus 332 ~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~-------~~~ksDVwSlGvvl~eLltG~~P 403 (579)
+|+++|..+.+||+|||+........ ........-..-|.|||.+.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987653211 11111122455799999997631 46789999999999999999999
Q ss_pred CCCCCcccc-chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 404 FDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 404 f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
|+......+ +.++.+.+. .......|.+.... +....+..++..||..+|.+||++.+|-..++...
T Consensus 158 ~~~~~~~~~~~eii~~~~~---------~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK---------GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccccccCChHHHHHHHHh---------cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 987543222 222222111 01111222222122 34447999999999999999999999999998654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=203.32 Aligned_cols=199 Identities=25% Similarity=0.277 Sum_probs=160.5
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCe
Q 008052 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 196 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~ 272 (579)
+++...+.|.+.+.||+|+||+||+|...+|+.||+|+=+...... |.-=.+++.||+ -+.|..+...+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 5566678899999999999999999999889999999977654431 222223444444 2344555555566677
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-------CCCCeEEe
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-------DSFEAKVA 345 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-------~~~~~kL~ 345 (579)
.+||+||.+.|+|.+++. ..+.|+|...+.|+.|+++.+++||.. +|||+||||+|+||. +...++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 889999999999999996 456799999999999999999999998 999999999999994 23458999
Q ss_pred ecccccccCC-CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCC
Q 008052 346 DFGLAKHSLD-TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 402 (579)
Q Consensus 346 DFGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~ 402 (579)
|||.+-.+.- .+......+++|-.+-++|...+..++...|.|.|..+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9998864321 22234566789999999999999999999999999999999999965
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=168.94 Aligned_cols=134 Identities=20% Similarity=0.273 Sum_probs=113.6
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+.||+|++|.||+|.. +|..|+||+....... ....+.+|+.++.++.|+|+.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 6677899986543211 123577899999999999998877787777888999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
++|++|.+++... .+ .+..++.+++.+|.+||+. +++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888532 22 7889999999999999998 999999999999999 78899999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=171.92 Aligned_cols=141 Identities=14% Similarity=0.133 Sum_probs=110.8
Q ss_pred CccccceecccCceEEEEEE--EeCCeEEEEEEeccCCch------------------------hHHHHHHHHHHHHhcC
Q 008052 203 NFSEANLLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQ------------------------GEREFQAEIEIISQVH 256 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~--~~~g~~vAvK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~ 256 (579)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 568999999998653210 0123568999999997
Q ss_pred CC--CcceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc-eEeCCCCCCc
Q 008052 257 HR--HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK-IIHRDIKSAN 333 (579)
Q Consensus 257 Hp--niv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-ivHrDikp~N 333 (579)
+. .+.+++++ ...+|||||+++.+|...+... ..+...+...++.|++.+|.+||.. + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 63 34444443 2358999999998887654222 2355556778999999999999998 8 9999999999
Q ss_pred eEeCCCCCeEEeeccccccc
Q 008052 334 ILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 334 ILl~~~~~~kL~DFGla~~~ 353 (579)
||++ ++.++|+|||++...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 789999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=165.56 Aligned_cols=145 Identities=18% Similarity=0.140 Sum_probs=113.6
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCch----------------------hHHHHHHHHHHH
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ----------------------GEREFQAEIEII 252 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~----------------------~~~~~~~Ei~~l 252 (579)
.++......|...+.||+|+||.||++...+|+.||||++...... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444458888999999999999999888999999987543210 112356789999
Q ss_pred HhcCCC--CcceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCC
Q 008052 253 SQVHHR--HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK 330 (579)
Q Consensus 253 ~~l~Hp--niv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDik 330 (579)
.++.|. .+...++. ...++||||+++++|...... .....++.+++.++.++|+. +|+|||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 999887 44555442 345899999999999765421 23467889999999999998 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccC
Q 008052 331 SANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 331 p~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|+||||++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-18 Score=190.19 Aligned_cols=137 Identities=22% Similarity=0.306 Sum_probs=112.4
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEE-eccC-Cc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ-LKAG-SG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~-l~~~-~~------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
...|...+.||+|+||.||+|.+.+.. +++|+ +... .. ...+.+.+|++++.+++|++++..+.++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567899999999999999986544 33333 2211 11 123467899999999999999998888888778
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+|||||+++++|.+++. ....++.+++++|.|||+. +|+||||||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998874 4567899999999999998 99999999999999 577999999999976
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=164.00 Aligned_cols=130 Identities=22% Similarity=0.299 Sum_probs=106.6
Q ss_pred eecccCceEEEEEEEeCCeEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.||+|+||.||+|.+ ++..|++|........ ....+.+|++++.+++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 5678999986543211 1245778999999999887666555666667778999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+|++|.+.+..... .++.+++.+|.+||+. +++|||+||.|||++ ++.++|+|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887743210 7899999999999998 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-18 Score=174.13 Aligned_cols=197 Identities=23% Similarity=0.245 Sum_probs=137.9
Q ss_pred CCCCcceEEEEEEeC---------------------------CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHH
Q 008052 256 HHRHLVSLVGYCTFG---------------------------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308 (579)
Q Consensus 256 ~Hpniv~l~g~~~~~---------------------------~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ 308 (579)
.|||||++.++|.+. ...||||.-. ..+|..+|..+. .+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 499999998876432 3567888876 348888886543 444556668889
Q ss_pred HHHHHHHhhhcCCCceEeCCCCCCceEe--CCCC--CeEEeecccccccCCCCc-----ceeecccccccccChhhhccC
Q 008052 309 SARGLAYLHEDCQPKIIHRDIKSANILL--DDSF--EAKVADFGLAKHSLDTDT-----HVSTRVMGTFGYLAPEYASSG 379 (579)
Q Consensus 309 ia~gL~yLH~~~~~~ivHrDikp~NILl--~~~~--~~kL~DFGla~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~ 379 (579)
+++|+.|||.+ +|.|||+|++|||| |+|+ .+.|+|||+|--...-.. ...-..-|....||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999998 4444 468899998753211000 001123477889999988542
Q ss_pred --C----CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHH
Q 008052 380 --K----LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAA 453 (579)
Q Consensus 380 --~----~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~ 453 (579)
+ .-.|+|.|+.|.+.||++...-||..... ...+ ...+.+ ..|...+..++..+.+
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~--------------~r~Yqe---~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLD--------------TRTYQE---SQLPALPSRVPPVARQ 488 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heec--------------hhhhhh---hhCCCCcccCChHHHH
Confidence 2 23699999999999999999999976322 1001 111111 1222344556677899
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHh
Q 008052 454 CAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 454 l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
++...++.||.+|++..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999765555543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-18 Score=193.24 Aligned_cols=212 Identities=23% Similarity=0.325 Sum_probs=144.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.+|+.+++|..|.||-||...++ ..+.+|.|+ +++. .+.+- |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-------------------
Confidence 67899999999999999999876 467888844 3221 11110 22223333333
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC---
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD--- 357 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~--- 357 (579)
|+-...+...+ .++ .+++.+++|||+. +|+|||+||.|.||+.-|++|++||||.+......
T Consensus 136 --gDc~tllk~~g--~lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIG--PLP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCC--CCc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33333332221 122 1237889999998 99999999999999999999999999987532211
Q ss_pred ---------cc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 358 ---------TH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 358 ---------~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
++ ....++||+.|+|||++....|...+|+|++|+|+||.+-|..||.++.+.. +. ..++..
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lf---g~visd- 273 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LF---GQVISD- 273 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HH---hhhhhh-
Confidence 11 1234689999999999999999999999999999999999999998764321 11 111100
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQI 472 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ev 472 (579)
+..+. +-+.....+..+++...|+++|..|--...-
T Consensus 274 --~i~wp--------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 274 --DIEWP--------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred --hcccc--------ccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 00000 1133445678889999999999999854433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-18 Score=182.52 Aligned_cols=170 Identities=25% Similarity=0.400 Sum_probs=128.6
Q ss_pred eEEEEEEecCCCchhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
..++.|++|.-.+|.++|.+ ......+|...+.++.|++.|++| + +.+|||+||.||+...+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 46799999999999999963 344567888999999999999999 5 8999999999999999999999999998
Q ss_pred cccCCCC-----cceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhh
Q 008052 351 KHSLDTD-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 351 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
....... ....+...||..||+||.+.+..|+.|+|||+||++|+||+. =...|+.... .
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t--------------~ 469 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT--------------L 469 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh--------------h
Confidence 7655443 223455679999999999999999999999999999999997 2233321110 1
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
..+.++.+.. ..+.+++ .-..++.+++...|.+||++
T Consensus 470 ~d~r~g~ip~---~~~~d~p-----~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 470 TDIRDGIIPP---EFLQDYP-----EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hhhhcCCCCh---HHhhcCc-----HHHHHHHHhcCCCcccCchH
Confidence 1111222220 0111222 23567889999999999933
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-16 Score=144.76 Aligned_cols=135 Identities=20% Similarity=0.146 Sum_probs=116.0
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
+.+.||+|.++.||++...+ +.++||....... ...+.+|+.++..++| .++.++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999855 7799999866543 5678999999999986 58999999988888899999999988
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+..+ ++.....++.+++++|++||.....+++|+|||++|||+++++.++|.|||+++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 87543 5567778899999999999986545799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=150.64 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=99.5
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchh---HHH---------------------HHHHHHHHHhcCCCC--c
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG---ERE---------------------FQAEIEIISQVHHRH--L 260 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~---~~~---------------------~~~Ei~~l~~l~Hpn--i 260 (579)
.+.||+|+||.||+|...+++.||||+++...... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542211 111 135666666665443 4
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCchhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeCCCCCCceEeCC
Q 008052 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFH-LHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDD 338 (579)
Q Consensus 261 v~l~g~~~~~~~~~lV~E~~~~g~L~~~-l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~ 338 (579)
.+.+++ ...+|||||++++.+... +.... .. .....++.+++.++.+||. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 445443 246899999999654321 11110 11 5677899999999999998 6 999999999999999
Q ss_pred CCCeEEeecccccccC
Q 008052 339 SFEAKVADFGLAKHSL 354 (579)
Q Consensus 339 ~~~~kL~DFGla~~~~ 354 (579)
++.++|+|||++....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=149.01 Aligned_cols=136 Identities=18% Similarity=0.205 Sum_probs=105.4
Q ss_pred cceec-ccCceEEEEEEEeCCeEEEEEEeccCC-------------chhHHHHHHHHHHHHhcCCCCc--ceEEEEEEeC
Q 008052 207 ANLLG-QGGFGYVHKGVLTNGKVVAIKQLKAGS-------------GQGEREFQAEIEIISQVHHRHL--VSLVGYCTFG 270 (579)
Q Consensus 207 ~~~LG-~G~fg~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~~~~Ei~~l~~l~Hpni--v~l~g~~~~~ 270 (579)
...|| .||.|+||+.... +..++||+++... ......+.+|++++.+|+|++| +..++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999885 5678888875321 1123457889999999998875 6777775543
Q ss_pred C----eEEEEEEecCC-CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEe
Q 008052 271 S----QRLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (579)
Q Consensus 271 ~----~~~lV~E~~~~-g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~ 345 (579)
. ..+|||||++| .+|.+++... .++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 22599999997 6888887532 23332 367899999999998 99999999999999998899999
Q ss_pred eccccccc
Q 008052 346 DFGLAKHS 353 (579)
Q Consensus 346 DFGla~~~ 353 (579)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-16 Score=177.73 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=188.0
Q ss_pred CccccceecccCceEEEEEEEeC--CeEEEEEEeccCC--chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGS--GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.|...+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |.|++++++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34555679999999999887643 3456667664433 222234455777777777 999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCceEeCCCCCCceEeCCCC-CeEEeecccccccCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLD 355 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGla~~~~~ 355 (579)
+|..++++...+...+...++....-.+..|+..+|.|+| .. ++.||||||+|.+++..+ ..|++|||++.....
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999988883233324566667778999999999999 76 899999999999999999 999999999987665
Q ss_pred --CCcceeecccc-cccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 356 --TDTHVSTRVMG-TFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 356 --~~~~~~~~~~g-t~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
.........+| ++.|+|||...+ .......|+||.|+++.-+++|..|++...... .....|...- +.
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~-------~~ 249 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK-------GR 249 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc-------cc
Confidence 22233445678 999999999987 466788999999999999999999998765432 2223332210 00
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+. ............++...++..++..|.+.+++..
T Consensus 250 ~~-------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 FT-------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cc-------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 0112223345667778888899999999887753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-14 Score=154.95 Aligned_cols=144 Identities=24% Similarity=0.270 Sum_probs=103.5
Q ss_pred CccccceecccCceEEEEEEEeCCeEEEEEEeccCCchh----------------------------------------H
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG----------------------------------------E 242 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~----------------------------------------~ 242 (579)
.|. .+.||.|++|.||+|++.+|+.||||+.+.+.... +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 46899999999999999999999999987642111 0
Q ss_pred HHHHHHHHHHHhcC----CCCcceEEEEEE-eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHh
Q 008052 243 REFQAEIEIISQVH----HRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR-GLAYL 316 (579)
Q Consensus 243 ~~~~~Ei~~l~~l~----Hpniv~l~g~~~-~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~-gL~yL 316 (579)
-+|..|+..+.++. |.+-|.+-.+|. .....+|||||++|++|.+.+..... .. .+.+++..++. .+..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHH
Confidence 12455666666652 333344333333 24567899999999999877642211 12 24456666666 46788
Q ss_pred hhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 317 H~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|.. |++|+|+||.||+++.++.++|+|||++....
T Consensus 274 ~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 887 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.4e-13 Score=145.13 Aligned_cols=247 Identities=22% Similarity=0.248 Sum_probs=178.8
Q ss_pred cCccccceecc--cCceEEEEEEE---eCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeE
Q 008052 202 DNFSEANLLGQ--GGFGYVHKGVL---TNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~--G~fg~Vy~~~~---~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~ 273 (579)
..|...+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....+++ |+|.|+....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999987 3578899998443222 22222345677777775 99999988888888999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeecc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFG 348 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFG 348 (579)
++-.|++. .+|..+.+.... .++......+..+..+ ||.++|.. .++|-|+||.||++..+ ...+++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 99999885 778777765332 3555566666777777 99999998 99999999999999999 889999999
Q ss_pred cccccCCCCcc----eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 349 LAKHSLDTDTH----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 349 la~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
+...+.+.... ...+..|...|++||.+. +.++...|+|+||.++++..+|......... ..|..- .
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~~--r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQL--R 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCcccc--c
Confidence 99877655422 223346888999999988 6788999999999999999998776543311 113210 0
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
+ .+ +-+ ++......++..++..+++.++..|++.+.++
T Consensus 340 ~-----~~--ip~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 340 Q-----GY--IPL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred c-----cc--Cch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0 00 000 22222234455588999999999999877665
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.7e-13 Score=123.34 Aligned_cols=131 Identities=18% Similarity=0.076 Sum_probs=98.0
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeEEEEEEecCCCch
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV-SLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
.+.|+.|.++.||++... ++.|++|....... ....+..|+.++..+.+.+++ +++++. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999875 67899998765432 233567899999998765554 455443 3345799999999888
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC--QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.... . ....++.+++++|+.||... ...++|+|+++.||+++ ++.++|+|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5430 1 11245678999999999873 22369999999999999 56899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4e-13 Score=132.94 Aligned_cols=207 Identities=19% Similarity=0.299 Sum_probs=141.1
Q ss_pred HHHHHHHHHHhcCCCCcceEEEEEEeCC-----eEEEEEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHh
Q 008052 244 EFQAEIEIISQVHHRHLVSLVGYCTFGS-----QRLLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYL 316 (579)
Q Consensus 244 ~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-----~~~lV~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yL 316 (579)
..+.-++-|-.+.|-|||++..|+.+.. ...++.|||..|+|..+|+.. ....+......+|+.||..||.||
T Consensus 113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 3344455666778999999999986533 457899999999999999753 234577777889999999999999
Q ss_pred hhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC----CcceeecccccccccChhhhccCCCCcccceechHH
Q 008052 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT----DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 392 (579)
Q Consensus 317 H~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGv 392 (579)
|+ |.|.|+|+++..+-|++..++-+|+.-- .-...... .........+-++|.+||+=.....+-.+|||+||+
T Consensus 193 hs-~~PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 193 HS-CDPPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred hc-cCCccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 98 7899999999999999999998888421 11100000 000111234678999999987777888999999999
Q ss_pred HHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 008052 393 LLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQI 472 (579)
Q Consensus 393 vl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ev 472 (579)
..+||..|..--..... ...++-........+.++ .-..++..|++..|..||+|+++
T Consensus 271 cAlemailEiq~tnseS---~~~~ee~ia~~i~~len~-------------------lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSES---KVEVEENIANVIIGLENG-------------------LQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred HHHHHHHheeccCCCcc---eeehhhhhhhheeeccCc-------------------cccCcCcccccCCCCCCcchhhh
Confidence 99999877542111110 000111000000011111 12345678999999999999998
Q ss_pred HH
Q 008052 473 VR 474 (579)
Q Consensus 473 l~ 474 (579)
+.
T Consensus 329 lf 330 (458)
T KOG1266|consen 329 LF 330 (458)
T ss_pred hc
Confidence 64
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-12 Score=141.37 Aligned_cols=145 Identities=19% Similarity=0.191 Sum_probs=97.7
Q ss_pred hcCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCchh--------------------------------------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQG-------------------------------------- 241 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~-------------------------------------- 241 (579)
..+|+. +.||.|++|.||+|++.+ |+.||||+++++-...
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999987 9999999997542110
Q ss_pred --HHHHHHHHHHHHhcC----CCCcceEEEEEEe-CCeEEEEEEecCCCchhhh--hcCCCCCCCCHHHHHHHHHHHHH-
Q 008052 242 --EREFQAEIEIISQVH----HRHLVSLVGYCTF-GSQRLLVYEFVPNKTLEFH--LHGKDRPVMNWPTRMKIALGSAR- 311 (579)
Q Consensus 242 --~~~~~~Ei~~l~~l~----Hpniv~l~g~~~~-~~~~~lV~E~~~~g~L~~~--l~~~~~~~l~~~~~~~ia~~ia~- 311 (579)
+-+|.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.|.+. +...+ .+.. .++...+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHH
Confidence 012445665555553 4445554444443 5678899999999999764 22111 2211 22222222
Q ss_pred HHHHhhhcCCCceEeCCCCCCceEeCCCC----CeEEeecccccccCC
Q 008052 312 GLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGLAKHSLD 355 (579)
Q Consensus 312 gL~yLH~~~~~~ivHrDikp~NILl~~~~----~~kL~DFGla~~~~~ 355 (579)
-+..++.. |++|+|+||.||+++.++ .+++.|||++.....
T Consensus 272 ~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 12333445 999999999999999888 999999999876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.3e-13 Score=143.14 Aligned_cols=247 Identities=19% Similarity=0.207 Sum_probs=179.6
Q ss_pred hhcCccccceecccCceEEEEEEEe--CCeEEEEEEeccCCchhHHHH--HHHHHHHHhcC-CCCcceEEEEEEeCCeEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSGQGEREF--QAEIEIISQVH-HRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~~~~~~~--~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~ 274 (579)
...+|.++..||.|.|+.|++...+ ++..+++|.+.........++ ..|+-+...+. |.|+++++..+...++.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3467999999999999999998754 578899999877655444443 35777777764 999999888888888888
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeeccccccc
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKHS 353 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFGla~~~ 353 (579)
+-.|||.++++...+ .....++...++++..+++.++.++|+. .++|+|+||+||++..+ +..++.|||++..+
T Consensus 343 ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence 999999999987665 2234577788899999999999999988 89999999999999886 88999999998752
Q ss_pred CCCCcceeecccccccc-cChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 354 LDTDTHVSTRVMGTFGY-LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y-~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.-. .......+..| .+++.+....+..+.|+|+||.-+.|.++|..--. +.+.|... ..+.+
T Consensus 418 ~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~i------~~~~~ 480 (524)
T KOG0601|consen 418 AFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLTI------RSGDT 480 (524)
T ss_pred cee---cccccccccccccchhhccccccccccccccccccccccccCcccCc--------ccccceee------ecccc
Confidence 111 11111223334 35666667788999999999999999999864221 12222211 11111
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le 477 (579)
...+. ....+..+++.++..++..||.+.++....+
T Consensus 481 --------p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 481 --------PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --------cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111 1145667788899999999999888776554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.6e-11 Score=132.45 Aligned_cols=166 Identities=18% Similarity=0.263 Sum_probs=125.8
Q ss_pred EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHH
Q 008052 223 LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302 (579)
Q Consensus 223 ~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~ 302 (579)
..++..|.|+..+..........++-++.|+.|+||||++++..++..+..|||.|-+. -|..++.. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence 34678888888877665445567788999999999999999999999999999999874 34444432 224455
Q ss_pred HHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccccccccChhhhccCCCC
Q 008052 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT 382 (579)
Q Consensus 303 ~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~ 382 (579)
...+.||+.||.|||++| +++|++|.-+.|+|+..|+.||++|-++........ ......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 667899999999999887 899999999999999999999999998865433221 011111222466676654322
Q ss_pred cccceechHHHHHHHHhC
Q 008052 383 EKSDVFSFGVLLLELITG 400 (579)
Q Consensus 383 ~ksDVwSlGvvl~eLltG 400 (579)
-..|.|-|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.1e-11 Score=117.69 Aligned_cols=142 Identities=20% Similarity=0.252 Sum_probs=111.7
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCC---eEEEEEEecC
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHH--RHLVSLVGYCTFGS---QRLLVYEFVP 281 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~---~~~lV~E~~~ 281 (579)
+.|+.|.++.||++...+|+.++||+...... .....+..|++++..+.+ .++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999987778899999765432 134578899999999976 34677888876542 5689999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC----------------------------------------- 320 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~----------------------------------------- 320 (579)
|.++...+.. ..++...+..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9998776531 23677788888889999999888521
Q ss_pred ------------CCceEeCCCCCCceEeCC--CCCeEEeecccccc
Q 008052 321 ------------QPKIIHRDIKSANILLDD--SFEAKVADFGLAKH 352 (579)
Q Consensus 321 ------------~~~ivHrDikp~NILl~~--~~~~kL~DFGla~~ 352 (579)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.4e-10 Score=110.79 Aligned_cols=136 Identities=15% Similarity=0.137 Sum_probs=98.1
Q ss_pred ceecccCceEEEEEEEeC-------CeEEEEEEeccCC----------------------chhHHHHH----HHHHHHHh
Q 008052 208 NLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGS----------------------GQGEREFQ----AEIEIISQ 254 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~----------------------~~~~~~~~----~Ei~~l~~ 254 (579)
..||.|.-+.||.|.-.+ +..+|||+.+... ......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999998543 4789999864311 01122333 79999999
Q ss_pred cCC--CCcceEEEEEEeCCeEEEEEEecCCCchh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceEeCCCC
Q 008052 255 VHH--RHLVSLVGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIK 330 (579)
Q Consensus 255 l~H--pniv~l~g~~~~~~~~~lV~E~~~~g~L~-~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~ivHrDik 330 (579)
+.. -++..++++ ...+|||||+.+..+. ..|.. ..++..+...+..+++.+|..| |.. +|||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 863 456666654 4567999999775442 12211 1244455667889999999999 776 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccC
Q 008052 331 SANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 331 p~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+.|||+++ +.+.|+|||.+....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCC
Confidence 99999974 579999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.6e-10 Score=103.06 Aligned_cols=143 Identities=19% Similarity=0.219 Sum_probs=104.2
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccC--------CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--------SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~--------~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
...+|-+|.-+.|+++.+. |+.+.||.--.. .....+..++|+.+|.++.--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999985 666667653211 1122345678999999987444443333555566667999
Q ss_pred EecCC-CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC---CeEEeecccccc
Q 008052 278 EFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKH 352 (579)
Q Consensus 278 E~~~~-g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~kL~DFGla~~ 352 (579)
||+++ .++.+++...............++..|-+.|.-||.+ .|||+||..+||+|..++ .+.|+||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4677777654443334444478889999999999999 999999999999996554 358999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.7e-10 Score=102.65 Aligned_cols=131 Identities=20% Similarity=0.252 Sum_probs=97.9
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCc----h----hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----Q----GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~----~----~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
..|++|+-..+|.+.+.+.. +++|.-..... . ....-.+|+.+|.++.--.|..-+=|..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999875433 56665322111 1 112456799999998754444333355566777899999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
++|-.|.+.+... +..++..+-.-+.-||.. +|||+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888543 356777888889999998 999999999999998774 99999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-11 Score=138.08 Aligned_cols=247 Identities=19% Similarity=0.213 Sum_probs=161.9
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
..+.|.+.+-+-.|.|+.++.+.-. .|...+.|...... .+..+..+.+-.++-..+||-+++...-+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456666777888888888876633 24334444332211 1112223333333333445666554433334567789
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|++|+.+++|...||... +.+..-....+..+...++|||.. .++|||++|.|+|+..++..+++|||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999987654 234333334555678889999987 689999999999999999999999984322110
Q ss_pred C------------------------Cc------ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCC
Q 008052 356 T------------------------DT------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405 (579)
Q Consensus 356 ~------------------------~~------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~ 405 (579)
. .. .......||+.|++||.+.+......+|+|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00 01123569999999999999999999999999999999999999997
Q ss_pred CCCccccchhhhhhhhHhhhcccCCCchhhhchhhh--cCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008052 406 KADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMS 470 (579)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 470 (579)
...... .++.+...... .-......+...++...+..++.+|-.|.
T Consensus 1037 a~tpq~-------------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQ-------------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhh-------------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 655421 11111111111 22333445567777888888998888776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.8e-09 Score=106.31 Aligned_cols=141 Identities=16% Similarity=0.049 Sum_probs=101.9
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCch-----------hHHHHHHHHHHHHhcCCCC--cceEEEEEEe-----
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-----------GEREFQAEIEIISQVHHRH--LVSLVGYCTF----- 269 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------~~~~~~~Ei~~l~~l~Hpn--iv~l~g~~~~----- 269 (579)
+.+-.-....|+++.+ +|+.|.||+....... ....+.+|+..+.+|...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4454444455778766 6788999976443211 0114778999999986433 3455666643
Q ss_pred CCeEEEEEEecCCC-chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-------CCC
Q 008052 270 GSQRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-------SFE 341 (579)
Q Consensus 270 ~~~~~lV~E~~~~g-~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-------~~~ 341 (579)
....+||+|++++. +|.+++........+...+..++.+++..+.-||.. ||+|+|++++||||+. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999986 788887532223345567778999999999999999 9999999999999975 468
Q ss_pred eEEeecccccc
Q 008052 342 AKVADFGLAKH 352 (579)
Q Consensus 342 ~kL~DFGla~~ 352 (579)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-08 Score=107.64 Aligned_cols=168 Identities=18% Similarity=0.206 Sum_probs=125.3
Q ss_pred CceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE----eCCeEEEEEEecCC-Cchhh
Q 008052 214 GFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT----FGSQRLLVYEFVPN-KTLEF 287 (579)
Q Consensus 214 ~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~----~~~~~~lV~E~~~~-g~L~~ 287 (579)
--.+.||++. .||..|++|++..+..+....-..-+++.+++.|.|+|.+..++. .+..++|||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 4467899985 489999999995444333333445688999999999999988875 34577899999987 45544
Q ss_pred hhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 288 HLHGK-------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 288 ~l~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+-... ....+.+..++.++.|++.||.++|+. |+.-+-|.+.+||++.+.+++|...|+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 33211 123467788999999999999999998 99999999999999999999998888776543
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCC
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 402 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~ 402 (579)
.... |-+.. -.+-|.=.||.+|+-|.||..
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 3321 11111 125688889999999999954
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.9e-09 Score=98.34 Aligned_cols=126 Identities=20% Similarity=0.255 Sum_probs=82.6
Q ss_pred EEEEEEEeCCeEEEEEEeccCCc--------------------------hhHHHHHHHHHHHHhcCCC--CcceEEEEEE
Q 008052 217 YVHKGVLTNGKVVAIKQLKAGSG--------------------------QGEREFQAEIEIISQVHHR--HLVSLVGYCT 268 (579)
Q Consensus 217 ~Vy~~~~~~g~~vAvK~l~~~~~--------------------------~~~~~~~~Ei~~l~~l~Hp--niv~l~g~~~ 268 (579)
.||.|...+|..+|||+.+.... ......++|++.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999998643210 0112356899999999865 456665442
Q ss_pred eCCeEEEEEEecC--CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceEeCCCCCCceEeCCCCCeEEe
Q 008052 269 FGSQRLLVYEFVP--NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL-HEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (579)
Q Consensus 269 ~~~~~~lV~E~~~--~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~ivHrDikp~NILl~~~~~~kL~ 345 (579)
..+|||||++ |..+..+.... +.......++.+++..+..+ |.. +|||+||.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3469999998 55554433211 11344566777888866664 666 99999999999999988 99999
Q ss_pred ecccccccC
Q 008052 346 DFGLAKHSL 354 (579)
Q Consensus 346 DFGla~~~~ 354 (579)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.2e-07 Score=91.00 Aligned_cols=138 Identities=14% Similarity=0.114 Sum_probs=103.9
Q ss_pred ecccCceEEEEEEEeCCeEEEEEEeccCC------chhHHHHHHHHHHHHhcCCC--CcceEEEEEEe-----CCeEEEE
Q 008052 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGS------GQGEREFQAEIEIISQVHHR--HLVSLVGYCTF-----GSQRLLV 276 (579)
Q Consensus 210 LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~Hp--niv~l~g~~~~-----~~~~~lV 276 (579)
-|+||.+-|++..+. |+.+-||+-...- ...+..|.+|+..|.+|..- .+.+++ ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477999999998775 4568888764211 23467899999999999632 344555 4332 1235799
Q ss_pred EEecCC-CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC--eEEeecccccc
Q 008052 277 YEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLAKH 352 (579)
Q Consensus 277 ~E~~~~-g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~--~kL~DFGla~~ 352 (579)
+|-+.| -+|.+++........+...+..++.++++.|.-||+. ++.|+|+.+.|||++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5788888655444567778889999999999999999 9999999999999986666 99999976653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.2e-09 Score=115.33 Aligned_cols=149 Identities=22% Similarity=0.390 Sum_probs=106.3
Q ss_pred HHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc--------ceeecccccccccChhhhcc
Q 008052 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT--------HVSTRVMGTFGYLAPEYASS 378 (579)
Q Consensus 307 ~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~--------~~~~~~~gt~~y~APE~~~~ 378 (579)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+++........ ...--..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4455999999987 4999999999999999999999999998865433111 01111224557999999999
Q ss_pred CCCCcccceechHHHHHHHHhCCCC-CCCCCccccchhhhhhhhHhhhcccCCCchh-hhchhhhcCCHHHHHHHHHHHH
Q 008052 379 GKLTEKSDVFSFGVLLLELITGFRP-FDKADTFADDSMVDWAKPFLAQGLADGNFDA-LVDQKLEEYDSAEMTRMAACAA 456 (579)
Q Consensus 379 ~~~~~ksDVwSlGvvl~eLltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~d~~l~~~~~~~~~~l~~l~~ 456 (579)
...+.++|+|||||++|.+..|..+ +....... .. .+.. ..+-....+..+.+.++.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~------------~~~~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SY------------SFSRNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-----hh------------hhhhcccccccccccccCcHHHHHHHH
Confidence 8899999999999999999965544 33222111 00 0111 1111122455677788999999
Q ss_pred HhhccCCCCCCCHHHHHH
Q 008052 457 ACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 457 ~cl~~dp~~RPtm~evl~ 474 (579)
+++..+...||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999998887753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.8e-08 Score=93.01 Aligned_cols=106 Identities=21% Similarity=0.239 Sum_probs=84.5
Q ss_pred HHHHHHHHHHHHhcCC--CCcceEEEEEEeC----CeEEEEEEecCCC-chhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 008052 242 EREFQAEIEIISQVHH--RHLVSLVGYCTFG----SQRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314 (579)
Q Consensus 242 ~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~----~~~~lV~E~~~~g-~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~ 314 (579)
.....+|...+.+|.. =.....+++.+.. ...+||+|++++. +|.+++..... ++...+..++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3467788998888864 3455667776652 2447999999984 78888865322 566677889999999999
Q ss_pred HhhhcCCCceEeCCCCCCceEeCCCC---CeEEeecccccc
Q 008052 315 YLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKH 352 (579)
Q Consensus 315 yLH~~~~~~ivHrDikp~NILl~~~~---~~kL~DFGla~~ 352 (579)
-||+. ||+|+|+++.|||++.+. .+.|+||+.++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999998886 899999998775
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.7e-07 Score=96.44 Aligned_cols=256 Identities=20% Similarity=0.234 Sum_probs=155.9
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEE------EEeCC-eEEEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY------CTFGS-QRLLVYE 278 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~------~~~~~-~~~lV~E 278 (579)
.+.||+|+-+.+|-.-.- +..| .|+......-...+ .+..|... .||-+-.-+.+ .-+.. ..-++|.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hchh-heeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 467999999999964322 1223 35554332221122 23344444 35543331111 01111 2446777
Q ss_pred ecCCCc-hhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 279 FVPNKT-LEFHLH----GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 279 ~~~~g~-L~~~l~----~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
.+.+.- +..++. .+.-+...|.-.++.+..++.+.+-||+. |.+-+|+.++|+|+.+++.|.|.|-.-....
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 776642 122221 12235689999999999999999999998 9999999999999999999999986543322
Q ss_pred CCCCcceeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhC-CCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITG-FRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
.+......-+|...|..||.-. +-.-+...|.|.|||+|++|+.| ++||.+.....+. ..-++..+
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a------p~p~E~~I 239 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA------PNPLETDI 239 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC------CCcchhhh
Confidence 1222334457899999999765 33456789999999999999985 9999875422110 00011112
Q ss_pred cCCCchhhhchhh------hcCC-HHHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHhc
Q 008052 428 ADGNFDALVDQKL------EEYD-SAEMTRMAACAAACIRHS--ARRRPRMSQIVRALEG 478 (579)
Q Consensus 428 ~~~~~~~l~d~~l------~~~~-~~~~~~l~~l~~~cl~~d--p~~RPtm~evl~~Le~ 478 (579)
..+.+..-.|... ...+ .-.+..+..+..+|+... +.-||+.+.++..|..
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 2222211111111 1122 223456777888888654 5689999999888764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.6e-07 Score=92.35 Aligned_cols=136 Identities=17% Similarity=0.173 Sum_probs=95.8
Q ss_pred ccccceecccCceEEEEEEEeCCeEEEEEEeccCCc----------------------hhHHHHHHHHHHHHhcCCC--C
Q 008052 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----------------------QGEREFQAEIEIISQVHHR--H 259 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~----------------------~~~~~~~~Ei~~l~~l~Hp--n 259 (579)
..+.+.||-|.-+.||.|....|..+|||.=+.... ......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455689999999999999999999999997432211 0122356899999999754 5
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC
Q 008052 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (579)
Q Consensus 260 iv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~ 339 (579)
+.+-+++ +...+||||++|--|...- ++-...-.|+..|+.-+.-+-.. ||||+|+..-|||+++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 5555544 4567999999987664322 11222233444444444444344 89999999999999999
Q ss_pred CCeEEeeccccccc
Q 008052 340 FEAKVADFGLAKHS 353 (579)
Q Consensus 340 ~~~kL~DFGla~~~ 353 (579)
|.+.|+||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999877543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.2e-07 Score=103.41 Aligned_cols=146 Identities=21% Similarity=0.272 Sum_probs=96.5
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchh----------------------------------------
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG---------------------------------------- 241 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~---------------------------------------- 241 (579)
..|+ .+.|+.++-|.||+|++.+|+.||||+..++-...
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3444 36799999999999999999999999976542210
Q ss_pred HHHHHHHHHHHHhcC----CCCcceEEEEEE-eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHH-HHH
Q 008052 242 EREFQAEIEIISQVH----HRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG-LAY 315 (579)
Q Consensus 242 ~~~~~~Ei~~l~~l~----Hpniv~l~g~~~-~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~g-L~y 315 (579)
+-++..|...+.++. +..-+.+=.+|+ ..+...|+|||++|--+.+...-+. ..++.. .|+..++++ +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q 280 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQ 280 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHH
Confidence 012344555555542 222333334444 3567889999999988877642221 234433 333333332 222
Q ss_pred hhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 316 LH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
+-.+ |++|.|..|.||+++.++++.+.|||+.....+
T Consensus 281 ~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2233 899999999999999999999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.7e-08 Score=108.60 Aligned_cols=190 Identities=19% Similarity=0.148 Sum_probs=136.6
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~lV~ 277 (579)
..+..+...+.+++|.+++++|.+-...+...++.+... ....-++++|.+++||| .+..++-+..+...++++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 334445555778999999999987443444445555332 34556899999999999 677777777777888999
Q ss_pred EecCCC-chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 278 EFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 278 E~~~~g-~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
+++..+ +-..... .....+...+...+...-+++|+|||+. .=+||| |||..+ +..|..||+....+...
T Consensus 314 ~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 314 RICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc
Confidence 999877 2211111 1111234444556667778899999986 358999 888776 57899999988765443
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCC
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf 404 (579)
. ......+++.|+|||+...+.+..+.|+|++|+--.++--|-+|-
T Consensus 385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 3 345567999999999999999999999999998777777776664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.3e-06 Score=84.29 Aligned_cols=139 Identities=17% Similarity=0.177 Sum_probs=87.3
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEEEEEEeCCeEEEEEEecCCCc-
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVGYCTFGSQRLLVYEFVPNKT- 284 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~~~~~~~~~lV~E~~~~g~- 284 (579)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24457788876533 2345788999999987443 4677888877777889999999963
Q ss_pred hhhh---------------------hcCCCCCCCCHHHHHH-HHH----------HHHH-HHHHhhhc-CCCceEeCCCC
Q 008052 285 LEFH---------------------LHGKDRPVMNWPTRMK-IAL----------GSAR-GLAYLHED-CQPKIIHRDIK 330 (579)
Q Consensus 285 L~~~---------------------l~~~~~~~l~~~~~~~-ia~----------~ia~-gL~yLH~~-~~~~ivHrDik 330 (579)
+... ||...........+.. +.. .+.. ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1111 2221111111111111 000 0011 12222211 13467899999
Q ss_pred CCceEeCCCCCeEEeecccccc
Q 008052 331 SANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 331 p~NILl~~~~~~kL~DFGla~~ 352 (579)
+.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.9e-06 Score=81.03 Aligned_cols=140 Identities=17% Similarity=0.235 Sum_probs=96.1
Q ss_pred HHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHH---------HHHHHHHHhcCC---CCcceEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREF---------QAEIEIISQVHH---RHLVSLVG 265 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~---------~~Ei~~l~~l~H---pniv~l~g 265 (579)
.....+|...+++-......|.+-.. +|+.+++|..+......++.| .+++..+.++.. -.++.++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34557888888898888888888777 467889998866543333333 345555555532 22233222
Q ss_pred EEE-----eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC
Q 008052 266 YCT-----FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (579)
Q Consensus 266 ~~~-----~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 340 (579)
++. .....+|||||++|-.|.+... ++. .++..+.+.|.-||.. |++|+|+.|+|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence 222 2345578999999988865432 222 2456677889999999 99999999999999966
Q ss_pred CeEEeecccccc
Q 008052 341 EAKVADFGLAKH 352 (579)
Q Consensus 341 ~~kL~DFGla~~ 352 (579)
.+++.||+.-+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.3e-06 Score=95.02 Aligned_cols=142 Identities=21% Similarity=0.233 Sum_probs=90.9
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchh-------------------------------------HHHHHHHH
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-------------------------------------EREFQAEI 249 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-------------------------------------~~~~~~Ei 249 (579)
.+.||.-..|.||+|++++|+.||||+-+++-... +-+|..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999866542211 01244555
Q ss_pred HHHHhc----CCCCc---ceEEEEEE-eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 008052 250 EIISQV----HHRHL---VSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321 (579)
Q Consensus 250 ~~l~~l----~Hpni---v~l~g~~~-~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~ 321 (579)
+-..++ .|-++ |.+=.+++ ....+.|+||||+|.-+.+...- ....++-..... .+.++ |++....
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~---~l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILN---KLVEA--YLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHH---HHHHH--HHHHHHh
Confidence 544443 35551 22222333 34678999999999877654321 112244444333 33332 2222222
Q ss_pred CceEeCCCCCCceEeCC----CCCeEEeecccccccC
Q 008052 322 PKIIHRDIKSANILLDD----SFEAKVADFGLAKHSL 354 (579)
Q Consensus 322 ~~ivHrDikp~NILl~~----~~~~kL~DFGla~~~~ 354 (579)
.|++|+|-.|.|||++. ++++.+-|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 28999999999999983 6789999999987643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.6e-06 Score=82.28 Aligned_cols=143 Identities=18% Similarity=0.182 Sum_probs=86.7
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--CcceEEEEEEe---CCeEEEEEEecC
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVSLVGYCTF---GSQRLLVYEFVP 281 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hp--niv~l~g~~~~---~~~~~lV~E~~~ 281 (579)
++.|+.|..+.||+....+ ..+++|..... .....+..|+.++..+... .+.+++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999877 57889986554 4456788999999888633 35677765533 335689999999
Q ss_pred CCchhh----------------h---hcCC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHhhh
Q 008052 282 NKTLEF----------------H---LHGK--DRPVMNWPTR---------MKI------------ALGSAR-GLAYLHE 318 (579)
Q Consensus 282 ~g~L~~----------------~---l~~~--~~~~l~~~~~---------~~i------------a~~ia~-gL~yLH~ 318 (579)
+..+.. . ||.. ....+.+... ... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988776 1 1111 1111111110 000 111222 3333332
Q ss_pred c----CCCceEeCCCCCCceEeC-CCCCeEEeecccccc
Q 008052 319 D----CQPKIIHRDIKSANILLD-DSFEAKVADFGLAKH 352 (579)
Q Consensus 319 ~----~~~~ivHrDikp~NILl~-~~~~~kL~DFGla~~ 352 (579)
. ....++|+|+.+.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 234799999999999999 566667999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.8e-06 Score=82.85 Aligned_cols=139 Identities=17% Similarity=0.137 Sum_probs=85.7
Q ss_pred ecccCc-eEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecCCCchhh
Q 008052 210 LGQGGF-GYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 287 (579)
Q Consensus 210 LG~G~f-g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~ 287 (579)
|-.|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.++++++...+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444544 889998764 4678888875443 345778999988885 4445577887776667889999999987753
Q ss_pred h-------------------hcCCCCC--CCC--HHHHHHHHHH--------------------HHHHHHHhhh----cC
Q 008052 288 H-------------------LHGKDRP--VMN--WPTRMKIALG--------------------SARGLAYLHE----DC 320 (579)
Q Consensus 288 ~-------------------l~~~~~~--~l~--~~~~~~ia~~--------------------ia~gL~yLH~----~~ 320 (579)
. ||..... .+. +..++..... +...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 3 1221110 111 0011100000 1111222211 12
Q ss_pred CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 321 ~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 35699999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.9e-06 Score=80.99 Aligned_cols=103 Identities=21% Similarity=0.191 Sum_probs=81.4
Q ss_pred HHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEEEecCCCchhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 008052 246 QAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323 (579)
Q Consensus 246 ~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 323 (579)
..|.-+|+.+++ +++.+++|+|- .++|.||+..+.+...-.. ..-...+|..|.+||.++++.+.+|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999986 69999999993 4689999987765321000 01123799999999999999999999854335
Q ss_pred eEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 324 IIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 324 ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+.-.|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=78.06 Aligned_cols=152 Identities=17% Similarity=0.175 Sum_probs=98.4
Q ss_pred CHHHHHHhhcCccccc---eecccCceEEEEEEEeCCeEEEEEEeccCCchh-------------------HH-----HH
Q 008052 193 TYEELKIATDNFSEAN---LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-------------------ER-----EF 245 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~---~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-------------------~~-----~~ 245 (579)
+++.|....+...+.. .|..|.-..||+|.-.++..+|||+.+...... .+ ..
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3445555555554444 455677778999998889999999986532111 11 12
Q ss_pred HHHHHHHHhcC--CCCcceEEEEEEeCCeEEEEEEecCCCch-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 008052 246 QAEIEIISQVH--HRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322 (579)
Q Consensus 246 ~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~lV~E~~~~g~L-~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 322 (579)
.+|+.-|.++. +=.+.+-+++. .-.|||||+...-+ .-.|..- .+.......+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 46777787774 33444444443 33599999965421 1222111 1222245566777888888776643
Q ss_pred ceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 323 ~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
++||+||..=|||+. ++.+.|+|||-+....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 899999999999999 7799999999887543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-05 Score=92.79 Aligned_cols=146 Identities=17% Similarity=0.262 Sum_probs=93.5
Q ss_pred cceecccCceEEEEEEEeCC---eEEEEEEeccCCc-hhHHHHHHHHHHHHhcC-CCCc--ceEEEEEEeC---CeEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTNG---KVVAIKQLKAGSG-QGEREFQAEIEIISQVH-HRHL--VSLVGYCTFG---SQRLLV 276 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g---~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~-Hpni--v~l~g~~~~~---~~~~lV 276 (579)
.+.|+.|.++.+|+....++ ..+++|+...... .....+.+|+.+|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999887654 4677777544321 23457889999999996 6665 7888888764 467899
Q ss_pred EEecCCCchhh-----------------------hhcCCCCC---------CCCHH--HHHHHH---------------H
Q 008052 277 YEFVPNKTLEF-----------------------HLHGKDRP---------VMNWP--TRMKIA---------------L 307 (579)
Q Consensus 277 ~E~~~~g~L~~-----------------------~l~~~~~~---------~l~~~--~~~~ia---------------~ 307 (579)
|||++|..+.+ .||..... ...+. +..++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 12221110 01111 111110 1
Q ss_pred HHHHHHHHhhhcCC--------CceEeCCCCCCceEeCCC-CC-eEEeecccccc
Q 008052 308 GSARGLAYLHEDCQ--------PKIIHRDIKSANILLDDS-FE-AKVADFGLAKH 352 (579)
Q Consensus 308 ~ia~gL~yLH~~~~--------~~ivHrDikp~NILl~~~-~~-~kL~DFGla~~ 352 (579)
.+...+++|..+.. +.+||+|+++.|||++.+ .. +-|.||.++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 23344667755422 359999999999999853 33 57899998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.1e-05 Score=74.02 Aligned_cols=125 Identities=27% Similarity=0.453 Sum_probs=91.2
Q ss_pred cCccccceecccCc-eEEEEEEEeCCeEEEEEEeccCC-----------c----------hhHHHHHHHHHHHHhcC---
Q 008052 202 DNFSEANLLGQGGF-GYVHKGVLTNGKVVAIKQLKAGS-----------G----------QGEREFQAEIEIISQVH--- 256 (579)
Q Consensus 202 ~~f~~~~~LG~G~f-g~Vy~~~~~~g~~vAvK~l~~~~-----------~----------~~~~~~~~Ei~~l~~l~--- 256 (579)
.+++..+.||.|.- |.|||+.+ +|+.+|+|.++... . .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999999 57899999943210 0 01124778999888886
Q ss_pred CCCc--ceEEEEEEeCC------------------eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 008052 257 HRHL--VSLVGYCTFGS------------------QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316 (579)
Q Consensus 257 Hpni--v~l~g~~~~~~------------------~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yL 316 (579)
+.++ |+++||..-.. .+.||.||++... .+ ..+-+.+|.+-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHH
Confidence 4466 99999974321 2357888775543 01 223356677788889
Q ss_pred hhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 317 H~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
|.. +|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 987 9999999999987 4599999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.6e-05 Score=78.30 Aligned_cols=79 Identities=11% Similarity=0.071 Sum_probs=58.8
Q ss_pred ccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC---CCcceEEEEEEeC---CeEEEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---RHLVSLVGYCTFG---SQRLLVY 277 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H---pniv~l~g~~~~~---~~~~lV~ 277 (579)
....+.||.|..+.||+....+++ +.||..+.. .....|..|.+.|+.|.- -.+.+++++|..+ +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344578999999999998876664 566764431 123578899999999863 3678889888653 5689999
Q ss_pred EecCCCch
Q 008052 278 EFVPNKTL 285 (579)
Q Consensus 278 E~~~~g~L 285 (579)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=3e-05 Score=76.72 Aligned_cols=139 Identities=19% Similarity=0.222 Sum_probs=78.4
Q ss_pred ceecccCceE-EEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC---CcceEEEEEEeCC---eEEEEEEec
Q 008052 208 NLLGQGGFGY-VHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR---HLVSLVGYCTFGS---QRLLVYEFV 280 (579)
Q Consensus 208 ~~LG~G~fg~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hp---niv~l~g~~~~~~---~~~lV~E~~ 280 (579)
+.|+.||... ||+. +..+++|..... .....+.+|+++|..+... .+.++++.+...+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 5678777774 8875 235677875542 2345788999999888632 3344454443322 347899999
Q ss_pred CCCchhhh------------------hcCCCCCC--C-------------CHHHHH--HHH-------HHHHHHH-H-Hh
Q 008052 281 PNKTLEFH------------------LHGKDRPV--M-------------NWPTRM--KIA-------LGSARGL-A-YL 316 (579)
Q Consensus 281 ~~g~L~~~------------------l~~~~~~~--l-------------~~~~~~--~ia-------~~ia~gL-~-yL 316 (579)
+|.++... ||...... . .|.... .+. .+.+..+ + ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 99776422 22211100 0 121110 000 0111111 1 11
Q ss_pred hh--cCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 317 HE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 317 H~--~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+. ...+.++|+|+.+.|||++++...-|+||+.+..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234599999999999998775567999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.7e-05 Score=71.31 Aligned_cols=128 Identities=19% Similarity=0.185 Sum_probs=86.8
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcce-EEEEEEeCCeEEEEEEecCCCc
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS-LVGYCTFGSQRLLVYEFVPNKT 284 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~-l~g~~~~~~~~~lV~E~~~~g~ 284 (579)
..+.|++|.+|.||+|.+.+ ..+|+|+-+.++. ...+..|+++|..+.--++-. ++.|-. ..+.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccC-ceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 34789999999999999965 4788888766543 568999999999998766654 444432 235599999988
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCC-CCceEeCCCCCeEEeecccccc
Q 008052 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIK-SANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDik-p~NILl~~~~~~kL~DFGla~~ 352 (579)
|...-... +- +-...+++.---|-.. ||-|+.|. |..++|..+..+.|+||.-|+.
T Consensus 99 L~~~~~~~-----~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG-----DR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc-----cH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 86554321 11 2233444443334333 89999987 4444444444899999998863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00015 Score=69.69 Aligned_cols=129 Identities=21% Similarity=0.260 Sum_probs=89.8
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccCC----------------chhHHHHHHHHHHHHhcC------CCCcceE
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----------------GQGEREFQAEIEIISQVH------HRHLVSL 263 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------Hpniv~l 263 (579)
....||+|+.-.||.- .+....+||++.... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4568999999999963 444556788887655 122356666776666655 8899999
Q ss_pred EEEEEeCCeEEEEEEecCC------CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC
Q 008052 264 VGYCTFGSQRLLVYEFVPN------KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 337 (579)
Q Consensus 264 ~g~~~~~~~~~lV~E~~~~------g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~ 337 (579)
+|+...+...-+|+|.+.+ -+|.+++... .++. . +...+-+-..||-++ .|+.+||+|.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 9999998888899998754 3567777432 2443 2 333334445677776 899999999999995
Q ss_pred CCC----CeEEee
Q 008052 338 DSF----EAKVAD 346 (579)
Q Consensus 338 ~~~----~~kL~D 346 (579)
.+. .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.95 E-value=9.7e-05 Score=72.89 Aligned_cols=141 Identities=21% Similarity=0.238 Sum_probs=83.1
Q ss_pred cceecccCceEEEEEEEeC--CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeEEEEEEecCCC
Q 008052 207 ANLLGQGGFGYVHKGVLTN--GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
.+.|..|-...+|+....+ ++.|++|+....... ..+..+|+.++..+...+ ..++++.+. ..+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567888889999998764 577888976543221 123457888888886433 344544432 23799999997
Q ss_pred chhhh-----------------hcCCCCC---------CC-CHHHHHHHHH----------------------HHHHHHH
Q 008052 284 TLEFH-----------------LHGKDRP---------VM-NWPTRMKIAL----------------------GSARGLA 314 (579)
Q Consensus 284 ~L~~~-----------------l~~~~~~---------~l-~~~~~~~ia~----------------------~ia~gL~ 314 (579)
++... +|..... .. -|..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 1211111 11 1222112111 1111111
Q ss_pred Hh----hhc-CCCceEeCCCCCCceEeCC-CCCeEEeecccccc
Q 008052 315 YL----HED-CQPKIIHRDIKSANILLDD-SFEAKVADFGLAKH 352 (579)
Q Consensus 315 yL----H~~-~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~~ 352 (579)
.| ... ....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11 111 2347999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.6e-05 Score=76.03 Aligned_cols=142 Identities=17% Similarity=0.159 Sum_probs=87.5
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEEEE------EEeCCeEEEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVGY------CTFGSQRLLVYE 278 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~------~~~~~~~~lV~E 278 (579)
.+.|..|-...+|+....++ .+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 56677888889999876544 688888764 22456777888888885432 4444432 233456689999
Q ss_pred ecCCCchhh--------------hhcCC----CC-----CCCCHHHHHH----------HHHHHHHHHHHhhh----cCC
Q 008052 279 FVPNKTLEF--------------HLHGK----DR-----PVMNWPTRMK----------IALGSARGLAYLHE----DCQ 321 (579)
Q Consensus 279 ~~~~g~L~~--------------~l~~~----~~-----~~l~~~~~~~----------ia~~ia~gL~yLH~----~~~ 321 (579)
|++|..+.. .||.. .. ....|..... ....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 01110 00 1123322210 11122334445443 123
Q ss_pred CceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 322 ~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+++|+|+.+.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0004 Score=73.80 Aligned_cols=76 Identities=20% Similarity=0.153 Sum_probs=53.9
Q ss_pred cceecccCceEEEEEEEeCC-eEEEEEEeccC-----C--chhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTNG-KVVAIKQLKAG-----S--GQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g-~~vAvK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~l 275 (579)
.+.||.|.+..||+....+| +.|+||.-... . ......+..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36799999999999998877 58999985321 1 123345677888888763 2456677665 3456789
Q ss_pred EEEecCCCc
Q 008052 276 VYEFVPNKT 284 (579)
Q Consensus 276 V~E~~~~g~ 284 (579)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00033 Score=70.19 Aligned_cols=138 Identities=15% Similarity=0.123 Sum_probs=80.7
Q ss_pred eecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEecCCCchhh
Q 008052 209 LLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPNKTLEF 287 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~g~L~~ 287 (579)
.+..|-.+.+|+... +++.+++|........-.-...+|..++..+....+ .++++++. .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356677889998874 567788887654322211245778899988864433 34554432 368999999876642
Q ss_pred h-----------------hcCCCC--CCCCHHHH-HHHHHHH---------HHHHHHhhhc-----CCCceEeCCCCCCc
Q 008052 288 H-----------------LHGKDR--PVMNWPTR-MKIALGS---------ARGLAYLHED-----CQPKIIHRDIKSAN 333 (579)
Q Consensus 288 ~-----------------l~~~~~--~~l~~~~~-~~ia~~i---------a~gL~yLH~~-----~~~~ivHrDikp~N 333 (579)
. ||.... ..++...+ ..+..++ ...+..+-.. ..+.++|+|+.+.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 232221 11222211 1111111 1112222111 13368999999999
Q ss_pred eEeCCCCCeEEeecccccc
Q 008052 334 ILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 334 ILl~~~~~~kL~DFGla~~ 352 (579)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00071 Score=70.08 Aligned_cols=157 Identities=15% Similarity=0.157 Sum_probs=87.0
Q ss_pred cCHHHHHHhhcCccc-----cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEE
Q 008052 192 FTYEELKIATDNFSE-----ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLV 264 (579)
Q Consensus 192 ~~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~ 264 (579)
.+.+++......|.. .+.|+.|....+|+....+| .+++|+.... ....+..|+.++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 344555544455544 35567777789999887665 5788887521 2334445666666654222 33333
Q ss_pred E------EEEeCCeEEEEEEecCCCchhh--------------hhcCCCC---------CCCCH-HHHHHH---------
Q 008052 265 G------YCTFGSQRLLVYEFVPNKTLEF--------------HLHGKDR---------PVMNW-PTRMKI--------- 305 (579)
Q Consensus 265 g------~~~~~~~~~lV~E~~~~g~L~~--------------~l~~~~~---------~~l~~-~~~~~i--------- 305 (579)
. +....+..++++||++|..+.. .||.... ..+.| .....-
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 1233566789999999875421 1121110 11212 221111
Q ss_pred ---H-HHHHHHHHHhhh----cCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 306 ---A-LGSARGLAYLHE----DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 306 ---a-~~ia~gL~yLH~----~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+ ..+...++.+.. ....++||+|+.+.|||++.+...-|+||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1 111112233321 1345899999999999999765568999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00069 Score=69.88 Aligned_cols=157 Identities=17% Similarity=0.190 Sum_probs=91.1
Q ss_pred CHHHHHHhhcCccc-----cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEEE
Q 008052 193 TYEELKIATDNFSE-----ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVG 265 (579)
Q Consensus 193 ~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g 265 (579)
+.++|....+.|.. .+.|+.|-...+|+....+| .+++|+...... ..++..|++++..|.... +.+++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 44555554445543 45677777789999876555 577887654321 344566777777774322 344443
Q ss_pred EE------EeCCeEEEEEEecCCCchhh--------------hhcCCCC----------CCCCHHHHHH-----------
Q 008052 266 YC------TFGSQRLLVYEFVPNKTLEF--------------HLHGKDR----------PVMNWPTRMK----------- 304 (579)
Q Consensus 266 ~~------~~~~~~~lV~E~~~~g~L~~--------------~l~~~~~----------~~l~~~~~~~----------- 304 (579)
.. ...+..++++||++|..+.. .+|.... ..-.|.....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 22456789999998855421 1221100 0112221110
Q ss_pred -HHHHHHHHHHHhhh----cCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 305 -IALGSARGLAYLHE----DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 305 -ia~~ia~gL~yLH~----~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
....+.+.++++.. ....+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 01123334555532 2345899999999999999887678999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00075 Score=69.33 Aligned_cols=140 Identities=23% Similarity=0.276 Sum_probs=85.7
Q ss_pred ceecccCceEEEEEEEeC-------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEe
Q 008052 208 NLLGQGGFGYVHKGVLTN-------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~ 279 (579)
+.|..|-...||+....+ ++.+++|+...... ...+..+|++++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 566777788999988765 47888998765432 23456788888888864333 356655532 368999
Q ss_pred cCCCchhhh-----------------hcCCCCCC---------CCHHHHHH--------------------------HHH
Q 008052 280 VPNKTLEFH-----------------LHGKDRPV---------MNWPTRMK--------------------------IAL 307 (579)
Q Consensus 280 ~~~g~L~~~-----------------l~~~~~~~---------l~~~~~~~--------------------------ia~ 307 (579)
++|..+... ||...... .-|....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 22211110 01111111 011
Q ss_pred HHHHHHHHhhh------cCCCceEeCCCCCCceEeCCC----CCeEEeecccccc
Q 008052 308 GSARGLAYLHE------DCQPKIIHRDIKSANILLDDS----FEAKVADFGLAKH 352 (579)
Q Consensus 308 ~ia~gL~yLH~------~~~~~ivHrDikp~NILl~~~----~~~kL~DFGla~~ 352 (579)
.+..-+.+|-. .....++|+|+.+.|||++++ +.++|+||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334432 234579999999999999985 7899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00027 Score=81.74 Aligned_cols=196 Identities=18% Similarity=0.188 Sum_probs=132.8
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEEeCCeEE----EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 008052 245 FQAEIEIISQVHHRHLVSLVGYCTFGSQRL----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320 (579)
Q Consensus 245 ~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~----lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 320 (579)
...|++.+.++.|+|++.+++|-.+....- +..|++..-++..++... ...+..+.+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 345777888899999999998876644332 446777777777777543 3477778888899999999999997
Q ss_pred CCceEeCCCCCC---ceEeCCCCCeEEe--ecccccccCCCCcceeecccccccccChhhhccCCCCc--ccceechHHH
Q 008052 321 QPKIIHRDIKSA---NILLDDSFEAKVA--DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE--KSDVFSFGVL 393 (579)
Q Consensus 321 ~~~ivHrDikp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~--ksDVwSlGvv 393 (579)
.+.|.=|..+ +...+..+.+.+. ||+..+...+.... ....-...|.++|......++. ..|+|++|..
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 5555555444 4445666677777 88888766543322 2223455677888776555544 4799999999
Q ss_pred HHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 394 LLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 394 l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
+..+..|..+-.... .+...+.. .....+......|+..+.++|+...+++
T Consensus 382 ~~~~~~~~~i~~~~~--------------------------~~~~~l~~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA--------------------------VPVSLLDV---LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HhhhhhcCccccccc--------------------------chhhhhcc---ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 999999865422111 01111110 0111466777889999999999999998
Q ss_pred HHH
Q 008052 474 RAL 476 (579)
Q Consensus 474 ~~L 476 (579)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 654
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=97.39 E-value=8.8e-05 Score=50.74 Aligned_cols=30 Identities=40% Similarity=0.848 Sum_probs=17.9
Q ss_pred ccceEehHhHHHHHHHHHHHHHHHHhhhcc
Q 008052 73 LAGMVVGVVIGAGIVLAAVGIFLIFYKRRK 102 (579)
Q Consensus 73 ~~~i~vgv~v~~~~~l~~~~~~~~~~~rr~ 102 (579)
.++|++||++.+++++++++++|++++||+
T Consensus 10 ~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 10 TVAIAVGVVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred eEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence 455666666666666666666666554444
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0022 Score=65.17 Aligned_cols=31 Identities=26% Similarity=0.483 Sum_probs=25.9
Q ss_pred CceEeCCCCCCceEeCCCCC-eEEeecccccc
Q 008052 322 PKIIHRDIKSANILLDDSFE-AKVADFGLAKH 352 (579)
Q Consensus 322 ~~ivHrDikp~NILl~~~~~-~kL~DFGla~~ 352 (579)
+.++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00061 Score=69.01 Aligned_cols=147 Identities=20% Similarity=0.220 Sum_probs=97.3
Q ss_pred cCHHHHHHhhc---CccccceecccCceEEEEEEEeCCeEEEEEEeccCCc------------------h----hHHHHH
Q 008052 192 FTYEELKIATD---NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------------------Q----GEREFQ 246 (579)
Q Consensus 192 ~~~~el~~~~~---~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------------------~----~~~~~~ 246 (579)
+.|-.|+.... -++..+.||-|.-+.||.+...+|+..++|.-..... . .+-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 44555544443 3677899999999999999998899988885321110 0 011235
Q ss_pred HHHHHHHhcC-CCC-cceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 008052 247 AEIEIISQVH-HRH-LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324 (579)
Q Consensus 247 ~Ei~~l~~l~-Hpn-iv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 324 (579)
+|+..|+.|. |.. +.+.+++ +..++|||++.+-.|...-+- .+..++..-++++ +--|-.+ |+
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~---Iv~la~~---Gl 223 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGL---IVRLANH---GL 223 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHH---HHHHHHc---Cc
Confidence 6888888886 333 2333333 456799999999888654432 2223333333322 3334445 99
Q ss_pred EeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 325 IHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 325 vHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
||+|+.-=||+|++++.++++||--+...
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhhcc
Confidence 99999999999999999999999765543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0024 Score=65.17 Aligned_cols=141 Identities=18% Similarity=0.242 Sum_probs=74.2
Q ss_pred ccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEEEEec
Q 008052 204 FSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
....+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+.+++....+..+||+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445779999999999987 5677888998652 23356888999888884 345778888887777789999999
Q ss_pred CCCch-----------hhhhcC-CCC-------------------CCCCHHH-----HHHHHHHH--------------H
Q 008052 281 PNKTL-----------EFHLHG-KDR-------------------PVMNWPT-----RMKIALGS--------------A 310 (579)
Q Consensus 281 ~~g~L-----------~~~l~~-~~~-------------------~~l~~~~-----~~~ia~~i--------------a 310 (579)
+.+.. -..||. ... -.-+|.. |+.-..+. .
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 87711 011222 110 1123322 11111111 1
Q ss_pred HH-HHHhhhc-CCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 311 RG-LAYLHED-CQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 311 ~g-L~yLH~~-~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
+. ...|+.. -.|-++|+||.+.|++.+.++.+.|.|=.
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 11 1223321 25679999999999999999989988754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0092 Score=62.65 Aligned_cols=140 Identities=20% Similarity=0.221 Sum_probs=83.7
Q ss_pred ceecccCceEEEEEEEeC-----CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcc-eEEEEEEeCCeEEEEEEecC
Q 008052 208 NLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV-SLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~lV~E~~~ 281 (579)
..|-.|-...+|+..+.+ ++.|++|+....... .-+-.+|+.++..+..-++. ++++++..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456568888999987643 367889987654322 22336788898888654443 566665332 5899998
Q ss_pred CCchhhh-----------------hcCCCC---C-CCCHHHHHHHHHH-----------------HHHHHHHh----hh-
Q 008052 282 NKTLEFH-----------------LHGKDR---P-VMNWPTRMKIALG-----------------SARGLAYL----HE- 318 (579)
Q Consensus 282 ~g~L~~~-----------------l~~~~~---~-~l~~~~~~~ia~~-----------------ia~gL~yL----H~- 318 (579)
+.+|... +|.... . ..-|.+..++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 222211 1 1123332232211 11112222 21
Q ss_pred cCCCceEeCCCCCCceEeCC-CCCeEEeecccccc
Q 008052 319 DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKH 352 (579)
Q Consensus 319 ~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~~ 352 (579)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12346899999999999986 46899999988753
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0003 Score=62.99 Aligned_cols=30 Identities=40% Similarity=0.625 Sum_probs=14.7
Q ss_pred cccceEehHhHHHHHHHHHHHHHHHHhhhccc
Q 008052 72 ALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103 (579)
Q Consensus 72 ~~~~i~vgv~v~~~~~l~~~~~~~~~~~rr~~ 103 (579)
.++|++|||.+ .++|++++++||||+|+||
T Consensus 50 IVIGvVVGVGg--~ill~il~lvf~~c~r~kk 79 (154)
T PF04478_consen 50 IVIGVVVGVGG--PILLGILALVFIFCIRRKK 79 (154)
T ss_pred EEEEEEecccH--HHHHHHHHhheeEEEeccc
Confidence 45555555443 2334444455555555444
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.00019 Score=84.69 Aligned_cols=159 Identities=12% Similarity=-0.004 Sum_probs=111.5
Q ss_pred HHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEEEEecCCCchhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHhhhcC
Q 008052 245 FQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDC 320 (579)
Q Consensus 245 ~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV~E~~~~g~L~~~l~~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~ 320 (579)
...|.+.++...|++++....-... ....+.+++|+.+|.+...|-.... +.++..-......+......-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3455666666789888776554432 3456789999999999888754322 22333322222333344555555443
Q ss_pred CC--ceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHH
Q 008052 321 QP--KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 398 (579)
Q Consensus 321 ~~--~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLl 398 (579)
+. -.+|+++|+-|.+|..+..+|+.++||.+... ......+...+++.|+.++....-+++.++|+|..|+.+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 21 36899999999999999999999999998321 2222334456888999999999889999999999999999998
Q ss_pred hCCCCC
Q 008052 399 TGFRPF 404 (579)
Q Consensus 399 tG~~Pf 404 (579)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887665
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.011 Score=61.55 Aligned_cols=141 Identities=23% Similarity=0.338 Sum_probs=85.6
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC------cceEEEEE--EeCC--eEEEEE
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH------LVSLVGYC--TFGS--QRLLVY 277 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn------iv~l~g~~--~~~~--~~~lV~ 277 (579)
..|.. .-..||+....+|+. ++|+.... ....++..|...|..|.-.. +..+=|-. .... ..+-|+
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34554 567899999887776 88887765 34567777888888774222 22222211 1123 667899
Q ss_pred EecCCCchhh-h--------------hc--CCC--------CCCCCHHH---H----------HHHHHHHHHHHHHhhhc
Q 008052 278 EFVPNKTLEF-H--------------LH--GKD--------RPVMNWPT---R----------MKIALGSARGLAYLHED 319 (579)
Q Consensus 278 E~~~~g~L~~-~--------------l~--~~~--------~~~l~~~~---~----------~~ia~~ia~gL~yLH~~ 319 (579)
+|++|..+.. . || .++ .....|.. + .....++...++.+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988772 1 11 011 11234430 0 11223334444444433
Q ss_pred ----CCCc---eEeCCCCCCceEeCCCCC-eEEeecccccc
Q 008052 320 ----CQPK---IIHRDIKSANILLDDSFE-AKVADFGLAKH 352 (579)
Q Consensus 320 ----~~~~---ivHrDikp~NILl~~~~~-~kL~DFGla~~ 352 (579)
.... +||+|+.+.|||++.+.. +.+.||+-|..
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 2223 899999999999999875 88999998753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0077 Score=62.24 Aligned_cols=140 Identities=16% Similarity=0.190 Sum_probs=93.7
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccC------Cc----------------hhH----HHHHHHHHHHHhcCCCC
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG------SG----------------QGE----REFQAEIEIISQVHHRH 259 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~------~~----------------~~~----~~~~~Ei~~l~~l~Hpn 259 (579)
+..+|..|.-..||.++-.+|..+|||+.+.. .. ..+ -....|+.-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34678889999999999999999999987531 00 001 12346888888886443
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCch-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC
Q 008052 260 LVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (579)
Q Consensus 260 iv~l~g~~~~~~~~~lV~E~~~~g~L-~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~ 338 (579)
|.----+. -....|||+|+..... .-.|. .-.++......+-.+++.-+.-|-..| ++||.||.--|+|+.+
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 32110011 1234699999953222 11221 123555566777788888888888888 8999999999999865
Q ss_pred CCCeEEeeccccccc
Q 008052 339 SFEAKVADFGLAKHS 353 (579)
Q Consensus 339 ~~~~kL~DFGla~~~ 353 (579)
|.+.|+|-+-+...
T Consensus 301 -G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEH 314 (520)
T ss_pred -CEEEEEEccccccC
Confidence 47999999877643
|
|
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0007 Score=56.90 Aligned_cols=20 Identities=40% Similarity=0.508 Sum_probs=15.0
Q ss_pred CCCCCCCCcccceEehHhHH
Q 008052 64 RNGYLPPGALAGMVVGVVIG 83 (579)
Q Consensus 64 ~~~~l~~~~~~~i~vgv~v~ 83 (579)
..++++.++++||+||++++
T Consensus 59 ~~~~ls~gaiagi~vg~~~~ 78 (96)
T PTZ00382 59 NRSGLSTGAIAGISVAVVAV 78 (96)
T ss_pred CCCCcccccEEEEEeehhhH
Confidence 34678888888888887743
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.012 Score=60.41 Aligned_cols=31 Identities=35% Similarity=0.396 Sum_probs=26.4
Q ss_pred CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 321 ~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
..+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 357999999999999988 5789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0011 Score=44.59 Aligned_cols=16 Identities=31% Similarity=0.710 Sum_probs=9.7
Q ss_pred ccceEehHhHHHHHHH
Q 008052 73 LAGMVVGVVIGAGIVL 88 (579)
Q Consensus 73 ~~~i~vgv~v~~~~~l 88 (579)
.++|++||++|.++++
T Consensus 5 ~IaIIv~V~vg~~iii 20 (38)
T PF02439_consen 5 TIAIIVAVVVGMAIII 20 (38)
T ss_pred hhhHHHHHHHHHHHHH
Confidence 4667777776654433
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.022 Score=58.64 Aligned_cols=144 Identities=19% Similarity=0.283 Sum_probs=84.1
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEec--cCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCC--eEEEEEEec
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLK--AGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGS--QRLLVYEFV 280 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~--~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~--~~~lV~E~~ 280 (579)
.+.+..|---.+|..... ++.++++ .. .......+...+|..+|..+.- --+-..+++|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344433333334444433 7778888 32 1223334567788888888753 23445677887766 668999999
Q ss_pred CCCchhhhh---------------------cCC---------------CCCCCCHHHHHHHHH--------HHHHHHHHh
Q 008052 281 PNKTLEFHL---------------------HGK---------------DRPVMNWPTRMKIAL--------GSARGLAYL 316 (579)
Q Consensus 281 ~~g~L~~~l---------------------~~~---------------~~~~l~~~~~~~ia~--------~ia~gL~yL 316 (579)
+|..+...+ |.- .++...|....+.+. ....-..||
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 884332221 110 011122222221110 122335556
Q ss_pred hhcC-----CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 317 HEDC-----QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 317 H~~~-----~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+.+. .+.++|+|+.+.||+|+.+..+=|.||+++..
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 5542 34689999999999999988899999999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.022 Score=59.62 Aligned_cols=73 Identities=16% Similarity=0.124 Sum_probs=46.9
Q ss_pred eecccCceEEEEEEEeCC-eEEEEEEeccCC-------chhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeEEEEEE
Q 008052 209 LLGQGGFGYVHKGVLTNG-KVVAIKQLKAGS-------GQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~~~~g-~~vAvK~l~~~~-------~~~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.||.|....||++...+| +.|+||.-.... ........-|.+.|.... -|..|.-+ |+.+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence 589999999999998654 689999853211 112233446777776654 35444433 2334556679999
Q ss_pred ecCC
Q 008052 279 FVPN 282 (579)
Q Consensus 279 ~~~~ 282 (579)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0013 Score=57.43 Aligned_cols=19 Identities=26% Similarity=0.496 Sum_probs=14.0
Q ss_pred CCCCCcccceEehHhHHHH
Q 008052 67 YLPPGALAGMVVGVVIGAG 85 (579)
Q Consensus 67 ~l~~~~~~~i~vgv~v~~~ 85 (579)
.++.+++++||+||++|++
T Consensus 60 ~fs~~~i~~Ii~gv~aGvI 78 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVI 78 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHH
T ss_pred CccccceeehhHHHHHHHH
Confidence 6777788888888887654
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.029 Score=59.75 Aligned_cols=73 Identities=14% Similarity=0.137 Sum_probs=49.0
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCc-------hhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG-------QGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-------~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~lV 276 (579)
.+.||.|....||+.... ++.++||+-..... .....-..|.+.|..+. ..++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567999999999998764 45688998542111 11222233466666553 347788888886 456789
Q ss_pred EEecCC
Q 008052 277 YEFVPN 282 (579)
Q Consensus 277 ~E~~~~ 282 (579)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.092 Score=54.65 Aligned_cols=138 Identities=15% Similarity=0.148 Sum_probs=78.2
Q ss_pred ccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--Ccce---EEE--EEEeCCeEEEEEEecCCCc
Q 008052 212 QGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVS---LVG--YCTFGSQRLLVYEFVPNKT 284 (579)
Q Consensus 212 ~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hp--niv~---l~g--~~~~~~~~~lV~E~~~~g~ 284 (579)
.+.-..||+....+++.+++|+..... ....++..|++.+..|... .++. .-| +...++..+.|+++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345678999988788889999875432 2356677888888777421 1222 112 2233567788999998864
Q ss_pred hhh--------------hhcC--CC-----CCCCCHHHH-----H-----------------HHHHHHHHHHHH-hhh-c
Q 008052 285 LEF--------------HLHG--KD-----RPVMNWPTR-----M-----------------KIALGSARGLAY-LHE-D 319 (579)
Q Consensus 285 L~~--------------~l~~--~~-----~~~l~~~~~-----~-----------------~ia~~ia~gL~y-LH~-~ 319 (579)
... .||. .. ++.+++... . .++.++..-++- +.. .
T Consensus 114 ~~~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 193 (325)
T PRK11768 114 PELDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPSDLRPAYLAAADQLLAAVEACWARGD 193 (325)
T ss_pred CCCCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 321 1222 11 122221110 0 111111111111 111 1
Q ss_pred CCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 320 ~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
...++||+|+.+.|||++ + .+.|+||+-+..
T Consensus 194 ~~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 194 VRLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CCccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 234789999999999995 4 578999998763
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0016 Score=56.85 Aligned_cols=40 Identities=13% Similarity=0.249 Sum_probs=24.4
Q ss_pred CCCCCCCcccceEehHhHHHHHHHHHHHHHHH-Hhhhccch
Q 008052 65 NGYLPPGALAGMVVGVVIGAGIVLAAVGIFLI-FYKRRKRK 104 (579)
Q Consensus 65 ~~~l~~~~~~~i~vgv~v~~~~~l~~~~~~~~-~~~rr~~~ 104 (579)
...+......+.++||++|+++.+++++++++ |+||+|||
T Consensus 54 ~~ql~h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 54 RSQLVHRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp --SSSSSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred CcccccCccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 44577788999999999998776655544444 44444443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.039 Score=66.12 Aligned_cols=142 Identities=17% Similarity=0.202 Sum_probs=80.2
Q ss_pred ceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-------CCCcceEE-----EEEEe-CC--e
Q 008052 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-------HRHLVSLV-----GYCTF-GS--Q 272 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-------Hpniv~l~-----g~~~~-~~--~ 272 (579)
+.|+ |..-.+|+....+|+.+++|+...... ...+..|..+|..|. -|.+++-. ..+.. ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 5564 456888999888888899999876532 234444555555442 22223211 11111 22 4
Q ss_pred EEEEEEecCCCchhhh-----------------hc----CC----CCCCCCHHH-----------------HHHHHHHHH
Q 008052 273 RLLVYEFVPNKTLEFH-----------------LH----GK----DRPVMNWPT-----------------RMKIALGSA 310 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~-----------------l~----~~----~~~~l~~~~-----------------~~~ia~~ia 310 (579)
.+-+|+|++|..|... || .. ....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999777541 11 01 111233421 112222332
Q ss_pred HHHH----HhhhcCCCceEeCCCCCCceEeCCCC--CeE-Eeecccccc
Q 008052 311 RGLA----YLHEDCQPKIIHRDIKSANILLDDSF--EAK-VADFGLAKH 352 (579)
Q Consensus 311 ~gL~----yLH~~~~~~ivHrDikp~NILl~~~~--~~k-L~DFGla~~ 352 (579)
..+. .........+||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 11122344799999999999999875 555 999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.035 Score=57.31 Aligned_cols=32 Identities=16% Similarity=0.321 Sum_probs=28.5
Q ss_pred CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 321 ~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
..+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999998999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.025 Score=58.98 Aligned_cols=139 Identities=17% Similarity=0.258 Sum_probs=81.5
Q ss_pred ceecccCceEEEEEEEeC----CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.|..|=...+|+....+ +..|++|+....... .-+-.+|+.++..+..-++ .++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 456668888899987643 237888987654322 2234678888888875555 45666653 22 58999987
Q ss_pred Cchhh-----------------hhcCCCCC----CCCHHHHHHHHHHH----------------------HHHHHHhhh-
Q 008052 283 KTLEF-----------------HLHGKDRP----VMNWPTRMKIALGS----------------------ARGLAYLHE- 318 (579)
Q Consensus 283 g~L~~-----------------~l~~~~~~----~l~~~~~~~ia~~i----------------------a~gL~yLH~- 318 (579)
..|.. .||..... .--|....++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76532 12322111 11233322222111 111222211
Q ss_pred ----cCCCceEeCCCCCCceEeCC-CCCeEEeeccccc
Q 008052 319 ----DCQPKIIHRDIKSANILLDD-SFEAKVADFGLAK 351 (579)
Q Consensus 319 ----~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~ 351 (579)
....-++|+|+.+.|||+++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11224789999999999974 5689999998875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.0094 Score=57.81 Aligned_cols=122 Identities=20% Similarity=0.225 Sum_probs=60.7
Q ss_pred CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEecCCCchhhh----------------
Q 008052 226 GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPNKTLEFH---------------- 288 (579)
Q Consensus 226 g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~g~L~~~---------------- 288 (579)
.+.|+||+...... ..-.-..|..+++.+..-++ .++++++.. . +|+||+++..|...
T Consensus 2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~--g--~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFEN--G--RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETT--E--EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCC--C--cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 35788888866532 23466778889988874444 556665432 2 57799977665321
Q ss_pred -hcCC-----CCCCCCHHHHHHH----------------------HHHHHHHHHHhhh----c-CCCceEeCCCCCCceE
Q 008052 289 -LHGK-----DRPVMNWPTRMKI----------------------ALGSARGLAYLHE----D-CQPKIIHRDIKSANIL 335 (579)
Q Consensus 289 -l~~~-----~~~~l~~~~~~~i----------------------a~~ia~gL~yLH~----~-~~~~ivHrDikp~NIL 335 (579)
+|.. .....-|....++ ...+.+-+..+.+ . ....++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 1110 0111112222222 0111222222221 1 1125789999999999
Q ss_pred e-CCCCCeEEeecccccc
Q 008052 336 L-DDSFEAKVADFGLAKH 352 (579)
Q Consensus 336 l-~~~~~~kL~DFGla~~ 352 (579)
+ +.++.++|+||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8889999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.025 Score=54.64 Aligned_cols=151 Identities=16% Similarity=0.170 Sum_probs=89.0
Q ss_pred CceEEEEEEEeCCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCCchhhhhcCC
Q 008052 214 GFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK 292 (579)
Q Consensus 214 ~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~ 292 (579)
|-.+.-++...-|. ..+|++..-.-. ...-|..+..++++++ .|++|..- .+...-++.|+|-.-..
T Consensus 74 gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 34444444433343 345555443333 4456788999999885 46676521 33345588888732111
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccccccccC
Q 008052 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372 (579)
Q Consensus 293 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~A 372 (579)
+ -..++.--++.|.-.|+. +.+.+|+|..|+||+-|..|.+||.|=+..-. . +.-|.-
T Consensus 142 ----~----~~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---~----------~V~~vN 199 (308)
T PF07387_consen 142 ----N----FSNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---N----------QVNMVN 199 (308)
T ss_pred ----c----hhHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh---h----------eeeEEe
Confidence 1 112233235778888964 45899999999999999999999999775321 0 111111
Q ss_pred hhhhccCCCCcccceechHHHHHHHHhCC
Q 008052 373 PEYASSGKLTEKSDVFSFGVLLLELITGF 401 (579)
Q Consensus 373 PE~~~~~~~~~ksDVwSlGvvl~eLltG~ 401 (579)
-|| ...+.++.+-+|=.-++++....
T Consensus 200 ~~Y---~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 200 IEY---ESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred eec---cccChHHHHHHHHHHHHHHHHHH
Confidence 111 23455666666666666666543
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 579 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-71 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-70 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-41 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-28 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-19 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 551 bits (1423), Expect = 0.0
Identities = 152/316 (48%), Positives = 209/316 (66%), Gaps = 11/316 (3%)
Query: 179 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS 238
+ P + +G K F+ EL++A+DNFS N+LG+GGFG V+KG L +G +VA+K+LK
Sbjct: 8 EDPEVHLGQLK-RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 239 GQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK--DRP 295
QG E +FQ E+E+IS HR+L+ L G+C ++RLLVY ++ N ++ L + +P
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
++WP R +IALGSARGLAYLH+ C PKIIHRD+K+ANILLD+ FEA V DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS- 414
DTHV+T V GT G++APEY S+GK +EK+DVF +GV+LLELITG R FD A DD
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 415 -MVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQI 472
++DW K L + +ALVD L+ Y E+ ++ A C + S RP+MS++
Sbjct: 247 MLLDWVKGL----LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 473 VRALEGNMPLDDLNEG 488
VR LEG+ + E
Sbjct: 303 VRMLEGDGLAERWEEW 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 515 bits (1330), Expect = 0.0
Identities = 120/325 (36%), Positives = 180/325 (55%), Gaps = 11/325 (3%)
Query: 164 LSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVL 223
+ + S ++ S V +L+ AT+NF L+G G FG V+KGVL
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 224 TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283
+G VA+K+ S QG EF+ EIE +S H HLVSL+G+C ++ +L+Y+++ N
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 284 TLEFHLHGKDRPV--MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341
L+ HL+G D P M+W R++I +G+ARGL YLH IIHRD+KS NILLD++F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 342 AKVADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400
K+ DFG++K + D TH+ST V GT GY+ PEY G+LTEKSDV+SFGV+L E++
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 401 FRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACI 459
++ ++ +WA G + +VD L + + + A C+
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNN----GQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 460 RHSARRRPRMSQIVRALEGNMPLDD 484
S+ RP M ++ LE + L +
Sbjct: 294 ALSSEDRPSMGDVLWKLEYALRLQE 318
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 497 bits (1281), Expect = e-175
Identities = 111/312 (35%), Positives = 183/312 (58%), Gaps = 23/312 (7%)
Query: 179 QSPGMPVGNFKSTFTYEELKIATDNFSE------ANLLGQGGFGYVHKGVLTNGKVVAIK 232
+S + F +F++ ELK T+NF E N +G+GGFG V+KG + N VA+K
Sbjct: 3 KSLEVSDTRFH-SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 233 QLKAG----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 288
+L A + + +++F EI+++++ H +LV L+G+ + G LVY ++PN +L
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 289 LHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347
L D P ++W R KIA G+A G+ +LHE+ IHRDIKSANILLD++F AK++DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 348 GLAKHS-LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDK 406
GLA+ S T +++R++GT Y+APE G++T KSD++SFGV+LLE+ITG D+
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 407 ADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR 466
++D + + + +D+K+ + DS + M + A+ C+ +R
Sbjct: 237 --HREPQLLLDIKEEIEDEE---KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 467 PRMSQIVRALEG 478
P + ++ + L+
Sbjct: 292 PDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 1e-93
Identities = 73/319 (22%), Positives = 122/319 (38%), Gaps = 31/319 (9%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEI 249
E L + + +G FG V K L + VA+K Q + + E+
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEV 69
Query: 250 EIISQVHHRHLVSLVGYCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
+ + H +++ +G G+ L+ F +L L V++W I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHI 126
Query: 306 ALGSARGLAYLHED-------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTD 357
A ARGLAYLHED +P I HRDIKS N+LL ++ A +ADFGLA
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 358 THVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
+ +GT Y+APE + D+++ G++L EL + D D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP---VD 243
Query: 413 DSMVDWAKPFLAQGLADGNFDALVDQKL-----EEYDSAEMTR-MAACAAACIRHSARRR 466
+ M+ + + + + +V +K + + + C H A R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 467 PRMSQIVRALEGNMPLDDL 485
+ + L ++
Sbjct: 304 LSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 5e-74
Identities = 69/338 (20%), Positives = 132/338 (39%), Gaps = 50/338 (14%)
Query: 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 251
E + DN L+G+G +G V+KG L + + VA+K + + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58
Query: 252 --ISQVHHRHLVSLVGYCTFGS-----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
+ + H ++ + + + LLV E+ PN +L +L +W + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 305 IALGSARGLAYLHED------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK------- 351
+A RGLAYLH + +P I HRD+ S N+L+ + ++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 352 HSLDTDTHVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELITGFRPF 404
+ + + +GT Y+APE ++ D+++ G++ E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR---- 231
Query: 405 DKADTFADDSMVDWAKPFLAQGLADGNF----DALVDQKL-------EEYDSAEMTRMAA 453
D F +S+ ++ F + F + +K + +S + +
Sbjct: 232 -CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 454 CAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEGITP 491
C A R + M + + N+ ++P
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-68
Identities = 77/313 (24%), Positives = 134/313 (42%), Gaps = 29/313 (9%)
Query: 171 DSDKPFPRQS-PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVV 229
P P F+ +++ I + + +G G FG VH+ +G V
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDV 63
Query: 230 AIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 287
A+K L + EF E+ I+ ++ H ++V +G T +V E++ +L
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 288 HLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346
LH R ++ R+ +A A+G+ YLH P I+HR++KS N+L+D + KV D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 347 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDK 406
FGL++ + S GT ++APE EKSDV+SFGV+L EL T +P+
Sbjct: 183 FGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
Query: 407 ADTFADDSMVDWAK--PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSAR 464
+ + V + + + ++ ++ + C +
Sbjct: 242 LNPAQVVAAVGFKCKRLEIPRN---------LNPQVAAI----IEG-------CWTNEPW 281
Query: 465 RRPRMSQIVRALE 477
+RP + I+ L
Sbjct: 282 KRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-67
Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 53/307 (17%)
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-------RE 244
+A + +G+GGFG VHKG + + VVAIK L G +GE +E
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 245 FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
FQ E+ I+S ++H ++V L G + +V EFVP L L K P + W +++
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLR 126
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHSLDTDTH 359
+ L A G+ Y+ + P I+HRD++S NI L E AKVADFGL++ S+ +
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--- 182
Query: 360 VSTRVMGTFGYLAPE--YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
+ ++G F ++APE A TEK+D +SF ++L ++TG PFD+ +
Sbjct: 183 -VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IK 237
Query: 418 WAKPFLAQGL-------ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 470
+ +GL + + C ++RP S
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNV------------IEL-------CWSGDPKKRPHFS 278
Query: 471 QIVRALE 477
IV+ L
Sbjct: 279 YIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 8e-65
Identities = 87/291 (29%), Positives = 133/291 (45%), Gaps = 45/291 (15%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIIS 253
Y+E+++ ++G+G FG V K K VAIKQ++ S + F E+ +S
Sbjct: 7 YKEIEVE-------EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLS 56
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARG 312
+V+H ++V L G C + LV E+ +L LHG + P M L ++G
Sbjct: 57 RVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
+AYLH +IHRD+K N+LL K+ DFG A T G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWM 170
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA-----KPFLAQG 426
APE +EK DVFS+G++L E+IT +PFD+ A + WA +P L +
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAVHNGTRPPLIKN 228
Query: 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
L ++L MTR C +RP M +IV+ +
Sbjct: 229 L-PKPIESL------------MTR-------CWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 80/298 (26%), Positives = 121/298 (40%), Gaps = 48/298 (16%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG----SGQGEREFQAEI 249
+ EL + ++G GGFG V++ G VA+K + Q + E
Sbjct: 6 FAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
++ + + H ++++L G C LV EF L L GK P + A+
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP---PDILVNWAVQI 114
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AKVADFGLAKHSLDTDTHVS 361
ARG+ YLH++ IIHRD+KS+NIL+ E K+ DFGLA+ T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--- 171
Query: 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK- 420
G + ++APE + ++ SDV+S+GVLL EL+TG PF D A V K
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231
Query: 421 -PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ + + M C RP + I+ L
Sbjct: 232 ALPIPST---------CPEPFAKL----MED-------CWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-63
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 44/293 (15%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEI 251
+++L L + G + KG G + +K LK S + R+F E
Sbjct: 9 FKQLNFL-------TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+ H +++ ++G C + ++P +L LH V++ +K AL
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
ARG+A+LH +P I + S ++++D+ A+++ + + S M
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 370 YLAPE---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK--PFLA 424
++APE +D++SF VLL EL+T PF V P +
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233
Query: 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
G+ + L M C+ +RP+ IV LE
Sbjct: 234 PGI-SPHVSKL------------MKI-------CMNEDPAKRPKFDMIVPILE 266
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 9e-63
Identities = 74/318 (23%), Positives = 120/318 (37%), Gaps = 56/318 (17%)
Query: 210 LGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
LG+G FG K G+V+ +K+L + +R F E++++ + H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
+ + E++ TL + D W R+ A A G+AYLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTH-------------VSTRVMGTFGYLAPEY 375
+ S N L+ ++ VADFGLA+ +D T V+G ++APE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 376 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435
+ EK DVFSFG++L E+I D
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------------DYLPRTMDFG 233
Query: 436 VDQKLEEYDSAEMTRMAAC-------AAACIRHSARRRPRMSQIVRALE-------GNMP 481
++ + + C C +RP ++ LE G++P
Sbjct: 234 LNVR----GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
Query: 482 LDDLNEGITPGHSTIYGS 499
L E + G Y
Sbjct: 290 LGPQLEQLDRGFWETYRR 307
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 6e-62
Identities = 71/329 (21%), Positives = 125/329 (37%), Gaps = 49/329 (14%)
Query: 165 STSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT 224
+ SL S + FPR++ +++ +E I + L+G+G FG V+ G
Sbjct: 3 EMNLSLLSARSFPRKAS-------QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW- 54
Query: 225 NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282
+G+V AI+ + + + F+ E+ Q H ++V +G C ++
Sbjct: 55 HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113
Query: 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342
+TL + + V++ +IA +G+ YLH I+H+D+KS N+ D+ +
Sbjct: 114 RTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDN-GKV 168
Query: 343 KVADFGLAKHSLDTDTHVSTRVM----GTFGYLAPEYASSGKL---------TEKSDVFS 389
+ DFGL S + G +LAPE ++ SDVF+
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 390 FGVLLLELITGFRPFDKADTFADDSMVDW-AKPFLAQGLADGNFDALVDQKLEEYDSAEM 448
G + EL PF A + KP L+Q + +
Sbjct: 229 LGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDI------------L 276
Query: 449 TRMAACAAACIRHSARRRPRMSQIVRALE 477
C RP ++++ LE
Sbjct: 277 LF-------CWAFEQEERPTFTKLMDMLE 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-61
Identities = 76/297 (25%), Positives = 136/297 (45%), Gaps = 39/297 (13%)
Query: 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIE 250
++ +I + +G G FG V+KG +G V A+K L + Q + F+ E+
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVG 72
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++ + H +++ +GY T Q +V ++ +L HLH + + IA +A
Sbjct: 73 VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTA 130
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFG 369
RG+ YLH IIHRD+KS NI L + K+ DFGLA S + +H ++ G+
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 370 YLAPE---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA------K 420
++APE S + +SDV++FG++L EL+TG P+ + +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLS 244
Query: 421 PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
P L++ ++ ++++ M C++ RP +I+ +E
Sbjct: 245 PDLSKVRSN------CPKRMKRL----MAE-------CLKKKRDERPSFPRILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-58
Identities = 63/300 (21%), Positives = 120/300 (40%), Gaps = 45/300 (15%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVG 265
+G+G +G V +G G+ VA+K + + E+ + E E+ + H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 266 YCTFGS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-- 319
Q L+ + +L +L ++ + ++I L A GLA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 320 ---CQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAP 373
+P I HRD+KS NIL+ + + +AD GLA S + + +GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 374 E------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427
E ++ D+++FG++L E+ + D+ PF
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE--------DYKPPFYDVVP 238
Query: 428 ADGNFD----ALVDQKL------EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
D +F+ + + + +T +A C + R +I + L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-57
Identities = 64/348 (18%), Positives = 125/348 (35%), Gaps = 54/348 (15%)
Query: 160 FNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVH 219
+ P + L G+P+ +G+G +G V
Sbjct: 4 YIPPGESLRDLIEQSQSSGSGSGLPL------LVQR---TIAKQIQMVKQIGKGRYGEVW 54
Query: 220 KGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVGYCTFGS----QR 273
G G+ VA+K E + E EI + H +++ + G+ Q
Sbjct: 55 MGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110
Query: 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-----CQPKIIHRD 328
L+ ++ N +L +L ++ + +K+A S GL +LH + +P I HRD
Sbjct: 111 YLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 329 IKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAPE------YASSG 379
+KS NIL+ + +AD GLA + +GT Y+ PE +
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439
+ +D++SFG++L E+ + ++ P+ +D +++ + +
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVE--------EYQLPYHDLVPSDPSYEDMREIV 279
Query: 440 LEE----------YDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ + +M C H+ R ++ + L
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 8e-55
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 45/300 (15%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVG 265
+G+G FG V +G G+ VA+K + + ER + E EI + H +++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 266 YCT----FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED-- 319
+Q LV ++ + +L +L+ R + +K+AL +A GLA+LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 320 ---CQPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAP 373
+P I HRD+KS NIL+ + +AD GLA + DT +GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 374 E------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427
E + +++D+++ G++ E+ + + P+
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--------QLPYYDLVP 272
Query: 428 ADGNFDAL----VDQKL------EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+D + + + +QKL + MA C + R +I + L
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-49
Identities = 66/281 (23%), Positives = 114/281 (40%), Gaps = 45/281 (16%)
Query: 210 LGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYC 267
+G+G FG V G L VA+K + + +F E I+ Q H ++V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
T +V E V L + + T +++ +A G+ YL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARL-RVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY--LAPEYASSGKLTEKS 385
D+ + N L+ + K++DFG+++ D + ++ + APE + G+ + +S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 386 DVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEE-Y 443
DV+SFG+LL E + G P+ L+ N + +E+
Sbjct: 297 DVWSFGILLWETFSLGASPY--------------------PNLS--NQQTR--EFVEKGG 332
Query: 444 DSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 477
+ C A C + +RP S I + L+
Sbjct: 333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-44
Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 36/287 (12%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
G C +R L+ E++P +L +L K + ++ ++ +G+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGK 380
+ IHRD+ + NIL+++ K+ DFGL K + G + APE + K
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 381 LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA--DGNFDALVDQ 438
+ SDV+SFGV+L EL T+ + S A+ G + +
Sbjct: 194 FSVASDVWSFGVVLYELF----------TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243
Query: 439 KLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 477
L+ + R C C ++ +RP + ++
Sbjct: 244 LLKNNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 35/286 (12%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG+G FG V G +VA+KQL+ +R+FQ EI+I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
G ++ LV E++P+ L L + R ++ + + +G+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGK 380
+ +HRD+ + NIL++ K+ADFGLAK + R G + APE S
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 381 LTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439
+ +SDV+SFGV+L EL T + + F + P L++ + +
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR----------LLEL 256
Query: 440 LEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 477
LEE + AC A C S + RP S + L+
Sbjct: 257 LEEGQ---RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-44
Identities = 69/232 (29%), Positives = 101/232 (43%), Gaps = 13/232 (5%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ 233
P P P E LK+ LG G FG V VA+K
Sbjct: 167 VPCMSSKPQKPWEKDAWEIPRESLKLE-------KKLGAGQFGEVWMATYNKHTKVAVKT 219
Query: 234 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
+K GS F AE ++ + H LV L T ++ EF+ +L L +
Sbjct: 220 MKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE 277
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
P + + A G+A++ + IHRD+++ANIL+ S K+ADFGLA+
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334
Query: 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
D + + APE + G T KSDV+SFG+LL+E++T G P+
Sbjct: 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 36/287 (12%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG+G FG V G+VVA+K+L+ + + R+F+ EIEI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
G C +R L+ E++P +L +L K + ++ ++ +G+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGK 380
+ IHRD+ + NIL+++ K+ DFGL K + + G + APE + K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 381 LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA--DGNFDALVDQ 438
+ SDV+SFGV+L EL T+ + S A+ G + +
Sbjct: 225 FSVASDVWSFGVVLYELF----------TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 439 KLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 477
L+ + R C C ++ +RP + ++
Sbjct: 275 LLKNNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-44
Identities = 78/314 (24%), Positives = 135/314 (42%), Gaps = 44/314 (14%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKV-VAIK 232
P P+++ G + +E + + + + LG G +G V++GV + VA+K
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWE---MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 251
Query: 233 QLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK 292
LK + + E EF E ++ ++ H +LV L+G CT ++ EF+ L +L
Sbjct: 252 TLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+R ++ + +A + + YL + IHR++ + N L+ ++ KVADFGL++
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 411
+ APE + K + KSDV++FGVLL E+ T G P+
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------- 420
Query: 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEE-YDSAEMTRMAACAAA-------CIRHSA 463
G+ V + LE+ Y M R C C + +
Sbjct: 421 -------------PGIDLSQ----VYELLEKDY---RMERPEGCPEKVYELMRACWQWNP 460
Query: 464 RRRPRMSQIVRALE 477
RP ++I +A E
Sbjct: 461 SDRPSFAEIHQAFE 474
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 20/235 (8%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ 233
KP + F + +G+G FG V G G VA+K
Sbjct: 169 KPKVMEGTVAAQ----DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC 223
Query: 234 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGK 292
+K + + F AE +++Q+ H +LV L+G L +V E++ +L +L +
Sbjct: 224 IKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281
Query: 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
R V+ +K +L + YL + +HRD+ + N+L+ + AKV+DFGL K
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338
Query: 353 --SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
S + + APE K + KSDV+SFG+LL E+ + G P+
Sbjct: 339 ASSTQDTGKLPVKWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VA+K +K GS E EF E + + ++ H LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+V E++ N L +L + +++ G+A+L + IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVST------RVMGTFGYLAPEYASSGKLTE 383
+ N L+D KV+DFG+ ++ LD S + APE K +
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYFKYSS 184
Query: 384 KSDVFSFGVLLLELIT-GFRPF 404
KSDV++FG+L+ E+ + G P+
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPY 206
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 69/198 (34%), Positives = 100/198 (50%), Gaps = 6/198 (3%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
+ +V E++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 387
D+++ANIL+ ++ KVADFGLA+ D + + APE A G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 388 FSFGVLLLELIT-GFRPF 404
+SFG+LL EL T G P+
Sbjct: 365 WSFGILLTELTTKGRVPY 382
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 12/202 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
LG G FG V +GV K VAIK LK G+ + + E E +I+ Q+ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
C +LV E L L GK + ++ + G+ YL E +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLEEK---NFV 132
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLTE 383
HRD+ + N+LL + AK++DFGL+K D++ + R G + + APE + K +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 384 KSDVFSFGVLLLELIT-GFRPF 404
+SDV+S+GV + E ++ G +P+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPY 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 16/217 (7%)
Query: 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 251
F + +G+G FG V G G VA+K +K + + F AE +
Sbjct: 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASV 67
Query: 252 ISQVHHRHLVSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++Q+ H +LV L+G L +V E++ +L +L + R V+ +K +L
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGTF 368
+ YL + +HRD+ + N+L+ + AKV+DFGL K S + +
Sbjct: 128 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--- 181
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
APE K + KSDV+SFG+LL E+ + G P+
Sbjct: 182 ---APEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKV----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 264
LG+G FG V++GV TN K VA+K K + +F +E I+ + H H+V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G ++ E P L +L +++ + T + +L + +AYL
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESI---NC 134
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
+HRDI NIL+ K+ DFGL+++ D D + ++ +++PE + + T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 385 SDVFSFGVLLLELIT-GFRPF 404
SDV+ F V + E+++ G +PF
Sbjct: 195 SDVWMFAVCMWEILSFGKQPF 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-43
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 210 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG G FG V+KG+ K+ VAIK+L+ + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G C S L+ + +P L ++ + + + + + A+G+ YL + +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT---FGYLAPEYASSGK 380
++HRD+ + N+L+ K+ DFGLAK + G ++A E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRI 195
Query: 381 LTEKSDVFSFGVLLLELIT-GFRPFD 405
T +SDV+S+GV + EL+T G +P+D
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYD 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-43
Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 6/196 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
LG G FG V G VA+K LK GS + F AE ++ Q+ H+ LV L T
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
++ E++ N +L L + + +A A G+A++ E IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 389
++ANIL+ D+ K+ADFGLA+ D + + APE + G T KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 390 FGVLLLELIT-GFRPF 404
FG+LL E++T G P+
Sbjct: 196 FGILLTEIVTHGRIPY 211
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-43
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKV-----VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
+G G FG V+KG+L VAIK LKAG + +R +F E I+ Q H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
G + +++ E++ N L+ L + + + + G A G+ YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM---N 167
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY--LAPEYASSGKL 381
+HRD+ + NIL++ + KV+DFGL++ D T G APE S K
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 382 TEKSDVFSFGVLLLELIT-GFRPF 404
T SDV+SFG+++ E++T G RP+
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPY 251
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-43
Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 6/196 (3%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
+G G FG VH G N VAIK ++ G+ E +F E E++ ++ H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329
+ LV EF+ + L +L R + T + + L G+AYL E +IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDL 130
Query: 330 KSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 389
+ N L+ ++ KV+DFG+ + LD ST + +PE S + + KSDV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 390 FGVLLLELIT-GFRPF 404
FGVL+ E+ + G P+
Sbjct: 191 FGVLMWEVFSEGKIPY 206
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 210 LGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLV 264
+G+G FG VH+G+ + + VAIK K + R +F E + Q H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G T + ++ E L L + ++ + + A + LAYL +
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
+HRDI + N+L+ + K+ DFGL+++ D+ + +++ ++APE + + T
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 385 SDVFSFGVLLLELIT-GFRPF 404
SDV+ FGV + E++ G +PF
Sbjct: 198 SDVWMFGVCMWEILMHGVKPF 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 36/287 (12%)
Query: 210 LGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG+G FG V G+ VA+K LK SG + + EIEI+ ++H ++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 264 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G CT L+ EF+P+ +L+ +L K++ +N ++K A+ +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSG 379
+ +HRD+ + N+L++ + K+ DFGL K + + + + APE
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 380 KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438
K SDV+SFGV L EL+T D + + + +
Sbjct: 205 KFYIASDVWSFGVTLHELLTYC----DSDSSPMALFLKMIGPTHGQMTVTR------LVN 254
Query: 439 KLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 477
L+E + C C R ++ E
Sbjct: 255 TLKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 18/220 (8%)
Query: 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI 251
Y +I + + LG G FG V G VAIK +K GS E EF E ++
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKV 72
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ + H LV L G CT ++ E++ N L +L + R +++
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCE 131
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST------RVM 365
+ YL + +HRD+ + N L++D KV+DFGL+++ LD + S R
Sbjct: 132 AMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
PE K + KSD+++FGVL+ E+ + G P+
Sbjct: 189 ------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLV 264
LG G FG V KG KV VA+K LK + E AE ++ Q+ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G C +LV E L +L + + +++ + G+ YL E
Sbjct: 85 GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKLT 382
+HRD+ + N+LL AK++DFGL+K + + + G + + APE + K +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 383 EKSDVFSFGVLLLELIT-GFRPF 404
KSDV+SFGVL+ E + G +P+
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPY 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 68/239 (28%), Positives = 107/239 (44%), Gaps = 19/239 (7%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VV 229
P + P V F + I ++G G FG V G L V
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISID-------KVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 230 AIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 288
AIK LK G + +R +F E I+ Q H +++ L G T ++V E++ N +L+
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 289 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
L K + + G A G+ YL + +HRD+ + NIL++ + KV+DFG
Sbjct: 137 LR-KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFG 192
Query: 349 LAKHSLDTDTHVSTRVMGTFGYL--APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
L + D T G +PE + K T SDV+S+G++L E+++ G RP+
Sbjct: 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 210 LGQGGFGYVHKGVLTNGKV-VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
LG G +G V++GV + VA+K LK + + E EF E ++ ++ H +LV L+G CT
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328
++ EF+ L +L +R ++ + +A + + YL + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVST-------RVMGTFGYLAPEYASSGKL 381
+ + N L+ ++ KVADFGL++ + DT+ + + APE + K
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT------APESLAYNKF 189
Query: 382 TEKSDVFSFGVLLLELIT-GFRPF 404
+ KSDV++FGVLL E+ T G P+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPY 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 77/294 (26%), Positives = 117/294 (39%), Gaps = 61/294 (20%)
Query: 208 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
++G+G FG V+ G L + A+K L + GE +F E I+ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 263 LVGYCTFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L+G C L+V ++ + L + + + L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL------APEY 375
K +HRD+ + N +LD+ F KVADFGLA+ D + + V G A E
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALES 203
Query: 376 ASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434
+ K T KSDV+SFGVLL EL+T G P+ + FD
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPY--------------------PDVN--TFDI 241
Query: 435 LVDQKLEE-YDSAEMTRMAA---CAAA-------CIRHSARRRPRMSQIVRALE 477
L + R+ C C A RP S++V +
Sbjct: 242 T--VYLLQGR------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 19/239 (7%)
Query: 174 KPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT---NGKV-V 229
+P + PG +F + I ++G G G V G L V V
Sbjct: 28 EPHTYEEPGRAGRSFTREIEASRIHIE-------KIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 230 AIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFH 288
AIK LKAG + +R +F +E I+ Q H +++ L G T G ++V E++ N +L+
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 289 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
L D + + G G+ YL + +HRD+ + N+L+D + KV+DFG
Sbjct: 141 LRTHDGQF-TIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 349 LAKHSLDTDTHVSTRVMGTFGYL--APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
L++ D T G APE + + SDV+SFGV++ E++ G RP+
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 36/286 (12%)
Query: 210 LGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG+G FG V G++VA+K LKA +G R ++ EI+I+ ++H H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 264 VGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G C LV E+VP +L +L + + A G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSI--GLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSG 379
IHRD+ + N+LLD+ K+ DFGLAK + + R G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 380 KLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438
K SDV+SFGV L EL+T F + + + + + + +
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR----------LTE 262
Query: 439 KLEEYDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 477
LE + R C A C A RP ++ L+
Sbjct: 263 LLER--GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 19/298 (6%)
Query: 119 GKPHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPR 178
HH S + P P + + S + + S +
Sbjct: 7 MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI 66
Query: 179 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQL 234
+ + + ++ ++G+G FG V+ G L + A+K L
Sbjct: 67 DLSALN-PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125
Query: 235 KAGSGQGER-EFQAEIEIISQVHHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHGK 292
+ GE +F E I+ H +++SL+G C L+V ++ + L +
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-N 184
Query: 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+ + L A+G+ +L K +HRD+ + N +LD+ F KVADFGLA+
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241
Query: 353 SLDTDTHVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
D + T L A E + K T KSDV+SFGVLL EL+T G P+
Sbjct: 242 MYDKEFDSVHN--KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-42
Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 208 NLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
++G+G FG V+ G + AIK L + + F E ++ ++H ++++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 263 LVGYCTFGS-QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L+G ++ ++ + L + + + L ARG+ YL E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL-----APEYA 376
K +HRD+ + N +LD+SF KVADFGLA+ LD + + + L A E
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ--HRHARLPVKWTALESL 200
Query: 377 SSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435
+ + T KSDV+SFGVLL EL+T G P+ + + FD
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPY--------------------RHID--PFDLT 238
Query: 436 VDQKLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRALE 477
L + + + C + C RP +V +E
Sbjct: 239 --HFLAQGR---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-41
Identities = 69/198 (34%), Positives = 100/198 (50%), Gaps = 6/198 (3%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
LGQG FG V G VAIK LK G+ E F E +++ ++ H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
+ +V E++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 387
D+++ANIL+ ++ KVADFGLA+ D + + APE A G+ T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 388 FSFGVLLLELIT-GFRPF 404
+SFG+LL EL T G P+
Sbjct: 448 WSFGILLTELTTKGRVPY 465
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-41
Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 11/267 (4%)
Query: 144 PSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDN 203
P LP++P A NE S + + + + + + +I +
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 204 FSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGER-EFQAEIEIISQVHHR 258
+G+G FG VH+G+ + + VAIK K + R +F E + Q H
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
H+V L+G T + ++ E L L + ++ + + A + LAYL
Sbjct: 452 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLES 509
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+ +HRDI + N+L+ + K+ DFGL+++ D+ + +++ ++APE +
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 379 GKLTEKSDVFSFGVLLLELIT-GFRPF 404
+ T SDV+ FGV + E++ G +PF
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-41
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 210 LGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSLVG 265
LG G FG V +GV K VAIK LK G+ + + E E +I+ Q+ + ++V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325
C +LV E L L R + ++ + G+ YL E +
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY--LAPEYASSGKLTE 383
HR++ + N+LL + AK++DFGL+K D++ + R G + APE + K +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 384 KSDVFSFGVLLLELIT-GFRPFDK 406
+SDV+S+GV + E ++ G +P+ K
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKK 542
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 7e-41
Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 68/302 (22%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V N +VA+K LK + ++FQ E E+++ + H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 264 VGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKIALGS 309
G C G ++V+E++ + L + + + + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
A G+ YL +HRD+ + N L+ + K+ DFG+++ TD + +G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGGHT 195
Query: 370 YL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFL 423
L PE K T +SDV+SFGV+L E+ T G +P+
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW------------------- 236
Query: 424 AQGLADGNFDALVDQKLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVRA 475
L+ N + + + + + + R C C + ++R + +I +
Sbjct: 237 -FQLS--NTEVI--ECITQGR---VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 476 LE 477
L
Sbjct: 289 LH 290
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 210 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG G FG VHKGV + K+ V IK ++ SG+ + I + H H+V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G C GS LV +++P +L H+ + R + + + A+G+ YL E
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKL 381
++HR++ + N+LL + +VADFG+A L D ++A E GK
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVAD-LLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 382 TEKSDVFSFGVLLLELIT-GFRPFD 405
T +SDV+S+GV + EL+T G P+
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYA 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 58/206 (28%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 210 LGQGGFGYVHKGVLTNGKV----VAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVS 262
LG G FG V +G VA+K LK + +F E+ + + HR+L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
L G +V E P +L L K + T + A+ A G+ YL
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 323 KIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY--LAPEYASSGK 380
+ IHRD+ + N+LL K+ DFGL + D H + + APE +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 381 LTEKSDVFSFGVLLLELIT-GFRPFD 405
+ SD + FGV L E+ T G P+
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWI 226
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 60/254 (23%), Positives = 92/254 (36%), Gaps = 21/254 (8%)
Query: 177 PRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK 235
G F + I ++ LG+GGF YV L +G A+K++
Sbjct: 4 SHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63
Query: 236 AGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR----LLVYEFVPNKTLEFHLHG 291
Q E Q E ++ +H +++ LV YC L+ F TL +
Sbjct: 64 CHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123
Query: 292 KDRPVMNWPTR--MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349
+ + LG RGL +H HRD+K NILL D + + D G
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 350 AKHSLDTDTHVSTRVM--------GTFGYLAPE---YASSGKLTEKSDVFSFGVLLLELI 398
+ + T Y APE S + E++DV+S G +L ++
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240
Query: 399 TGFRPFDKADTFAD 412
G P+D D
Sbjct: 241 FGEGPYDMVFQKGD 254
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 210 LGQGGFGYVHKGVLT----NGKV-VAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVSL 263
LG G FG V+KG+ K+ VAIK+L+ + E E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK 323
+G C S L+ + +P L ++ + + + + + A+G+ YL + +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 324 IIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF--GYLAPEYASSGKL 381
++HRD+ + N+L+ K+ DFGLAK L + G ++A E
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAK-LLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 382 TEKSDVFSFGVLLLELIT-GFRPFD 405
T +SDV+S+GV + EL+T G +P+D
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYD 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-40
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 28/216 (12%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LGQG FG V++GV VAIK + + ER EF E ++ + + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTR---MKIALGSARGLA 314
L+G + G L++ E + L+ +L + PV+ P+ +++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL--- 371
YL+ + K +HRD+ + N ++ + F K+ DFG+ + +TD + G G L
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 205
Query: 372 --APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
+PE G T SDV+SFGV+L E+ T +P+
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-40
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 210 LGQGGFGYVHKGVLTNGKV--------VAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
LGQG F + KGV V +K L F ++S++ H+HLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G C G + +LV EFV +L+ +L K++ +N ++++A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLEEN-- 132
Query: 322 PKIIHRDIKSANILLDDSFE--------AKVADFGLAKHSLDTD-THVSTRVMGTFGYLA 372
+IH ++ + NILL + K++D G++ L D +
Sbjct: 133 -TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------P 185
Query: 373 PEYASSGKL-TEKSDVFSFGVLLLELIT-GFRPF 404
PE + K +D +SFG L E+ + G +P
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHHRHLVSLVG 265
+G+G F V+KG+ VA + + + + F+ E E++ + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 266 YCTFGSQ---RLLVY-EFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+ +++ E + + TL+ +L M +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 320 CQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
P IIHRD+K NI + K+ D GLA + V+GT ++APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKA-VIGTPEFMAPEMYEE 204
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPF 404
E DV++FG+ +LE+ T P+
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPY 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V N +VA+K LK S ++FQ E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 264 VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-------------MKIALGSA 310
G CT G L+V+E++ + L L + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
G+ YL +HRD+ + N L+ K+ DFG+++ TD R +G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YR-VGGRTM 221
Query: 371 L-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
L PE K T +SDV+SFGV+L E+ T G +P+
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 60/229 (26%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
+F E L+G GGFG V K +GK IK++K + + E++ ++++ H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 261 VSLVGY-------------CTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMNWPTRMK 304
V G + S+ ++ EF TLE + + ++ ++
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
+ +G+ Y+H K+I+RD+K +NI L D+ + K+ DFGL SL D +
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKNDGKRTRSK 182
Query: 365 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 412
GT Y++PE SS ++ D+++ G++L EL+ F+ + F D
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 67/303 (22%), Positives = 113/303 (37%), Gaps = 69/303 (22%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG+ FG V+KG L VAIK LK + R EF+ E + +++ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR--------------MKIALG 308
L+G T +++ + + L L + T + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
A G+ YL ++H+D+ + N+L+ D K++D GL + D + +
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----KLLGN 189
Query: 369 GYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 422
L APE GK + SD++S+GV+L E+ + G +P+
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY------------------ 231
Query: 423 LAQGLADGNFDALVDQKLEE-YDSAEMTRMAACAAA-------CIRHSARRRPRMSQIVR 474
G + N D + + + + C A C RRPR I
Sbjct: 232 --CGYS--NQDVV--EMIRNRQ---VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 282
Query: 475 ALE 477
L
Sbjct: 283 RLR 285
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 35/221 (15%)
Query: 208 NLLGQGGFGYVHKGVLTNGKV---VAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLVS 262
+++G+G FG V K + + AIK++K + + + +F E+E++ ++ HH ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 263 LVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKIALG 308
L+G C L E+ P+ F + ++ + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
ARG+ YL + + IHRD+ + NIL+ +++ AK+ADFGL++ + +V T
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK----TM 200
Query: 369 GYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRP 403
G L A E + T SDV+S+GVLL E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 264
LG GG V+ VAIK + + E + F+ E+ SQ+ H+++VS++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
LV E++ TL ++ ++ T + G+ + H+ +I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
+HRDIK NIL+D + K+ DFG+AK +T + V+GT Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 385 SDVFSFGVLLLELITGFRPFDKADT 409
+D++S G++L E++ G PF+ +T
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFN-GET 216
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG G FG V++G ++ VA+K L + + +F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTRMKIALGSARGLAYLH 317
+G R ++ E + L+ L + + +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 318 EDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTDTHVSTRVMGTFGYL--- 371
E+ IHRDI + N LL AK+ DFG+A+ + G L
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAMLPVK 210
Query: 372 --APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
PE G T K+D +SFGVLL E+ + G+ P+
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 64/257 (24%), Positives = 106/257 (41%), Gaps = 29/257 (11%)
Query: 170 LDSDKPFPRQSPGM-PVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK- 227
+ S S G+ P G+ + E++ I + +LG+G FG V +G L
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 228 ---VVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCT-----FGSQRLLVY 277
VA+K +K S + EF +E + H +++ L+G C + +++
Sbjct: 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 278 EFVPNKTL-EF---HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333
F+ L + + T +K + A G+ YL +HRD+ + N
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARN 177
Query: 334 ILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL-----APEYASSGKLTEKSDVF 388
+L D VADFGL+K D + G + A E + T KSDV+
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQ----GRIAKMPVKWIAIESLADRVYTSKSDVW 233
Query: 389 SFGVLLLELIT-GFRPF 404
+FGV + E+ T G P+
Sbjct: 234 AFGVTMWEIATRGMTPY 250
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 210 LGQGGFGYVHKGVLTNGK----VVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSL 263
LG+G FG V + L VA+K LKA + EF E + + H H+ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 264 VGYCT------FGSQRLLVYEFVPNKTL-EF---HLHGKDRPVMNWPTRMKIALGSARGL 313
VG +++ F+ + L F G++ + T ++ + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYL-- 371
YL IHRD+ + N +L + VADFGL++ D + G L
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ----GCASKLPV 203
Query: 372 ---APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
A E + T SDV++FGV + E++T G P+
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 208 NLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 259
LG G FG V + VA+K LK+ + E+ +E++I+S + H +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------------MKIAL 307
+V+L+G CT G L++ E+ L L K R + P + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
A+G+A+L IHRD+ + N+LL + AK+ DFGLA+ ++ ++
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK----G 224
Query: 368 FGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 399
L APE T +SDV+S+G+LL E+ +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 51/240 (21%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+F E +LGQG FG V K + + AIK+++ + +E+ +++ ++H++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 260 LVSLVGYCTFGSQRL---------------LVYEFVPNKTLEFHLHGKDRP-----VMNW 299
+V Y + +R + E+ N TL +H ++
Sbjct: 64 VVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 300 PTRMK-IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK------- 351
+ I L+Y+H IIHRD+K NI +D+S K+ DFGLAK
Sbjct: 122 ---FRQILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 352 -------HSLDTDTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRP 403
+ + ++++ + GT Y+A E +G EK D++S G++ E+I F
Sbjct: 172 ILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 14/240 (5%)
Query: 171 DSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVV 229
P P + Y L NF +G+G F V++ L +G V
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 230 AIKQLKAGSGQGEREFQA---EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286
A+K+++ + EI+++ Q++H +++ ++ +V E L
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 287 FHL--HGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
+ K + ++ T K + L ++H +++HRDIK AN+ + + K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 177
Query: 345 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
D GL + T + V GT Y++PE KSD++S G LL E+ PF
Sbjct: 178 GDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-37
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 9/201 (4%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
+LG+G +G V+ G L+N +AIK++ + + EI + + H+++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
+ + E VP +L L K P+ N T GL YLH++ +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 327 RDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE--YASSGKLTE 383
RDIK N+L++ S K++DFG +K + T GT Y+APE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 384 KSDVFSFGVLLLELITGFRPF 404
+D++S G ++E+ TG PF
Sbjct: 205 AADIWSLGCTIIEMATGKPPF 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG G FG V++G ++ VA+K L + + +F E IIS+ +H+++V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGKDRPVMNWPTRMKIALGSARGLAYLH 317
+G R ++ E + L+ L + + +A A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 318 EDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTDTHVSTRVMGTFGYL--- 371
E+ IHRDI + N LL AK+ DFG+A+ + G L
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLPVK 251
Query: 372 --APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPF 404
PE G T K+D +SFGVLL E+ + G+ P+
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
LG+G FG V K + K VA+K LK + E + +E ++ QV+H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 263 LVGYCTFGSQRLLVYEFVPN----------------------KTLEFHLHGKDRPVMNWP 300
L G C+ LL+ E+ L D +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
+ A ++G+ YL E K++HRD+ + NIL+ + + K++DFGL++ + D++V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 361 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 399
+ G + A E T +SDV+SFGVLL E++T
Sbjct: 208 K----RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 65/282 (23%), Positives = 122/282 (43%), Gaps = 29/282 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREF-QAEIEIISQVHHR 258
+++ +G G +G K ++GK++ K+L + E++ +E+ ++ ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 259 HLVSLVG-YCTFGSQRL-LVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLA 314
++V + L +V E+ L + K+R ++ +++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 315 YLHE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
H D ++HRD+K AN+ LD K+ DFGLA+ L+ DT + +GT Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFVGTPYYMS 184
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432
PE + EKSD++S G LL EL PF A + + LA + +G F
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKE----------LAGKIREGKF 233
Query: 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
++ S E+ + + RP + +I+
Sbjct: 234 R-----RIPYRYSDELNEI---ITRMLNLKDYHRPSVEEILE 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEII 252
+ A ++F LG+G FG V+ + ++A+K L +G + + E+EI
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQ 63
Query: 253 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
S + H +++ L Y F L+ E+ P T+ L K T I A
Sbjct: 64 SHLRHPNILRL--YGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITE-LA 119
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
L+Y H ++IHRDIK N+LL + E K+ADFG + H+ + + GT Y
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDY 173
Query: 371 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
L PE EK D++S GVL E + G PF+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 60/247 (24%), Positives = 93/247 (37%), Gaps = 22/247 (8%)
Query: 169 SLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGK 227
S + QSPG +S F +F + LG G +G V K +G+
Sbjct: 32 SFRGEASETLQSPGYDPSRPESFFQ--------QSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 228 VVAIKQLKAGSGQGEREFQ---AEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNK 283
+ A+K+ + +G ++ AE+ +V H V L G L E
Sbjct: 84 LYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141
Query: 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343
+L+ H + + LA+LH ++H D+K ANI L K
Sbjct: 142 SLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 344 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
+ DFGL L T + G Y+APE G +DVFS G+ +LE+
Sbjct: 198 LGDFGLLVE-LGTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
Query: 404 FDKADTF 410
+ +
Sbjct: 255 PHGGEGW 261
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHHRHLVSL- 263
+LG GG VH L + + VA+K L+ A F+ E + + ++H +V++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 264 -VGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
G + L +V E+V TL +H M +++ + + L + H++
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV--STRVMGTFGYLAPEYASS 378
IIHRD+K ANI++ + KV DFG+A+ D+ V + V+GT YL+PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
+ +SDV+S G +L E++TG PF D+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT-GDS 223
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 25/244 (10%)
Query: 178 RQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LK 235
S G+ +G F + + + +S +G GG V + + ++ AIK L+
Sbjct: 6 HHSSGVDLGTENLYF--QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63
Query: 236 AGSGQGEREFQAEIEIISQV--HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
Q ++ EI ++++ H ++ L Y +V E N L L K
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK 122
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH- 352
++ R + +H+ I+H D+K AN L+ D K+ DFG+A
Sbjct: 123 S--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQM 176
Query: 353 SLDTDTHVSTRVMGTFGYLAPE-----------YASSGKLTEKSDVFSFGVLLLELITGF 401
DT + V +GT Y+ PE S K++ KSDV+S G +L + G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 402 RPFD 405
PF
Sbjct: 237 TPFQ 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 64/311 (20%), Positives = 118/311 (37%), Gaps = 77/311 (24%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQVHHRHLVS 262
+G+G FG V + +VA+K LK + + +FQ E ++++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 263 LVGYCTFGSQRLLVYEFVPN----------------------KTLEFHLHGKDRPVMNWP 300
L+G C G L++E++ + + P ++
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
++ IA A G+AYL E K +HRD+ + N L+ ++ K+ADFGL+++ D +
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 361 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDS 414
+ PE + T +SDV+++GV+L E+ + G +P+
Sbjct: 231 ---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---------- 277
Query: 415 MVDWAKPFLAQGLADGN-FDALVDQKLEEYDSAEMTRMAACAAA-------CIRHSARRR 466
G+A + D + + C C R
Sbjct: 278 ----------YGMAHEEVIYYVRDGNI-------LACPENCPLELYNLMRLCWSKLPADR 320
Query: 467 PRMSQIVRALE 477
P I R L+
Sbjct: 321 PSFCSIHRILQ 331
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 210 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 259
LG+G FG V VA+K LK + + + + +E+E++ + H++
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 260 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 305
+++L+G CT ++ E+ + ++ M + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+ + D +
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 215
Query: 366 GTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 399
T G L APE T +SDV+SFGVL+ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 63/300 (21%), Positives = 108/300 (36%), Gaps = 52/300 (17%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 259
+F LG+GGFG V + + AIK+++ + + RE E++ ++++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 260 LVSLVGY---------CTFGSQRLLVY---EFVPNKTL-EFHLHGKDRPVMNWPTRMKIA 306
+V S ++ +Y + + L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS----- 361
L A + +LH ++HRD+K +NI KV DFGL ++D D
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTP 180
Query: 362 -------TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 414
T +GT Y++PE + K D+FS G++L EL+ PF
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----- 232
Query: 415 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
+ + + F L QK M + S RP I+
Sbjct: 233 -----RVRTLTDVRNLKFPPLFTQK-----YPCEYVM---VQDMLSPSPMERPEAINIIE 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 36/219 (16%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 261
LG G FG V + VA+K LK + ER +E++++S + +H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 262 SLVGYCTFGSQRLLVYEFVPN----------------KTLEFHLHGKDRPVMNWPTRMKI 305
+L+G CT G L++ E+ + D ++ +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+ A+G+A+L IHRD+ + NILL K+ DFGLA+ + +V
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK--- 204
Query: 366 GTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 399
L APE + T +SDV+S+G+ L EL +
Sbjct: 205 -GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 47/208 (22%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHH 257
+ + +G+G FG +G+ IK++ S +E + E+ +++ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI-SRMSSKEREESRREVAVLANMKH 82
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
++V +V ++ L ++ + + + + L ++H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 377
+ KI+HRDIKS NI L ++ DFG+A+ L++ ++ +GT YL+PE
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICE 198
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFD 405
+ KSD+++ G +L EL T F+
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFE 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 12/208 (5%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 264
L+G+GG G V++ ++VA+K + Q E ++ H+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
+ Q + + L L + + + P + I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTE 383
HRD+K NIL+ A + DFG+A + D T + +GT Y+APE S T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATY 214
Query: 384 KSDVFSFGVLLLELITGFRPFDKADTFA 411
++D+++ +L E +TG P+ D +
Sbjct: 215 RADIYALTCVLYECLTGSPPYQ-GDQLS 241
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 210 LGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 261
LG+G FG V + + VA+K LK G+ E +E++I+ + HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 262 SLVGYCT-FGSQRLLVYEFVPNKTL--------------EFHLHGKDRPVMNWPTRMKIA 306
+L+G CT G +++ EF L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
A+G+ +L K IHRD+ + NILL + K+ DFGLA+ +V
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK---- 207
Query: 367 TFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 399
L APE T +SDV+SFGVLL E+ +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 210 LGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRHLV 261
LG G FG V VA+K LK + ER +E+++++Q+ H ++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 262 SLVGYCTFGSQRLLVYEFVPN------------KTLEFHLHGKDRPVMNWPTR------- 302
+L+G CT L++E+ K E + +++ +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 303 --MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360
+ A A+G+ +L +HRD+ + N+L+ K+ DFGLA+ + +V
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 361 STRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 399
L APE G T KSDV+S+G+LL E+ +
Sbjct: 230 VR----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 61/257 (23%), Positives = 110/257 (42%), Gaps = 25/257 (9%)
Query: 179 QSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG 237
S G G +S F + +++ +L +GGF +V++ + +G+ A+K+L +
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 238 SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR--------LLVYEFVPNKTLEFH 288
+ R E+ + ++ H ++V + G + LL+ E + +EF
Sbjct: 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 289 LHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
+ R ++ T +KI + R + ++H +P IIHRD+K N+LL + K+ DFG
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183
Query: 349 LA---KHSLDTDTHVSTRVM--------GTFGYLAPE---YASSGKLTEKSDVFSFGVLL 394
A H D R + T Y PE S+ + EK D+++ G +L
Sbjct: 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
Query: 395 LELITGFRPFDKADTFA 411
L PF+
Sbjct: 244 YLLCFRQHPFEDGAKLR 260
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 210 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 259
LG+G FG V VA+K LK + + + + +E+E++ + H++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 260 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 305
+++L+G CT ++ E+ + ++ M + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
ARG+ YL K IHRD+ + N+L+ ++ K+ADFGLA+ + D +
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 261
Query: 366 GTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 399
T G L APE T +SDV+SFGVL+ E+ T
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 262
LLG+G F V++ + G VAIK + +G +R Q E++I Q+ H ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQR-VQNEVKIHCQLKHPSILE 75
Query: 263 LVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHED 319
L Y F LV E N + +L + +P R + + G+ YLH
Sbjct: 76 LYNY--FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI--ITGMLYLH-- 129
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
I+HRD+ +N+LL + K+ADFGLA L + GT Y++PE A+
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ-LKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFD 405
+SDV+S G + L+ G PFD
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD 213
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 63/281 (22%), Positives = 100/281 (35%), Gaps = 37/281 (13%)
Query: 141 SLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIA 200
L P + G+ D DK + + V Y LK
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI----YSILK-- 62
Query: 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQVHH- 257
+G GG V + + ++ AIK L+ Q ++ EI ++++
Sbjct: 63 --------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 258 -RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
++ L Y +V E N L L K ++ R + +
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTI 171
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFGYLAPE- 374
H+ I+H D+K AN L+ D K+ DFG+A DT + V +G Y+ PE
Sbjct: 172 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 375 ----------YASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
S K++ KSDV+S G +L + G PF
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 68/216 (31%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEII 252
K D+F LG+G FG V+ N ++A+K L G + + EIEI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQ 68
Query: 253 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGS 309
S + H +++ + Y F ++ L+ EF P L L K + + L
Sbjct: 69 SHLRHPNILRM--YNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELAD 125
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
A L Y HE K+IHRDIK N+L+ E K+ADFG + H+ GT
Sbjct: 126 A--LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLD 177
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
YL PE EK D++ GVL E + G PFD
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 210 LGQGGFGYVHKGVLTNGK--------VVAIKQLKAGSGQGER-EFQAEIEIISQV-HHRH 259
LG+G FG V VA+K LK+ + + + + +E+E++ + H++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 260 LVSLVGYCTFGSQRLLVYEFVPN--------------KTLEFHLHGKDRPVMNWPTRMKI 305
+++L+G CT ++ E+ ++ ++ +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+ D +
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK---- 249
Query: 366 GTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT 399
T G L APE T +SDV+SFGVLL E+ T
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 26/238 (10%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV 255
+ + +++LGQG V +G G + AIK + E E++ ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 256 HHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSA 310
+H+++V L + ++L+ EF P +L L + + +
Sbjct: 65 NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
G+ +L E+ I+HR+IK NI+ D K+ DFG A+ L+ D + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-G 177
Query: 367 TFGYLAPE--------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 416
T YL P+ K D++S GV TG PF + + V
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 23/227 (10%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQ--LKAGSGQGEREFQAEIEII 252
E + + +S +G GG V + + ++ AIK L+ Q ++ EI +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 253 SQV--HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
+++ H ++ L Y +V E N L L K ++ R
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNML 118
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFG 369
+ +H+ I+H D+K AN L+ D K+ DFG+A DT + V +GT
Sbjct: 119 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 370 YLAPE-----------YASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
Y+ PE S K++ KSDV+S G +L + G PF
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 63/262 (24%), Positives = 106/262 (40%), Gaps = 22/262 (8%)
Query: 151 PLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLL 210
P P P A ++ G+ + P + + +S Y + L
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPE--VLVDPRSRRRYVRGR----------FL 49
Query: 211 GQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
G+GGF + +V A K + + EI I + H+H+V G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
+V E ++L LH + + + R G YLH + ++IH
Sbjct: 110 FEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIH 164
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSD 386
RD+K N+ L++ E K+ DFGLA ++ D + GT Y+APE S + + D
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVD 223
Query: 387 VFSFGVLLLELITGFRPFDKAD 408
V+S G ++ L+ G PF+ +
Sbjct: 224 VWSIGCIMYTLLVGKPPFETSC 245
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 43/205 (20%), Positives = 80/205 (39%), Gaps = 22/205 (10%)
Query: 209 LLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRHLVSL-- 263
+ GG G+++ + NG+ V +K L + AE + +++V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 264 VGYCTFGSQRLLVY---EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
T + Y E+V ++L+ K + + L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 380
+++ D+K NI+L + + K+ D G + GT G+ APE
Sbjct: 202 --GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIVR-TG 252
Query: 381 LTEKSDVFSFGVLLLELITGFRPFD 405
T +D+++ G L L +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG+GGF + +V A K + + EI I + H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
G+ +V E ++L LH + + + R G YLH + ++
Sbjct: 82 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRV 136
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
IHRD+K N+ L++ E K+ DFGLA ++ D + GT Y+APE S + +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 385 SDVFSFGVLLLELITGFRPFDKADT 409
DV+S G ++ L+ G PF+ +
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCL 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 54/238 (22%), Positives = 93/238 (39%), Gaps = 26/238 (10%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV 255
+ + +++LGQG V +G G + AIK + E E++ ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 256 HHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPV-MNWPTRMKIALGSA 310
+H+++V L + ++L+ EF P +L L + + +
Sbjct: 65 NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
G+ +L E+ I+HR+IK NI+ D K+ DFG A+ L+ D + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-G 177
Query: 367 TFGYLAPE--------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 416
T YL P+ K D++S GV TG PF + + V
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 46/224 (20%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQL-----------------KAGSGQGEREFQAEIEII 252
L QG F + + K A+K+ K +F+ E++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 253 SQVHHRHLVSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS- 309
+ + + + ++ + ++YE++ N ++ N+ + I +
Sbjct: 98 TDIKNEYCLTC--EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 310 -----ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
+Y+H + I HRD+K +NIL+D + K++DFG +++ +D S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 365 MGTFGYLAPEYASSGKLT---EKSDVFSFGVLLLELITGFRPFD 405
GT+ ++ PE S + + K D++S G+ L + PF
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 59/270 (21%), Positives = 101/270 (37%), Gaps = 21/270 (7%)
Query: 141 SLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIA 200
S S+G L ++ S S L P + G+ + YE +
Sbjct: 2 SGSVSSGQAHSLASLA----KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEY-REE 56
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ +G+G FG VH+ G A+K+++ E E+ + +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPR 111
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V L G G + E + +L + K + + + GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 320 CQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTR----VMGTFGYLAPE 374
+I+H D+K+ N+LL D A + DFG A S + GT ++APE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 375 YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
K D++S ++L ++ G P+
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-32
Identities = 71/221 (32%), Positives = 99/221 (44%), Gaps = 17/221 (7%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 258
+ LG GGFGYV + + G+ VAIKQ + RE + EI+I+ +++H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 259 HLVSLV------GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP-VMNWPTRMKIALGSAR 311
++VS LL E+ L +L+ + + + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGTF 368
L YLHE+ +IIHRD+K NI+L + K+ D G AK LD + V GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-LDQGELCTEFV-GTL 187
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
YLAPE K T D +SFG L E ITGFRPF
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-32
Identities = 47/295 (15%), Positives = 90/295 (30%), Gaps = 32/295 (10%)
Query: 138 PKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPV--GNFKSTFTYE 195
P+ S + + P +++ L L P +
Sbjct: 3 PQMSSLGTVDAPNFIVGNP---WDDKL-IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT 58
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGEREFQAEI 249
E ++ + +LLG+G F V++ N + +K K + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP---VMNWPTRMKIA 306
E + + F + +LV E TL ++ VM + A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-----------KVADFGLAK--HS 353
+ + +H+ +IIH DIK N +L + F + D G +
Sbjct: 179 MRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
T + + T G+ E S+ + D F + ++ G K +
Sbjct: 236 FPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 67/222 (30%), Positives = 99/222 (44%), Gaps = 41/222 (18%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 258
+ F++ +G+G FG V KG+ KVVAIK + + E E Q EI ++SQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 259 HLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
++ G Y GS + + L+ +I
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLD---------------ETQI 121
Query: 306 AL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
A +GL YLH + K IHRDIK+AN+LL + E K+ADFG+A DT +T
Sbjct: 122 ATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178
Query: 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+GT ++APE K+D++S G+ +EL G P
Sbjct: 179 -FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 31/301 (10%)
Query: 123 HWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPG 182
+ + P E+P+ + P F E + S PF
Sbjct: 107 QNFLSHTGPDLIPEVPRQLVTNCTQRLEQGP--CKDLFQELTRLTHEYLSVAPFADYLDS 164
Query: 183 MPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAG- 237
+ F E + + F + +LG+GGFG V + GK+ A K+L+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKR 221
Query: 238 --SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKD 293
+GE E +I+ +V+ R +VSL + ++ L LV + L+FH++
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSL--AYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 294 RPVMNWPTRMK-----IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348
+ R I G L LH + +I++RD+K NILLDD +++D G
Sbjct: 280 QAGFPEA-RAVFYAAEICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLG 331
Query: 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
LA H + T + RV GT GY+APE + + T D ++ G LL E+I G PF +
Sbjct: 332 LAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
Query: 409 T 409
Sbjct: 390 K 390
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-31
Identities = 72/273 (26%), Positives = 109/273 (39%), Gaps = 28/273 (10%)
Query: 155 VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGG 214
F L + PF + F E + D F + +LG+GG
Sbjct: 138 AGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGG 197
Query: 215 FGYV----HKGVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
FG V K GK+ A K+L +G + E +I+++VH R +VSL
Sbjct: 198 FGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL--AY 252
Query: 268 TFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWP-TRMK-----IALGSARGLAYLHED 319
F ++ L LV + + +H++ D + R I G L +LH+
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR 308
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
II+RD+K N+LLDD +++D GLA T GT G++APE
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
+ D F+ GV L E+I PF +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 39/240 (16%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEII 252
+ ++ + +G+G +G V+K V +G+++A+K++++ + E++ +++++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 253 -SQVHHRHLVSLVG-------------YCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPV 296
++V G + + VY + + E L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL------- 127
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
KI L + + L +L E KIIHRDIK +NILLD S K+ DFG++ L
Sbjct: 128 ------GKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ-L-V 177
Query: 357 DTHVSTRVMGTFGYLAPE----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
D+ TR G Y+APE AS +SDV+S G+ L EL TG P+ K ++ D
Sbjct: 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 25/254 (9%)
Query: 161 NEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD---NFSEANLLGQGGFGY 217
+ +SG + QS + FK+ + D +G+G G
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAA--LRMVVDQGDPRLLLDSYVKIGEGSTGI 60
Query: 218 VHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276
V +G+ VA+K + Q E+ I+ H ++V + G + ++
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMK------IALGSARGLAYLHEDCQPKIIHRDIK 330
EF+ G +++ R+ + + LAYLH +IHRDIK
Sbjct: 121 MEFLQG--------GALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 331 SANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSF 390
S +ILL K++DFG + V GT ++APE S + D++S
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSL 227
Query: 391 GVLLLELITGFRPF 404
G++++E++ G P+
Sbjct: 228 GIMVIEMVDGEPPY 241
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 39/268 (14%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREF-QAEIEIISQV 255
++ D+F + + LG G G V K +G V+A K + R E++++ +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 256 HHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
+ ++V G + GS ++ + + E L
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQIL------------- 133
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT--DTHV 360
K+++ +GL YL E KI+HRD+K +NIL++ E K+ DFG++ +D+ ++ V
Sbjct: 134 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191
Query: 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 420
GT Y++PE + +SD++S G+ L+E+ G P D + M
Sbjct: 192 -----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246
Query: 421 PFLAQGLADGNFDALVDQKLEEYDSAEM 448
A DS
Sbjct: 247 EGDAAETPPRPRTPGRPLNKFGMDSRPP 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 38/237 (16%)
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEII-S 253
+++ D+ LG+G +G V K +G+++A+K+++A E++ +++I
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 254 QVHHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNW 299
V V+ G + +T+ E L
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDIL---------- 111
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
KIA+ + L +LH + +IHRD+K +N+L++ + K+ DFG++ + L D
Sbjct: 112 ---GKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGY-L-VDDV 164
Query: 360 VSTRVMGTFGYLAPE----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
G Y+APE + + KSD++S G+ ++EL P+D T
Sbjct: 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 46/242 (19%), Positives = 80/242 (33%), Gaps = 46/242 (19%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-AGSGQGEREFQ-AEIEIISQV-H 256
T F E +G G FG V K V +G + AIK+ K +G + + E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL--HGKDRPVMNWPTRMKIALGSARGLA 314
H H+V L+ E+ +L + + + + L RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 315 YLHEDCQPKIIHRDIKSANILLD-------------------DSFEAKVADFGLAKHSLD 355
Y+H ++H DIK +NI + + K+ D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 356 TDTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
G +LA E + K+D+F+ + ++ D
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPLPRNGD 235
Query: 409 TF 410
+
Sbjct: 236 QW 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 43/225 (19%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ + LG G FG V+K G + A K ++ S + ++ EIEI++ H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 260 LVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
+V L+G +C G+ ++ + E I
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQ----------------IQ 120
Query: 307 L---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
+ L +LH +IIHRD+K+ N+L+ + ++ADFG++ +L T +
Sbjct: 121 VVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS- 176
Query: 364 VMGTFGYLAPEYASSGKLTE-----KSDVFSFGVLLLELITGFRP 403
+GT ++APE + + K+D++S G+ L+E+ P
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
++ +GQG G V+ + + G+ VAI+Q+ + EI ++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 260 LVSLVG-------------YCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPVMNWPTRMKI 305
+V+ + Y GS + + V + E + +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQI-------------AAV 121
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+ L +LH + ++IHRDIKS NILL K+ DFG + ST V
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
GT ++APE + K D++S G++ +E+I G P+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ F LG+G +G V+K + G++VAIKQ+ +E EI I+ Q H
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 260 LVSLVG-------------YCTFGSQRLL-VYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
+V G YC GS + + E + I
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGS--VSDIIRLRNKTLTEDEI-------------ATI 130
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+ +GL YLH + IHRDIK+ NILL+ AK+ADFG+A DT +T +
Sbjct: 131 LQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI- 186
Query: 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
GT ++APE +D++S G+ +E+ G P+
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 50/233 (21%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHR 258
F L+G G +G V+KG + G++ AIK + +G E E + EI ++ + HHR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 259 HLVSLVG-------------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNW 299
++ + G +C GS L+ N E
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW----------- 130
Query: 300 PTRMKIAL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
IA RGL++LH+ K+IHRDIK N+LL ++ E K+ DFG++ T
Sbjct: 131 -----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 357 DTHVSTRVMGTFGYLAPEYASSGKLTE-----KSDVFSFGVLLLELITGFRPF 404
+T +GT ++APE + + + KSD++S G+ +E+ G P
Sbjct: 183 VGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-H 256
+ +F ++LG G G + + + + VA+K++ + E++++ +
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDE 76
Query: 257 HRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +++ +CT ++ + E TL+ ++ KD + + + GLA
Sbjct: 77 HPNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLA 132
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHSLDTDTHVSTR---VMG 366
+LH I+HRD+K NIL+ A ++DFGL K L H +R V G
Sbjct: 133 HLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK-LAVGRHSFSRRSGVPG 188
Query: 367 TFGYLAPEY---ASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 406
T G++APE T D+FS G + +I+ G PF K
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 30/225 (13%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 259
D++ ++G G V + VAIK++ Q + EI+ +SQ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 260 LVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
+VS + GS ++ V + V++ T I
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------SGVLDESTIATIL 127
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
GL YLH++ IHRD+K+ NILL + ++ADFG++ +V
Sbjct: 128 REVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 367 TF-G---YLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDK 406
TF G ++APE + K+D++SFG+ +EL TG P+ K
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 65/312 (20%), Positives = 119/312 (38%), Gaps = 39/312 (12%)
Query: 122 HHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSP 181
HH + + S + + + + ++ L P +
Sbjct: 4 HHHHHSSGVDL----GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRT 59
Query: 182 GMPVGNFKST---FTYEELKIATDNFSE------ANLLGQGGFGYVHKGV-LTNGKVVAI 231
+ + F + + + +LG G FG VHK G +A
Sbjct: 60 SALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAA 119
Query: 232 KQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL------ 285
K +K + + E + EI +++Q+ H +L+ L + +LV E+V L
Sbjct: 120 KIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179
Query: 286 -EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-- 342
++L D + MK G+ ++H+ I+H D+K NIL +
Sbjct: 180 ESYNLTELDTILF-----MKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQI 228
Query: 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 402
K+ DFGLA+ + GT +LAPE + ++ +D++S GV+ L++G
Sbjct: 229 KIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
Query: 403 PF---DKADTFA 411
PF + A+T
Sbjct: 287 PFLGDNDAETLN 298
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 64/290 (22%), Positives = 109/290 (37%), Gaps = 32/290 (11%)
Query: 139 KPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELK 198
KP P + ++ G + K + V + + + ++
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVD--EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 199 IATDNFSE----ANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIIS 253
I D+ + LG G FG VH+ G A K + + + EI+ +S
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-------EFHLHGKDRPVMNWPTRMKIA 306
+ H LV+L ++ +++YEF+ L + + M+
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQV 264
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLDTDTHVSTRV 364
GL ++HE+ +H D+K NI+ K+ DFGL H LD V
Sbjct: 265 CK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT 317
Query: 365 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
GT + APE A + +D++S GVL L++G PF + +T
Sbjct: 318 -GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 366
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 63/263 (23%), Positives = 100/263 (38%), Gaps = 55/263 (20%)
Query: 171 DSDKPFPRQSPGMPVGNFKSTFTYEELKIA------TDNFSEANLLGQGGFGYVHKGV-L 223
+ F MP G + ++ FS+ +G G FG V+ +
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76
Query: 224 TNGKVVAIKQLKAGSGQGEREF---QAEIEIISQVHHRHLVSLVG-------------YC 267
N +VVAIK++ Q ++ E+ + ++ H + + G YC
Sbjct: 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL---GSARGLAYLHEDCQPKI 324
+ LL E E IA G+ +GLAYLH +
Sbjct: 137 LGSASDLL--EVHKKPLQEVE----------------IAAVTHGALQGLAYLHSH---NM 175
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTE- 383
IHRD+K+ NILL + K+ DFG A ++ +GT ++APE + +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQY 230
Query: 384 --KSDVFSFGVLLLELITGFRPF 404
K DV+S G+ +EL P
Sbjct: 231 DGKVDVWSLGITCIELAERKPPL 253
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 26/242 (10%), Positives = 47/242 (19%), Gaps = 43/242 (17%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
L G V + + A+K S +++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS--------------- 309
V + D V N+ M A
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 310 ---------------ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
R A L ++H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWK-- 243
Query: 355 DTDTHVSTRVMGTFGYLAPEYASSGKL--TEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
Y E+ ++ T + + G+ + + F PF
Sbjct: 244 --VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 413 DS 414
S
Sbjct: 302 GS 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 31/265 (11%)
Query: 171 DSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSE----ANLLGQGGFGYVHKGV-LTN 225
D P + + + +++ + + LG G FG VH+ V
Sbjct: 17 KYDGPKINDYDK-FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT 75
Query: 226 GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285
G+V K + + + EI I++Q+HH L++L + +L+ EF+ L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 286 -------EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338
++ + + M+ A GL ++HE I+H DIK NI+ +
Sbjct: 136 FDRIAAEDYKMSEAEVINY-----MRQACE---GLKHMHEH---SIVHLDIKPENIMCET 184
Query: 339 SFEA--KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLE 396
+ K+ DFGLA L+ D V T + APE + +D+++ GVL
Sbjct: 185 KKASSVKIIDFGLATK-LNPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYV 242
Query: 397 LITGFRPF---DKADTFADDSMVDW 418
L++G PF D +T + DW
Sbjct: 243 LLSGLSPFAGEDDLETLQNVKRCDW 267
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 40/233 (17%), Positives = 78/233 (33%), Gaps = 48/233 (20%)
Query: 201 TDNFSEANLLGQG--GFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQAEIEIISQV 255
+ ++G+G V+ G+ V +++ L+A S + Q E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 256 HHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
+H ++V + +GS + L+ + E
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------------- 129
Query: 303 MKIAL---GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
IA G + L Y+H +HR +K+++IL+ + ++ +
Sbjct: 130 --IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 360 VSTRVM------GTFGYLAPEYASSGKL--TEKSDVFSFGVLLLELITGFRPF 404
+L+PE KSD++S G+ EL G PF
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 40/236 (16%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE-FQAEIEII 252
+ + ++ +G G G V K G V+A+KQ++ + E + +++++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 253 -SQVHHRHLVSLVG-------------YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 298
++V G + + + + E L
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERIL--------- 126
Query: 299 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
K+ + + L YL E + +IHRD+K +NILLD+ + K+ DFG++ L D
Sbjct: 127 ----GKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGR-L-VDD 178
Query: 359 HVSTRVMGTFGYLAPE-----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
R G Y+APE + ++DV+S G+ L+EL TG P+ T
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 71/274 (25%), Positives = 109/274 (39%), Gaps = 37/274 (13%)
Query: 155 VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYE-ELKIATDNFSEANLLGQG 213
VP F + F + F E + + ++FS ++G+G
Sbjct: 141 VPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRG 200
Query: 214 GFGYV----HKGVLTNGKVVAIKQLKAG---SGQGEREFQAEIEIISQVH---HRHLVSL 263
GFG V GK+ A+K L QGE E ++S V +V +
Sbjct: 201 GFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 257
Query: 264 VGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-----IALGSARGLAYL 316
F + +L + + + L +HL M+ I LG L ++
Sbjct: 258 --SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHM 308
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 376
H +++RD+K ANILLD+ +++D GLA H V GT GY+APE
Sbjct: 309 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVL 362
Query: 377 SSGKLTEKS-DVFSFGVLLLELITGFRPFDKADT 409
G + S D FS G +L +L+ G PF + T
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHL 260
+ +LG G G V G+ VA+K++ EI+++++ H ++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 261 VSLVGYCTFGSQRL--LVYEFVPNKTL-----EFHLHGKDRPVMNWPTRMKIALGSARGL 313
+ YC+ + R + E N L ++ ++ + + + A G+
Sbjct: 72 IRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 314 AYLHEDCQPKIIHRDIKSANILLD-------------DSFEAKVADFGLAKHSLDTDTHV 360
A+LH KIIHRD+K NIL+ ++ ++DFGL K LD+
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK-LDSGQSS 184
Query: 361 STRVM----GTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELIT-GFRPFD 405
+ GT G+ APE + +LT D+FS G + +++ G PF
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 64/252 (25%), Positives = 100/252 (39%), Gaps = 25/252 (9%)
Query: 170 LDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTN 225
+D PR G + K ++F +LG+G F V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPP---QPRKKRPEDFKFGKILGEGSFSTVVLARELA---T 54
Query: 226 GKVVAIKQLKAGSGQGEREFQ---AEIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFV 280
+ AIK L+ E + E +++S++ H V L Y TF L +
Sbjct: 55 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL--YFTFQDDEKLYFGLSYA 112
Query: 281 PNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339
N L ++ K TR A + SA L YLH IIHRD+K NILL++
Sbjct: 113 KNGELLKYIR-KIGSFDETCTRFYTAEIVSA--LEYLHGK---GIIHRDLKPENILLNED 166
Query: 340 FEAKVADFGLAKHSLDTDTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 398
++ DFG AK GT Y++PE + + SD+++ G ++ +L+
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 399 TGFRPFDKADTF 410
G PF + +
Sbjct: 227 AGLPPFRAGNEY 238
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 32/242 (13%)
Query: 181 PGMPVGNFKST---FTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-- 234
PG + + +T F I +D + +LG+G FG V G+ A+K +
Sbjct: 2 PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61
Query: 235 -KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
+ + E++++ Q+ H +++ L + LV E L F D
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL-F-----D 115
Query: 294 RPVMNWP-------TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAK 343
+ ++ L G+ Y+H++ KI+HRD+K N+LL +
Sbjct: 116 EIISRKRFSEVDAARIIRQVLS---GITYMHKN---KIVHRDLKPENLLLESKSKDANIR 169
Query: 344 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
+ DFGL+ H + +GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 170 IIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
Query: 404 FD 405
F+
Sbjct: 227 FN 228
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 60/251 (23%), Positives = 95/251 (37%), Gaps = 39/251 (15%)
Query: 174 KPFPRQSPGMPVGNFKST---FTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVV 229
+ G+ ++T F + ++ + LG G +G V
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 230 AIKQL-KAGSGQGERE-FQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF 287
AIK + K E+ ++ + H +++ L + LV E L F
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-F 124
Query: 288 HLHGKDRPVMNWPTR-----------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336
D + R +K L G+ YLH+ I+HRD+K N+LL
Sbjct: 125 -----DEII----HRMKFNEVDAAVIIKQVLS---GVTYLHKH---NIVHRDLKPENLLL 169
Query: 337 ---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVL 393
+ K+ DFGL+ + +GT Y+APE K EK DV+S GV+
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 394 LLELITGFRPF 404
L L+ G+ PF
Sbjct: 227 LFILLAGYPPF 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 27/224 (12%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
+ + A LG+G FG VH+ V ++ K K +K G + + EI I++ HR+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTL-------EFHLHGKDRPVMNWPTRMKIALGSARG 312
++ L + ++++EF+ + F L+ ++ +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---A 114
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLDTDTHVSTRVMGTFGY 370
L +LH I H DI+ NI+ + K+ +FG A+ L + Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEY 169
Query: 371 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
APE ++ +D++S G L+ L++G PF
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-27
Identities = 39/330 (11%), Positives = 84/330 (25%), Gaps = 64/330 (19%)
Query: 122 HHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSP 181
HH + + Y + P + P V ++ + SL S + P
Sbjct: 3 HHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAAD-SLVSTSLWNTGQP 61
Query: 182 GMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQ 240
+S +LGQ + G+ +
Sbjct: 62 F----RVESELGERPR-----TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 112
Query: 241 GERE----------------------------FQAEIEIISQVHHRHLVSLVGYC--TFG 270
F +++ + ++ + +
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172
Query: 271 SQRLLVYEFVPNKTLEF----HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
R +Y + + F H + R+++ L R LA LH ++H
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVH 229
Query: 327 RDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-------- 378
++ +I+LD + F + G+ PE +
Sbjct: 230 TYLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVSRGFEPPELEARRATISYHR 284
Query: 379 ---GKLTEKSDVFSFGVLLLELITGFRPFD 405
+T D ++ G+++ + P
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 33/222 (14%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
LG G F V K + G A K Q +A RE + E+ I+ QV H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
L + +L+ E V L + L ++ +K L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 317 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
H KI H D+K NI+L K+ DFGLA ++ GT ++A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVA 186
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
PE + L ++D++S GV+ L++G PF K +T A
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 38/214 (17%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
+LG G F V GK+ A+K +K + + EI ++ ++ H ++V+L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS-------------ARGLA 314
+ LV + V L F DR + G +
Sbjct: 76 ESTTHYYLVMQLVSGGEL-F-----DRIL---------ERGVYTEKDASLVIQQVLSAVK 120
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGTFGYL 371
YLHE+ I+HRD+K N+L E + DFGL+K + + GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYV 174
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
APE + ++ D +S GV+ L+ G+ PF
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 35/179 (19%), Positives = 64/179 (35%), Gaps = 15/179 (8%)
Query: 238 SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL-EFHLHGKDRPV 296
S +I + ++ V + + + + + L ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
+ I + A + +LH ++HRD+K +NI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 357 DTHVS-----------TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ + T +GT Y++PE + K D+FS G++L EL+ F
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 15/62 (24%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 259
+F +G+GGFG V + + AIK+++ + + RE E++ ++++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 260 LV 261
+V
Sbjct: 66 IV 67
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGERE-FQAEIEIISQVHH 257
+ ++ +LG+G FG V K + A+K + KA + + E+E++ ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIA 306
+++ L S +V E L F D + R +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL-F-----DEII----KRKRFSEHDAARIIKQV 130
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTR 363
G+ Y+H+ I+HRD+K NILL + + K+ DFGL+
Sbjct: 131 FS---GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKD 182
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+GT Y+APE G EK DV+S GV+L L++G PF
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
LG G FG VH ++G IK + K S + +AEIE++ + H +++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAYL 316
+V E L +R V MK + LAY
Sbjct: 90 EDYHNMYIVMETCEGGEL-L-----ERIVSAQARGKALSEGYVAELMKQMMN---ALAYF 140
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
H ++H+D+K NIL D+ K+ DFGLA+ +D H + GT Y+AP
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNAA-GTALYMAP 195
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
E +T K D++S GV++ L+TG PF
Sbjct: 196 EVF-KRDVTFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 47/232 (20%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK-------------AGSGQGEREFQ 246
+++ + LG G +G V AIK +K + E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 247 AEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR---- 302
EI ++ + H +++ L LV EF L F ++ + R
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-F-----EQII----NRHKFD 144
Query: 303 -------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKH 352
MK L G+ YLH+ I+HRDIK NILL + K+ DFGL+
Sbjct: 145 ECDAANIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ + +GT Y+APE K EK DV+S GV++ L+ G+ PF
Sbjct: 199 F--SKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 26/233 (11%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 250
+ D+F +G+G FG V K+ A+K + E + E++
Sbjct: 11 DVNFDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 251 IISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 307
I+ + H LV+L + +F + + +V + + L +HL ++ ++ I L
Sbjct: 68 IMQGLEHPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFICEL 124
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
A L YL +IIHRD+K NILLD+ + DF +A + + GT
Sbjct: 125 VMA--LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGT 177
Query: 368 FGYLAPEYASSGKLTEKS---DVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
Y+APE SS K S D +S GV EL+ G RP+ + + +V
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-26
Identities = 27/243 (11%), Positives = 61/243 (25%), Gaps = 43/243 (17%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQ---------- 254
+LGQ + G+ + ++ + E+ +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 255 ------------VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL---------HGKD 293
V ++ ++ F ++ +L H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
+ R+++ L R LA LH ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 354 LDTDTHVSTRVMGTFGYLAPE-----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
+ R A +T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 409 TFA 411
Sbjct: 322 ALG 324
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 21/240 (8%)
Query: 180 SPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-----Q 233
SPG+ G ++ + D + ++G+G F V + + G+ A+K +
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 234 LKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
+ G + + E I + H H+V L+ + +V+EF+ L F + +
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 294 RPVMNWPTR-----MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVA 345
+ M+ L L Y H++ IIHRD+K +LL ++S K+
Sbjct: 122 DAGFVYSEAVASHYMRQILE---ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLG 175
Query: 346 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
FG+A ++ RV GT ++APE + DV+ GV+L L++G PF
Sbjct: 176 GFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 37/299 (12%)
Query: 130 APSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFK 189
A + + LP + L P + N D+ +G
Sbjct: 22 ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-------QLKAGSGQG 241
+ K + +++G+G V + V G A+K +L +
Sbjct: 82 ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE 141
Query: 242 ERE-FQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGK 292
RE + E I+ QV H H+++L+ S LV++ + L F L K
Sbjct: 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-FDYLTEKVALSEK 200
Query: 293 DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352
+ + M+ L +++LH + I+HRD+K NILLDD+ + +++DFG + H
Sbjct: 201 ETRSI-----MRSLLE---AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 353 SLDTDTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
L+ + GT GYLAPE + ++ D+++ GV+L L+ G PF
Sbjct: 250 -LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
LG G F V K GK A K +L + RE + E+ I+ ++ H ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
L + +L+ E V L + L + +K L G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYL 124
Query: 317 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
H +I H D+K NI+L + K+ DFG+A ++ GT ++A
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-GTPEFVA 179
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
PE + L ++D++S GV+ L++G PF K +T
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGERE------FQAEIEIISQVHHRHL 260
LG G G V K VAI+ + + + RE + EIEI+ +++H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 261 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAY 315
+ + F ++ +V E + L F D+ V N + + Y
Sbjct: 203 IKIKN--FFDAEDYYIVLELMEGGEL-F-----DKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 316 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
LHE+ IIHRD+K N+LL ++ K+ DFG +K L + + T GT YLA
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTPTYLA 309
Query: 373 PE---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
PE + D +S GV+L ++G+ PF + T
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 33/221 (14%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGERE-FQAEIEIISQV-HHRHLVSLVG 265
LG+G F V + + + G+ A K L K GQ R EI ++ +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR---------MKIALGSARGLAYL 316
S+ +L+ E+ + F + +K L G+ YL
Sbjct: 97 VYENTSEIILILEYAAGGEI-F-----SLCLPELAEMVSENDVIRLIKQILE---GVYYL 147
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
H++ I+H D+K NILL + K+ DFG+++ + + + GT YLAP
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAP 202
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
E + +T +D+++ G++ L+T PF D +T+
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL 243
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 54/247 (21%), Positives = 85/247 (34%), Gaps = 54/247 (21%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVSL 263
+GQG +G V + + AIK +++ + + + E+ ++ ++HH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 264 VG-------------YCTFGS--QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
C G +L V+ + I
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 309 SAR-----------------------GLAYLHEDCQPKIIHRDIKSANILL--DDSFEAK 343
L YLH I HRDIK N L + SFE K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 344 VADFGLAKHSLDTDTHVSTRVM---GTFGYLAPE--YASSGKLTEKSDVFSFGVLLLELI 398
+ DFGL+K + + GT ++APE ++ K D +S GVLL L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 399 TGFRPFD 405
G PF
Sbjct: 271 MGAVPFP 277
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 28/234 (11%)
Query: 195 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGERE-FQA 247
+++++ ++F ++G+G FG V K KV A+K L + E F+
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123
Query: 248 EIEIISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
E +++ + + +L + F L LV ++ L L + + R +
Sbjct: 124 ERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 306 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
A + A + +H Q +HRDIK NIL+D + ++ADFG ++ T S+
Sbjct: 182 AEMVIA--IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 365 MGTFGYLAPE-----YASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTF 410
+GT Y++PE G+ + D +S GV + E++ G PF +T+
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 36/242 (14%)
Query: 177 PRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQL- 234
S G F+ TF + ++ +LG+G FG V K + A+K +
Sbjct: 5 HHHSSGRENLYFQGTFA--------ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56
Query: 235 -KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF------ 287
+ + E+E++ ++ H +++ L S +V E L F
Sbjct: 57 KASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-FDEIIKR 115
Query: 288 -HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAK 343
D + +K G+ Y+H+ I+HRD+K NILL + + K
Sbjct: 116 KRFSEHDAARI-----IKQVFS---GITYMHKH---NIVHRDLKPENILLESKEKDCDIK 164
Query: 344 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
+ DFGL+ +T + R+ GT Y+APE G EK DV+S GV+L L++G P
Sbjct: 165 IIDFGLSTC-FQQNTKMKDRI-GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
Query: 404 FD 405
F
Sbjct: 222 FY 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 33/222 (14%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIISQVHHRHLVS 262
LG G F V K + G A K Q +A RE + E+ I+ QV H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 263 LVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
L + +L+ E V L + L ++ +K L G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 317 HEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
H KI H D+K NI+L K+ DFGLA ++ GT ++A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVA 186
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
PE + L ++D++S GV+ L++G PF K +T A
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGERE-FQAEIEIIS 253
D + LG G F V K + G A K + K+ RE + E+ I+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTL------EFHLHGKDRPVMNWPTRMKIAL 307
++ H ++++L + +L+ E V L + L ++ +K L
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQIL 124
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKHSLDTDTHVSTR 363
G+ YLH +I H D+K NI+L K+ DFGLA +D
Sbjct: 125 N---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNI 177
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
GT ++APE + L ++D++S GV+ L++G PF K +T A
Sbjct: 178 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 83/355 (23%), Positives = 130/355 (36%), Gaps = 60/355 (16%)
Query: 87 VLAAVGIFLIFYKRRKRKLAAQNLPLKN----------------DPFAGKPHHW------ 124
+L G F+ YK R + + + PL N + F + W
Sbjct: 28 LLKNDGTFI-GYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIER 86
Query: 125 QQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMP 184
+V P + +E ++G P SG+ + + +
Sbjct: 87 TFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKH--- 143
Query: 185 VGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQ 240
++ + F LLG+G FG V K G+ A+K LK
Sbjct: 144 -------------RVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIV 187
Query: 241 GEREF---QAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRP 295
+ E E ++ H L +L +F + RL V E+ L FHL ++R
Sbjct: 188 AKDEVAHTLTENRVLQNSRHPFLTAL--KYSFQTHDRLCFVMEYANGGELFFHLS-RERV 244
Query: 296 VMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
R A + SA L YLH + +++RD+K N++LD K+ DFGL K +
Sbjct: 245 FSEDRARFYGAEIVSA--LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300
Query: 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
+ T GT YLAPE D + GV++ E++ G PF D
Sbjct: 301 KDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 34/217 (15%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLK----AGSGQGEREFQAEIEIISQVHHRHLVSL 263
LLG+G +G V + + A+K LK GE + EI+++ ++ H++++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 264 --VGYCTFGSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMKIALGSAR--------G 312
V Y + +V E+ E D R + A G
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML-----DSVPEK---RFPVC--QAHGYFCQLIDG 121
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA--KHSLDTDTHVSTRVMGTFGY 370
L YLH I+H+DIK N+LL K++ G+A H D T G+ +
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAF 177
Query: 371 LAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 405
PE A+ K D++S GV L + TG PF+
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 201 TDNFSEA----NLLGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQAEIEIIS 253
+ FS+ LG+G F V + V T G A K + K S + ++ + E I
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGKDRPVMNWPTRMKIA 306
++ H ++V L S LV++ V L F D ++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-FEDIVAREFYSEADASHC-----IQQI 114
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTR 363
L +AY H + I+HR++K N+LL + K+ADFGLA ++
Sbjct: 115 LE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGF 167
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
GT GYL+PE ++ D+++ GV+L L+ G+ PF
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 30/237 (12%)
Query: 195 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGERE-FQA 247
+E+++ D+F ++G+G F V K G+V A+K + +GE F+
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 248 EIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
E +++ R + L + F + L V E+ L L + R +
Sbjct: 111 ERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 306 A-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
A + A + +H + +HRDIK NILLD ++ADFG T S
Sbjct: 169 AEIVMA--IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 365 MGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRPF---DKADTFA 411
+GT YL+PE +G + D ++ GV E+ G PF A+T+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQA---EIEIISQVHHRHL 260
LG G FG+V V K V +K ++ + + EI I+S+V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGS--- 309
+ + + N+ +E H G + R+ L S
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIF 136
Query: 310 ---ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
+ YL IIHRDIK NI++ + F K+ DFG A + L+ T G
Sbjct: 137 RQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC-G 191
Query: 367 TFGYLAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 405
T Y APE G + +++S GV L L+ PF
Sbjct: 192 TIEYCAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEI 251
K F +LGQG FG V ++ A+K LK + + + E +I
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 252 ISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK----- 304
+ +V+H +V L + F ++ +L L+ +F+ L L + VM +K
Sbjct: 80 LVEVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAE 134
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRV 364
+AL L +LH II+RD+K NILLD+ K+ DFGL+K S+D + +
Sbjct: 135 LALA----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-F 186
Query: 365 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
GT Y+APE + T+ +D +SFGVL+ E++TG PF D
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGERE------FQAEIEIISQVHHRHL 260
LG G G V K VAIK + + + RE + EIEI+ +++H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 261 VSLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR----GLAY 315
+ + F ++ +V E + L F D+ V N + + Y
Sbjct: 78 IKIKN--FFDAEDYYIVLELMEGGEL-F-----DKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 316 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
LHE+ IIHRD+K N+LL ++ K+ DFG +K L + + T GT YLA
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTPTYLA 184
Query: 373 PE---YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
PE + D +S GV+L ++G+ PF + T
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 53/207 (25%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT 268
+G+G +G V V A K++ + F+ EIEI+ + H +++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 269 FGSQRLLVYEFVPNKTLEF-------HLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
+ LV E L F D + MK L +AY H+
Sbjct: 77 DNTDIYLVMELCTGGEL-FERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL-- 125
Query: 322 PKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+ HRD+K N L K+ DFGLA + T+V GT Y++P+
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTKV-GTPYYVSPQ-VLE 181
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFD 405
G + D +S GV++ L+ G+ PF
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFS 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIK--------QLKAGSGQGERE-FQAEIEIISQV-HHR 258
LG+G V + + K A+K A Q RE E++I+ +V H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEF-------HLHGKD-RPVMNWPTRMKIALGSA 310
+++ L + LV++ + L F L K+ R +M + L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRKIM------RALLE-- 135
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
+ LH+ I+HRD+K NILLDD K+ DFG + LD + GT Y
Sbjct: 136 -VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREVC-GTPSY 189
Query: 371 LAPE------YASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
LAPE + ++ D++S GV++ L+ G PF
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 63/248 (25%), Positives = 96/248 (38%), Gaps = 65/248 (26%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQA--------------- 247
+G+G +G V + A+K +L +G R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 248 ------EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV--PNKT-----LEFHLHGKDR 294
EI I+ ++ H ++V L E + PN+ E G
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQG--- 123
Query: 295 PVMNWPTRMKIALGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346
PVM PT ++ AR G+ YLH KIIHRDIK +N+L+ + K+AD
Sbjct: 124 PVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 347 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLT---EKSDVFSFGVLLLELITGFRP 403
FG++ +D +S V GT ++APE S + + DV++ GV L + G P
Sbjct: 181 FGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 404 FDKADTFA 411
F
Sbjct: 240 FMDERIMC 247
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 67/235 (28%), Positives = 108/235 (45%), Gaps = 20/235 (8%)
Query: 186 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQL-KAGSGQ 240
G+ +++ KI + F +LG+GG+G V GK+ A+K L KA +
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 241 GEREF---QAEIEIISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRP 295
++ +AE I+ +V H +V L F + +L L+ E++ L L ++
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDL--IYAFQTGGKLYLILEYLSGGELFMQLE-REGI 117
Query: 296 VMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
M +A + A L +LH+ II+RD+K NI+L+ K+ DFGL K S+
Sbjct: 118 FMEDTACFYLAEISMA--LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172
Query: 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
T T GT Y+APE D +S G L+ +++TG PF +
Sbjct: 173 HDGTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 34/213 (15%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL--KAGSGQGEREFQAEIEIISQVHHRHLVSLVGY 266
LG+G F V + V + G+ A + K S + ++ + E I + H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAY 315
+ L+++ V L F + V R ++ L + +
Sbjct: 79 ISEEGHHYLIFDLVTGGEL-F-----EDIV----AREYYSEADASHCIQQILE---AVLH 125
Query: 316 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
H+ ++HR++K N+LL K+ADFGLA ++ + GT GYL+
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFAGTPGYLS 181
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
PE + D+++ GV+L L+ G+ PF
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 195 EELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLK----AGSGQGEREFQ 246
+L++ +++ ++G+G FG V HK KV A+K L F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FW 117
Query: 247 AEIEIISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
E +I++ + +V L + F R L V E++P L + + V R
Sbjct: 118 EERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY 173
Query: 305 IA-LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
A + A L +H IHRD+K N+LLD S K+ADFG ++ + V
Sbjct: 174 TAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK-MNKEGMVRCD 227
Query: 364 VM-GTFGYLAPE----YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
GT Y++PE G + D +S GV L E++ G PF
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 35/248 (14%)
Query: 175 PFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQ 233
P G S F +DN+ LG+G F V + V T G A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 234 L--KAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG 291
+ K S + ++ + E I ++ H ++V L S LV++ V L F
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-F---- 116
Query: 292 KDRPVMNWPTR-----------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340
+ V R ++ L +AY H + I+HR++K N+LL
Sbjct: 117 -EDIV----AREFYSEADASHCIQQILE---SIAYCHSN---GIVHRNLKPENLLLASKA 165
Query: 341 EA---KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLEL 397
+ K+ADFGLA ++ GT GYL+PE ++ D+++ GV+L L
Sbjct: 166 KGAAVKLADFGLAIE-VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 223
Query: 398 ITGFRPFD 405
+ G+ PF
Sbjct: 224 LVGYPPFW 231
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 262
LG+G +G V V + VA+K + ++E I I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 314
G+ G+ + L E+ L F DR + M A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL-F-----DRIEPD--IGMPEP--DAQRFFHQLMAGVV 119
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD--TDTHVSTRVMGTFGYLA 372
YLH I HRDIK N+LLD+ K++DFGLA + ++ GT Y+A
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 373 PEYASSGKL--TEKSDVFSFGVLLLELITGFRPFDKAD 408
PE + E DV+S G++L ++ G P+D+
Sbjct: 176 PELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 63/279 (22%), Positives = 103/279 (36%), Gaps = 51/279 (18%)
Query: 143 PPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD 202
S+G + + + +++ + G F E
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE----- 60
Query: 203 NFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
LG+G V++ K A+K LK ++ + EI ++ ++ H +++
Sbjct: 61 -------LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS------------ 309
L ++ LV E V L F DR V G
Sbjct: 112 KLKEIFETPTEISLVLELVTGGEL-F-----DRIV---------EKGYYSERDAADAVKQ 156
Query: 310 -ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTHVSTRVM 365
+AYLHE+ I+HRD+K N+L K+ADFGL+K ++ + T
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC- 211
Query: 366 GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
GT GY APE + D++S G++ L+ GF PF
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 186 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQL---KAGSGQ 240
GN ++ E+ I N+ +G+G F V +LT G+ VAIK + +
Sbjct: 1 GNSIASCADEQPHI--GNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTS 57
Query: 241 GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMN 298
++ F+ E+ I+ ++H ++V L + +++ L+ E+ + +L R M
Sbjct: 58 LQKLFR-EVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MK 112
Query: 299 WPTRMKIA--LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356
+ SA + Y H Q +I+HRD+K+ N+LLD K+ADFG +
Sbjct: 113 EKEARSKFRQIVSA--VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV- 166
Query: 357 DTHVSTRVMGTFGYLAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 405
+ G Y APE GK + + DV+S GV+L L++G PFD
Sbjct: 167 GGKLDAFC-GAPPYAAPELF-QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGSGQGEREFQAEIEIISQVHHRHLVS 262
LG+G +G V V + VA+K + ++E I I ++H ++V
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVK 69
Query: 263 LVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 314
G+ G+ + L E+ L F DR + M A+ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGEL-F-----DRIEPD--IGMPEP--DAQRFFHQLMAGVV 119
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD--TDTHVSTRVMGTFGYLA 372
YLH I HRDIK N+LLD+ K++DFGLA + ++ GT Y+A
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 373 PEYASSGKL--TEKSDVFSFGVLLLELITGFRPFDKAD 408
PE + E DV+S G++L ++ G P+D+
Sbjct: 176 PELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 63/226 (27%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
K+ ++F LLG+G FG V K G+ A+K L+ + E E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 251 IISQVHHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK---- 304
++ H L +L F + RL V E+ L FHL + R +
Sbjct: 58 VLQNTRHPFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGA 112
Query: 305 -IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR 363
I L YLH +++RDIK N++LD K+ DFGL K + + T
Sbjct: 113 EIVSA----LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 364 VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
GT YLAPE D + GV++ E++ G PF D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 4e-22
Identities = 69/307 (22%), Positives = 116/307 (37%), Gaps = 40/307 (13%)
Query: 121 PHHWQQNVSAPSDYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQS 180
Q ++ L + N P P + + + + P +
Sbjct: 263 GISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERA-KIGQGTKAPEEK 321
Query: 181 PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKA 236
+ F + + +K+ +F+ +LG+G FG V KG ++ A+K LK
Sbjct: 322 TANTISKFDNNGNRDRMKL--TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKK 376
Query: 237 GSGQGEREF---QAEIEIISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLH 290
+ + E +++ L L + F + RL V E+V L +H+
Sbjct: 377 DVVIQDDDVECTMVEKRVLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQ 434
Query: 291 GKDRPVMNWPTRMKIALGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342
R A GL +L II+RD+K N++LD
Sbjct: 435 QVGR----------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHI 481
Query: 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFR 402
K+ADFG+ K ++ T GT Y+APE + + D ++FGVLL E++ G
Sbjct: 482 KIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
Query: 403 PFDKADT 409
PF+ D
Sbjct: 541 PFEGEDE 547
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 64/229 (27%), Positives = 90/229 (39%), Gaps = 32/229 (13%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 250
D F LG G FG V HK +G A+K L ++ + E
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 307
I+ V+ LV L +F L V E+V + HL + R A +
Sbjct: 94 ILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQI 150
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-G 366
YLH +I+RD+K N+L+D +V DFG AK T + G
Sbjct: 151 VLT--FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCG 200
Query: 367 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 415
T LAPE S + D ++ GVL+ E+ G+ PF FAD +
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-----FADQPI 244
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-22
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 33/228 (14%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVH 256
+ + + +G+G +G V+K + G++VA+K+++ + E E A EI ++ ++H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH 77
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
H ++VSL+ LV+EF+ K L+ L + RG+A+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHC 135
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-- 374
H+ +I+HRD+K N+L++ K+ADFGLA+ + V+ T Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 375 -----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
Y++S D++S G + E+ITG +P F + D
Sbjct: 192 MGSKKYSTS------VDIWSIGCIFAEMITG-KPL-----FPGVTDDD 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 78/297 (26%), Positives = 123/297 (41%), Gaps = 59/297 (19%)
Query: 143 PPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATD 202
P + V + + S D K + + +Y + K+
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV--- 61
Query: 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
+G G FG V++ L +G++VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 62 -------IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 110
Query: 262 SLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA----- 310
L + ++ LV ++VP +T+ V +R K L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-ETVY--------RVARHYSRAKQTLPVIYVKLY 161
Query: 311 -----RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS--- 361
R LAY+H I HRDIK N+LLD D+ K+ DFG AK + + +VS
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 362 TRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
+R Y APE + T DV+S G +L EL+ G +P F DS VD
Sbjct: 219 SRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI-----FPGDSGVD 264
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 65/253 (25%), Positives = 102/253 (40%), Gaps = 58/253 (22%)
Query: 186 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREF 245
+ Y K+ +G G FG V + L VAIK++ Q +R
Sbjct: 34 TGEQREIAYTNCKV----------IGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFK 79
Query: 246 QAEIEIISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNW 299
E++I+ V H ++V L + + LV E+VP +T+
Sbjct: 80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETV--------YRASRH 130
Query: 300 PTRMKIALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFG 348
++K + R LAY+H I HRDIK N+LLD S K+ DFG
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 349 LAKH--SLDTDTH-VSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
AK + + + + +R Y APE + T D++S G ++ EL+ G +P
Sbjct: 188 SAKILIAGEPNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
Query: 405 DKADTFADDSMVD 417
F +S +D
Sbjct: 242 -----FPGESGID 249
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 60/279 (21%), Positives = 95/279 (34%), Gaps = 70/279 (25%)
Query: 158 SAFNEPLS--TSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGF 215
S +PL + P + Y LLG+GGF
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAE------YRLGP----------LLGKGGF 44
Query: 216 GYVHKGV-LTNGKVVAIKQL------KAGSGQGEREFQAEIEIISQVH----HRHLVSLV 264
G V G LT+ VAIK + E+ ++ +V H ++ L
Sbjct: 45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL- 103
Query: 265 GYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGSAR----- 311
++ + LE L + D + +R
Sbjct: 104 ------------LDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGP--SRCFFGQ 147
Query: 312 ---GLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
+ + H ++HRDIK NIL+D AK+ DFG +L D + GT
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDFD-GT 201
Query: 368 FGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFD 405
Y PE+ S + + V+S G+LL +++ G PF+
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+ + +G+G +G V K ++VA+K+++ + E A EI ++ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKEL 58
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
H+++V L + LV+EF + L+ + + ++ +GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGF 116
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE- 374
H ++HRD+K N+L++ + E K+A+FGLA+ S V+ T Y P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 375 ------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
Y++S D++S G + EL RP F + + D
Sbjct: 173 LFGAKLYSTS------IDMWSAGCIFAELANAGRPL-----FPGNDVDD 210
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREFQ---AEIE 250
K + +F LG G FG V + NG+ A+K LK ++ + E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 251 IISQVHHRHLVSLVGYCTF-GSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-L 307
++S V H ++ + + TF +Q++ ++ +++ L L K + N + A +
Sbjct: 59 MLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEV 115
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM-G 366
A L YLH II+RD+K NILLD + K+ DFG AK+ D T + G
Sbjct: 116 CLA--LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCG 165
Query: 367 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 410
T Y+APE S+ + D +SFG+L+ E++ G+ PF ++T
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 65/260 (25%), Positives = 102/260 (39%), Gaps = 45/260 (17%)
Query: 181 PGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG 239
PG + + E + D F + GQG FG V G G VAIK++
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 240 QGEREFQAEIEIISQVHHRHLVSL------VGYCTFGSQRL-LVYEFVPNKTLEFHLHGK 292
RE Q ++ ++ +HH ++V L +G L +V E+VP+ LH
Sbjct: 62 FRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LH-- 113
Query: 293 DRPVMNWPTRMKIALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLD-DSFE 341
R ++A R + LH + HRDIK N+L++
Sbjct: 114 --RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGT 170
Query: 342 AKVADFGLAKHSLDTDTHVS---TRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLEL 397
K+ DFG AK ++ +V+ +R Y APE + T D++S G + E+
Sbjct: 171 LKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEM 225
Query: 398 ITGFRPFDKADTFADDSMVD 417
+ G P F D+
Sbjct: 226 MLG-EPI-----FRGDNSAG 239
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 50/224 (22%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL------KAGSGQGEREFQAEIEIISQVHHR--H 259
LLG GGFG V+ G+ +++ VAIK + G E+ ++ +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKT-----LEFHLHGK---DRPVMNWPTRMKIALGSAR 311
++ L ++ LE + D ++ L AR
Sbjct: 110 VIRL-------------LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEEL--AR 152
Query: 312 --------GLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVST 362
+ + H ++HRDIK NIL+D + E K+ DFG +L DT +
Sbjct: 153 SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTD 207
Query: 363 RVMGTFGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFD 405
GT Y PE+ + + V+S G+LL +++ G PF+
Sbjct: 208 FD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQL---KAGSGQGEREFQAEIEIISQVHHRHLVSLV 264
LG G FG V G G VA+K L K S + + EI+ + H H++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 265 GYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR--------GLA 314
Y + +V E+V L F D + R++ AR +
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGEL-F-----DYICKH--GRVEEM--EARRLFQQILSAVD 125
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 374
Y H + ++HRD+K N+LLD AK+ADFGL+ ++ +D G+ Y APE
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTSCGSPNYAAPE 180
Query: 375 YASSGKLTE--KSDVFSFGVLLLELITGFRPFD 405
SG+L + D++S GV+L L+ G PFD
Sbjct: 181 VI-SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 26/228 (11%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF----QAEI 249
K+ +NF +LG G +G V GK+ A+K LK + + + + E
Sbjct: 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 250 EIISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
+++ + LV+L + F ++ +L L+ +++ L HL + ++ +
Sbjct: 110 QVLEHIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVG 166
Query: 307 -LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM 365
+ A L +LH+ II+RDIK NILLD + + DFGL+K + +T +
Sbjct: 167 EIVLA--LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 366 GTFGYLAPE---YASSGKLTEKS-DVFSFGVLLLELITGFRPFDKADT 409
GT Y+AP+ SG +K+ D +S GVL+ EL+TG PF
Sbjct: 222 GTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASPFTVDGE 267
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 67/285 (23%), Positives = 101/285 (35%), Gaps = 49/285 (17%)
Query: 143 PPSNGPTAPLPT-VPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIAT 201
P P P P P P P+Q P V KS ++ I
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHV---KSGLQIKKNAIID 61
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRH 259
D + +LG G G V + + A+K L+ + + E+E+ + H
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPH 116
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK---DRPVMNWPTR--------- 302
+V +V VYE + + G R
Sbjct: 117 IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KVADFGLAKHSLDTDTH 359
MK +G A + YLH I HRD+K N+L K+ DFG AK +
Sbjct: 167 MKS-IGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNS 219
Query: 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
++T T Y+APE K + D++S GV++ L+ G+ PF
Sbjct: 220 LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 44/217 (20%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC 267
+G G FG ++VA+K ++ G+ E Q EI + H ++V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF---- 81
Query: 268 TFGSQRLLVYEFVPNKT-----LEFHLHGK--DRPVMNWPTRMKIALGSAR--------G 312
E + T +E+ G+ +R R AR G
Sbjct: 82 ---------KEVILTPTHLAIIMEYASGGELYERICNA--GRFSED--EARFFFQQLLSG 128
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEA--KVADFGLAKHSLDTDTHVSTRVMGTFGY 370
++Y H +I HRD+K N LLD S K+ DFG +K S+ + + V GT Y
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAY 183
Query: 371 LAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 405
+APE + + +DV+S GV L ++ G PF+
Sbjct: 184 IAPEVL-LRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 56/252 (22%), Positives = 101/252 (40%), Gaps = 39/252 (15%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 266
+LG+G V + L + A+K ++ G E+E++ Q HR+++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKD-------RPVMNWPTRMKIALGSARGLAYLHED 319
+ LV+E + ++ H+H + V+ +A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----DVA----SALDFLHN- 129
Query: 320 CQPKIIHRDIKSANILL---DDSFEAKVADFGLAK--HSLDTDTHVSTRVM----GTFGY 370
I HRD+K NIL + K+ DF L + +ST + G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 371 LAPE-----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 425
+APE + ++ D++S GV+L L++G+ PF A P
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 426 GLAD----GNFD 433
L + G ++
Sbjct: 248 MLFESIQEGKYE 259
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 31/229 (13%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+ + + LG+G F V+K ++VAIK++K G ++ A EI+++ ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
H +++ L+ S LV++F+ LE + + L + +GL Y
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEY 127
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE- 374
LH+ I+HRD+K N+LLD++ K+ADFGLAK + + +V+ T Y APE
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPEL 183
Query: 375 ------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
Y D+++ G +L EL+ PF DS +D
Sbjct: 184 LFGARMYGVG------VDMWAVGCILAELLLR-VPF-----LPGDSDLD 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 9e-21
Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 33/228 (14%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVH 256
+ + +G+G +G V+K G+ A+K+++ E E EI I+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELK 58
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
H ++V L + +LV+E + + L+ L + + T L G+AY
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYC 116
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-- 374
H+ +++HRD+K N+L++ E K+ADFGLA+ + ++ T Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVL 172
Query: 375 -----YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
Y+++ D++S G + E++ G P F S D
Sbjct: 173 MGSKKYSTT------IDIWSVGCIFAEMVNG-TPL-----FPGVSEAD 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 53/243 (21%), Positives = 89/243 (36%), Gaps = 51/243 (20%)
Query: 189 KSTFTYEELKIATDNFSE-----ANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE 242
++ + ++ +LG G G V + G+ A+K L
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----S 65
Query: 243 REFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HGK---D 293
+ + E++ Q H+V ++ VYE + + + G
Sbjct: 66 PKARQEVDHHWQASGGPHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFS 115
Query: 294 RPVMNWPTR---------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFE 341
R M+ +G+A + +LH I HRD+K N+L +
Sbjct: 116 RIQERGDQAFTEREAAEIMRD-IGTA--IQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169
Query: 342 AKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF 401
K+ DFG AK T + T T Y+APE K + D++S GV++ L+ GF
Sbjct: 170 LKLTDFGFAKE--TTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226
Query: 402 RPF 404
PF
Sbjct: 227 PPF 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 48/262 (18%)
Query: 173 DKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAI 231
S G+ +G F + + + L+G+G +G V K G++VAI
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQ------SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAI 55
Query: 232 KQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE 286
K+ + + A EI+++ Q+ H +LV+L+ C + LV+EFV + T+
Sbjct: 56 KKFLESD---DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTIL 111
Query: 287 FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346
L +++ K G+ + H IIHRDIK NIL+ S K+ D
Sbjct: 112 DDLELFPNG-LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCD 167
Query: 347 FGLAKH---SLDTDTH-VSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLL 395
FG A+ + V+TR Y APE Y + DV++ G L+
Sbjct: 168 FGFARTLAAPGEVYDDEVATR-----WYRAPELLVGDVKYGKA------VDVWAIGCLVT 216
Query: 396 ELITGFRPFDKADTFADDSMVD 417
E+ G P F DS +D
Sbjct: 217 EMFMG-EPL-----FPGDSDID 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 38/213 (17%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQL-KAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 266
LG+G F K V + + A+K + K ++E I + H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE----ITALKLCEGHPNIVKLHEV 74
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR-----------MKIALGSARGLAY 315
LV E + L F +R + M+ + +++
Sbjct: 75 FHDQLHTFLVMELLNGGEL-F-----ERIK----KKKHFSETEASYIMRKLVS---AVSH 121
Query: 316 LHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
+H+ ++HRD+K N+L +D+ E K+ DFG A+ + + T T Y A
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
PE + E D++S GV+L +++G PF
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 44/234 (18%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+ + + +G+G +G V K G++VAIK+ + A EI ++ Q+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQL 59
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK-IALGSARGLA 314
H +LV+L+ + LV+E+ + T+ L +K I + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTH-VSTRVMGTFGY 370
+ H+ IHRD+K NIL+ K+ DFG A+ D V+TR Y
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WY 168
Query: 371 LAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
+PE Y DV++ G + EL++G P + S VD
Sbjct: 169 RSPELLVGDTQYGPP------VDVWAIGCVFAELLSG-VPL-----WPGKSDVD 210
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 69/228 (30%), Positives = 103/228 (45%), Gaps = 33/228 (14%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
K+ ++F +LG+G FG V K + AIK LK + + E
Sbjct: 13 KLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 251 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDR-PVMNWPTRMK-- 304
++S H L + +CTF ++ L V E++ L +H+ + + +R
Sbjct: 70 VLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFY 123
Query: 305 ---IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361
I LG L +LH I++RD+K NILLD K+ADFG+ K ++ D +
Sbjct: 124 AAEIILG----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 176
Query: 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
T GT Y+APE K D +SFGVLL E++ G PF D
Sbjct: 177 T-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 47/234 (20%), Positives = 86/234 (36%), Gaps = 46/234 (19%)
Query: 195 EELKIATDNFSEA----NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI 249
++L + F++ +G G + + + A+K + E I
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66
Query: 250 EIISQ-VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
EI+ + H ++++L G +V E + L D+ +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-L-----DKIL---------RQK 111
Query: 309 S-------------ARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAK 351
+ + YLH ++HRD+K +NIL + ++ DFG AK
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
+ + T T ++APE D++S GVLL ++TG+ PF
Sbjct: 169 QLRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
++ +F+ +LG+G FG V KG ++ A+K LK + + E
Sbjct: 16 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 251 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK--- 304
+++ L L + F + RL V E+V L +H+ R
Sbjct: 73 VLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYA 127
Query: 305 --IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
IA+G L +L II+RD+K N++LD K+ADFG+ K ++ T
Sbjct: 128 AEIAIG----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
Query: 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
GT Y+APE + + D ++FGVLL E++ G PF+ D
Sbjct: 181 -FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 29/262 (11%)
Query: 159 AFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV 218
++P + P P S + +G + +F ++G+G FG V
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNP------HAKPSDFHFLKVIGKGSFGKV 54
Query: 219 ----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQ-VHHRHLVSLVGYCTFG 270
HK A+K L+ + ++E +E ++ + V H LV L + +F
Sbjct: 55 LLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL--HFSFQ 109
Query: 271 SQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHR 327
+ +L V +++ L +HL ++R + R A + SA L YLH I++R
Sbjct: 110 TADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASA--LGYLHSL---NIVYR 163
Query: 328 DIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 387
D+K NILLD + DFGL K +++ ++ ST GT YLAPE D
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 388 FSFGVLLLELITGFRPFDKADT 409
+ G +L E++ G PF +T
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNT 244
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-20
Identities = 19/205 (9%), Positives = 52/205 (25%), Gaps = 39/205 (19%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVHHRHLVSLV 264
G + + + VA+ + + +E + +S++ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324
+ L+V E++ +L+ P ++ A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA---GV 150
Query: 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEK 384
+ + + + +A + +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAY---------------------PATMPDA-------NPQ 182
Query: 385 SDVFSFGVLLLELITGFRPFDKADT 409
D+ G L L+ P +A
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGV 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 56/275 (20%), Positives = 107/275 (38%), Gaps = 50/275 (18%)
Query: 161 NEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHK 220
+ G+L++ P + S Y + LG+G +G V+K
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRI----------TKLGEGTYGEVYK 52
Query: 221 GV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQVHHRHLVSLVGYCTFGSQRL 274
+ + VAIK+++ E E A E+ ++ ++ HR+++ L +
Sbjct: 53 AIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334
L++E+ L+ ++ P ++ G+ + H + +HRD+K N+
Sbjct: 110 LIFEYA-ENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNL 163
Query: 335 LLDDSFEA-----KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE-------YASSGKLT 382
LL S + K+ DFGLA+ + ++ T Y PE Y++S
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTS---- 218
Query: 383 EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
D++S + E++ P F DS +D
Sbjct: 219 --VDIWSIACIWAEMLMK-TPL-----FPGDSEID 245
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 31/221 (14%)
Query: 200 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE-----REFQAEIEIIS 253
++ F + LG G + V+KG+ T G VA+K++K S +G RE I ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMK 58
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPN---KTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++ H ++V L ++ LV+EF+ N K ++ G +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
+GLA+ HE+ KI+HRD+K N+L++ + K+ DFGLA+ S+ V+ T Y
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 371 LAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
AP+ Y++S D++S G +L E+ITG +P
Sbjct: 175 RAPDVLMGSRTYSTS------IDIWSCGCILAEMITG-KPL 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 35/229 (15%)
Query: 202 DNFSEANLLGQGGFGYVHKG-VLTNGKVVAIKQLKAGSGQGE-----REFQAEIEIISQV 255
+ + + + LG+G + V+KG +VA+K+++ +G RE + ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 256 HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAY 315
H ++V+L LV+E++ +K L+ +L +N RGLAY
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNI-INMHNVKLFLFQLLRGLAY 115
Query: 316 LHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE- 374
H + K++HRD+K N+L+++ E K+ADFGLA+ V+ T Y P+
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 375 ------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
Y++ D++ G + E+ TG RP F ++ +
Sbjct: 172 LLGSTDYSTQ------IDMWGVGCIFYEMATG-RPL-----FPGSTVEE 208
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 23/223 (10%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
+ +F ++G+G + V K ++ A+K +K + + Q E
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 251 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA- 306
+ Q +H LV L + F ++ RL V E+V L FH+ + R + R A
Sbjct: 62 VFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAE 118
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
+ A L YLHE II+RD+K N+LLD K+ D+G+ K L ST G
Sbjct: 119 ISLA--LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCG 172
Query: 367 TFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
T Y+APE D ++ GVL+ E++ G PFD +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 82/299 (27%)
Query: 183 MPVGNFKSTFTYEELK--IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQL 234
+P+ Y+ K D LG+G FG V + + VA+K L
Sbjct: 1 LPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 60
Query: 235 KAGSGQGER-EFQAEIEIISQV-HHRHLVSLVGYCT-FGSQRLLVYEFVPNKTLEFHLHG 291
K G+ E +E++I+ + HH ++V+L+G CT G +++ EF L +L
Sbjct: 61 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
Query: 292 KDRPVMNWPTRMKIALGSARGLAYLHED-------------------------------C 320
K + + T+ + + D
Sbjct: 121 KRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180
Query: 321 QPKIIHRDIKSANILLDDSFE------------------------------AKVADFGLA 350
P+ +++D + L+ SF+ K+ DFGLA
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 351 KHSLDTDTHVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVLLLELIT-GFRP 403
+ +V L APE T +SDV+SFGVLL E+ + G P
Sbjct: 241 RDIYKDPDYVRKGD----ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 160 FNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYV- 218
++ P + + + + +S L + +F ++G+G + V
Sbjct: 12 YDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL--QDFDLLRVIGRGSYAKVL 69
Query: 219 ---HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIEIISQV-HHRHLVSLVGYCTFGS 271
K ++ A++ +K + + Q E + Q +H LV L + F +
Sbjct: 70 LVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL--HSCFQT 124
Query: 272 Q-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA-LGSARGLAYLHEDCQPKIIHRD 328
+ RL V E+V L FH+ + R + R A + A L YLHE II+RD
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLA--LNYLHER---GIIYRD 178
Query: 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 388
+K N+LLD K+ D+G+ K L ST GT Y+APE D +
Sbjct: 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWW 237
Query: 389 SFGVLLLELITGFRPFDKADT 409
+ GVL+ E++ G PFD +
Sbjct: 238 ALGVLMFEMMAGRSPFDIVGS 258
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 42/217 (19%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGS--GQGEREFQAEIEIISQVHHRHL 260
LG G FG V G G VA+K ++++ G+ RE I+ + H H+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRHPHI 78
Query: 261 VSLVGYCTFGSQR--LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR------- 311
+ L Y + +V E+V L F D N R+ +R
Sbjct: 79 IKL--YQVISTPSDIFMVMEYVSGGEL-F-----DYICKN--GRLDEKE--SRRLFQQIL 126
Query: 312 -GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
G+ Y H + ++HRD+K N+LLD AK+ADFGL+ D + T G+ Y
Sbjct: 127 SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNY 181
Query: 371 LAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 405
APE SG+L + D++S GV+L L+ G PFD
Sbjct: 182 AAPEVI-SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 67/229 (29%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIK-----QLKAGS--GQGEREFQAEIEIISQVHHRHL 260
LG+G FG V + VA+K LK + ERE I + + H H+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRHPHI 71
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKT-----LEF-------HL--HGKDRPVMNWPTRMKIA 306
+ L Y+ + T +E+ ++ RM
Sbjct: 72 IKL-------------YDVITTPTDIVMVIEYAGGELFDYIVEKK----------RMTED 108
Query: 307 LGSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
R + Y H + KI+HRD+K N+LLDD+ K+ADFGL+ ++ TD
Sbjct: 109 E--GRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLS--NIMTDG 161
Query: 359 HVSTRVMGTFGYLAPEYASSGKLTE--KSDVFSFGVLLLELITGFRPFD 405
+ G+ Y APE +GKL + DV+S G++L ++ G PFD
Sbjct: 162 NFLKTSCGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 44/241 (18%)
Query: 200 ATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI------EI- 251
AT + +G G +G V+K +G VA+K ++ + + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVA 63
Query: 252 ----ISQVHHRHLVSL----VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
+ H ++V L T ++ LV+E V ++ L +L P + T
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETI 122
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ RGL +LH + I+HRD+K NIL+ K+ADFGLA+ ++
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTP 178
Query: 363 RVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 416
V+ T Y APE YA+ D++S G + E+ +P F +S
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRR-KPL-----FCGNSEA 225
Query: 417 D 417
D
Sbjct: 226 D 226
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 69/230 (30%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 198 KIATDNFSEANLLGQGGFGYV----HKGVLTNGKVVAIKQLKAGSGQGEREF---QAEIE 250
++ DNF +LG+G FG V K G + A+K LK + + E
Sbjct: 19 RLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 251 IISQV-HHRHLVSLVGYCTFGSQ-RL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
I+S +H L L +C F + RL V EFV L FH+ R
Sbjct: 76 ILSLARNHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----------FDE 123
Query: 308 GSAR--------GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359
AR L +LH+ II+RD+K N+LLD K+ADFG+ K +
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180
Query: 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
+T GT Y+APE D ++ GVLL E++ G PF+ +
Sbjct: 181 TATFC-GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 67/246 (27%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQA--EIEIISQV 255
+ + +GQG FG V K G+ VA+K++ + E+E A EI+I+ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLL 73
Query: 256 HHRHLVSLVGYCTFGSQRL--------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
H ++V+L+ C + LV++F E L G +++ + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAG----LLS---NVLVKF 121
Query: 308 GSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA------- 350
+ GL Y+H + KI+HRD+K+AN+L+ K+ADFGLA
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 351 KHSLDTDTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITGFRP 403
+ T+ RV+ T Y PE Y D++ G ++ E+ T P
Sbjct: 179 NSQPNRYTN---RVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTR-SP 227
Query: 404 FDKADT 409
+ +T
Sbjct: 228 IMQGNT 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 202 DNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGERE---FQA--EIEI--- 251
+ +G+G +G V K + G+ VA+K+++ + E E+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRH 67
Query: 252 ISQVHHRHLVSL----VGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIA 306
+ H ++V L T +L LV+E V ++ L +L P + T +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 307 LGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMG 366
RGL +LH +++HRD+K NIL+ S + K+ADFGLA+ +++ V+
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVV- 181
Query: 367 TFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
T Y APE YA+ D++S G + E+ +P
Sbjct: 182 TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRR-KPL 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 57/247 (23%), Positives = 99/247 (40%), Gaps = 53/247 (21%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV---LTNGKVVAIKQLKAGSGQGEREFQ 246
F YE K+ G+G +G+V+K + K A+KQ++
Sbjct: 20 DLFEYEGCKV-----------GRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMS 64
Query: 247 A--EIEIISQVHHRHLVSLVGYCTFGSQRL--LVYEFVPN---KTLEFHLHGKDRP---V 296
A EI ++ ++ H +++SL + R L++++ + ++FH K
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 297 MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA----KVADFGLAKH 352
+ + G+ YLH + ++HRD+K ANIL+ K+AD G A+
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
Query: 353 ---SLDTDTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVLLLELITGFR 402
L + V+ TF Y APE Y T+ D+++ G + EL+T
Sbjct: 182 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS-E 233
Query: 403 PFDKADT 409
P
Sbjct: 234 PIFHCRQ 240
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 57/278 (20%), Positives = 102/278 (36%), Gaps = 75/278 (26%)
Query: 186 GNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE 244
G S+ Y K LG G FG V + +GK A+K++ +
Sbjct: 1 GLETSSKKYSLGKT----------LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPR 45
Query: 245 FQA-EIEIISQVHHRHLVSL--VGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPT 301
++ E++I+ + H +++ L Y T + + L +G + +
Sbjct: 46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIV 105
Query: 302 R---------------------MKIALGSA----------------RGLAYLHEDCQPKI 324
+K + S R + ++H I
Sbjct: 106 NPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGI 162
Query: 325 IHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVS---TRVMGTFGYLAPE-YASSG 379
HRDIK N+L++ K+ DFG AK + ++ V+ +R Y APE +
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGAT 217
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417
+ T D++S G + ELI G +P F+ ++ +D
Sbjct: 218 EYTPSIDLWSIGCVFGELILG-KPL-----FSGETSID 249
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 50/234 (21%), Positives = 86/234 (36%), Gaps = 51/234 (21%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQL--KAGSGQGEREFQA---------EI 249
++ + G +G V GV + G VAIK++ G+ EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
+++ HH +++ L + LV E + L V++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQ----VIHDQ---R 128
Query: 305 IALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
I + GL LHE ++HRD+ NILL D+ + + DF LA+
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 355 DTDT---HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+V+ R Y APE T+ D++S G ++ E+ +
Sbjct: 186 ADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 57/234 (24%), Positives = 88/234 (37%), Gaps = 37/234 (15%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEI-------------ISQ 254
LG G F V + N VA+K ++ E AE EI
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDS 82
Query: 255 VHHRHLVSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
+ H++ L+ + G ++V+E + L + R + +I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYVKQISKQLL 141
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDS------FEAKVADFGLAKHSLDTDTHVSTRV 364
GL Y+H C IIH DIK N+L++ + K+AD G A D H + +
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSI 196
Query: 365 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG---FRPFDKADTFADDSM 415
Y +PE +D++S L+ ELITG F P + DD
Sbjct: 197 QTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 44/231 (19%)
Query: 194 YEELKIA---TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEI 249
YE + D++ LG+G + V + + +TN + V +K LK +++ + EI
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREI 81
Query: 250 EIISQV-HHRHLVSLVGYCTFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
+I+ + ++++L LV+E V N + + T
Sbjct: 82 KILENLRGGPNIITL--ADIVKDPVSRTPALVFEHVNNTDF--------KQLYQTLTDYD 131
Query: 305 IA------LGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAK--HSLD 355
I L + L Y H I+HRD+K N+++D + + ++ D+GLA+ H
Sbjct: 132 IRFYMYEIL---KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 356 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKS-DVFSFGVLLLELITGFRPF 404
V++R + PE ++ + S D++S G +L +I PF
Sbjct: 186 EYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 51/240 (21%), Positives = 82/240 (34%), Gaps = 66/240 (27%)
Query: 187 NFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF 245
+ KS ++ I D + +LG G G V + + A+K L+ +
Sbjct: 3 HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKA 57
Query: 246 QAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHL-----HG---KDRPV 296
+ E+E+ + H+V +V VYE + + G R
Sbjct: 58 RREVELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQ 107
Query: 297 MNWPTR---------MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA---KV 344
MK +G A + YLH I HRD+K N+L K+
Sbjct: 108 DRGDQAFTEREASEIMKS-IGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKL 161
Query: 345 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404
DFG AK + Y + D++S GV++ L+ G+ PF
Sbjct: 162 TDFGFAKETTGE------------KY-----------DKSCDMWSLGVIMYILLCGYPPF 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 58/228 (25%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIE 250
+ +G G +G V + +G+ VAIK+L R FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELL 75
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
++ + H +++ L+ T S LV F ++ L M
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQ----------KIMG 120
Query: 305 IALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
+ +GL Y+H ++HRD+K N+ +++ E K+ DFGLA+H+
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 355 DTDTH-VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITG 400
T V TR Y APE S + D++S G ++ E++TG
Sbjct: 178 AEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 57/226 (25%), Positives = 89/226 (39%), Gaps = 53/226 (23%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 250
+ +G G G V + VAIK+L R FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELV 76
Query: 251 IISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLE--------FHLHGKD-RPVMN--- 298
++ V+H++++ L+ F P K+LE L + V+
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 299 WPTRMKIALGSA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357
RM L G+ +LH IIHRD+K +NI++ K+ DFGLA+ + +
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 358 T---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400
+V TR Y APE E D++S G ++ E+I G
Sbjct: 182 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---------EIE 250
+ +G G G V + VAIK+L R FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELV 113
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL------LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
++ V+H++++SL+ T LV E ++ +L + + RM
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMEL-DHERMS 167
Query: 305 IALGSA-RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT---HV 360
L G+ +LH IIHRD+K +NI++ K+ DFGLA+ + + +V
Sbjct: 168 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400
TR Y APE E D++S G ++ E++
Sbjct: 225 VTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 11/96 (11%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFG 369
+GL Y+H IIHRD+K N+ +++ E K+ DFGLA+ + T +V TR
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 370 YLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPF 404
Y APE + + T+ D++S G ++ E+ITG +
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 52/231 (22%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 250
++ + +G+G +G V N VAIK++ F+ EI+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHG--KDRPVMNWPTRM 303
I+ + H +++ + + +V + +E L+ K + + N
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICY 132
Query: 304 KI--ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH-- 359
+ L RGL Y+H ++HRD+K +N+LL+ + + K+ DFGLA+ + H
Sbjct: 133 FLYQIL---RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 360 -----VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPF 404
V+TR Y APE +S T+ D++S G +L E+++ RP
Sbjct: 187 FLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREF--QA--EIEIISQVHHR----- 258
++G+G FG V K + VA+K ++ E+ F QA EI I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 259 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
+++ ++ TF + + +E + E K + R K A + L LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALH 217
Query: 318 EDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTD-THVSTRVMGTFGYLAPE 374
+ +IIH D+K NILL KV DFG + + T++ +R F Y APE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F-YRAPE 269
Query: 375 YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ D++S G +L EL+TG+
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLL 299
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 11/96 (11%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFG 369
RGL Y+H IIHRD+K +N+ +++ E K+ DFGLA+H+ D T +V+TR
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 370 YLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPF 404
Y APE + + D++S G ++ EL+TG R
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 2e-12
Identities = 46/249 (18%), Positives = 73/249 (29%), Gaps = 61/249 (24%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAGSG---QGEREFQAEIEI 251
+ T+ +G+G FG V + + + K++AI+ +G + E EI I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKT--------------------------- 284
++ L V T G L V
Sbjct: 77 SKELSL--LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 285 ------LEFHLHGKD-----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333
LEF G D + + T I LA + HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 334 ILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP--EYASSGKLTEKSDVFSFG 391
+LL + K+ K S + + G +Y S + VF
Sbjct: 193 VLLKKTSLKKLHYTLNGKSST----------IPSCGLQVSIIDYTLSRLERDGIVVFCDV 242
Query: 392 VLLLELITG 400
+ +L TG
Sbjct: 243 SMDEDLFTG 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 43/228 (18%), Positives = 88/228 (38%), Gaps = 44/228 (19%)
Query: 210 LGQGGFGYVHKGV---------LTNGKVVAIKQLKAGSGQGEREF-----QAEIEIISQV 255
+ G +++ + ++K L A G+ E A+ +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 256 HHRHLVSLVG---YCTFGSQ----RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
+ L+ FG R LV + ++L+ L + V++ + +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHVSTR--- 363
L +LHE+ +H ++ + NI +D +++V A +G A + HV+
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 364 ---VMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVLLLELITGFRP 403
G E+ S G + +SD+ S G +L+ + GF P
Sbjct: 225 RSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 24/207 (11%)
Query: 208 NLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR----- 258
+L+G+G FG V K + VAIK +K + E+ ++ ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 259 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
++V L + F + LV+E + + + R V TR K A L +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLA 174
Query: 318 EDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDT-DTHVSTRVMGTFGYLAPE 374
+ IIH D+K NILL K+ DFG + ++ +R F Y +PE
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----F-YRSPE 228
Query: 375 YASSGKLTEKSDVFSFGVLLLELITGF 401
D++S G +L+E+ TG
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 47/250 (18%), Positives = 85/250 (34%), Gaps = 57/250 (22%)
Query: 165 STSGSLDSDKPFPRQSPGMPVGNFKSTFTYEELKIATDNFSEANLLGQGGFGYVHKGV-L 223
+ SGS + + P + + ++ D + +L+G G +G+V +
Sbjct: 19 TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDK 75
Query: 224 TNGKVVAIKQLKAGSGQGEREFQA---------EIEIISQVHHRHLVSLVGYCTFGSQRL 274
+VVAIK++ R F+ EI I+++++H H+V ++
Sbjct: 76 LEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128
Query: 275 -----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA----------RGLAYLHED 319
+V E + + R + L G+ Y+H
Sbjct: 129 FDELYVVLEI-----ADSDFKK----LF----RTPVYLTELHIKTLLYNLLVGVKYVHS- 174
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLA------KHSLDTDTHVSTRVMGTFGYLAP 373
I+HRD+K AN L++ KV DFGLA ++
Sbjct: 175 --AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 374 EYASSGKLTE 383
+LT
Sbjct: 233 TKNLKRQLTG 242
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 45/231 (19%), Positives = 86/231 (37%), Gaps = 48/231 (20%)
Query: 209 LLGQGGFGYVHKGVLTNGK------VVAIKQLKAGSGQGEREFQ-----AEIEIISQVHH 257
+GQGGFG ++ + + + +K + +G E + A+ E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 258 RHLVSLVGYCT---FGSQ-------RLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKI 305
+ +G G R ++ + L+ + + K + T +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---RFSRKTVLQL 157
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHV--- 360
+L L Y+HE +H DIK++N+LL+ +V D+GLA H
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 361 ---STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRP 403
GT E+ S + + D+ G +++ +TG P
Sbjct: 215 ADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 57/269 (21%), Positives = 89/269 (33%), Gaps = 73/269 (27%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--------HRHL 260
LG G F V + K VA+K +K+ E EI ++ V +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 261 VSLVGYCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
V L+ G+ +V+E + + L++ + + + P KI +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYL 162
Query: 317 HEDCQPKIIHRDIKSANILL---------------------------------------- 336
H C+ IIH DIK NILL
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 337 ---------DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 387
+ + K+AD G A H + + T Y + E +D+
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ-TRQYRSLEVLIGSGYNTPADI 276
Query: 388 FSFGVLLLELITG---FRPFDKADTFADD 413
+S + EL TG F P + D+
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDE 305
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDTH-------VST 362
RGL Y+H ++HRD+K AN+ ++ K+ DFGLA+ +H + T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 363 RVMGTFGYLAPE-YASSGKLTEKSDVFSFGVLLLELITGFRPF 404
+ Y +P S T+ D+++ G + E++TG +
Sbjct: 188 K-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 48/209 (22%), Positives = 79/209 (37%), Gaps = 49/209 (23%)
Query: 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQA---------EIE 250
DN+ +L+G+G +GYV+ K VAIK++ R F+ EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREIT 77
Query: 251 IISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKI 305
I++++ +++ L +V E + L + + I
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKK----LF----KTPI 124
Query: 306 ALGSA----------RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SL 354
L G ++HE IIHRD+K AN LL+ KV DFGLA+ +
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTE 383
+ DT++ + +LT
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 47/229 (20%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQ-----AEIEIISQVHHRH 259
+G GGFG ++ + A +K +G E + A+ + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 260 LVSLVGYCTF----------GSQRLLVYEFVPNKTLE--FHLHGKDRPVMNWPTRMKIAL 307
+ +G F S R +V E + L+ +G T +++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT----FKKSTVLQLGI 158
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV--ADFGLAKHSLDTDTHV----- 360
L Y+HE+ +H DIK+AN+LL +V AD+GL+ H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 361 -STRVMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVLLLELITGFRP 403
GT E+ S G L+ +SDV G +L + G P
Sbjct: 216 PRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 24/109 (22%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT------------ 358
R + LH +IHRD+K +N+L++ + + KV DFGLA+ ++
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 359 --HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVLLLELITGFRPF 404
V+TR Y APE +S K + DV+S G +L EL RP
Sbjct: 180 VEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 64/244 (26%), Positives = 94/244 (38%), Gaps = 84/244 (34%)
Query: 209 LLGQGGFGYV-----HKGVLTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR-- 258
LG+G FG V HK G+ VA+K +K +R +A EI+++ ++
Sbjct: 21 TLGEGAFGKVVECIDHK---AGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDP 73
Query: 259 ----HLVSLVGY-------C-TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKI 305
V ++ + C F L Y+F+ N L F L R K+
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDH---------IR-KM 123
Query: 306 ALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA-------------------KVAD 346
A + + +LH K+ H D+K NIL S KV D
Sbjct: 124 AYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 347 FGLAKHSLDTDTH---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLEL 397
FG A + D + H VSTR Y APE + ++ DV+S G +L+E
Sbjct: 181 FGSA--TYDDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIEY 227
Query: 398 ITGF 401
GF
Sbjct: 228 YLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 60/232 (25%)
Query: 209 LLGQGGFGYVHKGV--LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQVHHR----- 258
LG+G FG V + + VA+K ++ + +A EI ++ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 259 -HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
V + + F + +E + T EF +P R +A L +LH
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR-HMAYQLCHALRFLH 140
Query: 318 EDCQPKIIHRDIKSANILLDDSFEA-------------------KVADFGLAKHSLDTDT 358
E ++ H D+K NIL +S +VADFG A + D +
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEH 195
Query: 359 H---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGF 401
H V+TR Y PE + + DV+S G +L E GF
Sbjct: 196 HTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 68/238 (28%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQA---EIEIISQV-----HHRH 259
+G G FG V + N K A+K ++ ++ ++ E +I+ ++ ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRM--KIALGSARGLAYLH 317
+V G + L++E + E + + L YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGF---HIEDIKLYCIEILKALNYLR 154
Query: 318 EDCQPKIIHRDIKSANILLDDSFEA-------------------------KVADFGLAKH 352
+ + H D+K NILLDD + K+ DFG A
Sbjct: 155 KM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-- 209
Query: 353 SLDTDTH---VSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVLLLELITGF 401
+ +D H ++TR Y APE + SD++SFG +L EL TG
Sbjct: 210 TFKSDYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFGCVLAELYTGS 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 32/212 (15%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQ--LKAGSGQGEREFQ-----AEIEIISQVHHRHLV 261
+G G FG ++ G + G+ VAIK +K Q E + I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRW---- 72
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
G ++V E + +LE + R + T + +A + Y+H
Sbjct: 73 ----CGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 322 PKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD--TDTHVSTR----VMGTFGYLA 372
IHRD+K N L+ + DFGLAK D T H+ R + GT Y A
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 373 PEYASSGK-LTEKSDVFSFGVLLLELITGFRP 403
G + + D+ S G +L+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 49/213 (23%), Positives = 83/213 (38%), Gaps = 32/213 (15%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYC 267
+G+G FG + +G L N + VAIK S + + E + + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 268 TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
G +LV + + P+ LE L R + T A + +HE +++
Sbjct: 76 QEGLHNVLVIDLLGPS--LEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVY 129
Query: 327 RDIKSANILLDDSFEAK-----VADFGLAKHSLDTDT--HVSTR----VMGTFGYLAPEY 375
RDIK N L+ V DFG+ K D T H+ R + GT Y
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----ARY 184
Query: 376 AS----SGK-LTEKSDVFSFGVLLLELITGFRP 403
S G+ + + D+ + G + + + G P
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 32/213 (15%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYC 267
+G G FG + G L + VAIK S + E Q+ + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74
Query: 268 TFGSQRLLVYEFV-PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
G +V E + P+ LE DR + T + IA+ + Y+H +I+
Sbjct: 75 PCGKYNAMVLELLGPS--LEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN---LIY 128
Query: 327 RDIKSANILL---DDSFEAKV--ADFGLAKHSLDTDT--HVSTR----VMGTFGYLAPEY 375
RD+K N L+ + + + DF LAK +D +T H+ R + GT Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----ARY 183
Query: 376 AS----SGK-LTEKSDVFSFGVLLLELITGFRP 403
S GK + + D+ + G + + + G P
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 28/115 (24%), Positives = 48/115 (41%), Gaps = 25/115 (21%)
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
+ + YLH ++HRD+K +NILL+ KVADFGL++ ++ + +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 371 LAPEYASSGKLTE--------------------KS-DVFSFGVLLLELITGFRPF 404
LT+ K D++S G +L E++ G +P
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 1e-08
Identities = 59/351 (16%), Positives = 102/351 (29%), Gaps = 98/351 (27%)
Query: 133 DYQELPKPSLPPSNGPTAPLPTVPVSAFNEPLSTSGSLDSDKPFPRQSPGMPVGNFKSTF 192
+Y+ L P P+ + T + L + + R P
Sbjct: 90 NYKFLMSPIKTEQRQPS--MMTRMYIEQRDRLYNDNQVFAKYNVSRLQP----------- 136
Query: 193 TYEELKIATDNFSEANLL---GQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEI 249
Y +L+ A A + G G G K + A+ + Q + +F+
Sbjct: 137 -YLKLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDFKI-- 184
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRL-----LVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
++ + C L L+Y+ PN T D N R+
Sbjct: 185 ---------FWLN-LKNCNSPETVLEMLQKLLYQIDPNWT-----SRSDHSS-NIKLRIH 228
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD-FGL-AKHSLDTDTHVST 362
R L + + ++ ++L + AK + F L K ++T
Sbjct: 229 SIQAELRRL----------LKSKPYENCLLVLLNVQNAKAWNAFNLSCK------ILLTT 272
Query: 363 RVMGTFGYLAPEYASSGKLTEKSDVFSF--GVLLLELITGFRPFD---KADTFADDSMVD 417
R +L+ + L S + LL RP D + T
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN------ 326
Query: 418 WAKPFL----AQGLADG----------NFDAL---VDQKLEEYDSAEMTRM 451
P A+ + DG N D L ++ L + AE +M
Sbjct: 327 ---PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 210 LGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYC 267
+G G FG ++ G + + VAIK + + E +I + + ++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHR 327
G +LV + + +LE + R ++ T + +A + ++H +HR
Sbjct: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 328 DIKSANILL---DDSFEAKVADFGLAKHSLDTDT--HVSTR----VMGTFGYLAPEYASS 378
DIK N L+ + + + DFGLAK DT T H+ R + GT Y A
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHL 186
Query: 379 GK-LTEKSDVFSFGVLLLELITGFRP 403
G + + D+ S G +L+ + G P
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRGSLP 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 579 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.11 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.27 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.65 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.59 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.4 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.32 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.21 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.26 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 96.26 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 95.88 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.62 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.73 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 90.61 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.93 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.84 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.18 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 88.15 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 85.0 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 84.93 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 83.71 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.61 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=464.11 Aligned_cols=257 Identities=25% Similarity=0.453 Sum_probs=215.0
Q ss_pred hcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467888999999999999999864 47889999998877777789999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeE
Q 008052 275 LVYEFVPNKTLEFHLHGK-----------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~-----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~k 343 (579)
||||||++|+|.++|+.. ....++|.++++|+.||+.||+|||++ +||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 999999999999999653 234699999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhh
Q 008052 344 VADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 344 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
|+|||+++........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i-- 243 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECI-- 243 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH--
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH--
Confidence 9999999875443332 2234579999999999999999999999999999999999 99999765421 111111
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..+ .....+..++..+.+++.+||+.||++||+|.||++.|+..
T Consensus 244 ------~~~--------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 244 ------TQG--------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp ------HHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HcC--------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011 11123334556789999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-57 Score=465.52 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=209.6
Q ss_pred hcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|++|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467888899999999999999874 47899999998877777789999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC
Q 008052 275 LVYEFVPNKTLEFHLHGKD-------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE 341 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~-------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~ 341 (579)
||||||++|+|.++|+... ...++|.++++|+.||++||+|||++ +||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 9999999999999997542 23599999999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhh
Q 008052 342 AKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWA 419 (579)
Q Consensus 342 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~ 419 (579)
+||+|||+++....... ...+..+||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~- 272 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDC- 272 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHH-
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHH-
Confidence 99999999987644332 23345679999999999999999999999999999999999 99999765421 11111
Q ss_pred hhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 420 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
+.+ + .....+..++..+.+++.+||+.||++||+|.||++.|+...
T Consensus 273 ---i~~----g--------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 273 ---ITQ----G--------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ---HHH----T--------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---HHc----C--------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 111 1 001223345567899999999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=460.18 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=212.2
Q ss_pred cCccccceecccCceEEEEEEEe------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
+++++.+.||+|+||+||+|++. +++.||||+++... ....++|++|+.+|++++|||||+|+|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667789999999999999963 46899999997643 334578999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC
Q 008052 275 LVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 340 (579)
||||||++|+|.++|+... ...++|.++++|+.|||+||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996432 23589999999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhh
Q 008052 341 EAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 418 (579)
Q Consensus 341 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~ 418 (579)
.+||+|||+++....... ...+...||+.|||||++.++.|+.++|||||||+||||+| |+.||..... ..+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 999999999987543332 23345679999999999999999999999999999999999 8999976542 112211
Q ss_pred hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 419 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. ..+.. ...+..++..+.+++.+||+.||.+||+|.||++.|+..
T Consensus 260 i--------~~~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 I--------RNRQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H--------HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H--------HcCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 11111 122334566789999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-56 Score=453.64 Aligned_cols=260 Identities=28% Similarity=0.452 Sum_probs=206.4
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+..++|.+.+.||+|+||+||+|++.+ .||||+++... ....+.|.+|+.+|++++|||||+++|+|.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 345678889999999999999998753 58999987543 3445689999999999999999999999865 568999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||+||+|.++|+... ..++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999997543 3599999999999999999999998 9999999999999999999999999999875433
Q ss_pred C-cceeecccccccccChhhhcc---CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 357 D-THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 357 ~-~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
. .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||...+... .....+...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~------ 253 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRG------ 253 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTT------
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcC------
Confidence 2 223455689999999999963 469999999999999999999999997644211 111111111
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+.+.....+++..+.+++.+||+.||++||+|.||++.|+..
T Consensus 254 --~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 254 --YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp --CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred --CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112222233445567789999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=455.43 Aligned_cols=250 Identities=21% Similarity=0.360 Sum_probs=204.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.|++|+.+|++|+|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 68999999996543 3335678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
||+||+|.++|.......+++.+.+.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+..... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 99999999999766666689999999999999999999998 9999999999999999999999999999875322 1
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.. +.....+ .+.+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~-----~~~~------ 242 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKII-----SGSF------ 242 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-----HTCC------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH-----cCCC------
Confidence 2234568999999999999999999999999999999999999999765421 1111111 1111
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+......+.+|+.+||+.||.+||++.|+++
T Consensus 243 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 --PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122233467899999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=447.26 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=209.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||+++++|.+.+..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999976 68999999997655555567899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++|+|.+++.. ..+++.....|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 99999999864 2489999999999999999999999 99999999999999999999999999998764432 23
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.+..+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +... +... ..+.+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~----i~~~---------~~~~~ 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDN---------LPPRL 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHHS---------SCCCC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH----HHcC---------CCCCC
Confidence 456789999999999999999999999999999999999999997654311 1110 0000 00011
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+|+.+||+.||++||++.|+++
T Consensus 291 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223456889999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=441.66 Aligned_cols=269 Identities=22% Similarity=0.287 Sum_probs=203.2
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~lV~ 277 (579)
++|.+.+.||+|+||+||+|++ +|+.||||+++.... ....+..|+.++.+++|||||+++|+|.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 589999999975432 1223345666677899999999999998754 579999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-----QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
|||++|+|.++|+.. .++|..+++|+.|+++||+|||+++ .++||||||||+||||+.++.+||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999753 4899999999999999999999862 56899999999999999999999999999987
Q ss_pred cCCCCcc---eeecccccccccChhhhccC------CCCcccceechHHHHHHHHhCCCCCCCCCcccc----chhhhhh
Q 008052 353 SLDTDTH---VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD----DSMVDWA 419 (579)
Q Consensus 353 ~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~----~~~~~~~ 419 (579)
....... .....+||+.|||||++.+. .++.++|||||||+||||+||+.||........ .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6443322 22346799999999999754 477899999999999999999988765432111 0000111
Q ss_pred hhHhhhcccCCCchhhhchhhh--cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 420 KPFLAQGLADGNFDALVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+...+..+.+ ++.+. ....+....+.+++.+||+.||.+||||.||++.|+..
T Consensus 238 ~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111111111111 12221 12345677899999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-54 Score=447.06 Aligned_cols=267 Identities=26% Similarity=0.416 Sum_probs=218.7
Q ss_pred cCHHHHHHhhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCch-hHHHHHHHHHHHHhcCC-CCcceE
Q 008052 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHH-RHLVSL 263 (579)
Q Consensus 192 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H-pniv~l 263 (579)
+...++++..++|++.+.||+|+||+||+|.+.. ++.||||+++..... ..+.|.+|+.+|.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4455677788999999999999999999999753 368999999775443 35679999999999965 899999
Q ss_pred EEEEEeC-CeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCC
Q 008052 264 VGYCTFG-SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328 (579)
Q Consensus 264 ~g~~~~~-~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 328 (579)
+|+|.+. +..+||||||++|+|.++|+... ...++|..++.|+.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999764 56899999999999999996432 24589999999999999999999998 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCC
Q 008052 329 IKSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 406 (579)
Q Consensus 329 ikp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~ 406 (579)
|||+||||++++.+||+|||+|+........ ..+..+||+.|||||++.++.|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999976544333 3455789999999999999999999999999999999998 9999976
Q ss_pred CCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 407 ADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.... ..+. ..+.+ +. ....+......+.+++..||+.||.+||+|.||++.|+..
T Consensus 291 ~~~~--~~~~----~~i~~----g~--------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKID--EEFC----RRLKE----GT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCS--HHHH----HHHHH----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHH--HHHH----HHHHc----CC--------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 5421 1111 11111 10 0022333456789999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=441.21 Aligned_cols=251 Identities=20% Similarity=0.242 Sum_probs=206.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.|...+.||+|+||.||+|++. +|+.||||+++.... +.+|+.+|++++|||||+++++|.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56888899999999999999975 689999999975432 246999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeecccccccCCCCcc
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGla~~~~~~~~~ 359 (579)
+||+|.++|+.. ..+++.....|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999654 3599999999999999999999998 999999999999999987 6999999999876433211
Q ss_pred ----eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 360 ----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 360 ----~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.....+||+.|||||++.+..|+.++|||||||+||||+||+.||....... +.. ... .+.
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~-----~~~---- 272 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL---KIA-----SEP---- 272 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH---HHH-----HSC----
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHH-----cCC----
Confidence 2234679999999999999999999999999999999999999997654321 110 000 000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+.+..++......+.+++.+||+.||.+||++.||++.|...
T Consensus 273 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 273 --PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111123444567789999999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=449.74 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=209.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.|+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||+++++|.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 68999999997665555667899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
+||+|.+++... .+++.+...|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+...... ..
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 999999998643 489999999999999999999999 99999999999999999999999999998764432 23
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.+..+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +... +... ..+.+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~----i~~~---------~~~~~ 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDN---------LPPRL 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHHS---------CCCCC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH----HHcC---------CCCCC
Confidence 456789999999999999999999999999999999999999997654311 1110 0000 00111
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+|+.+||+.||.+||++.|+++
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223457889999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=434.33 Aligned_cols=247 Identities=20% Similarity=0.313 Sum_probs=207.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 68999999996432 233567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|||+||+|.++|... ..+++.....|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999654 3599999999999999999999999 99999999999999999999999999999764332
Q ss_pred -cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 -~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.. .+ ..... .+.+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~---~~~i~-----~~~~---- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LI---FAKII-----KLEY---- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHH-----HTCC----
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHH-----cCCC----
Confidence 23345678999999999999999999999999999999999999999765421 11 11111 1111
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
.++......+.+++.+||+.||.+||++.|++
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12233345688999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-53 Score=427.72 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=196.6
Q ss_pred cccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEEEE
Q 008052 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLVY 277 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~lV~ 277 (579)
.+.++||+|+||+||+|++. +++.||||++... .....+.|.+|+++|++|+|||||+++++|.. ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999975 5889999998643 33345679999999999999999999999865 34578999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecccccccCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~~~~~~ 356 (579)
|||++|+|.++|... ..+++..+..|+.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 999999999999653 4589999999999999999999997 123999999999999984 78999999999986432
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
......+||+.|||||++. +.|+.++|||||||+||||+||+.||...... ..+. +.+..+....
T Consensus 185 --~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~--------~~i~~~~~~~-- 249 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIY--------RRVTSGVKPA-- 249 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHH--------HHHTTTCCCG--
T ss_pred --CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHH--------HHHHcCCCCC--
Confidence 2334578999999999987 46999999999999999999999999754321 1111 1111111110
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.++......+.+++.+||+.||.+||++.|+++
T Consensus 250 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112346889999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=416.63 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=193.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+|++++|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 68999999996542 233467899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||| +|+|.+++... ..+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 68998888654 3599999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.....+||+.|||||++.+..+ +.++|||||||+||||+||+.||...+. ........ .+.+
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~-----~~~~---- 229 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNIS-----NGVY---- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-----HTCC----
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-----cCCC----
Confidence 2345789999999999998776 5799999999999999999999975432 11111111 1110
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 478 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~ 478 (579)
.++......+.+++.+||+.||.+||++.|+++ .++.
T Consensus 230 -----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 -----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 122233456889999999999999999999997 4553
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=425.06 Aligned_cols=247 Identities=28% Similarity=0.352 Sum_probs=197.2
Q ss_pred cCccccceecccCceEEEEEEEe----CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+.+..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 46899999996532 1223468899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|||||+||+|.++|... ..+++.+...|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999654 3599999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.. +....... +.
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-----~~---- 242 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILK-----AK---- 242 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-----CC----
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHc-----CC----
Confidence 322 234578999999999999999999999999999999999999999765431 11111110 11
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM-----SQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm-----~evl~ 474 (579)
+ .++......+.+++.+||+.||.+||++ .|+++
T Consensus 243 ----~-~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 ----L-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----C-CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----C-CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 1223345678899999999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=415.32 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=189.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--------
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-------- 271 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-------- 271 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999975 689999999975443 34567899999999999999999999987644
Q ss_pred ----eEEEEEEecCCCchhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEee
Q 008052 272 ----QRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (579)
Q Consensus 272 ----~~~lV~E~~~~g~L~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~D 346 (579)
..|||||||++|+|.+++..... ....+...+.|+.||+.||+|||++ +||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976543 2356677889999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCcc-----------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchh
Q 008052 347 FGLAKHSLDTDTH-----------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 415 (579)
Q Consensus 347 FGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~ 415 (579)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||..... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----~- 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----R- 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----H-
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----H-
Confidence 9999875432211 1234679999999999999999999999999999999996 7753210 0
Q ss_pred hhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 416 VDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
... + ..+....+.. ........+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~~----~-~~~~~~~~p~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRT----L-TDVRNLKFPP--------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH----H-HHHHTTCCCH--------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH----H-HHHhcCCCCC--------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 0 0011111111 11223345678999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=403.31 Aligned_cols=290 Identities=51% Similarity=0.858 Sum_probs=245.9
Q ss_pred CcCHHHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 008052 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (579)
Q Consensus 191 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 269 (579)
.|++.++....++|...+.||+|+||.||+|...+++.||||+++..... ....+.+|+.++.+++||||++++++|..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 68889999999999999999999999999999888999999999765322 23368999999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
.+..++||||+++|+|.+++.... ...++|..+..|+.|++.||+|||+++.++|+||||||+||||+.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999997653 335999999999999999999999987779999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCc--cccchhhhhhhhHhhh
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT--FADDSMVDWAKPFLAQ 425 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~~~ 425 (579)
|+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||+.... .....+.+|....+
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 256 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL-- 256 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT--
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh--
Confidence 99987655555555666799999999999989999999999999999999999999963221 12234455554432
Q ss_pred cccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCCCC
Q 008052 426 GLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDD 484 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~~~~ 484 (579)
....+..+.+..+. .+.......+.+++..||+.||.+||++.||++.|++......
T Consensus 257 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~ 314 (326)
T 3uim_A 257 --KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER 314 (326)
T ss_dssp --SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSS
T ss_pred --hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhh
Confidence 34455566666655 6788889999999999999999999999999999998654433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=400.53 Aligned_cols=282 Identities=41% Similarity=0.711 Sum_probs=241.0
Q ss_pred HHHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 194 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
+.++...+++|...+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||++++++|.+.+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34455677899999999999999999999888999999999877666678899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDR--PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
++||||+++|+|.+++..... ..++|..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999976542 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCC-cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 352 HSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 352 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
...... ........||+.|+|||++.++.++.++|||||||+||||++|+.||.............|..... ..+
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~----~~~ 263 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH----NNG 263 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH----TTT
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc----ccc
Confidence 644322 222344569999999999999999999999999999999999999998776655556666654432 234
Q ss_pred Cchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCC
Q 008052 431 NFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 482 (579)
Q Consensus 431 ~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~~ 482 (579)
.+..++++.+. .........+.+++.+||+.||++||++.||++.|+....+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 44555555554 56788899999999999999999999999999999976543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=411.40 Aligned_cols=267 Identities=20% Similarity=0.304 Sum_probs=201.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF------GSQ 272 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~------~~~ 272 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 67999999999999999999975 69999999996543 2334578899999999999999999999764 357
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.|||||||+ |+|.+++... ..+++.....|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 6798888654 4599999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCC---cceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhh-hhhhhH---hh
Q 008052 353 SLDTD---THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWAKPF---LA 424 (579)
Q Consensus 353 ~~~~~---~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~-~~~~~~---~~ 424 (579)
..... .......+||+.|||||++.+. .++.++|||||||+||||++|+.||.+.+.......+ ...... ..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 54322 2233457899999999998865 5699999999999999999999999876532111000 000000 00
Q ss_pred hcccCCCchhhhchh-------hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 QGLADGNFDALVDQK-------LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~-------l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...........+... +..........+.+|+.+||+.||.+|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000000 00011122356789999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=398.66 Aligned_cols=200 Identities=24% Similarity=0.357 Sum_probs=172.1
Q ss_pred HhhcCccccceecccCceEEEEEEEe----CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 273 (579)
...+.|++.+.||+|+||+||+|+.+ .++.||||++..... ...+.+|+++|.++ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 44678999999999999999999864 468899999865432 45688999999998 699999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeecccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAKH 352 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFGla~~ 352 (579)
+||||||++|+|.+++. .+++.+...++.|++.||+|||++ +||||||||+||||+.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999983 389999999999999999999998 99999999999999876 7999999999986
Q ss_pred cCCCCc---------------------------ceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCC
Q 008052 353 SLDTDT---------------------------HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPF 404 (579)
Q Consensus 353 ~~~~~~---------------------------~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf 404 (579)
..+... ...+..+||+.|||||++.+. .|+.++||||+||+||||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543211 112345799999999999865 5899999999999999999999999
Q ss_pred CCCC
Q 008052 405 DKAD 408 (579)
Q Consensus 405 ~~~~ 408 (579)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=421.78 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=209.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+++|+.+|++|+|||||+|++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999975 6899999999876666667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC--CCeEEeecccccccCCCC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS--FEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~--~~~kL~DFGla~~~~~~~ 357 (579)
|+||+|.++|.... ..+++.+...|+.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||+++......
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999886432 3589999999999999999999999 99999999999999854 899999999999764432
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... +.. ... ...+. +.+
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~---~i~-----~~~~~-~~~ 377 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLR---NVK-----SCDWN-MDD 377 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---HHH-----TTCCC-CCS
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH---HHH-----hCCCC-CCc
Confidence 3345689999999999999999999999999999999999999997654311 111 100 11110 001
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .......+.+|+.+||+.||.+||++.|+++
T Consensus 378 ~~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1122356789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=417.43 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=200.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHH---HHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQ---AEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~---~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ......+. .++.+++.++|||||+|++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 378999999999999999999976 68999999996421 11223333 446677778999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
|||||||+||+|.++|... ..+++.....++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999999654 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+. ...+
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~~i~--------- 407 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL--------- 407 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---HHHH---------
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---Hhhc---------
Confidence 4432 345689999999999975 57999999999999999999999999764332111111 1100
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
...+ .++......+.+|+..||+.||.+|++ +.||++
T Consensus 408 ----~~~~-~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 408 ----TMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----HCCC-CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCC-CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0000 233334567899999999999999998 688764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=377.31 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=213.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|...+.||+|+||.||+|... +++.||+|++........+.|.+|++++.+++||||++++++|.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367899999999999999999975 5899999999776666778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.... ..+++.+++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999997543 3589999999999999999999998 9999999999999999999999999999865433221
Q ss_pred e-------------eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 360 V-------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 360 ~-------------~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
. .....||+.|+|||++.+..++.++|||||||+||||++|..||.............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--------- 235 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--------- 235 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC---------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh---------
Confidence 1 114579999999999999999999999999999999999999987544321111000
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.....+. ..+...+..+.+++.+||+.||.+||++.||++.|+..
T Consensus 236 -----~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 236 -----VRGFLDR---YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -----HHHHHHH---TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----hhccccc---cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111111 12223345688999999999999999999999999865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=368.27 Aligned_cols=280 Identities=38% Similarity=0.676 Sum_probs=233.1
Q ss_pred cCcCHHHHHHhhcCcccc------ceecccCceEEEEEEEeCCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCC
Q 008052 190 STFTYEELKIATDNFSEA------NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRH 259 (579)
Q Consensus 190 ~~~~~~el~~~~~~f~~~------~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~Hpn 259 (579)
..|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++.+++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 368999999999999887 8999999999999987 57899999986532 234567999999999999999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCchhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC
Q 008052 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (579)
Q Consensus 260 iv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~ 338 (579)
|+++++++.+.+..++||||+++++|.+++.... ...++|..++.|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999886432 34689999999999999999999998 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhh
Q 008052 339 SFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD 417 (579)
Q Consensus 339 ~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~ 417 (579)
++.+||+|||+++....... .......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...... ..+..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--SBTTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch--HHHHH
Confidence 99999999999986543322 22334579999999998874 6899999999999999999999999865432 22222
Q ss_pred hhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 418 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+...... ....+...++..+..........+.+++..||+.||.+||++.+|++.|+..
T Consensus 246 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEIED---EEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHT---TSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhhh---hhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2222111 1234555666666667788889999999999999999999999999999865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=385.40 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=212.1
Q ss_pred hcCccccceecccCceEEEEEEEe--------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 270 (579)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.... ...+.+.+|+.+|.++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999863 356799999976543 3356799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl 336 (579)
+..+|||||+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999987543 23589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccch
Q 008052 337 DDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDS 414 (579)
Q Consensus 337 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 414 (579)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 99999999999999865443321 2233467889999999999999999999999999999999 99999765421 1
Q ss_pred hhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 415 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
+... +. .+. ....+......+.+++..||+.||.+||++.||++.|+..+
T Consensus 314 ~~~~----~~----~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 LFKL----LK----EGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHH----HH----TTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----Hh----cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 10 110 01122334567899999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=378.49 Aligned_cols=265 Identities=29% Similarity=0.436 Sum_probs=206.1
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~ 270 (579)
...++.+..++|++.+.||+|+||.||+|.. +|+.||||++.... ....+.|.+|+.+|.+++||||+++++++...
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3344555668899999999999999999987 68899999987653 23346789999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEeCCCCCCceEeCCCCCeEEeec
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDikp~NILl~~~~~~kL~DF 347 (579)
+..++||||+++|+|.+++..... ..+++..++.|+.|++.||+|||++ + |+||||||+||||+.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999975432 2389999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
|+++...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||....... ...... .
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~----~-- 253 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVG----F-- 253 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHH----H--
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----h--
Confidence 9998543322 22344679999999999999999999999999999999999999997654311 111100 0
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
... ....+......+.+++.+||+.||.+||++.||++.|+...
T Consensus 254 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 254 KCK---------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp SCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 00122334457899999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=370.89 Aligned_cols=250 Identities=21% Similarity=0.370 Sum_probs=208.7
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|...+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||++++++|...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36799999999999999999995 46899999999766555677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999998653 489999999999999999999998 999999999999999999999999999986544332
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.... + ........ +.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~----~~~~~~~~----------~~ 235 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIATNGT----------PE 235 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H----HHHHHHCS----------CC
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHhCCC----------CC
Confidence 23446799999999999999999999999999999999999999976543110 0 00000000 00
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+ ..+......+.+++.+||+.||.+||++.|+++
T Consensus 236 ~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 L-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp C-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 112233456889999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=372.89 Aligned_cols=261 Identities=22% Similarity=0.317 Sum_probs=216.3
Q ss_pred CcCHHHHHHhhcC----------ccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC
Q 008052 191 TFTYEELKIATDN----------FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259 (579)
Q Consensus 191 ~~~~~el~~~~~~----------f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn 259 (579)
.|++++++.+++. |...+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++.+++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 5788898888765 677789999999999999986 69999999998766666778999999999999999
Q ss_pred cceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC
Q 008052 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (579)
Q Consensus 260 iv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~ 339 (579)
|++++++|...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||||+.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999864 3489999999999999999999998 99999999999999999
Q ss_pred CCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhh
Q 008052 340 FEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 419 (579)
Q Consensus 340 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~ 419 (579)
+.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~- 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKR- 252 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH-
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-
Confidence 9999999999986543222 234567999999999999999999999999999999999999999765421 11111
Q ss_pred hhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 420 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+... ..+.+. ........+.+++.+||+.||.+||++.||++.
T Consensus 253 ---~~~~---------~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 ---LRDS---------PPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHS---------SCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HhcC---------CCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000000 111223568899999999999999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=376.75 Aligned_cols=257 Identities=28% Similarity=0.430 Sum_probs=209.3
Q ss_pred hcCccccceecccCceEEEEEEEe----CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|.+.+.||+|+||.||+|.+. .+..||||+++... ....+.|.+|+.+|.+++||||++++++|.+.+..+|
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999974 35579999997653 3345679999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999996543 3589999999999999999999998 999999999999999999999999999987644
Q ss_pred CCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 356 TDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 356 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+.... ..+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~--------~~~-- 270 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSV--------EEG-- 270 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHH--------HTT--
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH--------HcC--
Confidence 3222 2233456789999999999999999999999999999999 99999765421 111110 000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.....+......+.+++..||+.||.+||++.||++.|+...
T Consensus 271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000122334567899999999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=366.52 Aligned_cols=255 Identities=30% Similarity=0.459 Sum_probs=212.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.++|...+.||+|+||.||+|.+.+++.||||+++.... ..+++.+|+.++.+++||||++++++|.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 467999999999999999999998899999999976543 3567999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999996543 3589999999999999999999998 99999999999999999999999999998654433223
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.... . .+ .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~----~----~~--------~ 224 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDI----S----TG--------F 224 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----H----TT--------C
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH----h----cC--------c
Confidence 334557888999999999999999999999999999999 99999765421 111110 0 00 0
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++..|++.||.+||++.|+++.|+..
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0011122345688999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=365.75 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=213.7
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
..++|...+.||+|+||.||+|.+.++..||||+++.... ...++.+|+.++.+++||||++++++|...+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4578999999999999999999998888999999976543 346799999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999986532 3489999999999999999999998 9999999999999999999999999999876554433
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .. +. .+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~-~~----~~~------- 222 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VV---LK-VS----QGH------- 222 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH---HH-HH----TTC-------
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HH---HH-HH----cCC-------
Confidence 3344557788999999998899999999999999999999 999997654311 00 00 00 000
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+......+.+++..||+.||.+||++.||++.|+...
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred -CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00111122356889999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=399.08 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=215.3
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+++..++|...+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++|||||+++++|. .+..+||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 455668899999999999999999999888999999998654 34678999999999999999999999987 5678999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++|+|.++|+......+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999999765444588999999999999999999998 9999999999999999999999999999875432
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.........++..|+|||++..+.++.++|||||||+||||++ |+.||...... .+... +.....
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----i~~~~~------- 403 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYR------- 403 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----HHHTCC-------
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCC-------
Confidence 2222233456789999999999999999999999999999999 99999764321 11111 111000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
...+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 404 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 404 -----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0122334567899999999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=397.58 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=217.5
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
++..++|.+.+.||+|+||.||+|++.. ++.||||+++.... ..++|.+|+.+|.+++|||||+++++|...+..+||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3456789999999999999999999874 88999999976543 367899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||++|+|.++|.......+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999866566799999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.........++..|+|||++..+.++.++|||||||+||||++ |+.||...+.. .+... +....
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~-------- 436 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDY-------- 436 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTC--------
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC--------
Confidence 3322333456789999999999999999999999999999999 99999765421 11111 11100
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+...+..+.+++.+||+.||.+||++.+|++.|+...
T Consensus 437 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00122334567899999999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=381.05 Aligned_cols=268 Identities=26% Similarity=0.418 Sum_probs=216.8
Q ss_pred CcCHHHHHHhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcce
Q 008052 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVS 262 (579)
Q Consensus 191 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~ 262 (579)
.+...++....++|.+.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|++++.++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4566778888899999999999999999999853 357999999976543 3346799999999999 7999999
Q ss_pred EEEEEEeCCe-EEEEEEecCCCchhhhhcCCCC-----------------------------------------------
Q 008052 263 LVGYCTFGSQ-RLLVYEFVPNKTLEFHLHGKDR----------------------------------------------- 294 (579)
Q Consensus 263 l~g~~~~~~~-~~lV~E~~~~g~L~~~l~~~~~----------------------------------------------- 294 (579)
++++|.+.+. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987554 8999999999999999976432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 295 -----------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 295 -----------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1288999999999999999999998 99999999999999999999999999998654332
Q ss_pred c-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 358 T-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 358 ~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
. .......||+.|+|||++.+..++.++|||||||+||||++ |+.||....... .+... +.. +
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----~~~----~----- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR----LKE----G----- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHH----HHH----T-----
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHH----HHc----C-----
Confidence 2 23345678999999999999999999999999999999998 999997654211 11110 100 0
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.....+......+.+++..||+.||.+||++.||++.|+..
T Consensus 313 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 313 ---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00012222345688999999999999999999999999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=372.53 Aligned_cols=274 Identities=24% Similarity=0.325 Sum_probs=209.1
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRL 274 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~ 274 (579)
...++|+..+.||+|+||.||+|++. ++.||||+++.... ....+..|+.+|.+++|||||+++++|.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34578999999999999999999875 79999999975433 2345667999999999999999999998744 469
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------CCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-------QPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-------~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
|||||+++|+|.+++... .++|..++.|+.|++.||+|||+.+ .++|+||||||+||||+.++.+||+||
T Consensus 99 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999999653 3899999999999999999999862 348999999999999999999999999
Q ss_pred ccccccCCCCcc-eeecccccccccChhhhcc-----CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhh--
Q 008052 348 GLAKHSLDTDTH-VSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA-- 419 (579)
Q Consensus 348 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~-- 419 (579)
|+++........ ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.............+.
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999865443322 2234579999999999986 35677899999999999999999999865432211111100
Q ss_pred ---hhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 420 ---KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 420 ---~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+............+... .........+.+++.+||+.||.+||++.||++.|+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDY--WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGG--GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCcccc--ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000000001110001100 01234567799999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=367.12 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=208.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999965 68899999985432 23346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999998654 3589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .....+ ......
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~-----~~~~~~-- 231 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHI-----QDSVPN-- 231 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHH-----SSCCCC--
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHh-----hccCCC--
Confidence 3333445679999999999999999999999999999999999999997654211 111111 011100
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhcCCC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-RMSQIVRALEGNMP 481 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-tm~evl~~Le~~~~ 481 (579)
.........+..+.+++.+|++.||.+|| ++.++.+.|+....
T Consensus 232 --~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 --VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 01122333456789999999999999999 99999999997654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=373.64 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=206.8
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
..++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999997 47899999999654 233456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++|+|.+++... ..+++.....++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999998654 3489999999999999999999998 9999999999999999999999999999865433
Q ss_pred CcceeecccccccccChhhhccCCCC-cccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
. .....+||+.|+|||++.+..+. .++|||||||+||||++|+.||...+.. ........ +.+
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-----~~~--- 231 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLR-----GKY--- 231 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-----CCC---
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-----CCC---
Confidence 2 23456799999999999887765 7999999999999999999999765421 11111110 100
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+......+.+++.+||+.||.+||++.|+++.
T Consensus 232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1222234568899999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=376.49 Aligned_cols=265 Identities=25% Similarity=0.445 Sum_probs=215.7
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYC 267 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~ 267 (579)
.++....++|...+.||+|+||.||+|+..+ ++.||||+++.... ...+.|.+|+.++.+++||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455567899999999999999999999853 48899999976543 3356799999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 008052 268 TFGSQRLLVYEFVPNKTLEFHLHGKD----------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKII 325 (579)
Q Consensus 268 ~~~~~~~lV~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iv 325 (579)
.+.+..+|||||+++|+|.+++.... ...+++.+++.|+.||+.||+|||++ +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 99999999999999999999986532 14689999999999999999999998 999
Q ss_pred eCCCCCCceEeCCCCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCC
Q 008052 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRP 403 (579)
Q Consensus 326 HrDikp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~P 403 (579)
||||||+||||+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999976533221 12234568999999999999999999999999999999999 9999
Q ss_pred CCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 404 FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 404 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
|...... .+... +..+.. ...+......+.+++..||+.||.+||++.+|++.|+....
T Consensus 277 ~~~~~~~---~~~~~--------~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 277 YYGMAHE---EVIYY--------VRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTSCHH---HHHHH--------HHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCChH---HHHHH--------HhCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 9764421 11111 011111 11223344678999999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=382.77 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=199.6
Q ss_pred hcCccccceecccCceEEEEEEEe----CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|...+.||+|+||.||+|++. ++..||||+++... ....+.|.+|+.+|.+++||||++++++|...+..+|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999975 46789999997653 3345689999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++|+|.++++... ..+++.+++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999997543 3589999999999999999999998 999999999999999999999999999987544
Q ss_pred CCcce--eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 356 TDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 356 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||...... .+... +. .+
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~----i~----~~-- 266 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKA----VD----EG-- 266 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHH----HH----TT--
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH----cC--
Confidence 32211 122346788999999999999999999999999999998 99999754321 11111 00 00
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.....+...+..+.+++..||+.||.+||+|.||++.|+...
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 000122234567899999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=365.32 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=210.0
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+..++|...+.||+|+||.||+|.+.++..||||+++.... ..+++.+|++++.+++|+||++++++|...+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34578999999999999999999998888999999986543 35679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 100 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999997532 3489999999999999999999998 999999999999999999999999999987544332
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ... . +.+ +.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~---~-~~~----~~------ 238 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAE---H-IAQ----GL------ 238 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---H-HHT----TC------
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHH---H-Hhc----cc------
Confidence 22333457788999999999999999999999999999998 999997654311 100 0 000 00
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++..||+.||.+||++.||++.|+..
T Consensus 239 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 --RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0011122245688999999999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.18 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=218.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++...++|...+.||+|+||.||+|.+.. ++.||||+++... ...+.+.+|+.++++++|+||++++++|...+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 33456789999999999999999999864 8899999997654 345689999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++++|.+++.......+++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999876666799999999999999999999999 999999999999999999999999999987655
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+... +.... ....
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~----~~~~------- 229 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKDY------- 229 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HTTC-------
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hccC-------
Confidence 44444445568889999999999999999999999999999999 999997654311 11111 0000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++..|++.||.+||++.||++.|+..
T Consensus 230 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0012223346789999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=388.15 Aligned_cols=263 Identities=19% Similarity=0.266 Sum_probs=213.0
Q ss_pred cCHHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCCCCcceEEEEE
Q 008052 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHHRHLVSLVGYC 267 (579)
Q Consensus 192 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~Hpniv~l~g~~ 267 (579)
+.+.+++...++|+..++||+|+||+||+|++. +++.||||+++..... ....+.+|+.++.+++|||||+++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345677788899999999999999999999986 4789999999653211 123488999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 268 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
.+.+..+||||||++|+|.++|... ...+++..+..++.||+.||+|||+. +||||||||+||||+.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999999763 24589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCcccc-chhhhhhhh
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKP 421 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~ 421 (579)
|+++.............+||+.|+|||++. .+.++.++|||||||+||||++|+.||...+.... ..+..+...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 999876555444455578999999999997 56799999999999999999999999976543110 000010000
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR--RPRMSQIVR 474 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~ 474 (579)
+ ............+.+++.+||+.++++ ||++.||++
T Consensus 300 -------------~---~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 -------------F---QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -------------C---CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -------------c---cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 000111123456888999999888888 999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=385.04 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=209.3
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-eEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS-QRLLVY 277 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~lV~ 277 (579)
+..++|...+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.+|.+++|||||+++++|.... ..+|||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44578899999999999999999985 7899999998654 3568999999999999999999999988765 789999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 999999999999866555689999999999999999999998 9999999999999999999999999999854322
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.....++..|+|||.+.+..++.++|||||||+||||++ |+.||....... +... +. .+.
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~----~~~----- 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VE----KGY----- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HH----TTC-----
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HH----cCC-----
Confidence 122357889999999999999999999999999999998 999997654311 1110 11 110
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+..++..+.+++..||+.||.+||++.+|++.|+..
T Consensus 404 ---~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 ---KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0022334456789999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=358.76 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=202.8
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeC----CeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFG----SQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~~~----~~~~ 274 (579)
.++|...+.||+|+||.||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6899999998653 34566677777776 7899999999997652 4578
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEeCCCCCCceEeCCCCCeEEee
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH--------EDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~~ivHrDikp~NILl~~~~~~kL~D 346 (579)
+||||+++|+|.++++. ..+++..+++|+.|++.||+||| +. +|+||||||+||||+.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 99999999999999953 35899999999999999999999 66 999999999999999999999999
Q ss_pred cccccccCCCCcce---eecccccccccChhhhccC------CCCcccceechHHHHHHHHhC----------CCCCCCC
Q 008052 347 FGLAKHSLDTDTHV---STRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVLLLELITG----------FRPFDKA 407 (579)
Q Consensus 347 FGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~~~ksDVwSlGvvl~eLltG----------~~Pf~~~ 407 (579)
||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654433222 2234799999999999876 556799999999999999999 7777654
Q ss_pred CccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 408 DTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
..... ........ ... ......+.. ..+.......+.+++..||+.||.+||++.||++.|+..
T Consensus 237 ~~~~~-~~~~~~~~-~~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDP-SFEDMRKV-VCV---DQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSC-CHHHHHHH-HTT---SCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc-chhhhhHH-Hhc---cCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 32111 11111111 000 000000000 012345678899999999999999999999999999853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=389.54 Aligned_cols=259 Identities=30% Similarity=0.439 Sum_probs=208.7
Q ss_pred HHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++..++|...+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+.+|++++||||++++++|.+ +..+|||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 345678999999999999999999998888899999986543 35689999999999999999999999976 6789999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++.......+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999999754445689999999999999999999998 99999999999999999999999999998764433
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
........++..|+|||.+..+.++.++|||||||+||||++ |+.||...... .+... +. .+.
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----i~----~~~----- 398 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----VE----RGY----- 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HH----TTC-----
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH----cCC-----
Confidence 223334457889999999999999999999999999999999 99999754321 11111 10 110
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+...+..+.+++..||+.||.+||++.+|++.|+...
T Consensus 399 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 399 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 00122334567899999999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=382.58 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=210.5
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+..++|...+.||+|+||.||+|.+. +++.||||.++.... .....|.+|+.+|++++|||||+++++|...+..+||
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34578999999999999999999986 689999999976532 2345788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 191 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999986432 3489999999999999999999998 9999999999999999999999999999864332
Q ss_pred Cccee-ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 357 DTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 357 ~~~~~-~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
..... ....++..|+|||.+..+.++.++|||||||+||||++ |..||...... ....+ +. .+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~----~~----~~~~-- 333 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREF----VE----KGGR-- 333 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHH----HH----TTCC--
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH----cCCC--
Confidence 21111 12346778999999999999999999999999999998 99999765421 11111 11 1100
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+...+..+.+++..||+.||.+||++.+|++.|+..
T Consensus 334 ------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 ------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 012223446788999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=363.65 Aligned_cols=259 Identities=29% Similarity=0.424 Sum_probs=212.9
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
..+..++|...+.||+|+||.||+|...+++.||||.++.... ..+.+.+|++++.+++||||+++++++.. +..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 3455678999999999999999999998888999999976543 35689999999999999999999999874 568899
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999999654333589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.........++..|+|||.+.++.++.++|||||||++|||++ |+.||...... .+... +. .+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~----~~~---- 227 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQN----LE----RGY---- 227 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HH----TTC----
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHH----Hh----ccc----
Confidence 3333334457889999999998999999999999999999999 99999764321 11111 00 000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++..|++.||.+||++.+|++.|+..
T Consensus 228 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 228 ----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 0011223346789999999999999999999999999865
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=370.46 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=206.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|+..+.||+|+||.||+|+.. +|+.||||+++.. .......+.+|+.+|.+++||||+++++++...+..+||
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999976 6899999999653 223356788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999998643 3589999999999999999999998 9999999999999999999999999999864332
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ......... .
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~-----~----- 221 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILME-----E----- 221 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-----C-----
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcC-----C-----
Confidence 2 2234568999999999999999999999999999999999999999764421 111111110 0
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
+ .++......+.+++.+||+.||.+|| ++.||++
T Consensus 222 ---~-~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 ---I-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---C-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---C-CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 0 12223446789999999999999999 8999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=363.59 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=198.4
Q ss_pred HhhcCccccceecccCceEEEEEEEeC----CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
+..++|.+.+.||+|+||.||+|.... +..||||+++... ....+.+.+|+.++.+++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 445789999999999999999999743 5679999987643 334567899999999999999999999985 4678
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 89999999999999997543 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
............+++.|+|||.+....++.++|||||||++|||++ |..||...... .+.... ..+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i--------~~~~- 234 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI--------ENGE- 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH--------HTTC-
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH--------HcCC-
Confidence 5443333344567889999999999999999999999999999997 99999765431 111111 0110
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++..||+.||.+||++.||++.|+..
T Consensus 235 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0012233456788999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=363.76 Aligned_cols=265 Identities=22% Similarity=0.296 Sum_probs=201.9
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|+..+.||+|+||.||+|+..+|+.||||+++.... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 368999999999999999999998899999999975432 224678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 9985 7777775433 4589999999999999999999998 99999999999999999999999999998754322
Q ss_pred ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhh------------
Q 008052 359 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ------------ 425 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------ 425 (579)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..... .+..
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~-~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIFS-ILGTPNPREWPQVQEL 250 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHHH-HHCCCCTTTSGGGTTS
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HHCCCChHHhhhhhcc
Confidence 22344578999999999876 568999999999999999999999997654321 1111100 0000
Q ss_pred -cccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 -GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 -~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+....+..................+.+++.+||+.||.+||++.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000000001111123356889999999999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=376.84 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=213.7
Q ss_pred HhhcCccccceecccCceEEEEEEEe--------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~ 268 (579)
+..++|.+.+.||+|+||.||+|+.. .+..||||+++.... .....+.+|++++.++ +|||||+++++|.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999963 236799999976543 3346789999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCce
Q 008052 269 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (579)
Q Consensus 269 ~~~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NI 334 (579)
..+..+|||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 9999999999999999999987543 23589999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCcccc
Q 008052 335 LLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 412 (579)
Q Consensus 335 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~ 412 (579)
||+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987544332 22334567899999999999999999999999999999999 99999755421
Q ss_pred chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 413 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
.+.... . .+. ....+......+.+++..||+.||.+||++.||++.|+..+.
T Consensus 301 -~~~~~~----~----~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 -ELFKLL----K----EGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp -HHHHHH----H----TTC--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHH----H----cCC--------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 0 110 001122334578999999999999999999999999997754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=367.76 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=207.3
Q ss_pred hcCccccceecccCceEEEEEEEe-----CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~ 273 (579)
.++|+..+.||+|+||.||+|++. +++.||||+++.......+.|.+|+.+|.+++||||++++++|... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 468999999999999999999852 5889999999877766677899999999999999999999999653 458
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997543 3489999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCc--ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchh-----hhhhhhHhhhc
Q 008052 354 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM-----VDWAKPFLAQG 426 (579)
Q Consensus 354 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~-----~~~~~~~~~~~ 426 (579)
..... .......++..|+|||.+.+..++.++|||||||++|||++|..||........... ..+....+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE- 243 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH-
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH-
Confidence 43322 122334578889999999999999999999999999999999999864321000000 0000000000
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.+........+...+..+.+++..||+.||.+||++.||++.|+..
T Consensus 244 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 -------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000001122334557799999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=379.47 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=209.2
Q ss_pred hcCccccceecccCceEEEEEEEe------CCeEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++|.+.+.||+|+||.||+|++. +++.||||+++.. .......+.+|+.++.+++|||||+++++|......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999953 4678999999754 334456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC---CeEEe
Q 008052 274 LLVYEFVPNKTLEFHLHGKD-----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVA 345 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~kL~ 345 (579)
+|||||+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986532 24589999999999999999999998 999999999999999554 59999
Q ss_pred ecccccccCCCC-cceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHh
Q 008052 346 DFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 346 DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
|||+++...... ........||+.|+|||++.+..++.++|||||||+||||++ |..||...... .+.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~i~--- 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVT--- 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---
Confidence 999997542211 122344568999999999999999999999999999999998 99999765421 1111110
Q ss_pred hhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 424 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.+. ....+......+.+++..||+.||.+||++.||++.|+...
T Consensus 301 -----~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 -----SGG--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----cCC--------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 110 00122233456889999999999999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.11 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=203.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||++++++|.+++..+|||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 68999999999999999999976 689999999865432 2345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC-c
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-T 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~-~ 358 (579)
+++|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999654 3489999999999999999999998 99999999999999999999999999998643222 1
Q ss_pred ceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.......||+.|+|||++.+..+ +.++|||||||+||||++|+.||....... .....|... ... .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~--------~~~---~- 228 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK--------KTY---L- 228 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT--------CTT---S-
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc--------ccc---C-
Confidence 22345679999999999987765 789999999999999999999997654311 112222111 000 0
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.........+.+++.+||+.||.+||++.|+++.
T Consensus 229 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011223567889999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=371.11 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=205.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++|.+.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|+.+|.+++||||++++++|.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 5899999999754322 356899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC----CeEEeeccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 349 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~----~~kL~DFGl 349 (579)
+|||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999653 4599999999999999999999998 999999999999998877 799999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+ ..... .
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~---~~~i~-----~ 232 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANIT-----A 232 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHH-----T
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHH-----h
Confidence 98754432 224467999999999999999999999999999999999999999765421 11 11100 1
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.+. .+.. +.......+.+++..||+.||.+||++.|+++
T Consensus 233 ~~~~--~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VSYD--FDEE---FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TCCC--CCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCC--CCch---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1110 0000 00112356889999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=368.44 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=201.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCe----EEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.++|...+.||+|+||.||+|++. +++ .||+|.++... ....+.|.+|+.++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999964 343 46888885433 344578999999999999999999999998754 77
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+|+||+.+|+|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999987543 3589999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 355 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 355 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... ......+|..|+|||++.+..++.++|||||||+||||++ |+.||....... +... +. .+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~----~~~- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LE----KGE- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HH----TTC-
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH----HH----cCC-
Confidence 43322 2233457889999999999999999999999999999999 999997654311 1111 10 000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+......+.+++.+||+.||.+||++.||++.|+...
T Consensus 237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00122234457889999999999999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=383.41 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=210.3
Q ss_pred HHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 008052 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (579)
Q Consensus 194 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 269 (579)
+.+++...++|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++..++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4566677889999999999999999999976 588999999864211 112357899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccc
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGl 349 (579)
.+..+|||||+++|+|.+++... .+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999998643 489999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCC----CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhh
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 425 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 425 (579)
++.............+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+... ...
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~----- 283 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYS----- 283 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-----
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHH-----
Confidence 9876544433445678999999999997655 8899999999999999999999997654211 111
Q ss_pred cccCCCchhhhchhhh-cCC--HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 008052 426 GLADGNFDALVDQKLE-EYD--SAEMTRMAACAAACIRHSARR--RPRMSQIVRA 475 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~-~~~--~~~~~~l~~l~~~cl~~dp~~--RPtm~evl~~ 475 (579)
.++..... .++ ......+.+++.+||+.+|.+ ||++.||++.
T Consensus 284 --------~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 284 --------KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --------HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --------HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 11111000 111 123456889999999999988 9999999964
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=370.87 Aligned_cols=262 Identities=24% Similarity=0.438 Sum_probs=211.5
Q ss_pred HHhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 269 (579)
+...++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.+|.++ +||||++++++|..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345678999999999999999999962 45689999997543 23346789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCC
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKDR---------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 328 (579)
.+..+|||||+++|+|.+++..... ..+++..++.|+.|++.||+|||++ +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 9999999999999999999976432 2489999999999999999999998 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCC
Q 008052 329 IKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 406 (579)
Q Consensus 329 ikp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~ 406 (579)
|||+||||+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||+||||++ |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999986543332 22334568889999999999999999999999999999998 9999976
Q ss_pred CCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 407 ADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.... ..+... +..... ...+......+.+++..||+.||.+||++.||++.|+...
T Consensus 278 ~~~~--~~~~~~----~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 278 IPVD--ANFYKL----IQNGFK------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCCS--HHHHHH----HHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCcH--HHHHHH----HhcCCC------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 5421 111111 111000 0122233467899999999999999999999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=364.21 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=212.4
Q ss_pred HhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 271 (579)
...++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||++++++|.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34578999999999999999999862 45789999997653 334567899999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCC
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDR----------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi 329 (579)
..++||||+++++|.+++..... ..+++..++.|+.|++.||+|||++ +|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999875432 3488999999999999999999998 9999999
Q ss_pred CCCceEeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCC
Q 008052 330 KSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKA 407 (579)
Q Consensus 330 kp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~ 407 (579)
||+||||+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876443322 2233457889999999999999999999999999999999 99999765
Q ss_pred CccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 408 DTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
... .+... +. .+. ....+......+.+++..||+.||.+||++.||++.|+..
T Consensus 257 ~~~---~~~~~----~~----~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 257 PPE---RLFNL----LK----TGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CGG---GHHHH----HH----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH---HHHHH----hh----cCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 431 11111 10 110 0012223456789999999999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=365.06 Aligned_cols=251 Identities=20% Similarity=0.311 Sum_probs=206.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|...+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+.+|.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999976 58899999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC--CCCeEEeecccccccCCCC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~--~~~~kL~DFGla~~~~~~~ 357 (579)
+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999996543 3589999999999999999999998 9999999999999987 7899999999998764332
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......||+.|+|||++.+..++.++|||||||+||||++|..||...... . ........ .+. ...
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~---~~~~i~~~-----~~~-~~~ 224 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---Q---IIENIMNA-----EYT-FDE 224 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---H---HHHHHHHT-----CCC-CCH
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---H---HHHHHHcC-----CCC-CCh
Confidence 234467999999999999988999999999999999999999999764421 1 11111110 000 000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
... ......+.+++..||+.||.+||++.|+++
T Consensus 225 ~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 EAF----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 122456889999999999999999999997
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=363.99 Aligned_cols=259 Identities=19% Similarity=0.235 Sum_probs=208.3
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.++.++ +|+||+++++++...+..+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 4789999999875432 24688999999999 89999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC-----eEEeeccccccc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHS 353 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~-----~kL~DFGla~~~ 353 (579)
|+ +++|.+++... ...+++..++.|+.|++.||+|||++ +|+||||||+||||+.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999998754 34699999999999999999999998 9999999999999998887 999999999875
Q ss_pred CCCCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 354 LDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 354 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||............... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~~- 236 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---GDTK- 236 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH---HHHH-
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH---Hhhh-
Confidence 443321 124567999999999999999999999999999999999999999875432111111110 0000
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.. ..........+ .+.+++..|++.||.+||++.+|++.|+..
T Consensus 237 -------~~-~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 237 -------RA-TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp -------HH-SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -------cc-CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 00000011123 799999999999999999999999999854
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=396.48 Aligned_cols=260 Identities=30% Similarity=0.435 Sum_probs=214.2
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+++..++|.+.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+.+|++++|+|||+++++|.+ +..+||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 3455678999999999999999999998888999999986543 35689999999999999999999999976 678999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||++|+|.++|.......+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999999754445689999999999999999999998 9999999999999999999999999999875432
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.........++..|+|||++..+.++.++|||||||+||||++ |+.||...... .+... +. .+..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~----i~----~~~~--- 482 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----VE----RGYR--- 482 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHH----HH----TTCC---
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HH----cCCC---
Confidence 2222233457789999999999999999999999999999999 99999754321 11111 11 1100
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
...+..+...+.+++..||+.||++||++.+|++.|+...
T Consensus 483 -----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0122334567899999999999999999999999999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=356.49 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=211.4
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.++|...+.||+|+||.||+|...+++.||||+++.... ..+.+.+|++++.+++||||++++++|.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467899999999999999999998889999999976543 3468999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999987543 3589999999999999999999998 99999999999999999999999999998654332222
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +. .+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----i~----~~~-------- 222 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----IS----TGF-------- 222 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HH----TTC--------
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH----Hh----cCC--------
Confidence 233457889999999998999999999999999999999 89999764421 11111 00 000
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++..|++.||.+||++.|+++.|+..
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011122345688999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=362.15 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=213.4
Q ss_pred HhhcCccccceecccCceEEEEEEE------eCCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 270 (579)
...++|...+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+.++.++ +||||++++++|...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 4457899999999999999999986 2467899999976543 3356789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCce
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDR----------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~----------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NI 334 (579)
+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999875432 2489999999999999999999998 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCcccc
Q 008052 335 LLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 412 (579)
Q Consensus 335 Ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~ 412 (579)
|++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++ |+.||......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 254 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--
Confidence 9999999999999999876544322 2334567889999999999999999999999999999999 99999765421
Q ss_pred chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 413 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..+... +..... ...+......+.+++.+||+.||.+||++.||++.|+...
T Consensus 255 ~~~~~~----~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 SKFYKM----IKEGFR------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHH----HHHTCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHH----hccCCC------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111111 111000 0112223467899999999999999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=358.70 Aligned_cols=272 Identities=21% Similarity=0.267 Sum_probs=213.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++|.+++||||+++++++.... ..+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 67999999999999999999976 48999999997543 233567889999999999999999999998765 779999
Q ss_pred EecCCCchhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe----CCCCCeEEeecccccc
Q 008052 278 EFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKH 352 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl----~~~~~~kL~DFGla~~ 352 (579)
||+++++|.+++..... ..+++..++.|+.|++.||+|||+. +|+||||||+|||| +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976432 3489999999999999999999998 99999999999999 7888899999999987
Q ss_pred cCCCCcceeecccccccccChhhhc--------cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYAS--------SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
...... .....||+.|+|||++. +..++.++|||||||+||||++|+.||........ ........+.
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 241 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIIT 241 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhc
Confidence 544322 23456999999999986 57899999999999999999999999975443211 1111111111
Q ss_pred hcc----------cCCCchhhhc-hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 425 QGL----------ADGNFDALVD-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 425 ~~~----------~~~~~~~l~d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
... ....++-.-+ +....+.......+.+++..||+.||++||++.|+++...++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 100 0000000000 0111455778889999999999999999999999999998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=354.75 Aligned_cols=253 Identities=29% Similarity=0.464 Sum_probs=196.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCc----hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG----QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~----~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|++++.+++||||++++++|...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999974 88999999865432 2246789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC--------CCCeEEeecc
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--------SFEAKVADFG 348 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~--------~~~~kL~DFG 348 (579)
|||+++++|.+++.. ..+++..++.++.|++.||+|||++...+|+||||||+|||++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999999853 35899999999999999999999982222999999999999986 6789999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhccc
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 428 (579)
+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... . .+ ...
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~-~~--~~~----- 227 (271)
T 3dtc_A 162 LAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V-AY--GVA----- 227 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H-HH--HHH-----
T ss_pred ccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-HH--hhh-----
Confidence 998653322 224569999999999999999999999999999999999999997654211 0 00 000
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
.... ....+......+.+++.+|++.||.+||++.||++.|+.
T Consensus 228 ~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 MNKL-------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TSCC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCCC-------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0000 001223344678999999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=354.89 Aligned_cols=261 Identities=17% Similarity=0.203 Sum_probs=211.0
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.++.++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 4789999999865432 34688999999999 79999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC-----eEEeeccccccc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-----AKVADFGLAKHS 353 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~-----~kL~DFGla~~~ 353 (579)
|+ +++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999997543 3489999999999999999999998 9999999999999987776 999999999876
Q ss_pred CCCCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 354 LDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 354 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..................
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----- 236 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK----- 236 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-----
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh-----
Confidence 543221 234467999999999999999999999999999999999999999875432221111111000
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.............+..+.+++..||+.||.+||++.+|++.|+...
T Consensus 237 -------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 237 -------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp -------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -------ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 0000011111233467899999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=369.15 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=198.0
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeC-C---eEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 008052 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTN-G---KVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (579)
Q Consensus 196 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 269 (579)
++.+..++|...+.||+|+||.||+|++.. + ..||||+++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344556789999999999999999999653 3 27999999764 33446789999999999999999999999987
Q ss_pred CCeE------EEEEEecCCCchhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC
Q 008052 270 GSQR------LLVYEFVPNKTLEFHLHGKD----RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (579)
Q Consensus 270 ~~~~------~lV~E~~~~g~L~~~l~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~ 339 (579)
.... ++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||++ +|+||||||+||||+.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 89999999999999885321 22589999999999999999999998 99999999999999999
Q ss_pred CCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhh
Q 008052 340 FEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVD 417 (579)
Q Consensus 340 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~ 417 (579)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... +..
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~ 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH
Confidence 99999999999865433221 2233457889999999999999999999999999999999 999997654311 111
Q ss_pred hhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 418 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
. +........+......+.+++.+||+.||.+||++.++++.|+..+.
T Consensus 251 ~----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 251 Y----------------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp H----------------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H----------------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 00000011223344678999999999999999999999999997653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.37 Aligned_cols=250 Identities=27% Similarity=0.389 Sum_probs=200.9
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 273 (579)
...++|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.+|.++ +||||+++++++...+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999976 58999999997532 22345678999999998 699999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+|||||+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999998654 3489999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +......
T Consensus 175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~---------- 237 (353)
T 3txo_A 175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAIL---------- 237 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH----------
T ss_pred ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHH----------
Confidence 3222 2334568999999999999889999999999999999999999999765431 1111111
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM------SQIVR 474 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm------~evl~ 474 (579)
...+ .++......+.+++..||+.||.+||++ .||++
T Consensus 238 ---~~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 ---NDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---HCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---cCCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1000 1223344568899999999999999998 67764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.94 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=206.7
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~~lV 276 (579)
.++|...+.||+|+||.||+|++. ++.||||+++... ....+.|.+|+.++.+++||||++++++|... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 367899999999999999999985 8899999997643 33456799999999999999999999999887 778999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|||+++|+|.+++.......+++..++.|+.|++.||+|||+. + |+||||||+|||++.++.+||+|||+.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999876665799999999999999999999997 7 9999999999999999999999999876432
Q ss_pred CCCcceeecccccccccChhhhccCCCCc---ccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTE---KSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~---ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
. ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||....... ........ +.
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~----~~ 228 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALE----GL 228 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHS----CC
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhc----CC
Confidence 2 2346899999999998765554 8999999999999999999997654211 11111100 00
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++..||+.||.+||++.||++.|+..
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 --------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0012223445789999999999999999999999999865
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=372.20 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=201.4
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 274 (579)
..++|...++||+|+||.||+|+.. +++.||||+++.... .....+..|..+|.++ +|||||+++++|...+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3468999999999999999999976 588999999975422 2234578899999887 7999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|||||+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 130 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998653 3489999999999999999999998 99999999999999999999999999998633
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc--hhhhhhhhHhhhcccCCCc
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD--SMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 432 (579)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......... ...++...
T Consensus 205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~----------- 272 (396)
T 4dc2_A 205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ----------- 272 (396)
T ss_dssp CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH-----------
T ss_pred cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH-----------
Confidence 222 2334578999999999999999999999999999999999999999754321110 01111110
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
.+....+ .++......+.+++..||+.||.+||++
T Consensus 273 -~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 273 -VILEKQI-RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -HHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -HHhcccc-CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0111111 2333445678999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=357.97 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=197.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--------------------------hHHHHHHHHHHHH
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--------------------------GEREFQAEIEIIS 253 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--------------------------~~~~~~~Ei~~l~ 253 (579)
.++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999975 6899999998654311 1246889999999
Q ss_pred hcCCCCcceEEEEEEe--CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCC
Q 008052 254 QVHHRHLVSLVGYCTF--GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKS 331 (579)
Q Consensus 254 ~l~Hpniv~l~g~~~~--~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp 331 (579)
+++||||+++++++.+ .+..+|||||+++++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999987 5688999999999999887643 3589999999999999999999998 999999999
Q ss_pred CceEeCCCCCeEEeecccccccCCCCcceeecccccccccChhhhccCC---CCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 332 ANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 332 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
+||||+.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||+||||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999987544322 234467999999999998655 4788999999999999999999997543
Q ss_pred ccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 409 TFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .+.......... + .........+.+++.+||+.||.+||++.||++
T Consensus 245 ~~------~~~~~~~~~~~~---~---------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 IM------CLHSKIKSQALE---F---------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HH------HHHHHHHHCCCC---C---------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HH------HHHHHHhcccCC---C---------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 111111110000 0 001123456889999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=363.46 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=205.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+|.+++||||++++++|......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56999999999999999999976 589999999865432 13578999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC----CeEEeecccc
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGLA 350 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~----~~kL~DFGla 350 (579)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999643 4589999999999999999999998 999999999999999887 7999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .. ...... ..
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~~~~~---~~ 234 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANVSAV---NY 234 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHHT---CC
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHHhc---CC
Confidence 8754322 2234579999999999999999999999999999999999999997543211 10 000000 00
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+ .+. +.......+.+++..||+.||.+||++.|+++.
T Consensus 235 ~~---~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 EF---EDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC---CHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred Cc---Ccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000 011223568899999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=376.21 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=193.0
Q ss_pred cCcccc-ceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHh-cCCCCcceEEEEEEe----CCeEE
Q 008052 202 DNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQ-VHHRHLVSLVGYCTF----GSQRL 274 (579)
Q Consensus 202 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~-l~Hpniv~l~g~~~~----~~~~~ 274 (579)
++|... +.||+|+||+||+|... +++.||||+++.. ..+.+|++++.+ .+||||++++++|.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 566665 78999999999999976 6889999999642 457788888855 479999999999875 55789
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeeccccc
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 351 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFGla~ 351 (579)
||||||++|+|.+++.......+++..+..|+.||+.||+|||++ +|+||||||+||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876656799999999999999999999998 9999999999999987 7899999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc-hhhhhhhhHhhhcccCC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-SMVDWAKPFLAQGLADG 430 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 430 (579)
...... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......... .+... .. .+
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~-----~~ 282 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IR-----MG 282 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HH-----HT
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HH-----cC
Confidence 654322 234567999999999999999999999999999999999999999765432110 01000 00 00
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.+. +..+ ........+.+++..||+.||.+||++.||++.
T Consensus 283 ~~~-~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYE-FPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCC-CCTT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccc-CCCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0000 011234568899999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=363.49 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=198.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC-------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------- 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------- 271 (579)
.++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357999999999999999999986 78999999997543 334578999999999999999999999986643
Q ss_pred --------------------------------------------------eEEEEEEecCCCchhhhhcCCCC-CCCCHH
Q 008052 272 --------------------------------------------------QRLLVYEFVPNKTLEFHLHGKDR-PVMNWP 300 (579)
Q Consensus 272 --------------------------------------------------~~~lV~E~~~~g~L~~~l~~~~~-~~l~~~ 300 (579)
..++||||+++++|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27899999999999999976433 345677
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc-----------ceeeccccccc
Q 008052 301 TRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-----------HVSTRVMGTFG 369 (579)
Q Consensus 301 ~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~ 369 (579)
.++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999998 999999999999999999999999999987654321 12234579999
Q ss_pred ccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHH
Q 008052 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMT 449 (579)
Q Consensus 370 y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~ 449 (579)
|+|||++.+..++.++|||||||++|||++|..|+.... ... .......+ .........
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~-----~~~~~~~~--------~~~~~~~~~ 300 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RII-----TDVRNLKF--------PLLFTQKYP 300 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHH-----HHHHTTCC--------CHHHHHHCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHH-----HHhhccCC--------CcccccCCh
Confidence 999999999999999999999999999999876642110 000 00001111 111123345
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 450 RMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 450 ~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.+++..||+.||.+||++.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6789999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=368.76 Aligned_cols=270 Identities=16% Similarity=0.254 Sum_probs=206.3
Q ss_pred hcCccccceeccc--CceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQG--GFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|++.+.||+| +||.||+|+.. +++.||||+++... ....+.+.+|+.++++++|||||+++++|...+..+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3679999999999 99999999986 68999999996543 3334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|||||++|+|.+++.......+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999766556699999999999999999999998 999999999999999999999999999865422
Q ss_pred CCc------ceeecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 356 TDT------HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 356 ~~~------~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
... .......||..|+|||++.+ ..++.++|||||||+||||++|+.||....... .+.......+...+
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC---------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCccc
Confidence 111 11123468999999999987 679999999999999999999999997654321 11110000000000
Q ss_pred ------------------cCCCchhhh----------chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 428 ------------------ADGNFDALV----------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 428 ------------------~~~~~~~l~----------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
....+...+ +.....+.......+.+++.+||+.||.+||++.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000000 000001223345678999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=368.69 Aligned_cols=267 Identities=18% Similarity=0.233 Sum_probs=207.3
Q ss_pred hhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCchhH-----------HHHHHHHHHHHhcCCCCcce
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGE-----------REFQAEIEIISQVHHRHLVS 262 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~~-----------~~~~~Ei~~l~~l~Hpniv~ 262 (579)
..++|.+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+.+++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999764 47899999876543211 12335666777888999999
Q ss_pred EEEEEEeC----CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-
Q 008052 263 LVGYCTFG----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD- 337 (579)
Q Consensus 263 l~g~~~~~----~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~- 337 (579)
++++|... ...+|||||+ +++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 99999774 4578999999 99999998754 24599999999999999999999998 999999999999998
Q ss_pred -CCCCeEEeecccccccCCCCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcc
Q 008052 338 -DSFEAKVADFGLAKHSLDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 410 (579)
Q Consensus 338 -~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~ 410 (579)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~- 266 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK- 266 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT-
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-
Confidence 8899999999999865432211 11334599999999999999999999999999999999999999985332
Q ss_pred ccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 411 ADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+.+...... ..+..+++..+. ....+..+.+++..|++.+|.+||++.+|++.|+..+
T Consensus 267 -~~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 -DPKYVRDSKIRYR-----ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp -CHHHHHHHHHHHH-----HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred -CHHHHHHHHHHhh-----hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 1222222222111 123344444432 1123467899999999999999999999999998654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=379.51 Aligned_cols=262 Identities=22% Similarity=0.256 Sum_probs=210.2
Q ss_pred cCHHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 008052 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYC 267 (579)
Q Consensus 192 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~ 267 (579)
+.+.+++...++|+..+.||+|+||.||+++.. +|+.||||+++.... .....+.+|+.++.+++|+||++++++|
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345667777899999999999999999999985 689999999965321 1223578999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 268 TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 268 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
.+.+..+|||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999996532 3589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhc-------cCCCCcccceechHHHHHHHHhCCCCCCCCCcccc-chhhhhh
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-------SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWA 419 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~ 419 (579)
|+++.............+||+.|+|||++. .+.++.++|||||||+||||++|+.||...+.... ..+..+.
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 999876544433344568999999999997 46789999999999999999999999976543110 0011100
Q ss_pred hhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 008052 420 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR---PRMSQIVR 474 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~R---Ptm~evl~ 474 (579)
.. +. +..........+.+++.+||+ +|.+| |++.||++
T Consensus 287 ~~-------------~~---~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 EH-------------LS---LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HH-------------CC---CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cC-------------cC---CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00 00 001112334678999999999 99888 58999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=367.12 Aligned_cols=265 Identities=25% Similarity=0.457 Sum_probs=214.7
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEE
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYC 267 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~ 267 (579)
+++.+..++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.+++|+||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 345566789999999999999999999864 367899999976543 3345789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC
Q 008052 268 TFGSQRLLVYEFVPNKTLEFHLHGKD--------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339 (579)
Q Consensus 268 ~~~~~~~lV~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~ 339 (579)
.+.+..++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||++ +|+||||||+||||+.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999886421 23578999999999999999999998 99999999999999999
Q ss_pred CCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhh
Q 008052 340 FEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVD 417 (579)
Q Consensus 340 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~ 417 (579)
+.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+..
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~ 251 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR 251 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHH
Confidence 99999999999865433221 1223457889999999999999999999999999999999 89999764321 1111
Q ss_pred hhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 418 WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 418 ~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
. .. .+. +..........+.+++..||+.||.+||++.||++.|+..+.
T Consensus 252 ~---~~-----~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 F---VM-----EGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp H---HH-----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H---HH-----cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 00 111 111222344668899999999999999999999999997643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=370.55 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=208.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+|.+++||||++++++|.+....+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367999999999999999999975 6889999999876655567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC--CCCeEEeecccccccCCCC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~--~~~~kL~DFGla~~~~~~~ 357 (579)
+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||||+. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999986543 3589999999999999999999998 9999999999999974 5789999999998764432
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
. .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .... ......+ .+ +
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~i~~~~~---~~----~ 270 (387)
T 1kob_A 206 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---NVKRCDW---EF----D 270 (387)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---HHHHCCC---CC----C
T ss_pred c--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC---CC----C
Confidence 2 23457999999999999999999999999999999999999999765421 1111 1000000 00 0
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
. .........+.+++..||+.||.+||++.|+++.
T Consensus 271 ~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 E---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp S---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 1112234568899999999999999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=368.00 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=205.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++.+++|||||+++++|.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999975 58999999996543 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC---CCeEEeecccccccC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHSL 354 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kL~DFGla~~~~ 354 (579)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||+++...
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999988644 4589999999999999999999998 99999999999999865 459999999998764
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.. ... .+.+.
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~---~i~-----~~~~~- 248 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA---QIK-----AGAYD- 248 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-----HTCCC-
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHH-----hCCCC-
Confidence 332 223467999999999999999999999999999999999999999765421 1111 111 11110
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...+.. ......+.+++..||+.||.+||++.|+++.
T Consensus 249 ~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCcccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001 1224568899999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=363.53 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=211.3
Q ss_pred hhcCccccceecccCceEEEEEEEe--------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTF 269 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~ 269 (579)
..++|...+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999863 467899999976543 3456789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceE
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANIL 335 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NIL 335 (579)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999975432 3489999999999999999999998 9999999999999
Q ss_pred eCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccc
Q 008052 336 LDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADD 413 (579)
Q Consensus 336 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~ 413 (579)
|+.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||+||||++ |+.||......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 999999999999999875543322 2233457889999999998899999999999999999999 99999754321
Q ss_pred hhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 414 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
.+... +.. +. ....+......+.+++..||+.||.+||++.||++.|+....
T Consensus 267 ~~~~~----~~~----~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELFKL----LKE----GH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHH----HHH----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----Hhc----CC--------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 100 00 001222334678999999999999999999999999997643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=365.06 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=203.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.+.|.+.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+.++.+++||||++++++|.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999975 6899999998532 1223578999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC---eEEeeccc
Q 008052 275 LVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGL 349 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~---~kL~DFGl 349 (579)
|||||+++++|.+++... ....+++..+..|+.||+.||+|||++ +|+||||||+||||+.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998777532 233589999999999999999999998 9999999999999986654 99999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
++....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+. .... .
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~---~~i~-----~ 246 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF---EGII-----K 246 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH---HHHH-----H
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH---HHHH-----c
Confidence 987644322 23446799999999999999999999999999999999999999976321 111 1111 0
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.+. ..+... ......+.+++.+||+.||.+||++.|+++
T Consensus 247 ~~~~--~~~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYK--MNPRQW---SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCC--CCHHHH---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC--CCcccc---ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 000000 112356889999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=353.11 Aligned_cols=251 Identities=34% Similarity=0.596 Sum_probs=202.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh-------HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-------EREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-------~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
++|...+.||+|+||.||+|+.. +++.||||++....... .+.+.+|+.++.+++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67999999999999999999975 68999999986543221 167899999999999999999999987654
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEeCCCCCCceEeCCCCC-----eEEee
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFE-----AKVAD 346 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDikp~NILl~~~~~-----~kL~D 346 (579)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999988886543 4589999999999999999999998 7 999999999999988776 99999
Q ss_pred cccccccCCCCcceeecccccccccChhhh--ccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 347 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYA--SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 347 FGla~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
||+++.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||....... ..+......
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~ 244 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIRE 244 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhc
Confidence 999985432 23446799999999998 45567899999999999999999999997654311 111111110
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
.. .. ...+......+.+++..||+.||.+||++.||++.|+.
T Consensus 245 ~~-----~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 EG-----LR-------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SC-----CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cC-----CC-------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00 00 02223345678999999999999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=360.03 Aligned_cols=268 Identities=26% Similarity=0.427 Sum_probs=216.4
Q ss_pred cCHHHHHHhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceE
Q 008052 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSL 263 (579)
Q Consensus 192 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l-~Hpniv~l 263 (579)
+...++....++|...+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 456677777899999999999999999999852 4689999999765433 346789999999999 69999999
Q ss_pred EEEEEeCC-eEEEEEEecCCCchhhhhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCC
Q 008052 264 VGYCTFGS-QRLLVYEFVPNKTLEFHLHGKDR--------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRD 328 (579)
Q Consensus 264 ~g~~~~~~-~~~lV~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 328 (579)
+++|...+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99998755 48999999999999999976542 2278999999999999999999998 999999
Q ss_pred CCCCceEeCCCCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCC
Q 008052 329 IKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDK 406 (579)
Q Consensus 329 ikp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~ 406 (579)
|||+||||+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987544332 22344568899999999999999999999999999999998 9999976
Q ss_pred CCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 407 ADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.... ..+... +.. +. ....+......+.+++..||+.||.+||++.||++.|+..+
T Consensus 254 ~~~~--~~~~~~----~~~----~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKID--EEFCRR----LKE----GT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCS--HHHHHH----HHH----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchh--HHHHHH----hcc----Cc--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 4421 111110 100 00 00112223456889999999999999999999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.02 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=204.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.++.+++||||+++++++.+.+..+||
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999976 68999999996532 12346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999999654 3489999999999999999999998 9999999999999999999999999999865332
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ......+.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~------------ 217 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN------------ 217 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH------------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh------------
Confidence 23467999999999999999999999999999999999999999764421 11111111
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
..+ .++......+.+++.+||+.||.+|| ++.||++
T Consensus 218 -~~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 218 -AEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 000 12223345788999999999999999 8888874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.90 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=201.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.++ +|||||++++++...+..+||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67999999999999999999976 58999999997542 23345688999999998 899999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999998643 3489999999999999999999998 9999999999999999999999999999864322
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc--hhhhhhhhHhhhcccCCCchh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD--SMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 434 (579)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......... ....+... .
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------~ 230 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ------------V 230 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH------------H
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH------------H
Confidence 2 2234568999999999999999999999999999999999999999753321110 00011100 0
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
+....+ .++......+.+++.+||+.||.+||++
T Consensus 231 i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 231 ILEKQI-RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHCCC-CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHcCCC-CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111111 2233345678999999999999999995
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=359.62 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=193.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|+..+.||+|+||+||+|+.. +|+.||||++..... .....+..|+..+.++ +|+||++++++|.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999986 789999999865432 2334555666666665 8999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+ +++|.+++.... ..++|..+..|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 678888876543 3599999999999999999999998 99999999999999999999999999998654322
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......||+.|+|||++.+ .++.++|||||||+||||++|..|+..... |.. +..+...
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~~------~~~~~~~---- 270 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQQ------LRQGYLP---- 270 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HHH------HTTTCCC----
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHH------HhccCCC----
Confidence 2344569999999999875 799999999999999999999776643211 110 0111111
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+ .+.......+.+++..||+.||.+||++.|+++
T Consensus 271 ~---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 P---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 111123467899999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=368.41 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=204.3
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCe
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 272 (579)
....++|...+.||+|+||.||+|+.. +|+.||||+++... ......+..|..+|.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999986 68999999997532 22345678899999887 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+|||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999653 3489999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+.. .... +.
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~-----~~- 234 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFH---SIRM-----DN- 234 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH-----CC-
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HHHh-----CC-
Confidence 43222 2234568999999999999999999999999999999999999999765421 1111 1000 00
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS-QIV 473 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~-evl 473 (579)
..++......+.+++.+||+.||.+||++. ||+
T Consensus 235 --------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 --------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 012223346788999999999999999997 554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=353.18 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=204.4
Q ss_pred hhcCccccceecccCceEEEEEEEeC----CeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
..++|...+.||+|+||.||+|++.+ +..||||.++... ....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34789999999999999999999653 3469999997653 3345679999999999999999999999875 4568
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999986532 3489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
...........+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ..... .. +.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~----~~-- 231 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EK----GD-- 231 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HH----TC--
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hc----CC--
Confidence 443333344567889999999998999999999999999999998 999997544311 11110 00 00
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++.+||+.||.+||++.||++.|+..
T Consensus 232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0011122345688999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=368.30 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=205.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+|.+++|||||+++++|...+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999976 58899999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+.+|+|..++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999754 3589999999999999999999998 99999999999999999999999999998754322
Q ss_pred cceeecccccccccChhhhcc---CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 358 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
.....+||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+.....
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-------------- 233 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-------------- 233 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--------------
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--------------
Confidence 2345679999999999974 458999999999999999999999997554322111111110
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-m~evl~ 474 (579)
.....++......+.+++..||+.||.+||+ +.+|++
T Consensus 234 ---~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 ---TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0011233344567899999999999999998 777764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=365.07 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=203.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCe----EEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++|...+.||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.++.+++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 67899999999999999999965 344 38888875433 233356788999999999999999999986 456889
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++|+|.+++... ...+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999754 23589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... ......|+..|+|||++.++.++.++|||||||+||||++ |+.||....... +.... . .+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~----~~~~- 235 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLL----E----KGER- 235 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHH----H----TTCB-
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHH----H----cCCC-
Confidence 3322 2344568889999999999999999999999999999999 999998654311 11111 0 0000
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
...+......+.+++..||+.||.+||++.||++.|+...
T Consensus 236 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 -------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111122345788999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.86 Aligned_cols=208 Identities=26% Similarity=0.354 Sum_probs=182.4
Q ss_pred cCHHHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----CCCcceEEE
Q 008052 192 FTYEELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----HRHLVSLVG 265 (579)
Q Consensus 192 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----Hpniv~l~g 265 (579)
|++.+.....++|...+.||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.++.+++ |+|||++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344444556689999999999999999999974 6889999999753 234567788999999996 999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-------
Q 008052 266 YCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD------- 338 (579)
Q Consensus 266 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~------- 338 (579)
++...+..+|||||+ +++|.+++.......+++..+..|+.||+.||+|||+. +|+||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence 999999999999999 99999999876656699999999999999999999998 9999999999999975
Q ss_pred ------------------CCCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhC
Q 008052 339 ------------------SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG 400 (579)
Q Consensus 339 ------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG 400 (579)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999864332 2345799999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 008052 401 FRPFDKAD 408 (579)
Q Consensus 401 ~~Pf~~~~ 408 (579)
+.||....
T Consensus 256 ~~pf~~~~ 263 (360)
T 3llt_A 256 SLLFRTHE 263 (360)
T ss_dssp SCSCCCSS
T ss_pred CCCCCCCc
Confidence 99998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.19 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=200.6
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|...+.||+|+||.||+|...+|+.||||+++..... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578999999999999999999988999999999654322 236788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 986 8888886543 3589999999999999999999998 99999999999999999999999999998653322 1
Q ss_pred eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh---hcc----c---
Q 008052 360 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA---QGL----A--- 428 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~----~--- 428 (579)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+....+.... ..+ .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHCCCChhhchhhhcccc
Confidence 2234568999999999975 458999999999999999999999997654311 11110000000 000 0
Q ss_pred -CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 429 -DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 429 -~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+..........+.......+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000011122234467889999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.81 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=204.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.++|...+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467999999999999999999965 689999999976442 23457899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC---CCCCeEEeecccccccC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSL 354 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~---~~~~~kL~DFGla~~~~ 354 (579)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+ +++.+||+|||+++...
T Consensus 90 E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999888654 3589999999999999999999998 999999999999998 56789999999998754
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
.... ......||+.|+|||++.+..++.++|||||||+||+|++|..||...+.. .+.. ... .+.+.
T Consensus 165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~---~i~-----~~~~~- 231 (444)
T 3soa_A 165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQ---QIK-----AGAYD- 231 (444)
T ss_dssp TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHH-----HTCCC-
T ss_pred CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHH---HHH-----hCCCC-
Confidence 4322 234467999999999999999999999999999999999999999764421 1111 100 11110
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+ ........+.+++..||+.||.+||++.|+++
T Consensus 232 ~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSP----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 11123456889999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=365.37 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=201.5
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++...+..+|||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999997 468999999986432 122357889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+ +|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 78888887543 3489999999999999999999999 99999999999999999999999999998654332
Q ss_pred cceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.....+||+.|+|||++.+..+ +.++|||||||+||||++|+.||........ . +.+..+.
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~--------~~i~~~~----- 224 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---F--------KKVNSCV----- 224 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---B--------CCCCSSC-----
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---H--------HHHHcCC-----
Confidence 2244579999999999988776 6899999999999999999999976432110 0 0000000
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+......+.+++.+||+.||.+||++.|+++
T Consensus 225 ----~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 ----YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0122223456889999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=359.37 Aligned_cols=269 Identities=26% Similarity=0.378 Sum_probs=206.5
Q ss_pred cCccccceecccCceEEEEEEE-----eCCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC--CeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG--SQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~--~~~ 273 (579)
+.|+..+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|+.++.+++|+||++++++|... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688899999999999999984 368999999997543 33457899999999999999999999999876 668
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999985433 3489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCc--ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 354 LDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 354 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... .......||..|+|||.+.+..++.++|||||||++|||++|..|+...... ......+.... .....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~-~~~~~ 251 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQ-MTVTR 251 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGG-GHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccc-cCHHH
Confidence 54332 1233456888999999999999999999999999999999999986432110 00000000000 00000
Q ss_pred chh-hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 432 FDA-LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 432 ~~~-l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+.. +........+......+.+++..||+.||.+||++.||++.|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 000 000001123334456799999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=369.73 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=198.5
Q ss_pred cccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 205 SEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
...+.||+|+||.||+|... +|+.||||+++.......+.+.+|+.+|.+++|||||+++++|...+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34678999999999999975 68999999998776666778999999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe--CCCCCeEEeecccccccCCCCccee
Q 008052 284 TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 284 ~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++....... .
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9998886432 3489999999999999999999998 99999999999999 6678999999999987543322 2
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~ 441 (579)
....||+.|+|||++.++.++.++|||||||+||||++|+.||...... +.....+...+. +.....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~------~~~~~~- 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD------LEDEEF- 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC------SCSGGG-
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC------CChhhh-
Confidence 3456999999999999999999999999999999999999999765421 111111111000 001111
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 442 ~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
......+.+++..||+.||.+||++.|+++
T Consensus 313 ---~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 ---QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122456889999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.12 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=195.7
Q ss_pred hcCccccceecccCceEEEEEEE----eCCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
.++|...+.||+|+||.||+++. .+++.||||+++... ......+.+|+.+|.+++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999997 478999999997642 2234567899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+|||||+++++|.+++... ..+.+..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999998643 3488999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...... ........
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-------- 235 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK-------- 235 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH--------
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh--------
Confidence 43222 2234567999999999999999999999999999999999999999765421 11111110
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
..+ .++......+.+++.+||+.||.+|| ++.|+++
T Consensus 236 -----~~~-~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 -----CKL-NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----TCC-CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----CCC-CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 000 12223346788999999999999999 7778875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=356.73 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=204.8
Q ss_pred hcCccccceecccCceEEEEEEEeC-C-------eEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN-G-------KVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g-------~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
.++|...+.||+|+||.||+|+... + +.||+|++........+.+.+|+.++.+++||||++++++|...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999999653 3 5799999977666667889999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC--------eEE
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--------AKV 344 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~--------~kL 344 (579)
.++||||+++++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997543 3489999999999999999999998 9999999999999998887 999
Q ss_pred eecccccccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCC-CCCCCCccccchhhhhhhhH
Q 008052 345 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFR-PFDKADTFADDSMVDWAKPF 422 (579)
Q Consensus 345 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~-Pf~~~~~~~~~~~~~~~~~~ 422 (579)
+|||++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|.. ||...+.. .....
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~---- 230 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ---RKLQF---- 230 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHH----
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH---HHHHH----
Confidence 99999875432 133568999999999987 779999999999999999999554 44433211 00000
Q ss_pred hhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 423 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
... .. ..+......+.+++..||+.||.+||++.||++.|+....
T Consensus 231 ~~~---~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YED---RH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHT---TC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhc---cC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000 00 0111123457899999999999999999999999997754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=351.55 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=208.5
Q ss_pred hcCccccc-eecccCceEEEEEEEe---CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|...+ .||+|+||.||+|++. +++.||||+++... ....+.+.+|+.++.+++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666666 9999999999999853 57889999997753 33456799999999999999999999999 5567899
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999998643 34589999999999999999999998 999999999999999999999999999987644
Q ss_pred CCcce--eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 356 TDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 356 ~~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.... ..+.
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i--------~~~~- 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI--------EQGK- 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH--------HTTC-
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH--------hcCC-
Confidence 33221 223457899999999998899999999999999999998 99999765431 111111 0110
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
...++......+.+++..||+.||.+||++.||++.|+...
T Consensus 231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01222344567899999999999999999999999998653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=363.66 Aligned_cols=269 Identities=25% Similarity=0.326 Sum_probs=212.8
Q ss_pred hcCccccceecccCceEEEEEEE-----eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT--FGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~--~~~~~ 273 (579)
.++|...+.||+|+||.||+|++ .+++.||||++........+.+.+|++++.+++|+||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999985 368899999998777666778999999999999999999999987 45678
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+|||||+++++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 89999999999999986532 2489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 354 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 354 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... ...+.. ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~-----~~~~~~ 249 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGC-----ERDVPA 249 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC---------CCH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhccc-----cccccc
Confidence 443322 2233468889999999999999999999999999999999999986432110 000000 000000
Q ss_pred chh---hhchhh-hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 432 FDA---LVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 432 ~~~---l~d~~l-~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
... .+.... ...+......+.+++..||+.||.+||++.||++.|+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001 111111 12334455779999999999999999999999999997643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=354.79 Aligned_cols=260 Identities=30% Similarity=0.527 Sum_probs=197.9
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
..++|...+.||+|+||.||+|+.. ..||||+++... ....+.|.+|+.+|++++|+||+++++++. ....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence 3467999999999999999999864 359999987543 334567999999999999999999999764 55688999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999986543 4589999999999999999999998 99999999999999999999999999997643321
Q ss_pred -cceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 358 -THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 358 -~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
........||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ..+.... .. +.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~----~~-- 242 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMV----GR----GS-- 242 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHH----HH----TS--
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHh----cc----cc--
Confidence 22234457999999999986 667899999999999999999999999765421 1111111 11 11
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..+.+.......+..+.+++..||+.||.+||++.||++.|+...
T Consensus 243 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 --LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111112223344567999999999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=349.39 Aligned_cols=264 Identities=19% Similarity=0.273 Sum_probs=200.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|+..+.||+|+||+||+|... +++.||||+++... ......+.+|+.++.+++||||+++++++.+++..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999975 58899999996543 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|++++.+..+... ...+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9987554444432 23589999999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeecccccccccChhhhccCC-CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc---hh
Q 008052 359 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF---DA 434 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 434 (579)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||....... ..+....+. +. ......+ ..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~-~~-~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRL-LG-TPTEEQWPSMTK 232 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHH-HC-CCCTTTCTTGGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHH-hC-CCChhhhhhhcc
Confidence 2234457899999999998765 8999999999999999999888864433211 111111100 00 0000000 00
Q ss_pred hh----------chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LV----------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~----------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+. ...+..........+.+++..||+.||.+||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00011122234567889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=364.43 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=198.2
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~l 275 (579)
..++|.+.+.||+|+||.||++...+++.||||++.... ......+.+|+.+|.+++| +||+++++++...+..+|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 346799999999999999999998889999999986543 3344678999999999976 999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||| +.+++|.+++... ..+++..+..|+.|++.||+|||++ +|+||||||+||||+ ++.+||+|||+++....
T Consensus 87 v~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 999 5688999999754 4589999999999999999999998 999999999999997 56899999999987644
Q ss_pred CCcc-eeecccccccccChhhhcc-----------CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 356 TDTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 356 ~~~~-~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... ...
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~------ 229 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----ISK------ 229 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HHH------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----HHH------
Confidence 3322 2345679999999999865 67899999999999999999999999753210 000
Q ss_pred hhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 424 AQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+..++++... .++......+.+++..||+.||.+||++.|+++.
T Consensus 230 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 --------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0111111111 2222234568899999999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=363.95 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=190.4
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
..++|...+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.+|.+++||||++++++|...+..+||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999986 57899999997643 34578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeecccccccCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSLD 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFGla~~~~~ 355 (579)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999998654 3589999999999999999999998 9999999999999975 88999999999986533
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..+.. ... ..... .
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~---~i~-----~~~~~-~ 270 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFR---RIL-----NCEYY-F 270 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHH---HHH-----TTCCC-C
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHH---HHH-----hCCCc-c
Confidence 21 224467999999999999999999999999999999999999999754421 10110 000 11110 0
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .........+.+++.+||+.||.+||++.|+++
T Consensus 271 ~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 IS----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 111223456889999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=389.71 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=203.2
Q ss_pred cCccccc-eecccCceEEEEEEEe---CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+.+|.+++|||||+++++|.. +..+||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444444 7999999999999875 45689999997653 3346789999999999999999999999976 568999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||++|+|.++|... ...+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 414 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999999754 34589999999999999999999998 9999999999999999999999999999875433
Q ss_pred Ccce--eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 357 DTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 357 ~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... .....+++.|+|||++..+.++.++|||||||+||||++ |+.||...... .+.... ..+.
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i--------~~~~-- 556 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI--------EQGK-- 556 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHH--------HTTC--
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH--------HcCC--
Confidence 2221 122346789999999999999999999999999999998 99999765431 111111 1111
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+..++..+.+++..||+.||.+||++.+|++.|+..
T Consensus 557 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0122334557789999999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=359.91 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=202.9
Q ss_pred hcCccccceecccCceEEEEEEEeC-----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN-----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.++|...+.||+|+||.||+|.+.. +..||||+++.... .....+.+|+.++.+++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678888999999999999999753 24699999976533 33557899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|||||+++++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 123 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999987542 3589999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 355 DTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 355 ~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... ......+|..|+|||.+.+..++.++|||||||+||||++ |+.||...... .+... + ..+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~----~----~~~~ 267 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKA----I----NDGF 267 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----H----HTTC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----H----HCCC
Confidence 33221 1223346789999999999999999999999999999999 99999754321 11110 0 0110
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+......+.+++.+||+.||.+||++.+|++.|+...
T Consensus 268 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 --------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00112234467899999999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.68 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=204.4
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 273 (579)
...++|...+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..+|..+ +||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999986 47899999997532 22346688999999988 799999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+|||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999653 3489999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~---------- 234 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIM---------- 234 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH----------
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHH----------
Confidence 3222 2234567999999999999999999999999999999999999999764421 1111111
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
...+ .++......+.+++.+||+.||.+||+ +.||++
T Consensus 235 ---~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 235 ---EHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---HCCC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---hCCC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 123334567899999999999999995 466664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.82 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=204.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.+|.+++||||+++++++.+.+..+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999976 68999999986532 123467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999999654 3489999999999999999999998 9999999999999999999999999999875432
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. ....... .+.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~-----~~~------ 254 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIV-----SGK------ 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HCC------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHH-----cCC------
Confidence 23467999999999999999999999999999999999999999765421 1111111 010
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
+ .++......+.+++.+||+.||.+||+ +.||++
T Consensus 255 --~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 --V-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --C-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --C-CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0 122234467899999999999999998 788875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.37 Aligned_cols=266 Identities=28% Similarity=0.381 Sum_probs=208.1
Q ss_pred CccccceecccCceEEEEEEEe-----CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-----NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRL 274 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~ 274 (579)
.|...+.||+|+||.||++.+. +++.||||+++.... ...+.+.+|+++|++++||||++++++|.+ ....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3588999999999999998753 688999999976543 345678999999999999999999999988 46789
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+||||+++++|.+++... .+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999999654 389999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 355 DTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 355 ~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...... ......+...... ...+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~----~~~~ 260 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMT----VLRL 260 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHH----HHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchh----HHHH
Confidence 43321 223456888999999999999999999999999999999999998653210 0000011000000 0001
Q ss_pred hhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...++.... ..+......+.+++..||+.||.+||++.||++.|+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111111 23344557899999999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.30 Aligned_cols=271 Identities=23% Similarity=0.351 Sum_probs=203.6
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc--CCCCcceEEEEEEeC---
Q 008052 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV--HHRHLVSLVGYCTFG--- 270 (579)
Q Consensus 196 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l--~Hpniv~l~g~~~~~--- 270 (579)
.-....++|.+.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +|+||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445578999999999999999999985 8999999986432 34455566666554 899999999999887
Q ss_pred -CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEeCCCCCCceEeCCCCCeEE
Q 008052 271 -SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-----QPKIIHRDIKSANILLDDSFEAKV 344 (579)
Q Consensus 271 -~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDikp~NILl~~~~~~kL 344 (579)
...+|||||+++|+|.+++... .+++..++.|+.|++.||+|||+++ .++|+||||||+||||+.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7889999999999999999643 4899999999999999999999752 348999999999999999999999
Q ss_pred eecccccccCCCCcce---eecccccccccChhhhccCCCCcc------cceechHHHHHHHHhC----------CCCCC
Q 008052 345 ADFGLAKHSLDTDTHV---STRVMGTFGYLAPEYASSGKLTEK------SDVFSFGVLLLELITG----------FRPFD 405 (579)
Q Consensus 345 ~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~~~k------sDVwSlGvvl~eLltG----------~~Pf~ 405 (579)
+|||+++......... .....||+.|+|||++.+.....+ +|||||||+||||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997654332221 124579999999999987776665 9999999999999999 55554
Q ss_pred CCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 406 KADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
...... .....+... . ............ .........+.+++..||+.||.+||++.||++.|+....
T Consensus 264 ~~~~~~-~~~~~~~~~-~----~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 264 DLVPSD-PSYEDMREI-V----CIKKLRPSFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTSCSS-CCHHHHHHH-H----TTSCCCCCCCGG--GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCC-CchhhhHHH-H----hhhccCcccccc--chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 332211 011111100 0 000000000000 1123667889999999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=378.89 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=196.8
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
..++|...+.||+|+||.||+|... +|+.||||+++.. .......+.+|+.+|++++||||++++++|...+..+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 6899999999753 22334567889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
||||+++|+|.+++... ..+++..+..|+.||+.||+|||+ . +||||||||+||||+.++.+||+|||+++...
T Consensus 226 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999998653 358999999999999999999998 6 89999999999999999999999999998643
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. .+ ....... .+
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~---~~~i~~~-----~~-- 366 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL---FELILME-----EI-- 366 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHC-----CC--
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH---HHHHHhC-----CC--
Confidence 322 2234568999999999999999999999999999999999999999765421 11 1111100 00
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
.++......+.+++..||+.||.+|| ++.|+++
T Consensus 367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 12223346788999999999999999 9999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=355.01 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=201.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 378999999999999999999975 689999999975432 2246788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999998653 3489999999999999999999998 9999999999999999999999999999875544
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.........|++.|+|||++.+..++.++||||||++||||++|+.||...... .....+.. ..
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~----~~----- 251 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQ----AI----- 251 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHS----CC-----
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhcc----CC-----
Confidence 333334567999999999999999999999999999999999999999754321 11111111 00
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhcCCC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRP-RMSQIVRALEGNMP 481 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-tm~evl~~Le~~~~ 481 (579)
+.........+..+.+++.+||+.||.+|| ++.++++.|+....
T Consensus 252 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 252 -PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 001112233345688999999999999999 99999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=362.13 Aligned_cols=259 Identities=23% Similarity=0.272 Sum_probs=200.7
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC-----CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-----SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~ 270 (579)
+....++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++.+++||||++++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4455678999999999999999999975 6789999998643 233456899999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKD--------------------------------------RPVMNWPTRMKIALGSARG 312 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~ia~~ia~g 312 (579)
+..+|||||+++|+|.+++.... ...+++..+..|+.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999885210 1123566778899999999
Q ss_pred HHHhhhcCCCceEeCCCCCCceEeCCCC--CeEEeecccccccCCCCc---ceeecccccccccChhhhcc--CCCCccc
Q 008052 313 LAYLHEDCQPKIIHRDIKSANILLDDSF--EAKVADFGLAKHSLDTDT---HVSTRVMGTFGYLAPEYASS--GKLTEKS 385 (579)
Q Consensus 313 L~yLH~~~~~~ivHrDikp~NILl~~~~--~~kL~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~~~~--~~~~~ks 385 (579)
|+|||++ +|+||||||+||||+.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999998 999999999999998776 899999999986533221 12345679999999999975 6789999
Q ss_pred ceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCC
Q 008052 386 DVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARR 465 (579)
Q Consensus 386 DVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~ 465 (579)
|||||||+||||++|+.||....... .....+.... ....+.. ......+.+++.+||+.||.+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~------~~~~~~~----~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKL------CFENPNY----NVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC------CTTSGGG----GGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhccc------ccCCccc----ccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999997654311 1111111000 0001111 112356889999999999999
Q ss_pred CCCHHHHHH
Q 008052 466 RPRMSQIVR 474 (579)
Q Consensus 466 RPtm~evl~ 474 (579)
||++.|+++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=363.20 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=210.1
Q ss_pred HhhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 270 (579)
...++|...+.||+|+||.||+|.... .+.||||.++.... ...+.+.+|+.++.++ +||||++++++|...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999999642 24799999976543 3456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKD------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~ 338 (579)
+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence 99999999999999999886421 23589999999999999999999998 9999999999999999
Q ss_pred CCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhh
Q 008052 339 SFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMV 416 (579)
Q Consensus 339 ~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~ 416 (579)
++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||+||||++ |..||...... ..+.
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~ 277 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKFY 277 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHHH
Confidence 99999999999986543322 22334567889999999999999999999999999999999 99999764421 1111
Q ss_pred hhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 417 DWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.. +..... ...+......+.+++..||+.||.+||++.||++.|+..
T Consensus 278 ~~----~~~~~~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 278 KL----VKDGYQ------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HH----HHHTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HhcCCC------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11 111000 011222345788999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.70 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=198.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.+|.+++ |+|||++++++...+..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998889999999986543 334568999999999996 59999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|| +.+++|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+||||+ ++.+||+|||+++.....
T Consensus 135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 56889999987543 588999999999999999999998 999999999999996 578999999999875433
Q ss_pred Ccc-eeecccccccccChhhhcc-----------CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 357 DTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 357 ~~~-~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... ....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~----- 277 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL----- 277 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHH-----
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHH-----
Confidence 222 2345679999999999865 46899999999999999999999999753211 0011
Q ss_pred hcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 425 QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..++++... .++......+.+++..||+.||.+||++.||++.
T Consensus 278 --------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 --------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111 1222224568899999999999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=380.85 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=210.6
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
...++|...+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.+|.+++|||||++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34577999999999999999999975 68999999996532 223467889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|||||+++|+|.+++.......+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999999876656699999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.......... .....
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~------------- 400 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERL------------- 400 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHH-------------
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHH-------------
Confidence 332 2234579999999999999999999999999999999999999998654321111 00000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
+......++......+.+++.+||+.||.+|| ++.||++
T Consensus 401 -i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 401 -VKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -hhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00000123333456789999999999999999 7888874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.46 Aligned_cols=254 Identities=31% Similarity=0.481 Sum_probs=198.9
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.++|...+.||+|+||.||+|.+. ++.||||+++.. ...+.|.+|+.+|++++||||++++++|. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 367888999999999999999984 788999998754 33568999999999999999999999886 4478999999
Q ss_pred CCCchhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC-eEEeecccccccCCCCc
Q 008052 281 PNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE-AKVADFGLAKHSLDTDT 358 (579)
Q Consensus 281 ~~g~L~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~-~kL~DFGla~~~~~~~~ 358 (579)
++++|.+++..... ..+.+..++.++.|+++||+|||+.+..+|+||||||+||||+.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976442 34788999999999999999999943238999999999999988876 799999999754322
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....|... .+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~-------~~~~------ 222 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVH-------NGTR------ 222 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHHHH-------TTCC------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHHHh-------cCCC------
Confidence 23346999999999999999999999999999999999999999754321 111111100 0100
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..........+.+++.+||+.||.+||++.||++.|+...
T Consensus 223 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 223 --PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp --CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred --CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0111223456889999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.80 Aligned_cols=264 Identities=19% Similarity=0.232 Sum_probs=199.7
Q ss_pred hcCccccceecccCceEEEEEEEe----CCeEEEEEEeccCCchh-----------HHHHHHHHHHHHhcCCCCcceEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGSGQG-----------EREFQAEIEIISQVHHRHLVSLVG 265 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~-----------~~~~~~Ei~~l~~l~Hpniv~l~g 265 (579)
.++|.+.+.||+|+||.||+|... ++..||||++....... ...+.+|+.++..++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999985 56789999987654321 123667889999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-
Q 008052 266 YCTF----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF- 340 (579)
Q Consensus 266 ~~~~----~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~- 340 (579)
++.. ....+|||||+ +++|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 9988 67889999999 999999997544 699999999999999999999998 999999999999998877
Q ss_pred -CeEEeecccccccCCCCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc
Q 008052 341 -EAKVADFGLAKHSLDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 413 (579)
Q Consensus 341 -~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~ 413 (579)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~ 267 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD--P 267 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--H
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--c
Confidence 9999999999865332111 113457999999999999999999999999999999999999999643211 1
Q ss_pred hhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 414 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.........+.. .+...+..... ....+..+.+++..||+.||.+||++.+|++.|+..
T Consensus 268 ~~~~~~~~~~~~-----~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKTNLLD-----ELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHH-----TTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHHhhcc-----cccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111111100 00000000000 013345799999999999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.91 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=199.9
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe----CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 008052 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (579)
Q Consensus 196 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 269 (579)
++.+..++|...+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|+.++.+++||||++++++|..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34455678999999999999999999865 34589999987543 3334678999999999999999999999987
Q ss_pred CCe-----EEEEEEecCCCchhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC
Q 008052 270 GSQ-----RLLVYEFVPNKTLEFHLHG----KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF 340 (579)
Q Consensus 270 ~~~-----~~lV~E~~~~g~L~~~l~~----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~ 340 (579)
.+. .++||||+++++|.+++.. .....+++..++.|+.|++.||.|||++ +|+||||||+||||+.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 553 4899999999999998842 2335699999999999999999999998 999999999999999999
Q ss_pred CeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhh
Q 008052 341 EAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDW 418 (579)
Q Consensus 341 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~ 418 (579)
.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||+||||++ |..||...... .+...
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~ 261 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY 261 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH
Confidence 9999999999865433221 2233457889999999999999999999999999999999 88999765431 11111
Q ss_pred hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 419 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
. . .+ .....+......+.+++..||+.||.+||++.+|++.|+..
T Consensus 262 ~---~-----~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 262 L---L-----HG--------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp H---H-----TT--------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---H-----cC--------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 00 00012223345789999999999999999999999999865
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=365.62 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=205.7
Q ss_pred hcCccccceecccCceEEEEEEE----eCCeEEEEEEeccCC----chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCC
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL----TNGKVVAIKQLKAGS----GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGS 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 271 (579)
.++|...+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.+|.++ +|+||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 368999999986532 12335677899999999 6999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..+|||||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999998654 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
..............||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ....+.......
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~---- 281 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS---- 281 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC----
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhcc----
Confidence 754443334455679999999999985 347899999999999999999999997544221 111111111100
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVRAL 476 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~~L 476 (579)
...++......+.+++.+||+.||.+|| ++.|+++..
T Consensus 282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0122333456788999999999999999 999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.63 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=195.6
Q ss_pred CccccceecccCceEEEEEEEeC--C--eEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLV 276 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~--g--~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV 276 (579)
.|...+.||+|+||.||+|++.+ + ..||||.++... ....+.|.+|+.++++++||||++++++|.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999999642 2 468999986543 3445789999999999999999999999865 4577899
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++|+|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997543 4588999999999999999999998 9999999999999999999999999999865433
Q ss_pred Ccc---eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 357 DTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 357 ~~~---~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
... ......+|+.|+|||++.+..++.++|||||||+||||++ |..||....... +... +. .+.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~----~~~- 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LL----QGR- 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HH----TTC-
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HH----cCC-
Confidence 211 1233457889999999999999999999999999999999 777886554321 1111 00 010
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+...+..+.+++..||+.||.+||++.||++.|+...
T Consensus 314 -------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00112223457899999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=354.00 Aligned_cols=267 Identities=23% Similarity=0.293 Sum_probs=201.9
Q ss_pred hhcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCc-----hhHHHHHHHHHHHHhcC---CCCcceEEEEEEeC
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG-----QGEREFQAEIEIISQVH---HRHLVSLVGYCTFG 270 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-----~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~ 270 (579)
..++|+..+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++.+++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 4689999999864321 11346677888777765 99999999999876
Q ss_pred C-----eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEe
Q 008052 271 S-----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVA 345 (579)
Q Consensus 271 ~-----~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~ 345 (579)
. ..++||||+. ++|.+++.......+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5789999997 5999999877666699999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh--
Q 008052 346 DFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL-- 423 (579)
Q Consensus 346 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-- 423 (579)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+........
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence 999998654322 2345679999999999999999999999999999999999999997654321 1111100000
Q ss_pred -hhcccC------CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 424 -AQGLAD------GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 424 -~~~~~~------~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+.. ..+.......+.....+....+.+++.+||+.||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 000000000011111233467889999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=347.49 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=203.1
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC-TFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~-~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+|+.++.+++|+|++..+++| ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 47899999999999999999996 4789999998755432 23588899999999988877766666 56778899999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe---CCCCCeEEeecccccccCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl---~~~~~~kL~DFGla~~~~~ 355 (579)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||| +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99 999999986433 3489999999999999999999998 99999999999999 7889999999999987544
Q ss_pred CCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 356 TDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 356 ~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 233 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------- 233 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-------
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc-------
Confidence 3321 223457999999999999999999999999999999999999999865432221111110000
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.............+..+.+++..|++.||.+||++.+|++.|+...
T Consensus 234 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 234 -----KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -----HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -----cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0000000111122467899999999999999999999999998653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.73 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=206.5
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEE-EeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYC-TFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~-~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|+. .+++.||||++...... ..+.+|+.++.+++|++++..+++| ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999997 57899999998765432 4688999999999988877666665 56778899999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe---CCCCCeEEeecccccccCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl---~~~~~~kL~DFGla~~~~~ 355 (579)
|+ +++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+|||| +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 999999986432 3589999999999999999999998 99999999999999 4888999999999987554
Q ss_pred CCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 356 TDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 356 ~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
.... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||..................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 233 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------- 233 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-------
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc-------
Confidence 3321 124457999999999999999999999999999999999999999865432211111111000
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.............+..+.+++..||+.||.+||++.+|++.|+...
T Consensus 234 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 234 -----KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -----HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -----ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0000000111223467899999999999999999999999998653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=352.24 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=205.9
Q ss_pred HHhhcCccccc-eecccCceEEEEEEEe---CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 008052 198 KIATDNFSEAN-LLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (579)
Q Consensus 198 ~~~~~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 271 (579)
....++|.+.+ .||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.++.+++||||++++++| ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34456788887 9999999999999753 468899999976432 2356799999999999999999999999 567
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 789999999999999999754 3489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcce--eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhccc
Q 008052 352 HSLDTDTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 352 ~~~~~~~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 428 (579)
......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~--------~ 234 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML--------E 234 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH--------H
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH--------H
Confidence 764433222 122346789999999998899999999999999999999 99999765421 111111 0
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.+. ....+......+.+++..||+.||.+||++.+|++.|+..
T Consensus 235 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 235 KGE--------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TTC--------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 110 0012233456789999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=361.82 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=193.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
++|...+.||+|+||.||+++.. +++.||||++...... ...+.+|+.++++++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 67999999999999999999976 6899999999765432 356889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC--eEEeecccccccCCCCc
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLAKHSLDTDT 358 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~--~kL~DFGla~~~~~~~~ 358 (579)
++|+|.+++... ..+++..+..|+.|++.||+|||++ +|+||||||+||||+.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 99 SGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 999999988643 3489999999999999999999998 9999999999999987765 9999999997532221
Q ss_pred ceeecccccccccChhhhccCCCCcc-cceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEK-SDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~k-sDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......||+.|+|||++.+..++.+ +|||||||+||||++|+.||....... .........+.
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~------------- 236 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILS------------- 236 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHT-------------
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhc-------------
Confidence 2234579999999999988877655 899999999999999999997654321 11111111110
Q ss_pred hhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.... .........+.+++.+||+.||.+||++.|+++
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0000 001122356889999999999999999999996
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=346.29 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=204.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++.+++||||++++++|.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467999999999999999999976 4678999999776555677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe---CCCCCeEEeecccccccCCC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl---~~~~~~kL~DFGla~~~~~~ 356 (579)
+++++|.+++... ..+++..+..|+.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999888643 3489999999999999999999998 99999999999999 78899999999999865433
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... .. .... .+... ..
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~~-----~~~~~-~~ 227 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VM---LKIR-----EGTFT-FP 227 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHH-----HCCCC-CC
T ss_pred c--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HH---HHHH-----hCCCC-CC
Confidence 2 2234569999999999875 49999999999999999999999997654211 00 0000 00000 00
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.... ......+.+++..||+.||.+||++.|+++
T Consensus 228 ~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 012457889999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=360.45 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=195.7
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe----
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ---- 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~---- 272 (579)
.++|.+.+.||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999996 4789999999976532 234578899999999999999999999876543
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+|||||+++++|.++++.. ..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 48999999999999999654 3589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 353 SLDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 353 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... ....... ..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~----~~ 235 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVR----ED 235 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHH----CC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhc----CC
Confidence 5443221 2234569999999999999999999999999999999999999997654311 1111110 00
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHh
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV-RALE 477 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl-~~Le 477 (579)
... +. .........+.+++.+||+.||.+||++.+++ ..|.
T Consensus 236 ~~~----~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 236 PIP----PS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CCC----HH--HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCC----cc--cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 000 00 11112345688999999999999999766655 3443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.02 Aligned_cols=266 Identities=22% Similarity=0.328 Sum_probs=190.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|... +|+.||||+++..... ....+.+|+.++.+++||||+++++++...+..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999965 6899999999754322 34678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 279 FVPNKTLEFHLHGK----DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 279 ~~~~g~L~~~l~~~----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|++ ++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888877532 224589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhh---------hhhhHh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVD---------WAKPFL 423 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~---------~~~~~~ 423 (579)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.+ |....-
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3221 2234578999999999976 468999999999999999999999997654311100 000 000000
Q ss_pred hhcc-------cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 424 AQGL-------ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 424 ~~~~-------~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+ ....+...+.+.. .......+.+++.+||+.||.+||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGC---SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccc---cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 0000111111111 1123357899999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.31 Aligned_cols=268 Identities=23% Similarity=0.326 Sum_probs=210.2
Q ss_pred HHHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHh--cCCCCcceEEEEEEeCC
Q 008052 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ--VHHRHLVSLVGYCTFGS 271 (579)
Q Consensus 194 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~g~~~~~~ 271 (579)
+.--....++|...+.||+|+||.||+|+. +++.||||+++.. ....+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445567899999999999999999998 5899999999643 34678889999988 78999999999998876
Q ss_pred ----eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEeCCCCCCceEeCCC
Q 008052 272 ----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH--------EDCQPKIIHRDIKSANILLDDS 339 (579)
Q Consensus 272 ----~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~~ivHrDikp~NILl~~~ 339 (579)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||||+.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 789999999999999999643 4899999999999999999999 66 99999999999999999
Q ss_pred CCeEEeecccccccCCCCcc---eeecccccccccChhhhccC------CCCcccceechHHHHHHHHhC----------
Q 008052 340 FEAKVADFGLAKHSLDTDTH---VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVLLLELITG---------- 400 (579)
Q Consensus 340 ~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~~~ksDVwSlGvvl~eLltG---------- 400 (579)
+.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||+||||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999865443322 12345799999999999865 344789999999999999999
Q ss_pred CCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 401 FRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 401 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
+.||....... .....+..... ...+...+... .........+.+++.+||+.||.+||++.||++.|+..
T Consensus 264 ~~p~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 264 QLPYYDLVPSD-PSVEEMRKVVC-----EQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCTTTTTSCSS-CCHHHHHHHHT-----TSCCCCCCCGG--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCccccCcCc-ccHHHHHHHHH-----HHHhCCCCccc--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 67776543211 11222221111 11111000000 12346678899999999999999999999999999865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=349.92 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=202.3
Q ss_pred cCccccceecccCceEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~l 275 (579)
.+|...+.||+|+||.||+|++.+ ...||||.++.... ...+.+.+|+.++++++||||++++++|.. .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458888999999999999999643 23689999876443 345678999999999999999999999754 557789
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++|+|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997543 4589999999999999999999998 999999999999999999999999999986544
Q ss_pred CCc---ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 356 TDT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 356 ~~~---~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... .... .. .+.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~-----~~~ 249 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LL-----QGR 249 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HH-----TTC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---Hh-----cCC
Confidence 321 12234567889999999999999999999999999999999 556665443211 1110 00 000
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+......+.+++..||+.||.+||++.||++.|+...
T Consensus 250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111223456899999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=348.27 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=201.9
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
+.++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||++++++|.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3478999999999999999999976 57789999985432 1224678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999988643 3489999999999999999999998 999999999999999999999999999865432
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...... .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~---------- 221 (279)
T 3fdn_A 162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRIS-R---------- 221 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH-H----------
T ss_pred c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHH-h----------
Confidence 2 2244579999999999999999999999999999999999999997544211 000000 0
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
....++......+.+++..||+.||.+||++.||++.
T Consensus 222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0001222234568899999999999999999999963
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=351.15 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=200.1
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-CeEEEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-SQRLLVYE 278 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~lV~E 278 (579)
..++|...+.||+|+||.||+|.. .|+.||||+++... ..+.+.+|+.++.+++|+||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 347899999999999999999987 48899999997643 356789999999999999999999998654 46899999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999998654433478999999999999999999998 9999999999999999999999999998764332
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+... + ..+.
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~----~----~~~~------ 231 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----V----EKGY------ 231 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH----H----TTTC------
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----H----hcCC------
Confidence 123457889999999999999999999999999999998 99999765421 11110 0 0110
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+......+.+++..||+.||.+||++.||++.|+..
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0012223456789999999999999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=359.20 Aligned_cols=251 Identities=18% Similarity=0.201 Sum_probs=204.5
Q ss_pred HhhcCccccceecccCceEEEEEE------EeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEe
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTF 269 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~ 269 (579)
...++|.+.+.||+|+||.||+|+ ..+++.||||+++... ..++..|+.++.+++ |+||++++++|..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 445789999999999999999994 4468899999997653 457888888888887 9999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC--------
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGK---DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-------- 338 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-------- 338 (579)
.+..+|||||+++|+|.++++.. ....++|..++.|+.||+.||+|||++ +||||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999632 234699999999999999999999998 9999999999999998
Q ss_pred ---CCCeEEeecccccccCC-CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch
Q 008052 339 ---SFEAKVADFGLAKHSLD-TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 414 (579)
Q Consensus 339 ---~~~~kL~DFGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~ 414 (579)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999975432 22334455789999999999999999999999999999999999999996432210
Q ss_pred hhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHhcC
Q 008052 415 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRR-PRMSQIVRALEGN 479 (579)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~R-Ptm~evl~~Le~~ 479 (579)
|. ....+ ..+. ....+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 293 ---~~--------~~~~~--------~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 ---CK--------PEGLF--------RRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---EE--------ECSCC--------TTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---ee--------echhc--------cccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 10 00011 1111 13456788999999999888 6788888888764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.08 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=206.0
Q ss_pred HhhcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQR 273 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~ 273 (579)
+..++|...+.||+|+||.||++.. .+++.||||++........+.+.+|+.++.+++||||++++++|.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3457899999999999999999997 4789999999977666667789999999999999999999999973 3477
Q ss_pred EEEEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
++||||+++|+|.+++... ....+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 8999999999999888642 235689999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc--------eeecccccccccChhhhccCC---CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhh
Q 008052 352 HSLDTDTH--------VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK 420 (579)
Q Consensus 352 ~~~~~~~~--------~~~~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~ 420 (579)
........ ......||+.|+|||.+.... ++.++|||||||++|||++|+.||........ .+...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~-- 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA-- 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH--
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH--
Confidence 64321100 012245799999999987554 68999999999999999999999953211100 00000
Q ss_pred hHhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 421 PFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 421 ~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.. .... .........+.+++..||+.||.+||++.||++.|+...
T Consensus 260 --~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 --VQ-------------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --HH-------------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --hh-------------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 0000 111223457899999999999999999999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.15 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=199.3
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
+.|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.+|++++|||||+++++|...+..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999996 4789999999975432 23457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+. |+|.+++... ...+++..+..|+.|+++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 5777776432 23589999999999999999999998 9999999999999999999999999999865322
Q ss_pred cceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 358 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
....||+.|+|||++. .+.++.++|||||||+||||++|+.||....... ........ ..
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~-----~~-- 270 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-----ES-- 270 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-----CC--
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhc-----CC--
Confidence 3457999999999984 5789999999999999999999999997654211 11111100 00
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+.+ ........+.+++..||+.||.+||++.|+++.
T Consensus 271 ---~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ---PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 111223568899999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=388.74 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=198.7
Q ss_pred ceecccCceEEEEEEEe---CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
+.||+|+||.||+|.+. .++.||||+++.... ...++|.+|+.+|.+++|||||+++++|.. +..+||||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 467899999976432 335789999999999999999999999964 568899999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc--ce
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT--HV 360 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~--~~ 360 (579)
|+|.+++... ..+++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 9999999643 4589999999999999999999998 999999999999999999999999999987644332 12
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....+|+.|+|||++....++.++|||||||+||||++ |+.||...... .+... + ..+.
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i----~~~~-------- 589 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----L----EKGE-------- 589 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----H----HTTC--------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----H----HcCC--------
Confidence 233457889999999999999999999999999999998 99999765431 11111 1 1111
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
....+...+..+.+++..||+.||.+||++.+|++.|+..
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0122334456789999999999999999999999999853
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=346.84 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=200.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999986 6899999999754 234456788999999999 899999999999999999999
Q ss_pred EEecCCCchhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC----------------
Q 008052 277 YEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---------------- 338 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---------------- 338 (579)
|||+++++|.+++.... ...+++..++.|+.|++.||+|||++ +|+||||||+||||+.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999986532 24589999999999999999999998 9999999999999984
Q ss_pred ---CCCeEEeecccccccCCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccch
Q 008052 339 ---SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 414 (579)
Q Consensus 339 ---~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~ 414 (579)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 4479999999998754322 23589999999999866 677899999999999999999887643221
Q ss_pred hhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 415 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.... ..+. +...+......+.+++.+||+.||.+||++.|+++.
T Consensus 237 ~~~~---------~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHEI---------RQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHH---------HTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHH---------HcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1000 0111 111222234578999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=353.94 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=205.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++|...+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 367999999999999999999976 5899999998654321 357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC----CeEEeeccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 349 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~----~~kL~DFGl 349 (579)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999653 3589999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... . ...... .
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~---~~~~i~-----~ 232 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---E---TLANIT-----S 232 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---H---HHHHHH-----T
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---H---HHHHHH-----h
Confidence 98754432 223456999999999999999999999999999999999999999764321 1 111100 0
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.... .++.. .......+.+++..||+.||.+||++.|+++.
T Consensus 233 ~~~~--~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 233 VSYD--FDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TCCC--CCHHH---HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccc--cChhh---hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00000 01123568899999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=363.39 Aligned_cols=273 Identities=21% Similarity=0.268 Sum_probs=213.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|.+++||||+++++++...+ ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 67999999999999999999976 48999999997543 233567889999999999999999999998755 679999
Q ss_pred EecCCCchhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe----CCCCCeEEeecccccc
Q 008052 278 EFVPNKTLEFHLHGKDR-PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKVADFGLAKH 352 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~-~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl----~~~~~~kL~DFGla~~ 352 (579)
||+++|+|.+++..... ..+++..++.|+.|++.||+|||+. +|+||||||+|||| +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999975432 3389999999999999999999998 99999999999999 7788899999999987
Q ss_pred cCCCCcceeecccccccccChhhhcc--------CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
..... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.....+.
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~ 241 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT 241 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhc
Confidence 54332 2234569999999999865 56788999999999999999999999754321111 111111111
Q ss_pred hcc----------cCCCchhhhc-hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 425 QGL----------ADGNFDALVD-QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 425 ~~~----------~~~~~~~l~d-~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
..- ..+.++-.-+ +............+.+++..||+.||++||++.|+++.|+..+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 000 0000000000 01114557788899999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=355.48 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=203.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeE--EEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKV--VAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~--vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|...+.||+|+||.||+|+.. ++.. ||||.++... ....+.+.+|++++.++ +||||+++++++.+.+..+||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67899999999999999999965 5664 4999987532 33345789999999999 899999999999999999999
Q ss_pred EEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 277 YEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
|||+++++|.+++.... ...+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997543 24689999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhh
Q 008052 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
||+|||+++..... .......+++.|+|||++.+..++.++|||||||+||||++ |+.||...... .+...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~--- 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK--- 253 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHHH---
Confidence 99999998743211 11233457889999999998899999999999999999998 99999765421 11110
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
+..+. ....+......+.+++.+||+.||.+||++.|+++.|+...
T Consensus 254 -----~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 254 -----LPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp -----GGGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----hhcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00100 00112233467899999999999999999999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.51 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=200.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCe----EEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.++|...+.||+|+||.||+|.+. +++ .||+|.+... .....+.+.+|+.++.+++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999964 344 3678877543 3345678999999999999999999999998755 78
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+|+||+.+|+|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999987543 3589999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 355 DTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 355 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... ......+|+.|+|||.+.+..++.++|||||||+||||++ |+.||....... +... +. .+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~~----~~~- 236 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LE----KGE- 236 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HH----TTC-
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HH----cCC-
Confidence 33221 2233457889999999999999999999999999999999 999997654321 1111 00 000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+......+.+++..||+.||.+||++.||++.|+...
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00122233456889999999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=350.80 Aligned_cols=256 Identities=21% Similarity=0.349 Sum_probs=205.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~l 275 (579)
.++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||++++++|.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367999999999999999999976 68999999997543 3345678999999999999999999998854 568899
Q ss_pred EEEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc-----eEeCCCCCCceEeCCCCCeEEeecc
Q 008052 276 VYEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPK-----IIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-----ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
||||+++++|.+++... ....+++..++.|+.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998643 234589999999999999999999998 6 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhccc
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 428 (579)
+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .+... . .
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---i-----~ 229 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGK---I-----R 229 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---H-----H
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHH---H-----h
Confidence 998654322 1223456899999999999999999999999999999999999999765421 11111 0 0
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.+.+ ...+......+.+++.+||+.||.+||++.||++.+...
T Consensus 230 ~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 230 EGKF--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp HTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred hccc--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 1111 112223346789999999999999999999999887643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=345.36 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=184.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 367999999999999999999974 789999999864321 2246789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999987543 4589999999999999999999998 9999999999999999999999999999865432
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ + . .+....+
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~--------~-~~~~~~~---- 229 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L--------N-KVVLADY---- 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSCC----
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H--------H-HHhhccc----
Confidence 21 22345699999999999998999999999999999999999999976542110 0 0 0000000
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+......+.+++.+||+.||.+||++.||++
T Consensus 230 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 -----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112223456889999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.12 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=196.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHH-HHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEI-ISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|...+.||+|+||.||+|+.. +++.||||+++.... .....+..|..+ ++.++|||||+++++|...+..+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999976 578999999965432 223456677776 567899999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||||+++|+|.+++... ..+.+.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999998653 3488999999999999999999998 999999999999999999999999999986433
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....+
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~------------ 252 (373)
T 2r5t_A 192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNIL------------ 252 (373)
T ss_dssp CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHH------------
T ss_pred CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH------------
Confidence 22 2234568999999999999999999999999999999999999999764421 1111111
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
...+ .++......+.+++..||+.||.+||++.+.++.+..
T Consensus 253 -~~~~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 253 -NKPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp -HSCC-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred -hccc-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 1111 1222334568899999999999999998655444443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=371.96 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=207.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.+|++++||||+++++++...+..+|||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67999999999999999999976 68999999996532 123457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999653 3589999999999999999999998 99999999999999999999999999998754332
Q ss_pred cceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.....+||+.|+|||++.+..+ +.++|||||||+||||++|+.||...... ...... ..+.+
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i-----~~~~~---- 233 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKI-----CDGIF---- 233 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHH-----HTTCC----
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHH-----hcCCc----
Confidence 2344679999999999988765 68999999999999999999999764421 111111 11111
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEGN 479 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~~ 479 (579)
..+......+.+++.+||+.||.+||++.||++ .+...
T Consensus 234 -----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 -----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 111223356889999999999999999999996 45543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.05 Aligned_cols=267 Identities=20% Similarity=0.295 Sum_probs=199.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++.+++||||++++++|...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999986 5899999998654332 34578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|..++... ..+++..+..|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999888644 3489999999999999999999998 999999999999999999999999999987543222
Q ss_pred ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhh-h---hHhhhcccCCCc-
Q 008052 359 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA-K---PFLAQGLADGNF- 432 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~- 432 (579)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||............... . +.....+....+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2234579999999999975 67899999999999999999999999765532211110000 0 000000000000
Q ss_pred hh--hhch----hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 433 DA--LVDQ----KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 433 ~~--l~d~----~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. +.++ .+..........+.+++..||+.||.+||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 000001123456889999999999999999999996
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=344.36 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=205.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++|+||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999975 58899999986543 333467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC---eEEeecccccccC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSL 354 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~---~kL~DFGla~~~~ 354 (579)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999998888643 3589999999999999999999998 9999999999999986655 9999999997654
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .... ... .+.+.
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~---~~~-----~~~~~- 225 (284)
T 3kk8_A 160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA---QIK-----AGAYD- 225 (284)
T ss_dssp SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-----HTCCC-
T ss_pred cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHH---HHH-----hcccc-
Confidence 3322 23457999999999999999999999999999999999999999765421 1111 100 00000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 478 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~ 478 (579)
...+ ........+.+++..||+.||.+||++.|+++ .|++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 226 YPSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp CCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred CCch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 0000 01123356889999999999999999999987 4443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=356.94 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=205.5
Q ss_pred hhcCccccceecccCceEEEEEEE------eCCeEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVL------TNGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
..++|...+.||+|+||.||+|++ .+++.||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 347899999999999999999984 24678999999654 33445678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEE
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKV 344 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL 344 (579)
.+|||||+++++|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+||||+. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975432 3589999999999999999999998 9999999999999984 456999
Q ss_pred eecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhH
Q 008052 345 ADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPF 422 (579)
Q Consensus 345 ~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~ 422 (579)
+|||+++....... .......|++.|+|||++.+..++.++|||||||+||||++ |+.||..... ..+..+..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~-- 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVT-- 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH--
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHh--
Confidence 99999975433221 22334568999999999999999999999999999999998 9999976432 11111110
Q ss_pred hhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 423 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.+.. ...+......+.+++..||+.||.+||++.||++.|+...
T Consensus 260 ------~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 ------SGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ------TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------cCCC--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1100 0112233457889999999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=342.55 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=204.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367999999999999999999976 68999999986543 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998643 3589999999999999999999998 999999999999999999999999999976432221
Q ss_pred -ceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 359 -HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 359 -~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....|... ... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~--------~~~---~ 228 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK--------KTY---L 228 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT--------CTT---S
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc--------ccc---c
Confidence 12334579999999999987665 789999999999999999999997654311 112222110 000 0
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. ........+.+++..||+.||.+||++.||++
T Consensus 229 -~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 -N----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -T----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -C----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 01122356789999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=375.32 Aligned_cols=254 Identities=27% Similarity=0.390 Sum_probs=207.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.+|.+++||||+++++++...+..+||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 377999999999999999999985 68999999996532 12346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 277 YEFVPNKTLEFHLHGKD--RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~--~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987543 44699999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||........ ...+....+.
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~---------- 407 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE---------- 407 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH----------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh----------
Confidence 4322 22345899999999999999999999999999999999999999976542111 1111111110
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM-----SQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm-----~evl~ 474 (579)
.. ..++......+.+++.+||+.||.+||++ .+|++
T Consensus 408 ---~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 ---QA-VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---cc-cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 00 02333445678899999999999999975 56653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=355.91 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=179.9
Q ss_pred cceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecCCCc
Q 008052 207 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKT 284 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~g~ 284 (579)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|+.++.++. ||||++++++|.+....+|||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999985 5899999999643 3567889999999997 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC---CeEEeecccccccCCCCccee
Q 008052 285 LEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 285 L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~ 361 (579)
|.+++... ..+++..+..|+.|++.||+|||++ +|+||||||+||||+.++ .+||+|||+++...... ...
T Consensus 93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~ 166 (325)
T 3kn6_A 93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPL 166 (325)
T ss_dssp HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccc
Confidence 99999754 4599999999999999999999998 999999999999997665 89999999998654332 223
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCcccc-chhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ....+.... +..+.+. ...
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----i~~~~~~-~~~--- 237 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-----IKKGDFS-FEG--- 237 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-----HTTTCCC-CCS---
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-----HHcCCCC-CCc---
Confidence 445789999999999999999999999999999999999999986543211 111111111 1111110 000
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+++..||+.||.+||++.|+++
T Consensus 238 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 -EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp -HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred -ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 001123467899999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.05 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=202.5
Q ss_pred CccccceecccCceEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE-EEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR-LLV 276 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~-~lV 276 (579)
.|...+.||+|+||.||+|.+.+ +..||||.++.... ...+.+.+|+.++++++||||++++++|...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35566899999999999999643 23799999976443 3456789999999999999999999999876655 899
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+.+++|.+++... ...+++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999999999763 34589999999999999999999998 9999999999999999999999999999865432
Q ss_pred Cc---ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCC-CCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 357 DT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP-FDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 357 ~~---~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.. .......++..|+|||.+.+..++.++|||||||++|||++|..| |...+.. .+..... .+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~--------~~~- 245 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---DLTHFLA--------QGR- 245 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---GHHHHHH--------TTC-
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH---HHHHHhh--------cCC-
Confidence 21 122345688999999999999999999999999999999996555 4433221 1111110 000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+......+.+++..||+.||.+||++.++++.|+..+
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00112223457899999999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=347.51 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=204.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF---------- 269 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~---------- 269 (579)
.++|...+.||+|+||.||+|... +++.||||+++... ..+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 467999999999999999999986 78999999997654 356789999999999999999999864
Q ss_pred ------CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeE
Q 008052 270 ------GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAK 343 (579)
Q Consensus 270 ------~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~k 343 (579)
....++||||+++++|.+++.......+++..++.|+.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence 34578999999999999999765455699999999999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 344 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 344 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
|+|||+++....... .....||+.|+|||.+.+..++.++|||||||+||||++|..||.... .+...
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~-- 230 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTD-- 230 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHH--
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHH--
Confidence 999999987544322 234569999999999999999999999999999999999998874211 11110
Q ss_pred hhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 424 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
+..+.+ .......+.+++..||+.||.+||++.|+++.|+...
T Consensus 231 ---~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 ---LRDGII-----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---HHTTCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---hhcccc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011111 1112345789999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=362.86 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=193.0
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--------chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--------GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 269 (579)
...++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.+|.+++|||||++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999975 57899999986532 111235789999999999999999999975
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC---CCeEEee
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVAD 346 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kL~D 346 (579)
.+..+|||||+++|+|.+++... ..+++..+..|+.|++.||+|||++ +|+||||||+||||+.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 45689999999999999988654 4589999999999999999999998 99999999999999654 4599999
Q ss_pred cccccccCCCCcceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 347 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 347 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
||+++..... ......+||+.|+|||++. ...++.++|||||||+||||++|+.||....... .+....
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i---- 357 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI---- 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH----
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH----
Confidence 9999875432 2234567999999999985 3678899999999999999999999997643211 111110
Q ss_pred hhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 424 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+.+.. .... .......+.+++.+||+.||.+||++.|+++.
T Consensus 358 ----~~~~~~~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 ----TSGKYNF-IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----HTTCCCC-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----hcCCCCC-Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0111100 0000 01124568899999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.70 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=197.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|... +|+.||||+++.. .......+.+|+.++.+++|+||++++++|...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 57999999999999999999974 6899999999753 2334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 278 EFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 278 E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
||+++++|.+++.. .....+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998853 1234589999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...+.... ....+..+
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-----~~~~~~~~ 258 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-----EQCDYPPL 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH-----HTTCSCCC
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh-----hcccCCCC
Confidence 221 223456899999999999999999999999999999999999999754321 11111111 11111110
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
........+.+++..||+.||.+||++.+|++.|+...
T Consensus 259 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 259 -------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp -------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 01123456889999999999999999999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=353.56 Aligned_cols=271 Identities=23% Similarity=0.382 Sum_probs=198.9
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHH--HHhcCCCCcceEEEEEEe-----CCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEI--ISQVHHRHLVSLVGYCTF-----GSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~--l~~l~Hpniv~l~g~~~~-----~~~~ 273 (579)
.++|...+.||+|+||.||+|+. +++.||||+++... ...+..|.++ +..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999987 68999999997543 3344444444 445899999999986643 2256
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC------QPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
+|||||+++|+|.+++... .+++..+++|+.|++.||+|||+.+ .++|+||||||+||||+.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 8999999999999999644 3589999999999999999999863 338999999999999999999999999
Q ss_pred ccccccCCCCc-------ceeecccccccccChhhhcc-------CCCCcccceechHHHHHHHHhCCCCCCCCCccccc
Q 008052 348 GLAKHSLDTDT-------HVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 413 (579)
Q Consensus 348 Gla~~~~~~~~-------~~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~ 413 (579)
|+++....... .......||+.|+|||++.+ ..++.++|||||||+||||++|..||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99986543221 12234579999999999986 45678999999999999999998877544322111
Q ss_pred hhhhhhhhH--------hhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 414 SMVDWAKPF--------LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 414 ~~~~~~~~~--------~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.. .+.... +...+........+... ..........+.+++.+||+.||.+||++.||++.|+..+
T Consensus 245 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 245 QM-AFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CC-TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-hhhcccCCCchHHHHHhhhcccccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 00 000000 00000000000000000 0122346678999999999999999999999999999865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=357.82 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=201.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCC
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--------GEREFQAEIEIISQVHHRHLVSLVGYCTFGS 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 271 (579)
.++|...+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.+|.+++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467999999999999999999964 6899999999764321 2335778999999999999999999999999
Q ss_pred eEEEEEEecCCC-chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 272 QRLLVYEFVPNK-TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 272 ~~~lV~E~~~~g-~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
..++||||+.+| +|..++... ..+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 999988654 3499999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
+....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~ 238 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------E 238 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------T
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------h
Confidence 87544322 234579999999999988776 889999999999999999999996532100 0
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
... ..+......+.+++..||+.||.+||++.||++.
T Consensus 239 ~~~---------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAI---------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hcc---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0011123568899999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.69 Aligned_cols=255 Identities=22% Similarity=0.386 Sum_probs=198.7
Q ss_pred cCcccc-ceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
+.|.+. +.||+|+||.||+|... +++.||||+++.........+.+|+.+|.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567764 78999999999999954 6899999999776656677899999999995 79999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC---eEEeecccccccCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGLAKHSLD 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~---~kL~DFGla~~~~~ 355 (579)
|+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999998654 3589999999999999999999998 9999999999999998776 99999999876432
Q ss_pred CCc------ceeecccccccccChhhhcc-----CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhh----
Q 008052 356 TDT------HVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK---- 420 (579)
Q Consensus 356 ~~~------~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~---- 420 (579)
... .......||+.|+|||++.. ..++.++|||||||+||||++|+.||........ .|..
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~ 242 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC----GWDRGEAC 242 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS----CC----CC
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc----cccccccc
Confidence 211 11223469999999999875 5688999999999999999999999986543210 1110
Q ss_pred ----hHhhhcccCCCchhhhchhhhcCCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 421 ----PFLAQGLADGNFDALVDQKLEEYDS----AEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 421 ----~~~~~~~~~~~~~~l~d~~l~~~~~----~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.+.+..+.+ .++. .....+.+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000000100 1111 12457899999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=357.41 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=209.4
Q ss_pred hcCccccceecccCceEEEEEEE-----eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC--eE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-----TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS--QR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~ 273 (579)
.++|...+.||+|+||.||+|.+ .+++.||||+++.......+.+.+|+.++.+++|+||++++++|...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36788999999999999999985 368899999998776666778999999999999999999999987654 67
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 89999999999999997543 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccc-----cchhhhhhhhHhhhc
Q 008052 354 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA-----DDSMVDWAKPFLAQG 426 (579)
Q Consensus 354 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~ 426 (579)
...... ......++..|+|||.+.+..++.++|||||||+||||++|..||....... ......+....+
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 272 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL--- 272 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH---
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH---
Confidence 443321 1223457788999999998899999999999999999999999986421100 000000000000
Q ss_pred ccCCCchhhhchhh-hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 427 LADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 427 ~~~~~~~~l~d~~l-~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+.... ...+...+..+.+++..||+.||.+||++.||++.|+..
T Consensus 273 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 ------IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp ------HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00111000 012233456799999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=353.96 Aligned_cols=258 Identities=21% Similarity=0.306 Sum_probs=205.0
Q ss_pred HHHhhcCcccc-ceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC
Q 008052 197 LKIATDNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS 271 (579)
Q Consensus 197 l~~~~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~ 271 (579)
.+...+.|.+. +.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++.++. ||||++++++|...+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445667776 89999999999999976 58999999986532 334678999999999995 699999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeecc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFG 348 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFG 348 (579)
..++||||+++|+|.+++.......+++..++.|+.|++.||+|||++ +|+||||||+||||+. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999999766566799999999999999999999998 9999999999999988 7899999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhccc
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 428 (579)
+++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... ..... .+.
T Consensus 180 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i-----~~~-- 248 (327)
T 3lm5_A 180 MSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNI-----SQV-- 248 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-----HHT--
T ss_pred cccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHH-----Hhc--
Confidence 998754322 2234579999999999999999999999999999999999999997654311 00000 000
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...+ ...........+.+++..||+.||.+||++.|+++.
T Consensus 249 ~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NVDY-------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CCCC-------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cccc-------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0000 001112234568899999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.59 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=206.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
+.|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++.+++|+||++++++|......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56899999999999999999965 68899999996543 33457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 102 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 999999999854 3589999999999999999999998 999999999999999999999999999986543322
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
......|++.|+|||++.+..++.++||||||++||||++|+.||....... .... +.. +.
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~----~~-------- 235 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFL----IPK----NN-------- 235 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHH----SC--------
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHH----hhc----CC--------
Confidence 2234579999999999999999999999999999999999999997644211 1111 000 00
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...........+.+++..||+.||.+||++.||++.
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001112234568899999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=356.42 Aligned_cols=251 Identities=21% Similarity=0.344 Sum_probs=200.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|... +++.||||+++.... .+.+|+++|.++ +||||+++++++.+.+..+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999976 689999999976543 345688888888 79999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC----CCeEEeecccccccC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS----FEAKVADFGLAKHSL 354 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~----~~~kL~DFGla~~~~ 354 (579)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999998654 3589999999999999999999998 99999999999998543 359999999998754
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......... +...... .+.+.
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~i~-----~~~~~- 241 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILARIG-----SGKFS- 241 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHHHHH-----HCCCC-
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHHHHc-----cCCcc-
Confidence 4322 234467999999999999888999999999999999999999999764321111 1111111 11110
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+. ..+.......+.+++..||+.||.+||++.|+++
T Consensus 242 ~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LS----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CC----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cC----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0112233467889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.89 Aligned_cols=193 Identities=26% Similarity=0.376 Sum_probs=154.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~ 273 (579)
++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|.+++|+|||+++++|... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999965 6899999998653 233456788999999999999999999999543 568
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
||||||+ +++|..++... ..+++..+..|+.||+.||+|||+. +||||||||+||||+.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 57898888654 4599999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCc--------------------------ceeecccccccccChhhh-ccCCCCcccceechHHHHHHHHhC
Q 008052 354 LDTDT--------------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITG 400 (579)
Q Consensus 354 ~~~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~~~ksDVwSlGvvl~eLltG 400 (579)
..... ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 42211 123446789999999986 566799999999999999999994
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=361.34 Aligned_cols=261 Identities=15% Similarity=0.248 Sum_probs=206.4
Q ss_pred cCccccceecccCceEEEEEEEeC---------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcce----------
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTN---------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS---------- 262 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~---------- 262 (579)
++|.+.+.||+|+||.||+|+... ++.||||++... ..+.+|+.++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 679999999999999999999763 789999998754 46889999999999999987
Q ss_pred -----EEEEEEe-CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe
Q 008052 263 -----LVGYCTF-GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336 (579)
Q Consensus 263 -----l~g~~~~-~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl 336 (579)
+++++.. +...+|||||+ +++|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6788877 77889999999 99999999765445699999999999999999999998 99999999999999
Q ss_pred CCCC--CeEEeecccccccCCCCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 337 DDSF--EAKVADFGLAKHSLDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 337 ~~~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999865432211 1233579999999999999999999999999999999999999997654
Q ss_pred ccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 409 TFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
... ..+..+...+.. ....+.+.... .......+.+++..||+.||.+||++.+|++.|+...
T Consensus 273 ~~~-~~~~~~~~~~~~------~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 273 PNT-EDIMKQKQKFVD------KPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TCH-HHHHHHHHHHHH------SCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCH-HHHHHHHHhccC------Chhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 211 112222111110 00111111110 0112367899999999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=370.01 Aligned_cols=265 Identities=21% Similarity=0.278 Sum_probs=197.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~ 271 (579)
.++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+|++++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999965 6899999999754 333456788999999999999999999999654 4
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..+|||||++++ |...+.. .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 679999999765 5555532 389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhh-------------
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVD------------- 417 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~------------- 417 (579)
..... ...+..+||+.|+|||++.+..++.++|||||||+||||++|+.||...+...... ++.
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 65432 22345679999999999999999999999999999999999999998765321100 000
Q ss_pred --hhhhHhhhc--ccCCCchhhhchhhh----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 418 --WAKPFLAQG--LADGNFDALVDQKLE----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 418 --~~~~~~~~~--~~~~~~~~l~d~~l~----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+.++... .....+..+....+. .........+.+|+.+||+.||.+||++.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 000011111111110 1112235678999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=345.70 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=197.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+++|.+++||||++++++|...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57999999999999999999975 58899999986543 33457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe---CCCCCeEEeecccccccC
Q 008052 280 VPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 280 ~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl---~~~~~~kL~DFGla~~~~ 354 (579)
+++|+|.+++... ....+++..++.|+.|++.||+|||+. +|+||||||+|||| +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888532 234589999999999999999999998 99999999999999 456789999999998654
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
... ......||+.|+|||.+. +.++.++|||||||+||||++|+.||....... +.... .. ....+.
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~~---~~---~~~~~~- 245 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQKA---TY---KEPNYA- 245 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH---CCCCCC-
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhhh---cc---CCcccc-
Confidence 322 234457999999999986 578999999999999999999999997654211 11100 00 000000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+++.+||+.||.+||++.||++
T Consensus 246 -------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 -------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000012356789999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=357.44 Aligned_cols=263 Identities=21% Similarity=0.348 Sum_probs=195.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|...+.||+|+||.||+|... +++.||||+++...... ...+.+|+.+|.+++||||+++++++...+..+|||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999976 68899999997543221 12456799999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 97 58888776543 3589999999999999999999998 99999999999999999999999999998643322 2
Q ss_pred eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc-
Q 008052 360 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD- 437 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d- 437 (579)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........+.. .....+..+..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~-~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGT-PTEETWPGILSN 231 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC-CCTTTSTTGGGC
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC-CChHhchhhhcc
Confidence 2334568999999999876 568999999999999999999999998754321 11111110000 00000000000
Q ss_pred -------------hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 -------------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 -------------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+..........+.+++.+||+.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000111123456889999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.80 Aligned_cols=269 Identities=21% Similarity=0.353 Sum_probs=192.7
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCC--eE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGS--QR 273 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~--~~ 273 (579)
..++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+.+|.++. |+||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999975 6899999998643 2334556789999999997 999999999997644 68
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+||||||+ ++|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 588888864 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCC--------------------CcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCcccc
Q 008052 354 LDT--------------------DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412 (579)
Q Consensus 354 ~~~--------------------~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~ 412 (579)
... .....+..+||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 1112344679999999999976 6799999999999999999999999986553211
Q ss_pred ch-hhhh---hhhHhhhcccCCCchhhhc---------------------hhh-h-cCCHHHHHHHHHHHHHhhccCCCC
Q 008052 413 DS-MVDW---AKPFLAQGLADGNFDALVD---------------------QKL-E-EYDSAEMTRMAACAAACIRHSARR 465 (579)
Q Consensus 413 ~~-~~~~---~~~~~~~~~~~~~~~~l~d---------------------~~l-~-~~~~~~~~~l~~l~~~cl~~dp~~ 465 (579)
.. +... ........+.......++. ..+ . .........+.+++.+||+.||.+
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 00 0000 0000000000000000000 000 0 001123456889999999999999
Q ss_pred CCCHHHHHHH
Q 008052 466 RPRMSQIVRA 475 (579)
Q Consensus 466 RPtm~evl~~ 475 (579)
||++.|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.68 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=200.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.|....+||+|+||.||+|... +++.||||.+........+.+.+|+.++.+++||||++++++|...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44566679999999999999974 68899999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecccccccCCCCc
Q 008052 281 PNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 281 ~~g~L~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla~~~~~~~~ 358 (579)
++++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||||+. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999987543 23567888999999999999999998 9999999999999987 89999999999986543221
Q ss_pred ceeecccccccccChhhhccCC--CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 359 HVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
......|++.|+|||++.++. ++.++||||||+++|||++|+.||....... ...+... . .
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~-~-~----------- 241 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVG-M-F----------- 241 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHH-H-H-----------
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhc-c-c-----------
Confidence 223457999999999997654 8899999999999999999999996533211 0000000 0 0
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
......+......+.+++.+||+.||.+||++.|+++
T Consensus 242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000122334467889999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=348.95 Aligned_cols=254 Identities=22% Similarity=0.380 Sum_probs=204.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|...+.||+|+||.||+++.. +|+.||||+++.........+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999975 6899999999876555556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe---CCCCCeEEeecccccccCCC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl---~~~~~~kL~DFGla~~~~~~ 356 (579)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999888543 3489999999999999999999998 99999999999999 78899999999999764322
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+. .... .+.+. ..
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~i~-----~~~~~-~~ 227 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF---EKIK-----EGYYE-FE 227 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHH-----HCCCC-CC
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHH-----cCCCC-CC
Confidence 223456999999999999999999999999999999999999999764321 111 1110 01000 00
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 478 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~ 478 (579)
. .........+.+++..||+.||.+||++.|+++ .+++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 228 S----PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp T----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred c----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 0 111223457889999999999999999999996 4543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=354.37 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=205.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++.+++|+||++++++|.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367999999999999999999976 4789999998654 223456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++... ..+++..++.|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988643 3589999999999999999999998 9999999999999999999999999999865432
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.. ......||..|+|||++.+..++.++|||||||+||||++|+.||....... ....... ..+
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~-----~~~---- 258 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKK-----NEY---- 258 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-----TCC----
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhc-----CCC----
Confidence 22 2344579999999999999899999999999999999999999997643211 1000000 000
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.++......+.+++.+||+.||.+||++.|+++
T Consensus 259 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223356889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.83 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=201.9
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG------QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++|...+.||+|+||.||+|... +++.||||.++.... ...+.+.+|+.++.+++||||++++++|...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999986 689999999865422 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC----CeEEeeccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 349 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~----~~kL~DFGl 349 (579)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999998643 3589999999999999999999998 999999999999998877 899999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .+..+ ..
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~---------~~ 225 (283)
T 3bhy_A 159 AHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TLTNI---------SA 225 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH---------HT
T ss_pred ceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HHHHh---------Hh
Confidence 98654322 2234569999999999999999999999999999999999999997654211 00000 00
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.... ... .........+.+++.+||+.||.+||++.|+++
T Consensus 226 ~~~~--~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 VNYD--FDE---EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TCCC--CCH---HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccC--Ccc---hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000 000 000122356889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=357.52 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=190.0
Q ss_pred HHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe-----
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF----- 269 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~----- 269 (579)
+.....+|...+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3445568999999999999999999975 68999999997776666778999999999996 9999999999953
Q ss_pred ---CCeEEEEEEecCCCchhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEeCCCCCCceEeCCCCCeE
Q 008052 270 ---GSQRLLVYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLDDSFEAK 343 (579)
Q Consensus 270 ---~~~~~lV~E~~~~g~L~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDikp~NILl~~~~~~k 343 (579)
....++||||+. |+|.+++.. .....+++..++.|+.||+.||+|||+. + |+||||||+||||+.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 345789999996 788887753 2234599999999999999999999998 7 99999999999999999999
Q ss_pred EeecccccccCCCCcc-----------eeecccccccccChhhh---ccCCCCcccceechHHHHHHHHhCCCCCCCCCc
Q 008052 344 VADFGLAKHSLDTDTH-----------VSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409 (579)
Q Consensus 344 L~DFGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~---~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~ 409 (579)
|+|||+++........ ......||+.|+|||++ .+..++.++|||||||+||||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999875433221 11134699999999998 567789999999999999999999999975432
Q ss_pred cccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 410 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.. +. .+.+.. .........+.+++..||+.||.+||++.||++.|+...
T Consensus 259 ~~---~~------------~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 LR---IV------------NGKYSI-------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ----------------------CCC-------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---hh------------cCcccC-------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 00 000000 000111234788999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.01 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=204.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999976 57899999986432 22346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999988654 3489999999999999999999998 9999999999999999999999999998764332
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ...... ...
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~-----~~~----- 228 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIV-----NVD----- 228 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH-----TTC-----
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHh-----ccc-----
Confidence 1234579999999999999999999999999999999999999997644211 111110 000
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. .++......+.+++..||+.||.+||++.|+++
T Consensus 229 ---~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ---L-KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---C-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---c-CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 122223456889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.67 Aligned_cols=247 Identities=22% Similarity=0.360 Sum_probs=204.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++|+||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 67899999999999999999976 5789999998654 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999988543 3589999999999999999999998 99999999999999999999999999998654322
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .. .... ....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~----~~~~-----~~~~----- 232 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TY----LRIK-----KNEY----- 232 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HHHH-----TTCC-----
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHh-----hccC-----
Confidence 2 2334569999999999999899999999999999999999999997644211 00 0000 0000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+......+.+++.+||+.||.+||++.|+++
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 112223356889999999999999999999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=367.33 Aligned_cols=260 Identities=21% Similarity=0.271 Sum_probs=207.0
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~E 278 (579)
.++|.+.++||+|+||.||+|+. .+++.||||+++..... .++..|++++..++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 46899999988654432 358899999999986 566677777788889999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe---CCCCCeEEeecccccccCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl---~~~~~~kL~DFGla~~~~~ 355 (579)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +||||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999987433 3599999999999999999999998 99999999999999 5889999999999987654
Q ss_pred CCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 356 TDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 356 ~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 231 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------- 231 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-------
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-------
Confidence 4322 123567999999999999999999999999999999999999999875532222211111100
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.+...+.......+..+.+++..||+.+|.+||++.+|++.|+..
T Consensus 232 -----~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 232 -----KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp -----HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -----cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000001111112245789999999999999999999999998865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=355.04 Aligned_cols=265 Identities=19% Similarity=0.295 Sum_probs=206.3
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchh-----------------HHHHHHHHHHHHhcCCCCcceE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQG-----------------EREFQAEIEIISQVHHRHLVSL 263 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-----------------~~~~~~Ei~~l~~l~Hpniv~l 263 (579)
.++|...+.||+|+||.||+|.. +++.||||++....... ...+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986432111 1789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhh------hcCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeCCCCCCceEe
Q 008052 264 VGYCTFGSQRLLVYEFVPNKTLEFH------LHGKDRPVMNWPTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILL 336 (579)
Q Consensus 264 ~g~~~~~~~~~lV~E~~~~g~L~~~------l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDikp~NILl 336 (579)
++++.+.+..++||||+++++|.++ +.......+++..++.|+.|++.||+|||+ . +|+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 655445679999999999999999999998 7 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcceeecccccccccChhhhccC-CCCc-ccceechHHHHHHHHhCCCCCCCCCccccch
Q 008052 337 DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTE-KSDVFSFGVLLLELITGFRPFDKADTFADDS 414 (579)
Q Consensus 337 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~-ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~ 414 (579)
+.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999999875432 33456799999999999877 6666 999999999999999999999865431 11
Q ss_pred hhhhhhhHhhh-cccCC-CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 415 MVDWAKPFLAQ-GLADG-NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 415 ~~~~~~~~~~~-~~~~~-~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.......... ..... ....+...............+.+++..||+.||.+||++.|+++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111000000 00000 00000000000111334567899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.10 Aligned_cols=266 Identities=23% Similarity=0.291 Sum_probs=203.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC--------CCCcceEEEEEE---
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH--------HRHLVSLVGYCT--- 268 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~--------Hpniv~l~g~~~--- 268 (579)
.++|.+.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.+|.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 368999999999999999999964 6889999999754 234567889999999985 788999999987
Q ss_pred -eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-------
Q 008052 269 -FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF------- 340 (579)
Q Consensus 269 -~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~------- 340 (579)
.....+|||||+ +++|.+++.......+++..++.|+.||+.||+|||+++ +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 455789999999 555555554444456999999999999999999999864 799999999999999775
Q ss_pred ------------------------------------------CeEEeecccccccCCCCcceeecccccccccChhhhcc
Q 008052 341 ------------------------------------------EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378 (579)
Q Consensus 341 ------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~ 378 (579)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999865332 234579999999999999
Q ss_pred CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh-----------h------cc-cCCCchhh-----
Q 008052 379 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA-----------Q------GL-ADGNFDAL----- 435 (579)
Q Consensus 379 ~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~------~~-~~~~~~~l----- 435 (579)
..++.++|||||||+||||++|+.||............+....... . .+ ..+.+..+
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999986543221110000000000 0 00 00000000
Q ss_pred ---hchhhh--cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 ---VDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ---~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.... .+.......+.+|+.+||+.||.+||++.||++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000011 346777889999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=348.36 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=198.4
Q ss_pred hcCccccceecccCceEEEEEEEeC--Ce--EEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN--GK--VVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~--g~--~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++|...+.||+|+||.||+|++.. ++ .||||+++.. .....+.+.+|+.++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4679999999999999999999642 33 6899998754 2334568899999999999999999999998755 7
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999886532 3489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 354 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 354 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+... ... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~---~~~----~~ 241 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHK---IDK----EG 241 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH---HHT----SC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHH---HHc----cC
Confidence 443322 1233467889999999998899999999999999999999 99999765421 11111 100 00
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
.. ..........+.+++..||+.||.+||++.+|++.|+...+
T Consensus 242 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ER--------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CC--------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 00 01122344678999999999999999999999999997654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.07 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=204.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.++|...+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++.+++||||++++++|...+..+||||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999976 68999999997653 3335678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++... ..+++..+..|+.+++.||+|||+.+ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999999654 34899999999999999999999842 7999999999999999999999999998754221
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhh-----------hh--------
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVD-----------WA-------- 419 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~-----------~~-------- 419 (579)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... +.
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2234579999999999999999999999999999999999999997654211100000 00
Q ss_pred hhHhhhcccCCCchhhhchhhh----c-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 420 KPFLAQGLADGNFDALVDQKLE----E-YDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~----~-~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+............+++.... . ........+.+++..||+.||.+||++.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000011111111111 0 11123457899999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.58 Aligned_cols=280 Identities=22% Similarity=0.302 Sum_probs=203.8
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCch-----------hHHHHHHHHHHHHhcCCCCcc
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQ-----------GEREFQAEIEIISQVHHRHLV 261 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------~~~~~~~Ei~~l~~l~Hpniv 261 (579)
...++....++|...+.||+|+||.||+|...+|+.||||++...... ..+.+.+|+.++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356788889999999999999999999999888999999998543221 236789999999999999999
Q ss_pred eEEEEEEe-----CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe
Q 008052 262 SLVGYCTF-----GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336 (579)
Q Consensus 262 ~l~g~~~~-----~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl 336 (579)
+++++|.. ....++||||+. |+|.+++... ...+++..+..|+.|++.||.|||++ +|+||||||+||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 99999854 236799999998 5777777643 34589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccc-h
Q 008052 337 DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD-S 414 (579)
Q Consensus 337 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~-~ 414 (579)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999997543322 2344578999999999876 67999999999999999999999999865421110 0
Q ss_pred hhh------------hhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcCC
Q 008052 415 MVD------------WAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEGNM 480 (579)
Q Consensus 415 ~~~------------~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~~~ 480 (579)
+.. |........+ ...+..................+.+++..||+.||.+||++.|+++ .++...
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYL-RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHT-TTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHcCCCChHHhhhccchhhhHHH-HhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 000 0000000000 0000000111111112223456889999999999999999999996 344443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.75 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=201.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.+++||||++++++|...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367999999999999999999976 489999999865432 23456889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|..++... ..+++..+..|+.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999998887543 3489999999999999999999998 99999999999999999999999999997654322
Q ss_pred cceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhh----------hHhhh-
Q 008052 358 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK----------PFLAQ- 425 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~----------~~~~~- 425 (579)
.......||..|+|||++.+. .++.++|||||||++|||++|+.||....... .+..... ..+..
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhhc
Confidence 223345699999999999865 78999999999999999999999997654321 1111000 00000
Q ss_pred c-ccCCCchhhhchh-hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 G-LADGNFDALVDQK-LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 ~-~~~~~~~~l~d~~-l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. +....+..+.... ...........+.+++.+||+.||.+||++.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000100000 00111233567899999999999999999999885
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=352.13 Aligned_cols=257 Identities=23% Similarity=0.393 Sum_probs=205.9
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--------hhHHHHHHHHHHHHhc-CCCCcceEE
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--------QGEREFQAEIEIISQV-HHRHLVSLV 264 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l-~Hpniv~l~ 264 (579)
.......++|...+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344555678999999999999999999986 699999999865431 1134678999999999 799999999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEE
Q 008052 265 GYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344 (579)
Q Consensus 265 g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL 344 (579)
++|......+|||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999998643 3589999999999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCcceeecccccccccChhhhcc------CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhh
Q 008052 345 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 418 (579)
Q Consensus 345 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~ 418 (579)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... .....
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~ 316 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRM 316 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHH
Confidence 9999998754332 2244679999999999863 35889999999999999999999999764321 11110
Q ss_pred hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 419 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .+.+. ...+... .....+.+++..||+.||.+||++.|+++
T Consensus 317 ---i~-----~~~~~-~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 ---IM-----EGQYQ-FSSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HH-----HTCCC-CCHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HH-----hCCCC-CCCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 01100 0000011 12356889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.45 Aligned_cols=241 Identities=13% Similarity=0.160 Sum_probs=189.8
Q ss_pred hcCccccceecccCceEEEEEEE-eCCeEEEEEEeccC---CchhHHHHHHHH---HHHHhcCCCCcceEE-------EE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAG---SGQGEREFQAEI---EIISQVHHRHLVSLV-------GY 266 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei---~~l~~l~Hpniv~l~-------g~ 266 (579)
.++|...+.||+|+||.||+|+. .+|+.||||+++.. .....+.|.+|+ .+|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36788899999999999999996 46899999999743 333457889999 455556899999998 66
Q ss_pred EEeCC-----------------eEEEEEEecCCCchhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 008052 267 CTFGS-----------------QRLLVYEFVPNKTLEFHLHGKDR-----PVMNWPTRMKIALGSARGLAYLHEDCQPKI 324 (579)
Q Consensus 267 ~~~~~-----------------~~~lV~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 324 (579)
+...+ ..+|||||+ +|+|.+++..... ..++|..++.|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 278999999 6899999864321 2244688889999999999999998 99
Q ss_pred EeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccccccccChhhhccC-----------CCCcccceechHHH
Q 008052 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVL 393 (579)
Q Consensus 325 vHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~ksDVwSlGvv 393 (579)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986322 3345568 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 008052 394 LLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 394 l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl 473 (579)
||||++|+.||........ .. .+.. .. ......+.+++.+||+.||.+||++.|++
T Consensus 303 l~elltg~~Pf~~~~~~~~---~~----------------~~~~-~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---SE----------------WIFR-SC----KNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHHSSCCC------CC---SG----------------GGGS-SC----CCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHHCCCCCcccccccc---hh----------------hhhh-hc----cCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 9999999999976443110 00 0000 00 11235688999999999999999999998
Q ss_pred H
Q 008052 474 R 474 (579)
Q Consensus 474 ~ 474 (579)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=343.59 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=201.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCCCCcceEEEEEE--eCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHHRHLVSLVGYCT--FGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~--~~~~~ 273 (579)
.++|.+.+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++|+||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999974 68899999996532 233567999999999999999999999984 45578
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||++++ |.+++.......+++..+..|+.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999877 66666554455699999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCC-cceeecccccccccChhhhccCC--CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 354 LDTD-THVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 354 ~~~~-~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
.... ........||..|+|||++.+.. ++.++|||||||++|||++|+.||...... ....... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~-----~~ 228 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIG-----KG 228 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-----HC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHh-----cC
Confidence 4322 22234456999999999998644 478999999999999999999999764321 1111100 00
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhcC
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEGN 479 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~~ 479 (579)
.+ .++......+.+++.+||+.||.+||++.|+++ .++..
T Consensus 229 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 229 SY---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp CC---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred CC---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 00 112233456889999999999999999999996 45544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.94 Aligned_cols=264 Identities=18% Similarity=0.273 Sum_probs=193.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch--hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.++|...+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.+|++++||||+++++++...+..+|||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 468999999999999999999965 6899999999754332 2356789999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe-----CCCCCeEEeecccccc
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL-----DDSFEAKVADFGLAKH 352 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl-----~~~~~~kL~DFGla~~ 352 (579)
||+++ +|.+++.... .+++..+..|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.
T Consensus 113 e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 99984 8988886543 489999999999999999999998 99999999999999 4555699999999986
Q ss_pred cCCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH---------
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF--------- 422 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~--------- 422 (579)
..... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+.......
T Consensus 187 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 187 FGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTST
T ss_pred cCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCchhhhh
Confidence 54322 223445689999999999874 58999999999999999999999997654311 111110000
Q ss_pred ---hhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 423 ---LAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 423 ---~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+. ..+.......+. .........+.+++.+||+.||.+||++.|+++
T Consensus 264 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 000000000000 011112356789999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=353.03 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=199.6
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----
Q 008052 196 ELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF---- 269 (579)
Q Consensus 196 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~---- 269 (579)
++....++|...+.||+|+||.||+|+.. +++.||||++..... ....+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34445678999999999999999999974 689999999875433 346789999999999 79999999999987
Q ss_pred --CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 270 --GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 270 --~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
.+..++||||+++++|.+++.......+++..+..|+.|++.||.|||+. +|+||||||+||||+.++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999999765545689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 422 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 422 (579)
|++....... .......||+.|+|||++. ...++.++|||||||+||||++|+.||....... .+..
T Consensus 174 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----- 245 (326)
T 2x7f_A 174 GVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFL----- 245 (326)
T ss_dssp TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH-----
T ss_pred cCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHH-----
Confidence 9998653322 1223457999999999997 5678999999999999999999999997544211 0000
Q ss_pred hhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 423 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.. ... +.+ ........+.+++..||+.||.+||++.|+++
T Consensus 246 ~~~----~~~-----~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPR----NPA-----PRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH----SCC-----CCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhc----Ccc-----ccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 000 000 11122356889999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=340.38 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=196.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999986 68999999986532 22346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999998643 3489999999999999999999999 9999999999999999999999999999875432
Q ss_pred CcceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... .+.... . .+.
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~----~----~~~---- 227 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKI----R----GGV---- 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----H----HCC----
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHh----h----cCc----
Confidence 2 2234568999999999987765 68999999999999999999999754321 111110 0 000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
...+......+.+++..||+.||.+||++.||++.
T Consensus 228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122234568899999999999999999999973
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=342.30 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=197.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~ 274 (579)
+.|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++.+++||||++++++|.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34777889999999999999975 5788999998653 23345678999999999999999999999875 35678
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc--eEeCCCCCCceEeC-CCCCeEEeeccccc
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPK--IIHRDIKSANILLD-DSFEAKVADFGLAK 351 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--ivHrDikp~NILl~-~~~~~kL~DFGla~ 351 (579)
+||||+++++|.+++... ..+++..++.|+.|++.||.|||+. + |+||||||+||||+ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999653 3489999999999999999999998 6 99999999999997 78999999999997
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||....... .+.. . +..+.
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~---~-----~~~~~ 246 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR---R-----VTSGV 246 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH---H-----HTTTC
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHH---H-----HhccC
Confidence 64332 223456999999999887 569999999999999999999999997643211 1111 0 00111
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
... .++......+.+++..||+.||.+||++.||++
T Consensus 247 ~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPA-------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCG-------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccc-------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000 111112346889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.42 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=196.9
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--------hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--------QGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~ 270 (579)
..++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++|.+++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999975 588999999865321 1224588999999999999999999998765
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC---eEEeec
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADF 347 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~---~kL~DF 347 (579)
. .++||||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5 89999999999999988643 4589999999999999999999998 9999999999999987654 999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
|+++..... .......||+.|+|||++. ...++.++|||||||+||||++|+.||....... .+.... .
T Consensus 162 g~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~ 233 (322)
T 2ycf_A 162 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----T 233 (322)
T ss_dssp TTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----H
T ss_pred ccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----H
Confidence 999875432 1223457999999999974 5678999999999999999999999997654311 111111 0
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+.+.. . +.. .......+.+++.+||+.||.+||++.|+++
T Consensus 234 ----~~~~~~-~-~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 ----SGKYNF-I-PEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----HTCCCC-C-HHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----hCcccc-C-chh---hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000000 0 000 0122457889999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.89 Aligned_cols=200 Identities=27% Similarity=0.350 Sum_probs=168.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ce
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~ 272 (579)
.++|...+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+.+|.+++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999975 5889999999753 233456789999999999999999999999776 57
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.||||||+. ++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999986 5999988653 4589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCc---------------------ceeecccccccccChhhh-ccCCCCcccceechHHHHHHHHhCCCCCCC
Q 008052 353 SLDTDT---------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVLLLELITGFRPFDK 406 (579)
Q Consensus 353 ~~~~~~---------------------~~~~~~~gt~~y~APE~~-~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~ 406 (579)
...... ...+..+||+.|+|||++ ....++.++|||||||+||||++|..||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 543221 123556899999999986 566799999999999999999987666543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=352.09 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=198.4
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh-----HHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-----EREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-----~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
...++|...+.||+|+||.||+|+.. +|+.||||+++...... .+.+.+|+.++.+++||||++++++|.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 58999999997533211 2467899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++||||+++ +|..++.... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999986 8888876533 4588999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... .......||+.|+|||++.+. .++.++|||||||+||||++|..||....... .+......... .....
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~--~~~~~ 236 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGT--PTEEQ 236 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCC--CCTTT
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCC--CChhh
Confidence 54332 223446799999999999754 58999999999999999999999997654311 11111100000 00000
Q ss_pred ch---hhhc---------hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 432 FD---ALVD---------QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 432 ~~---~l~d---------~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
+. .+.+ ..+..........+.+++..||+.||.+||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000 00001112334678999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.70 Aligned_cols=200 Identities=25% Similarity=0.357 Sum_probs=175.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhc------CCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQV------HHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l------~Hpniv~l~g~~~~~~~~ 273 (579)
..+|.+.+.||+|+||.||+|... +++.||||+++... ...+++.+|+.++..+ +|+||++++++|...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357999999999999999999875 58999999997642 3346778899988887 577999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC--eEEeeccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE--AKVADFGLAK 351 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~--~kL~DFGla~ 351 (579)
+|||||+. ++|.+++.......+++..+..|+.||+.||+|||++ +||||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6888888766656699999999999999999999999 9999999999999999887 9999999997
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCc
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~ 409 (579)
..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+.
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 64322 2345799999999999999999999999999999999999999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.90 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=198.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++.+++||||++++++|...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999986 5889999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ 172 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence 99999998876432 3489999999999999999999998 9999999999999999999999999997542111 11
Q ss_pred eeecccccccccChhhh-----ccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 360 VSTRVMGTFGYLAPEYA-----SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~-----~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
......||..|+|||++ ....++.++|||||||++|||++|+.||...+... .+... .. .....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~~-----~~~~~ 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKI----AK-----SDPPT 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH----HH-----SCCCC
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHH----hc-----cCCcc
Confidence 12335689999999998 46778999999999999999999999997654211 11110 00 00000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+ ..+......+.+++..||+.||.+||++.||++
T Consensus 242 ~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 L------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 011222456889999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.69 Aligned_cols=252 Identities=13% Similarity=0.100 Sum_probs=184.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhc--CCCCcceEE-------EEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQV--HHRHLVSLV-------GYCT 268 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l--~Hpniv~l~-------g~~~ 268 (579)
.+|...+.||+|+||.||+|++. +|+.||||+++.... ...+.+++|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999975 789999999987543 3345677886555555 699988755 4444
Q ss_pred eC-----------------CeEEEEEEecCCCchhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCceE
Q 008052 269 FG-----------------SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR------MKIALGSARGLAYLHEDCQPKII 325 (579)
Q Consensus 269 ~~-----------------~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~------~~ia~~ia~gL~yLH~~~~~~iv 325 (579)
.. ...+|||||++ |+|.+++..... .+.+..+ +.|+.||+.||+|||++ +|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 33 33799999999 899999975422 3466667 78889999999999998 999
Q ss_pred eCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCC
Q 008052 326 HRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRP 403 (579)
Q Consensus 326 HrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~P 403 (579)
||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986532 1224567799999999987 6799999999999999999999999
Q ss_pred CCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 404 FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 404 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
|......... .|..... .......+. .........+.+++.+||+.||.+||++.|+++
T Consensus 293 f~~~~~~~~~---~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKG---SWKRPSL---------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTT---CCCBCCT---------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCccccc---chhhhhh---------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9876432111 1110000 000000000 111233467899999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.73 Aligned_cols=264 Identities=21% Similarity=0.291 Sum_probs=194.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 271 (579)
.++|...+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999975 6899999999653 2333467889999999999999999999997654
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999975 67777753 388999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhh-------------
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVD------------- 417 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~------------- 417 (579)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+...... +..
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 653321 2344679999999999999999999999999999999999999998654311000 000
Q ss_pred --hhhhHhhh--cccCCCchhhhchhhh----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 418 --WAKPFLAQ--GLADGNFDALVDQKLE----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 418 --~~~~~~~~--~~~~~~~~~l~d~~l~----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....++.. .+....+..+....+. .........+.+++.+||+.||.+||++.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000 0000111111111110 111234678999999999999999999999997
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.10 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=200.3
Q ss_pred cCccccceecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe--CCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF--GSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~--~~~~~lV~ 277 (579)
++|++.+.||+|+||.||+|+. .+++.||||+++... .+.+.+|+.+|.+++ |+||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999996 468999999997543 467899999999997 9999999999987 66789999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeecccccccCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDT 356 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGla~~~~~~ 356 (579)
||+++++|..++.. +++..+..|+.|++.||+|||++ +|+||||||+||||+.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998842 88999999999999999999998 999999999999999776 8999999999865433
Q ss_pred CcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH--------hhh--
Q 008052 357 DTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF--------LAQ-- 425 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~--------~~~-- 425 (579)
.. .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... ..+....... +..
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHHhc
Confidence 22 234578999999999977 679999999999999999999999996543211 1111111000 000
Q ss_pred ------------cccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 ------------GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 ------------~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
......+..+... .........+.+++.+||+.||.+||++.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHS---ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCT---TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccc---cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000001111111 111123467899999999999999999999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.35 Aligned_cols=264 Identities=20% Similarity=0.310 Sum_probs=205.4
Q ss_pred hcCccccceecccCceEEEEEEE--eCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC------CcceEEEEEEeCCe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVL--TNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR------HLVSLVGYCTFGSQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hp------niv~l~g~~~~~~~ 272 (579)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++.+++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999997 368999999997543 3356788999999998765 49999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC--------------
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-------------- 338 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-------------- 338 (579)
.+|||||+ +++|.+++.......+++..+..|+.|++.||+|||++ +|+||||||+||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 88999998766655689999999999999999999998 9999999999999987
Q ss_pred -----CCCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc
Q 008052 339 -----SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 413 (579)
Q Consensus 339 -----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~ 413 (579)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+.....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999864332 23457999999999999999999999999999999999999999765432111
Q ss_pred hhhhhh-----hhHhhhcccCCC------------------chhhhchhh--hcCCHHHHHHHHHHHHHhhccCCCCCCC
Q 008052 414 SMVDWA-----KPFLAQGLADGN------------------FDALVDQKL--EEYDSAEMTRMAACAAACIRHSARRRPR 468 (579)
Q Consensus 414 ~~~~~~-----~~~~~~~~~~~~------------------~~~l~d~~l--~~~~~~~~~~l~~l~~~cl~~dp~~RPt 468 (579)
...... ...+. ...... ......+.. ..........+.+++.+||+.||.+||+
T Consensus 244 ~~~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 244 AMMERILGPLPKHMIQ-KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHCSCCHHHHH-HCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHhCCCCHHHHh-hccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 110000 00000 000000 000000000 0123456778999999999999999999
Q ss_pred HHHHHH
Q 008052 469 MSQIVR 474 (579)
Q Consensus 469 m~evl~ 474 (579)
+.||++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=342.68 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=200.3
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
..++|...+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999976 58999999997643 24678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999988632 24589999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .. + . .... ....+
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~-~--~-~~~~-~~~~~------ 245 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AI-F--M-IPTN-PPPTF------ 245 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH-H--H-HHHS-CCCCC------
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HH-H--H-HhcC-CCccc------
Confidence 2234569999999999999999999999999999999999999997644211 00 0 0 0000 00000
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+++..||+.||.+||++.|+++
T Consensus 246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011122456889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=349.46 Aligned_cols=265 Identities=20% Similarity=0.259 Sum_probs=198.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTF--------G 270 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--------~ 270 (579)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++.+++|+||++++++|.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 67999999999999999999974 689999999855432 224578899999999999999999999987 4
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
+..+|||||+++ +|...+.... ..+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999986 6666665432 3489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCC---cceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 351 KHSLDTD---THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 351 ~~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
+...... ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ........ ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~-~~ 247 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLC-GS 247 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH-CC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh-CC
Confidence 8654222 122244578999999999876 4689999999999999999999999987543211 11000000 00
Q ss_pred ccCCCchhhhch---------hhhcCC-H------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 427 LADGNFDALVDQ---------KLEEYD-S------AEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 427 ~~~~~~~~l~d~---------~l~~~~-~------~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.....+....+. ...... . .....+.+++.+||+.||.+||++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000000 000000 0 012458899999999999999999999973
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=380.62 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=205.5
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 273 (579)
...++|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..+|..+ +|+||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999976 58899999997531 22345678899999987 699999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+|||||+++|+|.++++.. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999999754 3489999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.. +.....
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i----------- 554 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSI----------- 554 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-----------
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHH-----------
Confidence 3322 2334578999999999999999999999999999999999999999765421 111111
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM-----SQIVR 474 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm-----~evl~ 474 (579)
+...+ .++......+.+++..||+.||.+||++ .||++
T Consensus 555 --~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 555 --MEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --HSSCC-CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --HhCCC-CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11111 2333445678999999999999999997 66653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.86 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=187.0
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.+..++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999854 68899999986543 2335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccc
Q 008052 276 VYEFVPNKTLEFHLHG------KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGl 349 (579)
||||+++++|.+++.. .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999998853 1234589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCc----ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 350 AKHSLDTDT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 350 a~~~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
+........ .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ +. ..+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LM----LTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH----HHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HH----HHhc
Confidence 876543211 11234569999999999875 5689999999999999999999999976543211 00 0000
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .........+. .........+.+++.+||+.||.+||++.|+++
T Consensus 242 ~~-~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 ND-PPSLETGVQDK---EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SS-CCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cC-CCccccccccc---hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 00000000111 111223356889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=367.23 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=204.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+|.+++|||||+++++|...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999976 68999999985432 33467899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe---CCCCCeEEeeccccccc
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHS 353 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl---~~~~~~kL~DFGla~~~ 353 (579)
|||+.+|+|.+++... ..+++..+..|+.|++.||+|||++ +|+||||||+|||| +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999988654 3589999999999999999999998 99999999999999 56789999999999875
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+.... ..+.+.
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i--------~~~~~~ 245 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKV--------EKGKYT 245 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH--------HHCCCC
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH--------HcCCCC
Confidence 4332 2244579999999999875 7999999999999999999999999765431 111110 011110
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. ..+. .......+.+++..||+.||.+||++.|+++
T Consensus 246 ~-~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 F-ELPQ----WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-CSGG----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CCcc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 0001 1123456889999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.95 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=203.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---------hhHHHHHHHHHHHHhcC-CCCcceEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---------QGEREFQAEIEIISQVH-HRHLVSLVGYCTF 269 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---------~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~ 269 (579)
.++|...+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999975 689999999965431 12356789999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccc
Q 008052 270 GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGL 349 (579)
Q Consensus 270 ~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGl 349 (579)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999998653 3589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhc------cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
+....... ......|++.|+|||++. ...++.++||||||++||||++|+.||...... . ......
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~ 242 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---L---MLRMIM 242 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHH
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---H---HHHHHh
Confidence 98654322 223456999999999985 456889999999999999999999999754321 1 111111
Q ss_pred hhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 424 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. +.+. ...+. .......+.+++..||+.||.+||++.|+++
T Consensus 243 ~-----~~~~-~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 S-----GNYQ-FGSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H-----TCCC-CCTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c-----CCcc-cCccc----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 1100 00011 1123456889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.17 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=196.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 271 (579)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367999999999999999999974 6899999998543 2233467889999999999999999999997653
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 8899998864 3489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhhhh---hhHhhhc
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWA---KPFLAQG 426 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~~~---~~~~~~~ 426 (579)
..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+...... +.... ...+.+.
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 75332 244678999999999876 689999999999999999999999998655321100 00000 0000000
Q ss_pred ccCCCchhh-------hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDAL-------VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l-------~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+........ ....+..........+.+++.+||+.||.+||++.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000 001111222234567899999999999999999999997
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=379.22 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=206.5
Q ss_pred HHhhcCccccceecccCceEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
.+..++|...+.||+|+||.||+|.+.. +..||||+++.... ...+.|.+|+.+|.+++||||++++++|. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3455789999999999999999999742 56899999876433 33467999999999999999999999985 456
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred eEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 899999999999999997543 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
.............+|+.|+|||++.+..++.++|||||||+||||++ |..||...... .+..... .+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~--------~~- 608 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE--------NG- 608 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH--------HT-
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH--------cC-
Confidence 65444333344567889999999999999999999999999999997 99999765421 1111110 00
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.....+...+..+.+++..||+.||.+||++.||++.|+..
T Consensus 609 -------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 -------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00012233456789999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=366.29 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=197.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.+.|...+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+|++++|||||+++++|.+....+|||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356999999999999999999976 68899999987543 223567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeecccccccC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAKHSL 354 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFGla~~~~ 354 (579)
||+++|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999998888543 3489999999999999999999998 9999999999999976 4559999999998754
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .+. .... .+.+.
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~-----~~~~~- 255 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EIL---RKVE-----KGKYT- 255 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-----HTCCC-
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-----hCCCC-
Confidence 332 234467999999999987 57999999999999999999999999765431 111 1111 01000
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+.. ......+.+++..||+.||.+||++.|+++
T Consensus 256 ~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 FDSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000111 122356889999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=344.90 Aligned_cols=267 Identities=23% Similarity=0.340 Sum_probs=203.3
Q ss_pred hhcCccccceecccCceEEEEEEE--eCCeEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCcceEEEEEE----
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVL--TNGKVVAIKQLKAGSGQ--GEREFQAEIEIISQV---HHRHLVSLVGYCT---- 268 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~---- 268 (579)
..++|...+.||+|+||.||+|.. .+++.||||+++..... ....+.+|+.++.++ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999998 36889999998643221 123566777777766 8999999999997
Q ss_pred -eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeec
Q 008052 269 -FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADF 347 (579)
Q Consensus 269 -~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DF 347 (579)
.....++||||++ |+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 4567889999998 6999998766556699999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh---h
Q 008052 348 GLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL---A 424 (579)
Q Consensus 348 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---~ 424 (579)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... .+........ .
T Consensus 165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCG
T ss_pred cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCc
Confidence 9998653221 2234578999999999999999999999999999999999999998654311 1100000000 0
Q ss_pred hcccC------CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 QGLAD------GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 ~~~~~------~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.. ..+.......+..+.......+.+++.+||+.||.+||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 000000011111222334567889999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.56 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=200.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-------------hhHHHHHHHHHHHHhcCCCCcceEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-------------QGEREFQAEIEIISQVHHRHLVSLVGY 266 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~Ei~~l~~l~Hpniv~l~g~ 266 (579)
.++|...+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.+|.+++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999976 578999999865421 234678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC---CeE
Q 008052 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF---EAK 343 (579)
Q Consensus 267 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~---~~k 343 (579)
|.+....+||||||++|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+||||+.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999888643 3489999999999999999999998 999999999999998775 699
Q ss_pred EeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 344 VADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 344 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
|+|||+++...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .+.. ..
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i- 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIK---KV- 259 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HH-
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HH-
Confidence 99999998754332 234457999999999987 56999999999999999999999999765431 1111 10
Q ss_pred hhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 424 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.+.. ..+.. ......+.+++..||+.||.+||++.|+++
T Consensus 260 ----~~~~~~~-~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 ----EKGKYYF-DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ----HHCCCCC-CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HcCCCCC-Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0111000 00000 112356889999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.77 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=196.6
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------ 270 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------ 270 (579)
....++|...+.||+|+||.||+|+.. +|+.||||++..... .+.+|+.+|++++|+|||+++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 455678999999999999999999974 689999999865432 234799999999999999999998543
Q ss_pred --------------------------------CeEEEEEEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHh
Q 008052 271 --------------------------------SQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYL 316 (579)
Q Consensus 271 --------------------------------~~~~lV~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yL 316 (579)
...++||||++ ++|.+.+.. .....+++..+..|+.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 477666542 2234689999999999999999999
Q ss_pred hhcCCCceEeCCCCCCceEeC-CCCCeEEeecccccccCCCCcceeecccccccccChhhhccC-CCCcccceechHHHH
Q 008052 317 HEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLL 394 (579)
Q Consensus 317 H~~~~~~ivHrDikp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl 394 (579)
|+. +|+||||||+||||+ .++.+||+|||+++....... .....||..|+|||++.+. .++.++|||||||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 999999999999997 688999999999986543332 2345689999999998764 589999999999999
Q ss_pred HHHHhCCCCCCCCCccccchhhhhhhhHh-------h---hcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCC
Q 008052 395 LELITGFRPFDKADTFADDSMVDWAKPFL-------A---QGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSA 463 (579)
Q Consensus 395 ~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-------~---~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp 463 (579)
|||++|+.||...... +.+........ . .......+..+...... .++......+.+++.+||+.||
T Consensus 233 ~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999865432 11111111000 0 00000001111111111 1233345678999999999999
Q ss_pred CCCCCHHHHHH
Q 008052 464 RRRPRMSQIVR 474 (579)
Q Consensus 464 ~~RPtm~evl~ 474 (579)
.+||++.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=342.56 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=186.6
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch-h-HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ-G-EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~-~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
..++|+..+.||+|+||.||+|... +++.||||+++..... . .+.+.++..+++.++||||++++++|.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999974 7899999999765322 2 23445566668888999999999999999999999
Q ss_pred EEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 277 YEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
|||+++ +|.+++.. .....+++..+..|+.|++.||+|||+++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999974 77666643 12346999999999999999999999863 79999999999999999999999999998654
Q ss_pred CCCcceeecccccccccChhhh----ccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~----~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
... ......||+.|+|||++ ....++.++|||||||++|||++|+.||...... ...+. .... ..
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~----~~ 230 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQLK-QVVE----EP 230 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHHHH-HHHH----SC
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHHHH-HHhc----cC
Confidence 332 22334699999999996 5667899999999999999999999999753321 01110 0000 00
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. ...........+.+++.+||+.||.+||++.|+++
T Consensus 231 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 S--------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C--------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 00011123456899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=365.35 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=201.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.+|.+++|||||+++++|......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 367999999999999999999975 6899999998542 1233567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC---CCCCeEEeecccccccC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSL 354 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~---~~~~~kL~DFGla~~~~ 354 (579)
||+.+|+|.+++... ..+++..+..|+.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999888643 3489999999999999999999998 999999999999995 55679999999998654
Q ss_pred CCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchh
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (579)
... ......||+.|+|||++.+ .++.++|||||||+||+|++|+.||...... .+. .... .+.+..
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~-----~~~~~~ 241 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL---KRVE-----TGKYAF 241 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-----HTCCCS
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHH-----hCCCCC
Confidence 332 2344579999999999875 6999999999999999999999999765421 111 1110 111100
Q ss_pred hhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 435 l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+.. ......+.+++..||+.||.+||++.|+++
T Consensus 242 -~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 -DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -CSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -CCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00011 122356889999999999999999999997
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.68 Aligned_cols=267 Identities=19% Similarity=0.269 Sum_probs=200.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~ 273 (579)
.++|...+.||+|+||.||+|... +++.||||++..... .....+.+|+.+|.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357999999999999999999975 688999999975433 3346789999999999999999999999764 368
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+. ++|.+++... .+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999997 5898888543 489999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcc--eeecccccccccChhhhc-cCCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hhhhhhhHhhh---c
Q 008052 354 LDTDTH--VSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MVDWAKPFLAQ---G 426 (579)
Q Consensus 354 ~~~~~~--~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~~---~ 426 (579)
...... ......||+.|+|||++. ...++.++|||||||+||||++|+.||.......... +.......... .
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 432221 123457999999999875 4558999999999999999999999997765322110 00000000000 0
Q ss_pred ccCCCchhhhch-------hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+........... ............+.+++.+||+.||.+||++.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 000111223456889999999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.41 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=194.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC----C--eEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG----S--QRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~----~--~~~ 274 (579)
.+|...+.||+|+||.||+|++. +|+.||||++.... +.+.+|+++|++++|+|||+++++|... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999985 58999999986543 2344799999999999999999998542 2 356
Q ss_pred EEEEecCCCchhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-CCeEEeeccccc
Q 008052 275 LVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-FEAKVADFGLAK 351 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-~~~kL~DFGla~ 351 (579)
|||||+++ +|...+.. .....+++..+..++.||++||+|||++ +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 45444431 2234689999999999999999999998 99999999999999965 568999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH-------h
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF-------L 423 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~-------~ 423 (579)
....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...... +.+....... +
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 7543322 2345789999999999764 7999999999999999999999999875431 2222221110 0
Q ss_pred hhcccCCCchhhhchhhh------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 424 AQGLADGNFDALVDQKLE------EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~------~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
... ...+.....+.+. .+.......+.+|+.+||+.||.+||++.|+++
T Consensus 282 ~~~--~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REM--NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHH--CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Hhh--ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000 0011111001110 122233567899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=341.45 Aligned_cols=268 Identities=21% Similarity=0.299 Sum_probs=201.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----CeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~~ 273 (579)
.++|...+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 368999999999999999999976 689999999975433 3345788999999999999999999998764 678
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
++||||+. ++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 689888864 3589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcc---------eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 354 LDTDTH---------VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 354 ~~~~~~---------~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
...... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||...+... .+.... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~-~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH--QLLLIF-GII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH-HHh
Confidence 432211 1123468999999998764 779999999999999999999999998654211 000000 000
Q ss_pred hhcccCCCc--------hhhh-------chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 008052 424 AQGLADGNF--------DALV-------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 478 (579)
Q Consensus 424 ~~~~~~~~~--------~~l~-------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~ 478 (579)
......... ...+ ...+..........+.+++.+||+.||.+||++.|+++ .|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000000000 0000 00011111233467889999999999999999999997 4443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=345.17 Aligned_cols=270 Identities=21% Similarity=0.328 Sum_probs=205.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----------CCCcceEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----------HRHLVSLVGYCTF 269 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----------Hpniv~l~g~~~~ 269 (579)
++|.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 67999999999999999999974 68999999997533 34567889999999886 8999999999986
Q ss_pred CC----eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC------CC
Q 008052 270 GS----QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD------DS 339 (579)
Q Consensus 270 ~~----~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~------~~ 339 (579)
.+ ..++||||+ +++|.+++.......+++..++.|+.||+.||+|||+++ +|+||||||+||||+ ..
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 54 788999999 999999987655556999999999999999999999964 799999999999994 44
Q ss_pred CCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc----hh
Q 008052 340 FEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD----SM 415 (579)
Q Consensus 340 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~----~~ 415 (579)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||......... .+
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 58999999999865332 23457999999999999999999999999999999999999999865421110 01
Q ss_pred hhhhh-----------------hHhh-----hcccCCC---chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 008052 416 VDWAK-----------------PFLA-----QGLADGN---FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS 470 (579)
Q Consensus 416 ~~~~~-----------------~~~~-----~~~~~~~---~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ 470 (579)
..... .++. ..+.... +..+... ...++......+.+++..||+.||.+||++.
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE-KYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH-TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh-cccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 00000 0000 0000000 0011111 1145677888999999999999999999999
Q ss_pred HHHH--HHhcCC
Q 008052 471 QIVR--ALEGNM 480 (579)
Q Consensus 471 evl~--~Le~~~ 480 (579)
||++ .+.+..
T Consensus 330 ell~hp~f~~~~ 341 (373)
T 1q8y_A 330 GLVNHPWLKDTL 341 (373)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhhChhhhccc
Confidence 9997 455443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.74 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=196.8
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe------EEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ------RLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~------~~l 275 (579)
.+|...+.||+|+||.||+|++..+..||+|++..... ...+|+++|++++|+|||+++++|...+. .+|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 56999999999999999999998777799998865432 23469999999999999999999965433 789
Q ss_pred EEEecCCCchhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-CCCCeEEeeccccccc
Q 008052 276 VYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHS 353 (579)
Q Consensus 276 V~E~~~~g~L~~~l~-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-~~~~~kL~DFGla~~~ 353 (579)
||||++++.+....+ ......+++..+..++.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998865544332 11234589999999999999999999998 999999999999998 7899999999999875
Q ss_pred CCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH----------
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF---------- 422 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~---------- 422 (579)
..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...+.. +.+.......
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHh
Confidence 43322 2345789999999998764 5899999999999999999999999875532 1111111100
Q ss_pred hhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 423 LAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 423 ~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
....+....+..+....+. .+.......+.+++.+||+.||.+||++.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000001111111111111 1222345678999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=346.47 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=200.0
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--chhHHHHHHHHHHHHhcC--CCCcceEEEEEE
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVH--HRHLVSLVGYCT 268 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~ 268 (579)
.+..+....++|...+.||+|+||.||++...+++.||||++.... ......+.+|+.++.+++ |+||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 3334555668899999999999999999998889999999996543 334567899999999997 599999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 269 FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 269 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
..+..++||| +.+++|.+++... ..+++..++.|+.|++.||.|||++ +|+||||||+|||+++ +.+||+|||
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence 9999999999 5688999998654 3589999999999999999999998 9999999999999965 799999999
Q ss_pred cccccCCCCcc-eeecccccccccChhhhcc-----------CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhh
Q 008052 349 LAKHSLDTDTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 416 (579)
Q Consensus 349 la~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~ 416 (579)
+++........ ......||+.|+|||.+.+ ..++.++|||||||+||||++|+.||...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~- 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I- 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H-
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----H-
Confidence 99875433221 2234569999999999875 47889999999999999999999999754321 0
Q ss_pred hhhhhHhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 417 DWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.... .++++... .++......+.+++.+||+.||.+||++.||++
T Consensus 247 ~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 SKLH-------------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHH-------------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHH-------------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0000 11111111 122222456889999999999999999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=344.01 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=195.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEE-----------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCT----------- 268 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~----------- 268 (579)
.++|...+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367999999999999999999986 48999999998776666778999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-CCCCeEE
Q 008052 269 ---FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKV 344 (579)
Q Consensus 269 ---~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-~~~~~kL 344 (579)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999997 699998854 3488999999999999999999998 999999999999997 5679999
Q ss_pred eecccccccCCCCc--ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh
Q 008052 345 ADFGLAKHSLDTDT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 345 ~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
+|||+++....... .......+|..|+|||.+.. ..++.++|||||||+||||++|+.||........ +......
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh
Confidence 99999986543221 12234567999999998865 7799999999999999999999999986543111 0000000
Q ss_pred H------hhhcccCCCchhhhchh-------hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 422 F------LAQGLADGNFDALVDQK-------LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 422 ~------~~~~~~~~~~~~l~d~~-------l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. ..+.+. ..+...+... +..........+.+++.+||+.||.+||++.|+++
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 000000 0000000000 00111223567899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=351.72 Aligned_cols=262 Identities=22% Similarity=0.318 Sum_probs=185.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------C
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------S 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~ 271 (579)
.++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+.+|++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 378999999999999999999964 6899999999653 223456788999999999999999999999654 5
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 7899888854 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh------Hhh
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP------FLA 424 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~------~~~ 424 (579)
..... .+...||..|+|||++.+ ..++.++|||||||++|||++|+.||...+... .+...... ...
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELL 254 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 64332 244679999999999986 689999999999999999999999998755321 11100000 000
Q ss_pred hcccCCCchhhhch-------hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 425 QGLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 425 ~~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+........+.. .+..........+.+++.+||+.||.+||++.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000000000 0001111224568899999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.97 Aligned_cols=272 Identities=20% Similarity=0.266 Sum_probs=191.7
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ- 272 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~- 272 (579)
.+.....++|...+.||+|+||.||+|+.. +|+.||||++...... ...+.+|+..+..++||||++++++|...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677799999999999999999999975 6899999998654322 3456778888999999999999999976433
Q ss_pred ------EEEEEEecCCCchhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCceEeCCCCCCceEeCC-CCCe
Q 008052 273 ------RLLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGLAYLH--EDCQPKIIHRDIKSANILLDD-SFEA 342 (579)
Q Consensus 273 ------~~lV~E~~~~g~L~~~l~-~~~~~~l~~~~~~~ia~~ia~gL~yLH--~~~~~~ivHrDikp~NILl~~-~~~~ 342 (579)
.++||||++++.+..+.. ......+++..+..++.|++.||.||| +. +|+||||||+||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 789999998754332221 123345889999999999999999999 76 9999999999999996 8999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhh
Q 008052 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~ 421 (579)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...+... .+....+.
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHHH
Confidence 9999999987544332 2345789999999998655 48999999999999999999999998754321 11111110
Q ss_pred H------hhhcccC--CCchhh------hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 422 F------LAQGLAD--GNFDAL------VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 422 ~------~~~~~~~--~~~~~l------~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. ....+.. ..++.. ....+..........+.+++.+||+.||.+||++.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000000 000000 000011222234678999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.42 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=202.5
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 272 (579)
.+..+..++|...+.||+|+||.||+|...+ .||||+++.... ...+.+.+|+.++.+++|+||+++++++...+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3445556889999999999999999999854 489999865422 223567889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++||||+++++|.+++.... ..+++..++.|+.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999997543 3589999999999999999999998 999999999999998 67999999999875
Q ss_pred cCCCC----cceeecccccccccChhhhcc---------CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhh
Q 008052 353 SLDTD----THVSTRVMGTFGYLAPEYASS---------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWA 419 (579)
Q Consensus 353 ~~~~~----~~~~~~~~gt~~y~APE~~~~---------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~ 419 (579)
..... ........|++.|+|||.+.. ..++.++|||||||++|||++|+.||...... .+. +
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~-~- 253 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII-W- 253 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH-H-
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH-H-
Confidence 43211 112233459999999999874 45789999999999999999999999764421 111 0
Q ss_pred hhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 420 KPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
. + ..+.. +.+. .......+.+++..||+.||.+||++.+|++.|+...
T Consensus 254 -~-~----~~~~~-----~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 254 -Q-M----GTGMK-----PNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp -H-H----HTTCC-----CCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred -H-h----ccCCC-----CCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0 0 01100 0000 0112345889999999999999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=340.13 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=201.4
Q ss_pred hcCccccceecccCceEEEEEEEe-C-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC------cceEEEEEEeCCe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-N-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH------LVSLVGYCTFGSQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn------iv~l~g~~~~~~~ 272 (579)
.++|.+.+.||+|+||.||+|... + ++.||||+++... ...+.+.+|+.++.+++|+| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999975 3 4789999997542 34567889999999997665 9999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe----------------
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL---------------- 336 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl---------------- 336 (579)
.+|||||+ +++|.+++.......+++..++.|+.||+.||+|||++ +|+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 56666666555545699999999999999999999998 99999999999999
Q ss_pred ---CCCCCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccc
Q 008052 337 ---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 413 (579)
Q Consensus 337 ---~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~ 413 (579)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56789999999999864332 23457999999999999999999999999999999999999999865432110
Q ss_pred hhhhhh-----hhHhhhc------------ccCCC-----chhhhchhh--hcCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 008052 414 SMVDWA-----KPFLAQG------------LADGN-----FDALVDQKL--EEYDSAEMTRMAACAAACIRHSARRRPRM 469 (579)
Q Consensus 414 ~~~~~~-----~~~~~~~------------~~~~~-----~~~l~d~~l--~~~~~~~~~~l~~l~~~cl~~dp~~RPtm 469 (579)
...... ...+... +.... ......+.. ..........+.+++.+||+.||.+||++
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 000000 0000000 00000 000000000 01223456689999999999999999999
Q ss_pred HHHHH
Q 008052 470 SQIVR 474 (579)
Q Consensus 470 ~evl~ 474 (579)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.92 Aligned_cols=201 Identities=25% Similarity=0.335 Sum_probs=154.8
Q ss_pred cCccc-cceecccCceEEEEEEEe---CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEE
Q 008052 202 DNFSE-ANLLGQGGFGYVHKGVLT---NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLL 275 (579)
Q Consensus 202 ~~f~~-~~~LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~l 275 (579)
+.|.+ .++||+|+||.||+|++. +++.||||+++.... ...+.+|+.+|++++|||||+++++|.. ....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 457999999999999976 478899999975432 3468899999999999999999999965 678899
Q ss_pred EEEecCCCchhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe----CCCCCeEE
Q 008052 276 VYEFVPNKTLEFHLHG-------KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL----DDSFEAKV 344 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~-------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl----~~~~~~kL 344 (579)
||||+.+ +|.+++.. .....+++..+..|+.||+.||+|||++ +|+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 67666542 1123489999999999999999999998 99999999999999 77889999
Q ss_pred eecccccccCCCCc--ceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 345 ADFGLAKHSLDTDT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 345 ~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987543221 22344679999999999987 459999999999999999999999997654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.45 Aligned_cols=202 Identities=26% Similarity=0.309 Sum_probs=174.0
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CC-----CcceEEEEEEeCCe
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HR-----HLVSLVGYCTFGSQ 272 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hp-----niv~l~g~~~~~~~ 272 (579)
..++|...+.||+|+||.||+|+.. +++.||||+++... ....++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999976 68899999997542 33567788999998885 55 49999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC--CCCCeEEeecccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLA 350 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~--~~~~~kL~DFGla 350 (579)
.+|||||+. ++|.+++.......+++..+..|+.|++.||.|||.+ ..+||||||||+||||+ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 5999988766555699999999999999999999952 23899999999999994 4788999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCC
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~ 408 (579)
+..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 875432 234579999999999999999999999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=347.08 Aligned_cols=261 Identities=22% Similarity=0.332 Sum_probs=197.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE----
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR---- 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~---- 273 (579)
.++|...+.||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368999999999999999999975 68999999997643 23356788999999999999999999999876654
Q ss_pred --EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 274 --LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 274 --~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
++||||+. ++|..++.. .+++..+..|+.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 688877732 389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhh------hHhh
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK------PFLA 424 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~------~~~~ 424 (579)
..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+... .+..... ..+.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcHHHH
Confidence 64322 234578999999999987 789999999999999999999999998654311 1111000 0000
Q ss_pred hcccCCCchhhhch-------hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 425 QGLADGNFDALVDQ-------KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 425 ~~~~~~~~~~l~d~-------~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
..+........... ............+.+++..||+.||.+||++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000000 0001112235678999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=353.96 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=188.4
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.+|.++ +|||||++++++...+..+|||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3455678899999999987766789999999986532 35678999999986 8999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCC-----CCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC-------------CCe
Q 008052 281 PNKTLEFHLHGKDRPV-----MNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS-------------FEA 342 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~-----l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~-------------~~~ 342 (579)
. |+|.+++....... ..+..++.|+.||+.||+|||++ +|+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999997643211 13334578999999999999998 99999999999999653 489
Q ss_pred EEeecccccccCCCCcc---eeecccccccccChhhhcc-------CCCCcccceechHHHHHHHHh-CCCCCCCCCccc
Q 008052 343 KVADFGLAKHSLDTDTH---VSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 411 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~ 411 (579)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||+||||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 1234579999999999975 678999999999999999999 999997543211
Q ss_pred cchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .+.......... ..........+.+++.+||+.||.+||++.||++
T Consensus 248 ----~~----i~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SN----IIRGIFSLDEMK-------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HH----HHHTCCCCCCCT-------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH----HhcCCCCccccc-------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 01 111111111110 0123456678999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=341.70 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=176.6
Q ss_pred hcCcccc-ceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEE
Q 008052 201 TDNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRL 274 (579)
Q Consensus 201 ~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~ 274 (579)
.++|.+. ++||+|+||.||+|... +++.||||++.... ....+....+..+.|+||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678885 46999999999999986 68999999996532 222233334567789999999999976 44578
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeeccccc
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 351 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFGla~ 351 (579)
|||||+++|+|.+++.......+++..++.|+.|++.||+|||++ +|+||||||+||||+. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999876666799999999999999999999998 9999999999999976 4559999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.......... ... ..+..+.
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~-----~~~~~~~ 249 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMK-----RRIRLGQ 249 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHH-----Hhhhccc
Confidence 65332 2234568999999999998999999999999999999999999997654311000 000 0000000
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 478 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~ 478 (579)
+ .... .........+.+++..||+.||.+||++.|+++ .+..
T Consensus 250 ~-~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 Y-GFPN----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --CCCT----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred c-ccCc----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0 0000 111223456889999999999999999999997 5544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=335.13 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=193.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF---------- 269 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~---------- 269 (579)
.++|+..+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++.+++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999975 7899999999653 2345678999999999999999999999865
Q ss_pred ---CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEee
Q 008052 270 ---GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (579)
Q Consensus 270 ---~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~D 346 (579)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 346789999999999999997532 3478889999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCC-------------cceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCcccc
Q 008052 347 FGLAKHSLDTD-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412 (579)
Q Consensus 347 FGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~ 412 (579)
||+++...... ........||..|+|||.+.+. .++.++|||||||++|||++ ||.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--- 233 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--- 233 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---
Confidence 99998654221 1122345699999999999854 78999999999999999998 5532110
Q ss_pred chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 413 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
........ ..... .....+.......+.+++.+||+.||.+||++.|+++.
T Consensus 234 --~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 --RVNILKKL-----RSVSI-----EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHHHHH-----HSTTC-----CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHhc-----ccccc-----ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 01111110 00000 00012333445678899999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.04 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=192.2
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhc----CCCCcceEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQV----HHRHLVSLVGY 266 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l----~Hpniv~l~g~ 266 (579)
....++|...+.||+|+||.||+|... +++.||||+++..... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344578999999999999999999864 6889999999765332 123456799999999 89999999999
Q ss_pred EEeCCeEEEEEEe-cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-CCCCeEE
Q 008052 267 CTFGSQRLLVYEF-VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKV 344 (579)
Q Consensus 267 ~~~~~~~~lV~E~-~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-~~~~~kL 344 (579)
+...+..++|||| +.+++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 8899999998653 3489999999999999999999999 999999999999999 8899999
Q ss_pred eecccccccCCCCcceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh
Q 008052 345 ADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL 423 (579)
Q Consensus 345 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 423 (579)
+|||+++...... .....|+..|+|||++.+..+ +.++|||||||++|||++|+.||..... . .
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~-------~ 246 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I-------L 246 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------H
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H-------h
Confidence 9999998754322 234569999999999987666 4599999999999999999999964321 0 0
Q ss_pred hhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 424 AQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 424 ~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.. . . .++......+.+++.+||+.||.+||++.|+++.
T Consensus 247 ~~-----~--------~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 EA-----E--------L-HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HT-----C--------C-CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hh-----c--------c-CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 0 1122234568899999999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=341.67 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=197.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ----- 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~----- 272 (579)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++.+++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367999999999999999999975 68999999996542 2334678899999999999999999999987654
Q ss_pred -EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 273 -RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 273 -~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
.++||||+. ++|..++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 688877743 389999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhh------hHhh
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK------PFLA 424 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~------~~~~ 424 (579)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+... .+..... ..+.
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHHHH
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 64322 234578999999999986 678999999999999999999999998654311 1100000 0000
Q ss_pred hcccCCCchhhh-------chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 QGLADGNFDALV-------DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 ~~~~~~~~~~l~-------d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+.+........+ ...+..........+.+++.+||+.||.+||++.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000 00111122334567899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=332.24 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=201.9
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999976 68899999986532 23457899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC---CCeEEeeccccccc
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS---FEAKVADFGLAKHS 353 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~---~~~kL~DFGla~~~ 353 (579)
|||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999998887543 3489999999999999999999998 99999999999999754 47999999999865
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
..... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... . ...... .+.+.
T Consensus 175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~-----~~~~~ 240 (287)
T 2wei_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---D---ILKRVE-----TGKYA 240 (287)
T ss_dssp CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHH-----HCCCC
T ss_pred cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---H---HHHHHH-----cCCCC
Confidence 43321 233468999999999875 5899999999999999999999999765421 1 111111 11100
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. ..+.. ......+.+++..||+.||.+||++.|+++
T Consensus 241 ~-~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F-DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C-CSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-Cchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00001 122356889999999999999999999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=338.10 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=178.5
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHH-HHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIE-IISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.++|...+.||+|+||.||+|... +|+.||||+++.... ....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999985 689999999976533 33345556666 677789999999999999999999999
Q ss_pred EecCCCchhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 278 EFVPNKTLEFHLHG---KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 278 E~~~~g~L~~~l~~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
||+++ +|.+++.. .....+++..+..++.|++.||.|||+.. +|+||||||+||||+.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99986 77666542 22456899999999999999999999853 79999999999999999999999999998654
Q ss_pred CCCcceeecccccccccChhhh----ccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~----~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
... ......||+.|+|||++ .+..++.++|||||||+||||++|+.||....... +. +. .+..+
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~----~~-~~~~~ 245 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ----LT-QVVKG 245 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C-CCCCS
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH----HH-HHhcC
Confidence 322 22334699999999998 45678999999999999999999999997543210 00 00 00011
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
....+.. .........+.+++..||+.||.+||++.||++
T Consensus 246 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSN----SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCC----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCC----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1101100 111223457899999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.70 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=189.1
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
+...+|...+.||+|+||+||.....+++.||||++..... ..+.+|+.+|.++ +|||||++++++.+....+|||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 44467999999999999997665566789999999965432 2356899999999 7999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-----CCCeEEeecccccc
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKH 352 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-----~~~~kL~DFGla~~ 352 (579)
||+. |+|.+++..... .+.+...+.|+.||+.||+|||++ +|+||||||+||||+. ...+||+|||+++.
T Consensus 98 E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp ECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred ECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9996 599998876543 244556678999999999999998 9999999999999943 34688999999987
Q ss_pred cCCCCc--ceeecccccccccChhhhc---cCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhc
Q 008052 353 SLDTDT--HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 426 (579)
Q Consensus 353 ~~~~~~--~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 426 (579)
...... .......||+.|+|||++. ...++.++|||||||+||||++ |..||....... ... ..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~-~~-- 242 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANI-LL-- 242 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHH-HT--
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHH-Hh--
Confidence 543321 2234467999999999997 4667889999999999999999 999996433210 000 00
Q ss_pred ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.......+ .........+.+++.+||+.||.+||++.||++
T Consensus 243 -~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 -GACSLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -TCCCCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccCCcccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00011000 112234556789999999999999999999983
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.14 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=199.1
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcC--CCCcceEEEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVH--HRHLVSLVGYCT 268 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~ 268 (579)
....++|...+.||+|+||.||+|+.. +++.||||+++..... ....+.+|+.++.+++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344578999999999999999999964 6899999999654321 1245678999999996 599999999999
Q ss_pred eCCeEEEEEEecCC-CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-CCCCeEEee
Q 008052 269 FGSQRLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVAD 346 (579)
Q Consensus 269 ~~~~~~lV~E~~~~-g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-~~~~~kL~D 346 (579)
..+..++||||+.+ ++|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+||||+ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999986 8999988653 3589999999999999999999998 999999999999999 788999999
Q ss_pred cccccccCCCCcceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhh
Q 008052 347 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ 425 (579)
Q Consensus 347 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 425 (579)
||+++..... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||..... . ...
T Consensus 194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~-------~~~ 258 (320)
T 3a99_A 194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IRG 258 (320)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HHC
T ss_pred Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-------hcc
Confidence 9999875432 2234569999999999987665 7889999999999999999999964321 0 000
Q ss_pred cccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 426 GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 426 ~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .+.......+.+++.+||+.||.+||++.||++
T Consensus 259 ~~--------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 QV--------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CC--------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc--------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011122356889999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.70 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=180.2
Q ss_pred hhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh--HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~--~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
..++|...+.||+|+||.||+|... +|+.||||++....... .+.+.++..++..++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3468999999999999999999985 68999999997653322 23445556678888999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||+ ++.+..++.. ....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 5555544432 2345899999999999999999999831 8999999999999999999999999999765432
Q ss_pred CcceeecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 357 DTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
. ......||+.|+|||++. ...++.++|||||||+||||++|+.||...... . +........ .
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~~~~~-----~ 246 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--F---EVLTKVLQE-----E 246 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--H---HHHHHHHHS-----C
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--H---HHHHHHhcc-----C
Confidence 2 223456999999999994 567889999999999999999999999753321 0 111111100 0
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. +.+ .........+.+++..||+.||.+||++.||++
T Consensus 247 ~-----~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 P-----PLL-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C-----CCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C-----CCC-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 000 001123456889999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=322.26 Aligned_cols=232 Identities=12% Similarity=0.070 Sum_probs=185.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.|.+|+.++.+++|+||+++++++.+.+..+|||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999986 489999999976533 23467899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++... ....+.++|+.|++.||+|||++ +|+||||||+||||+.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999532 35557889999999999999998 99999999999999999999997443
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
|++ .++.++|||||||+||||++|+.||......... ..+. +.+ .+.. .
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~----~~~-~~~~---~- 223 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAE----RDT-AGQP---I- 223 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECC----BCT-TSCB---C-
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHH----HHh-ccCC---C-
Confidence 333 3688999999999999999999999876532110 0000 000 0000 0
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCCC
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPL 482 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~~ 482 (579)
............+.+++.+||+.||.+| ++.|+++.|+.....
T Consensus 224 -~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 -EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp -CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred -ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0011122334568999999999999999 999999999976543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=358.89 Aligned_cols=238 Identities=20% Similarity=0.320 Sum_probs=193.2
Q ss_pred hcCccccceecccCceEEEEEEEe--CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCe-----
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQ----- 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~----- 272 (579)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.+|.+++|||||+++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999985 58999999986543 3445678999999999999999999999987655
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.||||||+++++|.+++.. .++|.+++.|+.||+.||.|||++ +||||||||+||||+.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999887743 599999999999999999999998 99999999999999986 899999999987
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.... ....||+.|+|||++.++. +.++|||||||+||||++|..||....... +..
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------~~~--- 286 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------LPE--- 286 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------CCT---
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------ccc---
Confidence 5432 3456999999999998654 899999999999999999998876422100 000
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHhc
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVRALEG 478 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-m~evl~~Le~ 478 (579)
. .........+.+++.+||+.||.+||+ +.++...|.+
T Consensus 287 ---~-----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 ---D-----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ---T-----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---c-----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 000122356889999999999999995 6666666654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.79 Aligned_cols=230 Identities=21% Similarity=0.337 Sum_probs=179.9
Q ss_pred cCcccc-ceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHH-HhcCCCCcceEEEEEEe----CCeEE
Q 008052 202 DNFSEA-NLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEII-SQVHHRHLVSLVGYCTF----GSQRL 274 (579)
Q Consensus 202 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l-~~l~Hpniv~l~g~~~~----~~~~~ 274 (579)
++|... +.||+|+||.||+|... +++.||||+++.. ..+.+|+.++ ..++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567766 78999999999999974 6889999999642 4677888888 55689999999999987 66789
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeeccccc
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLAK 351 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFGla~ 351 (579)
|||||+++|+|.+++.......+++..++.|+.|++.||+|||+. +|+||||||+||||+. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 999999999999999876656799999999999999999999998 9999999999999998 7899999999986
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCC
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGN 431 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (579)
... +..++.++|||||||+||||++|+.||.......... . ....+..+.
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~-----~~~~~~~~~ 218 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G-----MKTRIRMGQ 218 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--C-----SCCSSCTTC
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--H-----HHHHHhhcc
Confidence 532 2456789999999999999999999997654311000 0 000000000
Q ss_pred chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 432 FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 432 ~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. .+..+.. ......+.+++..||+.||.+||++.|+++
T Consensus 219 ~-~~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 Y-EFPNPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp C-SSCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c-cCCchhc----ccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 0000000 123457899999999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=338.29 Aligned_cols=241 Identities=13% Similarity=0.141 Sum_probs=181.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch---hHHHHHHHHHHHHhcCC-CCcc----------e---
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---GEREFQAEIEIISQVHH-RHLV----------S--- 262 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~H-pniv----------~--- 262 (579)
..+|...+.||+|+||.||+|++. +|+.||||+++..... ..+.|++|+.++..++| +|.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 356788899999999999999964 6899999998744322 24679999999999987 3211 1
Q ss_pred --------EEEEEEe-----CCeEEEEEEecCCCchhhhhc-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 008052 263 --------LVGYCTF-----GSQRLLVYEFVPNKTLEFHLH-----GKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324 (579)
Q Consensus 263 --------l~g~~~~-----~~~~~lV~E~~~~g~L~~~l~-----~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 324 (579)
++.++.. ....+++|+++ +++|.+++. ......++|..++.|+.|+++||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 1111111 12346667655 789988884 23344588899999999999999999998 99
Q ss_pred EeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeecccccccccChhhh----------ccCCCCcccceechHHHH
Q 008052 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA----------SSGKLTEKSDVFSFGVLL 394 (579)
Q Consensus 325 vHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~~~ksDVwSlGvvl 394 (579)
|||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998864322 344568 999999999 556688999999999999
Q ss_pred HHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 395 LELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 395 ~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
|||++|+.||....... + +..++... ...+..+.+++..||+.||.+||++.|+++
T Consensus 308 ~elltg~~Pf~~~~~~~------~-------------~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALG------G-------------SEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGS------C-------------SGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhh------h-------------HHHHHhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999997654211 0 00111100 012356899999999999999999988864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=354.04 Aligned_cols=269 Identities=29% Similarity=0.391 Sum_probs=204.2
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCeE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF------GSQR 273 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~------~~~~ 273 (579)
++|.+.+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+.++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999974 6899999998764 33345678999999999999999999999765 6677
Q ss_pred EEEEEecCCCchhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCC---eEEeeccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKD-RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFE---AKVADFGL 349 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~---~kL~DFGl 349 (579)
++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+. +|+||||||+||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 23589999999999999999999998 9999999999999987665 99999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc--
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL-- 427 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-- 427 (579)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...|.........
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchh
Confidence 98754332 22446799999999999999999999999999999999999999975421 1222211110000
Q ss_pred ------cCCCchhh-hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHhcCC
Q 008052 428 ------ADGNFDAL-VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQ-----IVRALEGNM 480 (579)
Q Consensus 428 ------~~~~~~~l-~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~e-----vl~~Le~~~ 480 (579)
..+.+... ..+............+.+++..||+.||.+||++.| +++.|+...
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000000 000111344556788999999999999999999987 445555443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.09 Aligned_cols=243 Identities=16% Similarity=0.186 Sum_probs=187.1
Q ss_pred hhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCC--------chhHHHHHHHHHHHHhcC---------CCCcce
Q 008052 200 ATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS--------GQGEREFQAEIEIISQVH---------HRHLVS 262 (579)
Q Consensus 200 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------Hpniv~ 262 (579)
..++|...+.||+|+||.||+|+. +|+.||||+++... ....+.+.+|+.+|++++ |+|||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 346788999999999999999998 78999999997542 223467889999999885 899999
Q ss_pred EEEEEE------------------------------eCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 008052 263 LVGYCT------------------------------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 312 (579)
Q Consensus 263 l~g~~~------------------------------~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~g 312 (579)
+++++. ..+..+|||||+++|++.+.+.. ..+++..+..|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 888753 26789999999999977666633 458999999999999999
Q ss_pred HHHhh-hcCCCceEeCCCCCCceEeCCCC--------------------CeEEeecccccccCCCCcceeeccccccccc
Q 008052 313 LAYLH-EDCQPKIIHRDIKSANILLDDSF--------------------EAKVADFGLAKHSLDTDTHVSTRVMGTFGYL 371 (579)
Q Consensus 313 L~yLH-~~~~~~ivHrDikp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~ 371 (579)
|+||| ++ +|+||||||+||||+.++ .+||+|||+++.... ....||+.|+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeeccc
Confidence 99999 88 999999999999999887 899999999987543 2347999999
Q ss_pred ChhhhccCCCCcccceechHHH-HHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHH
Q 008052 372 APEYASSGKLTEKSDVFSFGVL-LLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTR 450 (579)
Q Consensus 372 APE~~~~~~~~~ksDVwSlGvv-l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~ 450 (579)
|||++.+.. +.++|||||+++ ++++++|..||... .|........+....+.. .............
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLKQMTFKT---KCNTPAMKQIKRK 311 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHHTCCCSS---CCCSHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhhhhccCc---ccchhhhhhcCHH
Confidence 999998665 899999998777 77888899998421 121111111000000000 0001123456788
Q ss_pred HHHHHHHhhccCCCCCCCHHHHH
Q 008052 451 MAACAAACIRHSARRRPRMSQIV 473 (579)
Q Consensus 451 l~~l~~~cl~~dp~~RPtm~evl 473 (579)
+.+++.+||+.| ++.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999977 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=297.67 Aligned_cols=186 Identities=18% Similarity=0.135 Sum_probs=131.4
Q ss_pred eecccCceEEEEEE-EeCCeEEEEEEeccCC----------chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 008052 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGS----------GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 209 ~LG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~----------~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++.|++|.+..++ .--|+.+|||.+.... ....++|.+|+++|+++ +|+||++|++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777776655 3358889999986531 12235799999999999 699999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
|||++|++|.++|.... .++.. +|+.||+.||+|||++ |||||||||+||||++++.+||+|||+++.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997543 35543 5899999999999999 9999999999999999999999999999875443
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCC
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf 404 (579)
.. ..+..+||++|||||++.+ .+..++|+|++|+++++|.++..++
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22 3345789999999999974 5778899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=268.78 Aligned_cols=184 Identities=16% Similarity=0.179 Sum_probs=146.7
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccCCc--h------hHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--Q------GEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~------~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
..+.||+|+||.||+|.. .++.+++|++..... . ..+.|.+|+++|++++||||+++..++...+..+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 567888888643221 1 1345889999999999999997666777788889999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++++|.+++.. ++.|+.|+++||+|||++ +|+||||||+|||++. .+||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999864 458999999999999998 9999999999999999 99999999999764432
Q ss_pred cce------eecccccccccChhhhcc--CCCCcccceechHHHHHHHHhCCCCCC
Q 008052 358 THV------STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVLLLELITGFRPFD 405 (579)
Q Consensus 358 ~~~------~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~eLltG~~Pf~ 405 (579)
... .....||+.|||||++.. ..|+...|+|+..+-.++.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 235689999999999986 668889999999999999888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.1e-25 Score=221.97 Aligned_cols=152 Identities=14% Similarity=0.092 Sum_probs=122.1
Q ss_pred HHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCc------------------hhHHHHHHHHHHHHhcCC
Q 008052 196 ELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------------------QGEREFQAEIEIISQVHH 257 (579)
Q Consensus 196 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H 257 (579)
.+......|...+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.+|.+++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444556777899999999999999997799999999965321 13456889999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC
Q 008052 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD 337 (579)
Q Consensus 258 pniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~ 337 (579)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+||||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 4 666665543 45689999999999988 421 23457999999999999998 999999999999999
Q ss_pred CCCCeEEeecccccccCCCCcceeecccccccccChhhhcc
Q 008052 338 DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378 (579)
Q Consensus 338 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~ 378 (579)
++.+||+|||+++. +..|+|||++..
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99999999999863 345789998863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=186.57 Aligned_cols=136 Identities=18% Similarity=0.156 Sum_probs=106.7
Q ss_pred ccccceecccCceEEEEEEE-eCCeE--EEEEEeccCCch------------------------hHHHHHHHHHHHHhcC
Q 008052 204 FSEANLLGQGGFGYVHKGVL-TNGKV--VAIKQLKAGSGQ------------------------GEREFQAEIEIISQVH 256 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~-~~g~~--vAvK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~ 256 (579)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999998 68999 999987543211 1236789999999998
Q ss_pred CCCc--ceEEEEEEeCCeEEEEEEecCC-C----chhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCceEeCC
Q 008052 257 HRHL--VSLVGYCTFGSQRLLVYEFVPN-K----TLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH-EDCQPKIIHRD 328 (579)
Q Consensus 257 Hpni--v~l~g~~~~~~~~~lV~E~~~~-g----~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~ivHrD 328 (579)
|+++ ..++++ +..+|||||+.+ | .|.+++.. +.+.....++.|++.+|.||| +. +|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8754 445443 356899999942 4 56555422 234567789999999999999 77 999999
Q ss_pred CCCCceEeCCCCCeEEeeccccccc
Q 008052 329 IKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 329 ikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
|||+|||++. .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7e-17 Score=168.76 Aligned_cols=136 Identities=14% Similarity=0.131 Sum_probs=101.7
Q ss_pred CccccceecccCceEEEEEEEeCCeEEEEEEeccCCc--------------hhHH--------HHHHHHHHHHhcCCCCc
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--------------QGER--------EFQAEIEIISQVHHRHL 260 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--------------~~~~--------~~~~Ei~~l~~l~Hpni 260 (579)
-|++.+.||.|+||.||+|...+|+.||||+++.... .... ....|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999988999999998754210 0011 12357777777765444
Q ss_pred c--eEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC
Q 008052 261 V--SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD 338 (579)
Q Consensus 261 v--~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~ 338 (579)
. ..+++ . ..+|||||++|+.|..++.. .....++.|++.+|.|||+. +||||||||.||||++
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 2 22222 1 23799999999998765421 12356889999999999998 9999999999999988
Q ss_pred CCC----------eEEeeccccccc
Q 008052 339 SFE----------AKVADFGLAKHS 353 (579)
Q Consensus 339 ~~~----------~kL~DFGla~~~ 353 (579)
++. +.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 763 899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=5.4e-13 Score=132.40 Aligned_cols=147 Identities=13% Similarity=0.048 Sum_probs=115.6
Q ss_pred HHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEE
Q 008052 197 LKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 197 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~l 275 (579)
+....+.|.....++.|+++.||+.... ++.+++|+...........+.+|+.+|..+. |.++.++++++...+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4445567888888999999999999754 6789999986532122346889999999985 6778899999999999999
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED------------------------------------ 319 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------ 319 (579)
||||++|.+|...+. .......++.+++++|..||..
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999987642 1123457889999999999981
Q ss_pred --------------------CCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 320 --------------------CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 320 --------------------~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..+.++|+|+++.|||++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01469999999999999876556799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=4.5e-12 Score=124.92 Aligned_cols=137 Identities=17% Similarity=0.086 Sum_probs=101.6
Q ss_pred CccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceEEEEEEeCCeEEEEEEec
Q 008052 203 NFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~g~~~~~~~~~lV~E~~ 280 (579)
++....+.+.|..+.||+....+|+.++||..... ....+..|+.+++.+.+.+ +.++++++..++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44443333455669999998777788999997654 2246788999999986545 456888888877889999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC---------------------------------------- 320 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~---------------------------------------- 320 (579)
+|.+|. ... .. ...++.++++.|..||...
T Consensus 98 ~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 98 PGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 999884 211 11 2356778888888888642
Q ss_pred ---------------CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 321 ---------------QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 321 ---------------~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
...++|+|+++.|||++++..+.|+|||.+..
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=6.7e-11 Score=123.04 Aligned_cols=143 Identities=16% Similarity=0.186 Sum_probs=108.3
Q ss_pred cccceecccCceEEEEEEEeCCeEEEEEEec--cCCc-hhHHHHHHHHHHHHhcC--CCCcceEEEEEEeC---CeEEEE
Q 008052 205 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLK--AGSG-QGEREFQAEIEIISQVH--HRHLVSLVGYCTFG---SQRLLV 276 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~--~~~~-~~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~---~~~~lV 276 (579)
...+.|+.|.++.||+....+ ..+++|+.. .... .....+.+|+.+|+.|. +.++.+++++|.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999988754 567888775 3321 22457889999999997 45688999998776 457899
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC------------------------------------ 320 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------ 320 (579)
|||++|..+.+.. ...++...+..++.++++.|+.||...
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999998885422 123678888899999999999999731
Q ss_pred -------------------CCceEeCCCCCCceEeCCCCC--eEEeecccccc
Q 008052 321 -------------------QPKIIHRDIKSANILLDDSFE--AKVADFGLAKH 352 (579)
Q Consensus 321 -------------------~~~ivHrDikp~NILl~~~~~--~kL~DFGla~~ 352 (579)
.+.++|+|+++.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.11 E-value=4.5e-11 Score=121.42 Aligned_cols=185 Identities=19% Similarity=0.220 Sum_probs=122.8
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCC--cceEEEEEEeCC---eEEEEEEec
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRH--LVSLVGYCTFGS---QRLLVYEFV 280 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpn--iv~l~g~~~~~~---~~~lV~E~~ 280 (579)
.+.|+.|.+..||+.. ..+++|+.... .....+.+|+.+|..+. +.. +.++++++...+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4679999999999863 45888886432 33567889999999884 332 345555544333 347899999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED----------------------------------------- 319 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----------------------------------------- 319 (579)
+|..|..... ..++..++..++.+++..|+.||..
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9998875332 1266777788888888888888851
Q ss_pred --------------CCCceEeCCCCCCceEeCC--CCCeEEeecccccccCCCCcceee--------------ccccccc
Q 008052 320 --------------CQPKIIHRDIKSANILLDD--SFEAKVADFGLAKHSLDTDTHVST--------------RVMGTFG 369 (579)
Q Consensus 320 --------------~~~~ivHrDikp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~--------------~~~gt~~ 369 (579)
..+.++|+|+++.|||+++ +..+.|+||+.+..... ...... ......+
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1246899999999999988 45678999998764311 100000 0011112
Q ss_pred ccC-hhhhccCCCCcccceechHHHHHHHHhCCCCC
Q 008052 370 YLA-PEYASSGKLTEKSDVFSFGVLLLELITGFRPF 404 (579)
Q Consensus 370 y~A-PE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf 404 (579)
+.. |+.... .....+.|++++++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222 332221 122368899999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=2.5e-07 Score=93.91 Aligned_cols=136 Identities=21% Similarity=0.208 Sum_probs=94.3
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC---CcceEEEEEE-eCCeEEEEEEecCC
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR---HLVSLVGYCT-FGSQRLLVYEFVPN 282 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hp---niv~l~g~~~-~~~~~~lV~E~~~~ 282 (579)
.+.++.|....||+. |+.++||+-. .......+..|+.+|..|.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467888999999987 5667888743 223356789999999999753 3567777774 34567899999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED------------------------------------------- 319 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------------- 319 (579)
..|...... .++...+..++.++++.|+.||..
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888653211 133444445555555555555532
Q ss_pred --------------CCCceEeCCCCCCceEeCC---CCC-eEEeecccccc
Q 008052 320 --------------CQPKIIHRDIKSANILLDD---SFE-AKVADFGLAKH 352 (579)
Q Consensus 320 --------------~~~~ivHrDikp~NILl~~---~~~-~kL~DFGla~~ 352 (579)
..+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999987 455 48999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=2.4e-07 Score=95.81 Aligned_cols=81 Identities=10% Similarity=-0.023 Sum_probs=57.6
Q ss_pred ccee-cccCceEEEEEEEe-------CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcC-C--CCcceEEEEEEeC--
Q 008052 207 ANLL-GQGGFGYVHKGVLT-------NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVH-H--RHLVSLVGYCTFG-- 270 (579)
Q Consensus 207 ~~~L-G~G~fg~Vy~~~~~-------~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--pniv~l~g~~~~~-- 270 (579)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+|..|. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88999999998765 26678888865432 111245778888888885 3 3567888888665
Q ss_pred -CeEEEEEEecCCCchhh
Q 008052 271 -SQRLLVYEFVPNKTLEF 287 (579)
Q Consensus 271 -~~~~lV~E~~~~g~L~~ 287 (579)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.6e-06 Score=85.75 Aligned_cols=135 Identities=17% Similarity=0.091 Sum_probs=93.7
Q ss_pred eecccCce-EEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 209 LLGQGGFG-YVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 209 ~LG~G~fg-~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
.+..|..| .||+.... ++..++||+-... ...++.+|..+|..+. +--+.++++++.+.+..+||||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 69987754 4567888886532 3467889999999885 33467889999999999999999999887
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------------
Q 008052 286 EFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED---------------------------------------------- 319 (579)
Q Consensus 286 ~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~---------------------------------------------- 319 (579)
.+..... ......++.+++..|.-||..
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 6543211 112233444555555555531
Q ss_pred ---------CCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 320 ---------CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 320 ---------~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999877677999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.27 E-value=2.5e-06 Score=87.08 Aligned_cols=140 Identities=19% Similarity=0.304 Sum_probs=81.3
Q ss_pred cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----CCCcceEE-E--EEEeCCeEEEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----HRHLVSLV-G--YCTFGSQRLLVYE 278 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----Hpniv~l~-g--~~~~~~~~~lV~E 278 (579)
.+.|+.|..+.||+....+| .+++|+.... ...+..|+.++..|. .|.++... | +....+..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987655 4889988652 233445556555553 24443310 1 1234677899999
Q ss_pred ecCCCchh--------------hhhcC----CC-C-------CCCCHHHHH-----------------------------
Q 008052 279 FVPNKTLE--------------FHLHG----KD-R-------PVMNWPTRM----------------------------- 303 (579)
Q Consensus 279 ~~~~g~L~--------------~~l~~----~~-~-------~~l~~~~~~----------------------------- 303 (579)
|++|..+. ..||. .. . ....|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11221 10 0 112343211
Q ss_pred --HHHHHHHHHHHHhhh----------cCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 304 --KIALGSARGLAYLHE----------DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 304 --~ia~~ia~gL~yLH~----------~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
.+...+..++++|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666763 124589999999999999888889999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=4.4e-06 Score=87.68 Aligned_cols=75 Identities=16% Similarity=0.105 Sum_probs=50.0
Q ss_pred cceecccCceEEEEEEEe-CCeEEEEEEeccCCc-------hhHHHHHHHHHHHHhcCC--CCc-ceEEEEEEeCCeEEE
Q 008052 207 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-------QGEREFQAEIEIISQVHH--RHL-VSLVGYCTFGSQRLL 275 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--pni-v~l~g~~~~~~~~~l 275 (579)
.+.||.|.++.||++... +++.++||....... .....+..|+++|..+.. +.+ .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 467899998653221 122356778899888742 343 456544 3455689
Q ss_pred EEEecCCC
Q 008052 276 VYEFVPNK 283 (579)
Q Consensus 276 V~E~~~~g 283 (579)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.10 E-value=8.5e-06 Score=81.59 Aligned_cols=80 Identities=16% Similarity=0.174 Sum_probs=59.9
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC---CCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---RHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H---pniv~l~g~~~~~~~~~lV~E 278 (579)
..+...+.+|.|..+.||+.++.||+.|+||+...........|..|+..|+.|.- -.+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 45666788999999999999999999999998755444444568899999998852 2345555543 2368999
Q ss_pred ecCCCch
Q 008052 279 FVPNKTL 285 (579)
Q Consensus 279 ~~~~g~L 285 (579)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.09 E-value=2.1e-05 Score=79.95 Aligned_cols=139 Identities=16% Similarity=0.150 Sum_probs=94.0
Q ss_pred cccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC---CCCcceEEEEEEeCCeEEEEEEecC
Q 008052 205 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH---HRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
...+.|+.|.+..+|+... ++..++||+.... ....|..|+..|+.|. ...+.++++++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3457799999999999876 4667888886542 3567889999998884 3568889999888888999999999
Q ss_pred CCchhh-----------hhcCCCC-C-------------------CCCHHHHH---HHH--HH--------------HHH
Q 008052 282 NKTLEF-----------HLHGKDR-P-------------------VMNWPTRM---KIA--LG--------------SAR 311 (579)
Q Consensus 282 ~g~L~~-----------~l~~~~~-~-------------------~l~~~~~~---~ia--~~--------------ia~ 311 (579)
+..+.. .||.... . .-+|.... ++. .+ ++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876521 2332211 0 12454321 111 11 111
Q ss_pred H-HHHhhh-cCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 312 G-LAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 312 g-L~yLH~-~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
- ...|.. ...+.+||+|+.+.|||++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223421 2356899999999999999887 8888974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.87 E-value=4.6e-05 Score=80.61 Aligned_cols=78 Identities=10% Similarity=0.101 Sum_probs=47.2
Q ss_pred CCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceeeccc--ccccccChhhhccC---CCCcccceechHHHHH
Q 008052 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVM--GTFGYLAPEYASSG---KLTEKSDVFSFGVLLL 395 (579)
Q Consensus 321 ~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~--gt~~y~APE~~~~~---~~~~ksDVwSlGvvl~ 395 (579)
.+.++|+|+++.|||++.++ ++|+||+.+...... ... .... -...|+++++.... .-....++..+...+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 34899999999999998876 999999988652110 000 0001 12346666655411 1122344557777777
Q ss_pred HHHhCC
Q 008052 396 ELITGF 401 (579)
Q Consensus 396 eLltG~ 401 (579)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.76 E-value=8.5e-05 Score=75.21 Aligned_cols=158 Identities=11% Similarity=0.095 Sum_probs=90.1
Q ss_pred CcCHHHHHHhhcCccc-----cceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC--cceE
Q 008052 191 TFTYEELKIATDNFSE-----ANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH--LVSL 263 (579)
Q Consensus 191 ~~~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l 263 (579)
.++.+++......|.. .+.|+.|....+|+....+| .+++|+..... ....+..|+.++..|...+ +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3556677666666654 34567788899999987666 57789876521 1234566777777764212 2223
Q ss_pred EE------EEEeCCeEEEEEEecCCCchhh--------------hhcCC----CCCC------CCHHHHHHH--------
Q 008052 264 VG------YCTFGSQRLLVYEFVPNKTLEF--------------HLHGK----DRPV------MNWPTRMKI-------- 305 (579)
Q Consensus 264 ~g------~~~~~~~~~lV~E~~~~g~L~~--------------~l~~~----~~~~------l~~~~~~~i-------- 305 (579)
+. +....+..+++|+|++|..+.. .+|.. .... ..|...+.-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 21 1123466789999999865421 12211 1110 123321110
Q ss_pred ----HHHHHHHHHHhhhc----CCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 306 ----ALGSARGLAYLHED----CQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 306 ----a~~ia~gL~yLH~~----~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
...+...+++|+.. ....++|+|+++.|||++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01134445555532 23479999999999999887556899998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00012 Score=77.80 Aligned_cols=73 Identities=21% Similarity=0.233 Sum_probs=51.3
Q ss_pred cceecccCceEEEEEEEeC--------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~ 277 (579)
.+.|+.|-...||+....+ ++.+++|+.... .....+..|+.++..|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4678889999999998753 467889987432 112455679999988863334 677776542 2899
Q ss_pred EecCCCch
Q 008052 278 EFVPNKTL 285 (579)
Q Consensus 278 E~~~~g~L 285 (579)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00074 Score=68.38 Aligned_cols=157 Identities=14% Similarity=0.121 Sum_probs=89.9
Q ss_pred cCHHHHHHhhcCcc-----ccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCC--CcceEE
Q 008052 192 FTYEELKIATDNFS-----EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHR--HLVSLV 264 (579)
Q Consensus 192 ~~~~el~~~~~~f~-----~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hp--niv~l~ 264 (579)
.+.+++....+.|. ....|+ |....||+....+|+.+++|....... ....+..|+.++..+... .+.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 34445544434332 234577 888999998776777799999864321 345677788888877422 233343
Q ss_pred EE-----EEeCCeEEEEEEecCCCchhh--------------hhcC----C---CCCCCCHHHH----HHH---------
Q 008052 265 GY-----CTFGSQRLLVYEFVPNKTLEF--------------HLHG----K---DRPVMNWPTR----MKI--------- 305 (579)
Q Consensus 265 g~-----~~~~~~~~lV~E~~~~g~L~~--------------~l~~----~---~~~~l~~~~~----~~i--------- 305 (579)
.. ...++..++||||++|..+.. .+|. . ....+++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 223556788999998865421 0111 1 0112232211 001
Q ss_pred ------HHHHHHHHHHhhhc----CCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 306 ------ALGSARGLAYLHED----CQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 306 ------a~~ia~gL~yLH~~----~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
...+...++.+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 00111122233221 234689999999999999 4 899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00034 Score=70.24 Aligned_cols=138 Identities=12% Similarity=0.063 Sum_probs=76.7
Q ss_pred ccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEec-CCC
Q 008052 206 EANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFV-PNK 283 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~-~~g 283 (579)
..+.|+.|....+|+. +.+++|+....... .....+|+.++..+...++ .++++++ .+.-++|+||+ ++.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 3678999999999998 45788887543211 1123568888877753333 4666543 33456899999 665
Q ss_pred chhh------------------hhcCCCCC---CCCH-HHHHHHHH--------------HHHHHHH----Hhhh-cCCC
Q 008052 284 TLEF------------------HLHGKDRP---VMNW-PTRMKIAL--------------GSARGLA----YLHE-DCQP 322 (579)
Q Consensus 284 ~L~~------------------~l~~~~~~---~l~~-~~~~~ia~--------------~ia~gL~----yLH~-~~~~ 322 (579)
+|.. .||..... .... .....+.. .+.+.+. .|.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 5531 12221110 0111 11111110 0111111 1111 1234
Q ss_pred ceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 323 KIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 323 ~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 6899999999999 5566789999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00051 Score=73.46 Aligned_cols=74 Identities=12% Similarity=0.086 Sum_probs=49.3
Q ss_pred cceecccCceEEEEEEEeC-CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEEEecCCCc
Q 008052 207 ANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVYEFVPNKT 284 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~g~ 284 (579)
.+.|+.|-...+|+....+ +..+++|+....... ..+...|..++..|...++ .++++++. +. +||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence 4678889899999998865 477888887443211 1122578899998875555 56777763 22 5999999855
Q ss_pred h
Q 008052 285 L 285 (579)
Q Consensus 285 L 285 (579)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00053 Score=69.80 Aligned_cols=141 Identities=14% Similarity=0.101 Sum_probs=73.2
Q ss_pred cceecccCceE-EEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEEEEEecCCC
Q 008052 207 ANLLGQGGFGY-VHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLLVYEFVPNK 283 (579)
Q Consensus 207 ~~~LG~G~fg~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~lV~E~~~~g 283 (579)
.+.|+.|.... +|+....+++.+++|....... .++..|+.++..+.. -.+.+++.++...+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566665554 6676654466777776543221 234556777776642 23556777654333 7899999776
Q ss_pred chhhhh---------------------cCCCC---CCCCHHHHH-------HH-------------HHHHHHHHHHhhh-
Q 008052 284 TLEFHL---------------------HGKDR---PVMNWPTRM-------KI-------------ALGSARGLAYLHE- 318 (579)
Q Consensus 284 ~L~~~l---------------------~~~~~---~~l~~~~~~-------~i-------------a~~ia~gL~yLH~- 318 (579)
.+...+ |.... +.++..... .+ ...+...++.|..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 654322 21111 111111100 00 0011112222211
Q ss_pred --cCCCceEeCCCCCCceEeCCC----CCeEEeecccccc
Q 008052 319 --DCQPKIIHRDIKSANILLDDS----FEAKVADFGLAKH 352 (579)
Q Consensus 319 --~~~~~ivHrDikp~NILl~~~----~~~kL~DFGla~~ 352 (579)
.....++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999874 6789999998864
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.40 E-value=3e-05 Score=52.05 Aligned_cols=21 Identities=24% Similarity=0.567 Sum_probs=14.0
Q ss_pred CCCCCCCcccceEehHhHHHH
Q 008052 65 NGYLPPGALAGMVVGVVIGAG 85 (579)
Q Consensus 65 ~~~l~~~~~~~i~vgv~v~~~ 85 (579)
+++++.++++||+||++++++
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~ 25 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAA 25 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHH
Confidence 346777777777777766543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00051 Score=71.58 Aligned_cols=140 Identities=17% Similarity=0.191 Sum_probs=84.0
Q ss_pred cceecccCceEEEEEEEeC--------CeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.+.|..|-...+|+....+ ++.+++|+..... .....+.+|..+++.|. +.-..+++++|.+ . +||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEE
Confidence 4567788889999988742 4678889863321 23456778999998885 3333567776643 2 899
Q ss_pred EecCCCchhhh-----------------hcCCCC---CCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 008052 278 EFVPNKTLEFH-----------------LHGKDR---PVMN--WPTRMKIALGSAR-------------------GLAYL 316 (579)
Q Consensus 278 E~~~~g~L~~~-----------------l~~~~~---~~l~--~~~~~~ia~~ia~-------------------gL~yL 316 (579)
||++|.+|... ||.... .... |.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998666321 222211 1122 3444444433321 22333
Q ss_pred hh----c-CCCceEeCCCCCCceEeCCC----CCeEEeeccccc
Q 008052 317 HE----D-CQPKIIHRDIKSANILLDDS----FEAKVADFGLAK 351 (579)
Q Consensus 317 H~----~-~~~~ivHrDikp~NILl~~~----~~~kL~DFGla~ 351 (579)
.+ . ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 1 23468999999999999876 689999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00045 Score=71.45 Aligned_cols=74 Identities=11% Similarity=0.032 Sum_probs=45.7
Q ss_pred cceecccCceEEEEEEEeC---------CeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-cceEEEEEEeCCeEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTN---------GKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-LVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~lV 276 (579)
.+.|+.|....+|+....+ ++.+++|+....... ..+...|..++..+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888889999998754 267888886543221 113467888888875334 34676554 2 2689
Q ss_pred EEecCCCch
Q 008052 277 YEFVPNKTL 285 (579)
Q Consensus 277 ~E~~~~g~L 285 (579)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00015 Score=50.09 Aligned_cols=30 Identities=20% Similarity=0.244 Sum_probs=16.3
Q ss_pred cceEehHhHHHHHHHHHHHHHHHHhhhccc
Q 008052 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103 (579)
Q Consensus 74 ~~i~vgv~v~~~~~l~~~~~~~~~~~rr~~ 103 (579)
.+|++||++|.++++++++++++++|||++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 346666666655555555555555555444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00015 Score=50.02 Aligned_cols=30 Identities=20% Similarity=0.298 Sum_probs=16.3
Q ss_pred cceEehHhHHHHHHHHHHHHHHHHhhhccc
Q 008052 74 AGMVVGVVIGAGIVLAAVGIFLIFYKRRKR 103 (579)
Q Consensus 74 ~~i~vgv~v~~~~~l~~~~~~~~~~~rr~~ 103 (579)
.+|++||++|.++++++++++++++||||+
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 446666666555555555555555555444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0012 Score=67.64 Aligned_cols=31 Identities=19% Similarity=0.293 Sum_probs=27.4
Q ss_pred CceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 322 ~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.011 Score=62.24 Aligned_cols=74 Identities=9% Similarity=0.085 Sum_probs=49.5
Q ss_pred cceecccCceEEEEEEEeC--------CeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeEEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ 277 (579)
.+.|..|-...+|+....+ ++.+++|+....... ..+..+|..+++.+. +.-..++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 4668888899999998763 577888886443211 123457888888875 33345666543 22 6899
Q ss_pred EecCCCch
Q 008052 278 EFVPNKTL 285 (579)
Q Consensus 278 E~~~~g~L 285 (579)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.0012 Score=45.28 Aligned_cols=30 Identities=23% Similarity=0.454 Sum_probs=15.1
Q ss_pred cccceEehHhHHHHHHHHHHHHHHHHhhhc
Q 008052 72 ALAGMVVGVVIGAGIVLAAVGIFLIFYKRR 101 (579)
Q Consensus 72 ~~~~i~vgv~v~~~~~l~~~~~~~~~~~rr 101 (579)
..++|++|+++|++++++++++++++||||
T Consensus 11 ~~~~I~~~vv~Gv~ll~~iv~~~~~~~rRr 40 (41)
T 2k9y_A 11 GNLAVIGGVAVGVVLLLVLAGVGFFIHRRR 40 (41)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred ceEEEEeehhHHHHHHHHHHHHheeEeeec
Confidence 345566666665555442444444444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=95.88 E-value=0.0033 Score=43.23 Aligned_cols=26 Identities=31% Similarity=0.514 Sum_probs=10.2
Q ss_pred EehHhHHHHHHHHHHHHHHHHhhhcc
Q 008052 77 VVGVVIGAGIVLAAVGIFLIFYKRRK 102 (579)
Q Consensus 77 ~vgv~v~~~~~l~~~~~~~~~~~rr~ 102 (579)
+++.++|.++++++.+++++|.||||
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhh
Confidence 44444553333333333333444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.63 E-value=0.11 Score=53.99 Aligned_cols=30 Identities=27% Similarity=0.405 Sum_probs=24.8
Q ss_pred ceEeCCCCCCceEe------CCCCCeEEeecccccc
Q 008052 323 KIIHRDIKSANILL------DDSFEAKVADFGLAKH 352 (579)
Q Consensus 323 ~ivHrDikp~NILl------~~~~~~kL~DFGla~~ 352 (579)
.++|+|+.+.|||+ +++..++|+||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4566799999988753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.62 E-value=0.063 Score=50.87 Aligned_cols=99 Identities=16% Similarity=0.097 Sum_probs=64.0
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcceee
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 362 (579)
-+|.+.|...+. .+++.+.+.++.|.++.|.-+-.... . ..+=+.+..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 478888876554 59999999999999999877621111 1 1233446899999999888764 1111
Q ss_pred cccccccccChhhhccCCCCcccceechHHHHHHHHh
Q 008052 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT 399 (579)
Q Consensus 363 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt 399 (579)
.....+.+||... ...+.+.=|||||++||.-+-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122356787764 345688899999999999876
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.73 E-value=0.71 Score=43.52 Aligned_cols=118 Identities=8% Similarity=0.044 Sum_probs=79.6
Q ss_pred hcCCCCcceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCc
Q 008052 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSAN 333 (579)
Q Consensus 254 ~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~N 333 (579)
...||+++.. .+-...+...+.|+.-+.+.=...+ ..++...+++++..|+.-..+++.. +|--|.|+|
T Consensus 41 ~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 41 EQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp GSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred hccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 3468999977 4556666666666544322212223 2378889999999999988777754 788999999
Q ss_pred eEeCCCCCeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCC
Q 008052 334 ILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405 (579)
Q Consensus 334 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~ 405 (579)
|+++.++.+++.-.|+-..+.... +..| .=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~~-------------~~ee----------~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPLP-------------VSEA----------EFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCCC-------------CCHH----------HHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCCCC-------------CCHH----------HHHHHHHHHHHHHHcCCCCHH
Confidence 999999999998887754322110 0111 112245678888888888775
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=90.61 E-value=0.12 Score=33.25 Aligned_cols=29 Identities=34% Similarity=0.720 Sum_probs=13.5
Q ss_pred CCCCcccceEehHhHHHHHHHHHHHHHHHHhhh
Q 008052 68 LPPGALAGMVVGVVIGAGIVLAAVGIFLIFYKR 100 (579)
Q Consensus 68 l~~~~~~~i~vgv~v~~~~~l~~~~~~~~~~~r 100 (579)
++.++++||++|.+ +..+++++.+||+.|
T Consensus 4 L~~gaIaGIVvgdi----~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 4 VSPGVLAGIVVGDL----VLTVLIALAVYFLGR 32 (33)
T ss_dssp CCTHHHHHHHHHHH----HHHHHHHHHHHHHCC
T ss_pred cCcceEEeEeHHHH----HHHHHHHHHHhheec
Confidence 44455555544444 334444444454443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.93 E-value=1.1 Score=42.35 Aligned_cols=86 Identities=7% Similarity=0.004 Sum_probs=62.3
Q ss_pred cCCCCcceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCceEeCCCCCCc
Q 008052 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA-YLHEDCQPKIIHRDIKSAN 333 (579)
Q Consensus 255 l~Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~-yLH~~~~~~ivHrDikp~N 333 (579)
..||++ -..+-.+++...+.|+.-+++.=...+ ..++...+++++..|+.... +++.. +|--|.|+|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N 114 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN 114 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence 368888 333446667766767654343333333 23788899999999998877 66654 788899999
Q ss_pred eEeCCCCCeEEeecccccc
Q 008052 334 ILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 334 ILl~~~~~~kL~DFGla~~ 352 (579)
|++|.++.++|.-.|+-..
T Consensus 115 L~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp EEECTTCCEEESCCEETTT
T ss_pred EEEeCCCcEEEEEcCCccc
Confidence 9999999999988887543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.84 E-value=0.2 Score=34.44 Aligned_cols=34 Identities=18% Similarity=0.298 Sum_probs=24.5
Q ss_pred CcccceEehHhHHHHHHHHHHHHHHHHhhhccch
Q 008052 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (579)
Q Consensus 71 ~~~~~i~vgv~v~~~~~l~~~~~~~~~~~rr~~~ 104 (579)
+++++-+||.+++++++++++.+++-.+++++++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~kR 44 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIVRKR 44 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCCSCC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhhccC
Confidence 3566666666666777778888889888877764
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.18 E-value=0.13 Score=35.35 Aligned_cols=34 Identities=18% Similarity=0.171 Sum_probs=25.7
Q ss_pred CcccceEehHhHHHHHHHHHHHHHHHHhhhccch
Q 008052 71 GALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (579)
Q Consensus 71 ~~~~~i~vgv~v~~~~~l~~~~~~~~~~~rr~~~ 104 (579)
+++++-+||.+++++++++++.+++-.++++++|
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhhhcc
Confidence 4577777776666777778888888888887775
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=88.15 E-value=0.077 Score=34.46 Aligned_cols=10 Identities=40% Similarity=0.448 Sum_probs=4.4
Q ss_pred HHHHHHhhhc
Q 008052 92 GIFLIFYKRR 101 (579)
Q Consensus 92 ~~~~~~~~rr 101 (579)
+.+.+++|||
T Consensus 25 l~~~~~iRRr 34 (35)
T 1iij_A 25 VVVGILIKRR 34 (35)
T ss_dssp TTTTHHHHHC
T ss_pred HHhheEEeec
Confidence 3344444544
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.00 E-value=0.68 Score=33.28 Aligned_cols=27 Identities=15% Similarity=0.034 Sum_probs=17.1
Q ss_pred cccceEehHhHHHHHHHHHHHHHHHHh
Q 008052 72 ALAGMVVGVVIGAGIVLAAVGIFLIFY 98 (579)
Q Consensus 72 ~~~~i~vgv~v~~~~~l~~~~~~~~~~ 98 (579)
....++++.++|++++++++.+++|.|
T Consensus 10 vp~wiIi~svl~GLllL~li~~~LwK~ 36 (54)
T 2knc_A 10 IPIWWVLVGVLGGLLLLTILVLAMWKV 36 (54)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 345666777777777766666666643
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.93 E-value=0.76 Score=32.91 Aligned_cols=27 Identities=7% Similarity=-0.070 Sum_probs=17.5
Q ss_pred cccceEehHhHHHHHHHHHHHHHHHHh
Q 008052 72 ALAGMVVGVVIGAGIVLAAVGIFLIFY 98 (579)
Q Consensus 72 ~~~~i~vgv~v~~~~~l~~~~~~~~~~ 98 (579)
....++++.++|++++++++++++|-|
T Consensus 7 vp~WiIi~svl~GLLLL~Lii~~LwK~ 33 (54)
T 2l8s_A 7 VPLWVILLSAFAGLLLLMLLILALWKI 33 (54)
T ss_dssp CCTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 345677777777777776666666633
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=83.71 E-value=0.39 Score=32.93 Aligned_cols=32 Identities=22% Similarity=0.367 Sum_probs=24.5
Q ss_pred cccceEehHhHHHHHHHHHHHHHHHHhhhccch
Q 008052 72 ALAGMVVGVVIGAGIVLAAVGIFLIFYKRRKRK 104 (579)
Q Consensus 72 ~~~~i~vgv~v~~~~~l~~~~~~~~~~~rr~~~ 104 (579)
.+++.+||+ +.++++++++++++-.++.+++|
T Consensus 13 ~Ia~~vVGv-ll~vi~~l~~~~~~RRR~~~~kK 44 (44)
T 2jwa_A 13 SIISAVVGI-LLVVVLGVVFGILIKRRQQKIRK 44 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHCSCCCC
T ss_pred chHHHHHHH-HHHHHHHHHHHhheehhhhhccC
Confidence 467788884 46777888888899888887764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.61 E-value=0.12 Score=55.17 Aligned_cols=61 Identities=3% Similarity=-0.020 Sum_probs=17.8
Q ss_pred ccceecccCceEEEEEEEeC-CeEEEE------EEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe
Q 008052 206 EANLLGQGGFGYVHKGVLTN-GKVVAI------KQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~~-g~~vAv------K~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~ 269 (579)
..+.|| ||.||+|.+.. ...||| |.++... ......|.+|..++..++|+|+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999999864 357888 7765432 2223468889999999999999999887643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 579 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-77 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-69 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-68 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-66 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-63 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (620), Expect = 6e-77
Identities = 76/294 (25%), Positives = 135/294 (45%), Gaps = 26/294 (8%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 254
++ +I + +G G FG V+KG V + + A + Q + F+ E+ ++ +
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
H +++ +GY T Q +V ++ +L HLH + + IA +A+G+
Sbjct: 61 TRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH-SLDTDTHVSTRVMGTFGYLAP 373
YLH IIHRD+KS NI L + K+ DFGLA S + +H ++ G+ ++AP
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 374 EYA---SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430
E + +SDV++FG++L EL+TG P+ + + D + +G
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG---- 225
Query: 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG---NMP 481
+ L + S M A C++ RP QI+ ++E ++P
Sbjct: 226 ----YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 3e-72
Identities = 79/283 (27%), Positives = 118/283 (41%), Gaps = 23/283 (8%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 254
+E ++ + LG G FG V G VA+K LK GS F AE ++ Q
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+ H+ LV L T ++ E++ N +L L + + +A A G+A
Sbjct: 65 LQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 374
++ E IHRD+++ANIL+ D+ K+ADFGLA+ D + + APE
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 375 YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDA 434
+ G T KSDV+SFG+LL E++T R T + + Q L G
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------VIQNLERGYRMV 230
Query: 435 LVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
D EE + C + RP + LE
Sbjct: 231 RPDNCPEE--------LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 1e-70
Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 9/221 (4%)
Query: 197 LKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQ 254
+++ D+F + + LG G G V K +G V+A K + R E++++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 255 VHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+ ++V G + + E + +L+ L R + K+++ +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 374
YL E KI+HRD+K +NIL++ E K+ DFG++ +D+ ++ +GT Y++PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 173
Query: 375 YASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSM 415
+ +SD++S G+ L+E+ G P D + M
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 2e-69
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 23/276 (8%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
+ +G G FG VH G N VAIK ++ G+ E +F E E++ ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L G C + LV+EF+ + L R + T + + L G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
+IHRD+ + N L+ ++ KV+DFG+ + LD ST + +PE S +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 382 TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441
+ KSDV+SFGVL+ E+ + + + + ++ + +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------------------VVEDISTGFRL 221
Query: 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
T + C + RP S+++R L
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 5e-69
Identities = 75/288 (26%), Positives = 114/288 (39%), Gaps = 23/288 (7%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEI 249
+ +I ++ LGQG FG V G VAIK LK G+ F E
Sbjct: 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEA 63
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+++ ++ H LV L + +V E++ +L L G+ + P + +A
Sbjct: 64 QVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
A G+AY+ + +HRD+++ANIL+ ++ KVADFGLA+ D +
Sbjct: 123 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 179
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429
+ APE A G+ T KSDV+SFG+LL EL T R +
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------- 223
Query: 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
D + + C R RP + LE
Sbjct: 224 --LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (562), Expect = 4e-68
Identities = 74/308 (24%), Positives = 128/308 (41%), Gaps = 40/308 (12%)
Query: 188 FKSTFTYEELKIATDNFSEA---------NLLGQGGFGYVHKGVLT----NGKVVAIKQL 234
F FT+E+ A F++ ++G G FG V G L VAIK L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 235 KAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD 293
K+G + + R+F +E I+ Q H +++ L G T + +++ EF+ N +L+ L D
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 122
Query: 294 RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353
+ + G A G+ YL +HRD+ + NIL++ + KV+DFGL++
Sbjct: 123 GQ-FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 354 LDTDTHVSTR----VMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
D + + + APE K T SDV+S+G+++ E+++
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----- 233
Query: 410 FADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRM 469
+ D + D +A+ + + C + RP+
Sbjct: 234 YWDMTNQDV-------------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 470 SQIVRALE 477
QIV L+
Sbjct: 281 GQIVNTLD 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 1e-67
Identities = 64/290 (22%), Positives = 122/290 (42%), Gaps = 29/290 (10%)
Query: 210 LGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF 269
+G+G FG V +G G+ VA+K + + +AEI + H +++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 270 G----SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC----- 320
+Q LV ++ + +L +L+ R + +K+AL +A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAK---HSLDTDTHVSTRVMGTFGYLAPEYAS 377
+P I HRD+KS NIL+ + +AD GLA + DT +GT Y+APE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 378 S------GKLTEKSDVFSFGVLLLELITGFRPF----DKADTFADDSMVDWAKPFLAQGL 427
+ +++D+++ G++ E+ D + D D + + + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ + + + ++ MA C + R +I + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALR--VMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-67
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 25/277 (9%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
+ + LG G FG V G VAIK +K GS E EF E +++ + H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L G CT ++ E++ N L +L +++ + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---S 118
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
+ +HRD+ + N L++D KV+DFGL+++ LD + S + PE K
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 382 TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441
+ KSD+++FGVL+ E+ + + P+ + + + Q L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKM-----------------PY--ERFTNSETAEHIAQGLR 219
Query: 442 EYDSAEMT-RMAACAAACIRHSARRRPRMSQIVRALE 477
Y + ++ +C A RP ++ +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 2e-66
Identities = 68/277 (24%), Positives = 110/277 (39%), Gaps = 29/277 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLV 261
+G+G FG V G G VA+K +K + + F AE +++Q+ H +LV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 262 SLVGYCTFGSQRL-LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
L+G L +V E++ +L +L + R V+ +K +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGK 380
+HRD+ + N+L+ + AKV+DFGL K + T + APE K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKK 176
Query: 381 LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440
+ KSDV+SFG+LL E+ + R + + D +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVP-----YPRIPLKDV-------------VPRVEKGYK 218
Query: 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ + C A RP Q+ LE
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 3e-66
Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 23/289 (7%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQGEREFQAE 248
S+ Y++ ++ + + + LG G +G V++GV VA+K LK + + E EF E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 249 IEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
++ ++ H +LV L+G CT ++ EF+ L +L +R ++ + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+ + YL + IHRD+ + N L+ ++ KVADFGL++
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428
+ APE + K + KSDV++FGVLL E+ T +
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------- 225
Query: 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
++ L E ++ AC + + RP ++I +A E
Sbjct: 226 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 8e-66
Identities = 64/314 (20%), Positives = 117/314 (37%), Gaps = 51/314 (16%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLK-AGSGQGEREFQ 246
L+ +N +G+G FG V + +VA+K LK S + +FQ
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 247 AEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR------------ 294
E ++++ + ++V L+G C G L++E++ L L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 295 ----------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKV 344
P ++ ++ IA A G+AYL E K +HRD+ + N L+ ++ K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 345 ADFGLAKHSLDTD-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRP 403
ADFGL+++ D ++ PE + T +SDV+++GV+L E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 404 FDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSA 463
+ + + + D + + C
Sbjct: 242 P-----YYGMAHEEV-------------IYYVRDGNILACPENCPLELYNLMRLCWSKLP 283
Query: 464 RRRPRMSQIVRALE 477
RP I R L+
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-64
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 32/291 (10%)
Query: 195 EELKIATDNFSEANL-LGQGGFGYVHKGVL---TNGKVVAIKQLKAGSGQGERE-FQAEI 249
++L + DN A++ LG G FG V +GV VAIK LK G+ + + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+I+ Q+ + ++V L+G C +LV E L L GK + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK--HSLDTDTHVSTRVMGT 367
+ G+ YL + +HRD+ + N+LL + AK++DFGL+K + D+ +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 368 FGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQG 426
+ APE + K + +SDV+S+GV + E ++ G +P+ +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK------KMKGPEV-------- 221
Query: 427 LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ K E + A + C + RP + + +
Sbjct: 222 -----MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 5e-64
Identities = 75/296 (25%), Positives = 120/296 (40%), Gaps = 36/296 (12%)
Query: 191 TFTYEELKIATDNFSEANLLGQGGFGYVHKGVLTNGK----VVAIKQLKAGSGQGE-REF 245
L + +F+E ++G+G FG V+ G L + A+K L + GE +F
Sbjct: 21 VIGPSSLIV---HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 246 QAEIEIISQVHHRHLVSLVGYCTFG-SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMK 304
E I+ H +++SL+G C L+V ++ + L + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG 134
Query: 305 IALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD---THVS 361
L A+G+ K +HRD+ + N +LD+ F KVADFGLA+ D + H
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKP 421
T ++A E + K T KSDV+SFGVLL EL+T P + D + D
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITV- 245
Query: 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
L+ + + C A RP S++V +
Sbjct: 246 ------------YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 1e-63
Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 29/282 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHR 258
+++ +G G +G K ++GK++ K+L GS ++ +E+ ++ ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 259 HLVSLVGYCTFGSQRLL--VYEFVPNKTLEFHLH--GKDRPVMNWPTRMKIALGSARGLA 314
++V + L V E+ L + K+R ++ +++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 315 YLHE--DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
H D ++HRD+K AN+ LD K+ DFGLA+ L+ DT + +GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMS 182
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432
PE + EKSD++S G LL EL PF S + LA + +G F
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKE-----LAGKIREGKF 231
Query: 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
+++ S E+ + + RP + +I+
Sbjct: 232 -----RRIPYRYSDELNEI---ITRMLNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-63
Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 30/295 (10%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLTNG-----KVVAIKQLKAGSGQGER-EFQAEIEI 251
+I + ++G G FG V+KG+L VAIK LKAG + +R +F E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ Q H +++ L G + +++ E++ N + + + + G A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD--THVSTRVMGTFG 369
G+ YL +HRD+ + NIL++ + KV+DFGL++ D T+ ++
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429
+ APE S K T SDV+SFG+++ E++T + +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------- 221
Query: 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDD 484
A+ D + + C + RRP+ + IV L+ + D
Sbjct: 222 -VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 9e-63
Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 34/291 (11%)
Query: 206 EANLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGSGQGE--REFQAEIEIISQVHHRHL 260
E LG G FG V KG K VA+K LK + E AE ++ Q+ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
V ++G C S +LV E L +L + +++ + G+ YL
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTR--VMGTFGYLAPEYASS 378
+ +HRD+ + N+LL AK++DFGL+K + + + + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 379 GKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437
K + KSDV+SFGVL+ E + G +P+ +M++ +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------------- 229
Query: 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMPLDDLNEG 488
E M C + RP + + L N D +NEG
Sbjct: 230 -GCPAGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLR-NYYYDVVNEG 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-61
Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 47/312 (15%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQGERE-FQA 247
+ + + S LG G FG V + VA+K LK + ERE +
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 248 EIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------------- 292
E++++S + +H ++V+L+G CT G L++ E+ L L K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 293 --DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350
D ++ + + A+G+A+L IHRD+ + NILL K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 351 KHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADT 409
+ + + V ++APE + T +SDV+S+G+ L EL +
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 410 FADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPR 468
D F ++ + M C +RP
Sbjct: 253 V------------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 294
Query: 469 MSQIVRALEGNM 480
QIV+ +E +
Sbjct: 295 FKQIVQLIEKQI 306
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-61
Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 32/277 (11%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHH 257
++F LG+G FG V+ + ++A+K L E + + E+EI S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
+++ L GY ++ L+ E+ P T+ L + + A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 377
++IHRDIK N+LL + E K+ADFG + H+ + + GT YL PE
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIE 177
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437
EK D++S GVL E + G PF+ ++ + K + F V
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISR---VEFTFPDFVT 228
Query: 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
+ + + ++H+ +RP + +++
Sbjct: 229 EGARD-----------LISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 1e-60
Identities = 66/305 (21%), Positives = 122/305 (40%), Gaps = 35/305 (11%)
Query: 194 YEELKI---ATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEI 249
YE + D + LG G FG V+K + A K + S + ++ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+I++ H ++V L+ + + ++ EF ++ + +RP + + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFG 369
L YLH+ KIIHRD+K+ NIL + K+ADFG++ + T + + GT
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175
Query: 370 YLAPEYA-----SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424
++APE K+DV+S G+ L+E+ P + + +
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----------VL 224
Query: 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR----ALEGNM 480
+A L S+ C+ + R SQ+++ ++ N
Sbjct: 225 LKIAKSEPPTL---AQPSRWSSNFKDF---LKKCLEKNVDARWTTSQLLQHPFVTVDSNK 278
Query: 481 PLDDL 485
P+ +L
Sbjct: 279 PIREL 283
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-60
Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 55/321 (17%)
Query: 190 STFTYEEL-KIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGE 242
+ Y+ + +N +LG G FG V VA+K LK + E
Sbjct: 24 REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83
Query: 243 RE-FQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGK-------- 292
RE +E+++++Q+ H ++V+L+G CT L++E+ L +L K
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 293 -------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS 339
D V+ + + A A+G+ +L +HRD+ + N+L+
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHG 200
Query: 340 FEAKVADFGLAKHSLDTDTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELI 398
K+ DFGLA+ + +V ++APE G T KSDV+S+G+LL E+
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 399 T-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAA 456
+ G P+ D NF L+ + + +
Sbjct: 261 SLGVNPYPGIPV-------------------DANFYKLIQNGFKMDQPFYATEEIYIIMQ 301
Query: 457 ACIRHSARRRPRMSQIVRALE 477
+C +R+RP + L
Sbjct: 302 SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-60
Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 32/273 (11%)
Query: 210 LGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGY 266
+G+G F V+KG+ T VA +L+ + + F+ E E++ + H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 267 CTFGSQR----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
+ +LV E + + TL+ +L VM +GL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRT-P 133
Query: 323 KIIHRDIKSANILLDD-SFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
IIHRD+K NI + + K+ D GLA + V+GT ++APE K
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYE-EKY 189
Query: 382 TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLE 441
E DV++FG+ +LE+ T P+ + + G+ +FD + +++
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 442 EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
E CIR + R + ++
Sbjct: 244 E-----------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-59
Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 42/295 (14%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNG---KVVAIKQLK-AGSGQGEREFQAEIEIISQV-H 256
++ +++G+G FG V K + AIK++K S R+F E+E++ ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTR 302
H ++++L+G C L E+ P+ L L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVST 362
+ A ARG+ YL Q + IHRD+ + NIL+ +++ AK+ADFGL++ T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 363 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF 422
++A E + T SDV+S+GVLL E+++ + + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----YCGMTCAEL---- 235
Query: 423 LAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
++ L E + C R RP +QI+ +L
Sbjct: 236 ---------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 2e-59
Identities = 66/282 (23%), Positives = 110/282 (39%), Gaps = 37/282 (13%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVH 256
FS+ +G G FG V+ + N +VVAIK++ Q ++ E+ + ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
H + + G LV E+ + K + + G+ +GLAYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 376
H +IHRD+K+ NILL + K+ DFG A ++ V GT ++APE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 183
Query: 377 SS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD-DSMVDWAKPFLAQGLADGNF 432
+ G+ K DV+S G+ +EL P + + + P L G F
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
VD C++ + RP +++
Sbjct: 244 RNFVDS-------------------CLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-59
Identities = 62/284 (21%), Positives = 113/284 (39%), Gaps = 28/284 (9%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSGQGERE-FQAEIEIIS 253
I + +G+G FG VH+G+ + VAIK K + RE F E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
Q H H+V L+G T ++ E L L + ++ + + A + L
Sbjct: 64 QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTAL 121
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
AYL + +HRDI + N+L+ + K+ DFGL+++ D+ + +++ ++AP
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433
E + + T SDV+ FGV + E++ + D
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------------------VIG 220
Query: 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ + + + + C + RRPR +++ L
Sbjct: 221 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-57
Identities = 62/289 (21%), Positives = 117/289 (40%), Gaps = 31/289 (10%)
Query: 197 LKIAT-DNFSEANLLGQGGFGYVHKGV-LTNGKV----VAIKQLK-AGSGQGEREFQAEI 249
L+I F + +LG G FG V+KG+ + G+ VAIK+L+ A S + +E E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 250 EIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGS 309
+++ V + H+ L+G C + +L + + +P L + + + + +
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL-LDYVREHKDNIGSQYLLNWCVQI 120
Query: 310 ARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTF 368
A+G+ YL +++HRD+ + N+L+ K+ DFGLAK + + +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLA 428
++A E T +SDV+S+GV + EL+T + +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-----YDGIPASEI---------- 222
Query: 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
L + + C A RP+ +++
Sbjct: 223 ---SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 3e-57
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHRH 259
+++ LG+G +G V V + VA+K + E + EI I ++H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V G+ G+ + L E+ L + M P + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLAPEYASS 378
I HRDIK N+LLD+ K++DFGLA + + ++ GT Y+APE
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 379 GKL-TEKSDVFSFGVLLLELITGFRPFD 405
+ E DV+S G++L ++ G P+D
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-57
Identities = 63/288 (21%), Positives = 99/288 (34%), Gaps = 31/288 (10%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLK---AGSGQGEREFQAEIEI 251
I + LG G FG V +G VA+K LK + +F E+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ + HR+L+ L G + +V E P +L K + T + A+ A
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSL-LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 312 GLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH--VSTRVMGTFG 369
G+ YL + IHRD+ + N+LL K+ DFGL + D H + F
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 370 YLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429
+ APE + + SD + FGV L E+ T + + + +G
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEG--- 231
Query: 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ + C H RP + L
Sbjct: 232 ---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-56
Identities = 68/302 (22%), Positives = 128/302 (42%), Gaps = 37/302 (12%)
Query: 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGSGQGER-EFQA 247
+E ++A + + + LGQG FG V++GV VAIK + + ER EF
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 248 EIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDR--------PVMNW 299
E ++ + + H+V L+G + G L++ E + L+ +L +
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 300 PTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-T 358
+++A A G+AYL K +HRD+ + N ++ + F K+ DFG+ + +TD
Sbjct: 133 SKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189
Query: 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 418
+ + +++PE G T SDV+SFGV+L E+ T + S
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGLSNEQV 244
Query: 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478
+++ L + + C +++ + RP +I+ +++
Sbjct: 245 -------------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
Query: 479 NM 480
M
Sbjct: 292 EM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-56
Identities = 74/303 (24%), Positives = 121/303 (39%), Gaps = 44/303 (14%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGV------LTNGKVVAIKQLKAGSGQGE-REFQAEIEI 251
D LG+G FG V + + VA+K LK G+ E R +E++I
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 252 ISQ-VHHRHLVSLVGYCTF-GSQRLLVYEFVPNKTLEFHLHGKD--------------RP 295
+ HH ++V+L+G CT G +++ EF L +L K +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
+ + + A+G+ +L K IHRD+ + NILL + K+ DFGLA+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 356 TDTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS 414
+V ++APE T +SDV+SFGVLL E+ + +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVK 241
Query: 415 MVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
+ + L +G + +Y + EM + C +RP S++V
Sbjct: 242 IDEEFCRRLKEG---------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVE 289
Query: 475 ALE 477
L
Sbjct: 290 HLG 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 8e-56
Identities = 58/294 (19%), Positives = 120/294 (40%), Gaps = 27/294 (9%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH 259
++ +GQG G V+ + + G+ VAI+Q+ + EI ++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V+ + G + +V E++ +L + M+ + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH-- 133
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
++IHRDIKS NILL K+ DFG + + + ++GT ++APE +
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439
K D++S G++ +E+I G P+ +++ + G + +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGNMPLDDLNEGITP 491
++ + R C+ +R ++++ L+ PL L I
Sbjct: 246 FRDF----LNR-------CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-53
Identities = 70/309 (22%), Positives = 121/309 (39%), Gaps = 46/309 (14%)
Query: 199 IATDNFSEANLLGQGGFGYVHKGVLT--------NGKVVAIKQLKAGSGQGE-REFQAEI 249
+ D LG+G FG V VA+K LK+ + + + + +E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 250 EIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRP------------- 295
E++ + H+++++L+G CT ++ E+ L +L + P
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 296 -VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354
++ + A ARG+ YL K IHRD+ + N+L+ + K+ADFGLA+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 355 DTDTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD 413
D + T ++APE T +SDV+SFGVLL E+ T +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-----YPGV 241
Query: 414 SMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIV 473
+ + F L + + S + C +RP Q+V
Sbjct: 242 PVEEL-------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 474 RALEGNMPL 482
L+ + L
Sbjct: 289 EDLDRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 8e-53
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 10/219 (4%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIIS 253
K ++F +LG+G F V L + AIK L+ E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
++ H V L + + N L ++ + L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSAL 121
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK-HSLDTDTHVSTRVMGTFGYLA 372
YLH IIHRD+K NILL++ ++ DFG AK S ++ + +GT Y++
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFA 411
PE + + SD+++ G ++ +L+ G PF + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 2e-51
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
D++ LG G FG VH+ G A K + + + EI+ +S + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
V+L ++ +++YEF+ L + + M+ ++ +GL ++HE+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN 144
Query: 321 QPKIIHRDIKSANILL--DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
+H D+K NI+ S E K+ DFGL H + T GT + APE A
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEG 199
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
+ +D++S GVL L++G PF +
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 175 bits (444), Expect = 3e-50
Identities = 66/271 (24%), Positives = 107/271 (39%), Gaps = 20/271 (7%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLK---AGSGQGEREFQAEIEIISQVH- 256
++FS ++G+GGFG V+ GK+ A+K L QGE E ++S V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 257 --HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLA 314
+V + + + + + L +HL V + A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLE 121
Query: 315 YLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPE 374
++H +++RD+K ANILLD+ +++D GLA H +GT GY+APE
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPE 175
Query: 375 YASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433
G +D FS G +L +L+ G PF + T + + L D
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSP 234
Query: 434 ALVD--QKLEEYDSAE-MTRMAACAAACIRH 461
L + L + D + + A
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (443), Expect = 3e-50
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 9/210 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
D + LG G FG VH+ V G+V K + + + EI I++Q+HH L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
++L + +L+ EF+ L + +D M+ + + GL ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE-- 145
Query: 321 QPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
I+H DIK NI+ + + K+ DFGLA + T + APE
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 202
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
+ +D+++ GVL L++G PF D
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (424), Expect = 8e-48
Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 16/265 (6%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIISQVHH 257
+F LG G FG VH NG+ A+K LK + E ++S V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
++ + G Q ++ +++ L L R + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 377
II+RD+K NILLD + K+ DFG AK+ D + GT Y+APE S
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVS 174
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437
+ + D +SFG+L+ E++ G+ PF ++T + A+ + D L
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL-- 232
Query: 438 QKLEEYDSAE-MTRMAACAAACIRH 461
+L D ++ + + H
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNH 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (420), Expect = 9e-48
Identities = 71/288 (24%), Positives = 122/288 (42%), Gaps = 32/288 (11%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGE---REFQAEIEIISQVH 256
+D + +LG GG VH L + VA+K L+A + F+ E + + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 257 HRHLVSLVGYC----TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARG 312
H +V++ G +V E+V TL +H + M +++ + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 313 LAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV--STRVMGTFGY 370
L + H+ IIHRD+K ANI++ + KV DFG+A+ D+ V + V+GT Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 371 LAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430
L+PE A + +SDV+S G +L E++TG PF DS V D
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSV---AYQHVREDP 231
Query: 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-MSQIVRALE 477
+ + L + A + + R + +++ L
Sbjct: 232 IPPSARHEGLSA-------DLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 1e-47
Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 194 YEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEI 251
+++ + D + ++LG G F V K+VAIK + + +G+ + EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 252 ISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSAR 311
+ ++ H ++V+L G L+ + V L + K ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLD 118
Query: 312 GLAYLHEDCQPKIIHRDIKSANILL---DDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+ YLH+ I+HRD+K N+L D+ + ++DFGL+K ++ V + GT
Sbjct: 119 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTP 173
Query: 369 GYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
GY+APE + ++ D +S GV+ L+ G+ PF
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-47
Identities = 47/207 (22%), Positives = 95/207 (45%), Gaps = 7/207 (3%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHR 258
+NF + +G+G +G V+K G+VVA+K+++ + EI ++ +++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
++V L+ ++ LV+EF+ ++ L+ + + P +GLA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
++HRD+K N+L++ K+ADFGLA+ + V+ +
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFD 405
+ D++S G + E++T F
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFP 204
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-47
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 10/207 (4%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
+ + A LG+G FG VH+ V ++ K K +K G + + EI I++ HR++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 261 VSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC 320
+ L + ++++EF+ + ++ +N + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS-- 120
Query: 321 QPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
I H DI+ NI+ S K+ +FG A+ D + Y APE
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQH 177
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFD 405
++ +D++S G L+ L++G PF
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFL 204
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-47
Identities = 61/292 (20%), Positives = 108/292 (36%), Gaps = 25/292 (8%)
Query: 200 ATDNFSEANLLGQGGFGYVHKG--VLTNGKVVAIKQLKAGSGQGEREFQAEIEI-----I 252
A + +G+G +G V K + G+ VA+K+++ +G+ E+ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 253 SQVHHRHLVSLVGYCTFGSQR-----LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIAL 307
H ++V L CT LV+E V + P + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMF 123
Query: 308 GSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGT 367
RGL +LH +++HRD+K NIL+ S + K+ADFGLA+ + + T V+ T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVT 178
Query: 368 FGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQ-- 425
Y APE D++S G + E+ F + + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 426 -----GLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQI 472
L F + Q +E++ + C+ + +R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (417), Expect = 3e-47
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSG---------QGEREFQAEIEI 251
+N+ +LG+G V + + K A+K + G + E++I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 252 ISQVH-HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
+ +V H +++ L + LV++ + L +L K ++ KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGY 370
+ LH+ I+HRD+K NILLDD K+ DFG + V GT Y
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSY 175
Query: 371 LAPEYASSG------KLTEKSDVFSFGVLLLELITGFRPFDKAD 408
LAPE ++ D++S GV++ L+ G PF
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-47
Identities = 70/265 (26%), Positives = 105/265 (39%), Gaps = 16/265 (6%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGERE---FQAEIEIIS-QVH 256
++F +LG+G FG V + AIK LK + + E ++S
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYL 316
H L + V E++ L +H+ + + A GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYA 376
H I++RD+K NILLD K+ADFG+ K ++ D +T GT Y+APE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 377 SSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436
K D +SFGVLL E++ G PF D + PF + L D L
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL- 234
Query: 437 DQKLEEYDSAEMTRMAACAAACIRH 461
KL + + R+ +H
Sbjct: 235 -VKLFVREPEK--RLGV-RGDIRQH 255
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 163 bits (413), Expect = 1e-46
Identities = 52/285 (18%), Positives = 104/285 (36%), Gaps = 18/285 (6%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLK--AGSGQGEREFQAEIEIISQVHHRH 259
+ + +G+G +G V+K G+ A+K+++ EI I+ ++ H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
+V L + +LV+E + + + + T L G+AY H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD- 118
Query: 320 CQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
+++HRD+K N+L++ E K+ADFGLA+ + ++ + S
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKADT----------FADDSMVDWAKPFLAQGLAD 429
K + D++S G + E++ G F + +W D
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN-VTELPKYD 235
Query: 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
NF E + + ++ +R Q +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 1e-45
Identities = 52/293 (17%), Positives = 98/293 (33%), Gaps = 31/293 (10%)
Query: 196 ELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQ 254
EL++ + + +G G FG ++ G + G+ VAIK + + E +I
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 255 VHHRHLVSLVGYC-TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
+ + + +C G ++V E + + + + T + +A +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRI 116
Query: 314 AYLHEDCQPKIIHRDIKSANIL---LDDSFEAKVADFGLAKHSLDTDTHV------STRV 364
Y+H IHRD+K N L + DFGLAK D TH + +
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 365 MGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424
GT Y + + + + D+ S G +L+ G P+ +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 230
Query: 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ + L + +E C +P S + +
Sbjct: 231 ------KKMSTPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 8e-45
Identities = 64/282 (22%), Positives = 112/282 (39%), Gaps = 21/282 (7%)
Query: 208 NLLGQGGFGYVHKGVLTN-GKVVAIKQLKAGSGQG-----EREFQAEIEIISQVHHRHLV 261
+ LG+G F V+K N ++VAIK++K G R EI+++ ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 262 SLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQ 321
L+ S LV++F+ + L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 322 PKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKL 381
I+HRD+K N+LLD++ K+ADFGLAK S + T + T Y APE ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 382 -TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV--------DWAKPFLAQGLADGNF 432
D+++ G +L EL+ + + + P + F
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474
+ L SA + + R +Q ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-44
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL 260
++++ ++G G FG V++ L +G++VAIK++ Q +R E++I+ ++ H ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 261 VSLVGYCTFGSQR------LLVYEFVPNKTLEFHLH-GKDRPVMNWPTRMKIALGSARGL 313
V L + ++ LV ++VP H + + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 314 AYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLA 372
AY+H I HRDIK N+LLD D+ K+ DFG AK L + + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 191
Query: 373 PEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTF 410
+ T DV+S G +L EL+ G F
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-43
Identities = 59/269 (21%), Positives = 97/269 (36%), Gaps = 13/269 (4%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK---AGSGQGEREFQAEIEIIS 253
K+ ++F LLG+G FG V G+ A+K L+ + E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 254 QVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGL 313
H L +L + V E+ L FHL + A +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYG---AEIV 115
Query: 314 AYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAP 373
+ L +++RDIK N++LD K+ DFGL K + GT YLAP
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAP 174
Query: 374 EYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433
E D + GV++ E++ G PF D ++ + + L+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 434 ALVDQKLEEYDSAE-MTRMAACAAACIRH 461
L L + D + + + A + H
Sbjct: 235 LL--AGLLKKDPKQRLGGGPSDAKEVMEH 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 4e-43
Identities = 40/282 (14%), Positives = 85/282 (30%), Gaps = 32/282 (11%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 266
+G+G FG + +G L N + VAIK + + E + + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIH 326
G +LV + + L + T A + +H + +++
Sbjct: 70 GQEGLHNVLVIDLLGP--SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 327 RDIKSANILLDDSFE-----AKVADFGLAKHSLDTDTHV------STRVMGTFGYLAPEY 375
RDIK N L+ V DFG+ K D T + GT Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 376 ASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435
+ + + D+ + G + + + G P+ + + + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--------IGEKKQSTP 236
Query: 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALE 477
+ + + + P +
Sbjct: 237 LRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 11/215 (5%)
Query: 201 TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE-FQAEIEIISQVHHR 258
++ + +G+G +G V N VAIK++ Q + EI+I+ + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHG--KDRPVMNWPTRMKIALGSARGLAYL 316
+++ + + + ++ + L+ K + ++ RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 317 HEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS--TRVMGTFGYLAPE 374
H ++HRD+K +N+LL+ + + K+ DFGLA+ + H T + T Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 375 YASSGKL-TEKSDVFSFGVLLLELITGFRPFDKAD 408
+ K T+ D++S G +L E+++ F
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 21/227 (9%)
Query: 190 STFTYEELKIATDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLK------AGSGQGE 242
+ F E + D + LG G F V K + G A K +K + G
Sbjct: 1 TVFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 243 REFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTR 302
+ + E+ I+ ++ H ++++L + +L+ E V L L K+ +
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEA 115
Query: 303 MKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD----SFEAKVADFGLAKHSLDTDT 358
+ G+ YLH I H D+K NI+L D K+ DFGLA +
Sbjct: 116 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFD 405
+ GT ++APE + L ++D++S GV+ L++G PF
Sbjct: 173 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-42
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 19/217 (8%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGY 266
+LG G G V + + A+K L+ + + E+E+ + H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 267 C----TFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQP 322
L+V E + L + + +I + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 323 KIIHRDIKSANILLDDSFE---AKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSG 379
I HRD+K N+L K+ DFG AK + ++ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 380 KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV 416
K + D++S GV++ L+ G+ PF A +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-42
Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 24/237 (10%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE------FQAEIEIISQVHHRH-- 259
LLG GGFG V+ G+ +++ VAIK ++ E E+ ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 260 LVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHED 319
++ L+ + +L+ E F +R + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN- 128
Query: 320 CQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
++HRDIK NIL+D + E K+ DFG DT T GT Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRY 183
Query: 379 GKL-TEKSDVFSFGVLLLELITGFRPFD------KADTFADDSMVDWAKPFLAQGLA 428
+ + V+S G+LL +++ G PF+ + F + + + LA
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 42/214 (19%), Positives = 85/214 (39%), Gaps = 8/214 (3%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHR 258
+ + +G+G +G V K ++VA+K+++ EI ++ ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 259 HLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHE 318
++V L + LV+EF ++ ++ + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFL---FQLLKGLGF 116
Query: 319 DCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASS 378
++HRD+K N+L++ + E K+A+FGLA+ S V+ + +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 379 GKLTEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
+ D++S G + EL RP + D
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 23/233 (9%)
Query: 189 KSTFTYEELKIAT----DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQG 241
+S F +E+ + + +G G +G V V G VAIK+L S
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 242 EREFQAEIEIISQVHHRHLVSLVGYCTFGSQR------LLVYEFVPNKTLEFHLHGKDRP 295
+ E+ ++ + H +++ L+ T LV F+ + H K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
+ + +GL Y+H IIHRD+K N+ +++ E K+ DFGLA+
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ--- 170
Query: 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
D+ ++ V+ + + + T+ D++S G ++ E+ITG F +D
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQG--EREFQAEIEIISQVHHR 258
+ + +GQG FG V K G+ VA+K++ + + EI+I+ + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 259 HLVSLVGYCTFGSQR--------LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSA 310
++V+L+ C + LV++F + + + ++ R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 311 RGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH---SLDTDTHVSTRVMGT 367
L L+ + KI+HRD+K+AN+L+ K+ADFGLA+ + ++ + T + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 368 FGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFD 405
Y PE + D++ G ++ E+ T
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 5e-39
Identities = 62/264 (23%), Positives = 92/264 (34%), Gaps = 14/264 (5%)
Query: 202 DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE---FQAEIEIISQVHH 257
D F LG G FG V +G A+K L ++ E I+ V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
LV L S +V E+V + HL R + P A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYAS 377
+I+RD+K N+L+D +V DFG AK + GT LAPE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIIL 211
Query: 378 SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437
S + D ++ GVL+ E+ G+ PF + K + + L+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSS-DLKDLLR 270
Query: 438 QKLEEYDSAEMTRMAACAAACIRH 461
L+ + + H
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNH 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 198 KIATDNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLK----AGSGQGEREFQAEI 249
K+ +NF +LG G +G V GK+ A+K LK + + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 250 EIISQV-HHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALG 308
+++ + LV+L ++ L+ +++ L HL ++R +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY----- 134
Query: 309 SARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVSTRVMGTF 368
+ L + II+RDIK NILLD + + DFGL+K + +T + GT
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 369 GYLAPEYASSGK--LTEKSDVFSFGVLLLELITGFRPFD 405
Y+AP+ G + D +S GVL+ EL+TG PF
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (331), Expect = 1e-34
Identities = 47/233 (20%), Positives = 95/233 (40%), Gaps = 22/233 (9%)
Query: 189 KSTFTYEELKIAT---DNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGERE 244
+ + YE + D++ LG+G + V + + +TN + V +K LK +++
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKK 75
Query: 245 FQAEIEIISQV-HHRHLVSLVGYCTFGSQRL--LVYEFVPNKTLEFHLHGKDRPVMNWPT 301
+ EI+I+ + ++++L R LV+E V N + +
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYD 130
Query: 302 RMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHV 360
+ L Y H I+HRD+K N+++D + + ++ D+GLA+ +
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 361 STRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFAD 412
+ + + PE ++ D++S G +L +I PF D
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 48/230 (20%), Positives = 89/230 (38%), Gaps = 25/230 (10%)
Query: 194 YEELKIATDNFSEAN------LLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQGERE 244
+ +++ F+ +G G G V + VAIK+L + +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 245 FQAEIEIISQVHHRHLVSLVGYCT------FGSQRLLVYEFVPNKTLEFHLHGKDRPVMN 298
E+ ++ V+H++++SL+ T LV E + + ++
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LD 117
Query: 299 WPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358
+ G+ +LH IHRD+K +NI++ K+ DFGLA+ +
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTS 172
Query: 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
+ T + T Y APE E D++S G ++ E++ F D
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 4e-32
Identities = 53/233 (22%), Positives = 93/233 (39%), Gaps = 23/233 (9%)
Query: 189 KSTFTYEELKIA----TDNFSEANLLGQGGFGYVHKGV-LTNGKVVAIKQLKAG--SGQG 241
+ TF +EL + + + +G G +G V G VA+K+L S
Sbjct: 1 RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 242 EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKD------RP 295
+ E+ ++ + H +++ L+ T + L HL G D
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQ 116
Query: 296 VMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355
+ + RGL Y+H HRD+K +N+ +++ E K+ DFGLA+H
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--- 170
Query: 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKAD 408
TD ++ V + + + D++S G ++ EL+TG F D
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 4e-31
Identities = 46/227 (20%), Positives = 81/227 (35%), Gaps = 20/227 (8%)
Query: 209 LLGQGGFGYVHKGV-LTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH---------- 257
LG G F V + N VA+K ++ E + EI+++ +V+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 258 -RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLH---GKDRPVMNWPTRMKIALGSARGL 313
H++ L+ + + V E L + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 314 AYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLDTDTHVSTR-VMGTFGYL 371
Y+H + IIH DIK N+L++ + +A + T Y
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 372 APEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDW 418
+PE +D++S L+ ELITG F+ + + D
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.9 bits (243), Expect = 4e-24
Identities = 26/154 (16%), Positives = 47/154 (30%), Gaps = 19/154 (12%)
Query: 208 NLLGQGGFGYVHKGVLTNGKVVAIKQLKAGS----------GQGEREFQAEIEIISQVHH 257
L+G+G V +K K G G+ F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 258 RHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLH 317
R L L G VY + N L + K+ + ++ +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 318 EDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351
I+H D+ N+L+ + + DF +
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 579 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.71 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.68 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=430.88 Aligned_cols=254 Identities=29% Similarity=0.462 Sum_probs=201.1
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
++|++.+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|...+..+|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999999889999999997654 345789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+|+|.+++.... ..++|..++.|+.|++.||+|||++ +|+||||||+||||++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999987543 4589999999999999999999998 999999999999999999999999999987655544444
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHhC-CCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG-FRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....||+.|||||++.++.++.++|||||||+||||+|+ ++||..... ..+..... ... .
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~----~~~------------~ 220 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIS----TGF------------R 220 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHH----HTC------------C
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----hcC------------C
Confidence 556799999999999999999999999999999999995 555543321 11111111 000 0
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+......+.+++..||+.||.+||+|+||++.|+..
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 012223346789999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=435.82 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=212.6
Q ss_pred HHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++..++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.|.+|+++|++++|||||+++|+|.+ +..+|||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 345578999999999999999999998889999999976543 35689999999999999999999998865 5678999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+++|+|.+++.......++|..+++|+.||++||.|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999999988765555699999999999999999999998 99999999999999999999999999999876554
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
........||+.|||||++.++.++.++|||||||+||||+||..|+..... ...+.... ..+.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i--------~~~~------ 227 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNL--------ERGY------ 227 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH--------HTTC------
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHH--------HhcC------
Confidence 4444556799999999999999999999999999999999996655433221 11111111 1110
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
....+...+..+.+++.+||+.||.+||+|.||++.|+.
T Consensus 228 --~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 001122344578999999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-54 Score=438.62 Aligned_cols=261 Identities=26% Similarity=0.356 Sum_probs=218.4
Q ss_pred HHhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
++..++|++.+.||+|+||+||+|++. +++.||||+++.+.. ..++|++|+.+|++++|||||+++|+|.+++..+||
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 345678999999999999999999986 588999999976543 356899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||++|+|.++|.......++|..+++|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999776667799999999999999999999998 9999999999999999999999999999976555
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.........|++.|||||++.++.++.++|||||||+||||++|..||...... ..+... +. .+.
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~----i~----~~~----- 233 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYEL----LE----KDY----- 233 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHH----HH----TTC-----
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHH----Hh----cCC-----
Confidence 444445567899999999999999999999999999999999977766433211 111111 11 100
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
....+...+..+.+++..||+.||.+||+|.||++.|+...
T Consensus 234 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 00223334567899999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-54 Score=432.25 Aligned_cols=260 Identities=29% Similarity=0.480 Sum_probs=206.2
Q ss_pred HhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+..++|.+.+.||+|+||+||+|++. ..||||+++.. .....+.|++|+.+|++++|||||+++|+|.+ +..+||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34578999999999999999999864 35999998654 34456789999999999999999999999865 567899
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||++|+|.++|+... ..++|..+++|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999997543 3599999999999999999999998 9999999999999999999999999999875443
Q ss_pred C-cceeecccccccccChhhhcc---CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 357 D-THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 357 ~-~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
. ........||+.|||||++.+ +.++.++|||||||+||||+||+.||....... . ....+.+.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~----~~~~~~~~------ 225 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIFMVGRG------ 225 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHHT------
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcC------
Confidence 2 223455679999999999964 458999999999999999999999997654311 1 11111111
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+.+.....+.+..+.+++.+||+.||.+||+|.||++.|+..
T Consensus 226 --~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 226 --YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp --SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111222233444557799999999999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-53 Score=431.81 Aligned_cols=267 Identities=27% Similarity=0.449 Sum_probs=204.4
Q ss_pred CcCHHHHHHhh---------cCccccceecccCceEEEEEEEeC-C---eEEEEEEeccCC-chhHHHHHHHHHHHHhcC
Q 008052 191 TFTYEELKIAT---------DNFSEANLLGQGGFGYVHKGVLTN-G---KVVAIKQLKAGS-GQGEREFQAEIEIISQVH 256 (579)
Q Consensus 191 ~~~~~el~~~~---------~~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~ 256 (579)
.++|+++..++ ++|++.++||+|+||+||+|++.. + ..||||++.... ....+.|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 34555555444 345667899999999999999752 2 368999986643 344568999999999999
Q ss_pred CCCcceEEEEEEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEe
Q 008052 257 HRHLVSLVGYCTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILL 336 (579)
Q Consensus 257 Hpniv~l~g~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl 336 (579)
|||||+++|+|...+..+||||||++|+|.+++.... ..++|.++++|+.||++||+|||++ +||||||||+||||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 9999999999999999999999999999999887543 3589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcc----eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccc
Q 008052 337 DDSFEAKVADFGLAKHSLDTDTH----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFA 411 (579)
Q Consensus 337 ~~~~~~kL~DFGla~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~ 411 (579)
+.++.+||+|||+++........ ......||+.|||||.+.++.++.++|||||||+||||+| |+.||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-- 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-- 239 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999876443221 1123458999999999999999999999999999999998 8999976542
Q ss_pred cchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 412 DDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..+.... ..+. + ...+.+.+..+.+++.+||+.||.+||+|.||++.|+..+
T Consensus 240 -~~~~~~i--------~~~~-------~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 240 -QDVINAI--------EQDY-------R-LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp -HHHHHHH--------HTTC-------C-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHHHHH--------HcCC-------C-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111111 0110 0 0223345567899999999999999999999999998653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-53 Score=420.01 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=215.0
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVP 281 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 281 (579)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|++|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 67899999999999999999998899999999986543 45789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCccee
Q 008052 282 NKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHVS 361 (579)
Q Consensus 282 ~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 361 (579)
+|+|..++.... ..+.+..+++|+.|+++||+|||++ +|+||||||+||||++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999998876543 3589999999999999999999998 999999999999999999999999999987655544444
Q ss_pred ecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 362 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 362 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+.. .+..+..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~--------~i~~~~~-------- 219 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAE--------HIAQGLR-------- 219 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH--------HHHTTCC--------
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHH--------HHHhCCC--------
Confidence 55679999999999999999999999999999999998 89999765431 1111 1111100
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
...+......+.+++.+||+.||++||++.||++.|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 01223344678999999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=419.01 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=202.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+++|+.+|++++|||||++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999975 68999999996543 23345789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC-c
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD-T 358 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~-~ 358 (579)
|++|+|.++|... ..+++.++..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+...... .
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999643 4599999999999999999999998 99999999999999999999999999998754332 2
Q ss_pred ceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
...+..+||+.|||||++.+..+ +.++|||||||+||||++|+.||....... .....+.. .....
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~~~--------~~~~~---- 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE--------KKTYL---- 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHHHT--------TCTTS----
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHHhc--------CCCCC----
Confidence 23455789999999999988776 678999999999999999999997654211 11111100 00000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.........+.+++.+||+.||.+||++.||++
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122356788999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=420.33 Aligned_cols=249 Identities=21% Similarity=0.368 Sum_probs=208.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
++|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 68999999997665555678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++|+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999887543 489999999999999999999998 999999999999999999999999999987644332 3
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
....+||+.|||||++.++.++.++|||||||+||||++|+.||...+... .+.. .... +.. .+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~----~~~~----~~~------~~ 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL----IATN----GTP------EL 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH----HHHH----CSC------CC
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HHHH----HHhC----CCC------CC
Confidence 345679999999999999999999999999999999999999997654211 1110 0100 000 00
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
..+......+.+++.+||+.||.+||++.|+++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233467889999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=419.16 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=208.5
Q ss_pred hcCccccce-ecccCceEEEEEEEe---CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 201 TDNFSEANL-LGQGGFGYVHKGVLT---NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 201 ~~~f~~~~~-LG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
.++|...+. ||+|+||.||+|++. ++..||||+++.... ...++|.+|+++|++++|||||+++|+|.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 466777774 999999999999864 356899999976543 345689999999999999999999999965 56889
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
|||||++|+|.+++.... ..+++..+++|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 86 vmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999876443 4599999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 356 TDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 356 ~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.... ......||+.|||||++..+.++.++|||||||+||||+| |+.||...... .+... + ..+..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i----~~~~~ 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----I----EQGKR 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----H----HTTCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----H----HcCCC
Confidence 4332 2234568999999999999999999999999999999998 99999765421 11111 1 11110
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+...+..+.+++..||+.||++||+|.+|++.|+..
T Consensus 231 --------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122334456789999999999999999999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-52 Score=413.67 Aligned_cols=245 Identities=27% Similarity=0.440 Sum_probs=206.4
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 68899999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|||++|+|.+++... ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999999999998643 3489999999999999999999998 9999999999999999999999999999875432
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......||+.|||||++.+..++.++|||||||+||||++|+.||...... .+. ... ....+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~---~~i-----~~~~~----- 221 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETY---KRI-----SRVEF----- 221 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHH-----HTTCC-----
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHH---HHH-----HcCCC-----
Confidence 234567999999999999999999999999999999999999999764421 111 100 01110
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.++......+.+++.+||+.||.+||++.||++
T Consensus 222 ----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122234467889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=420.65 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=194.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe--CCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF--GSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~lV 276 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.|.+|+++|++++|||||+++++|.+ .+..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999975 68999999997653 2334678899999999999999999999965 4567899
Q ss_pred EEecCCCchhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 277 YEFVPNKTLEFHLHGK--DRPVMNWPTRMKIALGSARGLAYLHEDC--QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~--~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
||||++|+|.+++... ....+++..++.|+.|++.||+|||+.. ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999988532 2456999999999999999999999862 12499999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
..... .......||+.|||||++.+..++.++|||||||+||||+||+.||...+.. .+. .. +..+.+
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~---~~-----i~~~~~ 231 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA---GK-----IREGKF 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HH-----HHHTCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHH---HH-----HHcCCC
Confidence 54332 2334578999999999999999999999999999999999999999764421 111 11 111111
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+......+.+++.+||+.||.+||++.|+++
T Consensus 232 --------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122233457899999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=419.84 Aligned_cols=258 Identities=29% Similarity=0.414 Sum_probs=206.9
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
.++|++.+.||+|+||+||+|++.+++.||||+++... ...+.|.+|+.+|++++|+|||+++|+|.+ +..+|||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 47899999999999999999999888899999997654 345789999999999999999999999964 5678999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++|+|..++.......++|.+++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999888765556699999999999999999999998 99999999999999999999999999998765444444
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKL 440 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l 440 (579)
.....||+.|+|||++..+.++.++|||||||+||||++|..||..... ...+..+.. .+. .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~--------~~~--------~ 232 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE--------RGY--------R 232 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH--------TTC--------C
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH--------hcC--------C
Confidence 4556799999999999999999999999999999999997666544322 111222211 000 0
Q ss_pred hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCCC
Q 008052 441 EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNMP 481 (579)
Q Consensus 441 ~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~~ 481 (579)
...+......+.+++.+||+.||++||+|.+|+++|+....
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 01223345678999999999999999999999999997543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-52 Score=417.63 Aligned_cols=258 Identities=27% Similarity=0.384 Sum_probs=201.9
Q ss_pred hcCccccceecccCceEEEEEEEeCC-----eEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNG-----KVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g-----~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
.+.|+..++||+|+||.||+|.+.+. ..||||+++.... ....+|++|+.+|++++|||||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999997642 4799999976543 33457999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
+|||||.+++|.+++.... ..++|.++++|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999988776433 4599999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCc--ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 355 DTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 355 ~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
.... .......||+.|||||++.++.++.++|||||||+||||++|..|+..... ...+.... ..+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i--------~~~-- 229 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAI--------NDG-- 229 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH--------HTT--
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHHH--------hcc--
Confidence 4322 223345689999999999999999999999999999999996665543221 11111111 111
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
.....+...+..+.+++.+||+.||.+||+|.||++.|+..+
T Consensus 230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111223345567899999999999999999999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=420.36 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=206.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
+.|++.+.||+|+||+||+|+.. +++.||||+++.......+.|.+|+++|++++|||||+++++|.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 68999999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV 360 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 360 (579)
++|+|.+++.... ..+++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++...... ..
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 9999999875432 3589999999999999999999998 99999999999999999999999999997542211 12
Q ss_pred eecccccccccChhhhc-----cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 361 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.....||+.|||||++. ...|+.++|||||||+||||++|+.||....... .+.. .. .+....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~----i~-----~~~~~~- 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLK----IA-----KSEPPT- 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHH----HH-----HSCCCC-
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHH----HH-----cCCCCC-
Confidence 23467999999999984 4568999999999999999999999997654321 1111 01 000000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+ ..+......+.+++.+||+.||.+||++.|+++
T Consensus 235 ----~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ----L-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----C-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----C-CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 112233457889999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=415.32 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=199.4
Q ss_pred ceecccCceEEEEEEEeC---CeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEecCC
Q 008052 208 NLLGQGGFGYVHKGVLTN---GKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFVPN 282 (579)
Q Consensus 208 ~~LG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 282 (579)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|+++|++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999999753 4689999996543 2335679999999999999999999999965 567899999999
Q ss_pred CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcce--
Q 008052 283 KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTHV-- 360 (579)
Q Consensus 283 g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~~-- 360 (579)
|+|.++++.. ..++|..+++|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999998654 3599999999999999999999998 99999999999999999999999999998765443322
Q ss_pred eecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhchh
Q 008052 361 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQK 439 (579)
Q Consensus 361 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~ 439 (579)
.....||+.|||||.+.++.++.++|||||||+||||+| |+.||...... .+... + ..+.
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~----i----~~~~-------- 227 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----L----EKGE-------- 227 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----H----HTTC--------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHH----H----HcCC--------
Confidence 234579999999999999999999999999999999998 89999765421 11111 1 1111
Q ss_pred hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 440 LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 440 l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
....+...+..+.+++.+||+.||.+||+|++|++.|+.
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 012233345678999999999999999999999998874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=425.22 Aligned_cols=259 Identities=25% Similarity=0.458 Sum_probs=209.6
Q ss_pred HhhcCccccceecccCceEEEEEEEeC------CeEEEEEEeccCC-chhHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTN------GKVVAIKQLKAGS-GQGEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 270 (579)
+..++|++.+.||+|+||+||+|++.. ...||||++.... ......|.+|+.+|.++ +|||||+++|+|.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345789999999999999999999753 2369999986543 23345789999999998 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCC
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDR---------------------PVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi 329 (579)
+..+||||||++|+|.++|+.... ..++|..++.|+.||++||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999975432 3589999999999999999999998 9999999
Q ss_pred CCCceEeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCC
Q 008052 330 KSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKA 407 (579)
Q Consensus 330 kp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~ 407 (579)
||+|||++.++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875544332 3345678999999999999999999999999999999998 89999765
Q ss_pred CccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhc
Q 008052 408 DTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEG 478 (579)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~ 478 (579)
... ..+... +.. + . ++ ..+...+..+.+++.+||+.||.+||+|+||++.|.-
T Consensus 271 ~~~--~~~~~~----~~~----~-~------~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVD--ANFYKL----IQN----G-F------KM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCS--HHHHHH----HHT----T-C------CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHH--HHHHHH----Hhc----C-C------CC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 431 111111 111 0 0 00 2233345678999999999999999999999999963
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=425.07 Aligned_cols=269 Identities=22% Similarity=0.338 Sum_probs=206.7
Q ss_pred HhhcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
+..++|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+|++++|||||+++++|.+.++.+||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34578999999999999999999975 68999999997643 33356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||++|+|.+++.... .+++..+..++.|++.||.|||+++ +|+||||||+||||+.++.+||+|||+|+...+.
T Consensus 83 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999996543 4899999999999999999999732 7999999999999999999999999999865322
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhh---------------hhhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV---------------DWAKP 421 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~---------------~~~~~ 421 (579)
..+..+||+.|||||++.+..|+.++|||||||+||||++|+.||...+........ .+...
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 234568999999999999999999999999999999999999999765431110000 00000
Q ss_pred Hh----hhcccCCCchhhhchhhh----cCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 422 FL----AQGLADGNFDALVDQKLE----EYD-SAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 422 ~~----~~~~~~~~~~~l~d~~l~----~~~-~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. ..........+..+.... ..+ ......+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000000000111111100 000 112356889999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-51 Score=417.56 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=215.3
Q ss_pred HHHHHHhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhcCCCCcceEEEE
Q 008052 194 YEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQVHHRHLVSLVGY 266 (579)
Q Consensus 194 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~ 266 (579)
+.+++...++|++.+.||+|+||+||+|++. +++.||||+++..... ..++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456677889999999999999999999975 3578999999765433 35679999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 008052 267 CTFGSQRLLVYEFVPNKTLEFHLHGKD----------------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKI 324 (579)
Q Consensus 267 ~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 324 (579)
|...+..++||||+++|+|.++|+... ...++|..++.|+.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999885321 23489999999999999999999998 99
Q ss_pred EeCCCCCCceEeCCCCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCC-C
Q 008052 325 IHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF-R 402 (579)
Q Consensus 325 vHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~-~ 402 (579)
|||||||+|||||.++.+||+|||+++....... ...+...||+.|+|||.+.+..++.++|||||||+||||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986543322 2334567899999999999999999999999999999999985 5
Q ss_pred CCCCCCccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 403 PFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 403 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
||...... .+.... ..+. ....+...+..+.+++.+||+.||.+||+|.||++.|+.+
T Consensus 242 p~~~~~~~---e~~~~v--------~~~~--------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHE---EVIYYV--------RDGN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHH---HHHHHH--------HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHH---HHHHHH--------HcCC--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 67654321 111111 1111 1122334456789999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=407.64 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=196.3
Q ss_pred ccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe----CCeEEEE
Q 008052 204 FSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF----GSQRLLV 276 (579)
Q Consensus 204 f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~lV 276 (579)
|...++||+|+||+||+|+.. +++.||||+++.. .....+.|.+|+++|++++|||||+++++|.. ....+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 355678999999999999976 5889999998654 33345678999999999999999999999875 3467899
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC-CCCCeEEeecccccccCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD-DSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~-~~~~~kL~DFGla~~~~~ 355 (579)
|||+++|+|.+++... ..+++..+..|+.||++||+|||++ .++||||||||+||||+ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999653 3589999999999999999999997 12399999999999996 578999999999986433
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
. .....+||+.|||||++.+ .++.++|||||||+||||++|+.||....... .+. +.+..+....
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~--------~~i~~~~~~~- 232 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY--------RRVTSGVKPA- 232 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH--------HHHTTTCCCG-
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHH--------HHHHcCCCCc-
Confidence 2 2345689999999999874 69999999999999999999999997543211 111 1111111100
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.++......+.+++.+||+.||++||++.|+++
T Consensus 233 ------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122345889999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=410.05 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=199.2
Q ss_pred HhhcCccccceecccCceEEEEEEEeC----CeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTN----GKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
+..++|++.+.||+|+||.||+|++.. +..||||.++.... ...+.|.+|+.+|++++|||||+++|+|. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999998743 45789999875443 33567999999999999999999999996 4678
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+++..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999998876443 4589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCc
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNF 432 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (579)
............||+.|+|||++.++.++.++|||||||+||||++ |..||...... .+.... ..+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i--------~~~~~ 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI--------ENGER 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH--------HTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHH--------HcCCC
Confidence 5544445556679999999999999999999999999999999998 89999765432 111110 11110
Q ss_pred hhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 433 DALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 433 ~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+...+..+.+++..||+.||.+||++.||++.|+..
T Consensus 228 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122334456789999999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-50 Score=418.11 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=209.3
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|.+.+.||+|+||.||+|+.. +|+.||||++........+.+++|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999975 6899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC--CCCCeEEeecccccccCCCC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~--~~~~~kL~DFGla~~~~~~~ 357 (579)
|++|+|.+++.... ..+++..+..|+.||+.||+|||++ +||||||||+||||+ .++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999886443 3499999999999999999999998 999999999999995 46789999999998764433
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......||+.|||||++.+..++.++|||||||+||||++|+.||...+.. . .......... .+. .
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~---~~~~i~~~~~---~~~---~ 246 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---E---TLRNVKSCDW---NMD---D 246 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHTCC---CSC---C
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---H---HHHHHHhCCC---CCC---c
Confidence 234567999999999999999999999999999999999999999755321 1 1111111000 000 0
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
.........+.+++.+||+.||.+|||+.|+++.
T Consensus 247 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 ----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223568899999999999999999999873
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=412.09 Aligned_cols=248 Identities=20% Similarity=0.328 Sum_probs=203.7
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 68999999986432 223467899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|||++|+|.+++... ..+++.....++.|++.||+|||++ +||||||||+||||++++.+||+|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999988654 3589999999999999999999998 99999999999999999999999999998764332
Q ss_pred -cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 358 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 358 -~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.......+||+.|||||++.+..++.++|||||||+||||++|+.||...+... +. . .+..+.+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~-----~i~~~~~---- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IF---Q-----KIIKLEY---- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---H-----HHHTTCC----
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HH---H-----HHHcCCC----
Confidence 223345679999999999999999999999999999999999999997654211 10 0 0111111
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.++......+.+++.+||+.||.+|||+.|+++
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 122233456889999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-50 Score=412.70 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=200.7
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.|+..+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+.+..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4899999999999999999965 689999999976543 233568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
||++|+|..++... ..+++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 99999998766433 4599999999999999999999998 999999999999999999999999999986432
Q ss_pred ceeecccccccccChhhhcc---CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 359 HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.....||+.|||||++.+ +.|+.++|||||||+||||++|+.||....... ....... +....
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~-----~~~~~- 233 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ-----NESPA- 233 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH-----SCCCC-
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHh-----CCCCC-
Confidence 234579999999999863 568999999999999999999999997543211 0000000 00000
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
+ .+......+.+++.+||+.||.+||++.|+++
T Consensus 234 ----~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 ----L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----C--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----C--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0 11123457889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-50 Score=412.50 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=191.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
.+.|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 689999999965432 234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC---CCCCeEEeecccccccCC
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~---~~~~~kL~DFGla~~~~~ 355 (579)
||++|+|.++|... ..+++.....|+.||+.||+|||++ +||||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999654 4599999999999999999999998 999999999999994 578999999999986543
Q ss_pred CCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhh
Q 008052 356 TDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDAL 435 (579)
Q Consensus 356 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 435 (579)
.. .....+||+.|||||++.+..++.++|||||||+||||++|+.||...... .+... .. .+... .
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~---i~-----~~~~~-~ 228 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQ---IL-----KAEYE-F 228 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---HH-----TTCCC-C
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHH---Hh-----ccCCC-C
Confidence 22 234567999999999999999999999999999999999999999765421 11111 01 11110 0
Q ss_pred hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 436 VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 436 ~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .........+.+++.+||+.||.+||++.|+++
T Consensus 229 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 DS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 111233456899999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.9e-50 Score=415.70 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=208.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEec
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEFV 280 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 280 (579)
++|++.+.||+|+||.||+|+.. +|+.||||+++.........+.+|+.+|++++|||||++++++.+.+..+||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 69999999998766666678899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC--CCCCeEEeecccccccCCCCc
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD--DSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~--~~~~~kL~DFGla~~~~~~~~ 358 (579)
++|+|.+++.... ..+++.+...|+.||+.||+|||++ +||||||||+||||+ .++.+||+|||+++......
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999988775433 3589999999999999999999998 999999999999997 67899999999998764432
Q ss_pred ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 359 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
......||+.|||||++.+..++.++|||||||+||||+||+.||....... +.. ... .+.+. .
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~---~i~-----~~~~~-~--- 247 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ---NVK-----RCDWE-F--- 247 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---HHH-----HCCCC-C---
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHH-----hCCCC-C---
Confidence 3345679999999999999999999999999999999999999997654311 111 000 00000 0
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...........+.+|+.+||+.||.+||++.|+++
T Consensus 248 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00112233456889999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=404.26 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=200.6
Q ss_pred hcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~E~ 279 (579)
.++|++.+.||+|+||.||+|.+ .|+.||||+++... ..+.|++|++++++++|||||+++|+|.+ .+..+|||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46788899999999999999998 47889999997643 34679999999999999999999999965 4567999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+++|+|.++|+......++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999765444589999999999999999999998 9999999999999999999999999999864332
Q ss_pred eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhch
Q 008052 360 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVDQ 438 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~ 438 (579)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.||..... ..+..+.. .+.
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~--------~~~------- 217 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE--------KGY------- 217 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHT--------TTC-------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHH--------cCC-------
Confidence 233468999999999999999999999999999999998 7888765432 22222211 110
Q ss_pred hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 439 KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 439 ~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...++.....++.+++.+||+.||.+||+|.||++.|+..
T Consensus 218 -~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1122333446788999999999999999999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=403.81 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=205.6
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC------chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS------GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.+.|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.|.+|+.+|++++|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999975 68999999986432 12357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC----CeEEeeccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF----EAKVADFGL 349 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~----~~kL~DFGl 349 (579)
+||||||++|+|.+++... ..+++..+..|+.|++.||+|||++ +||||||||+||||+.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999998654 3599999999999999999999998 999999999999998776 499999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 350 AKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 350 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .. ... ..
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~---~~i-----~~ 230 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---ANV-----SA 230 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-----HT
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HH---HHH-----Hh
Confidence 98754332 2344679999999999999999999999999999999999999997654211 10 000 01
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.... ... .........+.+++.+||+.||.+||++.|+++
T Consensus 231 ~~~~-~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNYE-FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCCC-CCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCC-CCc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100 000 011122456789999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=407.64 Aligned_cols=266 Identities=26% Similarity=0.401 Sum_probs=203.1
Q ss_pred CHHHHHHhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhc-CCCCcceEE
Q 008052 193 TYEELKIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQV-HHRHLVSLV 264 (579)
Q Consensus 193 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~ 264 (579)
+..++++..++|++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.++.++ +|+|||.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34455566788999999999999999999964 247899999976433 3456788888888887 689999999
Q ss_pred EEEEeC-CeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCC
Q 008052 265 GYCTFG-SQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDI 329 (579)
Q Consensus 265 g~~~~~-~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDi 329 (579)
+++... ...++|||||++|+|.++|+... ...++|..++.|+.||++||+|||++ +||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998764 46899999999999999986432 23589999999999999999999998 9999999
Q ss_pred CCCceEeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHhC-CCCCCCC
Q 008052 330 KSANILLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITG-FRPFDKA 407 (579)
Q Consensus 330 kp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG-~~Pf~~~ 407 (579)
||+||||++++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||+||||+|| ..||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999875443332 33456799999999999999999999999999999999996 4577654
Q ss_pred CccccchhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 408 DTFADDSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
... ..+ ...+.+ +.. ...+......+.+++.+||+.||.+||+|.||++.|+..
T Consensus 241 ~~~--~~~----~~~~~~----~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 241 KID--EEF----CRRLKE----GTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCS--HHH----HHHHHH----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH--HHH----HHHHhc----CCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 321 111 111111 100 012223445789999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=408.16 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=202.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCe----EEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGK----VVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 275 (579)
++|+..++||+|+||+||+|.+. +|+ .||||+++.. .....++|.+|+.+|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999975 343 6899998653 334567899999999999999999999999865 5678
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
++||+.+|+|.+++... ...++|..+++|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 89999999998887654 34589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 356 TDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 356 ~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
.... ......||+.|||||++.++.++.++|||||||+||||+| |..||....... +... +.. +
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~----i~~----~--- 229 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEK----G--- 229 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHH----HHH----T---
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHc----C---
Confidence 3332 2334568999999999999999999999999999999999 889987654311 1111 111 0
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.....+...+..+.+++.+||+.||.+||++.||++.|+..
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 00022334456789999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=401.00 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=202.4
Q ss_pred cceecccCceEEEEEEEeCC----eEEEEEEeccC-CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe-CCeEEEEEEec
Q 008052 207 ANLLGQGGFGYVHKGVLTNG----KVVAIKQLKAG-SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF-GSQRLLVYEFV 280 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g----~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~E~~ 280 (579)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|+|.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 36899999753 44445789999999999999999999999876 45889999999
Q ss_pred CCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc-
Q 008052 281 PNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH- 359 (579)
Q Consensus 281 ~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~- 359 (579)
++|+|.++++... ..+.+..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999887543 4578899999999999999999998 9999999999999999999999999999876543322
Q ss_pred --eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 360 --VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 360 --~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......||+.|+|||++..+.++.++||||||++||||+||..||..... ...+..+. . .+..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i---~-----~g~~----- 252 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYL---L-----QGRR----- 252 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---H-----TTCC-----
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHH---H-----cCCC-----
Confidence 22335689999999999999999999999999999999998888764321 11111111 1 1110
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
...+......+.+++.+||+.||++||+|.||++.|+...
T Consensus 253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0112233457889999999999999999999999998763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=401.38 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=198.3
Q ss_pred hcCccccceecccCceEEEEEEEeC--C--eEEEEEEeccC---CchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLTN--G--KVVAIKQLKAG---SGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~~--g--~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 273 (579)
.++|++.+.||+|+||.||+|++.. + ..||||+++.. .....++|.+|+.+|++++|||||+++|+|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999999653 2 37899998654 23345689999999999999999999999975 467
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHS 353 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~ 353 (579)
+|||||+++|+|.+++.... ..+++..+++++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred heeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 89999999999998876433 3499999999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCcc--eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 354 LDTDTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 354 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
...... ......|+..|+|||++.+..++.++|||||||+||||+| |+.||...+.. ....+.. . .+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i~---~----~~ 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKID---K----EG 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH---T----SC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHHH---h----CC
Confidence 554332 2234568889999999999999999999999999999998 89999765431 1222211 0 11
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.. + ..+...+..+.+++..||+.||.+||+|.||++.|+..
T Consensus 232 ~~-------~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ER-------L-PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CC-------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-------C-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00 0 11223345788999999999999999999999999853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=404.61 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=207.4
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
.++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..+||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999974 78999999996432 23356788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||++|+|.+++.... .+++.....++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+++.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999986543 488899999999999999999999 9999999999999999999999999999875433
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.. .+. .... .+.+
T Consensus 159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~---~~i~-----~~~~---- 222 (337)
T d1o6la_ 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---ELIL-----MEEI---- 222 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHH-----HCCC----
T ss_pred C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHH---HHHh-----cCCC----
Confidence 2 2334578999999999999999999999999999999999999999865431 111 1111 0110
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
.++......+.+++..||+.||.+|++ +.|+++
T Consensus 223 -----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 223334556889999999999999995 788875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=406.08 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=212.5
Q ss_pred HHhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCc-hhHHHHHHHHHHHHhcCCCCcceEEEEEEeC
Q 008052 198 KIATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSG-QGEREFQAEIEIISQVHHRHLVSLVGYCTFG 270 (579)
Q Consensus 198 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~ 270 (579)
++..++|.+.+.||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++|+|...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344578999999999999999999864 357899999975433 3345789999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGK--------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~--------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
+..++||||+++|+|.++++.. ....++|..+++|+.|+++||.|||++ +|+||||||+||||+.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 9999999999999999987532 223579999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCC-CCCCCCCccccchhhhhhh
Q 008052 343 KVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF-RPFDKADTFADDSMVDWAK 420 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~-~Pf~~~~~~~~~~~~~~~~ 420 (579)
||+|||+++........ ......||+.|+|||.+.++.++.++|||||||+||||+||. .||..... .++..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~ 246 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLR 246 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence 99999999876443332 233457999999999999999999999999999999999985 67754432 11111
Q ss_pred hHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 421 PFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 421 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
. +.+......+...+..+.+++.+||+.+|.+||+|.||++.|+..+
T Consensus 247 ~-------------i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 247 F-------------VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp H-------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H-------------HHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 1111111122334467999999999999999999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=402.65 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=212.3
Q ss_pred HhhcCccccceecccCceEEEEEEEe------CCeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEEEEeC
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLT------NGKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCTFG 270 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 270 (579)
+..++|++.+.||+|+||.||+|++. +++.||||+++..... ...+|.+|+.+++++ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34578999999999999999999863 4578999999765443 345789999999999 699999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCce
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKD----------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NI 334 (579)
+..+||||||++|+|.++|+... ...+++..+++|+.||++||+|||++ +||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999986432 23589999999999999999999999 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCcccc
Q 008052 335 LLDDSFEAKVADFGLAKHSLDTDT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 412 (579)
Q Consensus 335 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~ 412 (579)
|++.++.+||+|||+++....... ...+...||+.|+|||++.++.++.++|||||||+||||+| |.+||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999997655433 33345689999999999999999999999999999999999 55555443321
Q ss_pred chhhhhhhhHhhhcccCCCchhhhchhhh-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 413 DSMVDWAKPFLAQGLADGNFDALVDQKLE-EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~-~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..+... ++.... ..+...+..+.+|+.+||+.||++||+|.||+++|+..+
T Consensus 255 ~~~~~~-----------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 SKFYKM-----------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHH-----------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH-----------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 111111 111111 122234567899999999999999999999999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=403.05 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=201.1
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~lV~ 277 (579)
++|.+.+.||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|...+ ..+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4677889999999999999997 689999999965432 1222334555666789999999999998654 578999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC-----QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
|||++|+|.++|+.. .++|..+++++.|++.||+|||+.+ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999754 4899999999999999999999731 34899999999999999999999999999987
Q ss_pred cCCCCcc---eeecccccccccChhhhccC------CCCcccceechHHHHHHHHhCCCCCCCCCccccch----hhhhh
Q 008052 353 SLDTDTH---VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS----MVDWA 419 (579)
Q Consensus 353 ~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~----~~~~~ 419 (579)
....... ......||+.|||||++.+. .++.++|||||||+||||+||..||.......... ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6443322 23456799999999998754 36789999999999999999998886533211100 00111
Q ss_pred hhHhhhcccCCCchhhhchhhh--cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 420 KPFLAQGLADGNFDALVDQKLE--EYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 420 ~~~~~~~~~~~~~~~l~d~~l~--~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...+.+....+.+ ++.+. ....+....+.+++.+||+.||++||+|.||++.|+..
T Consensus 238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111111111111 11111 11334667799999999999999999999999999754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=403.49 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=204.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCe--EEEEEEeccC-CchhHHHHHHHHHHHHhc-CCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGK--VVAIKQLKAG-SGQGEREFQAEIEIISQV-HHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|++.++||+|+||.||+|++. +|. .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888999999999999999976 444 4788887543 333456799999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCe
Q 008052 277 YEFVPNKTLEFHLHGK--------------DRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEA 342 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~ 342 (579)
|||+++|+|.++|+.. ....++|..+++++.||+.||.|||++ +||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 235699999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCC-CCCCCCCccccchhhhhhhh
Q 008052 343 KVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGF-RPFDKADTFADDSMVDWAKP 421 (579)
Q Consensus 343 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~-~Pf~~~~~~~~~~~~~~~~~ 421 (579)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||+||||++|. .||...+. ..+..+.
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i-- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL-- 239 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHG--
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHH--
Confidence 999999998643221 123446899999999999999999999999999999999976 46754432 1111111
Q ss_pred HhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 422 FLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 422 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..+. ....+...+..+.+++.+||+.||++||+|.||++.|+...
T Consensus 240 ------~~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 240 ------PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp ------GGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HhcC--------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1110 01223334567999999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-48 Score=399.91 Aligned_cols=244 Identities=27% Similarity=0.387 Sum_probs=204.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 68999999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
|||+||+|..++.... .+.+.....++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999998886543 478888899999999999999998 9999999999999999999999999999876433
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
....+||+.|||||++.+..++.++|||||||+||||++|+.||...+... ...... .+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~-----~~~~----- 218 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKIL-----NAEL----- 218 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH-----HCCC-----
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHH-----cCCC-----
Confidence 234689999999999999999999999999999999999999997654211 111111 0100
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
.++......+.+++.+||+.||.+|+ ++.|+++
T Consensus 219 ----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 12223345688999999999999996 8999886
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=398.88 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=208.6
Q ss_pred HhhcCccccceecccCceEEEEEEEeC--------CeEEEEEEeccCCch-hHHHHHHHHHHHHhc-CCCCcceEEEEEE
Q 008052 199 IATDNFSEANLLGQGGFGYVHKGVLTN--------GKVVAIKQLKAGSGQ-GEREFQAEIEIISQV-HHRHLVSLVGYCT 268 (579)
Q Consensus 199 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~ 268 (579)
+..++|.+.+.||+|+||.||+|+... +..||||+++.+... ...++.+|+..+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345789999999999999999998642 247999999776543 346888999999998 7999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCce
Q 008052 269 FGSQRLLVYEFVPNKTLEFHLHGKD--------------RPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANI 334 (579)
Q Consensus 269 ~~~~~~lV~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NI 334 (579)
+++..++||||+++|+|.++|.... ...+++.++++++.||+.||+|||++ +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 9999999999999999999997543 24589999999999999999999999 999999999999
Q ss_pred EeCCCCCeEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCcccceechHHHHHHHHh-CCCCCCCCCcccc
Q 008052 335 LLDDSFEAKVADFGLAKHSLDTDTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELIT-GFRPFDKADTFAD 412 (579)
Q Consensus 335 Ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLlt-G~~Pf~~~~~~~~ 412 (579)
|++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||+||||++ |+.||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 9999999999999999876543322 3345679999999999999999999999999999999998 7888875442
Q ss_pred chhhhhhhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcCC
Q 008052 413 DSMVDWAKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGNM 480 (579)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~~ 480 (579)
..+..+. . .+.. ...+...+..+.+++.+||+.||.+||++.||++.|+..+
T Consensus 244 ~~~~~~i----~----~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 EELFKLL----K----EGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHH----H----TTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHH----H----cCCC--------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1111111 1 1100 0122234467899999999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-48 Score=392.41 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=200.7
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc---hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----e
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG---QGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----Q 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~ 272 (579)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.... .....|.+|+++|++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999974 799999999975432 33457899999999999999999999997644 3
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.||||||+++++|..++... ..+++.+.+.|+.||+.||+|||++ +||||||||+||||+.++..+|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 78999999999999888654 3589999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCc--ceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 353 SLDTDT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 353 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
...... ......+||+.|||||++.+..++.++|||||||+||||+||+.||...... +.....+. .+
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~----~~ 230 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVR----ED 230 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH----CC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHh----cC
Confidence 433222 2334567999999999999999999999999999999999999999765421 11111111 11
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhc
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-RMSQIVRALEG 478 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-tm~evl~~Le~ 478 (579)
... + .......+..+.+++.+||+.||.+|| +++++++.|..
T Consensus 231 ~~~----~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIP----P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCC----G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC----C--chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 100 0 011223346788999999999999999 89999988864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-48 Score=389.30 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=203.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch---------hHHHHHHHHHHHHhcC-CCCcceEEEEEEeC
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ---------GEREFQAEIEIISQVH-HRHLVSLVGYCTFG 270 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---------~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~ 270 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 7899999998654211 1235789999999997 99999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
+..|||||||++|+|.++|... ..+++.++..++.||++||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999654 3599999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhcc------CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhh
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLA 424 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 424 (579)
+...... ......||..|+|||++.+ ..++.++|||||||+||||++|+.||....... . .....
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~---~~~i~- 228 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---M---LRMIM- 228 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHH-
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---H---HHHHH-
Confidence 8764432 3345679999999999853 357889999999999999999999998654211 0 00111
Q ss_pred hcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 QGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 ~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+... ...+ ........+.+++.+||+.||.+||++.||++
T Consensus 229 ----~~~~~-~~~~----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 ----SGNYQ-FGSP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ----HTCCC-CCTT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----hCCCC-CCCc----ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11110 0111 11223457889999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=396.52 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=205.8
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.++|.+.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999975 689999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCC--CCeEEeecccccccCCCC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDS--FEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~--~~~kL~DFGla~~~~~~~ 357 (579)
|++|+|.+++.... ..+++.+...|+.||+.||+|||++ +|+||||||+||||+.+ +.+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999996543 3589999999999999999999998 99999999999999854 589999999998754332
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
......||+.|+|||.+.+..++.++|||||||+||||++|+.||....... ........ .-.+..
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~---~~~~~~--- 224 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNA---EYTFDE--- 224 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT---CCCCCH---
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC---CCCCCh---
Confidence 3344679999999999999999999999999999999999999997654311 11111100 000000
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
... ......+.+++..||+.||.+||++.|+++
T Consensus 225 ~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAF----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhc----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 112356789999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-47 Score=401.01 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=199.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHH---HHHHHHhcCCCCcceEEEEEEeCCeEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQA---EIEIISQVHHRHLVSLVGYCTFGSQRL 274 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~---Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 274 (579)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999975 68999999985422 122233444 466777778999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccC
Q 008052 275 LVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSL 354 (579)
Q Consensus 275 lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~ 354 (579)
||||||++|+|.++|... ..+.+..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++...
T Consensus 84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999654 3488999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCch
Q 008052 355 DTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFD 433 (579)
Q Consensus 355 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (579)
... ....+||+.|||||++.. ..++.++|||||||+||||+||+.||..........+... .....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--------~~~~~-- 225 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------TLTMA-- 225 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH--------SSSCC--
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------cccCC--
Confidence 432 344679999999999975 4689999999999999999999999986543211111100 00000
Q ss_pred hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 008052 434 ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPR-----MSQIVR 474 (579)
Q Consensus 434 ~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----m~evl~ 474 (579)
..++......+.+++.+||+.||.+||+ +.|+++
T Consensus 226 -------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0122233456899999999999999999 688874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-48 Score=400.70 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=204.6
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 277 (579)
++|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 69999999986432 223457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTD 357 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~ 357 (579)
||+.+|+|..++.... .+++.....|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999986543 489999999999999999999998 9999999999999999999999999999876432
Q ss_pred cceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhhc
Q 008052 358 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALVD 437 (579)
Q Consensus 358 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~d 437 (579)
.....||+.|||||++.+..++.++|||||||+||||+||+.||...+.. ....... .+..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~-----~~~~----- 255 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIV-----SGKV----- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-----HCCC-----
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHh-----cCCC-----
Confidence 23467999999999999999999999999999999999999999765421 1111111 0100
Q ss_pred hhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 438 QKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 438 ~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
.++......+.+++..||+.||.+|+ ++.|+++
T Consensus 256 ----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12223345788999999999999994 8999885
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=395.63 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=200.4
Q ss_pred hcCccccc-eecccCceEEEEEEE-eCCeEEEEEEeccCCchhHHHHHHHHHHHHhc-CCCCcceEEEEEEe----CCeE
Q 008052 201 TDNFSEAN-LLGQGGFGYVHKGVL-TNGKVVAIKQLKAGSGQGEREFQAEIEIISQV-HHRHLVSLVGYCTF----GSQR 273 (579)
Q Consensus 201 ~~~f~~~~-~LG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~----~~~~ 273 (579)
.++|.+.+ .||+|+||.||+|+. .+++.||||+++.. ..+.+|++++.++ +|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788764 699999999999997 46899999998642 4577899987765 79999999999865 3567
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC---CCCeEEeecccc
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD---SFEAKVADFGLA 350 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~---~~~~kL~DFGla 350 (579)
|||||||+||+|.++|.......+++.+...|+.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876556799999999999999999999998 9999999999999985 467999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
+...... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||........ ... +...+..+
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~----~~~~i~~~ 232 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPG----MKTRIRMG 232 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSC
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHH----HHHHHhcC
Confidence 8764433 23456799999999999999999999999999999999999999976543211 000 00011111
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.+. +.. .........+.+++.+||+.||.+||++.|+++
T Consensus 233 ~~~-~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYE-FPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSS-CCT----THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCC----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 110 000 011233467899999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=390.56 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=198.0
Q ss_pred ccceecccCceEEEEEEEe-CCeEEEEEEeccCCchh-----HHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 206 EANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQG-----EREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 206 ~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-----~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
.+++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|+.+|++++|||||++++++...+..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999965 68999999986543221 24688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+.++++..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999888776643 34588999999999999999999998 999999999999999999999999999987544332
Q ss_pred eeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh---hhcc-------c
Q 008052 360 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL---AQGL-------A 428 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~-------~ 428 (579)
.....+||+.|+|||++..+ .++.++|||||||+||||++|+.||......+ .+....+... ...+ .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccchhccch
Confidence 22345799999999998754 57999999999999999999999997654321 1110000000 0000 0
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHh
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALE 477 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le 477 (579)
...+.......+..........+.+++.+||+.||++|||+.|+++ .|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 284 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence 0000011111111111223456899999999999999999999987 454
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=396.49 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=202.5
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC---chhHHHHHHHHHHHH-hcCCCCcceEEEEEEeCCeEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS---GQGEREFQAEIEIIS-QVHHRHLVSLVGYCTFGSQRLLV 276 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~-~l~Hpniv~l~g~~~~~~~~~lV 276 (579)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|+.++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999975 68999999996432 223445667777765 68999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCC
Q 008052 277 YEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 277 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~ 356 (579)
||||++|+|.+++.... .+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999996543 488999999999999999999999 9999999999999999999999999999865433
Q ss_pred CcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCCCchhhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADGNFDALV 436 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 436 (579)
.. ..+...||+.|+|||++.++.++.++|||||||+||||++|+.||....... +.. ... .+..
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~-----~~~~---- 220 (320)
T d1xjda_ 157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH---SIR-----MDNP---- 220 (320)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHH-----HCCC----
T ss_pred cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHH-----cCCC----
Confidence 22 3345679999999999999999999999999999999999999997654311 110 000 0100
Q ss_pred chhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 008052 437 DQKLEEYDSAEMTRMAACAAACIRHSARRRPRMS-QIVR 474 (579)
Q Consensus 437 d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~-evl~ 474 (579)
.++......+.+++.+||+.||.+||++. ||++
T Consensus 221 -----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12223446689999999999999999985 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=387.05 Aligned_cols=268 Identities=21% Similarity=0.316 Sum_probs=201.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|+..+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|+++|++++|||||++++++.+.+..+||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 689999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
|+.++.+. ++.......+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~-~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSEEHHH-HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCCchhh-hhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 99765554 44334445699999999999999999999998 99999999999999999999999999998754332
Q ss_pred ceeecccccccccChhhhccCC-CCcccceechHHHHHHHHhCCCCCCCCCccccc----------hhhhhhhhHhhhcc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADD----------SMVDWAKPFLAQGL 427 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~ 427 (579)
.......||+.|+|||.+.... ++.++|||||||+||||++|+.||...+..... ....|........
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 235 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD- 235 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc-
Confidence 2234457999999999887655 588999999999999999999999765421100 0000100000000
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
....+..................+.+++.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000000011111223578899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-46 Score=379.41 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=201.9
Q ss_pred cCccccceecccCceEEEEEEEeCCeEEEEEEeccCCc--hhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG--QGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 279 (579)
++|...+.||+|+||+||+|+..+|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999966432 2246899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCcc
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDTH 359 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~~ 359 (579)
+.++.+..+.... ..+++..+..|+.||+.||+|||+. +||||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9888887776443 4599999999999999999999998 999999999999999999999999999987543322
Q ss_pred eeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccc----------hhhhhhhhHhhhccc
Q 008052 360 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADD----------SMVDWAKPFLAQGLA 428 (579)
Q Consensus 360 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~ 428 (579)
......|++.|+|||.+.+ ..++.++|||||||+||||++|+.||......+.. ....|....-....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~- 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY- 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc-
Confidence 2234468999999999875 45799999999999999999999999765421110 00111100000000
Q ss_pred CCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 429 DGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 429 ~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...+..........+.......+.+++.+||+.||++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000001122223457889999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=383.02 Aligned_cols=239 Identities=23% Similarity=0.347 Sum_probs=195.1
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCch------hHHHHHHHHHHHHhcC--CCCcceEEEEEEeCCe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQ------GEREFQAEIEIISQVH--HRHLVSLVGYCTFGSQ 272 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~~~ 272 (579)
++|++.+.||+|+||.||+|+.. +|+.||||+++..... ....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 6899999998643211 1234678999999997 8999999999999999
Q ss_pred EEEEEEecCC-CchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-CCCeEEeecccc
Q 008052 273 RLLVYEFVPN-KTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-SFEAKVADFGLA 350 (579)
Q Consensus 273 ~~lV~E~~~~-g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-~~~~kL~DFGla 350 (579)
.++||||+.+ +++.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+. ++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 5777776543 3589999999999999999999998 9999999999999985 479999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCC-CcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccC
Q 008052 351 KHSLDTDTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLAD 429 (579)
Q Consensus 351 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (579)
+..... ..+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||...+. + ...
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------~~~---- 219 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IRG---- 219 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HHC----
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------hhc----
Confidence 865332 2345679999999999987665 6779999999999999999999965321 0 000
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.. .++......+.+++.+||+.||.+|||+.|+++
T Consensus 220 -~~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 -QV---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cc---------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 011122356889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=379.16 Aligned_cols=265 Identities=23% Similarity=0.367 Sum_probs=198.7
Q ss_pred hcCccccceecccCceEEEEEEEe--CCeEEEEEEeccCCch--hHHHHHHHHHHHHhc---CCCCcceEEEEEEe----
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT--NGKVVAIKQLKAGSGQ--GEREFQAEIEIISQV---HHRHLVSLVGYCTF---- 269 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~---- 269 (579)
.++|++.+.||+|+||+||+|+.. +++.||||+++..... ....+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 3678999998643221 223466777777666 79999999999853
Q ss_pred -CCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecc
Q 008052 270 -GSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFG 348 (579)
Q Consensus 270 -~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFG 348 (579)
....+++|||+.++.+...... ....+++.....++.|++.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 3467899999999887655443 345689999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hh---------hh
Q 008052 349 LAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MV---------DW 418 (579)
Q Consensus 349 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~---------~~ 418 (579)
+++..... .......||+.|||||++.+..|+.++|||||||+||||++|+.||...+...... +. .|
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 98864322 23345679999999999999999999999999999999999999998654321100 00 11
Q ss_pred hhhHhhhcccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 419 AKPFLAQGLADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 419 ~~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
...... ....+.......+..+.......+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVAL---PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSS---CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccc---hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00000000111111222333456888999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-44 Score=364.75 Aligned_cols=258 Identities=20% Similarity=0.249 Sum_probs=196.9
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcce-EEEEEEeCCeEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVS-LVGYCTFGSQRLLVYEF 279 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~-l~g~~~~~~~~~lV~E~ 279 (579)
++|++.+.||+|+||.||+|++. +|+.||||++..... ..++..|++++++++|+|+|. +.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999974 689999999876433 245788999999998776555 45555778888999999
Q ss_pred cCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeC---CCCCeEEeecccccccCCC
Q 008052 280 VPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLD---DSFEAKVADFGLAKHSLDT 356 (579)
Q Consensus 280 ~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~---~~~~~kL~DFGla~~~~~~ 356 (579)
+. ++|...+... ...+++..++.++.|++.||+|||++ +||||||||+|||++ .+..+||+|||+++...+.
T Consensus 85 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 95 5555554432 23589999999999999999999998 999999999999985 4567999999999976543
Q ss_pred Ccc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhh-hhhhhHhhhcccC
Q 008052 357 DTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWAKPFLAQGLAD 429 (579)
Q Consensus 357 ~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 429 (579)
... ......||+.|||||.+.+..++.++|||||||++|||++|+.||............ .+....+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------ 233 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM------ 233 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC------
Confidence 322 234467999999999999999999999999999999999999999765432211111 1111000
Q ss_pred CCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 430 GNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 430 ~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
...........+..+.+++..|++.+|.+||++.++.+.|+..
T Consensus 234 -------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 234 -------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0001111223346789999999999999999999998888753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=370.46 Aligned_cols=269 Identities=19% Similarity=0.249 Sum_probs=195.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccC--CchhHHHHHHHHHHHHhcCCCCcceEEEEEEe--------C
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG--SGQGEREFQAEIEIISQVHHRHLVSLVGYCTF--------G 270 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--------~ 270 (579)
++|++.+.||+|+||+||+|+.. +|+.||||++... .......+.+|+.+|++++|+||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 78999999999999999999974 7999999998543 22334678899999999999999999999855 3
Q ss_pred CeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccc
Q 008052 271 SQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLA 350 (579)
Q Consensus 271 ~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla 350 (579)
+..++||||+.++.+...... ...+.......|+.|++.||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 457899999998887765543 34588899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCc---ceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhh-hhhhhHhhh
Q 008052 351 KHSLDTDT---HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWAKPFLAQ 425 (579)
Q Consensus 351 ~~~~~~~~---~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~-~~~~~~~~~ 425 (579)
+....... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||............ ........+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 76543221 122335799999999998755 6899999999999999999999999765431111110 000000000
Q ss_pred c---ccCCCchhhhc-hhhhcCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 426 G---LADGNFDALVD-QKLEEYDS-------AEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 426 ~---~~~~~~~~l~d-~~l~~~~~-------~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
. ........... ........ .....+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 00000000000 00000000 112456789999999999999999999963
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=376.55 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=194.9
Q ss_pred CccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCcceEEEEEEeC------CeEEE
Q 008052 203 NFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHLVSLVGYCTFG------SQRLL 275 (579)
Q Consensus 203 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~~~~l 275 (579)
+|+..++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|+|||+++++|... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 689999999976542 234799999999999999999998643 24689
Q ss_pred EEEecCCCchhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeeccccccc
Q 008052 276 VYEFVPNKTLEFHLHG-KDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHS 353 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~-~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGla~~~ 353 (579)
|||||+++.+..+.+. .....+++..+..|+.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765544331 2334699999999999999999999998 999999999999999775 8999999999876
Q ss_pred CCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhh-------hHhh-
Q 008052 354 LDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAK-------PFLA- 424 (579)
Q Consensus 354 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~-------~~~~- 424 (579)
..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ .+....+ ..+.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhh
Confidence 44332 234579999999998765 578999999999999999999999997654321 1111100 0000
Q ss_pred --hcccCCCchhhhchhh-hcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 --QGLADGNFDALVDQKL-EEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 --~~~~~~~~~~l~d~~l-~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.......+..+..... ..........+.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111111111001 1112233456889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6e-44 Score=361.91 Aligned_cols=260 Identities=17% Similarity=0.199 Sum_probs=206.1
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCeEEEEEE
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~E 278 (579)
.++|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+++|++++..++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 689999999865432 2457889999999975 899999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCC-----CCCeEEeeccccccc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDD-----SFEAKVADFGLAKHS 353 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~-----~~~~kL~DFGla~~~ 353 (579)
|+ +++|.+++.... ..+++.++..|+.|++.||+|||++ +||||||||+||||+. ++.+||+|||+++..
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 789988886543 3589999999999999999999998 9999999999999974 568999999999876
Q ss_pred CCCCcc------eeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcc
Q 008052 354 LDTDTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGL 427 (579)
Q Consensus 354 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 427 (579)
.+.... ......||+.|||||.+.+..++.++|||||||++|||++|+.||...................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 232 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc----
Confidence 443221 2234679999999999999999999999999999999999999998654322211111110000
Q ss_pred cCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhcC
Q 008052 428 ADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRALEGN 479 (579)
Q Consensus 428 ~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~Le~~ 479 (579)
.... ........+.++.+++..|++.+|.+||+++.+.+.|+..
T Consensus 233 ~~~~--------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 233 QSTP--------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHSC--------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCCC--------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0000 1111122345688999999999999999999998888754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=372.61 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=202.9
Q ss_pred cCccccceecccCceEEEEEEEe----CCeEEEEEEeccCC----chhHHHHHHHHHHHHhcCC-CCcceEEEEEEeCCe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT----NGKVVAIKQLKAGS----GQGEREFQAEIEIISQVHH-RHLVSLVGYCTFGSQ 272 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~ 272 (579)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 47899999986532 1234568899999999966 899999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.++||||+.+|+|.+++.... .+.......++.|++.||+|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999986543 367788889999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccChhhhccC--CCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHhhhcccCC
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFLAQGLADG 430 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (579)
.............|++.|++||.+... .++.++|||||||+||||++|+.||........ .........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~~~~~------- 249 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRIL------- 249 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHH-------
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcc-------
Confidence 655444444567899999999999754 478899999999999999999999976643221 111000000
Q ss_pred CchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 008052 431 NFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRP-----RMSQIVR 474 (579)
Q Consensus 431 ~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RP-----tm~evl~ 474 (579)
... ..++......+.+++.+||+.||.+|| +++|+++
T Consensus 250 ------~~~-~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ------KSE-PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------HCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------cCC-CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 000 022334567889999999999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=360.82 Aligned_cols=265 Identities=18% Similarity=0.256 Sum_probs=203.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCCeEEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGSQRLLVYE 278 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 278 (579)
++|++.+.||+|+||+||+|+.. +++.||||+++... ......+++|+.+|++++|+|||+++++|......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999974 78999999986543 2345788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCCCCc
Q 008052 279 FVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLDTDT 358 (579)
Q Consensus 279 ~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~~~~ 358 (579)
++.+++|..++... ..+.+..+..++.|++.||+|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999998887644 4588999999999999999999998 999999999999999999999999999987544332
Q ss_pred ceeecccccccccChhhhccCC-CCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh-----------hhc
Q 008052 359 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL-----------AQG 426 (579)
Q Consensus 359 ~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~-----------~~~ 426 (579)
......++..|+|||.+.... ++.++|||||||++|||++|+.||.......+ ...-..... ...
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhc
Confidence 223345788999999987665 68999999999999999999999754332111 000000000 000
Q ss_pred ccCCCchhh-hchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 427 LADGNFDAL-VDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 427 ~~~~~~~~l-~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
......... ...............+.+|+.+||+.||.+|||++||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 000111222333456889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=373.31 Aligned_cols=268 Identities=19% Similarity=0.238 Sum_probs=196.0
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC-chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC----eEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS-GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS----QRLL 275 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~l 275 (579)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+++|+++|++++|||||+++++|.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 57999999999999999999964 79999999997543 333567899999999999999999999997643 3355
Q ss_pred EEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccccCC
Q 008052 276 VYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKHSLD 355 (579)
Q Consensus 276 V~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~~~~ 355 (579)
+++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +||||||||+||||++++.+||+|||+++....
T Consensus 88 l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 56677799999998643 489999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcc--eeecccccccccChhhhc-cCCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhHh--hhcccCC
Q 008052 356 TDTH--VSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPFL--AQGLADG 430 (579)
Q Consensus 356 ~~~~--~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~ 430 (579)
.... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||................... .......
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 2221 234467999999999985 4567899999999999999999999997654321111000000000 0000000
Q ss_pred C--chhhhc--hh-----hhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 008052 431 N--FDALVD--QK-----LEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA 475 (579)
Q Consensus 431 ~--~~~l~d--~~-----l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~ 475 (579)
. ...... +. ...........+.+++..||+.||.+||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000 00 000011122468899999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=372.72 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=196.0
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeCC------
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFGS------ 271 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 271 (579)
.++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 69999999997532 233457889999999999999999999997654
Q ss_pred eEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 272 QRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 272 ~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
..+|||||+ +.+|..+++. ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 569999999 5677776643 3499999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCcccceechHHHHHHHHhCCCCCCCCCccccchhhhhhhhH------hh
Q 008052 352 HSLDTDTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMVDWAKPF------LA 424 (579)
Q Consensus 352 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~~~~~~~------~~ 424 (579)
..... .+...||+.|+|||.+.+ ..++.++|||||||+||||++|+.||...+.... +....... ..
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHHH
Confidence 75432 244679999999999875 4578999999999999999999999987643211 10000000 00
Q ss_pred hcccCCC-------chhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HhcC
Q 008052 425 QGLADGN-------FDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVRA--LEGN 479 (579)
Q Consensus 425 ~~~~~~~-------~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~~--Le~~ 479 (579)
....... +.......+..........+.+|+.+||+.||.+|||+.|+++. |+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000 00000001111122234567899999999999999999999974 6543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-43 Score=361.36 Aligned_cols=257 Identities=19% Similarity=0.280 Sum_probs=196.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEe--CCeEEEEE
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTF--GSQRLLVY 277 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~--~~~~~lV~ 277 (579)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .+.+.+|+++|.+++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 67999999999999999999974 68999999997543 467889999999996 9999999999975 35689999
Q ss_pred EecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC-CeEEeecccccccCCC
Q 008052 278 EFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF-EAKVADFGLAKHSLDT 356 (579)
Q Consensus 278 E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~-~~kL~DFGla~~~~~~ 356 (579)
|||.+++|..+. ..+++..+..++.||+.||+|||++ +||||||||+||||+.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999997764 2489999999999999999999999 999999999999998654 6999999999875433
Q ss_pred CcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccc--hh---------hhhhhhHhh
Q 008052 357 DTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADD--SM---------VDWAKPFLA 424 (579)
Q Consensus 357 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~--~~---------~~~~~~~~~ 424 (579)
. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... .+ ..|....-.
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 23446799999999998765 4799999999999999999999999765431110 00 011000000
Q ss_pred h-------c---ccCCCchhhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 425 Q-------G---LADGNFDALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 425 ~-------~---~~~~~~~~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
. . ............ .........+.+|+.+||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHS---ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCT---TTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccc---cccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 000000011100 111122356889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=360.01 Aligned_cols=263 Identities=20% Similarity=0.260 Sum_probs=191.8
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEe------CCe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTF------GSQ 272 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~------~~~ 272 (579)
++|++.++||+|+||+||+|++. +|+.||||+++... ......+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999976 69999999997543 3334578899999999999999999999964 368
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.|+|||||.++.+... + ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~-~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH-T----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhh-h----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 8999999977666544 2 2489999999999999999999999 999999999999999999999999999886
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch-hh---------------
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS-MV--------------- 416 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~-~~--------------- 416 (579)
.... ...+...||+.|+|||++.+..++.++||||+||++|||++|+.||...+...... +.
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 5332 23355679999999999999999999999999999999999999997654211100 00
Q ss_pred hhhhhHhhhccc--CCCchhhhchhhh----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 008052 417 DWAKPFLAQGLA--DGNFDALVDQKLE----EYDSAEMTRMAACAAACIRHSARRRPRMSQIVR 474 (579)
Q Consensus 417 ~~~~~~~~~~~~--~~~~~~l~d~~l~----~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~ 474 (579)
.....+...... ......+...... .........+.+|+.+||+.||++|||++||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000001111000 0011111111111 122345677899999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-43 Score=361.42 Aligned_cols=268 Identities=20% Similarity=0.291 Sum_probs=197.2
Q ss_pred hcCccccceecccCceEEEEEEEe-CCeEEEEEEeccCC--chhHHHHHHHHHHHHhcCCCCcceEEEEEEeC-----Ce
Q 008052 201 TDNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGS--GQGEREFQAEIEIISQVHHRHLVSLVGYCTFG-----SQ 272 (579)
Q Consensus 201 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~ 272 (579)
.++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|+|||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 478999999999999999999964 79999999997543 23345788999999999999999999998643 34
Q ss_pred EEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 273 RLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 273 ~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+++++|+.+|+|.++++.+ .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 56778888999999998543 499999999999999999999998 999999999999999999999999999975
Q ss_pred cCCCCcceeecccccccccChhhhccC-CCCcccceechHHHHHHHHhCCCCCCCCCccccchhh-hhh---hhHhhhcc
Q 008052 353 SLDTDTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVLLLELITGFRPFDKADTFADDSMV-DWA---KPFLAQGL 427 (579)
Q Consensus 353 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~~~-~~~---~~~~~~~~ 427 (579)
... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||...+.......+ ... ...+....
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 422 23446799999999987665 5689999999999999999999999765432111100 000 00000000
Q ss_pred cCCCch-------hhhchhhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHhc
Q 008052 428 ADGNFD-------ALVDQKLEEYDSAEMTRMAACAAACIRHSARRRPRMSQIVR--ALEG 478 (579)
Q Consensus 428 ~~~~~~-------~l~d~~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~evl~--~Le~ 478 (579)
...... ......+..........+.+|+.+||+.||.+|||+.|+++ .|..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 000000 00000000011123356789999999999999999999997 4543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-38 Score=327.49 Aligned_cols=274 Identities=21% Similarity=0.267 Sum_probs=196.3
Q ss_pred cCccccceecccCceEEEEEEEe-CCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-----------CCCcceEEEEEEe
Q 008052 202 DNFSEANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-----------HRHLVSLVGYCTF 269 (579)
Q Consensus 202 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----------Hpniv~l~g~~~~ 269 (579)
++|++.++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+.+|++++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 799999999976532 3457788999988875 5789999988865
Q ss_pred --CCeEEEEEEecCCCchh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCC------
Q 008052 270 --GSQRLLVYEFVPNKTLE-FHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSF------ 340 (579)
Q Consensus 270 --~~~~~lV~E~~~~g~L~-~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~------ 340 (579)
....+++++++..+... ..........+.+..+..++.||++||+|||+.. +|+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 34666777776655433 3333344556888999999999999999999832 899999999999997654
Q ss_pred CeEEeecccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHHHHHhCCCCCCCCCccccch----hh
Q 008052 341 EAKVADFGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLLELITGFRPFDKADTFADDS----MV 416 (579)
Q Consensus 341 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~eLltG~~Pf~~~~~~~~~~----~~ 416 (579)
.+||+|||.++..... ....+||+.|+|||++....++.++|||||||+|+||++|+.||...+...... +.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 3999999999864322 244679999999999999999999999999999999999999997654321111 11
Q ss_pred hhhhhH-----------------hh-----hcccCCCchhhhch--hhhcCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 008052 417 DWAKPF-----------------LA-----QGLADGNFDALVDQ--KLEEYDSAEMTRMAACAAACIRHSARRRPRMSQI 472 (579)
Q Consensus 417 ~~~~~~-----------------~~-----~~~~~~~~~~l~d~--~l~~~~~~~~~~l~~l~~~cl~~dp~~RPtm~ev 472 (579)
.+...+ .. ..+.........+. ............+.+|+.+||+.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 110000 00 00000000000000 0114556778899999999999999999999999
Q ss_pred HHH--HhcCCCC
Q 008052 473 VRA--LEGNMPL 482 (579)
Q Consensus 473 l~~--Le~~~~~ 482 (579)
++. |++....
T Consensus 326 L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 326 VNHPWLKDTLGM 337 (362)
T ss_dssp HTCGGGTTCTTC
T ss_pred hcCcccCCCCCc
Confidence 973 6644433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.1e-24 Score=203.40 Aligned_cols=170 Identities=15% Similarity=0.116 Sum_probs=122.0
Q ss_pred cccceecccCceEEEEEEEeCCeEEEEEEeccCCc------------------hhHHHHHHHHHHHHhcCCCCcceEEEE
Q 008052 205 SEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSG------------------QGEREFQAEIEIISQVHHRHLVSLVGY 266 (579)
Q Consensus 205 ~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~Ei~~l~~l~Hpniv~l~g~ 266 (579)
.+.+.||+|+||+||+|+..+|+.||||+++.... .....+..|+..|.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999998999999998753211 011234568899999999999998765
Q ss_pred EEeCCeEEEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeCCCCCCceEeCCCCCeEEee
Q 008052 267 CTFGSQRLLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDCQPKIIHRDIKSANILLDDSFEAKVAD 346 (579)
Q Consensus 267 ~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDikp~NILl~~~~~~kL~D 346 (579)
.. .+|+|||+++..+.. +.+.....++.|++++|+|||++ +|+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 32 379999998876643 23344567899999999999998 99999999999999976 589999
Q ss_pred cccccccCCCCcceeecccccccccChhhhccCCCCcccceechHHHHH
Q 008052 347 FGLAKHSLDTDTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVLLL 395 (579)
Q Consensus 347 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ 395 (579)
||+++........... ......+ .+.+ ...|..++|+||..--++
T Consensus 146 FG~a~~~~~~~~~~~l--~rd~~~~-~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREIL--ERDVRNI-ITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHH--HHHHHHH-HHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcHHHH--HHHHHHH-HHHH-cCCCCCcccHHHHHHHHh
Confidence 9999765432211000 0000000 1222 356788999999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.71 E-value=4.4e-08 Score=94.28 Aligned_cols=150 Identities=13% Similarity=0.063 Sum_probs=102.3
Q ss_pred HHHHHhhcCccccceecccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcC-CCCcceEEEEEEeCCeE
Q 008052 195 EELKIATDNFSEANLLGQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVH-HRHLVSLVGYCTFGSQR 273 (579)
Q Consensus 195 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~ 273 (579)
.|++...+.|+..+..+.+....||+... +++.++||+...........+.+|+.++..+. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 36777777888766655555679999865 45567788876543333445778888888775 43467888888888999
Q ss_pred EEEEEecCCCchhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------
Q 008052 274 LLVYEFVPNKTLEFHLHGKDRPVMNWPTRMKIALGSARGLAYLHEDC--------------------------------- 320 (579)
Q Consensus 274 ~lV~E~~~~g~L~~~l~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--------------------------------- 320 (579)
++||++++|.++....... . ....++.++++.|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886543211 1 12223444445555555311
Q ss_pred -----------------------CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 321 -----------------------QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 321 -----------------------~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+.++|+|+.+.|||++++..+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=1.2e-05 Score=76.27 Aligned_cols=141 Identities=20% Similarity=0.126 Sum_probs=86.4
Q ss_pred eecccC-ceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCC--CCcceEEEEEEeCCeEEEEEEecCCCch
Q 008052 209 LLGQGG-FGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHH--RHLVSLVGYCTFGSQRLLVYEFVPNKTL 285 (579)
Q Consensus 209 ~LG~G~-fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~lV~E~~~~g~L 285 (579)
.+..|. -..||+....++..+++|....... ..+..|+..|+.+.. -.+.++++++.+.+..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 445554 3689999887888888998765432 346778888877743 3456788888888889999999998776
Q ss_pred hhh-----------------hcCCC--CCCC--CHHHHHHHHH--------------------HHHHHHHHhhhc----C
Q 008052 286 EFH-----------------LHGKD--RPVM--NWPTRMKIAL--------------------GSARGLAYLHED----C 320 (579)
Q Consensus 286 ~~~-----------------l~~~~--~~~l--~~~~~~~ia~--------------------~ia~gL~yLH~~----~ 320 (579)
... ||... ...+ .+.....-.. .....+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 431 11110 0000 0110000000 011122222222 1
Q ss_pred CCceEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 321 QPKIIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 321 ~~~ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
.+.++|+|+.+.|||++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 23479999999999999876677999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=6.4e-05 Score=76.35 Aligned_cols=77 Identities=16% Similarity=0.104 Sum_probs=48.7
Q ss_pred cceecccCceEEEEEEEe-CCeEEEEEEeccC------C-chhHHHHHHHHHHHHhcC-C--CCcceEEEEEEeCCeEEE
Q 008052 207 ANLLGQGGFGYVHKGVLT-NGKVVAIKQLKAG------S-GQGEREFQAEIEIISQVH-H--RHLVSLVGYCTFGSQRLL 275 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~-~g~~vAvK~l~~~------~-~~~~~~~~~Ei~~l~~l~-H--pniv~l~g~~~~~~~~~l 275 (579)
.+.||.|....||+.... +++.|+||.-... . .........|++.|..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457999999999999865 4678899974321 0 111223456787777663 2 345566654 4456679
Q ss_pred EEEecCCCch
Q 008052 276 VYEFVPNKTL 285 (579)
Q Consensus 276 V~E~~~~g~L 285 (579)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.36 E-value=0.00013 Score=71.86 Aligned_cols=135 Identities=16% Similarity=0.179 Sum_probs=80.1
Q ss_pred ceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc--ceEE-----EEEEeCCeEEEEEEecCCCchhh
Q 008052 215 FGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL--VSLV-----GYCTFGSQRLLVYEFVPNKTLEF 287 (579)
Q Consensus 215 fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni--v~l~-----g~~~~~~~~~lV~E~~~~g~L~~ 287 (579)
--.||+....+|+.|++|+...+. ...+++..|...|..|....+ +..+ ..+..++..+.+++|++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 468999999999999999987653 235678889988888753222 1111 12244667889999998744321
Q ss_pred --------------hhc----CC---CCCCCCHHH-------------------HHHHHHHHHHHHHHhh----hcCCCc
Q 008052 288 --------------HLH----GK---DRPVMNWPT-------------------RMKIALGSARGLAYLH----EDCQPK 323 (579)
Q Consensus 288 --------------~l~----~~---~~~~l~~~~-------------------~~~ia~~ia~gL~yLH----~~~~~~ 323 (579)
.+| .. .+..+++.. +..+...+...++.+. .....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 011 11 111222211 1111112222233332 223457
Q ss_pred eEeCCCCCCceEeCCCCCeEEeecccccc
Q 008052 324 IIHRDIKSANILLDDSFEAKVADFGLAKH 352 (579)
Q Consensus 324 ivHrDikp~NILl~~~~~~kL~DFGla~~ 352 (579)
+||+|+.+.|||++++ ..++||+-|..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.11 E-value=0.00092 Score=67.43 Aligned_cols=73 Identities=21% Similarity=0.234 Sum_probs=51.1
Q ss_pred cceecccCceEEEEEEEeCC--------eEEEEEEeccCCchhHHHHHHHHHHHHhcCCCCc-ceEEEEEEeCCeEEEEE
Q 008052 207 ANLLGQGGFGYVHKGVLTNG--------KVVAIKQLKAGSGQGEREFQAEIEIISQVHHRHL-VSLVGYCTFGSQRLLVY 277 (579)
Q Consensus 207 ~~~LG~G~fg~Vy~~~~~~g--------~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~ 277 (579)
.+.|+.|-.-.+|+....++ +.|.+++.-. . .......+|..+++.+.-.++ .+++++|.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 46788899999999987543 4566666542 2 234456789999988863344 478877743 5799
Q ss_pred EecCCCch
Q 008052 278 EFVPNKTL 285 (579)
Q Consensus 278 E~~~~g~L 285 (579)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.68 E-value=0.0054 Score=59.21 Aligned_cols=157 Identities=13% Similarity=0.077 Sum_probs=84.9
Q ss_pred cCHHHHHHhhcCcccccee-----cccCceEEEEEEEeCCeEEEEEEeccCCchhHHHHHHHHHHHHhcCCCC-----cc
Q 008052 192 FTYEELKIATDNFSEANLL-----GQGGFGYVHKGVLTNGKVVAIKQLKAGSGQGEREFQAEIEIISQVHHRH-----LV 261 (579)
Q Consensus 192 ~~~~el~~~~~~f~~~~~L-----G~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~Hpn-----iv 261 (579)
.+.+|++....+|.+.+.. ..|---+.|+.+..+|+ +++|+..... ...++..|+++|..|...+ .+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4667888888888775444 35556788998887665 8889875532 2234556677777764222 22
Q ss_pred eEE---EEEEeCCeEEEEEEecCCCchhhh--------------hc----CCC----CCCCCH-----------------
Q 008052 262 SLV---GYCTFGSQRLLVYEFVPNKTLEFH--------------LH----GKD----RPVMNW----------------- 299 (579)
Q Consensus 262 ~l~---g~~~~~~~~~lV~E~~~~g~L~~~--------------l~----~~~----~~~l~~----------------- 299 (579)
... .+.........++.++.+...... ++ ... .....+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 012234556677777766433110 00 000 000000
Q ss_pred HHHHHHHHHHHHHHHHhhh-cCCCceEeCCCCCCceEeCCCCCeEEeeccccc
Q 008052 300 PTRMKIALGSARGLAYLHE-DCQPKIIHRDIKSANILLDDSFEAKVADFGLAK 351 (579)
Q Consensus 300 ~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDikp~NILl~~~~~~kL~DFGla~ 351 (579)
......+..+...+.-.+. ....++||+|+.+.|||++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011112222222222221 234479999999999999988777899999875
|